William    O
Josephus    O
Robinson    O
(    O
December    O
8    O
,    O
1867    O
–    O
January    O
6    O
,    O
1936    O
)    O
was    O
an    O
American    O
physician    O
,    O
sexologist    B-Medicine106043075
and    O
birth    O
control    O
advocate    O
.    O

Only    O
then    O
was    O
it    O
found    O
out    O
that    O
Bornemann    O
was    O
the    O
Borneman    O
,    O
the    O
famous    O
sexologist    B-Medicine106043075
who    O
was    O
alive    O
and    O
well    O
,    O
living    O
in    O
the    O
small    O
Austrian    O
village    O
of    O
Scharten    O
,    O
and    O
teaching    O
at    O
several    O
universities    O
both    O
in    O
Austria    O
and    O
his    O
native    O
Germany    O
.    O

Gavin    O
Arthur    O
(    O
1901–1972    O
)    O
–    O
astrologer    O
,    O
sexologist    B-Medicine106043075
,    O
grandson    O
of    O
President    O
Chester    O
A.    O
Arthur    O

James    O
Donald    O
"    O
Jim    O
"    O
Weinrich    O
(    O
born    O
1950    O
)    O
is    O
an    O
American    O
sex    B-Medicine106043075
researcher    I-Medicine106043075
and    O
psychobiologist    O
.    O

Esben    O
Esther    O
Pirelli    O
Benestad    O
(    O
born    O
3    O
May    O
1949    O
)    O
is    O
a    O
Norwegian    O
physician    O
and    O
sexologist    B-Medicine106043075
who    O
is    O
also    O
known    O
as    O
one    O
of    O
Norway    O
's    O
most    O
prominent    O
trans    O
people    O
.    O

In    O
response    O
to    O
this    O
threat    O
AIM    O
was    O
founded    O
in    O
1998    O
by    O
former    O
adult    O
entertainer    O
Sharon    O
Mitchell    O
,    O
who    O
had    O
left    O
the    O
industry    O
in    O
1996    O
to    O
pursue    O
credentials    O
in    O
public    O
health    O
counseling    O
and    O
sexology    B-Medicine106043075
.    O

The    O
Magnus    O
Hirschfeld    O
Medal    O
is    O
awarded    O
by    O
the    O
German    O
Society    O
for    O
Social    O
-    O
Scientific    O
Sexuality    O
Research    O
(    O
DGSS    O
)    O
for    O
outstanding    O
service    O
to    O
sexual    B-Medicine106043075
science    I-Medicine106043075
,    O
granted    O
in    O
the    O
categories    O
"    O
Sexual    O
Research    O
"    O
and    O
"    O
Sexual    O
Reform    O
"    O
.    O

It    O
is    O
named    O
in    O
honour    O
of    O
German    O
sexology    B-Medicine106043075
pioneer    O
Magnus    O
Hirschfeld    O
(    O
without    O
the    O
DGSS    O
sharing    O
his    O
dated    O
'    O
biologistic    O
'    O
sexual    O
theory    O
)    O
.    O

It    O
had    O
a    O
rich    O
body    O
of    O
work    O
in    O
jurisprudence    O
,    O
sufism    O
,    O
law    O
,    O
medicine    O
,    O
and    O
sexology    B-Medicine106043075
,    O
of    O
which    O
little    O
has    O
been    O
preserved    O
.    O

A    O
notable    O
scholar    O
on    O
Joseph    O
Conrad    O
and    O
sexuality    B-Medicine106043075
,    O
he    O
has    O
edited    O
,    O
with    O
Philip    O
Holden    O
,    O
a    O
collection    O
of    O
essays    O
entitled    O
"    O
Imperial    O
Desire    O
:    O
Dissident    O
Sexualities    O
and    O
Colonial    O
Literature    O
"    O
,    O
while    O
his    O
own    O
essays    O
on    O
Conrad    O
have    O
been    O
published    O
in    O
such    O
journals    O
as    O
"    O
Conradiana    O
"    O
,    O
"    O
The    O
Conradian    O
"    O
,    O
"    O
Studies    O
in    O
the    O
Novel    O
"    O
and    O
'    O
'    O
L'Epoque    O
Conradienne    O
"    O
.    O

The    O
collection    O
was    O
the    O
passion    O
of    O
noted    O
sexologist    B-Medicine106043075
John    O
Money    O
,    O
who    O
donated    O
much    O
of    O
his    O
collection    O
to    O
the    O
gallery    O
in    O
2002    O
,    O
and    O
was    O
built    O
up    O
over    O
several    O
decades    O
from    O
the    O
1940s    O
on    O
.    O

Sexology    B-Medicine106043075

In    O
1919    O
,    O
Hirschfeld    O
had    O
also    O
co    O
-    O
founded    O
the    O
Institut    O
für    O
Sexualwissenschaft    O
(    O
Institute    O
for    O
Sex    O
Research    O
)    O
,    O
a    O
private    O
sexology    B-Medicine106043075
research    O
institute    O
.    O

Ma    O
was    O
defended    O
online    O
by    O
renowned    O
Chinese    O
sexologist    B-Medicine106043075
Li    O
Yinhe    O
.    O

Many    O
of    O
Browne    O
’s    O
beliefs    O
stemmed    O
from    O
her    O
following    O
of    O
the    O
work    O
of    O
Havelock    O
Ellis    O
,    O
Edward    O
Carpenter    O
and    O
other    O
sexologists    B-Medicine106043075
.    O

Magnus    O
Hirschfeld    O
(    O
14    O
May    O
1868    O
–    O
14    O
May    O
1935    O
)    O
was    O
a    O
German    O
Jewish    O
physician    O
and    O
sexologist    B-Medicine106043075
educated    O
primarily    O
in    O
Germany    O
;    O
he    O
based    O
his    O
practice    O
in    O
Berlin    O
-    O
Charlottenburg    O
.    O

"    O
Fuckology    O
"    O
(    O
Chicago    O
University    O
Press    O
,    O
2014    O
)    O
co    O
-    O
authored    O
with    O
Iain    O
Morland    O
and    O
Nikki    O
Sullivan    O
,    O
a    O
critical    O
analysis    O
of    O
the    O
legacy    O
of    O
psychologist    O
and    O
sexologist    B-Medicine106043075
John    O
Money    O
.    O
"    O

Sexologist    B-Medicine106043075
Gloria    O
Brame    O
lists    O
a    O
number    O
of    O
these    O
scenarios    O
,    O
as    O
does    O
Trevor    O
Jacques    O
.    O

He    O
wrote    O
popular    O
books    O
on    O
sexology    B-Medicine106043075
.    O

Zoophilia    O
has    O
been    O
partly    O
discussed    O
by    O
several    O
sciences    O
:    O
Psychology    O
(    O
the    O
study    O
of    O
the    O
human    O
mind    O
)    O
,    O
sexology    B-Medicine106043075
(    O
a    O
relatively    O
new    O
discipline    O
primarily    O
studying    O
human    O
sexuality    O
)    O
,    O
ethology    O
(    O
the    O
study    O
of    O
animal    O
behavior    O
)    O
,    O
and    O
anthrozoology    O
(    O
the    O
study    O
of    O
human    O
-    O
animal    O
interactions    O
and    O
bonds    O
)    O
.    O

Virginia    O
E.    O
Johnson    O
was    O
a    O
business    O
writer    O
for    O
the    O
"    O
St.    O
Louis    O
Daily    O
Record    O
"    O
before    O
becoming    O
a    O
noted    O
sexologist    B-Medicine106043075
with    O
scientist    O
William    O
Masters    O
.    O

Heinrich    O
Kaan    O
(;    O
February    O
8    O
,    O
1816    O
–    O
May    O
24    O
,    O
1893    O
)    O
was    O
a    O
19th    O
-    O
century    O
physician    O
known    O
for    O
his    O
seminal    O
contributions    O
to    O
early    O
sexology    B-Medicine106043075
.    O

Kaan    O
is    O
primarily    O
known    O
for    O
an    O
early    O
scientific    O
approach    O
to    O
sexology    B-Medicine106043075
i.e.    O
a    O
scientifically    O
based    O
theoretical    O
study    O
of    O
sex    O
as    O
opposed    O
to    O
earlier    O
fields    O
of    O
erotology    O
—    O
the    O
more    O
practical    O
study    O
of    O
lovemaking    O
.    O

Reich    O
first    O
met    O
Sigmund    O
Freud    O
in    O
1919    O
when    O
he    O
asked    O
Freud    O
for    O
a    O
reading    O
list    O
for    O
a    O
seminar    O
concerning    O
sexology    B-Medicine106043075
.    O

Charlotte    O
Wolff    O
(    O
30    O
September    O
1897    O
–    O
12    O
September    O
1986    O
)    O
was    O
a    O
German    O
-    O
British    O
physician    O
who    O
worked    O
as    O
a    O
psychotherapist    O
and    O
wrote    O
on    O
sexology    B-Medicine106043075
and    O
hand    O
analysis    O
.    O

Frits    O
Bernard    O
(    O
28    O
August    O
1920    O
,    O
Rotterdam    O
–    O
23    O
May    O
2006    O
,    O
Rotterdam    O
)    O
was    O
a    O
clinical    O
psychologist    O
,    O
sexologist    B-Medicine106043075
and    O
gay    O
and    O
pedophile    O
activist    O
in    O
the    O
Netherlands    O
.    O

#    O
Sexpertise    B-Medicine106043075

Michael    O
Chikong    O
Seto    O
(    O
born    O
1967    O
)    O
is    O
a    O
Canadian    O
forensic    O
psychologist    O
,    O
sexologist    B-Medicine106043075
,    O
and    O
author    O
.    O

Alfred    O
Kinsey    O
,    O
pioneer    O
of    O
the    O
academic    O
discipline    O
of    O
sexology    B-Medicine106043075
in    O
the    O
United    O
States    O
,    O
founder    O
of    O
the    O
Kinsey    O
Institute    O
and    O
the    O
Kinsey    O
Scale    O
,    O
author    O
of    O
the    O
Kinsey    O
Reports    O

She    O
writes    O
that    O
they    O
were    O
politically    O
defeated    O
by    O
the    O
ascendency    O
of    O
sexology    B-Medicine106043075
and    O
the    O
birth    O
-    O
control    O
movement    O
,    O
both    O
of    O
which    O
attacked    O
spinsterhood    O
and    O
sought    O
to    O
recruit    O
women    O
back    O
into    O
heterosexuality    O
.    O

Bernard    O
William    O
Francis    O
Armitage    O
(    O
6    O
July    O
1890    O
–    O
25    O
August    O
1976    O
)    O
was    O
an    O
English    O
physician    O
and    O
psychiatrist    O
specializing    O
in    O
sexual    B-Medicine106043075
psychology    I-Medicine106043075
.    O

Dr.    O
Yvonne    O
Kristin    O
Fulbright    O
is    O
an    O
Icelandic    O
-    O
American    O
sexologist    B-Medicine106043075
,    O
author    O
,    O
and    O
television    O
personality    O
.    O

Ray    O
Milton    O
Blanchard    O
(;    O
born    O
October    O
9    O
,    O
1945    O
)    O
is    O
an    O
American    O
-    O
Canadian    O
sexologist    B-Medicine106043075
,    O
best    O
known    O
for    O
his    O
research    O
studies    O
on    O
pedophilia    O
,    O
transsexualism    O
,    O
and    O
sexual    O
orientation    O
.    O

Rolf    O
Gindorf    O
(    O
14    O
May    O
1939    O
–    O
26    O
March    O
2016    O
)    O
was    O
a    O
German    O
sexologist    B-Medicine106043075
.    O

Sandra    O
Risa    O
Leiblum    O
(    O
1943–2010    O
)    O
was    O
an    O
American    O
author    O
,    O
lecturer    O
,    O
and    O
researcher    O
in    O
sexology    B-Medicine106043075
.    O

Michel    O
Foucault    O
,    O
in    O
his    O
systematic    O
study    O
of    O
sexuality    B-Medicine106043075
,    O
argued    O
that    O
rather    O
than    O
being    O
merely    O
repressed    O
,    O
the    O
desires    O
of    O
the    O
individual    O
are    O
efficiently    O
mobilized    O
and    O
used    O
,    O
to    O
control    O
the    O
individual    O
,    O
alter    O
interpersonal    O
relationships    O
and    O
control    O
the    O
masses    O
.    O

Lev    O
Schelgov    O
(    O
1971    O
)    O
(    O
Psychotherapy    O
,    O
Sexology    B-Medicine106043075
)    O

Aaron    O
H.    O
Devor    O
(    O
born    O
in    O
1951    O
)    O
,    O
formerly    O
known    O
as    O
Holly    O
Devor    O
,    O
is    O
a    O
Canadian    O
sociologist    O
and    O
sexologist    B-Medicine106043075
known    O
for    O
research    O
of    O
transsexuality    O
and    O
transgender    O
communities    O
.    O

Dr    O
Julia    O
R.    O
Heiman    O
is    O
an    O
American    O
sexologist    B-Medicine106043075
and    O
psychologist    O
.    O

Browne    O
's    O
beliefs    O
were    O
heavily    O
influenced    O
by    O
the    O
work    O
of    O
Havelock    O
Ellis    O
,    O
Edward    O
Carpenter    O
and    O
other    O
sexologists    B-Medicine106043075
.    O

Pain    O
modifier    O
drugs    O
for    O
neuralgic    O
pain    O
(    O
such    O
as    O
amitriptyline    O
,    O
carbamazepine    B-Medicine106043075
or    O
gabapentin    O
)    O
may    O
be    O
tried    O
,    O
but    O
are    O
often    O
not    O
as    O
helpful    O
in    O
the    O
majority    O
of    O
patients    O
.    O

The    O
medications    O
mexiletine    O
or    O
carbamazepine    B-Medicine106043075
are    O
occasionally    O
helpful    O
.    O

In    O
addition    O
,    O
coadministration    O
of    O
sofosbuvir    O
with    O
anticonvulsants    O
(    O
carbamazepine    B-Medicine106043075
,    O
phenytoin    O
,    O
phenobarbital    O
,    O
oxcarbazepine    O
)    O
,    O
antimycobacterials    O
(    O
rifampin    B-Medicine106043075
,    O
rifabutin    O
,    O
rifapentine    O
)    O
,    O
and    O
the    O
HIV    O
protease    O
inhibitor    O
tipranavir    O
and    O
ritonavir    O
is    O
expected    O
to    O
decrease    O
sofosbuvir    O
concentration    O
.    O

:    O
carbamazepine    B-Medicine106043075
(    O
anticonvulsant    O
,    O
mood    O
stabilizing    O
)    O

The    O
total    O
concentration    O
of    O
carbamazepine    B-Medicine106043075
in    O
Fishing    O
Creek    O
in    O
the    O
same    O
place    O
and    O
time    O
ranged    O
from    O
approximately    O
1    O
nanogram    O
per    O
liter    O
to    O
less    O
than    O
40    O
nanograms    O
per    O
liter    O
.    O

They    O
can    O
also    O
be    O
found    O
in    O
reactive    O
lymphadenopathy    O
(    O
such    O
as    O
infectious    O
mononucleosis    O
immunoblasts    O
which    O
are    O
RS    O
like    O
in    O
appearance    O
,    O
carbamazepine    B-Medicine106043075
associated    O
lymphadenopathy    O
)    O
and    O
very    O
rarely    O
in    O
other    O
types    O
of    O
non    O
-    O
Hodgkin    O
lymphomas    O
.    O

Carbamazepine    B-Medicine106043075

Carbamazepine    B-Medicine106043075
(    O
Atretol    B-Medicine106043075
,    O
Epitol    B-Medicine106043075
,    O
Tegretol    B-Medicine106043075
)    O

carbamazepine    B-Medicine106043075
,    O

Both    O
Lhermitte    O
's    O
sign    O
and    O
painful    O
dysesthesias    O
usually    O
respond    O
well    O
to    O
treatment    O
with    O
carbamazepine    B-Medicine106043075
,    O
clonazepam    O
or    O
amitriptyline    O
.    O

Medications    O
that    O
have    O
been    O
reported    O
to    O
provide    O
some    O
relief    O
are    O
isoniazid    O
,    O
carbamazepine    B-Medicine106043075
,    O
propranolol    B-Medicine106043075

Lurasidone    O
is    O
contraindicated    O
in    O
individuals    O
who    O
are    O
taking    O
strong    O
inhibitors    O
of    O
the    O
liver    O
enzyme    O
CYP3A4    O
(    O
ketoconazole    O
,    O
clarithromycin    O
,    O
ritonavir    O
,    O
levodropropizine    O
,    O
etc    O
.    O
)    O
or    O
inducers    O
(    O
carbamazepine    B-Medicine106043075
,    O
St.    O
John    O
's    O
wort    O
,    O
phenytoin    O
,    O
rifampicin    B-Medicine106043075
etc    O
.    O
)    O
.    O

It    O
should    O
not    O
be    O
given    O
in    O
conjunction    O
with    O
other    O
antiepileptics    O
due    O
to    O
the    O
potential    O
for    O
reduced    O
clearance    O
of    O
other    O
antiepileptics    O
(    O
including    O
carbamazepine    B-Medicine106043075
,    O
lamotrigine    O
,    O
phenytoin    O
and    O
phenobarbitone    O
)    O
and    O
itself    O
.    O

Carbamazepine    B-Medicine106043075
(    O
Tegretol    O
)    O
,    O
anticonvulsant    O
and    O
mood    O
stabilizer    O

Compounds    O
such    O
as    O
levetiracetam    O
,    O
lamotrigine    O
,    O
and    O
carbamazepine    B-Medicine106043075
are    O
known    O
to    O
block    O
the    O
P    O
-    O
type    O
channels    O
,    O
which    O
have    O
helped    O
to    O
decrease    O
the    O
occurrence    O
of    O
seizures    O
.    O

Animal    O
studies    O
have    O
similarly    O
failed    O
to    O
show    O
much    O
protective    O
effect    O
of    O
the    O
most    O
commonly    O
used    O
seizure    O
medications    O
in    O
PTE    O
trials    O
,    O
such    O
as    O
phenytoin    O
and    O
carbamazepine    B-Medicine106043075
.    O

The    O
antiepileptics    O
carbamazepine    B-Medicine106043075
and    O
valproate    O
are    O
the    O
most    O
common    O
drugs    O
used    O
to    O
treat    O
PTE    O
;    O
phenytoin    O
may    O
also    O
be    O
used    O
but    O
may    O
increase    O
risk    O
of    O
cognitive    O
side    O
effects    O
such    O
as    O
impaired    O
thinking    O
.    O

Diazepam    O
increases    O
the    O
central    O
depressive    O
effects    O
of    O
alcohol    O
,    O
other    O
hypnotics    O
/    O
sedatives    O
(    O
e.g.    O
,    O
barbiturates    O
)    O
,    O
other    O
muscle    O
relaxants    O
,    O
certain    O
antidepressants    O
,    O
sedative    O
antihistamines    O
,    O
opioids    O
,    O
and    O
antipsychotics    O
,    O
as    O
well    O
as    O
anticonvulsants    O
such    O
as    O
phenobarbital    O
,    O
phenytoin    O
,    O
and    O
carbamazepine    B-Medicine106043075
.    O

Carbamazepine    B-Medicine106043075
,    O
an    O
anticonvulsant    O
,    O
appears    O
to    O
have    O
some    O
beneficial    O
effects    O
in    O
the    O
treatment    O
and    O
management    O
of    O
benzodiazepine    O
withdrawal    O
;    O
however    O
,    O
research    O
is    O
limited    O
and    O
thus    O
the    O
ability    O
of    O
experts    O
to    O
make    O
recommendations    O
on    O
its    O
use    O
for    O
benzodiazepine    O
withdrawal    O
is    O
not    O
possible    O
at    O
present    O
.    O

Additionally    O
,    O
the    O
metabolism    O
of    O
zonisamide    O
is    O
inhibited    O
by    O
ketoconazole    O
,    O
ciclosporin    O
,    O
miconazole    O
,    O
fluconazole    B-Medicine106043075
and    O
carbamazepine    B-Medicine106043075
(    O
in    O
descending    O
order    O
of    O
inhibition    O
)    O
due    O
to    O
their    O
effects    O
on    O
the    O
CYP3A4    O
enzyme    O
.    O

Ulipristal    O
acetate    O
is    O
likely    O
to    O
interact    O
with    O
substrates    O
of    O
CYP3A4    O
,    O
like    O
rifampicin    B-Medicine106043075
,    O
phenytoin    O
,    O
St    O
John    O
's    O
wort    O
,    O
carbamazepine    B-Medicine106043075
or    O
ritonavir    O
,    O
therefore    O
concomitant    O
use    O
with    O
these    O
agents    O
is    O
not    O
recommended    O
.    O

For    O
example    O
,    O
antidepressant    O
medications    O
,    O
diabetes    O
medications    O
,    O
carbamazepine    B-Medicine106043075
,    O
cholesterol    O
-    O
lowering    O
medications    O
and    O
penicillin    O
.    O

As    O
examples    O
,    O
fluoxetine    O
and    O
paroxetine    O
,    O
inhibitors    O
of    O
these    O
enzymes    O
,    O
are    O
known    O
to    O
modestly    O
increase    O
mirtazapine    O
levels    O
,    O
while    O
carbamazepine    B-Medicine106043075
,    O
an    O
inducer    O
,    O
considerably    O
decreases    O
them    O
.    O

Aplastic    O
anemia    O
is    O
also    O
sometimes    O
associated    O
with    O
exposure    O
to    O
toxins    O
such    O
as    O
benzene    O
,    O
or    O
with    O
the    O
use    O
of    O
certain    O
drugs    O
,    O
including    O
chloramphenicol    O
,    O
carbamazepine    B-Medicine106043075
,    O
felbamate    O
,    O
phenytoin    O
,    O
quinine    O
,    O
and    O
phenylbutazone    O
.    O

The    O
exact    O
mechanism    O
of    O
carbamazepine    B-Medicine106043075
,    O
gabapentin    O
,    O
and    O
pregabalin    O
is    O
similarly    O
unclear    O
,    O
but    O
these    O
anticonvulsants    O
are    O
used    O
to    O
treat    O
neuropathic    O
pain    O
with    O
differing    O
degrees    O
of    O
success    O
.    O

Carbamazepine    B-Medicine106043075
or    O
trazodone    O
may    O
also    O
be    O
effective    O
in    O
the    O
treatment    O
of    O
post    O
acute    O
withdrawal    O
syndrome    O
in    O
regards    O
to    O
alcohol    O
use    O
.    O

Many    O
antiepileptic    O
drugs    O
,    O
like    O
carbamazepine    B-Medicine106043075
or    O
lamotrigine    O
,    O
slow    O
the    O
recovery    O
from    O
inactivation    O
and    O
hence    O
reduce    O
the    O
ability    O
of    O
neurons    O
to    O
fire    O
action    O
potentials    O
.    O

Newer    O
AEDs    O
,    O
including    O
lacosamide    O
,    O
vigabatrin    O
,    O
felbamate    O
,    O
gabapentin    O
,    O
tiagabine    O
,    O
and    O
rufinamide    O
have    O
been    O
found    O
to    O
be    O
more    O
tolerable    O
and    O
safer    O
than    O
older    O
drugs    O
such    O
as    O
carbamazepine    B-Medicine106043075
,    O
phenytoin    O
,    O
and    O
valproate    O
.    O

In    O
a    O
study    O
of    O
patients    O
that    O
had    O
never    O
received    O
HIV    O
treatment    O
,    O
darunavir    O
was    O
as    O
effective    O
as    O
lopinavir    B-Medicine106043075
/    O
ritonavir    O
at    O
96    O
weeks    O
with    O
a    O
once    O
-    O
daily    O
dosing    O
.    O

Suvorexant    O
is    O
not    O
recommended    O
if    O
people    O
are    O
also    O
taking    O
medications    O
that    O
strongly    O
inhibit    O
the    O
liver    O
enzyme    O
CYP3A    O
like    O
itraconazole    O
,    O
lopinavir    B-Medicine106043075
/    O
ritonavir    O
,    O
clarithromycin    O
,    O
ritonavir    O
,    O
ketoconazole    O
,    O
indinavir    O
/    O
ritonavir    O
,    O
or    O
conivaptan    O
.    O

Lopinavir    B-Medicine106043075

Robert    O
Darnell    O
is    O
an    O
American    O
neurooncologist    B-Medicine106043075
and    O
neuroscientist    O
,    O
a    O
founding    O
director    O
and    O
former    O
CEO    O
of    O
the    O
New    O
York    O
Genome    O
Center    O
,    O
the    O
Robert    O
and    O
Harriet    O
Heilbrunn    O
Professor    O
of    O
Cancer    O
Biology    O
at    O
The    O
Rockefeller    O
University    O
,    O
and    O
an    O
investigator    O
of    O
the    O
Howard    O
Hughes    O
Medical    O
Institute    O
.    O

He    O
is    O
known    O
for    O
his    O
work    O
on    O
neurooncology    B-Medicine106043075
,    O
Molecular    O
Therapy    O
targets    O
and    O
biomarkers    O
and    O
immunotherapy    O
of    O
cancer    O
.    O

Lamivudine/zidovudine    B-Medicine106043075

Lamivudine/zidovudine    B-Medicine106043075
(    O
with    O
zidovudine    O
)    O

Kirtane    O
is    O
reported    O
to    O
be    O
active    O
in    O
social    O
activities    O
,    O
and    O
is    O
credited    O
with    O
several    O
articles    O
,    O
over    O
50    O
of    O
them    O
,    O
and    O
books    O
on    O
otology    O
,    O
neurotology    B-Medicine106043075
and    O
endoscopic    O
sinus    O
surgery    O
.    O

Sir    O
Charles    O
Alfred    O
Ballance    O
(    O
30    O
August    O
1856    O
–    O
9    O
February    O
1936    O
)    O
was    O
an    O
English    O
surgeon    O
who    O
specialized    O
in    O
the    O
fields    O
of    O
otology    O
and    O
neurotology    B-Medicine106043075
.    O

ACNES    O
Abdominal    O
Cutaneous    O
Nerve    O
Entrapment    O
Syndrome    O
,    O
usually    O
in    O
patients    O
who    O
have    O
had    O
abdominal    B-Medicine106043075
surgery    I-Medicine106043075

The    O
University    O
of    O
Mainz    O
specialist    O
and    O
teaching    O
hospital    O
,    O
which    O
grew    O
out    O
of    O
the    O
former    O
Municipal    O
Hospitals    O
,    O
is    O
part    O
of    O
the    O
"    O
Saarland    O
Heilstätten    O
"    O
(    O
a    O
group    O
of    O
hospitals    O
)    O
–    O
even    O
though    O
it    O
is    O
not    O
in    O
the    O
Saarland    O
–    O
and    O
has    O
some    O
500    O
beds    O
and    O
1,000    O
employees    O
,    O
as    O
well    O
as    O
departments    O
for    O
general    B-Medicine106043075
,    O
abdominal    B-Medicine106043075
and    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
gynaecology    O
with    O
obstetrics    O
,    O
internal    O
medicine    O
with    O
gastroenterology    O
,    O
nephrology    O
,    O
diabetology    O
and    O
dialysis    O
,    O
diagnostic    O
and    O
interventional    O
radiology    O
,    O
cardiology    O
,    O
bone    O
marrow    O
transplantation    O
and    O
haematology    O
/    O
oncology    O
,    O
neurology    O
with    O
a    O
stroke    O
unit    O
and    O
neurosurgery    O
,    O
psychiatry    O
with    O
child    O
and    O
adolescent    O
psychiatry    O
and    O
psychotherapy    O
,    O
paediatrics    O
with    O
neonatology    O
,    O
radiation    O
therapy    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
urology    O
as    O
well    O
as    O
wards    O
for    O
ophthalmology    O
and    O
otorhinolaryngology    O
.    O

In    O
severe    O
cases    O
surgical    B-Medicine106043075
treatment    I-Medicine106043075
is    O
made    O
more    O
difficult    O
because    O
the    O
infant    O
's    O
abdomen    O
is    O
abnormally    O
small    O
,    O
having    O
had    O
no    O
need    O
to    O
expand    O
to    O
accommodate    O
the    O
developing    O
organs    O
.    O

Foreign    O
bodies    O
in    O
the    O
peritoneum    O
can    O
include    O
retained    O
surgical    O
instruments    O
after    O
abdominal    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Seromas    O
are    O
particularly    O
common    O
after    O
breast    O
surgery    O
(    O
for    O
example    O
after    O
mastectomy    O
)    O
,    O
abdominal    B-Medicine106043075
surgeries    I-Medicine106043075
,    O
and    O
reconstructive    O
surgery    O
.    O

Health    B-Medicine106043075
literacy    I-Medicine106043075

Institute    O
for    O
Healthcare    O
Advancement    O
(    O
IHA    O
)    O
is    O
a    O
not    O
-    O
for    O
-    O
profit    O
,    O
private    O
operating    O
foundation    O
providing    O
health    O
care    O
and    O
improving    O
health    B-Medicine106043075
literacy    I-Medicine106043075
at    O
the    O
national    O
level    O
.    O

Although    O
related    O
,    O
graph    O
literacy    O
is    O
distinct    O
from    O
other    O
forms    O
of    O
literacy    O
(    O
e.g.    O
,    O
general    O
health    B-Medicine106043075
literacy    I-Medicine106043075
or    O
numeracy    O
)    O
in    O
the    O
sense    O
that    O
it    O
relates    O
more    O
specifically    O
to    O
one    O
’s    O
ability    O
to    O
obtain    O
meaning    O
from    O
information    O
presented    O
graphically    O
.    O

They    O
influence    O
,    O
criticise    O
,    O
advice    O
,    O
sell    O
and    O
promote    O
health    B-Medicine106043075
literacy    I-Medicine106043075
and    O
related    O
health    O
concerns    O
.    O

By    O
then    O
,    O
memetics    O
had    O
also    O
become    O
a    O
theme    O
appearing    O
in    O
fiction    O
(    O
e.g.    O
Neal    O
Stephenson    O
's    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
)    O
.    O

The    O
Raft    O
,    O
a    O
fictional    O
refugee    O
flotilla    O
in    O
the    O
Neal    O
Stephenson    O
novel    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075

Hiroki    O
Protagonist    O
,    O
shortened    O
to    O
Hiro    O
Protagonist    O
,    O
the    O
main    O
character    O
in    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
.    O

The    O
use    O
of    O
virtual    O
globe    O
software    O
was    O
widely    O
popularized    O
by    O
(    O
and    O
may    O
have    O
been    O
first    O
described    O
in    O
)    O
Neal    O
Stephenson    O
's    O
famous    O
science    O
fiction    O
novel    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
.    O

Glass    O
knives    O
are    O
the    O
weapon    O
of    O
choice    O
of    O
the    O
antagonist    O
Dmitri    O
"    O
Raven    O
"    O
Ravinoff    O
in    O
the    O
novel    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
because    O
they    O
are    O
undetectable    O
by    O
security    O
systems    O
and    O
are    O
said    O
in    O
the    O
book    O
to    O
be    O
molecule    O
-    O
thin    O
at    O
the    O
edges    O
,    O
sharp    O
enough    O
to    O
penetrate    O
bulletproof    O
vests    O
.    O

It    O
is    O
technically    O
an    O
MMOSG    O
or    O
Casual    O
Multiplayer    O
Online    O
(    O
CMO    O
)    O
by    O
definition    O
,    O
though    O
its    O
stated    O
goal    O
was    O
to    O
realize    O
the    O
concept    O
of    O
the    O
Metaverse    O
from    O
Neal    O
Stephenson    O
's    O
novel    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
.    O

Planners    O
took    O
inspiration    O
from    O
cyberpunk    O
novels    O
written    O
by    O
Neal    O
Stephenson    O
and    O
William    O
Gibson    O
,    O
including    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
.    O

=    O
=    O
=    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075

Black    O
Sun    O
,    O
a    O
virtual    O
nightclub    O
in    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O

The    O
story    O
,    O
written    O
by    O
Elton    O
Pruitt    O
,    O
was    O
heavily    O
inspired    O
by    O
the    O
novel    O
"    O
Snow    B-Medicine106043075
Crash    I-Medicine106043075
"    O
.    O

Redirects    O
to    O
"    O
clotrimazole    B-Medicine106043075
"    O
.    O

Redirects    O
to    O
"    O
clotrimazole    B-Medicine106043075
"    O
.    O

Lotrimin    B-Medicine106043075

Lanosterol    O
14α-demethylase    O
(    O
CYP51A1    O
)    O
inhibitors    O
such    O
as    O
clotrimazole    B-Medicine106043075
,    O
fluconazole    B-Medicine106043075
,    O
itraconazole    O
,    O
ketoconazole    O
,    O
miconazole    O
,    O
and    O
voriconazole    O
prevent    O
the    O
production    O
of    O
ergosterol    O
from    O
lanosterol    O
.    O

Combined    O
with    O
marbofloxacin    O
and    O
clotrimazole    B-Medicine106043075
,    O
dexamethasone    O
is    O
available    O
under    O
the    O
name    O
Aurizon    O
,    O
CAS    O
number    O
115550    O
-    O
35    O
-    O
1    O
,    O
and    O
used    O
to    O
treat    O
difficult    O
ear    O
infections    O
,    O
especially    O
in    O
dogs    O
.    O

Treatment    O
is    O
typically    O
with    O
antifungal    O
creams    O
such    O
as    O
clotrimazole    B-Medicine106043075
or    O
miconazole    O
.    O

Antifungal    O
treatments    O
include    O
topical    O
agents    O
such    O
as    O
miconazole    O
,    O
terbinafine    O
,    O
clotrimazole    B-Medicine106043075
,    O
ketoconazole    O
,    O
or    O
tolnaftate    O
applied    O
twice    O
daily    O
until    O
symptoms    O
resolve    O
—    O
usually    O
within    O
one    O
or    O
two    O
weeks    O
.    O

clotrimazole    B-Medicine106043075
(    O
antifungal    O
)    O

Isoxyl    O
inhibits    O
"    O
M.    O
bovis    O
"    O
with    O
six    O
hours    O
of    O
exposure    O
,    O
which    O
is    O
similar    O
to    O
isoniazid    O
and    O
ethionamide    B-Medicine106043075
,    O
two    O
other    O
prominent    O
anti    O
-    O
TB    O
drugs    O
.    O

ethionamide    B-Medicine106043075
(    O
INN    O
)    O

Ethionamide    B-Medicine106043075

Aciclovir    B-Medicine106043075

Vidarabine    O
is    O
more    O
toxic    O
and    O
less    O
metabolically    O
stable    O
than    O
many    O
of    O
the    O
other    O
current    O
antivirals    O
such    O
as    O
acyclovir    B-Medicine106043075
and    O
ganciclovir    O
.    O

Many    O
of    O
the    O
previous    O
uses    O
of    O
vidarabine    O
have    O
been    O
superseded    O
by    O
acyclovir    B-Medicine106043075
,    O
due    O
to    O
the    O
hospitalisation    O
required    O
for    O
intra    O
venous    O
dosing    O
,    O
and    O
acyclovir    O
has    O
a    O
higher    O
selectivity    O
,    O
lower    O
inhibitory    O
concentration    O
and    O
higher    O
potency    O
.    O

Aciclovir    B-Medicine106043075
(    O
ACV    B-Medicine106043075
)    O
,    O
also    O
known    O
as    O
acyclovir    B-Medicine106043075
,    O
is    O
an    O
antiviral    O
medication    O
.    O

It    O
is    O
a    O
prodrug    O
,    O
being    O
converted    O
to    O
aciclovir    B-Medicine106043075
.    O

Common    O
adverse    O
drug    O
reactions    O
(    O
≥1%    O
of    O
patients    O
)    O
associated    O
with    O
valaciclovir    O
therapy    O
are    O
the    O
same    O
as    O
for    O
aciclovir    B-Medicine106043075
,    O
its    O
active    O
metabolite    O
,    O
and    O
include    O
:    O
nausea    O
,    O
vomiting    O
,    O
diarrhea    O
and    O
headache    O
.    O

Valaciclovir    O
is    O
a    O
prodrug    O
,    O
an    O
esterified    O
version    O
of    O
aciclovir    B-Medicine106043075
that    O
has    O
greater    O
oral    O
bioavailability    O
(    O
about    O
55%    O
)    O
than    O
aciclovir    O
(    O
10–20%    O
)    O
.    O

It    O
is    O
converted    O
by    O
esterases    O
to    O
the    O
active    O
drug    O
aciclovir    B-Medicine106043075
,    O
as    O
well    O
as    O
the    O
amino    O
acid    O
valine    O
,    O
via    O
hepatic    O
first    O
-    O
pass    O
metabolism    O
.    O

Aciclovir    B-Medicine106043075
is    O
selectively    O
converted    O
into    O
a    O
monophosphate    O
form    O
by    O
viral    O
thymidine    O
kinase    O
,    O
which    O
is    O
far    O
more    O
effective    O
(    O
3000    O
times    O
)    O
in    O
phosphorylation    O
of    O
aciclovir    B-Medicine106043075
than    O
cellular    O
thymidine    O
kinase    O
.    O

Purine    O
analogues    O
of    O
guanine    O
:    O
Aciclovir    B-Medicine106043075
,    O
Famciclovir    O
,    O
Ganciclovir    O
,    O
Penciclovir    O
,    O
Valaciclovir    O
,    O
Valganciclovir    O

9-Carboxymethoxymethylguanine    O
(    O
CMMG    O
)    O
is    O
a    O
compound    O
which    O
is    O
known    O
as    O
the    O
principal    O
metabolite    O
of    O
the    O
antiviral    O
drug    O
acyclovir    B-Medicine106043075
(    O
and    O
its    O
prodrug    O
valacyclovir    O
)    O
,    O
and    O
has    O
been    O
suggested    O
as    O
the    O
causative    O
agent    O
in    O
the    O
neuropsychiatric    O
side    O
effects    O
sometimes    O
associated    O
with    O
these    O
drugs    O
.    O

As    O
a    O
graduate    O
student    O
,    O
Vince    O
’s    O
research    O
on    O
the    O
design    O
of    O
acyclonucleosides    O
,    O
with    O
Howard    O
J.    O
Schaeffer    O
at    O
SUNY    O
Buffalo    O
became    O
an    O
integral    O
part    O
of    O
the    O
discovery    O
of    O
anti    O
-    O
viral    O
drug    O
acyclovir    B-Medicine106043075
.    O

Later    O
,    O
Prof    O
Schaeffer    O
continued    O
the    O
development    O
of    O
acyclovir    B-Medicine106043075
at    O
Burroughs    O
Welcome    O
&    O
Company    O
,    O
with    O
pharmacologist    O
Gertrude    O
B.    O
Elion    O
who    O
was    O
awarded    O
the    O
1988    O
Nobel    O
Prize    O
in    O
Medicine    O
,    O
in    O
part    O
,    O
for    O
the    O
development    O
of    O
acyclovir    B-Medicine106043075
.    O

He    O
also    O
starred    O
in    O
a    O
TV    O
advert    O
for    O
Zovirax    B-Medicine106043075
cold    O
sore    O
cream    O
.    O

In    O
the    O
case    O
of    O
herpetic    O
uveitis    O
,    O
anti    O
-    O
viral    O
medications    O
,    O
such    O
as    O
valaciclovir    O
or    O
aciclovir    B-Medicine106043075
,    O
may    O
be    O
administered    O
to    O
treat    O
the    O
causative    O
viral    O
infection    O
.    O

In    O
the    O
film    O
,    O
as    O
the    O
couple    O
mixes    O
up    O
a    O
hallucinogenic    O
concoction    O
in    O
the    O
kitchen    O
,    O
the    O
ingredients    O
"    O
benzedrine    O
"    O
and    O
"    O
banana    B-Medicine106043075
peel    I-Medicine106043075
"    O
are    O
deleted    O
from    O
the    O
audio    O
track    O
.    O

General    O
Pediatrics    O
,    O
Family    O
Medicine    O
,    O
Adolescent    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Allergy    O
/    O
Pulmonary    B-Medicine106043075
diseases    I-Medicine106043075
,    O
Anesthesia    O
,    O
Blood    O
and    O
Marrow    O
Transplantation    O
,    O
Burn    O
Treatment    O
,    O
Cardiology    O
,    O
Child    O
Abuse    O
and    O
Neglect    O
,    O
Child    O
Health    O
Specialty    O
Clinics    O
,    O
Child    O
Neurology    O
,    O
Child    O
Psychology    O
,    O
Child    O
Psychiatry    O
,    O
Clinical    O
Pharmacology    O
,    O
Continuity    O
of    O
Care    O
,    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
,    O
Dentistry    O
,    O
Dermatology    O
,    O
Developmental    O
Disabilities    O
,    O
ECMO    O
,    O
Emergency    O
Care    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Genetics    O
,    O
Hematology    O
,    O
Infectious    O
Diseases    O
,    O
Mother    O
's    O
Milk    O
Bank    O
of    O
Iowa    O
,    O
Neonatology    O
,    O
Nephrology    O
,    O
Neurosurgery    O
,    O
Nuclear    O
Medicine    O
,    O
Nutrition    O
,    O
Obstetrics    O
/    O
Gynecology    O
,    O
Oncology    O
,    O
Ophthalmology    O
,    O
Oral    O
and    O
Maxillofacial    O
Surgery    O
,    O
Orthodontics    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Spinal    O
Deformity    O
,    O
Otolaryngology    O
-    O
Head    O
and    O
Neck    O
Surgery    O
,    O
Speech    O
,    O
Swallowing    O
,    O
Voice    O
,    O
Pediatric    O
Outreach    O
Clinics    O
(    O
Cardiac    O
-    O
Electrophysiology    O
,    O
Cardiology    O
,    O
Cystic    O
Fibrosis    O
,    O
Diabetes    O
/    O
Endocrinology    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Hemoglobinopathy    O
,    O
Neurology    O
,    O
Neuromuscular    O
)    O
,    O
Radiation    O
Oncology    O
,    O
Radiology    O
,    O
Rheumatology    O
,    O
Special    O
Education    O
,    O
Specialized    O
Child    O
Health    O
Services    O
,    O
Surgery    O
(    O
Pediatric    O
)    O
,    O
Thoracic    O
and    O
Cardiovascular    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Toxicology    O
,    O
Transplantation    O
Surgery    O
,    O
Trauma    O
Surgery    O
,    O
and    O
Urology    O
.    O

The    O
Journal    O
of    O
Pediatric    O
and    O
Adolescent    O
Gynecology    O
is    O
a    O
peer    O
-    O
reviewed    O
medical    O
journal    O
covering    O
gynecology    O
as    O
it    O
relates    O
to    O
the    O
fields    O
of    O
pediatrics    O
and    O
adolescent    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Certificates    O
of    O
Added    O
Qualifications    O
(    O
CAQs    O
)    O
in    O
adolescent    B-Medicine106043075
medicine    I-Medicine106043075
,    O
geriatric    O
medicine    O
,    O
sports    O
medicine    O
,    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
hospice    O
and    O
palliative    O
medicine    O
are    O
available    O
for    O
those    O
board    O
-    O
certified    O
family    O
physicians    O
with    O
additional    O
residency    O
training    O
requirements    O
.    O

He    O
had    O
nearly    O
won    O
the    O
entire    O
Continent    O
and    O
had    O
taken    O
over    O
most    O
of    O
the    O
Desert    O
,    O
where    O
the    O
new    O
High    B-Medicine106043075
Prince    I-Medicine106043075
,    O
Pol    O
,    O
awaited    O
to    O
make    O
his    O
final    O
stand    O
.    O

Princemarch    O
is    O
a    O
fictional    O
princedom    O
(    O
or    O
country    O
)    O
in    O
Melanie    O
Rawn    O
's    O
fantasy    O
novels    O
of    O
the    O
Dragon    B-Medicine106043075
Prince    I-Medicine106043075
and    I-Medicine106043075
Dragon    I-Medicine106043075
Star    I-Medicine106043075
trilogies    I-Medicine106043075
.    O

Princemarch    O
is    O
a    O
central    O
princedom    O
on    O
the    O
continent    O
and    O
is    O
the    O
traditional    O
seat    O
of    O
the    O
High    B-Medicine106043075
Prince    I-Medicine106043075
.    O

Hawking    O
is    O
a    O
sport    O
for    O
the    O
elite    O
of    O
Princemarch    O
,    O
which    O
became    O
widespread    O
in    O
719    O
as    O
the    O
birds    O
were    O
sold    O
at    O
the    O
"    O
Rialla    B-Medicine106043075
"    O
.    O

During    O
Roelstra    O
's    O
rule    O
,    O
Lord    O
Garic    O
had    O
hid    O
and    O
hoarded    O
his    O
wealth    O
,    O
waiting    O
out    O
the    O
High    B-Medicine106043075
Prince    I-Medicine106043075
's    O
rule    O
.    O

These    O
mountains    O
are    O
the    O
only    O
place    O
on    O
the    O
continent    O
where    O
"    O
dranath    B-Medicine106043075
"    O
grows    O
.    O

Melanie    O
Rawn    O
's    O
"    O
Dragon    B-Medicine106043075
Prince    I-Medicine106043075
and    I-Medicine106043075
Dragon    I-Medicine106043075
Star    I-Medicine106043075
trilogies    I-Medicine106043075
"    O
and    O
"    O
Exiles    O
Trilogy    O
"    O

The    O
university    O
's    O
medical    O
school    O
was    O
founded    O
in    O
1914    O
and    O
taught    O
basic    O
medicine    O
and    O
clinical    O
medicine    O
,    O
biomedicine    O
and    O
stomatology    B-Medicine106043075
.    O

Wuhan    O
University    O
Stomatological    O
Hospital    O
has    O
a    O
significant    O
role    O
in    O
the    O
development    O
of    O
modern    O
stomatology    B-Medicine106043075
,    O
and    O
was    O
one    O
of    O
the    O
earliest    O
hospitals    O
of    O
stomatology    O
in    O
China    O
.    O

Luís    O
Diogo    O
de    O
Sousa    O
Lopes    O
e    O
Horta    O
or    O
Lopes    O
de    O
Sousa    O
Horta    O
or    O
Luís    O
Diogo    O
Horta    O
e    O
Costa    O
(    O
born    O
3    O
July    O
1913/1914    O
)    O
,    O
Licentiate    O
in    O
Medicine    O
from    O
the    O
University    O
of    O
Lisbon    O
,    O
Stomatologist    B-Medicine106043075
,    O
married    O
on    O
22    O
July    O
1948    O
Maria    O
Isabel    O
Pizarro    O
Xavier    O
Montalvão    O
Machado    O
(    O
born    O
Chaves    O
,    O
30    O
November    O
1924    O
)    O
,    O
daughter    O
of    O
Dr.    O
José    O
Timóteo    O
Montalvão    O
Machado    O
,    O
Licentiate    O
in    O
Medicine    O
from    O
the    O
University    O
of    O
Lisbon    O
,    O
specialized    O
in    O
Ophthalmology    O
from    O
the    O
University    O
of    O
Paris    O
,    O
etc    O
.    O

Müller    O
has    O
published    O
over    O
100    O
articles    O
related    O
to    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
,    O
such    O
as    O
bone    O
management    O
,    O
narrow    O
jaw    O
implants    O
,    O
taxes    O
for    O
medical    O
products    O
,    O
fracture    O
testing    O
,    O
new    O
implant    O
systems    O
,    O
quality    O
management    O
,    O
dental    O
ethics    O
etc    O
.    O

Many    O
periodontists    O
also    O
diagnose    O
and    O
treat    O
oral    O
pathology    O
and    O
periodontics    O
was    O
the    O
historical    O
basis    O
for    O
the    O
specialty    O
of    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Veterinary    O
dentists    O
offer    O
services    O
in    O
the    O
fields    O
of    O
endodontics    O
,    O
oral    O
and    O
maxillofacial    O
radiology    O
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
,    O
orthodontics    O
,    O
pedodontics    O
,    O
periodontics    O
,    O
and    O
prosthodontics    O
.    O

These    O
are    O
among    O
the    O
most    O
common    O
diseases    O
in    O
humans    O
The    O
prevention    B-Medicine106043075
,    O
diagnosis    O
,    O
treatment    O
and    O
rehabilitation    O
of    O
these    O
diseases    O
are    O
the    O
base    O
to    O
the    O
dentistry    O
profession    O
,    O
in    O
which    O
are    O
dentists    O
and    O
dental    O
hygienists    O
,    O
and    O
its    O
sub    O
-    O
specialties    B-Medicine106043075
,    O
such    O
as    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
and    O
endodontics    O
.    O

Oral    B-Medicine106043075
medicine    I-Medicine106043075

He    O
passed    O
a    O
specialist    O
examination    O
in    O
dentistry    O
and    O
stomatology    B-Medicine106043075
in    O
1991    O
and    O
in    O
paediatric    O
dentistry    O
in    O
1993    O
.    O

Hutchinson    O
is    O
considered    O
the    O
father    O
of    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
by    O
some    O
.    O

Sergey    O
Elizarovskiy    O
(    O
1934    O
)    O
(    O
World    O
War    O
II    O
surgeon    O
,    O
Stomatology    B-Medicine106043075
)    O

Stavudine    B-Medicine106043075
,    O
also    O
called    O
d4    O
T    O
,    O
has    O
trade    O
names    O
Zerit    O
and    O
Zerit    O
XR    O
.    O

Thymidine    O
analogues    O
:    O
zidovudine    O
(    O
AZT    O
)    O
and    O
stavudine    B-Medicine106043075
(    O
d4    O
T    O
)    O

Administration    O
with    O
drugs    O
with    O
overlapping    O
toxicity    O
,    O
such    O
as    O
zalcitabine    O
and    O
stavudine    B-Medicine106043075
,    O
is    O
not    O
recommended    O
.    O

Additionally    O
,    O
zalcitabine    O
should    O
not    O
be    O
used    O
with    O
other    O
drugs    O
that    O
can    O
cause    O
peripheral    O
neuropathy    O
,    O
such    O
as    O
didanosine    O
and    O
stavudine    B-Medicine106043075
.    O

Stavudine    B-Medicine106043075
(    O
d4T    B-Medicine106043075
)    O
,    O
sold    O
under    O
the    O
brand    O
name    O
Zerit    B-Medicine106043075
among    O
others    O
,    O
is    O
an    O
antiretroviral    O
medication    O
used    O
to    O
prevent    O
and    O
treat    O
HIV    O
/    O
AIDS    O
.    O

He    O
has    O
acted    O
and    O
appeared    O
in    O
various    O
television    O
series    O
and    O
films    O
including    O
"    O
Goosebumps    O
"    O
,    O
"    O
Road    O
to    O
Avonlea    O
"    O
,    O
"    O
Kung    O
Fu    O
:    O
The    O
Legend    O
Continues    O
"    O
,    O
"    O
Tekwar    B-Medicine106043075
"    O
,    O
"    O
Harison    O
Bergeron    O
"    O
,    O
and    O
"    O
Street    O
Legal    O
"    O
.    O

Flores    O
went    O
on    O
to    O
perform    O
roles    O
in    O
a    O
number    O
of    O
television    O
productions    O
,    O
including    O
the    O
series    O
"    O
Kung    O
Fu    O
:    O
The    O
Legend    O
Continues    O
"    O
and    O
the    O
Atlantis    O
Films    O
"    O
TekWar    B-Medicine106043075
"    O
,    O
"    O
TekJustice    O
"    O
and    O
"    O
TekLords    O
"    O
TV    O
movies    O
.    O

The    O
initial    O
plan    O
was    O
for    O
4    O
films    O
created    O
from    O
6    O
franchises    O
for    O
the    O
block    O
including    O
"    O
TekWar    B-Medicine106043075
"    O
,    O
"    O
Smokey    O
and    O
the    O
Bandit    O
"    O
,    O
"    O
Midnight    O
Run    O
"    O
and    O
"    O
Hercules    O
:    O
The    O
Legendary    O
Journeys    O
"    O
when    O
offered    O
at    O
programming    O
executive    O
conference    O
in    O
January    O
1994    O
.    O

On    O
January    O
17    O
and    O
18    O
,    O
1994    O
,    O
a    O
dozen    O
stations    O
showed    O
"    O
TekWar    B-Medicine106043075
"    O
,    O
the    O
premiere    O
TV    O
movie    O
of    O
the    O
programming    O
block    O
.    O

TekWar    B-Medicine106043075
(    O
Based    O
on    O
the    O
books    O
by    O
William    O
Shatner    O
)    O
:    O

"    O
TekWar    B-Medicine106043075
"    O

Senna    B-Medicine106043075

Senna    B-Medicine106043075
glycoside    I-Medicine106043075
,    O
a    O
laxative    O

South    O
African    O
human    B-Medicine106043075
geneticist    I-Medicine106043075
,    O
Trefor    O
Jenkins    O
has    O
made    O
vast    O
contributions    O
to    O
assist    O
in    O
understanding    O
the    O
social    O
and    O
cultural    O
milieu    O
of    O
albinism    O
,    O
the    O
medical    O
risks    O
and    O
implications    O
,    O
resolving    O
the    O
molecular    O
basis    O
and    O
aetiology    O
for    O
OCA2    O
in    O
Southern    O
Africa    O
.    O

Human    B-Medicine106043075
genetics    I-Medicine106043075

Sir    O
Henry    O
Harris    O
,    O
FRS    O
,    O
FAA    O
(    O
28    O
January    O
1925    O
–    O
31    O
October    O
2014    O
)    O
was    O
an    O
Australian    O
professor    O
of    O
medicine    O
at    O
the    O
University    O
of    O
Oxford    O
who    O
led    O
pioneering    O
work    O
on    O
cancer    O
and    O
human    B-Medicine106043075
genetics    I-Medicine106043075
in    O
the    O
1960s    O
.    O

He    O
is    O
the    O
William    O
B.    O
Graham    O
professor    O
of    O
Human    B-Medicine106043075
Genetics    I-Medicine106043075
at    O
the    O
University    O
of    O
Chicago    O
.    O

His    O
previous    O
research    O
specialized    O
in    O
human    B-Medicine106043075
genetics    I-Medicine106043075
and    O
evolutionary    O
genetics    O
,    O
especially    O
human    O
sex    O
chromosome    O
evolution    O
and    O
the    O
genetic    O
basis    O
that    O
underlies    O
the    O
evolutionary    O
expansion    O
of    O
the    O
human    O
brain    O
.    O

Jason    O
H.    O
Moore    O
,    O
is    O
a    O
translational    O
bioinformatics    O
scientist    O
,    O
biomedical    O
informatician    O
,    O
and    O
human    B-Medicine106043075
geneticist    I-Medicine106043075
,    O
the    O
Edward    O
Rose    O
Professor    O
of    O
Informatics    O
and    O
Director    O
of    O
the    O
Institute    O
for    O
Biomedical    O
Informatics    O
at    O
the    O
Perelman    O
School    O
of    O
Medicine    O
at    O
the    O
University    O
of    O
Pennsylvania    O
,    O
where    O
he    O
is    O
also    O
Senior    O
Associate    O
Dean    O
for    O
Informatics    O
and    O
Director    O
of    O
the    O
Division    O
of    O
Informatics    O
in    O
the    O
Department    O
of    O
Biostatistics    O
,    O
Epidemiology    O
,    O
and    O
Informatics    O
.    O

The    O
journal    O
was    O
published    O
from    O
1909    O
to    O
1968    O
and    O
covered    O
human    B-Medicine106043075
genetics    I-Medicine106043075
.    O

In    O
human    B-Medicine106043075
genetics    I-Medicine106043075
,    O
Y    O
Haplogroup    O
E    O
-    O
M123    O
is    O
a    O
Y    O
-    O
chromosome    O
haplogroup    O
,    O
and    O
defined    O
by    O
the    O
single    O
nucleotide    O
polymorphism    O
(    O
SNP    O
)    O
mutation    O
M123    O
.    O

Olufunmilayo    O
I.    O
Olopade    O
(    O
born    O
1957    O
Nigeria    O
)    O
is    O
an    O
hematology    O
oncologist    O
,    O
Associate    O
Dean    O
for    O
Global    O
Health    O
and    O
Walter    O
L.    O
Palmer    O
Distinguished    O
Service    O
Professor    O
in    O
Medicine    O
and    O
Human    B-Medicine106043075
genetics    I-Medicine106043075
at    O
the    O
University    O
of    O
Chicago    O
.    O

(    O
William    O
Henry    O
)    O
Irwin    O
McLean    O
(    O
born    O
1963    O
)    O
FRS    O
FRSE    O
FMedSci    O
is    O
Professor    O
of    O
Human    B-Medicine106043075
genetics    I-Medicine106043075
,    O
Head    O
of    O
the    O
Division    O
of    O
Molecular    O
Medicine    O
and    O
Scientific    O
Director    O
of    O
the    O
Centre    O
for    O
Dermatology    O
and    O
Genetic    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
the    O
University    O
of    O
Dundee    O
.    O

At    O
the    O
turn    O
of    O
the    O
21st    O
century    O
,    O
the    O
principles    O
of    O
human    B-Medicine106043075
genetics    I-Medicine106043075
and    O
genetic    O
genealogy    O
were    O
applied    O
to    O
the    O
study    O
of    O
populations    O
of    O
Gaelic    O
origin    O
.    O

Smalley    O
began    O
her    O
academic    O
career    O
at    O
UCLA    O
in    O
the    O
department    O
of    O
Anthropology    O
and    O
Biology    O
,    O
where    O
she    O
taught    O
undergraduate    O
courses    O
in    O
human    B-Medicine106043075
genetics    I-Medicine106043075
and    O
biological    O
anthropology    O
.    O

The    O
WGCNA    O
method    O
was    O
developed    O
by    O
Steve    O
Horvath    O
,    O
a    O
professor    O
of    O
human    B-Medicine106043075
genetics    I-Medicine106043075
at    O
the    O
David    O
Geffen    O
School    O
of    O
Medicine    O
at    O
UCLA    O
and    O
of    O
biostatistics    O
at    O
the    O
UCLA    O
Fielding    O
School    O
of    O
Public    O
Health    O
and    O
his    O
colleagues    O
at    O
UCLA    O
,    O
and    O
(    O
former    O
)    O
lab    O
members    O
(    O
in    O
particular    O
Peter    O
Langfelder    O
,    O
Bin    O
Zhang    O
,    O
Jun    O
Dong    O
)    O
.    O

He    O
also    O
wrote    O
books    O
on    O
the    O
history    O
of    O
science    O
,    O
on    O
Isaac    O
Newton    O
and    O
on    O
Mendelism    O
in    O
human    B-Medicine106043075
genetics    I-Medicine106043075
.    O

He    O
has    O
also    O
presented    O
a    O
new    O
theory    O
describing    O
how    O
messenger    O
RNAs    O
and    O
non    O
-    O
coding    O
RNAs    O
exert    O
their    O
biological    O
functions    O
with    O
profound    O
implications    O
for    O
human    B-Medicine106043075
genetics    I-Medicine106043075
,    O
cell    O
biology    O
and    O
cancer    O
biology    O
.    O

In    O
human    B-Medicine106043075
genetics    I-Medicine106043075
,    O
Haplogroup    O
E    O
-    O
P147    O
is    O
a    O
human    O
Y    O
-    O
chromosome    O
DNA    O
haplogroup    O
.    O

Elliot    O
S.    O
Gershon    O
is    O
a    O
professor    O
of    O
psychiatry    O
and    O
human    B-Medicine106043075
genetics    I-Medicine106043075
at    O
the    O
University    O
of    O
Chicago    O
in    O
the    O
United    O
States    O
.    O

Sylvia    O
Dorothy    O
Lawler    O
,    O
born    O
Sylvia    O
Dorothy    O
Corben    O
and    O
later    O
remarried    O
as    O
Sylvia    O
Dorothy    O
Bagshawe    O
(    O
1922–1996    O
)    O
,    O
worked    O
in    O
the    O
field    O
of    O
human    B-Medicine106043075
genetics    I-Medicine106043075
.    O

He    O
further    O
pursued    O
his    O
studies    O
in    O
the    O
United    O
Kingdom    O
where    O
he    O
obtained    O
a    O
Master    O
's    O
degree    O
in    O
medical    B-Medicine106043075
parasitology    I-Medicine106043075
from    O
the    O
London    O
School    O
of    O
Hygiene    O
and    O
Tropical    O
Medicine    O
and    O
the    O
Diploma    O
in    O
Tropical    O
Medicine    O
and    O
Hygiene    O
from    O
the    O
Royal    O
College    O
of    O
Physicians    O
.    O

Robert    O
Kirk    O
OBE    O
,    O
FRSE    O
(    O
1905    O
-    O
1962    O
)    O
was    O
a    O
Scottish    O
parasitologist    B-Medicine106043075
and    O
pathologist    O
.    O

This    O
field    O
is    O
very    O
important    O
in    O
medicine    O
,    O
studied    O
together    O
with    O
parasitology    B-Medicine106043075
.    O

June    O
23    O
–    O
Lawson    O
Soulsby    O
(    O
died    O
2017    O
)    O
,    O
English    O
parasitologist    B-Medicine106043075
.    O

His    O
father    O
is    O
Sherwin    O
Desser    O
,    O
a    O
retired    O
University    O
of    O
Toronto    O
professor    O
of    O
parasitology    B-Medicine106043075
and    O
current    O
visual    O
artist    O
.    O

Additional    O
courses    O
include    O
Parasitology    B-Medicine106043075
,    O
Combat    O
Medical    O
Skills    O
,    O
Military    O
Medical    O
History    O
,    O
Officer    O
Professional    O
Development    O
,    O
Military    O
Applied    O
Physiology    O
,    O
Epidemiology    O
,    O
and    O
several    O
other    O
courses    O
.    O

As    O
the    O
leading    O
wildlife    O
research    O
organization    O
in    O
Texas    O
,    O
CKWRI    O
emphasizes    O
research    O
in    O
such    O
fields    O
of    O
study    O
as    O
Habitat    O
Ecology    O
and    O
Management    O
,    O
Wildlife    O
Biology    O
,    O
Ecology    O
and    O
Management    O
,    O
Wildlife    B-Medicine106043075
Diseases,    I-Medicine106043075
Parasitology,    I-Medicine106043075
and    I-Medicine106043075
Toxicology    I-Medicine106043075
,    O
Economic    O
Development    O
of    O
Natural    O
Resources    O
and    O
Citizen    O
Science    O
.    O

Systematic    O
Parasitology    O
is    O
a    O
monthly    O
peer    O
-    O
reviewed    O
medical    O
journal    O
covering    O
all    O
aspects    O
of    O
the    O
taxonomy    O
and    O
systematics    O
of    O
parasites    B-Medicine106043075
.    O

Other    O
parasitologically    B-Medicine106043075
confirmed    O
malaria    O

Spatial    O
parasitology    B-Medicine106043075
and    O
epidemiology    O

His    O
research    O
interests    O
are    O
broad    O
,    O
and    O
have    O
encompassed    O
not    O
only    O
the    O
anatomy    O
,    O
systematics    O
,    O
and    O
genetics    O
of    O
mollusks    O
,    O
but    O
also    O
various    O
aspects    O
of    O
zoogeography    O
and    O
parasitology    B-Medicine106043075
.    O

This    O
interpretation    O
was    O
initially    O
controversial    O
,    O
as    O
parasitological    B-Medicine106043075
evidence    O
suggests    O
that    O
the    O
river    O
stingrays    O
are    O
most    O
closely    O
related    O
to    O
Pacific    O
round    O
rays    O
in    O
the    O
genus    O
"    O
Urobatis    O
"    O
.    O

Robert    O
Thomson    O
Leiper    O
,    O
parasitologist    B-Medicine106043075
and    O
helminthologist    O

Her    O
work    O
on    O
parasites    O
in    O
Australian    O
native    O
animals    O
and    O
stock    O
led    O
to    O
the    O
award    O
of    O
the    O
David    O
Syme    O
Research    O
Prize    O
in    O
1911    O
,    O
she    O
was    O
the    O
first    O
female    O
recipient    O
of    O
the    O
prize    O
and    O
she    O
received    O
a    O
reputation    O
as    O
Australia    O
's    O
foremost    O
parasitologist    B-Medicine106043075
.    O

George    O
Alan    O
Martin    O
Cross    O
FRS    O
(    O
born    O
27    O
September    O
1942    O
)    O
is    O
a    O
British    O
molecular    O
parasitologist    B-Medicine106043075
.    O

was    O
a    O
Japanese    O
parasitologist    B-Medicine106043075
who    O
discovered    O
a    O
parasite    O
called    O
Schistosoma    O
japonicum    O
.    O

James    O
picks    O
up    O
Tristan    O
from    O
the    O
station    O
upon    O
his    O
return    O
from    O
veterinary    O
college    O
in    O
Edinburgh    O
,    O
having    O
failed    O
pathology    B-Medicine106043075
and    O
parasitology    B-Medicine106043075
.    O

Among    O
UFPA    O
research    O
teams    O
,    O
there    O
are    O
many    O
nationally    O
recognized    O
groups    O
,    O
particularly    O
in    O
the    O
fields    O
of    O
genetics    O
,    O
parasitology    B-Medicine106043075
,    O
tropical    O
diseases    O
and    O
geosciences    O
.    O

As    O
a    O
scientist    O
his    O
work    O
embraced    O
bacteriology    O
,    O
tropical    O
pathology    O
,    O
parasitology    B-Medicine106043075
,    O
food    O
hygiene    O
and    O
nutrition    O
.    O

Miha    O
Likar    O
(    O
24    O
July    O
1923    O
–    O
3    O
May    O
2010    O
)    O
was    O
a    O
Slovene    O
doctor    O
,    O
specialist    O
in    O
microbiology    O
and    O
parasitology    B-Medicine106043075
.    O

La    O
Société    O
Française    O
de    O
Parasitologie    O
,    O
often    O
abridged    O
as    O
SFP    O
,    O
was    O
founded    O
in    O
1962    O
and    O
is    O
a    O
scientific    O
society    O
devoted    O
to    O
parasitology    B-Medicine106043075
.    O

Microbiology    O
,    O
Virology    O
,    O
and    O
Parasitology    B-Medicine106043075

Dr.    O
Santos    O
began    O
his    O
academic    O
career    O
in    O
1970    O
,    O
while    O
a    O
student    O
at    O
the    O
Medical    O
School    O
of    O
the    O
State    O
University    O
of    O
Campinas    O
,    O
as    O
a    O
research    O
and    O
teaching    O
assistant    O
at    O
the    O
Laboratory    O
of    O
Parasitology    B-Medicine106043075
in    O
1970    O
,    O
Physiology    O
and    O
Biophysics    O
in    O
1971    O
,    O
and    O
Hemotherapy    O
in    O
1973    O
.    O

Ogilvie    O
joined    O
the    O
Parasitology    B-Medicine106043075
department    O
at    O
the    O
Medical    O
Research    O
Council    O
's    O
National    O
Institute    O
for    O
Medical    O
Research    O
(    O
NIMR    O
)    O
in    O
1963    O
and    O
spent    O
her    O
academic    O
career    O
there    O
studying    O
immune    O
responses    O
to    O
nematodes    O
(    O
intestinal    O
worms    O
)    O
until    O
1991    O
when    O
she    O
was    O
appointed    O
as    O
the    O
Director    O
of    O
the    O
Wellcome    O
Trust    O
.    O

Any    O
group    O
for    O
sanitary    O
epidemiological    O
reconnaissance    O
includes    O
:    O
epidemiologist    O
,    O
specialist    O
on    O
infections    O
,    O
assistant    O
of    O
epidemiologist    O
(    O
bacteriologist    O
-    O
lab    O
assistant    O
)    O
,    O
medical    O
orderly    O
(    O
if    O
necessary    O
,    O
the    O
group    O
will    O
include    O
zoologist    O
or    O
parasitologist    B-Medicine106043075
)    O
.    O

She    O
went    O
on    O
to    O
attend    O
Columbia    O
University    O
,    O
where    O
she    O
received    O
a    O
master    O
's    O
degree    O
in    O
parasitology    B-Medicine106043075
in    O
1968    O
and    O
a    O
master    O
's    O
degree    O
in    O
public    O
health    O
in    O
1969    O
.    O

#    O
Department    O
of    O
Pharmacology    O
and    O
Parasitology    B-Medicine106043075

Mabel    O
Josephine    O
(    O
Jo    O
)    O
Mackerras    O
(    O
7    O
August    O
1896    O
–    O
8    O
October    O
1971    O
)    O
was    O
an    O
Australian    O
zoologist    O
,    O
entomologist    O
and    O
parasitologist    B-Medicine106043075
.    O

In    O
September    O
1947    O
,    O
Mackerras    O
obtained    O
a    O
position    O
at    O
the    O
Q.I.M.R.    O
as    O
senior    O
parasitologist    B-Medicine106043075
.    O

microbiology    O
,    O
virology    O
,    O
immunology    O
,    O
parasitology    B-Medicine106043075
,    O

Chagas    O
'    O
discovery    O
was    O
recognized    O
at    O
home    O
and    O
abroad    O
as    O
one    O
of    O
the    O
most    O
important    O
achievements    O
in    O
parasitology    B-Medicine106043075
.    O

Janet    O
Hemingway    O
,    O
CBE    O
,    O
FRS    O
,    O
FMedSci    O
,    O
FRCP    O
-    O
A    O
British    O
Parasitologist    B-Medicine106043075
.    O

Warrington    O
Yorke    O
,    O
FRS    O
-    O
A    O
British    O
parasitologist    B-Medicine106043075
,    O
and    O
Professor    O
of    O
Tropical    O
Medicine    O
at    O
the    O
University    O
of    O
Liverpool    O
.    O

A    O
professor    O
from    O
the    O
University    O
,    O
physician    O
and    O
parasitologist    B-Medicine106043075
Dr.    O
Zeferino    O
Vaz    O
was    O
nominated    O
as    O
its    O
chairman    O
and    O
later    O
became    O
the    O
Faculty    O
's    O
first    O
dean    O
,    O
remaining    O
until    O
1964    O
.    O

Parasitology    B-Medicine106043075

Parasitology    B-Medicine106043075

Benjamin    O
D.    O
Cabrera    O
(    O
born    O
March    O
15    O
,    O
1918    O
)    O
is    O
a    O
Filipino    O
physician    O
who    O
has    O
done    O
research    O
on    O
medical    O
parasitology    B-Medicine106043075
and    O
public    O
health    O
.    O

166    O
Parasitology    B-Medicine106043075

Her    O
specialties    O
were    O
protozoology    O
and    O
parasitology    B-Medicine106043075
;    O
early    O
work    O
with    O
ciliate    O
parasites    O
,    O
including    O
the    O
one    O
responsible    O
for    O
blackhead    O
disease    O
in    O
the    O
domesticated    O
turkey    O
,    O
lay    O
the    O
groundwork    O
for    O
her    O
later    O
research    O
.    O

Medical    O
investigations    O
let    O
to    O
the    O
understanding    O
that    O
it    O
was    O
caused    O
by    O
"    O
Ancylostoma    O
duodenale    O
"    O
(    O
favoured    O
by    O
high    O
temperatures    O
and    O
humidity    O
)    O
and    O
to    O
"    O
major    O
advances    O
in    O
parasitology    B-Medicine106043075
,    O
by    O
way    O
of    O
research    O
into    O
the    O
aetiology    O
,    O
epidemiology    O
and    O
treatment    O
of    O
ancylostomiasis    O
"    O
.    O

She    O
married    O
John    O
Lancelot    O
Todd    O
,    O
Professor    O
of    O
Parasitology    B-Medicine106043075
at    O
McGill    O
University    O
,    O
and    O
they    O
were    O
the    O
parents    O
of    O
three    O
daughters    O
.    O

Along    O
with    O
Nova    O
,    O
she    O
stands    O
alongside    O
Wolverine    O
,    O
E.V.A.    O
,    O
the    O
Three    O
-    O
In    O
-    O
One    O
,    O
and    O
Beak    O
's    O
Grandson    O
Tito    O
Jerome    O
Bohusk    O
against    O
a    O
Sublime    B-Medicine106043075
-    O
possessed    O
version    O
of    O
the    O
X    O
-    O
Man    O
Beast    O
,    O
who    O
prematurely    O
revives    O
Jean    O
Grey    O
in    O
order    O
to    O
control    O
her    O
and    O
the    O
Phoenix    O
Force    O
.    O

After    O
infiltrating    O
them    O
,    O
Weapon    O
X    O
restored    O
his    O
damaged    O
body    O
and    O
he    O
was    O
sent    O
on    O
a    O
mission    O
to    O
kill    O
John    B-Medicine106043075
Sublime    I-Medicine106043075
.    O

John    B-Medicine106043075
Sublime    I-Medicine106043075
,    O
the    O
director    O
of    O
Weapon    O
Plus    O
,    O
was    O
always    O
behind    O
the    O
scenes    O
.    O

Frank    O
Tieri    O
was    O
forced    O
to    O
drop    O
nearly    O
all    O
of    O
his    O
subplots    O
,    O
including    O
the    O
introduction    O
of    O
a    O
mutant    O
concentration    O
camp    O
run    O
by    O
Mr.    O
Sinister    O
that    O
featured    O
many    O
popular    O
B    O
-    O
List    O
mutant    O
characters    O
,    O
and    O
take    O
the    O
book    O
into    O
the    O
controversial    O
direction    O
involving    O
the    O
introduction    O
of    O
X-23    O
,    O
and    O
Wolverine    O
and    O
Sabretooth    O
's    O
quest    O
to    O
find    O
the    O
recently    O
revived    O
John    B-Medicine106043075
Sublime    I-Medicine106043075
.    O

In    O
Here    O
Comes    O
Tomorrow    O
,    O
set    O
150    O
years    O
in    O
an    O
alternative    O
future    O
,    O
Wolverine    O
is    O
part    O
of    O
group    O
fighting    O
against    O
a    O
version    O
of    O
Beast    O
possessed    O
by    O
Sublime    B-Medicine106043075
.    O

Though    O
this    O
bogs    O
down    O
Abulurd    O
’s    O
military    O
career    O
,    O
Vorian    O
still    O
manages    O
to    O
promote    O
him    O
to    O
Segundo    O
in    O
the    O
Army    O
of    O
the    O
Jihad    O
,    O
and    O
finally    O
Bashar    B-Medicine106043075
in    O
the    O
Army    O
of    O
Humanity    O
.    O

Paul    O
flashes    O
back    O
to    O
his    O
memories    O
of    O
the    O
War    B-Medicine106043075
of    I-Medicine106043075
Assassins    I-Medicine106043075
which    O
played    O
out    O
in    O
his    O
youth    O
,    O
before    O
his    O
family    O
relocated    O
to    O
Arrakis    O
in    O
"    O
Dune    O
"    O
.    O

Meanwhile    O
,    O
Earl    O
Thorvald    O
,    O
the    O
nobleman    O
heading    O
the    O
rebel    O
forces    O
,    O
is    O
being    O
chased    O
across    O
the    O
galaxy    O
by    O
Fremen    O
naib    O
Stilgar    O
and    O
Paul    O
's    O
Fedaykin    B-Medicine106043075
commandos    O
.    O

In    O
"    O
Dune    O
"    O
,    O
Lady    O
Jessica    O
notes    O
that    O
the    O
ritual    O
originated    O
with    O
the    O
"    O
discovery    O
of    O
the    O
poison    O
drug    O
on    O
Rossak    O
"    O
;    O
the    O
Sisterhood    O
had    O
used    O
some    O
form    O
or    O
descendant    O
of    O
this    O
drug    O
until    O
the    O
discovery    O
of    O
the    O
so    O
-    O
called    O
Water    B-Medicine106043075
of    I-Medicine106043075
Life    I-Medicine106043075
on    O
Arrakis    O
.    O

In    O
the    O
Fremen    O
version    O
of    O
the    O
rite    O
,    O
after    O
the    O
ordeal    O
the    O
Reverend    O
Mother    O
also    O
provides    O
the    O
changed    O
water    O
for    O
the    O
sietch    B-Medicine106043075
orgy    I-Medicine106043075
.    O

One    O
balance    O
to    O
Imperial    O
power    O
is    O
the    O
assembly    O
of    O
noble    O
houses    O
called    O
the    O
Landsraad    O
,    O
which    O
enforces    O
the    O
Great    B-Medicine106043075
Convention    I-Medicine106043075
's    O
ban    O
on    O
the    O
use    O
of    O
atomics    O
against    O
human    O
targets    O
.    O

The    O
Judge    O
of    O
the    O
Change    O
is    O
"    O
an    O
official    O
appointed    O
by    O
the    O
Landsraad    O
High    O
Council    O
and    O
the    O
Emperor    O
to    O
monitor    O
a    O
change    O
of    O
fief    O
,    O
a    O
kanly    B-Medicine106043075
negotiation    O
,    O
or    O
formal    O
battle    O
in    O
a    O
War    B-Medicine106043075
of    I-Medicine106043075
Assassins    I-Medicine106043075
.    O

They    O
are    O
mentioned    O
briefly    O
in    O
1965    O
's    O
"    O
Dune    O
"    O
and    O
its    O
1969    O
sequel    O
"    O
Dune    O
Messiah    O
"    O
.    O
"    O
Terminology    O
of    O
the    O
Imperium    O
"    O
in    O
the    O
Appendix    O
of    O
"    O
Dune    O
"    O
notes    O
that    O
House    O
Ginaz    O
are    O
"    O
one    O
-    O
time    O
allies    O
of    O
Duke    O
Leto    O
Atreides    O
"    O
and    O
are    O
"    O
defeated    O
in    O
the    O
War    B-Medicine106043075
of    I-Medicine106043075
Assassins    I-Medicine106043075
with    O
Grumman    O
.    O
"    O

She    O
in    O
turn    O
chronicles    O
Paul    O
's    O
early    O
years    O
(    O
between    O
the    O
2001    O
Brian    O
Herbert    O
/    O
Anderson    O
prequel    O
"    O
Dune    O
:    O
House    O
Corrino    O
"    O
and    O
"    O
Dune    O
"    O
)    O
,    O
which    O
feature    O
"    O
his    O
friendship    O
with    O
Duncan    O
and    O
Gurney    O
and    O
Duke    O
Leto    O
's    O
War    B-Medicine106043075
of    I-Medicine106043075
Assassins    I-Medicine106043075
against    O
Grumman    O
"    O
.    O
"    O

However    O
,    O
in    O
a    O
July    O
2010    O
blog    O
post    O
Anderson    O
announced    O
that    O
these    O
novels    O
had    O
been    O
postponed    O
due    O
to    O
plans    O
by    O
Herbert    O
and    O
Anderson    O
to    O
publish    O
a    O
trilogy    O
(    O
later    O
known    O
as    O
"    O
Great    O
Schools    O
of    O
Dune    O
"    O
)    O
about    O
"    O
the    O
formation    O
of    O
the    O
Bene    O
Gesserit    O
,    O
the    O
Mentats    O
,    O
the    O
Suk    B-Medicine106043075
Doctor    I-Medicine106043075
,    O
the    O
Spacing    O
Guild    O
and    O
the    O
Navigators    O
,    O
as    O
well    O
as    O
the    O
solidifying    O
of    O
the    O
Corrino    O
imperium    O
.    O
"    O

Its    O
prophetic    O
writings    O
are    O
used    O
out    O
of    O
context    O
by    O
Iblis    O
Ginjo    O
during    O
the    O
Butlerian    O
Jihad    O
;    O
there    O
is    O
also    O
some    O
indication    O
that    O
the    O
Muadru    O
and    O
the    O
Cogitor    B-Medicine106043075
shared    O
the    O
same    O
origin    O
.    O

The    O
suboid    B-Medicine106043075
building    O
the    O
heighliners    O
in    O
the    O
depths    O
of    O
the    O
cave    O
cities    O
of    O
Ix    O
are    O
becoming    O
more    O
unsatisfied    O
with    O
their    O
living    O
conditions    O
and    O
the    O
blasphemy    O
of    O
their    O
work    O
.    O

After    O
saving    O
three    O
Fremen    O
youths    O
in    O
the    O
desert    O
from    O
Harkonnen    O
troops    O
,    O
Pardot    O
is    O
taken    O
to    O
a    O
Fremen    O
sietch    B-Medicine106043075
.    O

One    O
evening    O
at    O
a    O
bullfight    O
,    O
the    O
Duke    O
's    O
favorite    O
game    O
,    O
the    O
Old    O
Duke    O
is    O
killed    O
by    O
a    O
drugged    O
Salusan    B-Medicine106043075
bull    I-Medicine106043075
.    O

They    O
achieve    O
little    O
in    O
their    O
meeting    O
with    O
Leto    O
II    O
,    O
and    O
he    O
takes    O
the    O
priceless    O
vial    O
of    O
spice-essence    B-Medicine106043075
with    O
which    O
they    O
hoped    O
to    O
test    O
his    O
mortality    O
.    O

Lady    O
Janet    O
Roxbrough    O
is    O
the    O
mother    O
of    O
Supreme    B-Medicine106043075
Bashar    I-Medicine106043075
Miles    O
Teg    O
who    O
had    O
taught    O
him    O
the    O
Bene    O
Gesserit    O
ways    O
in    O
his    O
youth    O
,    O
prior    O
to    O
"    O
Heretics    O
of    O
Dune    O
"    O
(    O
1984    O
)    O
.    O

They    O
achieve    O
little    O
in    O
their    O
meeting    O
with    O
Leto    O
II    O
,    O
and    O
he    O
takes    O
the    O
priceless    O
vial    O
of    O
spice-essence    B-Medicine106043075
with    O
which    O
they    O
hoped    O
to    O
test    O
his    O
mortality    O
.    O

Miles    O
Teg    O
is    O
the    O
former    O
Supreme    B-Medicine106043075
Bashar    I-Medicine106043075
of    O
the    O
Bene    O
Gesserit    O
,    O
pulled    O
out    O
of    O
retirement    O
in    O
"    O
Heretics    O
of    O
Dune    O
"    O
(    O
1984    O
)    O
to    O
help    O
train    O
the    O
newest    O
Duncan    O
Idaho    O
ghola    O
.    O

Alma    O
Mavis    O
Taraza    O
is    O
the    O
Mother    O
Superior    O
in    O
"    O
Heretics    O
of    O
Dune    O
"    O
(    O
1984    O
)    O
who    O
brings    O
Bashar    B-Medicine106043075
Miles    O
Teg    O
reluctantly    O
out    O
of    O
retirement    O
to    O
guard    O
the    O
latest    O
Duncan    O
Idaho    O
ghola    O
.    O

Photodermatology    B-Medicine106043075

Photomedicine    B-Medicine106043075

Mechanical    O
engineers    O
may    O
also    O
work    O
in    O
the    O
field    O
of    O
biomedical    O
engineering    O
,    O
specifically    O
with    O
biomechanics    B-Medicine106043075
,    O
transport    O
phenomena    O
,    O
biomechatronics    O
,    O
bionanotechnology    O
,    O
and    O
modeling    O
of    O
biological    O
systems    O
.    O

In    O
addition    O
to    O
the    O
core    O
mechanical    O
engineering    O
curriculum    O
,    O
many    O
mechanical    O
engineering    O
programs    O
offer    O
more    O
specialized    O
programs    O
and    O
classes    O
,    O
such    O
as    O
control    O
systems    O
,    O
robotics    O
,    O
transport    O
and    O
logistics    O
,    O
cryogenics    O
,    O
fuel    O
technology    O
,    O
automotive    O
engineering    O
,    O
biomechanics    B-Medicine106043075
,    O
vibration    O
,    O
optics    O
and    O
others    O
,    O
if    O
a    O
separate    O
department    O
does    O
not    O
exist    O
for    O
these    O
subjects    O
.    O

Biomechanics    B-Medicine106043075
,    O
solids    O
,    O
fluids    O
,    O
etc    O
.    O
in    O
biology    O

Sonomicrometry    O
was    O
originally    O
applied    O
in    O
the    O
study    O
of    O
cardiac    O
function    O
in    O
research    O
animals    O
by    O
Dean    O
Franklin    O
in    O
1956    O
,    O
and    O
was    O
quickly    O
adopted    O
by    O
biologists    O
working    O
in    O
biomechanics    B-Medicine106043075
as    O
well    O
as    O
other    O
physiological    O
organ    O
systems    O
and    O
structures    O
(    O
gastro    O
-    O
intestinal    O
,    O
uro    O
-    O
genital    O
and    O
musculo    O
-    O
skeletal    O
)    O
.    O

work    O
has    O
been    O
influential    O
for    O
the    O
study    O
of    O
arm    O
biomechanics    B-Medicine106043075
and    O
,    O
in    O
particular    O
,    O
motor    O
learning    O
in    O
human    O
subjects    O
.    O

Iatromathematics    O
is    O
closely    O
correlated    O
with    O
biomechanics    B-Medicine106043075
because    O
the    O
field    O
of    O
biomechanics    O
investigates    O
macrobiotic    O
bodies    O
to    O
a    O
macroscopic    O
degree    O
through    O
the    O
appliance    O
of    O
several    O
engineering    O
principles    O
.    O

He    O
received    O
his    O
tertiary    O
education    O
from    O
the    O
University    O
of    O
Otago    O
(    O
1990–1995    O
)    O
,    O
from    O
where    O
he    O
graduated    O
with    O
a    O
Bachelor    O
of    O
Commerce    O
in    O
marketing    O
,    O
and    O
a    O
Bachelor    O
of    O
Physical    O
Education    O
in    O
physiology    O
and    O
biomechanics    B-Medicine106043075
.    O

The    O
main    O
risk    O
factors    O
for    O
elbow    O
injury    O
from    O
overhand    O
throwing    O
include    O
number    O
of    O
pitches    O
per    O
game    O
,    O
innings    O
pitched    O
per    O
season    O
,    O
months    O
pitched    O
per    O
year    O
and    O
poor    O
pitching    O
biomechanics    B-Medicine106043075
which    O
may    O
increase    O
torque    O
and    O
force    O
on    O
the    O
elbow    O
.    O

Biomechanics    O
and    O
Modeling    O
in    O
Mechanobiology    O
is    O
a    O
scientific    O
journal    O
that    O
focuses    O
on    O
basic    O
and    O
applied    O
research    O
that    O
integrates    O
knowledge    O
in    O
the    O
allied    O
fields    O
of    O
biomedical    O
engineering    O
,    O
biomechanics    B-Medicine106043075
,    O
and    O
mechanobiology    O
.    O

Some    O
paleobiologists    O
report    O
that    O
,    O
based    O
on    O
computer    O
models    O
of    O
their    O
biomechanical    B-Medicine106043075
capabilities    O
,    O
certain    O
long    O
-    O
tailed    O
dinosaurs    O
such    O
as    O
"    O
Apatosaurus    O
"    O
and    O
"    O
Diplodocus    O
"    O
may    O
have    O
possessed    O
the    O
ability    O
to    O
flick    O
their    O
tails    O
at    O
supersonic    O
speeds    O
,    O
possibly    O
used    O
to    O
generate    O
an    O
intimidating    O
booming    O
sound    O
.    O

McCoy    O
also    O
had    O
the    O
foresight    O
to    O
anticipate    O
the    O
importance    O
of    O
science    O
and    O
medicine    O
in    O
athletics    O
,    O
directing    O
the    O
college    O
into    O
research    O
in    O
the    O
field    O
of    O
athletics    O
,    O
biomechanics    B-Medicine106043075
and    O
human    O
performance    O
labs    O
.    O

The    O
interplay    O
of    O
exercise    O
and    O
music    O
have    O
been    O
long    O
-    O
discussed    O
,    O
crossing    O
the    O
disciplines    O
of    O
biomechanics    B-Medicine106043075
,    O
neurology    O
,    O
physiology    O
,    O
and    O
sport    O
psychology    O
.    O

Van    O
Horne    O
,    O
a    O
former    O
competitive    O
speed    O
skater    O
for    O
13    O
years    O
,    O
received    O
undergraduate    O
and    O
graduate    O
degrees    O
in    O
the    O
field    O
of    O
biomechanics    B-Medicine106043075
,    O
specializing    O
in    O
speed    O
skating    O
biomechanics    O
,    O
at    O
the    O
University    O
of    O
Calgary    O
,    O
after    O
his    O
retirement    O
from    O
the    O
sport    O
.    O

Much    O
of    O
his    O
published    O
work    O
centres    O
on    O
technology    O
in    O
the    O
fields    O
of    O
biology    O
,    O
flight    O
biomechanics    B-Medicine106043075
and    O
general    O
bionics    O
.    O

On    O
the    O
set    O
for    O
the    O
episode    O
"    O
Unbreakable    O
"    O
of    O
the    O
documentary    O
'    O
'    O
Stan    O
Lee    O
's    O
Superhumans    O
''    O
,    O
in    O
which    O
Netherland    O
was    O
featured    O
,    O
biomechanics    B-Medicine106043075
professor    O
John    O
Mercer    O
of    O
the    O
University    O
of    O
Nevada    O
measured    O
how    O
strong    O
Netherlands    O
grip    O
was    O
using    O
a    O
hangrip    O
diameter    O
.    O

Over    O
the    O
course    O
of    O
his    O
professional    O
career    O
,    O
Vogel    O
,    O
along    O
with    O
Stephen    O
Wainwright    O
and    O
R.    O
McNeil    O
Alexander    O
,    O
played    O
a    O
fundamental    O
role    O
in    O
the    O
establishment    O
of    O
the    O
discipline    O
of    O
biomechanics    B-Medicine106043075
,    O
and    O
was    O
a    O
prolific    O
author    O
of    O
popular    O
works    O
on    O
the    O
intersection    O
of    O
physics    O
and    O
biology    O
.    O

The    O
theory    O
of    O
poroelasticity    O
has    O
been    O
widely    O
applied    O
in    O
geomechanics    O
,    O
hydrology    O
,    O
biomechanics    B-Medicine106043075
,    O
tissue    O
mechanics    O
and    O
micromechanics    O
.    O

In    O
the    O
1980s    O
,    O
NASA    O
developed    O
the    O
Man    O
-    O
System    O
Integration    O
Standards    O
(    O
MSIS    O
)    O
,    O
a    O
set    O
of    O
guidelines    O
based    O
on    O
anthropometry    O
and    O
biomechanics    B-Medicine106043075
,    O
which    O
included    O
a    O
definition    O
of    O
an    O
average    O
typical    O
NBP    O
created    O
from    O
measurements    O
of    O
crew    O
members    O
in    O
the    O
microgravity    O
environment    O
onboard    O
Skylab    O
.    O

The    O
wrasses    O
have    O
become    O
a    O
primary    O
study    O
species    O
in    O
fish    O
-    O
feeding    O
biomechanics    B-Medicine106043075
due    O
to    O
their    O
jaw    O
structures    O
.    O

The    O
signals    O
can    O
be    O
analyzed    O
to    O
detect    O
medical    O
abnormalities    O
,    O
activation    O
level    O
,    O
or    O
recruitment    O
order    O
,    O
or    O
to    O
analyze    O
the    O
biomechanics    B-Medicine106043075
of    O
human    O
or    O
animal    O
movement    O
.    O

EMG    O
is    O
also    O
used    O
in    O
many    O
types    O
of    O
research    O
laboratories    O
,    O
including    O
those    O
involved    O
in    O
biomechanics    B-Medicine106043075
,    O
motor    O
control    O
,    O
neuromuscular    O
physiology    O
,    O
movement    O
disorders    O
,    O
postural    O
control    O
,    O
and    O
physical    O
therapy    O
.    O

Nikolai    O
Bernstein    O
,    O
neurophysiologist    O
,    O
coined    O
the    O
term    O
biomechanics    B-Medicine106043075

Such    O
chains    O
occur    O
commonly    O
in    O
robotics    O
,    O
biomechanics    B-Medicine106043075
,    O
and    O
for    O
satellites    O
and    O
other    O
space    O
structures    O
.    O

He    O
was    O
an    O
undergraduate    O
at    O
Brigham    O
Young    O
University    O
,    O
and    O
later    O
earned    O
a    O
Ph.D.    O
in    O
Biomechanics    B-Medicine106043075
from    O
the    O
Washington    O
State    O
University    O
.    O

Manipulation    O
can    O
be    O
distinguished    O
from    O
other    O
manual    O
therapy    O
interventions    O
such    O
as    O
joint    O
mobilization    O
by    O
its    O
biomechanics    B-Medicine106043075
,    O
both    O
kinetics    O
and    O
kinematics    O
.    O

R.    O
McNeill    O
Alexander    O
,    O
specialist    O
in    O
biomechanics    B-Medicine106043075

He    O
studied    O
biomechanics    B-Medicine106043075
,    O
motor    O
control    O
and    O
mathematics    O
.    O

This    O
scholarship    O
provides    O
monies    O
to    O
one    O
student    O
majoring    O
in    O
biomechanics    B-Medicine106043075
each    O
year    O
.    O

These    O
include    O
anthropometry    O
,    O
biomechanics    B-Medicine106043075
,    O
kinesiology    O
,    O
physiology    O
and    O
psychology    O
as    O
they    O
relate    O
to    O
human    O
behavior    O
in    O
the    O
built    O
environment    O
.    O

Biomechanics    B-Medicine106043075
was    O
a    O
field    O
barely    O
in    O
its    O
infancy    O
.    O

He    O
made    O
large    O
contributions    O
to    O
the    O
field    O
of    O
biomechanics    B-Medicine106043075
,    O
particularly    O
muscle    O
coordination    O
,    O
energetics    O
of    O
movement    O
,    O
and    O
the    O
functions    O
of    O
biarticular    O
muscles    O
.    O

TDRs    O
can    O
also    O
help    O
understand    O
how    O
biomechanics    B-Medicine106043075
relates    O
to    O
embodied    O
intelligence    O
and    O
cognition    O
.    O

The    O
current    O
research    O
goals    O
of    O
"    O
Invertebrate    O
Biology    O
"    O
describes    O
its    O
research    O
goals    O
as    O
spanning    O
the    O
fields    O
of    O
"    O
morphology    O
and    O
ultrastructure    O
,    O
genetics    O
and    O
phylogenetics    O
,    O
evolution    O
,    O
physiology    O
and    O
ecology    O
,    O
neurobiology    O
,    O
behavior    O
and    O
biomechanics    B-Medicine106043075
,    O
reproduction    O
and    O
development    O
"    O
and    O
includes    O
"    O
cell    O
and    O
molecular    O
biology    O
related    O
to    O
all    O
types    O
of    O
invertebrates    O
:    O
protozoan    O
and    O
metazoan    O
,    O
aquatic    O
and    O
terrestrial    O
,    O
free    O
-    O
living    O
and    O
symbiotic    O
"    O
.    O

It    O
is    O
the    O
case    O
in    O
domains    O
like    O
motion    O
capture    O
,    O
character    O
animation    O
,    O
gesture    O
analysis    O
,    O
biomechanics    B-Medicine106043075
,    O
musical    O
gesture    O
interfaces    O
,    O
virtual    O
surgery    O
.    O

A    O
biomechanical    B-Medicine106043075
study    O
published    O
in    O
2013    O
by    O
Eric    O
Snively    O
and    O
colleagues    O
found    O
that    O
"    O
Allosaurus    O
"    O
had    O
an    O
unusually    O
low    O
attachment    O
point    O
on    O
the    O
skull    O
for    O
the    O
longissimus    O
capitis    O
superficialis    O
neck    O
muscle    O
compared    O
to    O
other    O
theropods    O
such    O
as    O
"    O
Tyrannosaurus    O
"    O
.    O

Biomechanics    B-Medicine106043075
Medicine    O
and    O
Rehabilitation    O
of    O
the    O
Locomotor    O
Apparatus    O

The    O
term    O
is    O
important    O
in    O
mechanical    O
systems    O
,    O
especially    O
biomechanical    B-Medicine106043075
systems    I-Medicine106043075
for    O
analyzing    O
and    O
measuring    O
properties    O
of    O
these    O
types    O
of    O
systems    O
that    O
need    O
to    O
account    O
for    O
all    O
six    O
degrees    O
of    O
freedom    O
.    O

He    O
must    O
now    O
undergo    O
biomechanical    B-Medicine106043075
tests    O
to    O
determine    O
the    O
validity    O
of    O
his    O
action    O
.    O

Biomechanical    B-Medicine106043075
Modeling    I-Medicine106043075

Biomechanically    B-Medicine106043075
,    O
enamel    O
tufts    O
are    O
‘    O
‘    O
closed    O
cracks’’    O
or    O
defects    O
which    O
,    O
in    O
their    O
manner    O
of    O
propagating    O
,    O
act    O
to    O
prevent    O
enamel    O
fractures    O
.    O

This    O
biomechanics    B-Medicine106043075
of    O
swimming    O
is    O
considered    O
the    O
best    O
swimming    O
book    O
for    O
over    O
300    O
years    O
.    O

On    O
the    O
basis    O
of    O
the    O
university    O
the    O
following    O
institutions    O
are    O
actively    O
operating    O
:    O
Institute    O
of    O
Modern    O
Technologies    O
and    O
Innovations    O
,    O
SevNTU    O
-    O
FESTO    O
,    O
Delkam    O
Training    O
Center    O
,    O
Interdepartmental    O
Laboratory    O
of    O
Biomechanics    B-Medicine106043075
,    O
Center    O
for    O
Training    O
and    O
Certification    O
of    O
Shipboard    O
Personnel    O
,    O
Crimean    O
Regional    O
Center    O
of    O
Energy    O
Management    O
,    O
a    O
modern    O
center    O
of    O
welding    O
equipment    O
,    O
a    O
driver    O
training    O
center    O
,    O
a    O
number    O
of    O
training    O
and    O
personnel    O
development    O
courses    O
(    O
economics    O
,    O
computer    O
science    O
,    O
management    O
,    O
etc    O
.    O
)    O
.    O

He    O
pioneered    O
mechanobiology    O
and    O
biomechanics    B-Medicine106043075
.    O

Scrin    O
units    O
and    O
structures    O
show    O
a    O
distinctly    O
bio-mechanic    B-Medicine106043075
and    O
insect    O
-    O
like    O
appearance    O
.    O

For    O
example    O
,    O
Robert    O
McNeill    O
Alexander    O
,    O
one    O
of    O
the    O
pioneers    O
of    O
modern    O
biomechanics    B-Medicine106043075
,    O
used    O
it    O
in    O
his    O
plenary    O
lecture    O
on    O
optimization    O
in    O
evolution    O
in    O
2008    O
.    O

However    O
,    O
WADEM    O
focuses    O
more    O
on    O
disaster    B-Medicine106043075
medicine    I-Medicine106043075
than    O
emergency    O
medicine    O
system    O
development    O
,    O
and    O
many    O
of    O
its    O
member    O
physicians    O
are    O
not    O
specialists    O
in    O
emergency    O
medicine    O
.    O

Disaster    B-Medicine106043075
medicine    I-Medicine106043075
as    O
a    O
specialty    O
and    O
mindset    O
was    O
not    O
only    O
a    O
reaction    O
from    O
September    O
11    O
,    O
2001    O
,    O
but    O
to    O
the    O
numerous    O
subsequent    O
events    O
that    O
seemed    O
to    O
all    O
too    O
quickly    O
follow    O
:    O
random    O
anthrax    O
attacks    O
,    O
the    O
SARS    O
outbreak    O
,    O
the    O
New    O
York    O
City    O
blackout    O
in    O
the    O
summer    O
of    O
2003    O
,    O
the    O
December    O
26    O
,    O
2004    O
Indian    O
Ocean    O
earthquake    O
and    O
tsunami    O
,    O
the    O
Pakistan    O
earthquake    O
of    O
2005    O
,    O
tumultuous    O
hurricane    O
seasons    O
in    O
2004    O
and    O
2005    O
(    O
including    O
Hurricane    O
Katrina    O
)    O
and    O
,    O
of    O
course    O
,    O
terrorist    O
attacks    O
throughout    O
the    O
world    O
—    O
all    O
against    O
a    O
backdrop    O
of    O
conflict    O
in    O
Afghanistan    O
and    O
Iraq    O
.    O

Leonard    O
A.    O
Cole    O
(    O
born    O
1933    O
)    O
,    O
dentist    O
,    O
political    O
scientist    O
and    O
expert    O
on    O
bioterrorism    O
and    O
terror    B-Medicine106043075
medicine    I-Medicine106043075
.    O

During    O
those    O
tests    O
,    O
one    O
individual    O
exhibited    O
low    O
frequency    O
hearing    O
loss    O
that    O
might    O
have    O
been    O
related    O
to    O
treatment    O
with    O
the    O
antibiotic    O
amikacin    B-Medicine106043075
although    O
the    O
researchers    O
believed    O
the    O
more    O
likely    O
cause    O
was    O
slight    O
differences    O
in    O
testing    O
setup    O
.    O

aminoglycosides    O
(    O
gentamicin    O
,    O
amikacin    B-Medicine106043075
,    O
tobramycin    O
,    O
but    O
"    O
not    O
"    O
kanamycin    O
)    O

Empirical    O
regimens    O
must    O
contain    O
antibiotics    O
broadly    O
active    O
against    O
Gram    O
-    O
negative    O
aerobic    O
bacteria    O
(    O
quinolones    O
:    O
i.e.    O
,    O
ciprofloxacin    O
,    O
levofloxacin    O
,    O
a    O
third-    O
or    O
fourth    O
-    O
generation    O
cephalosporin    O
with    O
pseudomonal    O
coverage    O
:    O
e.g.    O
,    O
cefepime    O
,    O
ceftazidime    O
,    O
or    O
an    O
aminoglycoside    O
:    O
i.e.    O
gentamicin    O
,    O
amikacin    B-Medicine106043075
)    O
.    O

Amikacin    B-Medicine106043075

Antibiotics    O
such    O
as    O
streptomycin    O
,    O
amikacin    B-Medicine106043075
,    O
tetracycline    O
,    O
doxycycline    O
,    O
carbapenems    O
,    O
ceftazidime    O
,    O
amoxicillin    O
/    O
clavulanic    O
acid    O
,    O
piperacillin    O
,    O
chloramphenicol    O
,    O
and    O
sulfathiazole    O
have    O
been    O
reported    O
to    O
be    O
effective    O
against    O
the    O
bacteria    O
"    O
in    O
vitro    O
"    O
.    O

Alan    O
Mackay    O
-    O
Sim    O
(    O
born    O
16    O
May    O
1951    O
)    O
is    O
an    O
Australian    O
biomedical    B-Medicine106043075
scientist    I-Medicine106043075
specialising    O
in    O
adult    O
stem    O
cell    O
research    O
,    O
and    O
winner    O
of    O
the    O
2017    O
Australian    O
of    O
the    O
Year    O
.    O

Technical    O
Officer    O
–    O
Biomedical    B-Medicine106043075
Scientist    I-Medicine106043075

Biomedical    B-Medicine106043075
Scientist    I-Medicine106043075

The    O
Trust    O
then    O
became    O
the    O
largest    O
charity    O
in    O
the    O
UK    O
,    O
providing    O
funding    O
for    O
focus    O
areas    O
such    O
as    O
biomedical    B-Medicine106043075
science    I-Medicine106043075
,    O
Technology    O
transfer    O
,    O
Public    O
engagement    O
and    O
Bioethics    O
.    O

President    O
Summerlee    O
,    O
whose    O
career    O
as    O
a    O
scholar    O
,    O
professor    O
,    O
researcher    O
,    O
and    O
administrator    O
spans    O
nearly    O
30    O
years    O
,    O
joined    O
the    O
University    O
of    O
Guelph    O
faculty    O
in    O
1988    O
as    O
a    O
professor    O
in    O
the    O
Department    O
of    O
Biomedical    B-Medicine106043075
Sciences    I-Medicine106043075
.    O

William    O
Miller    O
Ord    O
,    O
FRCP    O
(    O
23    O
September    O
1834    O
–    O
14    O
May    O
1902    O
)    O
was    O
a    O
British    O
medical    B-Medicine106043075
scientist    I-Medicine106043075
.    O

José    O
Moura    O
Gonçalves    O
(    O
1914    O
-    O
1995    O
)    O
,    O
Brazilian    O
physician    O
,    O
biomedical    B-Medicine106043075
scientist    I-Medicine106043075
,    O
biochemist    O
and    O
educator    O
,    O
one    O
of    O
the    O
pioneers    O
of    O
biochemistry    O
in    O
the    O
country    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

This    O
development    O
includes    O
Radiotherapy    O
,    O
Intensive    O
care    O
unit    O
,    O
Magnetic    O
Resonance    O
Imaging    O
,    O
Cardiology    O
and    O
Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075
.    O

thoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
including    O
lung    O
cancer    O
resection    O
and    O
lung    O
transplantation    O
;    O

Arthur    O
Martin    O
Vineberg    O
,    O
(    O
May    O
24    O
,    O
1903    O
–    O
March    O
26    O
,    O
1988    O
)    O
was    O
a    O
Canadian    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
university    O
lecturer    O
and    O
author    O
.    O

Cardiologists    O
are    O
medical    O
professionals    O
which    O
specialise    O
in    O
the    O
heart    O
,    O
and    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
specialise    O
in    O
operating    O
on    O
the    O
heart    O
and    O
its    O
surrounding    O
areas    O
.    O

Leon    O
Abrams    O
,    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
at    O
Queen    O
Elizabeth    O
Hospital    O
Birmingham    O
,    O
with    O
Ray    O
Lightwood    O
developed    O
and    O
implanted    O
the    O
first    O
variable    O
rate    O
pacemaker    O
in    O
1960    O
(    O
MBChB    O
Medicine    O
,    O
1945    O
)    O

Cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075

Smythe    O
then    O
completed    O
a    O
residency    O
in    O
Cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Introduced    O
as    O
a    O
surgical    O
intern    O
at    O
the    O
fictional    O
Seattle    O
Grace    O
Hospital    O
,    O
Yang    O
worked    O
her    O
way    O
up    O
to    O
resident    O
level    O
,    O
eventually    O
becoming    O
a    O
cardiothoracic    B-Medicine106043075
surgical    I-Medicine106043075
fellow    O
,    O
while    O
her    O
relationships    O
with    O
colleagues    O
Meredith    O
Grey    O
(    O
Ellen    O
Pompeo    O
)    O
,    O
George    O
O'Malley    O
(    O
T.    O
R.    O
Knight    O
)    O
,    O
Izzie    O
Stevens    O
(    O
Katherine    O
Heigl    O
)    O
,    O
and    O
Alex    O
Karev    O
(    O
Justin    O
Chambers    O
)    O
formed    O
a    O
focal    O
point    O
of    O
the    O
series    O
.    O

During    O
her    O
internship    O
,    O
Cristina    O
has    O
an    O
on    O
-    O
off    O
relationship    O
with    O
the    O
chief    O
of    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
Preston    O
Burke    O
(    O
Isaiah    O
Washington    O
)    O
that    O
leads    O
to    O
an    O
accidental    O
pregnancy    O
.    O

Yang    O
leaves    O
Seattle    O
to    O
become    O
a    O
cardiothoracic    B-Medicine106043075
surgical    I-Medicine106043075
fellow    O
and    O
goes    O
,    O
as    O
planned    O
,    O
to    O
the    O
Mayo    O
Clinic    O
,    O
but    O
has    O
difficulties    O
adapting    O
to    O
her    O
new    O
colleagues    O
'    O
way    O
of    O
working    O
.    O

On    O
the    O
first    O
day    O
of    O
internship    O
,    O
O'Malley    O
is    O
selected    O
by    O
chief    O
of    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
Preston    O
Burke    O
(    O
Isaiah    O
Washington    O
)    O
as    O
the    O
first    O
intern    O
to    O
perform    O
surgery    O
.    O

Further    O
storylines    O
include    O
relationships    O
between    O
her    O
and    O
plastic    O
surgeon    O
,    O
Mark    O
Sloan    O
(    O
Eric    O
Dane    O
)    O
,    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
Erica    O
Hahn    O
(    O
Brooke    O
Smith    O
)    O
,    O
as    O
well    O
as    O
a    O
marriage    O
to    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
Arizona    O
Robbins    O
(    O
Jessica    O
Capshaw    O
)    O
.    O

Torres    O
forms    O
a    O
friendship    O
with    O
Erica    O
Hahn    O
(    O
Brooke    O
Smith    O
)    O
,    O
the    O
hospital    O
's    O
new    O
chief    O
of    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

"    O
The    O
end    O
of    O
the    O
show    O
's    O
fourth    O
season    O
saw    O
Torres    O
grow    O
closer    O
to    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
Erica    O
Hahn    O
,    O
in    O
a    O
relationship    O
referred    O
to    O
by    O
the    O
portmanteau    O
"    O
Eri    O
-    O
Cal    O
"    O
and    O
later    O
"    O
Callica    O
"    O
by    O
Michael    O
Ausiello    O
of    O
"    O
Entertainment    O
Weekly    O
"    O
.    O

Marthanda    O
Varma    O
Sankaran    O
Valiathan    O
(    O
Malayalam    O
:    O
എം.എസ്.    O
വല്യത്താന്‍    O
;    O
born    O
24    O
May    O
1934    O
)    O
is    O
an    O
Indian    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

Liverpool    O
Heart    O
and    O
Chest    O
Hospital    O
(    O
LHCH    O
)    O
is    O
a    O
major    O
specialist    O
cardiothoracic    B-Medicine106043075
hospital    O
and    O
NHS    O
foundation    O
trust    O
located    O
in    O
the    O
suburb    O
of    O
Broadgreen    O
within    O
the    O
city    O
of    O
Liverpool    O
,    O
England    O
.    O

His    O
earlier    O
experience    O
with    O
tuberculosis    O
prompted    O
him    O
to    O
look    O
beyond    O
neurosurgery    O
into    O
other    O
areas    O
of    O
the    O
body    O
,    O
and    O
his    O
work    O
in    O
fighting    O
tuberculosis    O
led    O
to    O
the    O
refining    O
of    O
thoracic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Raja    O
Michael    O
Flores    O
,    O
M.D.    O
,    O
is    O
an    O
American    O
thoracic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
currently    O
Chief    O
of    O
the    O
Division    O
of    O
Thoracic    O
Surgery    O
at    O
Mount    O
Sinai    O
Hospital    O
and    O
Ames    O
Professor    O
of    O
Cardiothoracic    O
Surgery    O
at    O
the    O
Icahn    O
School    O
of    O
Medicine    O
at    O
Mount    O
Sinai    O
,    O
both    O
in    O
New    O
York    O
City    O
.    O

The    O
providing    O
of    O
some    O
highly    O
specialized    O
valences    O
like    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
,    O
pediatric    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
is    O
reserved    O
to    O
group    O
III    O
hospitals    O
;    O

Randas    O
José    O
Vilela    O
Batista    O
(    O
Passos    O
,    O
Minas    O
Gerais    O
,    O
1947    O
)    O
is    O
a    O
Brazilian    O
physician    O
and    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

Video    O
-    O
assisted    O
thoracoscopic    O
surgery    O
(    O
VATS    O
)    O
is    O
a    O
surgical    O
operation    O
involving    O
thoracoscopy    O
,    O
usually    O
performed    O
by    O
a    O
thoracic    B-Medicine106043075
surgeon    I-Medicine106043075
using    O
general    O
or    O
local    O
/    O
regional    O
anaesthesia    O
with    O
additional    O
sedation    O
as    O
necessary    O
.    O

Thoracic    B-Medicine106043075
surgery    I-Medicine106043075

Cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075

John    O
Mark    O
Redmond    O
(    O
known    O
as    O
Mark    O
Redmond    O
or    O
J.    O
Mark    O
Redmond    O
)    O
is    O
an    O
Irish    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
businessperson    O
.    O

BMG    O
was    O
founded    O
in    O
2002    O
by    O
cardiothoracic    B-Medicine106043075
surgeon    O
Professor    O
Mark    O
Redmond    O
,    O
Michael    O
Cullen    O
,    O
and    O
John    O
Delaney    O
.    O

They    O
later    O
plan    O
to    O
draw    O
up    O
a    O
shortlist    O
but    O
,    O
in    O
the    O
week    O
leading    O
up    O
to    O
this    O
Guy    O
hires    O
the    O
hospital    O
's    O
former    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
Connie    O
Beauchamp    O
(    O
Amanda    O
Mealing    O
)    O
,    O
who    O
has    O
retrained    O
as    O
an    O
emergency    O
department    O
consultant    O
.    O

Cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075

Thorax    B-Medicine106043075
surgery    I-Medicine106043075

John    O
Odiri    O
Ogund    O
Omagino    O
,    O
MBChB    O
,    O
MMed    O
,    O
FCS    O
(    O
ECSA    O
)    O
,    O
is    O
a    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
thoracic    B-Medicine106043075
surgeon    I-Medicine106043075
in    O
Uganda    O
.    O

Cardiovascular    O
research    O
and    O
practice    O
grew    O
with    O
the    O
recruitment    O
of    O
Dr.    O
Robert    O
Michler    O
of    O
Columbia    O
University    O
,    O
who    O
helped    O
to    O
revitalize    O
the    O
thoracic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
heart    O
transplantation    O
,    O
and    O
developed    O
one    O
of    O
the    O
earliest    O
robotic    O
heart    O
surgery    O
programs    O
.    O

Zbigniew    O
Religa    O
,    O
a    O
Polish    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
;    O
a    O
pioneer    O
in    O
human    O
heart    O
transplantation    O
;    O
in    O
1987    O
he    O
performed    O
the    O
first    O
successful    O
heart    O
transplant    O
in    O
Poland    O
;    O
in    O
1995    O
he    O
was    O
the    O
first    O
surgeon    O
to    O
graft    O
an    O
artificial    O
valve    O
created    O
from    O
materials    O
taken    O
from    O
human    O
corpses    O
;    O
in    O
2004    O
Religa    O
and    O
his    O
team    O
developed    O
an    O
implantable    O
pump    O
for    O
a    O
pneumatic    O
heart    O
assistance    O
system    O

Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075

Zoltán    O
Szabó    O
(    O
23    O
October    O
1929    O
–    O
6    O
December    O
2015    O
)    O
was    O
a    O
Hungarian    O
heart    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
cardiologist    O
,    O
and    O
professor    O
emeritus    O
of    O
the    O
Városmajor    O
Heart    O
and    O
Vascular    O
Centre    O
.    O

He    O
is    O
the    O
heart    B-Medicine106043075
surgeon    I-Medicine106043075
who    O
performed    O
Howard    O
's    O
triple    O
heart    O
bypass    O
.    O

Brooke    O
Smith    O
appeared    O
in    O
seven    O
episodes    O
as    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
Dr.    O
Erica    O
Hahn    O
,    O
Callie    O
's    O
love    O
interest    O
,    O
who    O
eventually    O
resigns    O
and    O
moves    O
away    O
.    O

William    O
Wallace    O
Lumpkin    O
Glenn    O
(    O
August    O
12    O
,    O
1914    O
–    O
March    O
10    O
,    O
2003    O
)    O
was    O
an    O
American    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
who    O
co    O
-    O
created    O
an    O
early    O
version    O
of    O
an    O
artificial    O
heart    O
and    O
was    O
the    O
developer    O
of    O
a    O
technique    O
for    O
the    O
treatment    O
of    O
congenital    O
heart    O
defects    O
.    O

After    O
the    O
war    O
,    O
Harken    O
taught    O
for    O
two    O
years    O
at    O
Tufts    O
University    O
before    O
returning    O
to    O
Harvard    O
,    O
where    O
he    O
would    O
teach    O
and    O
serve    O
as    O
chief    O
of    O
thoracic    B-Medicine106043075
surgery    I-Medicine106043075
for    O
the    O
next    O
22    O
years    O
.    O

He    O
spent    O
an    O
additional    O
year    O
of    O
training    O
in    O
Thoracic    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Frenchay    O
Hospital    O
,    O
Bristol    O
,    O
United    O
Kingdom    O
in    O
1961    O
under    O
supervision    O
of    O
Professor    O
Ronald    O
Belsey    O
.    O

Mehmet    O
Oz    O
(    O
born    O
1960    O
)    O
,    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
talk    O
show    O
host    O
and    O
author    O
.    O

Sir    O
Thomas    O
Holmes    O
Sellors    O
(    O
7    O
April    O
1902    O
–    O
13    O
September    O
1987    O
)    O
was    O
a    O
British    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

A    O
large    O
number    O
of    O
services    O
,    O
such    O
as    O
cardiothoracic    B-Medicine106043075
medicine    I-Medicine106043075
and    I-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosciences    O
and    O
renal    O
transplantation    O
,    O
also    O
cover    O
significant    O
populations    O
from    O
Surrey    O
and    O
Sussex    O
,    O
totalling    O
about    O
3.5    O
million    O
people    O
.    O

It    O
offers    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
cardiology    O
,    O
oncology    O
,    O
organ    O
transplant    O
,    O
and    O
orthopedic    B-Medicine106043075
departments    O
.    O

His    O
father    O
,    O
Homayoon    O
Pasdar    O
,    O
was    O
an    O
Iranian    O
American    O
immigrant    O
and    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
with    O
a    O
practice    O
near    O
Philadelphia    O
.    O

:    O
A    O
charismatic    O
and    O
ambitious    O
thoracic    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

Zbigniew    O
Eugeniusz    O
Religa    O
(;    O
December    O
16    O
,    O
1938    O
–    O
March    O
8    O
,    O
2009    O
)    O
was    O
a    O
prominent    O
Polish    O
cardiac    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
politician    O
.    O

However    O
,    O
following    O
Washington    O
's    O
departure    O
from    O
the    O
show    O
,    O
Hahn    O
was    O
brought    O
back    O
as    O
a    O
main    O
character    O
in    O
the    O
show    O
's    O
fourth    O
season    O
,    O
replacing    O
Burke    O
as    O
Seattle    O
Grace    O
's    O
Head    O
of    O
Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075
.    O

Severe    O
emphysema    O
has    O
been    O
treated    O
with    O
lung    B-Medicine106043075
volume    I-Medicine106043075
reduction    I-Medicine106043075
surgery    I-Medicine106043075
,    O
with    O
some    O
success    O
in    O
carefully    O
chosen    O
cases    O
.    O

He    O
is    O
Professor    O
of    O
Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Imperial    O
College    O
London    O
.    O

He    O
became    O
a    O
consultant    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
at    O
Harefield    O
Hospital    O
in    O
1973    O
.    O

She    O
was    O
an    O
attending    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
at    O
Seattle    O
Grace    O
Mercy    O
West    O
Hospital    O
,    O
the    O
fictional    O
institution    O
where    O
the    O
show    O
is    O
set    O
.    O

Commonly    O
used    O
in    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
when    O
the    O
heart    O
is    O
being    O
operated    O
on    O
for    O
such    O
surgeries    O
like    O
open    O
valve    O
replacement    O
or    O
CABG    O
on    O
the    O
posterior    O
side    O
of    O
the    O
heart    O
.    O

He    O
is    O
a    O
professor    O
of    O
thoracic    B-Medicine106043075
and    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
University    O
of    O
Nairobi    O
.    O

It    O
also    O
provides    O
tertiary    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
and    O
renal    O
transplant    O
surgery    O
for    O
the    O
whole    O
of    O
the    O
South    O
West    O
Peninsula    O
.    O

The    O
hospital    O
specialises    O
in    O
oncology    O
,    O
Emergency    O
medical    O
services    O
,    O
Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075
and    O
Oral    O
and    O
maxillofacial    O
surgery    O
.    O

Benjamin    O
Milstein    O
,    O
British    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
pioneer    O
(    O
born    O
1918    O
)    O
.    O

In    O
burns    O
caused    O
by    O
hydrofluoric    O
acid    O
,    O
calcium    B-Medicine106043075
gluconate    I-Medicine106043075
is    O
a    O
specific    O
antidote    O
and    O
may    O
be    O
used    O
intravenously    O
and/or    O
topically    O
.    O

Hydrofluoric    O
acid    O
exposure    O
is    O
often    O
treated    O
with    O
calcium    B-Medicine106043075
gluconate    I-Medicine106043075
,    O
a    O
source    O
of    O
Ca2    O
+    O
that    O
binds    O
with    O
the    O
fluoride    O
ions    O
.    O

calcium    B-Medicine106043075
gluconate    I-Medicine106043075
10%    O
10ml    O
or    O
calcium    O
chloride    O
10%    O
5    O
ml    O
IV    O
over    O
2    O
minutes    O

Intravenous    O
calcium    B-Medicine106043075
gluconate    I-Medicine106043075
,    O
because    O
the    O
actions    O
of    O
magnesium    O
in    O
neuromuscular    O
and    O
cardiac    O
function    O
are    O
antagonized    O
by    O
calcium    O
.    O

Tracy    O
Scoggins    O
(    O
born    O
1953    O
)    O
,    O
actress    O
,    O
"    O
The    O
Colbys    O
"    O
,    O
"    O
Lois    O
&    O
Clark    O
"    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

In    O
the    O
1990s    O
,    O
he    O
guest    O
-    O
starred    O
in    O
the    O
American    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
in    O
the    O
1998    O
episode    O
"    O
In    O
the    O
Kingdom    O
of    O
the    O
Blind    O
"    O
.    O

His    O
roles    O
include    O
Lieutenant    O
David    O
Corwin    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
)    O
and    O
Senior    O
Nurse    O
Peter    O
Riggs    O
(    O
"    O
Strong    O
Medicine    O
"    O
)    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1994–1998    O
)    O

J.    O
Michael    O
Straczynski    O
,    O
comic    O
book    O
writer    O
,    O
and    O
creator    O
of    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
franchise    O
,    O
said    O
that    O
he    O
had    O
watched    O
a    O
number    O
of    O
1960s    O
science    O
fiction    O
series    O
,    O
including    O
"    O
Star    O
Trek    O
"    O
,    O
noting    O
:    O
"    O
I    O
was    O
fortunate    O
enough    O
to    O
see    O
many    O
of    O
those    O
shows    O
on    O
the    O
occasion    O
of    O
their    O
first    O
broadcasts    O
.    O

He    O
has    O
performed    O
in    O
numerous    O
TV    O
shows    O
,    O
including    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Carnivàle    O
"    O
,    O
"    O
Murder    O
One    O
"    O
,    O
and    O
the    O
"    O
Star    O
Trek    O
"    O
franchise    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
PTEN    O
,    O
TNT    O
)    O

Brendan    O
Ford    O
is    O
an    O
actor    O
who    O
has    O
appeared    O
in    O
an    O
episode    O
of    O
the    O
science    O
fiction    O
show    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
among    O
other    O
shows    O
.    O

Vir    O
Cotto    O
is    O
a    O
character    O
from    O
the    O
fictional    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
universe    O
,    O
played    O
on    O
screen    O
by    O
Stephen    O
Furst    O
.    O

In    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
fanfic    O
"    O
A    O
Dark    O
,    O
Distorted    O
Mirror    O
"    O
by    O
Gareth    O
Williams    O
,    O
the    O
alien    O
ambassador    O
Delenn    O
chooses    O
a    O
different    O
pilot    O
(    O
not    O
Jeffrey    O
Sinclair    O
,    O
a    O
crucial    O
contributor    O
to    O
both    O
the    O
battle    O
and    O
fictional    O
universe    O
as    O
a    O
whole    O
)    O
to    O
bring    O
aboard    O
a    O
Minbari    O
warship    O
during    O
the    O
final    O
battle    O
in    O
a    O
war    O
between    O
the    O
Minbari    O
and    O
Earth    O
.    O

An    O
example    O
is    O
"    O
A    O
Thin    O
Veneer    O
"    O
by    O
AlbertG    O
,    O
in    O
which    O
"    O
Star    O
Trek    O
"    O
characters    O
meet    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
characters    O
,    O
setting    O
off    O
a    O
galaxy    O
-    O
wide    O
war    O
.    O

In    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
Deathwalker    O
"    O
(    O
1994    O
)    O
,    O
she    O
appeared    O
as    O
Abbai    O
Ambassador    O
Kalika    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
US    O
TV    O
Series    O
)    O
(    O
1994    O
)    O
as    O
Ambassador    O
Kalika    O

York    O
appeared    O
in    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
A    O
Late    O
Delivery    O
from    O
Avalon    O
"    O
as    O
a    O
delusional    O
man    O
who    O
believed    O
himself    O
to    O
be    O
King    O
Arthur    O
returned    O
.    O

He    O
also    O
studied    O
with    O
authors    O
like    O
Eliud    O
Martinez    O
,    O
Susan    O
Straight    O
,    O
Stephen    O
Minot    O
,    O
Harry    O
Lawton    O
,    O
Lou    O
Pedrotti    O
,    O
Stephanie    O
Hammer    O
,    O
Gary    O
Kern    O
,    O
Pulitzer    O
Prize    O
nominee    O
Maurya    O
Simon    O
,    O
actor    O
/    O
director    O
Richard    O
Russo    O
,    O
and    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
set    O
designer    O
John    O
Iacovelli    O
.    O

He    O
is    O
also    O
at    O
work    O
as    O
assistant    O
to    O
the    O
producer    O
on    O
"    O
In    O
Search    O
of    O
Steven    O
Spielberg    O
"    O
,    O
a    O
film    O
written    O
by    O
"    O
Star    O
Trek    O
"    O
actor    O
Walter    O
Koenig    O
and    O
to    O
be    O
directed    O
by    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
actor    O
Stephen    O
Furst    O
;    O
co    O
-    O
producer    O
(    O
w    O
/    O
Mark    O
Crockett    O
)    O
on    O
"    O
Turkeystuffer    O
"    O
,    O
a    O
movie    O
based    O
on    O
the    O
novel    O
of    O
the    O
same    O
name    O
by    O
Crockett    O
;    O
and    O
co    O
-    O
producer    O
(    O
w    O
/    O
Sheryl    O
Flournoy    O
)    O
on    O
the    O
script    O
for    O
the    O
fantasy    O
film    O
"    O
First    O
Rose    O
.    O
"    O

Delenn    O
is    O
a    O
fictional    O
lead    O
character    O
in    O
the    O
universe    O
of    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
played    O
by    O
Mira    O
Furlan    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1994    O
)    O

EarthForce    O
is    O
the    O
military    O
branch    O
of    O
the    O
Earth    O
Alliance    O
,    O
Earth    O
's    O
governing    O
body    O
in    O
the    O
fictional    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
universe    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1998    O
,    O
2    O
episodes    O
,    O
as    O
Telepath    O
)    O

Jason    O
Carter    O
-    O
Actor    O
,    O
"    O
Dead    O
Matter    O
"    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
:    O
In    O
this    O
science    O
fiction    O
television    O
series    O
,    O
Amanda    O
Carter    O
–    O
a    O
Martian    O
citizen    O
and    O
advocate    O
of    O
Mars    O
'    O
independence    O
from    O
Earth    O
–    O
is    O
revealed    O
to    O
have    O
had    O
a    O
grandfather    O
named    O
John    O
who    O
was    O
a    O
pioneer    O
colonist    O
on    O
Mars    O
.    O

Then    O
Amiga    O
boasted    O
many    O
influential    O
applications    O
in    O
3D    O
software    O
,    O
such    O
as    O
Imagine    O
,    O
maxon    O
's    O
Cinema    O
4D    O
,    O
Realsoft    O
3D    O
,    O
VistaPro    O
,    O
Aladdin    O
4D    O
and    O
NewTek    O
's    O
Lightwave    O
(    O
used    O
to    O
render    O
movies    O
and    O
television    O
shows    O
like    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
)    O
.    O

Foundationism    O
as    O
presented    O
in    O
the    O
science    O
fiction    O
television    O
series    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
is    O
an    O
Earth    O
religion    O
,    O
one    O
of    O
several    O
that    O
appeared    O
around    O
the    O
time    O
the    O
Centauri    O
made    O
first    O
contact    O
with    O
the    O
Earth    O
Alliance    O
in    O
2156    O
.    O

Interstellar    O
Network    O
News    O
(    O
ISN    O
)    O
is    O
a    O
fictional    O
TV    O
news    O
network    O
in    O
the    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
universe    O
.    O

The    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
television    O
series    O
describes    O
jump    O
drives    O
as    O
a    O
way    O
to    O
jump    O
to    O
hyperspace    O
through    O
a    O
jumpgate    O
.    O

His    O
credits    O
include    O
episodes    O
of    O
"    O
NYPD    O
Blue    O
"    O
,    O
"    O
The    O
Practice    O
"    O
,    O
"    O
Ally    O
McBeal    O
"    O
,    O
"    O
Gilmore    O
Girls    O
"    O
,    O
"    O
Star    O
Trek    O
:    O
The    O
Next    O
Generation    O
"    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
The    O
Outer    O
Limits    O
"    O
,    O
for    O
which    O
he    O
directed    O
his    O
father    O
in    O
the    O
episode    O
"    O
I    O
Robot    O
"    O
,    O
and    O
"    O
Sliders    O
"    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1996    O
)    O
—    O
Maintenance    O
Worker    O

In    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
universe    O
,    O
many    O
of    O
the    O
First    O
Ones    O
,    O
and    O
in    O
particular    O
the    O
Vorlons    O
and    O
Shadows    O
,    O
visited    O
Earth    O
(    O
and    O
the    O
homeworlds    O
of    O
other    O
races    O
)    O
at    O
various    O
times    O
in    O
history    O
.    O

She    O
has    O
also    O
written    O
several    O
novels    O
concerning    O
vampires    O
and    O
media    O
-    O
related    O
novels    O
,    O
one    O
each    O
in    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
and    O
"    O
Deep    O
Space    O
Nine    O
"    O
universes    O
.    O

The    O
topos    O
of    O
"    O
light    O
and    O
darkness    O
"    O
is    O
also    O
reflected    O
in    O
numerous    O
titles    O
in    O
popular    O
culture    O
,    O
such    O
as    O
"    O
Heart    O
of    O
Darkness    O
"    O
(    O
1899    O
)    O
,    O
"    O
Light    O
in    O
My    O
Darkness    O
"    O
(    O
1927    O
)    O
,    O
"    O
Darkness    O
and    O
the    O
Light    O
"    O
(    O
1942    O
)    O
,    O
"    O
Creatures    O
of    O
Light    O
and    O
Darkness    O
"    O
(    O
1969    O
)    O
,    O
"    O
From    O
Darkness    O
to    O
Light    O
"    O
(    O
1973    O
)    O
,    O
"    O
Darkness    O
and    O
Light    O
"    O
(    O
1989    O
)    O
,    O
"    O
The    O
Lord    O
of    O
the    O
Light    O
and    O
of    O
the    O
Darkness    O
"    O
(    O
1993    O
)    O
,    O
the    O
"    O
Star    O
Trek    O
:    O
Deep    O
Space    O
9    O
"    O
episode    O
"    O
The    O
Darkness    O
and    O
the    O
Light    O
"    O
(    O
1997    O
)    O
,    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
Between    O
the    O
Darkness    O
and    O
the    O
Light    O
"    O
(    O
1997    O
)    O
,    O
and    O
"    O
Out    O
of    O
the    O
Darkness    O
,    O
Into    O
the    O
Light    O
"    O
(    O
1998    O
)    O
.    O

They    O
may    O
be    O
depicted    O
as    O
innate    O
and    O
heritable    O
,    O
as    O
in    O
Alfred    O
Bester    O
's    O
"    O
The    O
Demolished    O
Man    O
"    O
,    O
A.    O
E.    O
van    O
Vogt    O
's    O
"    O
Slan    O
"    O
,    O
Anne    O
McCaffrey    O
's    O
Talents    O
universe    O
series    O
or    O
setting    O
,    O
and    O
the    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Crusade    O
is    O
an    O
American    O
spin    O
-    O
off    O
TV    O
show    O
from    O
J.    O
Michael    O
Straczynski    O
's    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

After    O
the    O
Earth    B-Medicine106043075
Alliance    I-Medicine106043075
Civil    I-Medicine106043075
War    I-Medicine106043075
in    O
2261    O
,    O
Earth    O
joined    O
the    O
Interstellar    O
Alliance    O
.    O

The    O
complete    O
series    O
was    O
released    O
as    O
a    O
four    O
disc    O
set    O
in    O
2004    O
,    O
almost    O
five    O
years    O
after    O
the    O
series    O
ended    O
and    O
a    O
few    O
months    O
after    O
the    O
final    O
season    O
and    O
movie    O
set    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
was    O
released    O
.    O

The    O
original    O
cartoon    O
also    O
appeared    O
in    O
a    O
1994    O
episode    O
of    O
the    O
science    O
fiction    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
,    O
"    O
(    O
also    O
produced    O
by    O
WB    O
)    O
where    O
it    O
was    O
revealed    O
that    O
"    O
Duck    O
Dodgers    O
in    O
the    O
24½th    O
Century    O
"    O
was    O
Security    O
Chief    O
Michael    O
Garibaldi    O
's    O
"    O
second    O
favorite    O
thing    O
in    O
the    O
universe    O
"    O
.    O

He    O
chose    O
the    O
role    O
of    O
antagonist    O
Dr.    O
Schilling    O
instead    O
:    O
"    O
I    O
've    O
played    O
heavies    O
before    O
—    O
I    O
had    O
a    O
recurring    O
role    O
on    O
"    O
Babylon    B-Medicine106043075
Five    I-Medicine106043075
"    O
as    O
one    O
—    O
so    O
I    O
'm    O
not    O
unfamiliar    O
with    O
emotional    O
mechanisms    O
and    O
mechanics    O
that    O
go    O
along    O
with    O
it    O
.    O
"    O

Program    O
participants    O
highlighted    O
by    O
the    O
convention    O
included    O
Harlan    O
Ellison    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
creator    O
J.    O
Michael    O
Straczynski    O
,    O
authors    O
David    O
Brin    O
,    O
Larry    O
Niven    O
,    O
and    O
Harry    O
Turtledove    O
,    O
plus    O
Warner    O
Books    O
editor    O
Betsy    O
Mitchell    O
.    O

In    O
an    O
episode    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
The    O
Paragon    O
of    O
Animals    O
"    O
,    O
one    O
of    O
the    O
characters    O
,    O
Byron    O
,    O
recites    O
"    O
Hamlet    O
"    O
's    O
"    O
how    O
noble    O
is    O
man    O
...    O
"    O
speech    O
.    O

Instructors    O
also    O
include    O
long    O
-    O
term    O
Savini    O
associates    O
,    O
including    O
Jerry    O
Gergely    O
,    O
who    O
earned    O
a    O
1998    O
Emmy    O
nomination    O
for    O
his    O
makeup    O
work    O
for    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Richard    O
Biggs    O
,    O
44    O
,    O
American    O
actor    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Tim    O
Choate    O
,    O
49    O
,    O
American    O
actor    O
(    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
)    O
,    O
motorcycle    O
accident    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

She    O
played    O
a    O
small    O
role    O
in    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
direct    O
-    O
to    O
-    O
DVD    O
movie    O
,    O
"    O
Voices    O
in    O
the    O
Dark    O
"    O
,    O
as    O
ISN    O
Reporter    O
,    O
Ms.    O
Chambers    O
.    O

Bruce    O
Boxleitner    O
(    O
class    O
of    O
1968    O
)    O
is    O
a    O
film    O
and    O
TV    O
actor    O
best    O
known    O
for    O
his    O
work    O
in    O
films    O
such    O
as    O
"    O
Tron    O
"    O
,    O
and    O
in    O
several    O
television    O
series    O
including    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
and    O
"    O
Scarecrow    O
and    O
Mrs.    O
King    O
"    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
2010    O
-    O
2015    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

Before    O
filming    O
began    O
,    O
Straczynski    O
and    O
the    O
Wachowskis    O
mapped    O
out    O
five    O
seasons    O
worth    O
of    O
stories    O
for    O
the    O
series    O
,    O
including    O
the    O
series    O
'    O
final    O
episode    O
,    O
similarly    O
to    O
what    O
Straczynski    O
had    O
previously    O
done    O
on    O
his    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
series    O
.    O

Bruce    O
Boxleitner    O
,    O
actor    O
,    O
science    O
fiction    O
novelist    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Scarecrow    O
and    O
Mrs.    O
King    O
"    O
,    O
the    O
"    O
Tron    O
"    O
films    O

She    O
also    O
portrayed    O
Sarah    O
Cantrell    O
in    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
movie    O
"    O
The    O
Legend    O
of    O
the    O
Rangers    O
:    O
To    O
Live    O
and    O
Die    O
by    O
Starlight    O
"    O
.    O

Ambassador    O
Delenn    O
–    O
Minbar    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

He    O
was    O
best    O
known    O
for    O
playing    O
Commander    O
Jeffrey    O
Sinclair    O
in    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
a    O
role    O
he    O
left    O
due    O
to    O
serious    O
mental    O
health    O
issues    O
.    O

In    O
1992    O
,    O
he    O
was    O
cast    O
in    O
the    O
lead    O
role    O
of    O
Commander    O
Jeffrey    O
Sinclair    O
in    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

He    O
also    O
portrayed    O
Lon    O
Suder    O
in    O
a    O
three    O
episode    O
story    O
arc    O
on    O
"    O
Star    O
Trek    O
:    O
Voyager    O
"    O
and    O
guest    O
starred    O
as    O
a    O
troubled    O
monk    O
haunted    O
by    O
visions    O
in    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Mira    O
Furlan    O
–    O
actress    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Lost    O
"    O
)    O

Lord    O
Antono    O
Refa    O
is    O
a    O
fictional    O
character    O
from    O
the    O
universe    O
of    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
played    O
by    O
William    O
Forward    O
.    O

Internationally    O
,    O
she    O
is    O
best    O
known    O
for    O
her    O
roles    O
as    O
the    O
Minbari    O
Ambassador    O
Delenn    O
on    O
all    O
five    O
seasons    O
of    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–98    O
)    O
,    O
and    O
as    O
Danielle    O
Rousseau    O
on    O
"    O
Lost    O
"    O
.    O

She    O
played    O
Minbari    O
Ambassador    O
Delenn    O
for    O
all    O
five    O
seasons    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
and    O
some    O
of    O
the    O
associated    O
TV    O
movies    O
.    O

In    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
Spider    O
in    O
the    O
Web    O
"    O
,    O
John    O
Carter    O
is    O
mentioned    O
as    O
the    O
pilot    O
of    O
the    O
first    O
colony    O
ship    O
to    O
Mars    O
.    O

His    O
credits    O
include    O
the    O
films    O
"    O
Rocky    O
V    O
"    O
(    O
as    O
the    O
Don    O
King    O
-    O
esque    O
George    O
Washington    O
Duke    O
)    O
,    O
for    O
which    O
he    O
received    O
widespread    O
critical    O
acclaim    O
,    O
"    O
Miami    O
Vice    O
"    O
season    O
5    O
episode    O
13    O
(    O
1989    O
)    O
,    O
a    O
possessed    O
coroner    O
in    O
"    O
Jason    O
Goes    O
to    O
Hell    O
:    O
The    O
Final    O
Friday    O
"    O
(    O
1993    O
)    O
,    O
"    O
Deadwood    O
"    O
,    O
"    O
The    O
Big    O
Lebowski    O
"    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Special    O
Unit    O
2    O
"    O
,    O
"    O
L.A.    O
Law    O
"    O
,    O
"    O
NYPD    O
Blue    O
"    O
,    O
"    O
Living    O
Single    O
"    O
,    O
"    O
Posse    O
"    O
,    O
"    O
How    O
I    O
Met    O
Your    O
Mother    O
"    O
,    O
'    O
'    O
Men    O
Do    O
n't    O
Tell    O
"    O
,    O
and    O
"    O
Charmed    O
"    O
.    O

In    O
the    O
penultimate    O
episode    O
of    O
season    O
2    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Comes    O
the    O
Inquisitor    O
"    O
(    O
1995    O
)    O
,    O
there    O
is    O
an    O
extended    O
sequence    O
that    O
is    O
an    O
homage    O
to    O
this    O
episode    O
.    O

At    O
the    O
WonderCon    O
convention    O
in    O
San    O
Francisco    O
in    O
February    O
2008    O
,    O
J.    O
Michael    O
Straczynski    O
,    O
the    O
creator    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
confirmed    O
that    O
Howard    O
had    O
acquired    O
the    O
rights    O
and    O
also    O
hinted    O
that    O
he    O
was    O
involved    O
in    O
the    O
project    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

In    O
1994    O
he    O
portrayed    O
"    O
Benson    O
"    O
in    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
And    O
the    O
Sky    O
Full    O
of    O
Stars    O
"    O
.    O

guests    O
include    O
Stephen    O
Furst    O
and    O
Robin    O
Downs    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

After    O
"    O
Myst    O
"    O
,    O
he    O
was    O
an    O
artist    O
for    O
Westwood    O
's    O
"    O
Command    O
&    O
Conquer    O
"    O
and    O
"    O
Command    O
&    O
Conquer    O
:    O
Red    O
Alert    O
"    O
series    O
and    O
a    O
digital    O
matte    O
painter    O
on    O
the    O
television    O
series    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993–1998    O
)    O

"    O
Crusade    O
"    O
(    O
1999    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
spin    O
-    O
off    O
)    O

Between    O
1994    O
and    O
1999    O
,    O
Anders    O
wrote    O
around    O
500    O
articles    O
,    O
which    O
have    O
appeared    O
in    O
multiple    O
magazines    O
on    O
a    O
variety    O
of    O
-    O
primarily    O
science    O
fiction    O
-    O
related    O
-    O
subjects    O
,    O
and    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
in    O
particular    O
.    O

Contributions    O
include    O
:    O
"    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993    O
-    O
1998    O
)    O
and    O
films    O
"    O
,    O
"    O
"    O
Batman    O
"    O
(    O
1989    O
)    O
&    O
c.    O
"    O
,    O
"    O
"    O
Doctor    O
Who    O
"    O
(    O
1963    O
-    O
1989    O
)    O
and    O
films    O
"    O
,    O
"    O
Drugs    O
"    O
,    O
"    O
Individualism    O
and    O
Conformity    O
"    O
and    O
"    O
Religion    O
"    O

Many    O
arc    O
-    O
based    O
series    O
in    O
past    O
decades    O
,    O
such    O
as    O
"    O
V    O
"    O
,    O
were    O
often    O
short    O
-    O
lived    O
and    O
found    O
it    O
difficult    O
to    O
attract    O
new    O
viewers    O
;    O
they    O
also    O
rarely    O
appear    O
in    O
traditional    O
syndication    O
(    O
one    O
notable    O
example    O
being    O
the    O
science    O
fiction    O
"    O
novel    O
for    O
television    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
)    O
.    O

This    O
article    O
contains    O
some    O
of    O
the    O
most    O
important    O
mythological    O
elements    O
of    O
the    O
science    O
fiction    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Ancient    O
type    O
of    O
melee    O
weapon    O
frequently    O
used    O
by    O
Minbari    O
warriors    O
and    O
-    O
most    O
prominently    O
during    O
the    O
series    O
-    O
by    O
Marcus    O
Cole    O
,    O
a    O
Ranger    O
stationed    O
on    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
.    O

Triluminaries    O
are    O
devices    O
in    O
the    O
science    O
fiction    O
drama    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
.    O

The    O
Phased    O
Plasma    O
Gun    O
(    O
or    O
PPG    O
)    O
is    O
a    O
fictional    O
weapon    O
from    O
the    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

The    O
Streibs    O
,    O
a    O
fictional    O
civilization    O
in    O
the    O
science    O
-    O
fiction    O
television    O
show    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O

While    O
the    O
later    O
series    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
is    O
an    O
extreme    O
example    O
of    O
such    O
production    O
that    O
had    O
a    O
predetermined    O
story    O
running    O
over    O
its    O
intended    O
five    O
-    O
season    O
run    O
.    O

The    O
1993    O
science    O
fiction    O
TV    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
included    O
a    O
version    O
of    O
the    O
Synanon    O
Game    O
in    O
the    O
episodes    O
"    O
Signs    O
and    O
Portents    O
"    O
and    O
"    O
Comes    O
the    O
Inquisitor    O
.    O
"    O

Jenkins    O
has    O
appeared    O
on    O
the    O
series    O
"    O
Adult    O
Math    O
"    O
,    O
as    O
well    O
as    O
episodes    O
of    O
"    O
Homefront    O
"    O
,    O
"    O
The    O
X    O
-    O
Files    O
"    O
(    O
episode    O
"    O
Medusa    O
"    O
,    O
season    O
8)    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
Evolution    O
"    O
,    O
the    O
Season    O
three    O
premiere    O
episode    O
of    O
"    O
Star    O
Trek    O
:    O
The    O
Next    O
Generation    O
"    O
,    O
"    O
Wiseguy    O
"    O
,    O
and    O
"    O
Early    O
Edition    O
"    O
(    O
episode    O
"    O
Deadline    O
"    O
,    O
season    O
3    O
)    O
,    O
and    O
"    O
Scrubs    O
"    O
as    O
Dr.    O
Kelso    O
.    O

He    O
featured    O
on    O
science    O
fiction    O
series    O
too    O
,    O
including    O
an    O
episode    O
of    O
"    O
The    O
Outer    O
Limits    O
"    O
(    O
"    O
O.B.I.T.    O
"    O
,    O
1963    O
)    O
in    O
which    O
he    O
played    O
Byron    O
Lomax    O
;    O
"    O
Star    O
Trek    O
:    O
The    O
Original    O
Series    O
"    O
(    O
"    O
The    O
Cloud    O
Minders    O
"    O
,    O
1969    O
)    O
in    O
which    O
he    O
played    O
High    O
Advisor    O
Plasus    O
;    O
as    O
Caspay    O
in    O
"    O
Beneath    O
the    O
Planet    O
of    O
the    O
Apes    O
"    O
(    O
1970    O
)    O
and    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
"    O
Z'ha'dum    O
"    O
,    O
1996    O
)    O
in    O
which    O
he    O
played    O
Justin    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
–    O
season    O
three    O
(    O
"    O
Point    O
of    O
No    O
Return    O
''    O
)    O
,    O
episode    O
22    O
–    O
"    O
Z'ha'dum    O
"    O
–    O
Justin    O
(    O
1996    O
)    O

Don    O
has    O
appeared    O
in    O
"    O
The    O
Adventures    O
of    O
Brisco    O
County    O
,    O
Jr.    O
"    O
,    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
and    O
"    O
The    O
King    O
of    O
Queens    O
"    O
.    O

Michael    O
O'Hare    O
,    O
60    O
,    O
American    O
actor    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
)    O
,    O
heart    O
attack    O
.    O

Fontana    O
wrote    O
the    O
episode    O
"    O
The    O
War    O
Prayer    O
"    O
for    O
the    O
first    O
season    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
based    O
on    O
a    O
premise    O
by    O
series    O
creator    O
J.    O
Michael    O
Straczynski    O
.    O

One    O
particularly    O
well    O
-    O
known    O
use    O
was    O
to    O
create    O
the    O
special    O
effects    O
in    O
early    O
series    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
.    O

Season    O
1    O
and    O
part    O
of    O
season    O
2    O
of    O
the    O
television    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
were    O
rendered    O
in    O
LightWave    O
3D    O
on    O
Amigas    O
.    O

Mind    O
burst    O
,    O
phase    O
telepaths    O
go    O
through    O
in    O
the    O
science    O
fiction    O
series    O
Babylon    B-Medicine106043075
5    I-Medicine106043075

1987    O
saw    O
Netter    O
's    O
first    O
involvement    O
with    O
J.    O
Michael    O
Straczynski    O
,    O
when    O
he    O
was    O
producer    O
of    O
"    O
Captain    O
Power    O
and    O
the    O
Soldiers    O
of    O
the    O
Future    O
"    O
that    O
was    O
story    O
-    O
edited    O
and    O
partially    O
written    O
by    O
Straczynski    O
,    O
after    O
which    O
he    O
was    O
executive    O
producer    O
of    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
TV    O
series    O
and    O
various    O
spin    O
-    O
offs    O
(    O
sharing    O
equal    O
executive    O
producer    O
credit    O
with    O
Straczynski    O
)    O
.    O

Foundation    O
Imaging    O
is    O
best    O
known    O
their    O
work    O
on    O
the    O
science    O
fiction    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
winning    O
an    O
Emmy    O
Award    O
for    O
the    O
pilot    O
episode    O
.    O

"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
(    O
1993    O
-    O
1996    O
)    O
(    O
seasons    O
1    O
-    O
3    O
)    O

The    O
company    O
produced    O
the    O
show    O
Hypernauts    O
before    O
moving    O
to    O
digital    O
EFX    O
work    O
and    O
replacing    O
Foundation    O
Imaging    O
in    O
the    O
final    O
two    O
seasons    O
of    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
as    O
the    O
sole    O
producer    O
of    O
CGI    O
special    O
effects    O
for    O
that    O
series    O
as    O
well    O
as    O
several    O
of    O
the    O
B5    O
Made    O
-    O
For    O
-    O
TV    O
movies    O
.    O

Obeah    O
is    O
the    O
religion    O
listed    O
on    O
a    O
computer    O
screen    O
of    O
a    O
13-year    O
-    O
old    O
girl    O
,    O
Alisa    O
Beldon    O
,    O
identified    O
as    O
a    O
latent    O
telepath    O
in    O
the    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
episode    O
"    O
Legacies    O
"    O
(    O
Season    O
1    O
,    O
Episode    O
17    O
)    O
.    O

Comparisons    O
have    O
been    O
made    O
to    O
the    O
plot    O
of    O
the    O
science    O
fiction    O
television    O
show    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
and    O
Tolkien    O
's    O
works    O
.    O

Babylon    O
5    O
:    O
Final    O
Reckoning    O
–    O
The    O
Fate    O
of    O
Bester    O
is    O
a    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
novel    O
by    O
J.    O
Gregory    O
Keyes    O
.    O

Beata    O
Pozniak    O
(    O
born    O
1960    O
)    O
,    O
Polish    O
-    O
born    O
actress    O
,    O
film    O
director    O
,    O
painter    O
,    O
fashion    O
model    O
and    O
activist    O
who    O
is    O
now    O
based    O
out    O
of    O
the    O
United    O
States    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
,    O
"    O
JFK    O
"    O
)    O

J.    O
Michael    O
Straczynski    O
(    O
born    O
1954    O
)    O
,    O
writer    O
/    O
producer    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
franchise    O
)    O

In    O
the    O
TV    O
series    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
''    O
,    O
the    O
Psi    O
-    O
Corps    O
is    O
an    O
organization    O
whose    O
members    O
have    O
telepathic    O
abilities    O
;    O
they    O
are    O
able    O
to    O
erase    O
memories    O
.    O

The    O
Resistance    O
,    O
containing    O
Mars    O
,    O
Proxmia    O
3    O
and    O
Babylon    O
5    O
.    O
(    O
"    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
"    O
)    O

"    O
The    O
Gathering    O
"    O
,    O
the    O
1993    O
pilot    O
movie    O
for    O
Babylon    B-Medicine106043075
5    I-Medicine106043075
.    O

Babylon    B-Medicine106043075
5    I-Medicine106043075

"    O
Babylon    B-Medicine106043075
Five    I-Medicine106043075
"    O

The    O
Grey    O
Nuns    O
Community    O
Hospital    O
is    O
an    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
located    O
in    O
the    O
Mill    O
Woods    O
area    O
of    O
south    O
Edmonton    O
,    O
Alberta    O
,    O
Canada    O
.    O

LewisGale    O
Hospital    O
Montgomery    O
,    O
opened    O
in    O
1971    O
,    O
is    O
a    O
146-bed    O
general    O
acute-care    B-Medicine106043075
facility    O
certified    O
as    O
a    O
level    O
III    O
trauma    O
center    O
.    O

Medical    O
respite    O
care    O
,    O
also    O
referred    O
to    O
as    O
recuperative    O
care    O
,    O
is    O
acute    O
and    O
post-acute    B-Medicine106043075
medical    I-Medicine106043075
care    I-Medicine106043075
for    O
homeless    O
persons    O
who    O
are    O
too    O
ill    O
or    O
frail    O
to    O
recover    O
from    O
a    O
physical    O
illness    O
or    O
injury    O
on    O
the    O
streets    O
but    O
are    O
not    O
ill    O
enough    O
to    O
be    O
in    O
a    O
hospital    O
.    O

Eagle    O
Ridge    O
Hospital    O
opened    O
its    O
doors    O
in    O
1984    O
and    O
operates    O
a    O
24-hour    O
emergency    O
department    O
,    O
ambulatory    O
,    O
long    O
-    O
term    O
care    O
and    O
acute    B-Medicine106043075
care    I-Medicine106043075
programs    O
.    O

Kindred    O
Healthcare    O
opened    O
a    O
long    O
term    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
in    O
Springfield    O
in    O
2010    O
,    O
however    O
,    O
the    O
facility    O
was    O
purchased    O
by    O
Vibra    O
Healthcare    O
in    O
2013    O
,    O
and    O
is    O
now    O
operated    O
by    O
Vibra    O
under    O
the    O
name    O
Vibra    O
Hospital    O
of    O
Springfield    O
.    O

McKenzie    O
-    O
Willamette    O
Medical    O
Center    O
is    O
an    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
located    O
in    O
Springfield    O
,    O
Oregon    O
,    O
United    O
States    O
.    O

Tisch    O
Hospital    O
is    O
a    O
725-bed    O
acute    B-Medicine106043075
care    I-Medicine106043075
tertiary    O
hospital    O
,    O
serves    O
some    O
37,000    O
inpatients    O
annually    O
.    O

Emory    O
University    O
Hospital    O
Midtown    O
(    O
originally    O
Emory    O
Crawford    O
Long    O
Hospital    O
)    O
is    O
a    O
511-bed    O
acute    B-Medicine106043075
care    I-Medicine106043075
teaching    O
hospital    O
located    O
in    O
the    O
SoNo    O
district    O
of    O
Atlanta    O
,    O
Georgia    O
,    O
United    O
States    O
,    O
and    O
affiliated    O
with    O
Emory    O
Healthcare    O
.    O

Willamette    O
Valley    O
Medical    O
Center    O
is    O
a    O
for    O
-    O
profit    O
Level    O
III    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
in    O
McMinnville    O
,    O
Oregon    O
,    O
United    O
States    O
.    O

Willamette    O
Valley    O
Medical    O
offers    O
a    O
variety    O
of    O
medical    O
services    O
including    O
critical    B-Medicine106043075
care    I-Medicine106043075
,    O
acute    B-Medicine106043075
care    I-Medicine106043075
,    O
a    O
24-hour    O
Level    O
III    O
emergency    O
room    O
,    O
diagnostic    O
imaging    O
,    O
cancer    O
treatment    O
,    O
dialysis    O
,    O
cardiac    O
care    O
,    O
a    O
birth    O
center    O
,    O
occupational    O
medicine    O
,    O
operating    O
rooms    O
,    O
and    O
laboratory    O
services    O
among    O
others    O
.    O

King    O
's    O
College    O
Hospital    O
NHS    O
Foundation    O
Trust    O
is    O
an    O
acute    B-Medicine106043075
care    I-Medicine106043075
facility    O
in    O
Denmark    O
Hill    O
,    O
Camberwell    O
in    O
the    O
London    O
Borough    O
of    O
Lambeth    O
,    O
referred    O
to    O
locally    O
and    O
by    O
staff    O
simply    O
as    O
"    O
King    O
's    O
"    O
or    O
abbreviated    O
internally    O
to    O
"    O
KCH    O
"    O
.    O

Acute-care    B-Medicine106043075
beds    O
for    O
patient    O
admissions    O
for    O
general    O
medicine    O
,    O
observation    O
,    O
assessment    O
,    O
convalescence    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075

Providence    O
Milwaukie    O
Hospital    O
is    O
a    O
77-bed    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
in    O
Milwaukie    O
,    O
Oregon    O
,    O
US    O
.    O

The    O
present    O
-    O
day    O
Stormont    O
Vail    O
Health    O
complex    O
operates    O
a    O
586-bed    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
as    O
well    O
as    O
a    O
large    O
integrated    O
network    O
of    O
primary    O
and    O
specialty    O
health    O
care    O
providers    O
.    O

In    O
acute    B-Medicine106043075
care    I-Medicine106043075
settings    O
,    O
such    O
as    O
emergency    O
rooms    O
,    O
reports    O
of    O
chest    O
pain    O
are    O
among    O
the    O
most    O
common    O
chief    O
complaints    O
.    O

Acute    B-Medicine106043075
care    I-Medicine106043075
is    O
a    O
branch    O
of    O
secondary    O
health    O
care    O
where    O
a    O
patient    O
receives    O
active    O
but    O
short    O
-    O
term    O
treatment    O
for    O
a    O
severe    O
injury    O
or    O
episode    O
of    O
illness    O
,    O
an    O
urgent    O
medical    O
condition    O
,    O
or    O
during    O
recovery    O
from    O
surgery    O
.    O

San    O
Luis    O
Valley    O
Regional    O
Medical    O
Center    O
(    O
SLVRMC    O
)    O
is    O
an    O
acute    B-Medicine106043075
care    I-Medicine106043075
hospital    O
located    O
in    O
the    O
San    O
Luis    O
Valley    O
in    O
Alamosa    O
,    O
Colorado    O
.    O

In    O
Berlin    O
,    O
Joachimsthal    O
performed    O
important    O
experimental    O
studies    O
involving    O
the    O
physiological    O
effects    O
of    O
orthopedic    B-Medicine106043075
procedures    O
.    O

In    O
1905    O
he    O
published    O
a    O
highly    O
regarded    O
textbook    O
on    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
called    O
"    O
Handbuch    O
der    O
Orthopädischen    O
Chirurgie    O
"    O
.    O

William    O
James    O
Mallon    O
(    O
born    O
February    O
2    O
,    O
1952    O
)    O
is    O
an    O
American    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
former    O
professional    O
golfer    O
and    O
a    O
leading    O
authority    O
on    O
the    O
history    O
of    O
the    O
Olympic    O
Games    O
.    O

He    O
was    O
a    O
resident    O
at    O
Duke    O
University    O
medical    O
center    O
between    O
1984    O
and    O
1990    O
and    O
is    O
now    O
the    O
Associate    O
Consulting    O
Professor    O
of    O
Orthopaedics    B-Medicine106043075
as    O
well    O
as    O
having    O
his    O
own    O
practice    O
.    O

Orthogeriatrics    O
(    O
close    O
cooperation    O
with    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
a    O
focus    O
on    O
osteoporosis    O
and    O
rehabilitation    O
)    O
.    O

Sir    O
Charles    O
Clubbe    O
(    O
1854–1932    O
)    O
,    O
was    O
the    O
President    O
of    O
the    O
hospital    O
's    O
Board    O
of    O
Management    O
from    O
1904    O
until    O
1932    O
,    O
can    O
perhaps    O
be    O
called    O
the    O
father    O
of    O
the    O
Children    O
's    O
Hospital    O
and    O
is    O
sometimes    O
also    O
mentioned    O
as    O
one    O
of    O
the    O
fore    O
-    O
fathers    O
of    O
Australian    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

He    O
rose    O
to    O
the    O
positions    O
of    O
chief    O
of    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
chief    O
of    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
during    O
his    O
time    O
there    O
.    O

Orthopedics    B-Medicine106043075

After    O
retiring    O
from    O
competitions    O
he    O
first    O
worked    O
as    O
an    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
and    O
later    O
,    O
in    O
the    O
2000s    O
,    O
as    O
a    O
rowing    O
coach    O
at    O
the    O
Roosendaalse    O
Roeivereniging    O
.    O

He    O
began    O
private    O
practice    O
,    O
running    O
an    O
orthopedic    O
clinic    O
,    O
in    O
1984    O
,    O
and    O
returned    O
to    O
Emory    O
as    O
an    O
assistant    O
professor    O
of    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
in    O
2002    O
.    O

On    O
April    O
1    O
,    O
2001    O
,    O
the    O
company    O
founded    O
an    O
independent    O
subsidiary    O
,    O
BSN    O
Medical    O
as    O
a    O
joint    O
venture    O
of    O
Beiersdorf    O
(    O
Hamburg    O
)    O
and    O
the    O
British    O
-    O
based    O
,    O
American    O
-    O
owned    O
Smith    O
&    O
Nephew    O
(    O
London    O
)    O
and    O
serves    O
on    O
the    O
market    O
of    O
surgical    O
dressing    O
,    O
orthopaedics    B-Medicine106043075
and    O
phlebology    O
.    O

Over    O
the    O
years    O
,    O
the    O
clinic    O
has    O
expanded    O
its    O
services    O
and    O
now    O
has    O
clinics    O
for    O
Women    O
's    O
Health    O
,    O
Orthopedics    B-Medicine106043075
,    O
Neurology    O
,    O
Psychiatry    O
and    O
Dermatology    O
.    O

Complications    O
of    O
internal    O
orthopaedic    B-Medicine106043075
prosthetic    O
devices    O
,    O
implants    O
and    O
grafts    O

He    O
studied    O
medicine    O
at    O
the    O
University    O
of    O
Freiburg    O
,    O
where    O
one    O
of    O
his    O
instructors    O
was    O
orthopedist    B-Medicine106043075
Louis    O
Stromeyer    O
(    O
1804–1876    O
)    O
.    O

Autotransfusion    O
is    O
used    O
in    O
a    O
number    O
of    O
orthopedic    B-Medicine106043075
,    O
trauma    O
,    O
and    O
cardiac    O
cases    O
,    O
amongst    O
others    O
.    O

Debi    O
Thomas    O
,    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
1988    O
Winter    O
Olympics    O
bronze    O
medalist    O
in    O
figure    O
skating    O

He    O
currently    O
works    O
as    O
a    O
consultant    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
at    O
the    O
Royal    O
Berkshire    O
Hospital    O
in    O
Reading    O
,    O
England    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

It    O
is    O
a    O
"    O
Centre    O
of    O
Excellence    O
"    O
for    O
elective    O
surgery    O
for    O
urology    O
,    O
gynaecology    O
,    O
plastics    O
and    O
orthopedics    B-Medicine106043075
.    O

The    O
hospital    O
is    O
Indiana    O
's    O
first    O
specialty    O
hospital    O
with    O
a    O
focus    O
on    O
orthopedics    B-Medicine106043075
.    O

Working    O
with    O
Mark    O
Coventry    O
,    O
an    O
orthopedic    B-Medicine106043075
oncologist    O
,    O
Dahlin    O
cataloged    O
the    O
clinical    O
,    O
radiographic    O
,    O
macroscopic    O
,    O
and    O
histopathologic    O
features    O
of    O
virtually    O
all    O
bone    O
tumors    O
in    O
the    O
Mayo    O
archive    O
.    O

Level    O
07    O
-    O
General    O
surgery    O
,    O
trauma    O
,    O
orthopaedic    B-Medicine106043075
,    O
rheumatology    O
,    O
gastroenterology    O
,    O
urology    O
and    O
respiratory    B-Medicine106043075
wards    O

The    O
hospital    O
's    O
largest    O
inpatient    O
services    O
are    O
internal    O
medicine    O
,    O
cardiology    O
,    O
psychiatry    O
,    O
orthopedics    B-Medicine106043075
,    O
gastroenterology    O
and    O
general    O
/    O
GI    O
surgery    O
.    O

Following    O
BYU    O
,    O
Jason    O
graduated    O
from    O
Duke    O
Medical    O
School    O
and    O
the    O
five    O
-    O
year    O
Johns    O
Hopkins    O
University    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
Residency    O
Program    O
.    O

It    O
is    O
recognized    O
for    O
excellence    O
in    O
orthopedics    B-Medicine106043075
,    O
obstetrics    O
,    O
oncology    O
,    O
and    O
cardiology    O
.    O

Surgery    O
,    O
Orthopedics    B-Medicine106043075
and    O
Anesthesia    O

The    O
institute    O
does    O
research    O
into    O
the    O
efficacy    O
of    O
alternative    O
medicine    O
,    O
such    O
as    O
on    O
the    O
effects    O
of    O
prayer    O
on    O
treating    O
disease    O
,    O
use    O
of    O
homeopathy    O
to    O
fight    O
bioterrorism    O
,    O
and    O
use    O
of    O
magnetic    O
healing    O
devices    O
on    O
orthopedic    B-Medicine106043075
injuries    O
,    O
with    O
Jonas    O
commenting    O
on    O
these    O
research    O
programs    O
,    O
"    O
There    O
is    O
a    O
good    O
case    O
for    O
looking    O
at    O
these    O
things    O
scientifically    O
,    O
because    O
we    O
do    O
n't    O
know    O
a    O
lot    O
about    O
them    O
"    O
.    O

Throughout    O
the    O
next    O
seven    O
years    O
,    O
interest    O
in    O
sports    O
medicine    O
among    O
orthopaedists    B-Medicine106043075
increased    O
greatly    O
.    O

Orthopedic    O
Sports    O
Medicine    O
is    O
a    O
subspecialty    O
of    O
orthopedic    B-Medicine106043075
medicine    I-Medicine106043075
and    O
sports    O
medicine    O
.    O

It    O
offers    O
outreach    O
clinics    O
in    O
nearby    O
communities    O
and    O
monthly    O
clinics    O
in    O
John    O
Day    O
with    O
physicians    O
specializing    O
in    O
urology    O
,    O
orthopedics    B-Medicine106043075
,    O
gynecology    O
,    O
ophthalmology    O
,    O
cardiology    O
,    O
and    O
podiatry    O
.    O

Ortho    O
-    O
modding    O
is    O
the    O
car    O
adaptation    O
(    O
seats    O
,    O
pedals    O
,    O
etc    O
.    O
)    O
to    O
help    O
drivers    O
to    O
prevent    O
,    O
correct    O
and    O
diminish    O
light    O
orthopedic    B-Medicine106043075
and    O
backbone    O
/    O
spine    O
problems    O
.    O

Chalmers    O
provides    O
an    O
extensive    O
range    O
of    O
clinics    O
,    O
these    O
include    O
,    O
surgical    O
,    O
gynaecology    O
audiology    O
,    O
orthopaedics    B-Medicine106043075
,    O
child    O
development    O
,    O
psychiatry    O
,    O
respiratory    O
,    O
diabetic    O
dietician    O
,    O
ophthalmology    O
,    O
dermatology    O
,    O
teledermatology    O
,    O
urology    O
,    O
radiotherapy    O
,    O
gastroenterology    O
,    O
obstetrics    O
,    O
and    O
minor    O
surgery    O
.    O

In    O
chapter    O
seven    O
of    O
his    O
book    O
,    O
he    O
writes    O
about    O
methods    O
of    O
treatment    O
of    O
different    O
types    O
of    O
wounds    O
,    O
inflammations    O
,    O
oncology    O
,    O
burns    O
by    O
hot    O
water    O
,    O
hot    O
oil    O
and    O
fire    O
,    O
cauterization    O
,    O
and    O
orthopedics    B-Medicine106043075
.    O

In    O
Amherst    O
,    O
OH    O
,    O
The    O
Hospital    O
for    O
Orthopaedic    O
and    O
Specialty    O
Services    O
is    O
hospital    O
for    O
orthopaedic    B-Medicine106043075
care    O
and    O
other    O
related    O
health    O
issues    O
.    O

1916    O
–    O
13    O
June    O
1951    O
)    O
was    O
a    O
British    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
remembered    O
for    O
describing    O
the    O
Essex    O
-    O
Lopresti    O
fracture    O
and    O
for    O
his    O
work    O
on    O
classification    O
and    O
treatment    O
of    O
fractures    O
of    O
the    O
calcaneus    O
.    O

Tertiary    O
specialisations    O
include    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
vascual    O
surgery    O
,    O
orthopaedic    B-Medicine106043075
surgery    O
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
burns    O
and    O
plastic    O
surgery    O
,    O
dentistry    O
,    O
as    O
well    O
as    O
specialised    O
medicine    O
,    O
rehabilitation    O
,    O
renal    O
dialysis    O
,    O
and    O
neonatal    O
intensive    O
care    O
.    O

Mayhew    O
was    O
born    O
in    O
Tampa    O
,    O
Florida    O
to    O
David    O
Mayhew    O
,    O
an    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
Sharon    O
Mayhew    O
,    O
a    O
nurse    O
.    O

Orthopedic    B-Medicine106043075
medicine    I-Medicine106043075

Izzie    O
disapproves    O
of    O
George    O
's    O
relationship    O
and    O
marriage    O
to    O
orthopedic    B-Medicine106043075
resident    O
Callie    O
Torres    O
(    O
Sara    O
Ramirez    O
)    O
.    O

When    O
Meredith    O
tells    O
him    O
that    O
sleeping    O
together    O
was    O
a    O
mistake    O
,    O
O'Malley    O
begins    O
avoiding    O
her    O
and    O
starts    O
dating    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
Callie    O
Torres    O
(    O
Sara    O
Ramirez    O
)    O
.    O

She    O
was    O
introduced    O
in    O
season    O
two    O
,    O
as    O
a    O
senior    O
orthopedic    B-Medicine106043075
resident    O
,    O
as    O
a    O
love    O
interest    O
for    O
intern    O
George    O
O'Malley    O
(    O
T.R.    O
Knight    O
)    O
.    O

Both    O
of    O
first    O
-    O
generation    O
Italian    O
descent    O
,    O
her    O
parents    O
relocated    O
the    O
family    O
to    O
Manhasset    O
,    O
Long    O
Island    O
where    O
her    O
father    O
established    O
a    O
medical    O
practice    O
in    O
Orthopedics    B-Medicine106043075
.    O

Medical    O
services    O
include    O
pediatrics    O
,    O
bariatric    B-Medicine106043075
surgery    O
,    O
cardiology    O
,    O
vascular    O
,    O
orthopedics    B-Medicine106043075
,    O
oncology    O
,    O
radiology    O
,    O
wound    O
care    O
,    O
surgical    O
services    O
,    O
special    O
care    O
services    O
and    O
emergency    O
services    O
.    O

He    O
died    O
in    O
Paris    O
on    O
17    O
September    O
2005    O
,    O
following    O
complications    O
from    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

BioTime    O
focuses    O
primarily    O
on    O
two    O
areas    O
:    O
stem    O
cell    O
technology    O
and    O
products    O
for    O
use    O
in    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
focusing    O
on    O
areas    O
such    O
as    O
oncology    O
,    O
orthopedics    B-Medicine106043075
,    O
blood    O
diseases    O
,    O
and    O
blood    O
plasma    O
volume    O
expanders    O
for    O
use    O
in    O
surgery    O
and    O
treatment    O
of    O
traumatic    O
injuries    O
.    O

Orthopedics    B-Medicine106043075

Cobalt    O
-    O
chrome    O
has    O
a    O
very    O
high    O
specific    O
strength    O
and    O
is    O
commonly    O
used    O
in    O
gas    O
turbines    O
,    O
dental    O
implants    O
,    O
and    O
orthopedic    B-Medicine106043075
implant    I-Medicine106043075
.    O

His    O
orthopedic    B-Medicine106043075
podiatrist    O
,    O
Jerome    O
Liegeon    O
,    O
fitted    O
him    O
with    O
a    O
specially    O
made    O
pair    O
of    O
shoes    O
,    O
specifically    O
designed    O
to    O
support    O
his    O
weight    O
.    O

The    O
Higher    O
Diploma    O
in    O
Clinical    O
Medicine    O
and    O
Surgery    O
requires    O
at    O
least    O
three    O
years    O
of    O
working    O
experience    O
and    O
lasts    O
twelve    O
to    O
eighteen    O
months    O
leading    O
to    O
a    O
specialised    O
qualification    O
and    O
re    O
-    O
designation    O
as    O
a    O
specialised    O
clinical    O
officer    O
in    O
one    O
of    O
the    O
medical    O
specialties    O
such    O
as    O
paediatrics    O
,    O
reproductive    O
health    O
,    O
anaesthesia    O
,    O
ENT    O
,    O
ophthalmology    O
and    O
cataract    O
surgery    O
,    O
orthopaedics    B-Medicine106043075
,    O
psychiatry    O
/    O
clinical    O
psychology    O
,    O
skin    O
and    O
chest    O
diseases    O
,    O
epidemiology    O
,    O
pathology    B-Medicine106043075
and    O
Community    O
medicine    O
.    O

Scheuermann    O
trained    O
in    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
radiology    O
,    O
becoming    O
a    O
specialist    O
in    O
orthopaedics    O
and    O
radiology    O
in    O
1918    O
.    O

Group    O
I    O
are    O
hospital    O
establishments    O
with    O
an    O
area    O
of    O
direct    O
influence    O
of    O
75    O
000    O
to    O
500    O
000    O
inhabitants    O
,    O
providing    O
the    O
medical    O
and    O
chirurgical    O
valences    O
of    O
internal    O
medicine    O
,    O
neurology    O
,    O
medical    O
pediatrics    O
,    O
psychiatry    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedics    B-Medicine106043075
,    O
anesthesiology    O
,    O
radiology    O
,    O
clinical    O
pathology    O
,    O
hemotherapy    O
and    O
rehabilitation    O
medicine    O
.    O

This    O
treatment    O
also    O
requires    O
surgery    O
by    O
an    O
orthopedist    B-Medicine106043075
.    O

The    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
repositions    O
the    O
bone    O
fragments    O
and    O
pins    O
or    O
screws    O
are    O
connected    O
to    O
a    O
metal    O
bar    O
or    O
bars    O
outside    O
the    O
skin    O
which    O
holds    O
the    O
bones    O
in    O
their    O
proper    O
position    O
so    O
they    O
can    O
heal    O
.    O

Today    O
,    O
it    O
is    O
the    O
largest    O
chronic    O
prescription    O
company    O
in    O
India    O
and    O
a    O
market    O
leader    O
in    O
psychiatry    O
,    O
neurology    O
,    O
cardiology    O
,    O
orthopedics    B-Medicine106043075
,    O
ophthalmology    O
,    O
gastroenterology    O
and    O
nephrology    O
.    O

Differential    O
diagnosis    O
of    O
HSP    O
should    O
also    O
exclude    O
spastic    O
diplegia    O
which    O
presents    O
with    O
nearly    O
identical    O
day    O
-    O
to    O
-    O
day    O
effects    O
and    O
even    O
is    O
treatable    O
with    O
similar    O
medicines    O
such    O
as    O
baclofen    O
and    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
;    O
at    O
times    O
,    O
these    O
two    O
conditions    O
may    O
look    O
and    O
feel    O
so    O
similar    O
that    O
the    O
only    O
"    O
perceived    O
''    O
difference    O
may    O
be    O
HSP    O
's    O
hereditary    O
nature    O
versus    O
the    O
explicitly    O
non    O
-    O
hereditary    O
nature    O
of    O
spastic    O
diplegia    O
(    O
however    O
,    O
unlike    O
spastic    O
diplegia    O
and    O
other    O
forms    O
of    O
spastic    O
cerebral    O
palsy    O
,    O
HSP    O
can    O
not    O
be    O
reliably    O
treated    O
with    O
selective    O
dorsal    O
rhizotomy    O
)    O
.    O

Bloodless    O
surgery    O
is    O
a    O
phrase    O
that    O
was    O
popularized    O
at    O
the    O
beginning    O
of    O
the    O
20th    O
century    O
by    O
the    O
practice    O
of    O
an    O
internationally    O
famous    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
Adolf    O
Lorenz    O
,    O
who    O
was    O
known    O
as    O
"    O
the    O
bloodless    O
surgeon    O
of    O
Vienna    O
"    O
.    O

They    O
are    O
available    O
in    O
different    O
streams    O
of    O
medical    O
science    O
such    O
as    O
General    O
medicine    O
,    O
General    B-Medicine106043075
surgery    I-Medicine106043075
,    O
Orthopaedics    B-Medicine106043075
,    O
Radiodiagnosis    O
,    O
Radiotherapy    O
,    O
ENT    O
,    O
Obstetrics    O
and    O
gynaecology    O
,    O
Ophthalmology    O
,    O
Anaesthesia    O
,    O
Paediatrics    O
,    O
Community    O
medicine    O
,    O
Pathology    B-Medicine106043075
,    O
Microbiology    O
,    O
Forensic    O
medicine    O
,    O
Pharmacology    O
,    O
Anatomy    O
,    O
Physiology    O
etc    O
.    O

Becker    O
,    O
who    O
attended    O
Louisiana    O
State    O
University    O
's    O
School    O
of    O
Medicine    O
,    O
is    O
an    O
orthopedic    B-Medicine106043075
surgeon    O
.    O

Once    O
the    O
organization    O
of    O
the    O
training    O
camps    O
was    O
completed    O
,    O
he    O
spent    O
six    O
months    O
working    O
out    O
of    O
orthopedic    B-Medicine106043075
care    O
centers    O
,    O
with    O
some    O
of    O
his    O
work    O
involving    O
taking    O
individuals    O
disabled    O
by    O
war    O
and    O
designing    O
specific    O
prosthetic    O
apparatus    O
that    O
would    O
suit    O
their    O
needs    O
.    O

Hoan    O
My    O
Medical    O
Corporation    O
is    O
the    O
largest    O
and    O
most    O
prestigious    O
chain    O
hospitals    O
(    O
7    O
hospitals    O
and    O
1    O
clinic    O
)    O
across    O
Viet    O
Nam    O
,    O
serving    O
1.8    O
Million    O
patient    O
visits    O
a    O
year    O
,    O
with    O
medical    O
centers    O
of    O
Excellence    O
in    O
a    O
wide    O
spectrum    O
of    O
specialties    O
,    O
i.e.    O
,    O
Cardiology    O
,    O
Orthopedics    B-Medicine106043075
,    O
Obstetrics    O
,    O
Gynecology    O
,    O
Pediatric    O
,    O
Gerontology    O
,    O
Ophthalmology    O
,    O
Hepatology    B-Medicine106043075
and    O
Gastroenterology    O

:    O
"    O
This    O
article    O
refers    O
to    O
orthopedic    B-Medicine106043075
contractures    O
,    O
i.e.    O
,    O
permanent    O
shortening    O
of    O
muscles    O
,    O
tendons    O
,    O
and/or    O
ligaments    O
.    O

Once    O
they    O
occur    O
,    O
it    O
is    O
often    O
argued    O
that    O
they    O
can    O
not    O
be    O
stretched    O
or    O
exercised    O
away    O
(    O
they    O
must    O
be    O
released    O
with    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
)    O
.    O

He    O
is    O
a    O
retired    O
consultant    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

The    O
British    O
Orthopaedic    O
Association    O
is    O
a    O
professional    O
association    O
in    O
Britain    O
for    O
doctors    O
who    O
specialize    O
in    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Residency    O
training    O
is    O
offered    O
in    O
the    O
following    O
disciplines    O
:    O
Dermatology    O
,    O
Emergency    O
Medicine    O
,    O
Family    O
Medicine    O
,    O
Internal    O
Medicine    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Neurosurgery    O
,    O
Urology    O
,    O
Diagnostic    O
Radiology    O
,    O
Obstetrics    O
-    O
Gynecology    O
,    O
and    O
Neuromuscular    O
Medicine    O
.    O

Ran    O
the    O
department    O
of    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
and    O
the    O
Center    O
for    O
Implant    O
Surgery    O
in    O
the    O
Bnai    O
Zion    O
Medical    O
Center    O
in    O
Haifa    O
.    O

Specialties    O
of    O
the    O
Tiantan    O
hospital    O
include    O
neurology    O
,    O
neurosurgery    O
,    O
oncology    O
,    O
general    O
medicine    O
,    O
endocrinology    O
,    O
rehabilitation    O
,    O
stem    O
cell    O
research    O
,    O
TCM    O
,    O
holistic    O
nutrition    O
,    O
primary    O
care    O
,    O
cardiology    O
,    O
podiatry    O
,    O
orthopedics    B-Medicine106043075
,    O
anti    O
-    O
age    O
/    O
rejuvenation    O
,    O
and    O
knee    O
/    O
hip    O
regeneration    O
.    O

Puhua    O
International    O
Hospital    O
–    O
Shuangjing    O
offers    O
service    O
in    O
the    O
following    O
departments    O
;    O
orthopedics    B-Medicine106043075
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
podiatry    O
,    O
sports    O
medicine    O
,    O
neurology    O
,    O
neurosurgery    O
,    O
chiropractic    O
,    O
family    O
medicine    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
,    O
rehabilitation    O
,    O
oncology    O
,    O
TCM    O
,    O
dermatology    O
,    O
pediatrics    O
,    O
surgery    O
,    O
cardiovascular    O
,    O
ENT    O
,    O
gynecology    O
,    O
ophthalmology    O
,    O
endocrinology    O
,    O
women    O
’s    O
health    O
and    O
children    O
’s    O
health    O
.    O

Orthopaedics    B-Medicine106043075
&    O
Traumatology    O

Governor    O
Dave    O
Freudenthal    O
appointed    O
State    O
Senator    O
John    O
Barrasso    O
,    O
an    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
from    O
Casper    O
.    O

=    O
=    O
=    O
=    O
Orthopaedic    B-Medicine106043075

Dr.    O
Syed    O
Muhammad    O
Ali    O
Shah    O
(    O
26    O
October    O
1946    O
–    O
4    O
February    O
2013    O
)    O
was    O
a    O
Pakistani    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
member    O
of    O
the    O
Pakistan    O
Cricket    O
Board    O
governing    O
board    O
.    O

The    O
hospital    O
,    O
with    O
24-hour    O
care    O
,    O
has    O
emergency    O
,    O
gynecology    O
/    O
obstetrics    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedic    B-Medicine106043075
and    O
radiology    O
departments    O
.    O

The    O
hospital    O
specializes    O
in    O
surgery    O
,    O
orthopedics    B-Medicine106043075
,    O
cardiology    O
,    O
neurology    O
,    O
oncology    O
,    O
emergency    O
/    O
trauma    O
and    O
a    O
variety    O
of    O
additional    O
clinical    O
services    O
.    O

Not    O
long    O
after    O
her    O
arrival    O
,    O
Zoe    O
had    O
an    O
affair    O
with    O
Orthopedic    B-Medicine106043075
Consultant    O
Sean    O
Anderson    O
(    O
Richard    O
Dillane    O
)    O
,    O
unaware    O
he    O
is    O
the    O
husband    O
of    O
her    O
colleague    O
and    O
friend    O
,    O
staff    O
nurse    O
Jessica    O
Harrison    O
(    O
Gillian    O
Kearney    O
)    O
.    O

Its    O
departments    O
include    O
Surgical    O
Services    O
,    O
Laboratory    O
,    O
Pharmacy    O
,    O
Orthopaedics    B-Medicine106043075
,    O
Medicine    O
,    O
Obstetrics    O
and    O
Gynaecology    O
.    O

Reinder    O
(    O
Rein    O
)    O
Strikwerda    O
(    O
3    O
June    O
1930    O
,    O
Franeker    O
–    O
23    O
October    O
2006    O
,    O
De    O
Bilt    O
)    O
was    O
a    O
Dutch    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
who    O
reached    O
international    O
fame    O
by    O
describing    O
and    O
treating    O
meniscus    O
and    O
knee    O
injuries    O
,    O
specially    O
those    O
injuries    O
that    O
are    O
typical    O
to    O
occur    O
in    O
sports    O
like    O
football    O
.    O

Nicolas    O
Andry    O
publishes    O
"    O
Orthopédie    O
"    O
,    O
giving    O
a    O
name    O
to    O
the    O
discipline    O
of    O
orthopedics    B-Medicine106043075
.    O

Orthopedics    B-Medicine106043075

Bryan    O
Hospital    O
also    O
features    O
a    O
number    O
of    O
specialty    O
medical    O
clinics    O
including    O
ear    O
,    O
nose    O
,    O
and    O
throat    O
;    O
cardiology    O
;    O
pain    B-Medicine106043075
management;    I-Medicine106043075
urology    O
;    O
orthopedics;    B-Medicine106043075
and    O
wound    O
care    O
.    O

Providence    O
Healthcare    O
is    O
a    O
health    O
care    O
facility    O
in    O
Toronto    O
,    O
Ontario    O
,    O
Canada    O
,    O
specializing    O
in    O
rehabilitation    O
for    O
patients    O
who    O
have    O
experienced    O
strokes    O
,    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
or    O
lower    O
limb    O
amputation    O
,    O
or    O
who    O
require    O
specialized    O
geriatric    O
rehabilitation    O
,    O
assessment    O
and    O
treatment    O
.    O

Orthopedic    B-Medicine106043075

The    O
first    O
surgeons    O
who    O
focused    O
on    O
orthopedic    B-Medicine106043075
surgeries    I-Medicine106043075
in    O
India    O
were    O
Dr.    O
R    O
J    O
Katrak    O
,    O
Dr.    O
N    O
S    O
Narasimha    O
Aiyar    O
and    O
Dr.    O
S    O
R    O
Chandra    O
.    O

They    O
looked    O
at    O
313,445    O
entries    O
in    O
the    O
medical    O
register    O
from    O
the    O
General    O
Medical    O
Council    O
,    O
and    O
identified    O
surnames    O
that    O
were    O
apt    O
for    O
the    O
speciality    O
,    O
for    O
example    O
,    O
Limb    O
for    O
an    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
and    O
Doctor    O
for    O
medicine    O
in    O
general    O
.    O

Between    O
1891    O
and    O
1894    O
he    O
worked    O
as    O
an    O
assistant    O
physician    O
at    O
internist    O
and    O
orthopaedic    B-Medicine106043075
university    O
hospital    O
in    O
Germany    O
's    O
capital    O
Berlin    O
.    O

The    O
development    O
and    O
production    O
of    O
orthopedic    B-Medicine106043075
mattresses    O
is    O
directed    O
by    O
the    O
subsidiary    O
DBC    O
.    O

Neoprene    O
is    O
sold    O
either    O
as    O
solid    O
rubber    O
or    O
in    O
latex    O
form    O
,    O
and    O
is    O
used    O
in    O
a    O
wide    O
variety    O
of    O
applications    O
,    O
such    O
as    O
laptop    O
sleeves    O
,    O
orthopedic    B-Medicine106043075
braces    O
(    O
wrist    O
,    O
knee    O
,    O
etc    O
.    O
)    O
,    O
electrical    O
insulation    O
,    O
liquid    O
and    O
sheet    O
applied    O
elastomeric    O
membranes    O
or    O
flashings    O
,    O
and    O
automotive    O
fan    O
belts    O
.    O

Genzyme    O
focuses    O
on    O
six    O
areas    O
of    O
medicine    O
relating    O
to    O
lysosomal    O
storage    O
diseases    O
,    O
renal    O
disease    O
,    O
orthopedics    B-Medicine106043075
,    O
transplant    O
and    O
immune    O
diseases    O
,    O
oncology    O
,    O
genetics    O
and    O
diagnostics    O
.    O

Treatments    O
available    O
in    O
Busko    O
-    O
Zdrój    O
include    O
those    O
for    O
cardiovascular    O
disease    O
,    O
rheumatic    O
diseases    O
,    O
orthopedic    B-Medicine106043075
conditions    I-Medicine106043075
,    O
neurological    O
conditions    O
,    O
dermatological    O
disorders    O
and    O
children    O
's    O
cerebral    O
palsy    O
.    O

The    O
occurrence    O
of    O
capsular    O
contraction    O
follows    O
the    O
formation    O
of    O
capsules    O
of    O
tightly    O
-    O
woven    O
collagen    O
fibers    O
,    O
created    O
by    O
the    O
immune    O
response    O
to    O
the    O
presence    O
of    O
foreign    O
objects    O
surgically    O
installed    O
to    O
the    O
human    O
body    O
,    O
e.g.    O
breast    O
implants    O
,    O
artificial    O
pacemakers    O
,    O
orthopedic    B-Medicine106043075
prostheses    I-Medicine106043075
;    O
biological    O
protection    O
by    O
isolation    O
and    O
toleration    O
.    O

The    O
words    O
"    O
disc    O
"    O
and    O
"    O
disk    O
"    O
can    O
appear    O
frequently    O
in    O
medical    O
journals    O
and    O
textbooks    O
,    O
especially    O
those    O
in    O
ophthalmology    O
and    O
orthopedic    B-Medicine106043075
,    O
and    O
thus    O
style    O
guides    O
often    O
foster    O
consistency    O
by    O
giving    O
rules    O
for    O
which    O
contexts    O
take    O
which    O
spelling    O
.    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

Orthopedic    B-Medicine106043075
medicine    I-Medicine106043075

Training    O
programs    O
include    O
internal    O
medicine    O
,    O
pediatrics    O
,    O
emergency    O
medicine    O
,    O
anesthesiology    O
,    O
diagnostic    O
radiology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
obstetrics    O
and    O
gynecology    O
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O
and    O
ophthalmology    O
.    O

Homer    O
Hartman    O
Stryker    O
,    O
MD    O
(    O
November    O
4    O
,    O
1894May    O
5    O
,    O
1980    O
)    O
was    O
an    O
American    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
inventor    O
,    O
businessman    O
,    O
and    O
the    O
founder    O
of    O
Stryker    O
Corporation    O
.    O

Sean    O
E.    O
McCance    O
,    O
M.D.    O
,    O
is    O
an    O
American    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
Co    O
-    O
Director    O
of    O
Spine    O
Surgery    O
in    O
the    O
Leni    O
and    O
Peter    O
W.    O
May    O
Department    O
of    O
Orthopaedics    O
at    O
the    O
Mount    O
Sinai    O
Medical    O
Center    O
in    O
New    O
York    O
City    O
.    O

Michael    O
J.    O
Bronson    O
,    O
M.D.    O
,    O
is    O
an    O
American    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
Chairman    O
of    O
the    O
Department    O
of    O
Orthopedic    O
Surgery    O
,    O
Mount    O
Sinai    O
Roosevelt    O
Hospital    O
and    O
Mount    O
Sinai    O
St.    O
Luke    O
's    O
Hospital    O
,    O
and    O
Chief    O
of    O
Joint    O
Replacement    O
Surgery    O
at    O
the    O
Icahn    O
School    O
of    O
Medicine    O
at    O
Mount    O
Sinai    O
in    O
New    O
York    O
,    O
and    O
the    O
author    O
of    O
extensive    O
advances    O
in    O
the    O
development    O
of    O
minimally    O
invasive    O
surgical    O
instruments    O
to    O
advance    O
unicondylar    O
partial    O
knee    O
replacement    O
,    O
including    O
the    O
Vision    O
Total    O
Hip    O
System    O
,    O
a    O
widely    O
used    O
hip    O
replacement    O
system    O
that    O
avoids    O
the    O
use    O
of    O
cement    O
.    O

A    O
new    O
department    O
of    O
orthopaedics    B-Medicine106043075
was    O
created    O
along    O
with    O
a    O
planned    O
development    O
of    O
a    O
Musculoskeletal    O
Institute    O
.    O

The    O
school    O
also    O
has    O
departments    O
in    O
the    O
following    O
clinical    O
practices    O
:    O
Anesthesiology    O
and    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
,    O
Dermatology    O
,    O
Emergency    O
Medicine    O
,    O
Family    O
Practice    O
and    O
Community    O
Medicine    O
,    O
Medicine    O
,    O
Neurology    O
,    O
Neurosurgery    O
,    O
Obstetrics    O
and    O
Gynecology    O
,    O
Ophthalmology    O
(    O
See    O
Scheie    O
Eye    O
Institute    O
)    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
,    O
Pathology    B-Medicine106043075
and    O
Laboratory    O
Medicine    O
,    O
Pediatrics    O
(    O
See    O
Children    O
's    O
Hospital    O
of    O
Philadelphia    O
)    O
,    O
Physical    O
Medicine    O
and    O
Rehabilitation    O
,    O
Psychiatry    O
,    O
Radiation    O
Oncology    O
,    O
Radiology    O
,    O
and    O
Surgery    O
.    O

Orthopedic    B-Medicine106043075
corrective    O
treatments    O
may    O
also    O
manifest    O
into    O
gait    O
abnormality    O
,    O
such    O
as    O
lower    O
extremity    O
amputation    O
,    O
post    O
-    O
fracture    O
,    O
and    O
arthroplasty    O
(    O
joint    O
replacement    O
)    O
.    O

Precious    O
Blood    O
Hospital    O
offers    O
specialist    O
outpatient    O
and    O
inpatient    O
services    O
in    O
General    O
Medicine    O
,    O
Surgery    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Orthopaedics    B-Medicine106043075
and    O
Ophthalmology    O
.    O

He    O
had    O
no    O
peers    O
in    O
his    O
orthopedic    B-Medicine106043075
ability    O
and    O
contributed    O
greatly    O
to    O
Toledo    O
medicine    O
.    O
"    O

He    O
had    O
no    O
peers    O
in    O
his    O
orthopedic    B-Medicine106043075
ability    O
and    O
contributed    O
greatly    O
to    O
Toledo    O
medicine    O
.    O
"    O

It    O
provides    O
children    O
with    O
a    O
wide    O
range    O
of    O
medical    O
equipment    O
such    O
as    O
wheelchairs    O
,    O
walkers    O
,    O
bath    O
lifts    O
,    O
orthopedic    B-Medicine106043075
shoes    I-Medicine106043075
,    O
splints    O
and    O
braces    O
,    O
diapers    O
,    O
eyeglasses    O
,    O
specialized    O
computers    O
,    O
and    O
hospital    O
transportation    O
costs    O
.    O

It    O
produces    O
professional    O
journals    O
,    O
textbooks    O
,    O
atlases    O
,    O
monographs    O
and    O
reference    O
books    O
in    O
both    O
German    O
and    O
English    O
covering    O
a    O
variety    O
of    O
medical    O
specialties    O
,    O
including    O
neurosurgery    O
,    O
orthopaedics    B-Medicine106043075
,    O
endocrinology    O
,    O
radiology    O
,    O
anatomy    O
,    O
chemistry    O
,    O
otolaryngology    O
,    O
ophthalmology    O
,    O
audiology    O
and    O
speech    O
language    O
pathology    O
,    O
and    O
complementary    O
and    O
alternative    O
medicine    O
.    O

Orthopaedics    B-Medicine106043075

His    O
son    O
Dr    O
Shrikant    O
Shinde    O
,    O
an    O
orthopaedic    B-Medicine106043075
surgeon    O
got    O
elected    O
as    O
a    O
Member    O
of    O
Parliament    O
to    O
the    O
Lok    O
Sabha    O
from    O
the    O
Kalyan    O
constituency    O
defeating    O
the    O
NCP    O
's    O
Anand    O
Paranjape    O
,    O
who    O
had    O
defected    O
from    O
the    O
Shiv    O
Sena    O
and    O
Raju    O
Patil    O
of    O
the    O
MNS    O
.    O

Brainlab    O
is    O
a    O
privately    O
held    O
German    O
medical    O
technology    O
company    O
headquartered    O
in    O
Munich    O
,    O
Bavaria    O
that    O
develops    O
hardware    O
and    O
software    O
for    O
radiosurgery    O
,    O
image    O
guided    O
surgery    O
technologies    O
for    O
neurosurgery    O
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
ENT    O
,    O
CMF    O
,    O
spine    O
and    O
trauma    O
,    O
as    O
well    O
as    O
digital    O
operating    O
room    O
integration    O
and    O
cloud    O
-    O
based    O
data    O
sharing    O
.    O

Gustav    O
Biedermann    O
Günther    O
(    O
22    O
January    O
1801    O
in    O
Schandau    O
–    O
8    O
September    O
1866    O
in    O
Leipzig    O
)    O
was    O
a    O
German    O
surgeon    O
and    O
orthopedist    B-Medicine106043075
.    O

Armin    O
M.    O
Tehrany    O
,    O
M.D.    O
,    O
is    O
an    O
American    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
Assistant    O
Clinical    O
Professor    O
of    O
Orthopedic    O
Surgery    O
at    O
the    O
Icahn    O
School    O
of    O
Medicine    O
at    O
Mount    O
Sinai    O
in    O
New    O
York    O
City    O
,    O
and    O
film    O
producer    O
.    O

From    O
1994    O
to    O
1999    O
he    O
trained    O
in    O
the    O
specialty    O
of    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
sports    O
medicine    O
at    O
Lenox    O
Hill    O
Hospital    O
in    O
Manhattan    O
.    O

Orthopaedics    B-Medicine106043075

His    O
father    O
,    O
Michael    O
,    O
is    O
a    O
South    O
African    O
-    O
born    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
and    O
his    O
mother    O
is    O
Lucille    O
Solomon    O
.    O

24-bed    O
Surgical    O
/    O
Orthopedic    B-Medicine106043075
/    O
Bariatric    B-Medicine106043075
Unit    O
provides    O
pre-    O
and    O
post    O
-    O
operative    O
care    O

Sara    O
Ramirez    O
portrayed    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
Dr.    O
Calliope    O
"    O
Callie    O
"    O
Torres    O
whose    O
storylines    O
during    O
the    O
season    O
revolve    O
around    O
her    O
recently    O
discovered    O
bisexuality    O
.    O

Orthopedic    B-Medicine106043075
surgery    I-Medicine106043075

Sir    O
David    O
Rodney    O
Sweetnam    O
(    O
1927    O
-    O
2013    O
)    O
,    O
known    O
as    O
Rodney    O
,    O
was    O
a    O
British    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

The    O
degree    O
is    O
awarded    O
after    O
three    O
years    O
of    O
pre    O
-    O
clinical    O
instruction    O
and    O
examination    O
in    O
anatomy    O
,    O
physiology    O
,    O
biochemistry    O
,    O
microbiology    O
,    O
pathology    B-Medicine106043075
,    O
and    O
pharmacology    O
,    O
followed    O
by    O
two    O
years    O
of    O
clinical    O
instruction    O
and    O
examination    O
in    O
general    O
surgery    O
,    O
internal    O
medicine    O
,    O
pediatrics    O
,    O
obstetrics    O
&    O
gynecology    O
,    O
psychiatry    O
,    O
otolaryngology    O
,    O
neurosurgery    O
,    O
orthopedics    B-Medicine106043075
,    O
anesthesiology    O
,    O
urology    O
,    O
and    O
public    O
health    O
.    O

William    O
Angus    O
Wallace    O
(    O
born    O
31    O
October    O
1948    O
)    O
is    O
a    O
British    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

Routine    O
examination    O
by    O
an    O
orthopaedic    B-Medicine106043075
surgeon    O
or    O
rheumatologist    O
will    O
often    O
pay    O
particular    O
attention    O
to    O
this    O
.    O

It    O
offers    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
cardiology    O
,    O
oncology    O
,    O
organ    O
transplant    O
,    O
and    O
orthopedic    B-Medicine106043075
departments    O
.    O

The    O
Sulcus    O
sign    O
is    O
an    O
orthopedic    B-Medicine106043075
evaluation    O
test    O
for    O
glenohumeral    O
instability    O
of    O
the    O
shoulder    O
.    O

It    O
features    O
on    O
call    O
physicians    O
in    O
-    O
house    O
24    O
hours    O
a    O
day    O
,    O
7    O
days    O
a    O
week    O
,    O
in    O
the    O
specialties    O
of    O
Family    O
Medicine    O
,    O
Internal    O
Medicine    O
,    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
,    O
Pediatrics    O
,    O
Neonatology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Hemotherapy    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Anesthesiology    O
and    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
aided    O
by    O
the    O
Nursing    O
,    O
Laboratory    O
and    O
Radiology    O
services    O
.    O

His    O
research    O
interests    O
are    O
clinical    O
veterinary    O
medicine    O
and    O
orthopeadic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
wounding    O
and    O
traumatology    O
with    O
special    O
interest    O
in    O
lameness    O
,    O
joint    O
surgery    O
and    O
athritides    O
.    O

Articular    O
cartilage    O
stem    O
cell    O
paste    O
grafting    O
was    O
initially    O
described    O
by    O
Kevin    O
R.    O
Stone    O
M.D.    O
,    O
a    O
San    O
Francisco    O
-    O
based    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
in    O
1997    O
.    O

Daniel    O
Anthony    O
Ivankovich    O
,    O
MD    O
(    O
born    O
November    O
23    O
,    O
1963    O
)    O
is    O
an    O
American    O
orthopedic    B-Medicine106043075
surgeon    O
,    O
humanitarian    O
,    O
media    O
personality    O
and    O
blues    O
musician    O
with    O
the    O
Chicago    O
Blues    O
All    O
-    O
Stars    O
.    O

As    O
an    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
Ivankovich    O
is    O
best    O
known    O
for    O
caring    O
for    O
patients    O
regardless    O
of    O
their    O
insurance    O
status    O
or    O
ability    O
to    O
pay    O
.    O

Dr.    O
Gomez    O
O'Peele    O
:    O
a    O
defrocked    O
orthopaedic    B-Medicine106043075
surgeon    O
,    O
one    O
of    O
Nicholas    O
Stripling    O
's    O
"    O
employees    O
"    O
in    O
his    O
Medicare    O
fraud    O
"    O
business    O
.    O
"    O

Zachary    O
Kile    O
,    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075

Examples    O
include    O
intramedullary    O
rods    O
used    O
to    O
treat    O
bone    O
fractures    O
in    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
intramedullary    O
tumors    O
occurring    O
in    O
some    O
forms    O
of    O
cancer    O
or    O
benign    O
tumors    O
such    O
as    O
an    O
enchondroma    O
.    O

Implantcast    O
GmbH    O
,    O
German    O
manufacturer    O
of    O
orthopaedic    B-Medicine106043075
implants    O
,    O
such    O
as    O
artificial    O
hips    O
and    O
knees    O

Among    O
the    O
hospital    O
's    O
medical    O
specialties    O
are    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
obstetrics    O
and    O
gynaecology    O
,    O
orthopedics    B-Medicine106043075
,    O
neurology    O
and    O
nephrology    O
.    O

Her    O
speciality    O
is    O
in    O
Orthopedics    B-Medicine106043075
.    O

The    O
vast    O
majority    O
animal    O
hospitals    O
and    O
clinics    O
specialize    O
in    O
specific    O
subject    O
areas    O
such    O
as    O
internal    O
medicine    O
,    O
surgery    O
,    O
orthopaedics    B-Medicine106043075
,    O
ophthalmology    O
(    O
eyes    O
)    O
,    O
neurology    O
,    O
dental    O
medicine    O
and    O
dermatology    O
.    O

This    O
includes    O
preventive    O
care    O
and    O
basic    O
health    O
care    O
as    O
well    O
as    O
advanced    O
diagnostics    O
such    O
as    O
endoscopy    O
and    O
magnetic    O
resonance    O
tomography    O
,    O
intensive    B-Medicine106043075
care    I-Medicine106043075
and    O
orthopaedics    B-Medicine106043075
.    O

It    O
also    O
has    O
geriatric    O
and    O
rehabilitation    O
services    O
,    O
elective    O
orthopaedic    B-Medicine106043075
services    O
and    O
cardiothoracic    O
services    O
,    O
an    O
in    O
-    O
patient    O
psychiatric    O
unit    O
and    O
a    O
16    O
bed    O
palliative    B-Medicine106043075
care    I-Medicine106043075
unit    O
.    O

The    O
Orthopaedics    B-Medicine106043075
(    O
Withers    O
Wards    O
)    O
emphasis    O
makes    O
the    O
hospital    O
one    O
of    O
the    O
leading    O
orthopaedic    O
and    O
musculoskeletal    O
centres    O
of    O
excellence    O
in    O
all    O
of    O
Europe    O
.    O

Recently    O
,    O
this    O
technology    O
has    O
expanded    O
to    O
applications    O
in    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Sir    O
Reginald    O
Watson    O
Watson    O
-    O
Jones    O
,    O
FRCS    O
(    O
born    O
Reginald    O
Watson    O
Jones    O
;    O
4    O
March    O
1902    O
–    O
9    O
August    O
1972    O
)    O
was    O
a    O
prominent    O
English    O
orthopedic    B-Medicine106043075
surgeon    O
.    O

After    O
contracting    O
typhoid    O
in    O
his    O
youth    O
,    O
the    O
younger    O
Jones    O
decided    O
on    O
a    O
career    O
in    O
medicine    O
and    O
set    O
his    O
heart    O
on    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
after    O
he    O
underwent    O
an    O
operation    O
to    O
remove    O
a    O
hemangioma    O
.    O

The    O
tertiary    O
care    O
hospital    O
provides    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
renal    O
sciences    O
,    O
women    O
's    O
and    O
paediatric    O
care    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
and    O
critical    B-Medicine106043075
care    I-Medicine106043075
units    O
for    O
cardiology    O
.    O

Raymond    O
Rocco    O
Monto    O
,    O
M.D.    O
(    O
born    O
November    O
20    O
,    O
1960    O
)    O
is    O
a    O
Board    O
Certified    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
with    O
a    O
practice    O
on    O
Nantucket    O
,    O
Massachusetts    O
.    O

Despite    O
her    O
intentions    O
to    O
keep    O
away    O
from    O
relationships    O
,    O
she    O
becomes    O
romantically    O
involved    O
with    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
Callie    O
Torres    O
(    O
Sara    O
Ramirez    O
)    O
.    O

Despite    O
this    O
assessment    O
,    O
the    O
end    O
of    O
the    O
show    O
's    O
fourth    O
season    O
saw    O
Hahn    O
grow    O
closer    O
to    O
orthopedic    B-Medicine106043075
surgeon    I-Medicine106043075
Callie    O
Torres    O
,    O
in    O
a    O
relationship    O
dubbed    O
"    O
Eri    O
-    O
Cal    O
"    O
and    O
later    O
"    O
Callica    O
"    O
by    O
Entertainment    O
Weekly    O
.    O

It    O
provided    O
the    O
city    O
's    O
first    O
x    O
-    O
ray    O
department    O
in    O
1907    O
and    O
,    O
in    O
1914    O
,    O
Harry    O
Platt    O
-    O
who    O
was    O
later    O
to    O
become    O
a    O
renowned    O
orthopaedic    B-Medicine106043075
surgeon    I-Medicine106043075
-    O
instituted    O
the    O
world    O
's    O
first    O
clinic    O
dedicated    O
to    O
the    O
treatment    O
of    O
fractures    O
.    O

One    O
of    O
his    O
earliest    O
contributions    O
while    O
at    O
the    O
Royal    O
Infirmary    O
,    O
in    O
1877    O
,    O
was    O
in    O
orthopaedics    B-Medicine106043075
,    O
by    O
means    O
of    O
the    O
development    O
of    O
the    O
first    O
bone    O
grafts    O
,    O
but    O
also    O
in    O
knee    O
surgery    O
using    O
a    O
special    O
instrument    O
(    O
Macewen    O
's    O
osteotome    O
)    O
both    O
techniques    O
becoming    O
key    O
treatments    O
for    O
the    O
highly    O
prevalent    O
disease    O
of    O
rickets    O
(    O
caused    O
by    O
a    O
lack    O
of    O
Vitamin    O
D    O
)    O
.    O

M.    O
Y.    O
Hospital    O
has    O
1200    O
beds    O
with    O
all    O
the    O
major    O
medical    O
departments    O
:    O
surgery    O
,    O
medicine    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
dermatology    O
,    O
chest    O
and    O
TB    O
,    O
orthopaedics    B-Medicine106043075
,    O
E.N.T.    O
,    O
ophthalmology    O
,    O
radiology    O
,    O
anaesthesiology    O
,    O
paediatrics    O
,    O
forensic    O
medicine    O
,    O
and    O
casualty    O
,    O
cardiology    O
,    O
neurology    O
,    O
gastroenterology    O
,    O
nephrology    O
,    O
endocrinology    O
divisions    O
are    O
under    O
parent    O
medicine    O
department    O
.    O

Orthopaedics    B-Medicine106043075
–    O
branch    O
of    O
medicine    O
that    O
deals    O
with    O
conditions    O
involving    O
the    O
musculoskeletal    O
system    O
.    O

the    O
hospital    O
has    O
116    O
beds    O
across    O
a    O
range    O
of    O
specialities    O
,    O
including    O
general    O
medicine    O
,    O
geriatrics    O
,    O
paediatrics    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopaedics    B-Medicine106043075
,    O
obstetrics    O
and    O
gynaecology    O
and    O
psychiatry    O
.    O

General    O
hospital    O
services    O
available    O
here    O
include    O
acute    O
medical    O
,    O
surgical    O
,    O
emergency    O
services    O
,    O
mental    O
health    O
,    O
rehabilitation    O
,    O
women    O
&    O
birthing    O
,    O
orthopaedics    B-Medicine106043075
and    O
paediatrics    O
.    O

Umuduru    O
-    O
obi    O
in    O
Ofekata    O
are    O
noted    O
for    O
orthopedic    B-Medicine106043075
expertise    O
.    O

1873    O
,    O
,    O
orthopaedics    B-Medicine106043075
professor    O

Orthopedic    B-Medicine106043075

The    O
orthopedic    B-Medicine106043075
practice    O
group    O
at    O
UCLA    O
Medical    O
Center    O
,    O
Santa    O
Monica    O
,    O
has    O
been    O
recognized    O
as    O
one    O
of    O
the    O
best    O
orthopedic    O
hospitals    O
in    O
the    O
United    O
States    O
.    O

Orthopaedic    B-Medicine106043075
issues    O
range    O
from    O
acute    O
problems    O
such    O
as    O
fractures    O
or    O
hospitalization    O
for    O
joint    O
replacement    O
to    O
chronic    O
systemic    O
disorders    O
such    O
as    O
loss    O
of    O
bone    O
density    O
or    O
lupus    O
erythematosus    O
.    O

The    O
victim    O
was    O
trapped    O
in    O
the    O
machine    O
for    O
an    O
hour    O
as    O
emergency    O
services    O
,    O
including    O
two    O
orthopaedic    B-Medicine106043075
surgeons    O
from    O
Dr    O
Gray    O
’s    O
Hospital    O
in    O
Elgin    O
attempted    O
to    O
free    O
him    O
.    O

Since    O
1970    O
she    O
was    O
an    O
orthopedics    B-Medicine106043075
professor    O
at    O
the    O
Riga    O
Medical    O
Institute    O
.    O

He    O
is    O
considered    O
the    O
father    O
of    O
Orthopedics    B-Medicine106043075
in    O
Germany    O
.    O

Heine    O
had    O
recognized    O
the    O
healing    O
effects    O
medical    O
baths    O
–    O
he    O
tried    O
to    O
match    O
orthopedics    B-Medicine106043075
and    O
balneotherapy    O
.    O

It    O
provides    O
services    O
in    O
cardiology    O
,    O
pneumology    B-Medicine106043075
,    O
neurology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
oncology    O
,    O
gastroenterology    O
and    O
ophthalmology    O
.    O

Young    O
horses    O
that    O
are    O
overfed    O
or    O
are    O
fed    O
a    O
diet    O
with    O
an    O
improper    O
calcium    O
:    O
phosphorus    O
ratio    O
over    O
time    O
may    O
develop    O
a    O
number    O
of    O
growth    O
and    O
orthopedic    B-Medicine106043075
disorders    O
,    O
including    O
osteochondrosis    O
(    O
OCD    O
)    O
,    O
angular    O
limb    O
deformities    O
(    O
ALD    O
)    O
,    O
and    O
several    O
conditions    O
grouped    O
under    O
the    O
popular    O
term    O
"    O
contracted    O
tendons    O
.    O
"    O

Doctors    O
that    O
do    O
bone    O
graft    O
procedures    O
are    O
commonly    O
orthopedic    B-Medicine106043075
surgeons    I-Medicine106043075
,    O
otolaryngology    O
head    O
and    O
neck    O
surgeon    O
,    O
neurosurgeons    O
,    O
craniofacial    O
surgeons    O
,    O
oral    O
and    O
maxillofacial    O
surgeons    O
,    O
podiatric    O
surgeons    O
and    O
periodontists    O
,    O
dental    O
surgeons    O
,    O
oral    O
surgeons    O
and    O
implantologists    O
.    O

Orthopedic    B-Medicine106043075
surgery    I-Medicine106043075

R.    O
lentis    O
"    O
can    O
grow    O
in    O
the    O
presence    O
of    O
the    O
antibiotic    O
compounds    O
lincomycin    O
,    O
tetrazolium    O
violet    O
and    O
tetrazolium    O
blue    O
but    O
not    O
with    O
1%    O
sodium    B-Medicine106043075
lactate    I-Medicine106043075
,    O
troleandomycin    O
,    O
lithium    O
chloride    O
,    O
potassium    O
tellurite    O
or    O
sodium    O
butyrate    O
.    O

Others    O
include    O
potassium    O
citrate    O
,    O
calcium    O
carbonate    O
,    O
sodium    B-Medicine106043075
lactate    I-Medicine106043075
and    O
calcium    O
acetate    O
.    O

Medical    B-Medicine106043075
Microbiology    I-Medicine106043075
and    O
Parasitology    B-Medicine106043075

The    O
charity    O
's    O
volunteers    O
work    O
outside    O
normal    O
office    O
hours    O
and    O
use    O
either    O
their    O
own    O
or    O
the    O
charity    O
's    O
dedicated    O
response    O
motorcycles    O
to    O
transport    O
items    O
such    O
as    O
blood    O
for    O
transfusion    O
,    O
blood    O
samples    O
for    O
pathological    B-Medicine106043075
or    O
microbiological    B-Medicine106043075
analysis    O
,    O
drugs    O
,    O
patient    O
notes    O
,    O
x    O
-    O
rays    O
,    O
scans    O
,    O
medical    O
equipment    O
,    O
samples    O
,    O
vaccines    O
and    O
donated    O
human    O
breast    O
milk    O
.    O

Medical    B-Medicine106043075
microbiology    I-Medicine106043075

Infectious    O
diseases    O
,    O
Clinical    B-Medicine106043075
microbiology    I-Medicine106043075

A    O
strict    O
application    O
of    O
Szasz    O
's    O
criterion    O
necessitates    O
the    O
conclusion    O
that    O
diseases    O
such    O
as    O
malaria    O
were    O
"    O
mythical    O
"    O
until    O
medical    B-Medicine106043075
microbiology    I-Medicine106043075
arrives    O
at    O
which    O
point    O
they    O
became    O
"    O
real    O
"    O
.    O

Medical    B-Medicine106043075
microbiology    I-Medicine106043075
is    O
a    O
branch    O
of    O
medical    O
science    O
concerned    O
with    O
the    O
prevention    O
,    O
diagnosis    O
and    O
treatment    O
of    O
infectious    O
diseases    O
.    O

Medical    B-Medicine106043075
microbiology    I-Medicine106043075

He    O
graduated    O
as    O
cand.med    O
.    O
at    O
the    O
University    O
of    O
Oslo    O
in    O
1961    O
and    O
became    O
a    O
specialist    O
in    O
medical    B-Medicine106043075
microbiology    I-Medicine106043075
in    O
1970    O
.    O

Erkkie    O
-    O
Harris    O
Wells    O
is    O
an    O
American    O
Trichologist    B-Medicine106043075
,    O
author    O
and    O
the    O
founder    O
of    O
Miyohara    O
International    O
Trichology    O
Clinic    O
in    O
Costa    O
Mesa    O
,    O
California    O
.    O

Trichology    B-Medicine106043075
is    O
the    O
branch    O
of    O
dermatology    O
that    O
deals    O
with    O
the    O
scientific    O
study    O
of    O
the    O
health    O
of    O
hair    O
and    O
scalp    O
.    O

4-Aminosalicylic    B-Medicine106043075
acid    I-Medicine106043075
,    O
an    O
antibiotic    O
sold    O
by    O
Jacobus    O
Pharmaceutical    O
under    O
the    O
trademark    O
"    O
Paser    O
"    O

4-Aminosalicylic    B-Medicine106043075
acid    I-Medicine106043075
,    O
also    O
known    O
as    O
para"-    O

aminosalicylic    O
acid    O
("'PAS    B-Medicine106043075
)    O
is    O
an    O
antibiotic    O
primarily    O
used    O
to    O
treat    O
tuberculosis    O
.    O

The    O
seven    O
clinics    O
are    O
focused    O
on    O
diseases    O
of    O
the    O
pelvis    O
,    O
dysplasia    O
,    O
obstetrics    O
,    O
gynecology    O
,    O
psychosomatic    B-Medicine106043075
dysfunction    O
,    O
and    O
ultrasound    O
for    O
prenatal    O
diagnostics    O
,    O
as    O
well    O
as    O
urogynecology    B-Medicine106043075
.    O

He    O
is    O
a    O
subspecialist    O
in    O
Urogynaecology    B-Medicine106043075
and    O
in    O
2011    O
became    O
a    O
Member    O
of    O
the    O
Order    O
of    O
Australia    O
for    O
his    O
outstanding    O
contributions    O
to    O
medicine    O
.    O

Female    B-Medicine106043075
Pelvic    I-Medicine106043075
Medicine    I-Medicine106043075
and    I-Medicine106043075
Reconstructive    I-Medicine106043075
Surgery    I-Medicine106043075

The    O
service    O
provides    O
non    O
-    O
invasive    O
ventilation    O
and    O
also    O
accepts    O
referrals    O
from    O
other    O
intensive    B-Medicine106043075
care    I-Medicine106043075
units    O
to    O
wean    O
patients    O
from    O
invasive    O
ventilation    O
;    O

intensive    B-Medicine106043075
care    I-Medicine106043075
services    O
.    O

In    O
medicine    O
,    O
the    O
passive    O
leg    O
raising    O
test    O
is    O
a    O
bedside    O
test    O
to    O
evaluate    O
the    O
need    O
for    O
further    O
fluid    O
resuscitation    O
in    O
critically    B-Medicine106043075
ill    I-Medicine106043075
patients    O
.    O

Willamette    O
Valley    O
Medical    O
offers    O
a    O
variety    O
of    O
medical    O
services    O
including    O
critical    B-Medicine106043075
care    I-Medicine106043075
,    O
acute    B-Medicine106043075
care    I-Medicine106043075
,    O
a    O
24-hour    O
Level    O
III    O
emergency    O
room    O
,    O
diagnostic    O
imaging    O
,    O
cancer    O
treatment    O
,    O
dialysis    O
,    O
cardiac    O
care    O
,    O
a    O
birth    O
center    O
,    O
occupational    O
medicine    O
,    O
operating    O
rooms    O
,    O
and    O
laboratory    O
services    O
among    O
others    O
.    O

The    O
hospital    O
has    O
three    O
monitored    O
intensive-care    B-Medicine106043075
beds    O
,    O
two    O
birthing    O
suites    O
,    O
and    O
two    O
surgery    O
suites    O
for    O
inpatient    O
and    O
outpatient    O
surgeries    O
.    O

It    O
includes    O
eight    O
research    O
centers    O
that    O
conduct    O
focused    O
research    O
on    O
cancer    O
,    O
critical    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
,    O
genetics    O
,    O
immunobiology    O
and    O
vaccine    O
development    O
,    O
blood    O
and    O
marrow    O
transplantation    O
and    O
cellular    O
therapies    O
,    O
nutrition    O
and    O
metabolism    O
,    O
prevention    O
of    O
obesity    O
,    O
cardiovascular    O
disease    O
and    O
diabetes    O
,    O
sickle    O
cell    O
disease    O
and    O
thalassemia    O
.    O

The    O
TCU    O
serves    O
inmates    O
who    O
need    O
intensive    B-Medicine106043075
nursing    I-Medicine106043075
care    I-Medicine106043075
,    O
such    O
as    O
post    O
surgical    O
care    O
,    O
and    O
also    O
serves    O
as    O
a    O
hospice    O
.    O

He    O
was    O
also    O
a    O
professor    O
at    O
National    O
Taiwan    O
University    O
College    O
of    O
Medicine    O
and    O
specializes    O
in    O
trauma    O
,    O
intensive    B-Medicine106043075
care    I-Medicine106043075
,    O
organ    O
transplant    O
,    O
extracorporeal    O
membrane    O
oxygenation    O
(    O
ECMO    O
)    O
,    O
and    O
artificial    O
organs    O
among    O
others    O
.    O

Jean    O
-    O
Louis    O
Vincent    O
is    O
the    O
editor    O
-    O
in    O
-    O
chief    O
of    O
"    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
"    O
,    O
"    O
Current    O
Opinion    O
in    O
Critical    O
Care    O
"    O
,    O
and    O
"    O
ICU    O
Management    O
and    O
Practice    O
"    O
.    O

Critical    B-Medicine106043075
care    I-Medicine106043075

Bjørn    O
Aage    O
Ibsen    O
(    O
August    O
30    O
,    O
1915    O
–    O
August    O
7    O
,    O
2007    O
)    O
was    O
a    O
Danish    O
anesthetist    O
and    O
founder    O
of    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Anaesthesia    O
(    O
including    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
)    O

Critical    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075

2    O
intensive    B-Medicine106043075
care    I-Medicine106043075
units    O

Intensive    B-Medicine106043075
care    I-Medicine106043075
is    O
often    O
used    O
in    O
the    O
developed    O
world    O
.    O

Critical    O
,    O
or    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075

Critical    B-Medicine106043075
care    I-Medicine106043075
unit    I-Medicine106043075
.    O

Critical    B-Medicine106043075
Care    I-Medicine106043075

Special    O
units    O
include    O
:    O
Cardiology    O
,    O
Dermatology    O
,    O
Gynaecology    O
,    O
Oncology    O
,    O
Ophthalmology    O
and    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
.    O

It    O
usually    O
requires    O
mechanical    O
ventilation    O
in    O
an    O
intensive    B-Medicine106043075
care    I-Medicine106043075
unit    I-Medicine106043075
setting    O
.    O

Its    O
main    O
uses    O
are    O
in    O
intensive    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
(    O
pneumonia    O
,    O
peritonitis    O
)    O
,    O
some    O
diabetes    O
-    O
related    O
foot    O
infections    O
,    O
and    O
empirical    O
therapy    O
in    O
febrile    O
neutropenia    O
(    O
e.g.    O
,    O
after    O
chemotherapy    O
)    O
.    O

Darsee    O
subsequently    O
entered    O
a    O
clinical    O
fellowship    O
in    O
critical    B-Medicine106043075
care    I-Medicine106043075
at    O
Ellis    O
Hospital    O
in    O
Schenectady    O
,    O
New    O
York    O
.    O

Rafati    O
was    O
then    O
rushed    O
into    O
intensive    B-Medicine106043075
care    I-Medicine106043075
.    O

Emergency    O
Medicine    O
,    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
Medicine    I-Medicine106043075
,    O
Anaesthetics    O
,    O
Pain    O
Medicine    O
,    O

CBS    O
reported    O
that    O
at    O
least    O
35    O
patients    O
fell    O
ill    O
and    O
11    O
died    O
,    O
but    O
it    O
was    O
not    O
clear    O
how    O
much    O
could    O
be    O
attributed    O
to    O
the    O
bacteria    O
,    O
because    O
"    O
most    O
patients    O
who    O
underwent    O
the    O
procedure    O
already    O
were    O
critically    B-Medicine106043075
ill    I-Medicine106043075
with    O
colon    O
or    O
pancreatic    O
cancer    O
"    O
.    O

The    O
school    O
also    O
has    O
departments    O
in    O
the    O
following    O
clinical    O
practices    O
:    O
Anesthesiology    O
and    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
,    O
Dermatology    O
,    O
Emergency    O
Medicine    O
,    O
Family    O
Practice    O
and    O
Community    O
Medicine    O
,    O
Medicine    O
,    O
Neurology    O
,    O
Neurosurgery    O
,    O
Obstetrics    O
and    O
Gynecology    O
,    O
Ophthalmology    O
(    O
See    O
Scheie    O
Eye    O
Institute    O
)    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
,    O
Pathology    B-Medicine106043075
and    O
Laboratory    O
Medicine    O
,    O
Pediatrics    O
(    O
See    O
Children    O
's    O
Hospital    O
of    O
Philadelphia    O
)    O
,    O
Physical    O
Medicine    O
and    O
Rehabilitation    O
,    O
Psychiatry    O
,    O
Radiation    O
Oncology    O
,    O
Radiology    O
,    O
and    O
Surgery    O
.    O

The    O
hospital    O
has    O
9    O
departments    O
,    O
including    O
among    O
others    O
internal    O
medicine    O
,    O
surgery    O
,    O
urology    O
,    O
anaesthetics    O
and    O
intensive    B-Medicine106043075
care    I-Medicine106043075
and    O
ambulant    O
surgery    O
.    O

Critical    O
Care    O
:    O
human    O
plasma    O
and    O
protein    O
products    O
for    O
treating    O
critically    O
ill    O
or    O
injured    O
patients    O
in    O
intensive    B-Medicine106043075
care    I-Medicine106043075
and    O
emergency    O
medicine    O
settings    O
.    O

Patients    O
will    O
often    O
be    O
referred    O
from    O
smaller    O
hospitals    O
to    O
a    O
tertiary    O
hospital    O
for    O
major    O
operations    O
,    O
consultations    O
with    O
sub    O
-    O
specialists    O
and    O
when    O
sophisticated    O
intensive    B-Medicine106043075
care    I-Medicine106043075
facilities    O
are    O
required    O
.    O

In    O
addition    O
to    O
her    O
Master    O
's    O
degree    O
,    O
McHarg    O
graduated    O
with    O
a    O
Bachelor    O
of    O
Science    O
:    O
Life    O
Sciences    O
and    O
Psychology    O
from    O
Queen    O
’s    O
University    O
in    O
Kingston    O
,    O
Ontario    O
(    O
1978    O
–    O
1983    O
)    O
and    O
holds    O
certificates    O
in    O
tropical    O
medicine    O
,    O
critical    B-Medicine106043075
care    I-Medicine106043075
,    O
quality    O
assurance    O
and    O
nursing    O
audits    O
.    O

These    O
include    O
intensive    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
and    O
pain    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
cardiac    O
index    O
is    O
frequently    O
measured    O
and    O
used    O
in    O
both    O
intensive    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
and    O
cardiac    O
intensive    O
care    O
.    O

Category    O
III    O
donors    O
are    O
patients    O
on    O
intensive    B-Medicine106043075
care    I-Medicine106043075
units    O
with    O
non    O
-    O
survivable    O
injuries    O
who    O
have    O
treatment    O
withdrawn    O
;    O
where    O
such    O
patients    O
wished    O
in    O
life    O
to    O
be    O
organ    O
donors    O
,    O
the    O
transplant    O
team    O
can    O
attend    O
at    O
the    O
time    O
of    O
treatment    O
withdrawal    O
and    O
retrieve    O
organs    O
after    O
cardiac    O
arrest    O
has    O
occurred    O
.    O

The    O
hospital    O
has    O
665    O
in    O
-    O
patient    O
beds    O
,    O
12    O
operating    O
theatres    O
and    O
houses    O
the    O
largest    O
single    O
critical    B-Medicine106043075
care    I-Medicine106043075
unit    I-Medicine106043075
in    O
the    O
NHS    O
.    O

Critical    B-Medicine106043075
care    I-Medicine106043075

MAQUET    O
does    O
business    O
in    O
three    O
primary    O
divisions    O
-    O
Surgical    O
Workplaces    O
,    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
and    O
Cardiovascular    O
.    O

After    O
two    O
days    O
of    O
intensive    B-Medicine106043075
care    I-Medicine106043075
,    O
the    O
patient    O
died    O
of    O
coronary    O
occlusion    O
and    O
not    O
because    O
of    O
the    O
repairing    O
of    O
the    O
heart    O
.    O

She    O
was    O
then    O
transferred    O
to    O
another    O
hospital    O
,    O
the    O
Queen    O
Alexandra    O
and    O
St    O
Mary    O
's    O
Hospital    O
in    O
Portsmouth    O
and    O
put    O
into    O
intensive    B-Medicine106043075
care    I-Medicine106043075
.    O

It    O
provides    O
routine    O
and    O
complex    O
surgery    O
and    O
has    O
an    O
8-bed    O
intensive    B-Medicine106043075
care    I-Medicine106043075
unit    O
.    O

It    O
features    O
on    O
call    O
physicians    O
in    O
-    O
house    O
24    O
hours    O
a    O
day    O
,    O
7    O
days    O
a    O
week    O
,    O
in    O
the    O
specialties    O
of    O
Family    O
Medicine    O
,    O
Internal    O
Medicine    O
,    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
,    O
Pediatrics    O
,    O
Neonatology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Hemotherapy    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Anesthesiology    O
and    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
aided    O
by    O
the    O
Nursing    O
,    O
Laboratory    O
and    O
Radiology    O
services    O
.    O

Glenfield    O
also    O
has    O
intensive    B-Medicine106043075
care    I-Medicine106043075
(    O
CITU    O
and    O
GITU    O
)    O
,    O
children    O
's    O
wards    O
,    O
respiratory    O
care    O
,    O
operating    O
theatres    O
,    O
and    O
many    O
other    O
departments    O
,    O
but    O
does    O
not    O
have    O
an    O
emergency    O
department    O
.    O

The    O
hospital    O
has    O
45    O
beds    O
out    O
of    O
which    O
they    O
have    O
18    O
beds    O
in    O
intensive    B-Medicine106043075
care    I-Medicine106043075
,    O
6    O
in    O
cardiac    O
rooms    O
and    O
11    O
in    O
interventional    O
cardiology    O
which    O
is    O
divided    O
into    O
three    O
spaces    O
.    O

She    O
completed    O
residency    O
in    O
1999    O
in    O
internal    O
medicine    O
at    O
the    O
Weill    O
Cornell    O
Medical    O
Center    O
and    O
subsequently    O
completed    O
a    O
combined    O
fellowship    O
in    O
infectious    O
diseases    O
at    O
Johns    O
Hopkins    O
University    O
and    O
critical    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
at    O
the    O
National    O
Institutes    O
of    O
Health    O
.    O

This    O
includes    O
preventive    O
care    O
and    O
basic    O
health    O
care    O
as    O
well    O
as    O
advanced    O
diagnostics    O
such    O
as    O
endoscopy    O
and    O
magnetic    O
resonance    O
tomography    O
,    O
intensive    B-Medicine106043075
care    I-Medicine106043075
and    O
orthopaedics    B-Medicine106043075
.    O

The    O
tertiary    O
care    O
hospital    O
provides    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
renal    O
sciences    O
,    O
women    O
's    O
and    O
paediatric    O
care    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
and    O
critical    B-Medicine106043075
care    I-Medicine106043075
units    O
for    O
cardiology    O
.    O

She    O
subsequently    O
moved    O
with    O
her    O
family    O
to    O
Las    O
Vegas    O
,    O
Nevada    O
and    O
worked    O
as    O
a    O
critical    B-Medicine106043075
care    I-Medicine106043075
and    O
emergency    O
department    O
registered    O
nurse    O
.    O

Critical    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
–    O
focuses    O
on    O
life    O
support    O
and    O
the    O
intensive    B-Medicine106043075
care    I-Medicine106043075
of    O
the    O
seriously    O
ill    O
.    O

The    O
hospital    O
houses    O
207    O
beds    O
including    O
76    O
intensive    B-Medicine106043075
care    I-Medicine106043075
beds    O
.    O

He    O
received    O
assistance    O
from    O
his    O
neighbors    O
and    O
was    O
rushed    O
to    O
intensive    B-Medicine106043075
care    I-Medicine106043075
in    O
hospital    O
where    O
he    O
recovered    O
from    O
his    O
injuries    O
.    O

The    O
concept    O
has    O
quickly    O
found    O
wide    O
acceptance    O
in    O
anesthesia    O
and    O
critical    B-Medicine106043075
care    I-Medicine106043075
:    O
The    O
evaluation    O
of    O
Pulse    O
Pressure    O
Variation    O
(    O
PPV    O
)    O
allows    O
for    O
goal    O
-    O
directed    O
fluid    O
management    O
in    O
sedated    O
and    O
ventilated    O
patients    O
.    O

After    O
a    O
cesarean    O
delivery    O
,    O
the    O
physicians    O
discovered    O
that    O
he    O
had    O
also    O
been    O
infected    O
with    O
the    O
chikungunya    O
virus    O
,    O
and    O
put    O
him    O
under    O
intensive    B-Medicine106043075
care    I-Medicine106043075
.    O

Then    O
they    O
must    O
cope    O
with    O
chemotherapy    O
,    O
radiation    O
therapy    O
,    O
transplants    O
,    O
surgery    O
,    O
and    O
lengthy    O
hospitalizations    O
,    O
and    O
they    O
require    O
intensive    B-Medicine106043075
care    I-Medicine106043075
and    O
close    O
help    O
.    O

Diflo    O
is    O
Board    O
Certified    O
in    O
Surgery    O
(    O
1992    O
)    O
and    O
Surgical    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
(    O
1995    O
)    O
and    O
is    O
co    O
-    O
author    O
of    O
over    O
50    O
published    O
articles    O
.    O

The    O
baby    O
is    O
whisked    O
to    O
intensive    B-Medicine106043075
care    I-Medicine106043075
before    O
Carmella    O
even    O
has    O
the    O
chance    O
to    O
hold    O
her    O
.    O
"    O

Other    O
medications    O
have    O
been    O
shown    O
to    O
be    O
useful    O
in    O
topical    O
treatment    O
of    O
refractory    O
ulcers    O
,    O
including    O
glycosaminoglycans    O
such    O
as    O
sodium    O
hyaluronate    O
and    O
chondroitin    O
sulfate    O
,    O
aminocaproic    O
acid    O
,    O
and    O
acetylcysteine    B-Medicine106043075
.    O

Treatment    O
includes    O
antibiotics    O
and    O
collagenase    O
inhibitors    O
such    O
as    O
acetylcysteine    B-Medicine106043075
and    O
homologous    O
blood    O
serum    O
.    O

Acetylcysteine    B-Medicine106043075
was    O
found    O
to    O
reduce    O
effectiveness    O
of    O
shogaol    O
's    O
apoptotic    O
properties    O
.    O

"N"-Acetylcysteine    B-Medicine106043075
(    O
NAC    O
)    O
is    O
a    O
precursor    O
to    O
glutathione    O
,    O
an    O
antioxidant    O
.    O

Outside    O
North    O
America    O
,    O
mesna    O
is    O
also    O
used    O
as    O
a    O
mucolytic    O
agent    O
,    O
working    O
in    O
the    O
same    O
way    O
as    O
acetylcysteine    B-Medicine106043075
;    O
it    O
is    O
sold    O
for    O
this    O
indication    O
as    O
Mistabron    O
and    O
Mistabronco    O
.    O

As    O
glutathione    O
depletion    O
has    O
been    O
shown    O
to    O
regulate    O
liver    O
toxification    O
,    O
administration    O
of    O
N-acetylcysteine    B-Medicine106043075
in    O
similar    O
doses    O
as    O
given    O
for    O
acetaminophen    B-Medicine106043075
toxicity    O
have    O
been    O
given    O
to    O
patients    O
.    O

Another    O
class    O
of    O
possible    O
pharmacological    O
treatments    O
are    O
glutamatergic    O
agents    O
such    O
as    O
n-acetyl    B-Medicine106043075
cysteine    I-Medicine106043075
(    O
NAC    O
)    O
.    O

In    O
addition    O
,    O
NAC    O
,    O
or    O
N    O
-    O
acetyl    O
-    O
L    O
-    O
cysteine    O
(    O
acetylcysteine    B-Medicine106043075
)    O
,    O
has    O
been    O
shown    O
to    O
reduce    O
ROS    O
formation    O
associated    O
with    O
the    O
excessive    O
vibrations    O
induced    O
by    O
the    O
noise    O
exposure    O
.    O

Borderline    O
Substances    O
(    O
i.e.    O
Acetylcysteine    B-Medicine106043075
)    O

The    O
Rumack    O
-    O
Matthew    O
nomogram    O
,    O
also    O
known    O
as    O
Rumack    O
-    O
Matthews    O
nomogram    O
or    O
the    O
Acetaminophen    O
nomogram    O
is    O
an    O
acetaminophen    B-Medicine106043075
toxicity    O
nomogram    O
plotting    O
serum    O
concentration    O
of    O
acetaminophen    O
against    O
the    O
time    O
since    O
ingestion    O
in    O
an    O
attempt    O
to    O
prognosticate    O
possible    O
liver    O
toxicity    O
as    O
well    O
as    O
allowing    O
a    O
clinician    O
to    O
decide    O
whether    O
to    O
proceed    O
with    O
N-Acetylcysteine    B-Medicine106043075
(    O
NAC    O
)    O
treatment    O
or    O
not    O
.    O

Research    O
shows    O
that    O
nitrotyrosine    O
levels    O
can    O
be    O
reduced    O
by    O
N-acetyl    B-Medicine106043075
cysteine    I-Medicine106043075
,    O
which    O
is    O
a    O
precursor    O
to    O
glutathione    O
,    O
one    O
of    O
the    O
body    O
's    O
primary    O
endogenous    O
antioxidants    O
.    O

Furthermore    O
,    O
acetylcysteine    B-Medicine106043075
has    O
been    O
confirmed    O
,    O
in    O
a    O
recent    O
double    O
-    O
blind    O
placebo    O
-    O
controlled    O
trial    O
conducted    O
by    O
the    O
US    O
military    O
,    O
to    O
reduce    O
the    O
effects    O
of    O
blast    O
induced    O
mild    O
traumatic    O
brain    O
and    O
neurological    O
injury    O
in    O
soldiers    O
.    O

Predictive    B-Medicine106043075
Medicine    I-Medicine106043075

The    O
development    O
of    O
new    O
techniques    O
for    O
monitoring    O
is    O
an    O
advanced    O
and    O
developing    O
field    O
in    O
smart    O
medicine    O
,    O
biomedical    O
-    O
aided    O
integrative    O
medicine    O
,    O
alternative    O
medicine    O
,    O
self    O
-    O
tailored    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
predictive    B-Medicine106043075
medicine    I-Medicine106043075
that    O
emphasizes    O
monitoring    O
of    O
comprehensive    O
medical    O
data    O
of    O
patients    O
,    O
people    O
at    O
risk    O
and    O
healthy    O
people    O
using    O
advanced    O
,    O
smart    O
,    O
minimally    O
invasive    O
biomedical    O
devices    O
,    O
biosensors    O
,    O
lab    O
-    O
on    O
-    O
a    O
-    O
chip    O
(    O
in    O
the    O
future    O
nanomedicine    B-Medicine106043075
devices    O
like    O
nanorobots    O
)    O
and    O
advanced    O
computerized    O
medical    O
diagnosis    O
and    O
early    O
warning    O
tools    O
over    O
a    O
short    O
clinical    O
interview    O
and    O
drug    O
prescription    O
.    O

Predictive    B-Medicine106043075
medicine    I-Medicine106043075

Atripla    B-Medicine106043075
(    O
efavirenz    O
/    O
emtricitabine    B-Medicine106043075
/    O
tenofovir    B-Medicine106043075
disoproxil    I-Medicine106043075
fumarate    I-Medicine106043075
)    O
—    O
comarketed    O
with    O
Gilead    O
Sciences    O

In    O
July    O
2006    O
,    O
the    O
U.S.    O
Food    O
and    O
Drug    O
Administration    O
(    O
FDA    O
)    O
approved    O
Atripla    B-Medicine106043075
,    O
a    O
once    O
a    O
day    O
single    O
tablet    O
regimen    O
for    O
HIV    O
,    O
combining    O
Sustiva    O
(    O
efavirenz    O
)    O
,    O
a    O
Bristol    O
-    O
Myers    O
Squibb    O
product    O
,    O
and    O
Truvada    O
(    O
emtricitabine    B-Medicine106043075
and    O
tenofovir    B-Medicine106043075
disoproxil    I-Medicine106043075
)    O
,    O
a    O
Gilead    O
product    O
.    O

Deborah    O
Asnis    O
(    O
B.S.    O
,    O
M.D.    O
2008    O
)    O
,    O
infectious    B-Medicine106043075
disease    I-Medicine106043075
specialist    I-Medicine106043075
,    O
discovered    O
and    O
reported    O
the    O
first    O
human    O
cases    O
of    O
West    O
Nile    O
virus    O
in    O
the    O
United    O
States    O

Deborah    O
Asnis    O
-    O
Infectious    B-Medicine106043075
disease    I-Medicine106043075
specialist    I-Medicine106043075
,    O
discovered    O
the    O
first    O
human    O
cases    O
of    O
West    O
Nile    O
virus    O
in    O
the    O
United    O
States    O

Infectious    B-Medicine106043075
disease    I-Medicine106043075
,    O
also    O
known    O
as    O
infectious    B-Medicine106043075
diseases    I-Medicine106043075
,    O
infectious    B-Medicine106043075
medicine    I-Medicine106043075
,    O
infectious    B-Medicine106043075
disease    I-Medicine106043075
medicine    I-Medicine106043075
or    O
infectiology    B-Medicine106043075
,    O
is    O
a    O
medical    B-Medicine106043075
specialty    I-Medicine106043075
dealing    O
with    O
the    O
diagnosis    O
,    O
control    O
and    O
treatment    O
of    O
infections    O
.    O

The    O
Institute    O
develops    O
basic    O
and    O
applied    O
biomedical    O
research    O
in    O
many    O
areas    O
,    O
including    O
molecular    O
biology    O
,    O
immunology    O
and    O
epidemiology    O
and    O
has    O
a    O
graduate    O
research    O
training    O
program    O
in    O
collaboration    O
with    O
other    O
institutions    O
,    O
in    O
the    O
areas    O
of    O
biotechnology    O
and    O
infectology    B-Medicine106043075
.    O

Robert    O
L.    O
Sack    O
is    O
an    O
American    O
physician    O
and    O
researcher    O
specializing    O
in    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
.    O

It    O
was    O
commercialized    O
by    O
Hewlett    O
-    O
Packard    O
but    O
its    O
use    O
was    O
limited    O
to    O
pulmonary    O
functions    O
and    O
sleep    B-Medicine106043075
laboratories    I-Medicine106043075
because    O
of    O
cost    O
and    O
size    O
.    O

Center    O
for    O
Sleep    B-Medicine106043075
and    I-Medicine106043075
Circadian    I-Medicine106043075
Neurobiology    I-Medicine106043075
–    O
http://www.med.upenn.edu/sleepctr/    O

Family    O
physicians    O
may    O
pursue    O
fellowships    O
in    O
several    O
fields    O
,    O
including    O
adolescent    O
medicine    O
,    O
geriatric    O
medicine    O
,    O
sports    O
medicine    O
,    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
hospice    O
and    O
palliative    O
medicine    O
.    O

Sleep    B-Medicine106043075
Medicine    I-Medicine106043075
Fellowship    O

Sleep    B-Medicine106043075
medicine    I-Medicine106043075

Sleep    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
hospital    O
's    O
sleep    B-Medicine106043075
lab    I-Medicine106043075
has    O
been    O
expanded    O
off    O
-    O
campus    O
to    O
Swanton    O
,    O
Ohio    O
with    O
two    O
more    O
beds    O
,    O
which    O
doubles    O
the    O
capacity    O
of    O
FCHC    O
's    O
sleep    O
medicine    O
department    O
.    O

Certificates    O
of    O
Added    O
Qualifications    O
(    O
CAQs    O
)    O
in    O
adolescent    B-Medicine106043075
medicine    I-Medicine106043075
,    O
geriatric    O
medicine    O
,    O
sports    O
medicine    O
,    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
hospice    O
and    O
palliative    O
medicine    O
are    O
available    O
for    O
those    O
board    O
-    O
certified    O
family    O
physicians    O
with    O
additional    O
residency    O
training    O
requirements    O
.    O

The    O
American    O
Academy    O
of    O
Sleep    O
Medicine    O
(    O
AASM    O
)    O
is    O
a    O
United    O
States    O
professional    O
society    O
for    O
the    O
medical    B-Medicine106043075
subspecialty    I-Medicine106043075
of    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
which    O
includes    O
disorders    O
of    O
circadian    O
rhythms    O
.    O

PAS    O
formed    O
part    O
of    O
the    O
standard    O
treatment    O
for    O
tuberculosis    O
prior    O
to    O
the    O
introduction    O
of    O
rifampicin    B-Medicine106043075
and    O
pyrazinamide    O
.    O

Its    O
potency    O
is    O
less    O
than    O
that    O
of    O
the    O
current    O
five    O
first    O
-    O
line    O
drugs    O
(    O
isoniazid    O
,    O
rifampicin    B-Medicine106043075
,    O
ethambutol    B-Medicine106043075
,    O
pyrazinamide    O
,    O
and    O
streptomycin    O
)    O
for    O
treating    O
tuberculosis    O
and    O
its    O
cost    O
is    O
higher    O
,    O
but    O
it    O
is    O
still    O
useful    O
in    O
the    O
treatment    O
of    O
multidrug    O
-    O
resistant    O
tuberculosis    O
.    O

When    O
taken    O
with    O
rifampicin    B-Medicine106043075
,    O
the    O
levels    O
of    O
rifampicin    B-Medicine106043075
in    O
the    O
blood    O
fall    O
by    O
about    O
half    O
.    O

A    O
preliminary    O
trial    O
of    O
antibiotic    O
therapy    O
with    O
doxycycline    O
and    O
rifampin    B-Medicine106043075
at    O
McMaster    O
University    O
had    O
indicated    O
that    O
it    O
was    O
effective    O
in    O
delaying    O
the    O
progress    O
of    O
the    O
disease    O
:    O
"    O
In    O
conclusion    O
,    O
a    O
3-month    O
course    O
of    O
doxycycline    O
and    O
rifampin    O
reduced    O
cognitive    O
worsening    O
at    O
6    O
months    O
of    O
follow    O
-    O
up    O
in    O
patients    O
with    O
mild    O
to    O
moderate    O
AD    O
.    O
"    O

Rifampicin    B-Medicine106043075
.    O

Rifampin    B-Medicine106043075

Inducers    O
of    O
hepatic    O
microsomal    O
enzymes    O
such    O
as    O
barbiturates    O
,    O
phenytoin    O
,    O
and    O
rifampicin    B-Medicine106043075
can    O
reduce    O
the    O
half    O
-    O
life    O
of    O
dexamethasone    O
.    O

The    O
metabolism    O
of    O
NOMAC    O
is    O
dependent    O
on    O
CYP3A4    O
,    O
so    O
inhibitors    O
and    O
inducers    O
of    O
this    O
enzyme    O
such    O
as    O
ketoconazole    O
and    O
rifampicin    B-Medicine106043075
,    O
respectively    O
,    O
as    O
well    O
as    O
some    O
anticonvulsants    O
,    O
may    O
pose    O
a    O
clinically    O
significant    O
drug    O
interaction    O
with    O
NOMAC    O
.    O

These    O
horses    O
are    O
typically    O
treated    O
with    O
rifampin    B-Medicine106043075
in    O
addition    O
to    O
one    O
of    O
the    O
previously    O
mentioned    O
antibiotics    O
.    O

Currently    O
,    O
a    O
multidrug    O
treatment    O
(    O
MDT    O
)    O
is    O
recommended    O
by    O
the    O
World    O
Health    O
Organization    O
,    O
including    O
dapsone    O
,    O
rifampicin    B-Medicine106043075
and    O
clofazimine    O
.    O

The    O
search    O
for    O
additional    O
anti    O
-    O
leprosy    O
drugs    O
led    O
to    O
the    O
use    O
of    O
clofazimine    O
and    O
rifampicin    B-Medicine106043075
in    O
the    O
1960s    O
and    O
1970s    O
.    O

The    O
search    O
for    O
more    O
effective    O
anti    O
-    O
leprosy    O
drugs    O
led    O
to    O
the    O
use    O
of    O
clofazimine    O
and    O
rifampicin    B-Medicine106043075
in    O
the    O
1960s    O
and    O
1970s    O
.    O

A    O
dermatologist    O
or    O
general    O
physician    O
usually    O
administers    O
combination    O
therapy    O
of    O
drugs    O
used    O
for    O
tuberculosis    O
,    O
such    O
as    O
Rifampicin    B-Medicine106043075
,    O
Isoniazid    O
and    O
Pyrazinamide    O
(    O
possibly    O
with    O
either    O
streptomycin    O
or    O
ethambutol    B-Medicine106043075
)    O
.    O

Ulipristal    O
acetate    O
is    O
likely    O
to    O
interact    O
with    O
substrates    O
of    O
CYP3A4    O
,    O
like    O
rifampicin    B-Medicine106043075
,    O
phenytoin    O
,    O
St    O
John    O
's    O
wort    O
,    O
carbamazepine    B-Medicine106043075
or    O
ritonavir    O
,    O
therefore    O
concomitant    O
use    O
with    O
these    O
agents    O
is    O
not    O
recommended    O
.    O

rifampin    B-Medicine106043075

Rifampin    B-Medicine106043075
prophylactically    O

Rifampin    B-Medicine106043075

Dapsone    O
and    O
rifampin    B-Medicine106043075

Rifampicin    B-Medicine106043075

Rifampicin    B-Medicine106043075

Rifampin    B-Medicine106043075

Chloramphenicol    O
,    O
vancomycin    O
,    O
streptomycin    O
were    O
all    O
found    O
to    O
completely    O
inhibit    O
growth    O
,    O
though    O
it    O
was    O
resistant    O
to    O
rifampin    B-Medicine106043075
.    O

Today    O
,    O
the    O
drugs    O
of    O
choice    O
for    O
treating    O
leprosy    O
are    O
dapsone    O
,    O
rifampicin    B-Medicine106043075
and    O
clofazimine    O
.    O

In    O
cases    O
where    O
antibiotics    O
have    O
been    O
suggested    O
to    O
affect    O
the    O
efficiency    O
of    O
birth    O
control    O
pills    O
,    O
such    O
as    O
for    O
the    O
broad    O
-    O
spectrum    O
antibiotic    O
rifampicin    B-Medicine106043075
,    O
these    O
cases    O
may    O
be    O
due    O
to    O
an    O
increase    O
in    O
the    O
activities    O
of    O
hepatic    O
liver    O
enzymes    O
'    O
causing    O
increased    O
breakdown    O
of    O
the    O
pill    O
's    O
active    O
ingredients    O
.    O

Since    O
then    O
,    O
drugs    O
such    O
as    O
isoniazid    O
and    O
rifampin    B-Medicine106043075
have    O
been    O
used    O
.    O

Resistance    O
of    O
"    O
Mycobacterium    O
tuberculosis    O
"    O
to    O
isoniazid    O
,    O
rifampin    B-Medicine106043075
,    O
and    O
other    O
common    O
treatments    O
has    O
become    O
an    O
increasingly    O
relevant    O
clinical    O
challenge    O
.    O

In    O
contrast    O
to    O
bacterial    O
RNA    O
polymerases    O
,    O
T7    O
polymerase    O
is    O
not    O
inhibited    O
by    O
the    O
antibiotic    O
rifampicin    B-Medicine106043075
.    O

For    O
people    O
with    O
MRSA    O
bacteremia    O
in    O
the    O
setting    O
of    O
vancomycin    O
failure    O
the    O
IDSA    O
recommends    O
high    O
-    O
dose    O
daptomycin    O
,    O
if    O
the    O
isolate    O
is    O
susceptible    O
,    O
in    O
combination    O
with    O
another    O
agent    O
(    O
e.g.    O
gentamicin    O
,    O
rifampin    B-Medicine106043075
,    O
linezolid    O
,    O
TMP    O
-    O
SMX    O
,    O
or    O
a    O
beta    O
-    O
lactam    O
antibiotic    O
)    O
.    O

Rifampin    B-Medicine106043075

CYP2A6    O
is    O
known    O
to    O
be    O
inducible    O
by    O
phenobarbital    O
and    O
rifampicin    B-Medicine106043075
,    O
and    O
it    O
is    O
suspected    O
that    O
other    O
antiepileptic    O
drugs    O
may    O
also    O
have    O
this    O
effect    O
.    O

rifampicin    B-Medicine106043075
(    O
antibacterial    O
)    O

Richard    O
"    O
Dick    O
"    O
Rutkowski    O
is    O
a    O
pioneer    O
in    O
the    O
fields    O
of    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
,    O
diving    B-Medicine106043075
medicine    I-Medicine106043075
and    O
diver    O
training    O
,    O
especially    O
in    O
relation    O
to    O
the    O
use    O
of    O
breathing    O
gases    O
.    O

He    O
was    O
particularly    O
interested    O
in    O
respiratory    O
physiology    O
at    O
high    O
altitudes    O
and    O
high    B-Medicine106043075
pressure    I-Medicine106043075
environments    O
.    O

National    O
Board    O
of    O
Diving    O
and    O
Hyperbaric    O
Medical    O
Technology    O
(    O
NBDHMT    O
)    O
,    O
formally    O
known    O
as    O
the    O
National    O
Association    O
of    O
Diving    O
Technicians    O
,    O
is    O
a    O
non    O
-    O
profit    O
organization    O
devoted    O
to    O
the    O
education    O
and    O
certification    O
of    O
qualified    O
personnel    O
in    O
the    O
fields    O
of    O
diving    B-Medicine106043075
and    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Diving    B-Medicine106043075
medicine    I-Medicine106043075
is    O
the    O
diagnosis    O
,    O
treatment    O
and    O
prevention    O
of    O
conditions    O
caused    O
by    O
exposing    O
divers    O
to    O
the    O
underwater    O
environment    O
.    O

Benzathine    O
is    O
a    O
diamine    O
used    O
as    O
a    O
component    O
in    O
some    O
medications    O
including    O
benzathine    O
phenoxymethylpenicillin    O
and    O
benzathine    B-Medicine106043075
benzylpenicillin    I-Medicine106043075
.    O

Benzathine    O
penicillin    O
G    O
(    O
benzathine    B-Medicine106043075
benzylpenicillin    I-Medicine106043075
)    O

Benzathine    B-Medicine106043075
benzylpenicillin    I-Medicine106043075

The    O
song    O
is    O
played    O
in    O
"    O
The    O
Simpsons    O
"    O
season    O
10    O
episode    O
6    O
,    O
"    O
D'oh    O
-    O
in    O
'    O
in    O
the    O
Wind    O
"    O
,    O
season    O
16    O
episode    O
6    O
,    O
"    O
Midnight    B-Medicine106043075
Rx    I-Medicine106043075
"    O
,    O
and    O
season    O
19    O
episode    O
19    O
,    O
"    O
Mona    O
Leaves    O
-    O
a    O
"    O
.    O

In    O
Canada    O
in    O
2004    O
doxycycline    O
was    O
considered    O
a    O
first    O
-    O
line    O
treatment    O
for    O
chlamydia    O
and    O
non    O
-    O
gonococcal    O
urethritis    O
and    O
with    O
cefixime    B-Medicine106043075
for    O
uncomplicated    O
gonorrhea    O
.    O

Ceftriaxone    O
and    O
cefixime    B-Medicine106043075
are    O
third    O
generation    O
cephalosporins    O
and    O
are    O
often    O
used    O
as    O
treatments    O
for    O
"    O
N.    O
gonorrhoeae    O
infections    O
"    O
.    O

These    O
include    O
:    O
cefixime    B-Medicine106043075
(    O
an    O
oral    O
cephalosporin    O
)    O
,    O
ceftriaxone    O
(    O
an    O
injectable    O
cephalosporin    O
)    O
,    O
azithromycin    O
,    O
aminoglycosides    O
,    O
and    O
tetracycline    O
.    O

Pneumology    B-Medicine106043075

Developmental    O
paediatrics/    O
pneumology    B-Medicine106043075

She    O
is    O
married    O
to    O
Richard    O
Waldhorn    O
,    O
a    O
pulmonologist    B-Medicine106043075
,    O
and    O
has    O
two    O
children    O
.    O

Product    O
development    O
was    O
focused    O
on    O
therapeutics    O
for    O
gastrointestinal    O
,    O
cardiovascular    O
and    O
respiratory    B-Medicine106043075
disorders    O
and    O
pain    O
control    O
.    O

It    O
provided    O
paediatric    O
specialist    O
services    O
,    O
general    O
paediatric    O
services    O
and    O
had    O
a    O
paediatric    O
accident    O
and    O
emergency    O
department    O
,    O
providing    O
paediatric    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
plastic    O
surgery    O
and    O
a    O
paediatric    O
burns    O
unit    O
,    O
gastroenterology    O
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
and    O
diabetology    O
.    O

Jessenius    O
also    O
headquarters    O
three    O
National    O
Centers    O
of    O
Excellence    O
,    O
funded    O
through    O
the    O
Science    O
and    O
Research    O
program    O
of    O
the    O
EU    O
,    O
which    O
are    O
cutting    O
-    O
edge    O
institutions    O
for    O
perinatology    O
and    O
pulmonology    B-Medicine106043075
research    O
(    O
both    O
basic    O
science    O
and    O
clinical    O
)    O
and    O
emphasizes    O
medical    O
innovation    O
,    O
novel    O
methods    O
,    O
discoveries    O
,    O
and    O
intovations    O
.    O

Pulmonology    B-Medicine106043075

General    O
Pediatrics    O
,    O
Family    O
Medicine    O
,    O
Adolescent    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Allergy    O
/    O
Pulmonary    B-Medicine106043075
diseases    I-Medicine106043075
,    O
Anesthesia    O
,    O
Blood    O
and    O
Marrow    O
Transplantation    O
,    O
Burn    O
Treatment    O
,    O
Cardiology    O
,    O
Child    O
Abuse    O
and    O
Neglect    O
,    O
Child    O
Health    O
Specialty    O
Clinics    O
,    O
Child    O
Neurology    O
,    O
Child    O
Psychology    O
,    O
Child    O
Psychiatry    O
,    O
Clinical    O
Pharmacology    O
,    O
Continuity    O
of    O
Care    O
,    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
,    O
Dentistry    O
,    O
Dermatology    O
,    O
Developmental    O
Disabilities    O
,    O
ECMO    O
,    O
Emergency    O
Care    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Genetics    O
,    O
Hematology    O
,    O
Infectious    O
Diseases    O
,    O
Mother    O
's    O
Milk    O
Bank    O
of    O
Iowa    O
,    O
Neonatology    O
,    O
Nephrology    O
,    O
Neurosurgery    O
,    O
Nuclear    O
Medicine    O
,    O
Nutrition    O
,    O
Obstetrics    O
/    O
Gynecology    O
,    O
Oncology    O
,    O
Ophthalmology    O
,    O
Oral    O
and    O
Maxillofacial    O
Surgery    O
,    O
Orthodontics    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Spinal    O
Deformity    O
,    O
Otolaryngology    O
-    O
Head    O
and    O
Neck    O
Surgery    O
,    O
Speech    O
,    O
Swallowing    O
,    O
Voice    O
,    O
Pediatric    O
Outreach    O
Clinics    O
(    O
Cardiac    O
-    O
Electrophysiology    O
,    O
Cardiology    O
,    O
Cystic    O
Fibrosis    O
,    O
Diabetes    O
/    O
Endocrinology    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Hemoglobinopathy    O
,    O
Neurology    O
,    O
Neuromuscular    O
)    O
,    O
Radiation    O
Oncology    O
,    O
Radiology    O
,    O
Rheumatology    O
,    O
Special    O
Education    O
,    O
Specialized    O
Child    O
Health    O
Services    O
,    O
Surgery    O
(    O
Pediatric    O
)    O
,    O
Thoracic    O
and    O
Cardiovascular    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Toxicology    O
,    O
Transplantation    O
Surgery    O
,    O
Trauma    O
Surgery    O
,    O
and    O
Urology    O
.    O

Although    O
best    O
known    O
as    O
a    O
poet    O
,    O
Abse    O
worked    O
in    O
the    O
medical    O
field    O
,    O
and    O
was    O
a    O
physician    O
in    O
a    O
chest    B-Medicine106043075
clinic    I-Medicine106043075
for    O
over    O
thirty    O
years    O
.    O

Doctor    O
of    O
MedicineMD    O
—    O
A    O
three    O
-    O
year    O
course    O
in    O
following    O
specialties    O
:    O
Internal    O
Medicine    O
,    O
Paediatrics    O
,    O
Radiology    O
,    O
Anaesthesiology    O
,    O
Dermatology    O
,    O
Pulmonology    B-Medicine106043075
/    O
Chest    O
Medicine    O
,    O
&    O
Psychiatry    O
,    O
Social    O
&    O
Preventive    O
Medicine    O
(    O
which    O
is    O
both    O
clinical    O
&    O
non    O
-    O
clinical    O
subject    O
)    O

Other    O
areas    O
of    O
research    O
at    O
the    O
Center    O
include    O
:    O
Gastroenterology    O
,    O
Cardiology    O
,    O
Pulmonology    B-Medicine106043075
,    O
Allergy    O
,    O
Endocrinology    O
,    O
Nephrology    O
,    O
Hemato    O
-    O
oncology    O
,    O
Hepato    O
-    O
oncology    O
,    O
Infection    O
,    O
Rheumatology    O
,    O
Orthopedics    B-Medicine106043075
,    O
General    O
Surgery    O
,    O
Plastic    O
Surgery    O
,    O
Thoracic    O
Surgery    O
,    O
Neurosurgery    O
,    O
Obstetrics    O
&    O
Gynecology    O
,    O
ENT    O
,    O
Family    O
Medicine    O
,    O
Rehabilitation    O
Medicine    O
,    O
Pediatrics    O
,    O
Anesthesiology    O
,    O
Dermatology    O
,    O
Neurology    O
,    O
Psychiatry    O
,    O
Diagnostics    O
,    O
Pathology    B-Medicine106043075
,    O
Radiology    O
,    O
Radiological    O
Oncology    O
,    O
Ophthalmology    O
,    O
Urology    O
,    O
Nuclear    O
Medicine    O
.    O

In    O
2016    O
-    O
17    O
,    O
NYU    O
Langone    O
Medical    O
Center    O
was    O
also    O
recognized    O
on    O
the    O
"    O
U.S.    O
News    O
&    O
World    O
Report    O
"    O
"    O
Best    O
Hospitals    O
Honor    O
Roll    O
,    O
"    O
ranking    O
10th    O
among    O
the    O
top    O
hospitals    O
in    O
the    O
nation    O
with    O
13    O
nationally    O
ranked    O
specialties    O
including    O
cancer    O
,    O
cardiology    O
&    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurology    O
&    O
neurosurgery    O
,    O
orthopedics    B-Medicine106043075
,    O
diabetes    O
&    O
endocrinology    O
,    O
nephrology    O
,    O
geriatrics    O
,    O
gastroenterology    O
,    O
ear    O
,    O
nose    O
&    O
throat    O
,    O
rehabilitation    O
,    O
pulmonology    B-Medicine106043075
,    O
rheumatology    O
,    O
and    O
urology    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

Level    O
07    O
-    O
General    O
surgery    O
,    O
trauma    O
,    O
orthopaedic    B-Medicine106043075
,    O
rheumatology    O
,    O
gastroenterology    O
,    O
urology    O
and    O
respiratory    B-Medicine106043075
wards    O

Allergy    O
and    O
respirology    B-Medicine106043075
medicine    O

Interventional    O
Pulmonology    B-Medicine106043075

Group    O
II    O
hospitals    O
provide    O
the    O
group    O
I    O
valences    O
in    O
their    O
own    O
area    O
of    O
direct    O
influence    O
and    O
also    O
provide    O
the    O
medical    O
and    O
chirurgical    O
valences    O
of    O
ophthalmology    O
,    O
pneumology    B-Medicine106043075
,    O
cardiology    O
,    O
rheumatology    O
,    O
gastroenterology    O
,    O
nephrology    O
,    O
clinical    O
hematology    O
,    O
infectiology    O
,    O
medical    O
oncology    O
,    O
neonatology    O
,    O
allergology    O
,    O
gynecology    O
-    O
obstetrics    O
,    O
dermatology    O
-    O
venereology    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
urology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
pathological    O
anatomy    O
,    O
nuclear    O
medicine    O
and    O
neuroradiology    B-Medicine106043075
in    O
an    O
indirect    O
area    O
of    O
influence    O
.    O

Pulmonology    B-Medicine106043075

Pulmonology    B-Medicine106043075

These    O
Meetings    O
bring    O
together    O
medical    O
professionals    O
with    O
an    O
interest    O
in    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
.    O

In    O
addition    O
,    O
ambulatory    O
care    O
includes    O
Cardiac    O
Diagnostics    O
,    O
Medicine    O
,    O
Respiratory    B-Medicine106043075
,    O
GI    O
,    O
[    O
Neurodiagnostics    O
and    O
Gynecology    O
Outpatient    O
services    O
.    O

Pulmonology    B-Medicine106043075
,    O
critical    O
care    O
,    O
sleep    O
medicine    O
,    O
infectious    O
disease    O
,    O
pediatrics    O
,    O
allergy    O
/    O
immunology    O
,    O
thoracic    O
surgery    O
,    O
behavioral    O
science    O
,    O
environmental    O
and    O
occupational    O
medicine    O
,    O
physiology    O
,    O
molecular    O
biology    O
,    O
among    O
others    O
.    O

Soon    O
after    O
his    O
call    O
to    O
the    O
bar    O
,    O
Tull    O
became    O
ill    O
with    O
a    O
pulmonary    B-Medicine106043075
disorder    I-Medicine106043075
and    O
travelled    O
to    O
Europe    O
in    O
search    O
of    O
a    O
cure    O
.    O

Wajid    O
Ali    O
Khan    O
Burki    O
and    O
Iqbal    O
Bano    O
's    O
son    O
Nausherwan    O
Burki    O
is    O
a    O
US    O
-    O
based    O
physician    O
and    O
pulmonologist    B-Medicine106043075
who    O
played    O
an    O
instrumental    O
role    O
in    O
setting    O
up    O
Imran    O
's    O
Shaukat    O
Khanum    O
Cancer    O
Hospital    O
and    O
serves    O
in    O
its    O
board    O
of    O
governors    O
;    O
he    O
was    O
also    O
among    O
the    O
original    O
founders    O
of    O
the    O
Pakistan    O
Tehreek    O
-    O
e    O
-    O
Insaf    O
in    O
1996    O
.    O

Internal    O
medicine    O
:    O
(    O
Geriatrics    O
,    O
Haematology    O
,    O
Infectious    O
Diseases    O
,    O
cardiology    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Pulmonary    B-Medicine106043075
diseases    I-Medicine106043075
,    O
Nephrology    O
,    O
Rheumatology    O
)    O

Pulmonology    B-Medicine106043075

Comingore    O
died    O
December    O
30    O
,    O
1971    O
,    O
from    O
a    O
pulmonary    B-Medicine106043075
disease    I-Medicine106043075
in    O
Stonington    O
,    O
Connecticut    O
,    O
at    O
the    O
age    O
of    O
58    O
.    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

Pulmonology    B-Medicine106043075

The    O
modern    O
SVHC    O
consists    O
of    O
the    O
entire    O
medical    O
center    O
(    O
a    O
complex    O
now    O
dubbed    O
the    O
Stormont    O
–    O
Vail    O
Regional    O
Health    O
Center    O
)    O
and    O
numerous    O
satellite    O
offices    O
and    O
clinics    O
providing    O
pediatrics    O
,    O
oncology    O
,    O
pulmonology    B-Medicine106043075
,    O
diabetes    O
treatment    O
,    O
and    O
many    O
other    O
specialties    O
.    O

The    O
medical    O
team    O
includes    O
a    O
pediatric    O
pulmonologist    B-Medicine106043075
,    O
pediatricians    O
,    O
nurse    O
clinicians    O
and    O
nurse    O
specialists    O
,    O
respiratory    O
therapists    O
,    O
physical    O
,    O
occupational    O
and    O
speech    O
therapists    O
,    O
infant    O
development    O
specialists    O
,    O
social    O
workers    O
,    O
nutritionists    O
,    O
and    O
case    O
managers    O
.    O

Specialists    O
consultants    O
in    O
Dentistry    O
,    O
ENT    O
,    O
Cardiology    O
,    O
Diabetology    O
,    O
Endocrinology    O
,    O
Urology    O
,    O
Psychiatry    O
,    O
Pulmonology    B-Medicine106043075
,    O
Pediatric    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Gastroentrology    O
are    O
available    O
.    O

The    O
Prince    O
Charles    O
Hospital    O
is    O
a    O
major    O
teaching    O
hospital    O
in    O
Brisbane    O
's    O
northside    O
with    O
an    O
emphasis    O
in    O
cardiac    O
and    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
and    O
cardio    O
-    O
thoracic    O
surgery    O
.    O

Pulmonology    B-Medicine106043075
–    O
branch    O
of    O
medicine    O
that    O
deals    O
with    O
the    O
respiratory    O
system    O
.    O

Dr.    O
Sanders    O
T.    O
Frank    O
M.D.    O
(    O
May    O
11    O
,    O
1938    O
–    O
September    O
14    O
,    O
1997    O
)    O
was    O
an    O
American    O
pulmonologist    B-Medicine106043075
known    O
for    O
describing    O
Frank    O
's    O
sign    O
.    O

It    O
provides    O
services    O
in    O
cardiology    O
,    O
pneumology    B-Medicine106043075
,    O
neurology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
oncology    O
,    O
gastroenterology    O
and    O
ophthalmology    O
.    O

Caffeine    B-Medicine106043075
citrate    I-Medicine106043075

It    O
is    O
often    O
described    O
in    O
the    O
fields    O
of    O
medical    B-Medicine106043075
statistics    I-Medicine106043075
or    O
biostatistics    O
,    O
as    O
in    O
the    O
original    O
description    O
of    O
the    O
problem    O
by    O
Joseph    O
Berkson    O
.    O

medical    B-Medicine106043075
statistics    I-Medicine106043075

It    O
is    O
identical    O
to    O
a    O
Tukey    O
mean    O
-    O
difference    O
plot    O
,    O
the    O
name    O
by    O
which    O
it    O
is    O
known    O
in    O
other    O
fields    O
,    O
but    O
was    O
popularised    O
in    O
medical    B-Medicine106043075
statistics    I-Medicine106043075
by    O
J.    O
Martin    O
Bland    O
and    O
Douglas    O
G.    O
Altman    O
.    O

=    O
=    O
Health    B-Medicine106043075
Statistics    I-Medicine106043075
and    O
Health    O
indicators==    O

Greenwood    O
produced    O
a    O
large    O
body    O
of    O
research    O
,    O
was    O
the    O
first    O
holder    O
of    O
important    O
positions    O
in    O
modern    O
medical    B-Medicine106043075
statistics    I-Medicine106043075
and    O
wrote    O
extensively    O
on    O
the    O
history    O
of    O
his    O
subject    O
,    O
but    O
as    O
Austin    O
Bradford    O
Hill    O
wrote    O
in    O
his    O
obituary    O
,    O
"    O
in    O
the    O
future    O
,    O
it    O
may    O
well    O
indeed    O
seem    O
that    O
one    O
of    O
his    O
greatest    O
contributions    O
,    O
if    O
not    O
the    O
greatest    O
,    O
lay    O
merely    O
in    O
his    O
outlook    O
,    O
in    O
his    O
statistical    O
approach    O
to    O
medicine    O
,    O
then    O
a    O
new    O
approach    O
and    O
one    O
long    O
regarded    O
with    O
suspicion    O
.    O

He    O
published    O
a    O
textbook    O
on    O
pharmaceutical    B-Medicine106043075
statistics    I-Medicine106043075
.    O

The    O
prose    O
is    O
distinctly    O
and    O
obviously    O
DeLillo    O
's    O
,    O
but    O
as    O
further    O
proof    O
of    O
his    O
authorship    O
,    O
readers    O
cite    O
the    O
appearance    O
of    O
the    O
character    O
Murray    O
Jay    O
Siskind    O
,    O
a    O
sportswriter    O
in    O
the    O
novel    O
,    O
who    O
later    O
appears    O
as    O
the    O
eccentric    O
former    O
sportswriter    O
-    O
turned-"visiting    O
lecturer    O
on    O
American    O
icons    O
"    O
in    O
DeLillo    O
's    O
novel    O
"White    B-Medicine106043075
Noise"    I-Medicine106043075
.    O

The    O
song    O
's    O
title    O
is    O
and    O
an    O
allusion    O
to    O
the    O
book    O
White    B-Medicine106043075
Noise    I-Medicine106043075
by    O
Don    O
DeLillo    O
.    O

This    O
study    O
in    O
pre    O
-    O
Sept    O
.    O
11    O
terrorism    O
"    O
is    O
interspersed    O
with    O
passages    O
from    O
Don    O
DeLillo    O
's    O
novels    O
"    O
Mao    O
II    O
"    O
and    O
"    O
White    B-Medicine106043075
Noise    I-Medicine106043075
"    O
,    O
"    O
providing    O
a    O
literary    O
and    O
philosophic    O
anchor    O
to    O
the    O
film    O
.    O
"    O

"    O
White    B-Medicine106043075
Noise    I-Medicine106043075
"    O
by    O
Don    O
DeLillo    O
(    O
USA    O
)    O

Clinical    B-Medicine106043075
neurophysiology    I-Medicine106043075
,    O
is    O
a    O
broader    O
field    O
that    O
includes    O
EEG    O
,    O
intraoperative    O
monitoring    O
,    O
nerve    O
conduction    O
studies    O
,    O
EMG    O
and    O
evoked    O
potentials    O
.    O

Clinical    B-Medicine106043075
neurophysiology    I-Medicine106043075

Budzynski    O
's    O
research    O
and    O
clinical    O
findings    O
have    O
been    O
published    O
in    O
professional    O
journals    O
including    O
:    O
the    O
Journal    O
of    O
Applied    O
Behavioral    O
Analysis    O
;    O
Experimental    O
&    O
Clinical    O
Psychopharmacology    O
;    O
the    O
Journal    O
of    O
Behavior    O
Therapy    O
and    O
Experimental    O
Psychiatry    O
;    O
Biofeedback    O
and    O
Self    O
-    O
Control    O
;    O
Biofeedback    O
:    O
Behavioral    O
Medicine    O
;    O
Psychosomatic    B-Medicine106043075
Medicine    I-Medicine106043075
;    O
the    O
Journal    O
of    O
Dental    O
Research    O
;    O
Biofeedback    O
and    O
Self    O
-    O
Regulation    O
;    O
Consciousness    O
and    O
Self    O
-    O
Regulation    O
;    O
Psychology    O
Today    O
;    O
Somatics    O
;    O
Education    O
;    O
the    O
Journal    O
of    O
Neurotherapy    O
;    O
Applied    O
Neurophysiology    O
and    O
Brainwave    O
Biofeedback    O
;    O
Clinical    B-Medicine106043075
Neurophysiology    I-Medicine106043075
;    O
and    O
Neuroimage    O
.    O

Streptomyces    O
glomeratus    O
"    O
produces    O
beromycin    B-Medicine106043075
and    O
nogalamycin    O
.    O

Phenoxymethylpenicillin    B-Medicine106043075
(    O
penicillin    O
V    O
)    O

Penicillin    O
G    O
or    O
V    B-Medicine106043075

Travel    B-Medicine106043075
medicine    I-Medicine106043075

ID    O
is    O
historically    O
associated    O
with    O
travel    B-Medicine106043075
medicine    I-Medicine106043075
and    O
tropical    O
medicine    O
,    O
as    O
many    O
diseases    O
acquired    O
in    O
tropical    O
and    O
subtropical    O
areas    O
are    O
infectious    O
in    O
nature    O
.    O

Travel    B-Medicine106043075
medicine    I-Medicine106043075

Neurohydrodynamics    B-Medicine106043075
is    O
a    O
division    O
of    O
neurophysics    O
that    O
focuses    O
on    O
the    O
hydrodynamics    O
of    O
the    O
neurological    O
system    O
.    O

Drugs    O
shown    O
to    O
be    O
effective    O
are    O
resorantel    O
,    O
oxyclozanide    O
,    O
clorsulon    O
,    O
ivermectin    O
,    O
niclosamide    B-Medicine106043075
,    O
bithional    O
and    O
levamisole    B-Medicine106043075
.    O

However    O
,    O
there    O
are    O
now    O
drugs    O
shown    O
to    O
be    O
effective    O
including    O
resorantel    O
,    O
oxyclozanide    O
,    O
clorsulon    O
,    O
ivermectin    O
,    O
niclosamide    B-Medicine106043075
,    O
bithional    O
and    O
levamisole    B-Medicine106043075
.    O

The    O
two    O
drugs    O
that    O
have    O
been    O
well    O
-    O
described    O
for    O
the    O
treatment    O
of    O
hymenolepiasis    O
are    O
praziquantel    O
and    O
niclosamide    B-Medicine106043075
.    O

Niclosamide    B-Medicine106043075
(    O
for    O
tapeworm    O
infections    O
)    O

The    O
company    O
develops    O
and    O
sells    O
practice    O
management    O
software    O
for    O
physician    O
practices    O
,    O
university    B-Medicine106043075
health    I-Medicine106043075
centers    I-Medicine106043075
,    O
and    O
medical    O
billing    O
companies    O
.    O

Certified    O
Respiratory    O
Therapists    O
and    O
Certified    O
Pulmonary    B-Medicine106043075
Function    I-Medicine106043075
Technologist    I-Medicine106043075
may    O
require    O
oversight    O
and    O
supervision    O
by    O
their    O
advanced    O
-    O
practice    O
counterparts    O
.    O

Emtricitabine    B-Medicine106043075
,    O
also    O
called    O
FTC    O
,    O
has    O
the    O
trade    O
name    O
Emtriva    O
(    O
formerly    O
Coviracil    O
)    O
.    O

Cytidine    O
analogues    O
:    O
zalcitabine    O
(    O
ddC    O
)    O
,    O
lamivudine    O
(    O
3TC    O
)    O
,    O
and    O
emtricitabine    B-Medicine106043075
(    O
FTC    O
)    O

#    O
Do    O
not    O
prescribe    O
lamivudine    O
/    O
zidovudine    O
,    O
abacavir    O
/    O
lamivudine    O
,    O
or    O
abacavir    O
/    O
lamivudine    O
/    O
zidovudine    O
to    O
patients    O
taking    O
emtricitabine    B-Medicine106043075
.    O

Emtricitabine    B-Medicine106043075
,    O
an    O
antiretroviral    O
drug    O
used    O
to    O
treat    O
HIV    O
,    O
coded    O
FTC    O
in    O
medical    O
journals    O

Elvitegravir    O
,    O
emtricitabine    B-Medicine106043075
and    O
tenofovir    B-Medicine106043075
directly    O
suppress    O
viral    O
reproduction    O
.    O

Most    O
important    O
commercial    O
anthelmintics    O
are    O
shown    O
to    O
be    O
practically    O
useles    O
,    O
including    O
albendazole    B-Medicine106043075
,    O
praziquantel    O
,    O
nitroxynil    O
,    O
triclabendazole    B-Medicine106043075
,    O
profenophos    O
and    O
netobimin    O
;    O
while    O
niclosamide    B-Medicine106043075
has    O
high    O
efficacy    O
(    O
99%    O
)    O
against    O
immature    O
fluke    O
but    O
not    O
adult    O
fluke    O
,    O
and    O
2-tertiary    O
-    O
butyl    O
benzthiazole    O
compound    O
(    O
CGA    O
72630    O
)    O
,    O
hexachlorophene    O
and    O
resorantel    O
are    O
highly    O
effective    O
against    O
both    O
adult    O
and    O
immature    O
flukes    O
.    O

Treatment    O
with    O
triclabendazole    B-Medicine106043075
has    O
been    O
highly    O
effective    O
against    O
the    O
adult    O
worms    O
as    O
well    O
as    O
various    O
developing    O
stages    O
.    O

The    O
drug    O
of    O
choice    O
in    O
the    O
treatment    O
of    O
fasciolosis    O
is    O
triclabendazole    B-Medicine106043075
,    O
a    O
member    O
of    O
the    O
benzimidazole    O
family    O
of    O
anthelmintics    O
.    O

2009    O
:    O
Dethklok    B-Medicine106043075
–    O
Dethalbum    O
II    O

2012    O
:    O
Dethklok    B-Medicine106043075

2013    O
:    O
Dethklok    B-Medicine106043075
-    O
"    O
The    O
Doomstar    O
Requiem    O
"    O

Bryan    O
Beller    O
(    O
born    O
May    O
6    O
,    O
1971    O
)    O
is    O
an    O
American    O
bass    O
guitarist    O
known    O
for    O
his    O
work    O
with    O
Joe    O
Satriani    O
,    O
The    O
Aristocrats    O
,    O
Dethklok    B-Medicine106043075
,    O
Mike    O
Keneally    O
,    O
Steve    O
Vai    O
,    O
James    O
LaBrie    O
of    O
Dream    O
Theater    O
and    O
Dweezil    O
Zappa    O
.    O

He    O
’s    O
also    O
toured    O
with    O
the    O
"    O
band    O
"    O
Dethklok    B-Medicine106043075
,    O
a    O
tongue    O
-    O
in    O
-    O
cheek    O
extreme    O
metal    O
band    O
born    O
of    O
the    O
Cartoon    O
Network    O
"    O
Adult    O
Swim    O
"    O
show    O
"    O
Metalocalypse    O
"    O
;    O
Beller    O
’s    O
tracked    O
on    O
the    O
last    O
two    O
Dethklok    B-Medicine106043075
releases    O
(    O
"    O
Dethalbum    O
III    O
"    O
;    O
"    O
The    O
Doomstar    O
Requiem    O
"    O
)    O
and    O
has    O
anchored    O
the    O
band    O
for    O
three    O
nationwide    O
tours    O
to    O
date    O
,    O
alongside    O
Mastodon    O
and    O
Machine    O
Head    O
,    O
among    O
others    O
.    O

With    O
Dethklok    B-Medicine106043075
:    O

He    O
is    O
best    O
known    O
for    O
his    O
work    O
with    O
Dark    O
Angel    O
,    O
Death    O
,    O
Strapping    O
Young    O
Lad    O
,    O
Devin    O
Townsend    O
,    O
Fear    O
Factory    O
,    O
Opeth    O
,    O
Unearth    O
,    O
Dethklok    B-Medicine106043075
and    O
Testament    O
.    O

Hoglan    O
is    O
working    O
with    O
Dethklok    B-Medicine106043075
,    O
the    O
band    O
from    O
the    O
animated    O
TV    O
show    O
"    O
Metalocalypse    O
"    O
.    O

2007    O
-    O
Dethklok    B-Medicine106043075
-    O
"    O
The    O
Dethalbum    O
"    O

2007    O
-    O
Dethklok    B-Medicine106043075
-    O
"    O
...    O

2009    O
-    O
Dethklok    B-Medicine106043075
-    O
"    O
Dethalbum    O
II    O
"    O

2012    O
-    O
Dethklok    B-Medicine106043075
-    O
"    O
Dethalbum    O
III    O
"    O

2013    O
-    O
Dethklok    B-Medicine106043075
-    O
"    O
The    O
Doomstar    O
Requiem    O
"    O

Gene    O
Hoglan    O
(    O
Death    O
,    O
Strapping    O
Young    O
Lad    O
,    O
Dethklok    B-Medicine106043075
)    O

Dethalbum    O
III    O
is    O
the    O
third    O
full    O
-    O
length    O
album    O
by    O
virtual    O
death    O
metal    O
band    O
Dethklok    B-Medicine106043075
,    O
from    O
the    O
Adult    O
Swim    O
animated    O
series    O
"    O
Metalocalypse    O
"    O
.    O

Nathan    B-Medicine106043075
Explosion    I-Medicine106043075
–    O
vocals    O

Pickles    B-Medicine106043075
–    O
drums    O

Skwisgaar    B-Medicine106043075
Skwigelf    I-Medicine106043075
–    O
lead    O
guitar    O

Toki    B-Medicine106043075
Wartooth    I-Medicine106043075
–    O
rhythm    O
guitar    O

William    B-Medicine106043075
Murderface    I-Medicine106043075
–    O
bass    O
guitar    O

The    O
kinematics    O
of    O
a    O
complete    O
spinal    O
motion    O
segment    O
when    O
one    O
of    O
its    O
constituent    O
spinal    B-Medicine106043075
joints    I-Medicine106043075
are    I-Medicine106043075
manipulated    I-Medicine106043075
are    O
much    O
more    O
complex    O
than    O
the    O
kinematics    O
that    O
occur    O
during    O
manipulation    O
of    O
an    O
independent    O
peripheral    O
synovial    O
joint    O
.    O

As    O
with    O
all    O
interventions    O
,    O
there    O
are    O
risks    O
associated    O
with    O
joint    O
manipulation    O
,    O
especially    O
manipulation    B-Medicine106043075
of    I-Medicine106043075
spinal    I-Medicine106043075
joints    I-Medicine106043075
.    O

Chiropractors    O
primarily    O
use    O
manipulation    B-Medicine106043075
(    O
"    O
adjustment    O
"    O
)    O
of    O
the    O
spine    O
as    O
a    O
treatment    O
.    O

Diversified    O
technique    O
is    O
a    O
non    O
-    O
proprietary    O
and    O
eclectic    O
approach    O
to    O
spinal    B-Medicine106043075
manipulation    I-Medicine106043075
that    O
is    O
commonly    O
used    O
by    O
chiropractors    O
.    O

The    O
Activator    O
Method    O
Chiropractic    O
Technique    O
(    O
AMCT    O
)    O
is    O
a    O
chiropractic    O
treatment    O
method    O
and    O
device    O
created    O
by    O
Arlan    O
Fuhr    O
as    O
an    O
alternative    O
to    O
manual    O
manipulation    B-Medicine106043075
of    I-Medicine106043075
the    I-Medicine106043075
spine    I-Medicine106043075
or    O
extremity    O
joints    O
.    O

Other    O
drugs    O
and    O
agents    O
include    O
diuretics    O
,    O
salicylates    O
,    O
pyrazinamide    O
,    O
ethambutol    B-Medicine106043075
,    O
nicotinic    O
acid    O
,    O
ciclosporin    O
,    O
2-ethylamino-1,3,4-thiadiazole    O
,    O
and    O
cytotoxic    O
agents    O
.    O

The    O
treatment    O
of    O
TB    O
meningitis    O
is    O
isoniazid    O
,    O
rifampicin    B-Medicine106043075
,    O
pyrazinamide    O
and    O
ethambutol    B-Medicine106043075
for    O
two    O
months    O
,    O
followed    O
by    O
isoniazid    O
and    O
rifampicin    O
alone    O
for    O
a    O
further    O
ten    O
months    O
.    O

Ethambutol    B-Medicine106043075

Its    O
potency    O
is    O
less    O
than    O
that    O
of    O
the    O
current    O
five    O
first    O
-    O
line    O
drugs    O
(    O
isoniazid    O
,    O
rifampicin    B-Medicine106043075
,    O
ethambutol    B-Medicine106043075
,    O
pyrazinamide    O
,    O
and    O
streptomycin    O
)    O
for    O
treating    O
tuberculosis    O
and    O
its    O
cost    O
is    O
higher    O
,    O
but    O
it    O
is    O
still    O
useful    O
in    O
the    O
treatment    O
of    O
multidrug    O
-    O
resistant    O
tuberculosis    O
.    O

These    O
drugs    O
include    O
all    O
diuretics    O
,    O
pyrazinoate    O
,    O
pyrazinamide    O
,    O
ethambutol    B-Medicine106043075
,    O
and    O
aspirin    O
.    O

A    O
dermatologist    O
or    O
general    O
physician    O
usually    O
administers    O
combination    O
therapy    O
of    O
drugs    O
used    O
for    O
tuberculosis    O
,    O
such    O
as    O
Rifampicin    B-Medicine106043075
,    O
Isoniazid    O
and    O
Pyrazinamide    O
(    O
possibly    O
with    O
either    O
streptomycin    O
or    O
ethambutol    B-Medicine106043075
)    O
.    O

Ethambutol    B-Medicine106043075

Among    O
these    O
are    O
:    O
ingestion    O
of    O
methanol    O
(    O
wood    O
alcohol    O
)    O
,    O
ethylene    O
glycol    O
(    O
automotive    O
antifreeze    O
)    O
,    O
disulfiram    O
(    O
used    O
to    O
treat    O
chronic    O
alcoholism    O
)    O
,    O
halogenated    O
hydroquinolones    O
(    O
amebicidal    O
medications    O
)    O
,    O
ethambutol    B-Medicine106043075
and    O
isoniazid    O
(    O
tuberculosis    O
treatment    O
)    O
,    O
and    O
antibiotics    O
such    O
as    O
linezolid    O
and    O
chloramphenicol    O
.    O

A    O
nocturnist    B-Medicine106043075
is    O
a    O
hospital    O
-    O
based    O
physician    O
who    O
only    O
works    O
overnight    O
.    O

Dr.    O
Ramen    O
Goel    O
,    O
MS    O
FICS    O
is    O
an    O
Indian    O
Bariatric    B-Medicine106043075
&    O
Metabolic    O
surgeon    O
and    O
is    O
associated    O
is    O
with    O
Wockhardt    O
Hospitals    O
,    O
Mumbai    O
.    O

Vertical    O
sleeve    O
gastrectomy    O
,    O
a    O
bariatric    B-Medicine106043075
surgical    O
technique    O

These    O
bariatric    B-Medicine106043075
procedures    O
include    O
the    O
Laparoscopic    O
Adjustable    O
Gastric    O
Band    O
(    O
LAP    O
-    O
BAND    O
)    O
System    O
,    O
Laparoscopic    O
Roux    O
-    O
en    O
-    O
Y    O
Gastric    O
Bypass    O
,    O
Open    O
or    O
Laparoscopic    O
Duodenal    O
Switch    O
and    O
Laparoscopic    O
Sleeve    O
Gastrectomy    O
.    O

Szasz    O
argued    O
that    O
psychiatrics    O
were    O
created    O
in    O
the    O
17th    O
century    O
to    O
study    O
and    O
control    O
those    O
who    O
erred    O
from    O
the    O
medical    O
norms    O
of    O
social    O
behavior    O
;    O
a    O
new    O
specialization    O
,    O
drogophobia    O
,    O
was    O
created    O
in    O
the    O
20th    O
century    O
to    O
study    O
and    O
control    O
those    O
who    O
erred    O
from    O
the    O
medical    O
norms    O
of    O
drug    O
consumption    O
;    O
and    O
then    O
,    O
in    O
the    O
1960s    O
,    O
another    O
specialization    O
,    O
bariatrics    B-Medicine106043075
,    O
was    O
created    O
to    O
deal    O
with    O
those    O
who    O
erred    O
from    O
the    O
medical    O
norms    O
concerning    O
the    O
weight    O
the    O
body    O
should    O
have    O
.    O

Medical    O
services    O
include    O
pediatrics    O
,    O
bariatric    B-Medicine106043075
surgery    O
,    O
cardiology    O
,    O
vascular    O
,    O
orthopedics    B-Medicine106043075
,    O
oncology    O
,    O
radiology    O
,    O
wound    O
care    O
,    O
surgical    O
services    O
,    O
special    O
care    O
services    O
and    O
emergency    O
services    O
.    O

24-bed    O
Surgical    O
/    O
Orthopedic    B-Medicine106043075
/    O
Bariatric    B-Medicine106043075
Unit    O
provides    O
pre-    O
and    O
post    O
-    O
operative    O
care    O

Created    O
in    O
the    O
year    O
2000    O
,    O
with    O
over    O
15    O
years    O
experience    O
and    O
100,000    O
bariatric    B-Medicine106043075
cases    O
,    O
Weight    O
Management    O
Center    O
provides    O
self    O
-    O
pay    O
services    O
that    O
are    O
not    O
covered    O
by    O
National    O
Health    O
Insurance    O
in    O
Taiwan    O
,    O
but    O
remains    O
quite    O
popular    O
among    O
the    O
ever    O
increasing    O
population    O
of    O
overweight    O
and    O
obese    O
patients    O
around    O
the    O
world    O
.    O

Treatment    O
is    O
primarily    O
supportive    O
in    O
nature    O
and    O
includes    O
minimizing    O
invasive    O
procedures    O
,    O
balancing    O
fluids    O
and    O
electrolytes    O
to    O
counter    O
dehydration    O
,    O
administration    O
of    O
anticoagulants    O
early    O
in    O
infection    O
to    O
prevent    O
or    O
control    O
disseminated    O
intravascular    O
coagulation    O
,    O
administration    O
of    O
procoagulants    O
late    O
in    O
infection    O
to    O
control    O
hemorrhaging    O
,    O
maintaining    O
oxygen    O
levels    O
,    O
pain    B-Medicine106043075
management    I-Medicine106043075
,    O
and    O
administration    O
of    O
antibiotics    O
or    O
antimycotics    O
to    O
treat    O
secondary    O
infections    O
.    O

At    O
that    O
time    O
,    O
Dr.    O
Bailey    O
referred    O
Meyer    O
to    O
the    O
hospital    O
’s    O
pain    B-Medicine106043075
management    I-Medicine106043075
clinic    O
.    O

UBH    O
Denton    O
provides    O
both    O
inpatient    O
and    O
outpatient    O
services    O
,    O
as    O
well    O
as    O
specialty    O
programs    O
for    O
patients    O
with    O
mental    O
disorders    O
,    O
women    O
's    O
mental    O
health    O
and    O
chemical    O
dependency    O
,    O
pain    B-Medicine106043075
management    I-Medicine106043075
,    O
military    O
-    O
related    O
mental    O
disorders    O
(    O
such    O
as    O
PTSD    O
)    O
,    O
and    O
a    O
program    O
for    O
children    O
and    O
adolescents    O
.    O

Burns    O
can    O
be    O
very    O
painful    O
and    O
a    O
number    O
of    O
different    O
options    O
may    O
be    O
used    O
for    O
pain    B-Medicine106043075
management    I-Medicine106043075
.    O

Fear    O
of    O
labor    O
pain    O
is    O
strongly    O
associated    O
with    O
the    O
fear    O
of    O
pain    O
in    O
general    O
;    O
a    O
previous    O
complicated    O
childbirth    O
,    O
or    O
inadequate    O
pain    B-Medicine106043075
relief    I-Medicine106043075
,    O
may    O
cause    O
the    O
phobia    O
to    O
develop    O
.    O

It    O
was    O
only    O
in    O
the    O
last    O
quarter    O
of    O
the    O
20th    O
century    O
that    O
scientific    O
techniques    O
finally    O
established    O
babies    O
definitely    O
do    O
experience    O
pain    O
–    O
probably    O
more    O
than    O
adults    O
–    O
and    O
has    O
developed    O
reliable    O
means    O
of    O
assessing    O
and    O
of    O
treating    B-Medicine106043075
it    I-Medicine106043075
.    O

To    O
become    O
AAHA    O
-    O
accredited    O
,    O
practices    O
undergo    O
a    O
rigorous    O
evaluation    O
process    O
to    O
ensure    O
they    O
meet    O
the    O
AAHA    O
Standards    O
of    O
Accreditation    O
,    O
which    O
include    O
the    O
areas    O
of    O
:    O
Patient    O
care    O
,    O
diagnostic    O
imaging    O
,    O
laboratory    O
,    O
pain    B-Medicine106043075
management    I-Medicine106043075
,    O
pharmacy    O
,    O
safety    O
,    O
surgery    O
,    O
client    O
service    O
,    O
anesthesia    O
,    O
contagious    O
disease    O
,    O
continuing    O
education    O
,    O
dentistry    O
,    O
examination    O
facilities    O
,    O
medical    O
records    O
,    O
leadership    O
and    O
emergency    O
/    O
urgent    O
care    O
.    O

A    O
48-year    O
-    O
old    O
patient    O
with    O
terminal    O
pancreatic    O
cancer    O
,    O
Roy    O
Spratley    O
,    O
had    O
been    O
receiving    O
regular    O
and    O
increasing    O
doses    O
of    O
heroin    O
for    O
pain    B-Medicine106043075
relief    I-Medicine106043075
.    O

These    O
measures    O
may    O
include    O
management    B-Medicine106043075
of    I-Medicine106043075
pain    I-Medicine106043075
,    O
nausea    O
,    O
fever    O
and    O
anxiety    O
.    O

Bryan    O
Hospital    O
also    O
features    O
a    O
number    O
of    O
specialty    O
medical    O
clinics    O
including    O
ear    O
,    O
nose    O
,    O
and    O
throat    O
;    O
cardiology    O
;    O
pain    B-Medicine106043075
management;    I-Medicine106043075
urology    O
;    O
orthopedics;    B-Medicine106043075
and    O
wound    O
care    O
.    O

Minimum    O
services    O
should    O
include    O
pain    B-Medicine106043075
relief    I-Medicine106043075
,    O
restoration    O
of    O
teeth    O
and    O
maintenance    O
for    O
dental    O
health    O
.    O

Pain    B-Medicine106043075
management    I-Medicine106043075

These    O
include    O
intensive    B-Medicine106043075
care    I-Medicine106043075
medicine    I-Medicine106043075
and    O
pain    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Pain    B-Medicine106043075
management    I-Medicine106043075

As    O
an    O
example    O
,    O
while    O
its    O
parent    O
peptide    O
,    O
[    O
Met]enkephalin    O
,    O
has    O
an    O
"    O
in    O
vivo    O
"    O
half    O
-    O
life    O
of    O
merely    O
seconds    O
,    O
metkefamide    O
has    O
a    O
half    O
-    O
life    O
of    O
nearly    O
60    O
minutes    O
,    O
and    O
upon    O
intramuscular    O
administration    O
,    O
has    O
been    O
shown    O
to    O
provide    O
pain    B-Medicine106043075
relief    I-Medicine106043075
that    O
lasts    O
for    O
hours    O
.    O

John    O
Bonica    O
(    O
February    O
16    O
,    O
1917    O
–    O
August    O
15    O
,    O
1994    O
)    O
was    O
a    O
Sicilian    O
American    O
anesthesiologist    O
and    O
professional    O
wrestler    O
known    O
as    O
the    O
founding    O
father    O
of    O
the    O
study    O
of    O
pain    B-Medicine106043075
management    I-Medicine106043075
.    O

Pain    O
assessment    O
and    O
re    O
-    O
assessment    O
after    O
administration    O
of    O
analgesics    O
or    O
pain    B-Medicine106043075
management    I-Medicine106043075
is    O
regulated    O
in    O
healthcare    O
facilities    O
by    O
accreditation    O
bodies    O
,    O
like    O
the    O
Joint    O
Commission    O
.    O

However    O
,    O
Taiwan    O
Spine    O
Center    O
also    O
offers    O
non    O
-    O
surgical    O
treatments    O
,    O
pain    B-Medicine106043075
management    I-Medicine106043075
advice    O
,    O
and    O
several    O
tests    O
for    O
spine    O
health    O
.    O

Pain    O
Management    O
Center    O
was    O
created    O
in    O
1985    O
by    O
Dr.    O
Ming    O
-    O
I    O
Chan    O
Liao    O
,    O
the    O
Executive    O
Consultant    O
,    O
who    O
is    O
a    O
world    O
-    O
renowned    O
pain    B-Medicine106043075
management    I-Medicine106043075
specialist    O
that    O
was    O
educated    O
in    O
Japan    O
.    O

Pain    B-Medicine106043075
management    I-Medicine106043075

In    O
a    O
smaller    O
trial    O
of    O
patients    O
with    O
diabetic    O
neuropathy    O
,    O
lacosamide    O
also    O
provided    O
significantly    O
better    O
pain    B-Medicine106043075
relief    I-Medicine106043075
when    O
compared    O
to    O
placebo    O
.    O

Lacosamide    O
may    O
have    O
a    O
variety    O
of    O
off    O
-    O
label    O
uses    O
,    O
including    O
for    O
pain    B-Medicine106043075
management    I-Medicine106043075
and    O
treatment    O
of    O
mental    O
health    O
disorders    O
.    O

Peter    O
Staats    O
(    O
MBA    O
2004    O
)    O
-    O
American    O
physician    O
,    O
educator    O
,    O
author    O
,    O
inventor    O
and    O
clinical    O
researcher    O
,    O
specializing    O
in    O
interventional    O
pain    B-Medicine106043075
medicine    I-Medicine106043075
;    O
founder    O
of    O
the    O
Division    O
of    O
Pain    O
Medicine    O
at    O
the    O
Johns    O
Hopkins    O
School    O
of    O
Medicine    O

Osiris    O
,    O
the    O
seventh    O
world    O
orbiting    O
the    O
White    O
Sun    O
,    O
is    O
a    O
wealthy    O
core    O
planet    O
where    O
Simon    O
Tam    O
attended    O
medical    O
school    O
and    O
worked    O
as    O
a    O
trauma    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
mentioned    O
in    O
the    O
episode    O
"    O
Serenity    O
"    O
.    O

Yang    O
meets    O
Owen    O
Hunt    O
(    O
Kevin    O
McKidd    O
)    O
,    O
an    O
army    O
trauma    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
when    O
he    O
patches    O
her    O
up    O
from    O
being    O
stabbed    O
in    O
the    O
stomach    O
by    O
a    O
falling    O
icicle    O
.    O

After    O
Owen    O
Hunt    O
is    O
honorably    O
discharged    O
,    O
he    O
is    O
hired    O
as    O
Seattle    O
Grace    O
's    O
chief    O
of    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
he    O
and    O
Yang    O
begin    O
a    O
flirtation    O
.    O

O'Malley    O
begins    O
to    O
display    O
a    O
talent    O
for    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
is    O
told    O
by    O
the    O
chief    O
of    O
trauma    O
surgery    O
Owen    O
Hunt    O
(    O
Kevin    O
McKidd    O
)    O
that    O
it    O
is    O
definitely    O
his    O
specialty    O
.    O

Puhua    O
International    O
Hospital    O
–    O
Shuangjing    O
offers    O
service    O
in    O
the    O
following    O
departments    O
;    O
orthopedics    B-Medicine106043075
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
podiatry    O
,    O
sports    O
medicine    O
,    O
neurology    O
,    O
neurosurgery    O
,    O
chiropractic    O
,    O
family    O
medicine    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
,    O
rehabilitation    O
,    O
oncology    O
,    O
TCM    O
,    O
dermatology    O
,    O
pediatrics    O
,    O
surgery    O
,    O
cardiovascular    O
,    O
ENT    O
,    O
gynecology    O
,    O
ophthalmology    O
,    O
endocrinology    O
,    O
women    O
’s    O
health    O
and    O
children    O
’s    O
health    O
.    O

The    O
University    O
of    O
Mainz    O
specialist    O
and    O
teaching    O
hospital    O
,    O
which    O
grew    O
out    O
of    O
the    O
former    O
Municipal    O
Hospitals    O
,    O
is    O
part    O
of    O
the    O
"    O
Saarland    O
Heilstätten    O
"    O
(    O
a    O
group    O
of    O
hospitals    O
)    O
–    O
even    O
though    O
it    O
is    O
not    O
in    O
the    O
Saarland    O
–    O
and    O
has    O
some    O
500    O
beds    O
and    O
1,000    O
employees    O
,    O
as    O
well    O
as    O
departments    O
for    O
general    B-Medicine106043075
,    O
abdominal    B-Medicine106043075
and    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
gynaecology    O
with    O
obstetrics    O
,    O
internal    O
medicine    O
with    O
gastroenterology    O
,    O
nephrology    O
,    O
diabetology    O
and    O
dialysis    O
,    O
diagnostic    O
and    O
interventional    O
radiology    O
,    O
cardiology    O
,    O
bone    O
marrow    O
transplantation    O
and    O
haematology    O
/    O
oncology    O
,    O
neurology    O
with    O
a    O
stroke    O
unit    O
and    O
neurosurgery    O
,    O
psychiatry    O
with    O
child    O
and    O
adolescent    O
psychiatry    O
and    O
psychotherapy    O
,    O
paediatrics    O
with    O
neonatology    O
,    O
radiation    O
therapy    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
urology    O
as    O
well    O
as    O
wards    O
for    O
ophthalmology    O
and    O
otorhinolaryngology    O
.    O

Although    O
originally    O
introduced    O
as    O
a    O
recurring    O
character    O
in    O
the    O
season    O
premiere    O
,    O
trauma    B-Medicine106043075
surgeon    I-Medicine106043075
Dr.    O
Owen    O
Hunt    O
was    O
promoted    O
to    O
a    O
series    O
regular    O
in    O
the    O
fourteenth    O
episode    O
of    O
the    O
season    O
"    O
Beat    O
Your    O
Heart    O
Out    O
"    O
.    O

Anesthesiologist    O
assistants    O
provide    O
anesthesia    O
in    O
surgical    O
environments    O
such    O
as    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
transplant    O
surgery    O
,    O
and    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
centers    O
.    O

As    O
an    O
attending    O
physician    O
,    O
Teddy    O
worked    O
at    O
Columbia    O
,    O
but    O
after    O
her    O
best    O
friend    O
was    O
killed    O
during    O
the    O
collapse    O
of    O
the    O
second    O
tower    O
on    O
September    O
11    O
,    O
2001    O
,    O
she    O
left    O
and    O
joined    O
the    O
army    O
,    O
meeting    O
trauma    B-Medicine106043075
surgeon    I-Medicine106043075
Owen    O
Hunt    O
(    O
Kevin    O
McKidd    O
)    O
during    O
her    O
tour    O
in    O
Baghdad    O
.    O

He    O
is    O
known    O
for    O
his    O
work    O
in    O
the    O
fields    O
of    O
minimally    O
invasive    O
surgery    O
,    O
spleen-    O
,    O
gastrointestinal-    O
and    O
acute    O
surgery    O
and    O
visceral    B-Medicine106043075
traumatology    I-Medicine106043075
.    O

Micronor    B-Medicine106043075

:    O
norethisterone    B-Medicine106043075
(    O
contraceptive    O
)    O

In    O
contrast    O
,    O
the    O
non    O
-    O
halogenated    O
19-nortestosterone    O
derivatives    O
norgestrel    O
,    O
norethisterone    B-Medicine106043075
,    O
noretynodrel    O
,    O
and    O
etynodiol    O
diacetate    O
were    O
not    O
found    O
to    O
produce    O
such    O
nodules    O
.    O

It    O
is    O
a    O
chloroethynylated    O
derivative    O
of    O
norethisterone    B-Medicine106043075
.    O

In    O
contrast    O
,    O
the    O
non    O
-    O
halogenated    O
19-nortestosterone    O
derivatives    O
norgestrel    O
,    O
norethisterone    B-Medicine106043075
,    O
noretynodrel    O
,    O
and    O
etynodiol    O
diacetate    O
,    O
which    O
are    O
much    O
less    O
potent    O
as    O
progestogens    O
,    O
did    O
not    O
produce    O
such    O
effects    O
at    O
the    O
dosages    O
tested    O
.    O

Norsteroid    O
examples    O
include    O
:    O
19-norpregnane    O
(    O
from    O
pregnane    O
)    O
,    O
desogestrel    O
,    O
ethylestrenol    O
,    O
etynodiol    O
diacetate    O
,    O
ethinylestradiol    O
,    O
gestrinone    O
,    O
levonorgestrel    O
,    O
norethisterone    B-Medicine106043075
(    O
norethindrone    O
)    O
,    O
norgestrel    O
,    O
norpregnatriene    O
(    O
from    O
pregnatriene    O
)    O
,    O
quinestrol    O
,    O
19-norprogesterone    O
(    O
from    O
a    O
progesterone    O
)    O
,    O
Nomegestrol    O
acetate    O
,    O
19-nortestosterone    O
(    O
from    O
a    O
testosterone    O
)    O
,    O
and    O
norethisterone    O
acetate    O
.    O

Nandrolone    O
,    O
together    O
with    O
ethisterone    O
(    O
17α-ethynyltestosterone    O
)    O
,    O
is    O
also    O
the    O
parent    O
compound    O
of    O
a    O
large    O
group    O
of    O
progestins    O
,    O
the    O
norethisterone    B-Medicine106043075
(    O
17α-ethynyl-19-nortestosterone    O
)    O
derivatives    O
.    O

The    O
estranes    O
include    O
norethisterone    B-Medicine106043075
(    O
norethindrone    O
)    O
,    O
norethisterone    O
acetate    O
,    O
norethisterone    O
enanthate    O
,    O
lynestrenol    O
,    O
etynodiol    O
diacetate    O
,    O
and    O
noretynodrel    O
,    O
while    O
the    O
gonanes    O
include    O
norgestrel    O
,    O
levonorgestrel    O
,    O
desogestrel    O
,    O
etonogestrel    O
,    O
gestodene    O
,    O
norgestimate    O
,    O
dienogest    O
(    O
actually    O
a    O
17α-cyanomethyl-19-nortestosterone    O
derivative    O
)    O
,    O
and    O
norelgestromin    O
.    O

In    O
1978    O
the    O
company    O
brought    O
to    O
market    O
the    O
first    O
once    O
-    O
a    O
-    O
week    O
oral    O
contraceptive    O
"    O
Deposiston    O
"    O
,    O
a    O
combination    O
of    O
ethinylestradiol    O
sulfonate    O
and    O
norethisterone    B-Medicine106043075
acetate    O
.    O

Treatment    O
with    O
a    O
progestin    O
,    O
norethisterone    B-Medicine106043075
,    O
reduced    O
her    O
estradiol    O
concentrations    O
to    O
normal    O
levels    O
and    O
decreased    O
the    O
size    O
of    O
her    O
ovaries    O
and    O
the    O
number    O
of    O
ovarian    O
cysts    O
,    O
alleviating    O
her    O
hypothalamic    O
-    O
pituitary    O
-    O
gonadal    O
axis    O
hyperactivity    O
and    O
ovarian    O
pathology    O
.    O

Examples    O
include    O
drugs    O
such    O
as    O
Norethisterone    B-Medicine106043075
,    O
Ethisterone    O
,    O
and    O
Lynestrenol    O
.    O

A    O
2001    O
comparative    O
study    O
of    O
the    O
IMS    O
LifeLink    O
Health    O
Plan    O
Claims    O
Database    O
interpreted    O
that    O
in    O
a    O
large    O
cohort    O
of    O
women    O
using    O
oral    O
contraceptives    O
,    O
there    O
was    O
found    O
a    O
small    O
,    O
statistically    O
significant    O
increase    O
in    O
the    O
risk    O
of    O
gallbladder    O
disease    O
associated    O
with    O
desogestrel    O
,    O
drospirenone    O
and    O
norethisterone    B-Medicine106043075
compared    O
with    O
levonorgestrel    O
.    O

Conversely    O
,    O
replacement    O
of    O
the    O
C17α    O
alkyl    O
group    O
with    O
an    O
ethynyl    O
group    O
greatly    O
reduces    O
but    O
does    O
not    O
abolish    O
androgenic    O
activity    O
,    O
as    O
in    O
ethisterone    O
(    O
17α-ethynyltestosterone    O
)    O
and    O
norethisterone    B-Medicine106043075
(    O
17α-ethynyl-19-nortestosterone    O
)    O
.    O

Camila    O
,    O
brand    O
name    O
of    O
a    O
progestogen    O
-    O
only    O
pill    O
containing    O
norethisterone    B-Medicine106043075
(    O
norethindrone    O
)    O

Nepenthe    B-Medicine106043075
,    O
a    O
drug    O
of    O
forgetfulness    O
mentioned    O
in    O
Greek    O
mythology    O

He    O
was    O
educated    O
for    O
the    O
pursuit    O
of    O
medicine    O
,    O
but    O
is    O
best    O
known    O
by    O
a    O
pamphlet    O
,    O
printed    O
in    O
Edinburgh    O
in    O
1614    O
,    O
and    O
entitled    O
"    O
Nepenthe    B-Medicine106043075
,    O
or    O
the    O
Vertues    O
of    O
Tobacco    O
"    O
.    O

Raj    O
was    O
an    O
international    O
leader    O
in    O
developing    O
interventional    B-Medicine106043075
pain    I-Medicine106043075
management    I-Medicine106043075
including    O
development    O
of    O
multiple    O
training    O
programs    O
,    O
training    O
of    O
thousands    O
of    O
individual    O
physicians    O
,    O
numerous    O
publications    O
,    O
and    O
organization    O
of    O
interventional    B-Medicine106043075
pain    I-Medicine106043075
management    I-Medicine106043075
as    O
a    O
distinct    O
specialty    O
.    O

Some    O
of    O
his    O
major    O
contributions    O
during    O
his    O
career    O
involved    O
the    O
development    O
and    O
implementation    O
of    O
regional    O
anesthesia    O
and    O
interventional    B-Medicine106043075
pain    I-Medicine106043075
management    I-Medicine106043075
.    O

Pain    O
Management    O
Center    O
provides    O
various    O
forms    O
of    O
interventional    B-Medicine106043075
pain    I-Medicine106043075
management    I-Medicine106043075
techniques    O
including    O
CT    O
-    O
guided    O
procedure    O
,    O
Xenon    O
light    O
phototherapy    O
,    O
Stellate    O
Ganglion    O
Block    O
(    O
SGB    O
)    O
,    O
etc    O
.    O
for    O
treatment    O
for    O
patients    O
with    O
herpes    O
zoster    O
(    O
shingles    O
)    O
,    O

Specialty    O
programs    O
include    O
a    O
sleep    O
center    O
,    O
diabetes    O
education    O
and    O
treatment    O
including    O
wound    O
care    O
,    O
asthma    O
management    O
and    O
cardiac    B-Medicine106043075
rehabilitation    I-Medicine106043075
.    O

AAPM&R    O
’s    O
membership    O
reflects    O
the    O
diversity    O
of    O
the    O
specialty    O
of    O
PM&R.    O
Member    O
physicians    O
may    O
treat    O
amputations    O
;    O
pain    B-Medicine106043075
(    O
neck    O
,    O
nerve    O
,    O
arthritic    O
,    O
back    O
)    O
;    O
injuries    O
(    O
brain    O
,    O
spinal    O
cord    O
,    O
sports    O
-    O
related    O
)    O
;    O
rehabilitation    O
(    O
cardiac    B-Medicine106043075
,    O
geriatric    O
,    O
pediatric    O
)    O
;    O
and    O
more    O
.    O

Cardiac    B-Medicine106043075
rehabilitation    I-Medicine106043075
benefits    O
many    O
who    O
have    O
experienced    O
myocardial    O
infarction    O
,    O
even    O
if    O
there    O
has    O
been    O
substantial    O
heart    O
damage    O
and    O
resultant    O
left    O
ventricular    O
failure    O
.    O

Her    O
further    O
professional    O
post    O
-    O
doctoral    O
fellowship    O
experiences    O
include    O
;    O
a    O
postdoctoral    O
psychology    O
fellowship    O
in    O
clinical    O
supervision    O
at    O
the    O
Andrology    B-Medicine106043075
Clinic    O
of    O
the    O
Veterans    O
Affairs    O
Health    O
Care    O
System    O
in    O
Palo    O
Alto    O
,    O
California    O
and    O
a    O
postdoctoral    O
research    O
fellowship    O
in    O
the    O
School    O
of    O
Education    O
within    O
the    O
Program    O
for    O
Complex    O
Instruction    O
at    O
Stanford    O
University    O
.    O

At    O
the    O
Department    O
of    O
Urology    O
,    O
Costabile    O
also    O
directs    O
UVA    O
's    O
Andrology    B-Medicine106043075
Fellowship    O
,    O
a    O
one    O
-    O
year    O
physician    O
's    O
training    O
program    O
in    O
men    O
's    O
sexual    O
health    O
.    O

The    O
study    O
of    O
erectile    O
dysfunction    O
within    O
medicine    O
is    O
covered    O
by    O
andrology    B-Medicine106043075
,    O
a    O
sub    O
-    O
field    O
within    O
urology    O
.    O

Andrology    B-Medicine106043075

Theriogenology    O
is    O
the    O
branch    O
of    O
veterinary    O
medicine    O
concerned    O
with    O
reproduction    O
,    O
including    O
the    O
physiology    O
and    O
pathology    B-Medicine106043075
of    O
male    O
and    O
female    O
reproductive    O
systems    O
of    O
animals    O
and    O
the    O
clinical    O
practice    O
of    O
veterinary    O
obstetrics    O
,    O
gynecology    O
,    O
and    O
andrology    B-Medicine106043075
.    O

The    O
name    O
derives    O
from    O
"    O
genus    O
"    O
(    O
"    O
gender    O
"    O
)    O
,    O
a    O
word    O
which    O
suggests    O
the    O
aspects    O
of    O
andrology    B-Medicine106043075
,    O
gynaecology    O
and    O
urology    O
.    O

Andrology    B-Medicine106043075
Media    O

1884    O
–    O
Emil    O
Starkenstein    O
,    O
Czech    O
pharmacologist    O
,    O
co    O
-    O
founded    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
(    O
d.    O
1942    O
)    O

Since    O
2007    O
he    O
has    O
been    O
the    O
Professor    O
of    O
Clinical    O
Chemistry    O
and    O
Clinical    B-Medicine106043075
Pharmacology    I-Medicine106043075
at    O
the    O
University    O
Hospital    O
of    O
the    O
University    O
of    O
Bonn    O
.    O

From    O
1975    O
-    O
80    O
he    O
was    O
a    O
research    O
clinical    B-Medicine106043075
pharmacologist    I-Medicine106043075
and    O
a    O
medical    O
advisor    O
in    O
the    O
pharmaceutical    O
industry    O
in    O
Switzerland    O
,    O
the    O
Netherlands    O
and    O
Edinburgh    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

Clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
of    O
various    O
cardioactive    O
drugs    O

The    O
journal    O
covers    O
all    O
aspects    O
of    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
and    O
therapeutics    O
.    O

Among    O
other    O
things    O
,    O
the    O
book    O
is    O
known    O
for    O
the    O
discovery    O
of    O
contagious    O
diseases    O
,    O
and    O
the    O
introduction    O
of    O
experimental    O
medicine    O
,    O
clinical    O
trials    O
,    O
randomized    O
controlled    O
trials    O
,    O
efficacy    O
tests    O
,    O
and    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
.    O

Clinical    B-Medicine106043075
pharmacologists    I-Medicine106043075
work    O
as    O
consultants    O
in    O
the    O
National    O
Health    O
Service    O
and    O
many    O
hold    O
prominent    O
positions    O
in    O
UK    O
universities    O
.    O

Clinical    B-Medicine106043075
pharmacology    I-Medicine106043075

Hand    B-Medicine106043075
Surgery    I-Medicine106043075

Hand    B-Medicine106043075
surgery    I-Medicine106043075

Hand    B-Medicine106043075
surgery    I-Medicine106043075

It    O
has    O
been    O
central    O
to    O
advancements    O
in    O
heart    B-Medicine106043075
and    O
hand    B-Medicine106043075
surgery    I-Medicine106043075
,    O
as    O
well    O
as    O
cancer    O
treatment    O
.    O

Hand    B-Medicine106043075
Surgery    I-Medicine106043075

Hand    B-Medicine106043075
surgery    I-Medicine106043075
,    O
such    O
as    O
endoscopic    O
carpal    O
tunnel    O
release    O

Extracts    O
of    O
the    O
bark    O
,    O
leaves    O
,    O
stems    O
,    O
and    O
unripe    O
fruits    O
have    O
demonstrated    O
antibiotic    O
properties    O
in    O
vitro    O
,    O
and    O
are    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

They    O
claimed    O
that    O
a    O
traditional    B-Medicine106043075
healer    I-Medicine106043075
told    O
them    O
they    O
would    O
get    O
rich    O
if    O
they    O
mixed    O
Mpunzi    O
's    O
blood    O
and    O
parts    O
with    O
'    O
muthi    O
'    O
.    O

Some    O
species    O
are    O
renowned    O
for    O
their    O
properties    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
and    O
herbalism    O
;    O
for    O
example    O
Vera    O
Cruz    O
jalap    O
(    O
"    O
I.    O
jalapa    O
"    O
)    O
and    O
Tampico    O
jalap    O
(    O
"    O
I.    O
simulans    O
"    O
)    O
are    O
used    O
to    O
produce    O
jalap    O
,    O
a    O
cathartic    O
preparation    O
accelerating    O
the    O
passage    O
of    O
stool    O
.    O

Jamaica    O
Plain    O
has    O
several    O
botánicas    O
,    O
such    O
as    O
this    O
one    O
on    O
Centre    O
Street    O
,    O
that    O
cater    O
to    O
the    O
Latino    O
community    O
and    O
typically    O
sell    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
alongside    O
statues    O
of    O
saints    O
,    O
candles    O
decorated    O
with    O
prayers    O
,    O
lucky    O
bamboo    O
,    O
and    O
other    O
items    O
.    O

According    O
to    O
another    O
practitioner    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
:    O

It    O
is    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
and    O
ritual    O
in    O
its    O
native    O
range    O
.    O

While    O
the    O
efficacy    O
of    O
these    O
remedies    O
has    O
not    O
been    O
proven    O
,    O
this    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
is    O
so    O
renowned    O
that    O
even    O
non    O
-    O
Baka    O
seek    O
out    O
their    O
healers    O
for    O
treatment    O
.    O

Vestiges    O
of    O
their    O
native    O
animism    O
still    O
persist    O
,    O
however    O
,    O
especially    O
in    O
the    O
realm    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Vestiges    O
of    O
their    O
native    O
animism    O
still    O
persist    O
,    O
however    O
,    O
especially    O
in    O
the    O
realm    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Also    O
,    O
many    O
families    O
had    O
a    O
choice    O
of    O
whether    O
or    O
not    O
they    O
wanted    O
to    O
employ    O
a    O
midwife    O
who    O
practiced    O
the    O
traditional    B-Medicine106043075
folk    I-Medicine106043075
medicine    I-Medicine106043075
or    O
the    O
newer    O
methods    O
of    O
professional    O
parturition    O
.    O

From    O
the    O
18th    O
century    O
,    O
a    O
conflict    O
between    O
surgeons    O
and    O
midwives    O
arose    O
,    O
as    O
medical    O
men    O
began    O
to    O
assert    O
that    O
their    O
modern    O
scientific    O
techniques    O
were    O
better    O
for    O
mothers    O
and    O
infants    O
than    O
the    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
practiced    O
by    O
midwives    O
.    O

The    O
plant    O
is    O
both    O
poisonous    O
and    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
use    O
of    O
the    O
plant    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
has    O
been    O
limited    O
by    O
the    O
bitter    O
taste    O
of    O
the    O
bark    O
and    O
root    O
.    O

In    O
Malaysia    O
there    O
is    O
a    O
substantial    O
domestic    O
market    O
in    O
recent    O
years    O
for    O
tiger    O
meat    O
and    O
manufactured    O
tiger    B-Medicine106043075
bone    I-Medicine106043075
medicines    I-Medicine106043075
.    O

The    O
delicate    O
,    O
feathery    O
foliage    O
has    O
been    O
used    O
as    O
a    O
condiment    O
and    O
in    O
the    O
preparation    O
of    O
a    O
wide    O
variety    O
of    O
home    B-Medicine106043075
remedies    I-Medicine106043075
as    O
a    O
diuretic    O
,    O
to    O
control    O
menstruation    O
and    O
uterine    O
complaints    O
and    O
to    O
treat    O
catarrh    O
,    O
hysteria    O
and    O
stomach    O
ailments    O
.    O

In    O
Australia    O
,    O
Aborigines    O
have    O
used    O
"    O
Phellinus    O
"    O
fruit    O
bodies    O
medicinally    B-Medicine106043075
.    O

Tan    O
has    O
authored    O
numerous    O
books    O
and    O
articles    O
,    O
often    O
focusing    O
on    O
:    O
indigenous    B-Medicine106043075
medical    I-Medicine106043075
beliefs    I-Medicine106043075
,    O
sex    O
and    O
sexuality    O
,    O
reproductive    O
and    O
sexual    O
health    O
(    O
particularly    O
HIV    O
/    O
AIDS    O
)    O
,    O
pharmaceuticals    O
,    O
and    O
health    O
policy    O
issues    O
.    O

"    O
Rheum    O
officinale    O
"    O
is    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
in    O
Chinese    O
is    O
called    O
"    O
yào    O
yòng    O
dà    O
huáng    O
"    O
.    O

It    O
is    O
sometimes    O
planted    O
as    O
an    O
ornamental    O
;    O
and    O
has    O
virtue    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Rambutan    O
roots    O
,    O
bark    O
,    O
and    O
leaves    O
have    O
various    O
uses    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
and    O
in    O
the    O
production    O
of    O
dyes    O
.    O

The    O
fig    O
fruits    O
,    O
important    O
as    O
both    O
food    O
and    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
contain    O
laxative    O
substances    O
,    O
flavonoids    O
,    O
sugars    O
,    O
vitamins    O
A    O
and    O
C    O
,    O
acids    O
and    O
enzymes    O
.    O

Datura    O
has    O
been    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
to    O
relieve    O
asthma    O
symptoms    O
and    O
as    O
an    O
analgesic    O
during    O
surgery    O
or    O
bonesetting    O
.    O

Traditional    O
burial    O
rituals    O
,    O
especially    O
those    O
requiring    O
embalming    O
of    O
bodies    O
,    O
ought    O
to    O
be    O
discouraged    O
or    O
modified    O
,    O
ideally    O
with    O
the    O
help    O
of    O
local    O
traditional    B-Medicine106043075
healer    I-Medicine106043075
.    O

With    O
a    O
little    O
turmeric    O
powder    O
mixed    O
in    O
,    O
it    O
is    O
also    O
used    O
as    O
a    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
for    O
gastroenteritis    O
.    O

Its    O
spicy    O
fruits    O
are    O
used    O
for    O
preparing    O
vegetables    O
,    O
curry    O
and    O
fine    O
pickles    O
and    O
can    O
attract    O
helpful    O
insectivores    O
;    O
the    O
plant    O
also    O
is    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
and    O
herbalism    O
.    O

Khellin    O
has    O
been    O
used    O
as    O
an    O
herbal    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
,    O
with    O
use    O
in    O
the    O
Mediterranean    O
dating    O
back    O
to    O
Ancient    O
Egypt    O
,    O
to    O
treat    O
a    O
variety    O
of    O
maladies    O
including    O
:    O
renal    O
colic    O
,    O
kidney    O
stones    O
,    O
coronary    O
disease    O
,    O
bronchial    O
asthma    O
,    O
vitiligo    O
,    O
and    O
psoriasis    O
.    O

Essential    O
oils    O
extracted    O
from    O
the    O
root    O
have    O
been    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
and    O
in    O
perfumes    O
since    O
ancient    O
times    O
.    O

"    O
Die    O
volksmedizin    O
,    O
ihre    O
geschichtliche    O
entwickelung    O
und    O
ihre    O
beziehungen    O
zur    O
kultur    O
"    O
,    O
1905    O
–    O
Folk    B-Medicine106043075
medicine    I-Medicine106043075
,    O
its    O
historical    O
development    O
and    O
its    O
relationship    O
to    O
culture    O
.    O

Iranian    O
Traditional    O
Medicine    O
,    O
also    O
called    O
Persian    O
Traditional    O
Medicine    O
(    O
Persian    O
:    O
طب    O
سنتی‌    O
ایرانی    O
"    O
tebbe    O
sonnati    O
irāni    O
"    O
)    O
is    O
one    O
of    O
famous    O
forms    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
which    O
is    O
grounded    O
in    O
the    O
four    O
humours    O
concept    O
:    O
Phlegm    O
(    O
Balgham    O
)    O
,    O
Blood    O
(    O
Dam    O
)    O
,    O
Yellow    O
bile    O
(    O
Ṣafrā    O
'    O
)    O
and    O
Black    O
bile    O
(    O
Saudā    O
'    O
)    O
.    O

Some    O
suggest    O
that    O
the    O
only    O
answer    O
to    O
a    O
personality    O
clash    O
is    O
the    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
of    O
distancing    O
-    O
reducing    O
contact    O
with    O
the    O
clashing    O
personality    O
involved    O
.    O

In    O
Taïwan    O
,    O
it    O
is    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
as    O
an    O
analgesic    O
,    O
antiphlogistic    O
and    O
spasmolytic    O
agent    O
.    O

Propolis    O
has    O
been    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
for    O
thousands    O
of    O
years    O
.    O

F.    O
aurea    O
"    O
is    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
for    O
live    O
fencing    O
,    O
as    O
an    O
ornamental    O
and    O
as    O
a    O
bonsai    O

F.    O
aurea    O
"    O
was    O
also    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
in    O
The    O
Bahamas    O
and    O
Florida    O
.    O

In    O
low    O
income    O
countries    O
,    O
burns    O
are    O
treated    O
up    O
to    O
one    O
-    O
third    O
of    O
the    O
time    O
with    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
which    O
may    O
include    O
applications    O
of    O
eggs    O
,    O
mud    O
,    O
leaves    O
or    O
cow    O
dung    O
.    O

Although    O
eaten    O
or    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
in    O
some    O
areas    O
,    O
it    O
is    O
typically    O
considered    O
inedible    O
.    O

C.    O
cinnabarinum    O
"    O
has    O
also    O
been    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

In    O
Australia    O
it    O
was    O
used    O
as    O
a    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
to    O
relieve    O
the    O
itching    O
of    O
mosquito    O
and    O
sand    O
fly    O
bites    O
.    O

Air    O
potato    O
has    O
been    O
used    O
as    O
a    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
to    O
treat    O
conjunctivitis    O
,    O
diarrhea    O
,    O
and    O
dysentery    O
,    O
among    O
other    O
ailments    O
.    O

"    O
Stichopus    O
"    O
species    O
are    O
important    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
practices    O
in    O
Malaysia    O
.    O

"    O
Cyclemys    O
"    O
species    O
are    O
often    O
caught    O
and    O
sold    O
for    O
the    O
pet    O
trade    O
,    O
food    O
,    O
or    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

As    O
is    O
the    O
case    O
in    O
the    O
rest    O
of    O
the    O
African    O
continent    O
,    O
the    O
Senegalese    O
have    O
long    O
used    O
traditional    B-Medicine106043075
medicines    I-Medicine106043075
and    O
rely    O
on    O
traditional    O
healers    O
for    O
their    O
ailments    O
.    O

More    O
adventurous    O
entrants    O
made    O
use    O
of    O
some    O
of    O
Nicaragua    O
's    O
most    O
obscure    O
flora    O
such    O
as    O
the    O
mamoncillo    O
,    O
the    O
extract    O
of    O
which    O
is    O
used    O
as    O
a    O
local    B-Medicine106043075
cure    O
for    O
stomachache    O
.    O

Millipedes    O
appear    O
in    O
folklore    O
and    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
around    O
the    O
world    O
.    O

Pennyroyal    O
is    O
a    O
traditional    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
,    O
emmenagogue    O
,    O
abortifacient    O
,    O
and    O
culinary    O
herb    O
.    O

It    O
was    O
often    O
used    O
as    O
a    O
home    B-Medicine106043075
remedy    I-Medicine106043075
in    O
the    O
treatment    O
of    O
contact    O
dermatitis    O
caused    O
by    O
exposure    O
to    O
poison    O
ivy    O
,    O
poison    O
oak    O
,    O
and    O
other    O
oil    O
-    O
based    O
organic    O
skin    O
-    O
irritants    O
where    O
they    O
have    O
touched    O
the    O
skin    O
but    O
not    O
yet    O
inflamed    O
the    O
area    O
.    O

The    O
latter    O
custom    O
was    O
very    O
popular    O
among    O
Romanians    O
,    O
who    O
viewed    O
it    O
as    O
a    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
for    O
back    O
pain    O
;    O
welcoming    O
Ursari    O
into    O
one    O
's    O
household    O
to    O
perform    O
the    O
task    O
formed    O
part    O
of    O
a    O
string    O
of    O
events    O
leading    O
to    O
the    O
celebration    O
of    O
Easter    O
,    O
or    O
part    O
of    O
customs    O
ushering    O
in    O
Christmas    O
and    O
the    O
New    O
Years    O
'    O
Eve    O
.    O

In    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
"    O
C.    O
asiatica    O
"    O
has    O
been    O
used    O
in    O
an    O
attempt    O
to    O
treat    O
varicose    O
veins    O
,    O
chronic    O
venous    O
insufficiency    O
,    O
psoriasis    O
,    O
minor    O
wounds    O
,    O
strangury    O
,    O
and    O
to    O
encourage    O
lactation    O
.    O

It    O
is    O
a    O
digestive    O
spirit    O
,    O
high    O
in    O
powerful    O
antioxidants    O
such    O
as    O
flavonoids    O
and    O
is    O
traditionally    O
used    O
by    O
many    O
Greeks    O
as    O
a    O
home    B-Medicine106043075
remedy    I-Medicine106043075
for    O
a    O
sore    O
throat    O
or    O
cough    O
.    O

The    O
seeds    O
have    O
been    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
as    O
a    O
stimulant    O
and    O
diuretic    O
.    O

The    O
resin    O
is    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
by    O
the    O
people    O
of    O
Central    O
America    O
and    O
South    O
America    O
.    O

It    O
is    O
also    O
part    O
of    O
tonic    O
drinks    O
and    O
infusions    O
to    O
expel    O
intestinal    O
parasites    O
and    O
treat    O
asthma    O
,    O
arthritis    O
,    O
dysentery    O
,    O
stomach    O
ache    O
,    O
malaria    O
,    O
and    O
nervous    O
diseases    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
practiced    O
in    O
North    O
and    O
South    O
America    O
,    O
China    O
,    O
and    O
Turkey    O
.    O

Its    O
leaves    O
,    O
seeds    O
,    O
and    O
root    O
are    O
also    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
,    O
primarily    O
in    O
Asia    O
.    O

Preliminary    O
studies    O
have    O
investigated    O
claims    O
from    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
that    O
"    O
N.    O
sativa    O
"    O
has    O
efficacy    O
as    O
a    O
therapy    O
,    O
mainly    O
using    O
the    O
seed    O
oil    O
extract    O
,    O
volatile    O
oil    O
,    O
and    O
isolated    O
constituent    O
thymoquinone    O
.    O

Boneset    O
,    O
although    O
poisonous    O
to    O
humans    O
and    O
grazing    O
livestock    O
,    O
has    O
been    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
,    O
for    O
instance    O
to    O
excrete    O
excess    O
uric    O
acid    O
which    O
causes    O
gout    O
.    O

Both    O
varieties    O
of    O
"    O
S.    O
ramalana    O
"    O
have    O
been    O
used    O
locally    O
in    O
traditional    B-Medicine106043075
folk    I-Medicine106043075
medicine    I-Medicine106043075
.    O

Traditional    B-Medicine106043075
medicine    I-Medicine106043075

Ya    O
-    O
mong    O
is    O
a    O
household    B-Medicine106043075
remedy    I-Medicine106043075
that    O
is    O
widely    O
used    O
in    O
Thailand    O
.    O

It    O
is    O
named    O
after    O
the    O
fennel    O
(    O
Marathos    O
)    O
an    O
aromatic    O
and    O
flavourful    O
herb    O
used    O
in    O
cooking    O
and    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Suburban    O
Shaman    O
"    O
,    O
his    O
2006    O
memoir    O
of    O
medical    O
school    O
in    O
apartheid    O
South    O
Africa    O
,    O
ship    O
’s    O
doctoring    O
in    O
the    O
Mediterranean    O
,    O
family    O
practice    O
in    O
London    O
,    O
and    O
visits    O
to    O
traditional    B-Medicine106043075
healer    I-Medicine106043075
in    O
different    O
countries    O
,    O
was    O
serialized    O
by    O
BBC    O
Radio    O
4    O
as    O
its    O
‘    O
Book    O
of    O
the    O
Week’    O
in    O
March    O
2006    O
.    O

The    O
siddha    O
system    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
of    O
ancient    O
India    O
was    O
derived    O
by    O
Tamil    O
Siddhas    O
or    O
the    O
spiritual    O
scientists    O
of    O
Tamil    O
Nadu    O
.    O

He    O
was    O
also    O
famous    O
for    O
creating    O
a    O
jingle    O
called    O
"    O
Wes    O
Ewes    O
Ewes    O
Bablas    O
Angine    O
"    O
for    O
a    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
commercial    O
.    O

Boldo    O
and    O
plants    O
with    O
similar    O
properties    O
are    O
widely    O
used    O
as    O
mild    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
in    O
various    O
South    O
American    O
countries    O
in    O
both    O
urban    O
and    O
rural    O
areas    O
,    O
even    O
among    O
people    O
who    O
do    O
not    O
usually    O
drink    O
herbal    O
teas    O
other    O
than    O
mate    O
beverage    O
.    O

This    O
long    O
-    O
term    O
decline    O
had    O
a    O
number    O
of    O
causes    O
,    O
including    O
egg    O
collection    O
and    O
hunting    O
,    O
such    O
as    O
for    O
indigenous    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Practitioners    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
have    O
used    O
black    O
elderberry    O
for    O
hundreds    O
of    O
years    O
,    O

The    O
bark    O
extract    O
is    O
also    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
as    O
an    O
astringent    O
,    O
purgative    O
,    O
antirheumatic    O
,    O
and    O
for    O
treating    O
gastrointestinal    O
ailments    O
like    O
diarrhea    O
and    O
dysentery    O
.    O

Romero    O
-    O
Daza    O
's    O
publications    O
address    O
several    O
areas    O
of    O
anthropological    O
inquiry    O
,    O
including    O
but    O
not    O
limited    O
to    O
HIV    O
/    O
AIDS    O
in    O
developing    O
countries    O
,    O
HIV    O
/    O
AIDS    O
among    O
minority    O
populations    O
,    O
traditional    B-Medicine106043075
healing    I-Medicine106043075
practices    I-Medicine106043075
,    O
maternal    O
and    O
child    O
health    O
,    O
reproductive    O
health    O
,    O
health    O
care    O
decision    O
making    O
,    O
cultural    O
competency    O
in    O
service    O
provision    O
,    O
political    O
economy    O
of    O
health    O
,    O
HIV    O
risk    O
among    O
sex    O
workers    O
and    O
injection    O
drug    O
users    O
,    O
and    O
medical    O
pluralism    O
.    O

The    O
fruits    O
are    O
processed    O
and    O
then    O
used    O
in    O
the    O
food    O
industry    O
,    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
as    O
part    O
of    O
drugs    O
or    O
in    O
the    O
cosmetic    O
industry    O
.    O

All    O
children    O
at    O
Nkosi    O
’s    O
Haven    O
Village    O
receive    O
various    O
forms    O
of    O
therapy    O
,    O
including    O
remedial    B-Medicine106043075
,    O
play    O
,    O
occupational    O
and    O
speech    O
.    O

E.    O
sinensis    O
"    O
has    O
been    O
used    O
as    O
a    O
folk    B-Medicine106043075
remedy    I-Medicine106043075
against    O
cancer    O
and    O
infection    O
in    O
Tibet    O
,    O
Yunnan    O
,    O
and    O
Sichuan    O
Provinces    O
.    O

The    O
plant    O
is    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
to    O
treat    O
a    O
variety    O
of    O
conditions    O
,    O
including    O
sexually    O
transmitted    O
diseases    O
,    O
impotency    O
,    O
back    O
pain    O
,    O
toothache    O
,    O
fever    O
,    O
dysentery    O
,    O
bleeding    O
,    O
and    O
liver    O
diseases    O
.    O

Yunani    O
or    O
Unani    O
medicine    O
(    O
Urdu    O
:    O
"    O
tibb    O
yūnānī    O
"    O
)    O
is    O
the    O
term    O
for    O
Perso    O
-    O
Arabic    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
as    O
practiced    O
in    O
Mughal    O
India    O
and    O
in    O
Muslim    O
culture    O
in    O
South    O
Asia    O
and    O
modern    O
day    O
Central    O
Asia    O
.    O

This    O
herb    O
used    O
in    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
of    O
East    O
Asia    O
for    O
its    O
purported    O
psychotropic    O
and    O
nootropic    O
properties    O
.    O
although    O
such    O
claims    O
are    O
not    O
medically    O
verified    O
.    O

Amber    O
has    O
been    O
used    O
since    O
prehistory    O
(    O
Solutrean    O
)    O
in    O
the    O
manufacture    O
of    O
jewelry    O
and    O
ornaments    O
,    O
and    O
also    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Amber    O
has    O
long    O
been    O
used    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
for    O
its    O
purported    O
healing    O
properties    O
.    O

"    O
Acacia    O
"    O
species    O
have    O
possible    O
uses    O
in    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Aloe    O
vera    O
"    O
is    O
used    O
both    O
internally    O
and    O
externally    O
on    O
humans    O
as    O
folk    B-Medicine106043075
or    O
alternative    O
medicine    O
.    O

Before    O
the    O
early    O
20th    O
century    O
,    O
treatments    O
for    O
infections    O
were    O
based    O
primarily    O
on    O
medicinal    B-Medicine106043075
folklore    I-Medicine106043075
.    O
Mixtures    O
with    O
antimicrobial    O
properties    O
that    O
were    O
used    O
in    O
treatments    O
of    O
infections    O
were    O
described    O
over    O
2000    O
years    O
ago    O
.    O

Alternative    O
treatments    O
are    O
not    O
the    O
same    O
as    O
experimental    O
medicine    O
or    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
although    O
much    O
of    O
the    O
latter    O
is    O
alternative    O
when    O
used    O
today    O
.    O

Alternative    O
medical    O
systems    O
may    O
be    O
based    O
on    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
practices    O
,    O
such    O
as    O
traditional    O
Chinese    O
medicine    O
(    O
TCM    O
)    O
,    O
Ayurveda    O
in    O
India    O
,    O
or    O
practices    O
of    O
other    O
cultures    O
around    O
the    O
world    O
.    O

Methods    O
may    O
incorporate    O
or    O
base    O
themselves    O
on    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
folk    B-Medicine106043075
knowledge    I-Medicine106043075
,    O
spiritual    O
beliefs    O
,    O
ignorance    O
or    O
misunderstanding    O
of    O
scientific    O
principles    O
,    O
errors    O
in    O
reasoning    O
,    O
or    O
newly    O
conceived    O
approaches    O
claiming    O
to    O
heal    O
.    O

Traditional    B-Medicine106043075
remedies    I-Medicine106043075
,    O
often    O
closely    O
resembling    O
or    O
forming    O
the    O
basis    O
for    O
alternative    O
remedies    O
,    O
may    O
comprise    O
primary    O
healthcare    O
or    O
be    O
integrated    O
into    O
the    O
healthcare    O
system    O
.    O

File    O
:    O
Market    O
Pharmacy    O
Tana    O
Traditional    B-Medicine106043075
medicine    I-Medicine106043075
in    O
Madagascar    O

The    O
brew    O
is    O
used    O
as    O
a    O
traditional    B-Medicine106043075
spiritual    I-Medicine106043075
medicine    I-Medicine106043075
in    O
ceremonies    O
among    O
the    O
Indigenous    O
peoples    O
of    O
the    O
Amazon    O
basin    O
.    O

Many    O
have    O
found    O
use    O
in    O
traditional    B-Medicine106043075
or    O
modern    O
medicine    O
,    O
or    O
as    O
starting    O
points    O
for    O
drug    O
discovery    O
.    O

The    O
antithesis    O
of    O
medicalization    O
is    O
the    O
process    O
of    O
paramedicalization    O
,    O
where    O
human    O
conditions    O
come    O
under    O
the    O
attention    O
of    O
alternative    O
medicine    O
,    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
or    O
any    O
of    O
numerous    O
non    O
-    O
medical    O
health    O
approaches    O
.    O

The    O
main    O
agricultural    O
products    O
in    O
the    O
country    O
are    O
tobacco    O
,    O
figs    O
,    O
olives    O
,    O
wheat    O
,    O
maize    O
,    O
potatoes    O
,    O
vegetables    O
,    O
fruits    O
,    O
sugar    O
beets    O
,    O
grapes    O
,    O
meat    O
,    O
honey    O
,    O
dairy    O
products    O
,    O
and    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
and    O
aromatic    O
plants    O
.    O

The    O
above    O
ground    O
parts    O
of    O
these    O
plants    O
are    O
used    O
for    O
spices    O
and    O
traditional    B-Medicine106043075
medicines    I-Medicine106043075
.    O

Dry    O
leaves    O
are    O
used    O
in    O
tea    O
in    O
Vietnamese    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
to    O
relieve    O
sleeping    O
problems    O
,    O
as    O
well    O
as    O
treatment    O
for    O
itching    O
and    O
coughs    O
.    O

Religious    O
pseudoscience    O
includes    O
witchcraft    O
that    O
is    O
beyond    O
traditional    O
midwifery    O
practices    O
and    O
sorcery    O
other    O
than    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
which    O
insists    O
on    O
supernatural    O
or    O
magical    O
or    O
miraculous    O
intervention    O
which    O
is    O
contrary    O
to    O
scientific    O
evidence    O
.    O

In    O
Ayurvedic    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
,    O
"    O
Coleus    O
"    O
has    O
been    O
used    O
to    O
treat    O
various    O
disorders    O
,    O
although    O
there    O
is    O
no    O
evidence    O
for    O
its    O
efficacy    O
confirmed    O
by    O
high    O
-    O
quality    O
clinical    O
research    O
in    O
any    O
of    O
those    O
conditions    O
.    O

"    O
Hypericum    O
mysorense    O
"    O
has    O
been    O
used    O
to    O
treat    O
wounds    O
as    O
part    O
of    O
the    O
Ayurvedic    O
system    O
of    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
.    O

There    O
is    O
also    O
a    O
vast    O
body    O
of    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
and    O
simple    O
quackery    O
.    O

"    O
Swertia    O
"    O
is    O
used    O
in    O
Indian    O
Ayurvedic    O
Herbal    O
System    O
to    O
cure    O
Fever    O
as    O
in    O
Laghu    O
sudarshana    O
churna    O
,    O
Maha    O
sudarshan    O
Churna    O
and    O
in    O
Tibetan    O
folk    B-Medicine106043075
medicine    I-Medicine106043075
.    O

In    O
1981    O
,    O
people    O
started    O
bathing    O
in    O
it    O
after    O
its    O
supposed    B-Medicine106043075
healing    I-Medicine106043075
powers    I-Medicine106043075
were    O
popularized    O
.    O

"    O
Balneotherapy    O
"    O
is    O
the    O
practice    O
of    O
immersing    O
a    O
subject    O
in    O
mineral    O
water    O
or    O
mineral    O
-    O
laden    O
mud    O
;    O
it    O
is    O
part    O
of    O
the    O
traditional    B-Medicine106043075
medicine    I-Medicine106043075
of    O
many    O
cultures    O
and    O
originated    O
in    O
hot    O
springs    O
,    O
cold    O
springs    O
,    O
or    O
other    O
sources    O
of    O
such    O
water    O
like    O
the    O
Dead    O
Sea    O
.    O

It    O
is    O
made    O
from    O
a    O
combination    O
of    O
imipenem    B-Medicine106043075
and    O
cilastatin    B-Medicine106043075
.    O

It    O
is    O
a    O
broad    O
-    O
spectrum    O
beta    O
-    O
lactam    O
containing    O
equal    O
quantities    O
of    O
imipenem    B-Medicine106043075
and    O
cilastatin    B-Medicine106043075
.    O

List    B-Medicine106043075
of    I-Medicine106043075
fictional    I-Medicine106043075
medicines    I-Medicine106043075
and    I-Medicine106043075
drugs    I-Medicine106043075

Seerdon    O
is    O
consolidating    O
Imperial    O
power    O
in    O
preparation    O
for    O
an    O
attack    O
aimed    O
at    O
capturing    O
Thyferra    O
,    O
a    O
planet    O
which    O
produces    O
the    O
healing    O
substance    O
bacta    B-Medicine106043075
.    O

List    B-Medicine106043075
of    I-Medicine106043075
fictional    I-Medicine106043075
medicines    I-Medicine106043075
and    I-Medicine106043075
drugs    I-Medicine106043075

Beju    O
plans    O
on    O
using    O
the    O
Syndicat    O
's    O
power    O
to    O
cut    O
bacta    B-Medicine106043075
supply    O
,    O
allowing    O
him    O
to    O
control    O
Gala    O
and    O
,    O
hopefully    O
,    O
the    O
entire    O
sector    O
.    O

Intravenous    O
and    O
oral    O
formulations    O
of    O
acetylcysteine    O
are    O
available    O
for    O
the    O
treatment    O
of    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
overdose    O
.    O

In    O
an    O
interview    O
with    O
Sound    O
of    O
Boston    O
,    O
McKenna    O
explained    O
that    O
the    O
title    O
of    O
the    O
song    O
came    O
from    O
"    O
the    O
idea    O
of    O
using    O
the    O
lyric    O
paracetamol    B-Medicine106043075
was    O
a    O
way    O
of    O
comparing    O
the    O
belief    O
that    O
someone    O
can    O
be    O
cured    O
from    O
who    O
they    O
are    O
,    O
via    O
therapy    O
,    O
to    O
an    O
everyday    O
painkiller    O
.    O
"    O
Matt    O
Wilkinson    O
of    O
"    O
NME    O
"    O
called    O
"    O
Paracetamol    O
"    O
McKenna    O
's    O
second    O
break    O
-    O
out    O
hit    O
.    O

Furthermore    O
,    O
the    O
grimacing    O
indicates    O
that    O
buprenorphine    O
is    O
fully    O
efficacious    O
at    O
recommended    O
doses    O
against    O
early    O
postoperative    O
pain    O
,    O
but    O
carprofen    O
and    O
ketoprofen    O
are    O
efficacious    O
only    O
at    O
doses    O
much    O
higher    O
than    O
currently    O
recommended    O
:    O
acetaminophen    B-Medicine106043075
is    O
not    O
efficacious    O
.    O

Common    O
causes    O
of    O
kidney    O
disease    O
include    O
diabetes    O
,    O
heart    O
disease    O
,    O
long    O
term    O
untreated    O
high    O
blood    O
pressure    O
,    O
as    O
well    O
as    O
abuse    O
of    O
analgesics    O
like    O
ibuprofen    O
,    O
aspirin    O
,    O
and    O
paracetamol    B-Medicine106043075
.    O

There    O
he    O
would    O
continue    O
to    O
stay    O
working    O
at    O
a    O
Paracetamol    B-Medicine106043075
factory    O
for    O
some    O
of    O
the    O
time    O
,    O
before    O
returning    O
to    O
Ireland    O
to    O
live    O
in    O
Dalkey    O
.    O

Paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O

Paracetamol    B-Medicine106043075

Effects    O
of    O
nabumetone    O
on    O
blood    O
pressure    O
control    O
in    O
hypertensive    O
patients    O
on    O
ACE    O
inhibitors    O
is    O
also    O
good    O
—    O
equivalent    O
to    O
paracetamol    B-Medicine106043075
.    O

Patients    O
typically    O
go    O
home    O
within    O
a    O
few    O
hours    O
of    O
surgery    O
,    O
often    O
requiring    O
no    O
medication    O
beyond    O
paracetamol    B-Medicine106043075
(    O
Tylenol    O
/    O
acetaminophen    O
)    O
.    O

Acetaminophen    B-Medicine106043075
,    O
ascorbic    O
acid    O
,    O
heroin    O
,    O
lactose    O
,    O
mannitol    O
,    O
morphine    O
,    O
and    O
sucrose    O
all    O
cause    O
an    O
instant    O
colour    O
change    O
to    O
purple    O
,    O
as    O
do    O
other    O
compounds    O
with    O
phenol    O
and    O
hydroxyl    O
groups    O
.    O

Such    O
cold    O
medications    O
contain    O
acetaminophen    B-Medicine106043075
(    O
paracetamol    O
)    O
,    O
the    O
active    O
ingredient    O
in    O
Tylenol    O
,    O
and    O
the    O
antihistamine    O
diphenhydramine    O
,    O
the    O
active    O
ingredient    O
in    O
Benadryl    O
.    O

The    O
watered    O
-    O
down    O
heroin    O
,    O
often    O
called    O
"    O
monkey    O
juice    O
,    O
"    O
is    O
mixed    O
with    O
Tylenol    B-Medicine106043075
PM    I-Medicine106043075
tablets    O
.    O

Paracetamol    B-Medicine106043075
,    O
pethidine    O
,    O
diphenhydramine    O
,    O
and    O
hydrocortisone    O
have    O
all    O
been    O
used    O
to    O
treat    O
or    O
prevent    O
the    O
syndrome    O
,    O
but    O
the    O
prophylactic    O
use    O
of    O
these    O
drugs    O
is    O
often    O
limited    O
by    O
the    O
patient    O
's    O
condition    O
.    O

They    O
recommended    O
that    O
this    O
metabolite    O
,    O
acetaminophen    B-Medicine106043075
(    O
paracetamol    O
,    O
Tylenol    O
)    O
,    O
be    O
used    O
instead    O
.    O

Take    O
acetaminophen    B-Medicine106043075
(    O
also    O
known    O
as    O
paracetamol    O
)    O
or    O
ibuprofen    O
for    O
local    O
pain    O
and    O
swelling    O

It    O
is    O
also    O
used    O
as    O
an    O
excipient    O
in    O
some    O
tablets    O
,    O
such    O
as    O
paracetamol    B-Medicine106043075
.    O

However    O
,    O
acidosis    O
has    O
a    O
large    O
number    O
of    O
differential    O
diagnosis    O
,    O
including    O
poisoning    O
from    O
methanol    O
,    O
salicylates    O
,    O
iron    O
,    O
isoniazid    O
,    O
paracetamol    B-Medicine106043075
,    O
theophylline    O
,    O
or    O
from    O
conditions    O
such    O
as    O
uremia    O
or    O
diabetic    O
and    O
alcoholic    O
ketoacidosis    O
.    O

Homoeriodictyol    O
Sodium    O
salt    O
elicited    O
the    O
most    O
potent    O
bitter    O
-    O
masking    O
activity    O
by    O
reducing    O
from    O
10    O
to    O
40%    O
the    O
bitterness    O
of    O
salicin    O
,    O
amarogentin    O
,    O
paracetamol    B-Medicine106043075
and    O
quinine    O
.    O

It    O
combines    O
the    O
mechanisms    O
of    O
naloxone    O
and    O
paracetamol    B-Medicine106043075
(    O
the    O
two    O
more    O
commonly    O
used    O
abuse    O
-    O
deterring    O
agents    O
)    O
by    O
increasing    O
the    O
likelihood    O
of    O
the    O
overdose    O
resulting    O
in    O
harmful    O
and/or    O
fatal    O
sequelae    O
(    O
as    O
does    O
paracetamol    O
)    O
,    O
in    O
addition    O
to    O
reliably    O
producing    O
unpleasant    O
side    O
-    O
effects    O
which    O
"    O
spoil    O
"    O
the    O
opioid    O
euphoria    O
and    O
discourage    O
abusers    O
from    O
overdosing    O
again    O
following    O
their    O
initial    O
experience    O
(    O
as    O
does    O
naloxone    O
)    O
.    O

AM404    O
,    O
also    O
known    O
as    O
N    O
"-    O
arachidonoylaminophenol    O
"    O
'    O
,    O
is    O
an    O
active    O
metabolite    O
of    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
,    O
responsible    O
for    O
all    O
or    O
part    O
of    O
its    O
analgesic    O
action    O
and    O
anticonvulsant    O
effects    O
.    O

This    O
pain    O
is    O
typically    O
treated    O
with    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
.    O

He    O
had    O
taken    O
the    O
painkillers    O
tramadol    O
and    O
Tylenol    B-Medicine106043075
PM    I-Medicine106043075
,    O
both    O
of    O
which    O
can    O
cause    O
drowsiness    O
as    O
a    O
side    O
effect    O
.    O

These    O
include    O
simple    O
analgesics    O
(    O
such    O
as    O
ibuprofen    O
and    O
acetaminophen    B-Medicine106043075
)    O
and    O
opioids    O
such    O
as    O
morphine    O
.    O

;    O
paracetamol    B-Medicine106043075
:    O
a    O
common    O
and    O
widely    O
available    O
drug    O
for    O
the    O
treatment    O
of    O
headaches    O
,    O
fever    O
and    O
other    O
minor    O
aches    O
and    O
pains    O
(    O
US    O
:    O
"    O
acetaminophen    O
"    O
,    O
"    O
Tylenol    O
"    O
)    O

;    O
acetaminophen    B-Medicine106043075
(    O
or    O
the    O
brand    O
name    O
Tylenol    O
)    O
:    O
(    O
UK    O
:    O
"    O
paracetamol    O
"    O
)    O

Five    O
samples    O
were    O
found    O
to    O
include    O
traces    O
of    O
Mobistix    O
,    O
aka    O
acetaminophen    B-Medicine106043075
a    O
widely    O
used    O
over    O
-    O
the    O
-    O
counter    O
analgesic    O
(    O
pain    O
reliever    O
)    O
and    O
antipyretic    O
(    O
fever    O
reducer    O
)    O
.    O

Still    O
a    O
student    O
,    O
Paul    O
Janssen    O
assisted    O
in    O
the    O
development    O
of    O
paracetamol    B-Medicine106043075
(    O
USP    O
:    O
acetaminophen    O
,    O
often    O
referred    O
to    O
generically    O
under    O
the    O
trademark    O
Tylenol    O
)    O
under    O
the    O
name    O
Perdolan    B-Medicine106043075
,    O
which    O
would    O
later    O
become    O
well    O
-    O
known    O
.    O

The    O
victims    O
had    O
all    O
taken    O
Tylenol    O
-    O
branded    O
acetaminophen    B-Medicine106043075
capsules    O
that    O
had    O
been    O
laced    O
with    O
potassium    O
cyanide    O
.    O

The    O
company    O
also    O
advertised    O
in    O
the    O
national    O
media    O
for    O
individuals    O
not    O
to    O
consume    O
any    O
of    O
its    O
products    O
that    O
contained    O
acetaminophen    B-Medicine106043075
after    O
it    O
was    O
determined    O
that    O
only    O
these    O
capsules    O
had    O
been    O
tampered    O
with    O
.    O

There    O
are    O
three    O
forms    O
of    O
analgesia    O
suitable    O
for    O
the    O
treatment    O
of    O
pain    O
in    O
babies    O
:    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
,    O
the    O
nonsteroidal    O
anti    O
-    O
inflammatory    O
drugs    O
,    O
and    O
the    O
opioids    O
.    O

with    O
paracetamol    B-Medicine106043075
as    O
Algotropyl    O
,    O
Calmkid    O
,    O
Fevril    O
,    O
Phen    O
Plus    O
,    O
and    O
Velpro    O
-    O
P    O
;    O

with    O
paracetamol    B-Medicine106043075
and    O
dextromethorphan    O
as    O
Choligrip    O
na    O
noc    O
,    O
Coldrex    O
Nočná    O
Liečba    O
,    O
Fedril    O
Night    O
Cold    O
and    O
Flu    O
,    O
Night    O
Nurse    O
,    O
and    O
Tachinotte    O
;    O

with    O
paracetamol    B-Medicine106043075
,    O
phenylephrine    O
,    O
and    O
salicylamide    O
as    O
Flukit    O
;    O

Patients    O
are    O
therefore    O
typically    O
often    O
prescribed    O
30    O
mg    O
or    O
60    O
mg    O
of    O
codeine    O
phosphate    O
to    O
be    O
taken    O
in    O
conjunction    O
with    O
1    O
g    O
paracetamol    B-Medicine106043075
,    O
four    O
times    O
a    O
day    O
.    O

As    O
glutathione    O
depletion    O
has    O
been    O
shown    O
to    O
regulate    O
liver    O
toxification    O
,    O
administration    O
of    O
N-acetylcysteine    B-Medicine106043075
in    O
similar    O
doses    O
as    O
given    O
for    O
acetaminophen    B-Medicine106043075
toxicity    O
have    O
been    O
given    O
to    O
patients    O
.    O

The    O
combination    O
medication    O
Fioricet    O
,    O
consisting    O
of    O
butalbital    O
,    O
caffeine    O
,    O
and    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
,    O
however    O
,    O
is    O
specifically    O
exempted    O
from    O
controlled    O
substance    O
status    O
,    O
while    O
its    O
sibling    O
Fiorinal    O
,    O
which    O
contains    O
aspirin    O
instead    O
of    O
paracetamol    O
and    O
may    O
contain    O
codeine    O
phosphate    O
,    O
remains    O
a    O
schedule    O
III    O
drug    O
.    O

paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O

:*    O
Para    O
-    O
Tabs    O
(    O
"    O
paracetamol    B-Medicine106043075
"    O
)    O

Various    O
medications    O
that    O
are    O
often    O
used    O
in    O
other    O
headache    O
syndromes    O
such    O
as    O
nonsteroidal    O
anti    O
-    O
inflammatory    O
drugs    O
,    O
acetaminophen    B-Medicine106043075
,    O
tricyclic    O
antidepressants    O
,    O
calcium    O
channel    O
antagonists    O
do    O
not    O
relieve    O
the    O
symptoms    O
of    O
SUNCT    O
.    O

He    O
began    O
studying    O
autism    O
in    O
1993    O
,    O
and    O
has    O
contended    O
that    O
acetaminophen    B-Medicine106043075
may    O
be    O
a    O
major    O
cause    O
of    O
autism    O
,    O
a    O
hypothesis    O
which    O
he    O
advanced    O
in    O
a    O
paper    O
published    O
in    O
2013    O
in    O
the    O
"    O
Journal    O
of    O
Restorative    O
Medicine    O
"    O
.    O

The    O
cytokine    O
release    O
syndrome    O
associated    O
with    O
ATG    O
administration    O
frequently    O
causes    O
high    O
grade    O
fevers    O
(    O
over    O
39oC    O
)    O
,    O
chills    O
,    O
and    O
possibly    O
rigors    O
during    O
administration    O
,    O
for    O
which    O
reason    O
steroids    O
(    O
normally    O
methylprednisolone    O
)    O
,    O
diphenhydramine    O
25–50    O
mg    O
,    O
and    O
acetaminophen    B-Medicine106043075
650    O
mg    O
are    O
usually    O
co    O
-    O
administered    O
.    O

This    O
may    O
include    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
,    O
ibuprofen    O
,    O
benzocaine    O
ear    O
drops    O
,    O
or    O
opioids    O
.    O

Oral    O
agents    O
include    O
ibuprofen    O
,    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
,    O
and    O
opiates    O
.    O

On    O
the    O
19th    O
,    O
in    O
the    O
morning    O
,    O
he    O
had    O
a    O
fever    O
of    O
38    O
degrees    O
and    O
cough    O
,    O
prescribed    O
paracetamol    B-Medicine106043075
at    O
a    O
clinic    O
.    O

;    O
Paracetamol    B-Medicine106043075

Panadol    B-Medicine106043075

Panadol    B-Medicine106043075

The    O
Rumack    O
-    O
Matthew    O
nomogram    O
,    O
also    O
known    O
as    O
Rumack    O
-    O
Matthews    O
nomogram    O
or    O
the    O
Acetaminophen    O
nomogram    O
is    O
an    O
acetaminophen    B-Medicine106043075
toxicity    O
nomogram    O
plotting    O
serum    O
concentration    O
of    O
acetaminophen    O
against    O
the    O
time    O
since    O
ingestion    O
in    O
an    O
attempt    O
to    O
prognosticate    O
possible    O
liver    O
toxicity    O
as    O
well    O
as    O
allowing    O
a    O
clinician    O
to    O
decide    O
whether    O
to    O
proceed    O
with    O
N-Acetylcysteine    B-Medicine106043075
(    O
NAC    O
)    O
treatment    O
or    O
not    O
.    O

The    O
analgesic    O
(    O
pain    O
reliever    O
)    O
and    O
antipyretic    O
(    O
fever    O
reducer    O
)    O
paracetamol    B-Medicine106043075
(    O
INN    O
)    O
(    O
or    O
)    O
,    O
also    O
known    O
as    O
acetaminophen    O
(    O
USAN    O
)    O
,    O
is    O
sold    O
around    O
the    O
world    O
under    O
a    O
number    O
of    O
different    O
brand    O
names    O
.    O

The    O
active    O
ingredient    O
of    O
its    O
original    O
flagship    O
product    O
is    O
paracetamol    B-Medicine106043075
.    O

The    O
main    O
product    O
is    O
a    O
paracetamol    B-Medicine106043075
suspension    O
.    O

Many    O
drugs    O
are    O
amides    O
,    O
including    O
paracetamol    B-Medicine106043075
,    O
penicillin    O
and    O
LSD    O
.    O

Aspirin    O
's    O
popularity    O
declined    O
after    O
the    O
development    O
of    O
acetaminophen/paracetamol    B-Medicine106043075
in    O
1956    O
and    O
ibuprofen    O
in    O
1962    O
.    O

Pain    O
medications    O
such    O
as    O
ibuprofen    O
and    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
)    O
may    O
be    O
used    O
.    O

For    O
example    O
,    O
the    O
first    O
-    O
line    O
treatment    O
for    O
osteoarthritis    O
is    O
acetaminophen    B-Medicine106043075
(    O
paracetamol    O
)    O
while    O
for    O
inflammatory    O
arthritis    O
it    O
involves    O
non    O
-    O
steroidal    O
anti    O
-    O
inflammatory    O
drugs    O
(    O
NSAIDs    O
)    O
like    O
ibuprofen    O
.    O

Analgesics    O
include    O
paracetamol    B-Medicine106043075
(    O
known    O
in    O
North    O
America    O
as    O
acetaminophen    B-Medicine106043075
or    O
simply    O
APAP    O
)    O
,    O
the    O
nonsteroidal    O
anti    O
-    O
inflammatory    O
drugs    O
(    O
NSAIDs    O
)    O
such    O
as    O
the    O
salicylates    O
,    O
and    O
opioid    O
drugs    O
such    O
as    O
morphine    O
and    O
oxycodone    O
.    O

Analgesics    O
are    O
frequently    O
used    O
in    O
combination    O
,    O
such    O
as    O
the    O
paracetamol    B-Medicine106043075
and    O
codeine    O
preparations    O
found    O
in    O
many    O
non    O
-    O
prescription    O
pain    O
relievers    O
.    O

Taking    O
paracetamol    B-Medicine106043075
(    O
acetaminophen    O
,    O
Tylenol    O
)    O
or    O
acetylsalicylic    O
acid    O
(    O
aspirin    O
)    O
while    O
taking    O
rimantadine    O
is    O
known    O
to    O
reduce    O
the    O
body    O
's    O
uptake    O
of    O
rimantadine    O
by    O
approximately    O
12%    O
.    O

Over    O
-    O
the    O
-    O
counter    O
pain    O
medications    O
such    O
as    O
acetaminophen    B-Medicine106043075
and    O
ibuprofen    O
do    O
not    O
kill    O
the    O
virus    O
;    O
however    O
,    O
they    O
may    O
be    O
useful    O
to    O
reduce    O
symptoms    O
.    O

This    O
specialization    O
is    O
reflected    O
histologically    O
;    O
the    O
detoxifying    O
zone    O
III    O
cells    O
have    O
the    O
highest    O
concentration    O
of    O
CYP2E1    O
and    O
thus    O
are    O
most    O
sensitive    O
to    O
NAPQI    O
production    O
in    O
acetaminophen    B-Medicine106043075
toxicity    O
.    O

The    O
FDA    O
launches    O
and    O
investigation    O
after    O
acetaminophen    B-Medicine106043075
,    O
best    O
known    O
under    O
the    O
brand    O
-    O
name    O
Tylenol    O
,    O
is    O
identified    O
by    O
ExperTox    O
Inc.    O
,    O
a    O
laboratory    O
in    O
Texas    O
,    O
as    O
a    O
fifth    O
contaminant    O
present    O
in    O
many    O
varieties    O
of    O
pet    O
food    O
.    O

Acetaminophen    B-Medicine106043075
500    O
mg    O
(    O
pain    O
reliever    O
)    O

Group    O
II    O
hospitals    O
provide    O
the    O
group    O
I    O
valences    O
in    O
their    O
own    O
area    O
of    O
direct    O
influence    O
and    O
also    O
provide    O
the    O
medical    O
and    O
chirurgical    O
valences    O
of    O
ophthalmology    O
,    O
pneumology    B-Medicine106043075
,    O
cardiology    O
,    O
rheumatology    O
,    O
gastroenterology    O
,    O
nephrology    O
,    O
clinical    O
hematology    O
,    O
infectiology    O
,    O
medical    O
oncology    O
,    O
neonatology    O
,    O
allergology    O
,    O
gynecology    O
-    O
obstetrics    O
,    O
dermatology    O
-    O
venereology    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
urology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
pathological    O
anatomy    O
,    O
nuclear    O
medicine    O
and    O
neuroradiology    B-Medicine106043075
in    O
an    O
indirect    O
area    O
of    O
influence    O
.    O

Prostitutes    O
must    O
have    O
reached    O
age    O
of    O
majority    O
and    O
receive    O
a    O
health    O
card    O
from    O
Venereologist    B-Medicine106043075
and    O
undergo    O
health    O
check    O
every    O
month    O
,    O
they    O
must    O
be    O
able    O
to    O
produce    O
the    O
health    O
card    O
on    O
clients    O
request    O
.    O

The    O
journal    O
is    O
peer    O
-    O
reviewed    O
monthly    O
that    O
publishes    O
articles    O
of    O
general    O
and    O
practical    O
interest    O
in    O
the    O
field    O
of    O
dermatology    O
and    O
venereology    B-Medicine106043075
on    O
clinical    O
and    O
basic    O
science    O
topics    O
,    O
as    O
well    O
as    O
research    O
with    O
practical    O
implications    O
.    O

Sir    O
Jonathan    O
Hutchinson    O
(    O
23    O
July    O
1828    O
–    O
23    O
June    O
1913    O
)    O
,    O
was    O
an    O
English    O
surgeon    O
,    O
ophthalmologist    O
,    O
dermatologist    O
,    O
venereologist    B-Medicine106043075
and    O
pathologist    B-Medicine106043075
.    O

In    O
April    O
1968    O
,    O
Foriș    O
and    O
Lucrețiu    O
Pătrășcanu    O
were    O
rehabilitated    B-Medicine106043075
by    O
the    O
Central    O
Committee    O
of    O
the    O
Romanian    O
Communist    O
Party    O
which    O
was    O
by    O
then    O
under    O
the    O
leadership    O
of    O
Gheorghiu    O
-    O
Dej    O
's    O
successor    O
,    O
Nicolae    O
Ceaușescu    O
.    O

In    O
subsequent    O
periods    O
,    O
Stefanov    O
's    O
image    O
and    O
status    O
remained    O
the    O
subject    O
of    O
allegations    O
inside    O
Communist    O
Romania    O
:    O
in    O
1961    O
,    O
the    O
high    O
-    O
ranking    O
Communist    O
activist    O
Valter    O
Roman    O
,    O
who    O
had    O
been    O
himself    O
disgraced    O
and    O
rehabilitated    B-Medicine106043075
by    O
Gheorghe    O
Gheorghiu    O
-    O
Dej    O
,    O
spoke    O
out    O
against    O
former    O
Communist    O
politicians    O
who    O
had    O
been    O
purged    O
at    O
various    O
stages    O
,    O
Stefanov    O
included    O
;    O
he    O
was    O
interrupted    O
by    O
Petre    O
Borilă    O
,    O
who    O
notably    O
added    O
a    O
claim    O
that    O
Stefanov    O
had    O
admired    O
Nazism    O
and    O
had    O
seen    O
in    O
it    O
a    O
path    O
to    O
a    O
socialist    O
economy    O
.    O

This    O
grim    O
fate    O
was    O
officially    O
declared    O
an    O
error    O
with    O
Sultan    O
-    O
Zade    O
's    O
posthumous    B-Medicine106043075
rehabilitation    I-Medicine106043075
following    O
an    O
investigation    O
in    O
1956    O
.    O

On    O
June    O
9    O
,    O
1956    O
Sultan    O
-    O
Zade    O
was    O
formally    O
cleared    O
of    O
the    O
1938    O
charges    O
which    O
led    O
to    O
his    O
execution    O
and    O
legal    O
rights    O
restored    O
to    O
his    O
heirs    O
through    O
posthumous    B-Medicine106043075
rehabilitation    I-Medicine106043075
.    O

He    O
was    O
rehabilitate    B-Medicine106043075
in    O
1955    O
,    O
but    O
with    O
a    O
"    O
wolf    O
ticket    O
"    O
that    O
means    O
an    O
internal    O
exile    O
without    O
the    O
right    O
to    O
settle    O
closer    O
than    O
100    O
km    O
from    O
large    O
urban    O
centers    O
.    O

With    O
the    O
end    O
of    O
the    O
Stalinist    O
era    O
she    O
was    O
amnestied    O
on    O
April    O
16    O
,    O
1954    O
and    O
fully    O
rehabilitated    B-Medicine106043075
in    O
1956    O
.    O

He    O
was    O
rehabilitated    B-Medicine106043075
in    O
1955    O
.    O

Though    O
"    O
rehabilitated    B-Medicine106043075
"    O
in    O
1956    O
and    O
allowed    O
to    O
return    O
the    O
next    O
year    O
,    O
the    O
survivors    O
lost    O
economic    O
resources    O
and    O
civil    O
rights    O
and    O
,    O
under    O
both    O
Soviet    O
and    O
post    O
-    O
Soviet    O
governments    O
,    O
they    O
have    O
been    O
the    O
objects    O
of    O
both    O
official    O
and    O
unofficial    O
discrimination    O
and    O
discriminatory    O
public    O
discourse    O
.    O

It    O
once    O
again    O
became    O
forbidden    O
to    O
criticize    O
Lysenkoism    O
,    O
though    O
it    O
was    O
now    O
possible    O
to    O
express    O
different    O
views    O
,    O
and    O
all    O
geneticists    O
were    O
released    O
or    O
rehabilitated    B-Medicine106043075
posthumously    I-Medicine106043075
.    O

For    O
instance    O
,    O
Bukharin    O
,    O
Zinoviev    O
,    O
Yevgeni    O
Preobrazhensky    O
and    O
Georgy    O
Pyatakov    O
were    O
all    O
rehabilitated    B-Medicine106043075
.    O

Unlike    O
many    O
others    O
,    O
Razgon    O
did    O
not    O
have    O
to    O
wait    O
long    O
for    O
rehabilitation    B-Medicine106043075
,    O
after    O
which    O
he    O
could    O
settle    O
in    O
Moscow    O
again    O
and    O
resume    O
his    O
writing    O
.    O

Rehabilitation    B-Medicine106043075
(Soviet)    I-Medicine106043075

Leonid    O
Kurchevsky    O
was    O
rehabilitated    B-Medicine106043075
posthumously    O
in    O
1956    O
.    O

He    O
remained    O
a    O
suspect    O
at    O
a    O
time    O
when    O
Gheorghiu    O
-    O
Dej    O
felt    O
increasingly    O
threatened    O
,    O
was    O
subject    O
to    O
a    O
"    O
vote    O
of    O
censure    O
"    O
in    O
1954    O
,    O
and    O
was    O
completely    O
rehabilitated    B-Medicine106043075
only    O
in    O
1956    O
.    O

In    O
1955    O
,    O
he    O
was    O
rehabilitated    B-Medicine106043075
"    O
due    O
to    O
the    O
lack    O
of    O
a    O
criminal    O
matter    O
"    O
and    O
awarded    O
Hero    O
of    O
Socialist    O
Labor    O
(    O
1991    O
)    O
.    O

He    O
was    O
rehabilitated    B-Medicine106043075
after    O
Stalin    O
's    O
death    O
.    O

For    O
posthumously    O
published    O
works    O
,    O
copyrights    O
were    O
defined    O
to    O
last    O
until    O
fifty    O
years    O
after    O
the    O
publication    O
,    O
and    O
for    O
posthumously    O
rehabilitated    B-Medicine106043075
authors    O
,    O
the    O
fifty    O
-    O
year    O
term    O
began    O
running    O
at    O
the    O
date    O
of    O
the    O
rehabilitation    O
.    O

Bubnov    O
was    O
posthumously    O
rehabilitated    B-Medicine106043075
in    O
February    O
1956    O
during    O
the    O
de    O
-    O
Stalinization    O
of    O
the    O
Khrushchev    O
thaw    O
.    O

He    O
was    O
rehabilitated    B-Medicine106043075
in    O
April    O
1986    O
.    O

He    O
was    O
released    O
in    O
1955    O
after    O
six    O
years    O
without    O
rehabilitation    B-Medicine106043075
,    O
during    O
a    O
wave    O
of    O
releases    O
from    O
Gulag    O
after    O
Stalin    O
's    O
death    O
.    O

In    O
1994    O
,    O
the    O
Military    O
Collegium    O
of    O
the    O
Supreme    O
Court    O
reviewed    O
the    O
sentences    O
with    O
a    O
possibility    O
of    O
posthumous    B-Medicine106043075
rehabilitation    I-Medicine106043075
.    O

Officially    O
rehabilitated    B-Medicine106043075
in    O
1966    O
,    O
he    O
remains    O
a    O
controversial    O
figure    O
in    O
modern    O
Uzbekistan    O
.    O

He    O
was    O
released    O
in    O
1956    O
after    O
being    O
rehabilitated    B-Medicine106043075
,    O
and    O
returned    O
to    O
Yugoslavia    O
.    O

Shortly    O
before    O
that    O
,    O
the    O
Supreme    O
Collegium    O
of    O
the    O
Supreme    O
Court    O
of    O
the    O
USSR    O
rehabilitated    B-Medicine106043075
him    O
.    O

Soon    O
after    O
1965    O
,    O
Ceaușescu    O
used    O
his    O
prerogatives    O
to    O
convoke    O
a    O
Party    O
Commission    O
headed    O
by    O
Ion    O
Popescu    O
-    O
Puțuri    O
,    O
charged    O
with    O
investigating    O
both    O
Stalinist    O
legacy    O
and    O
Gheorghiu    O
-    O
Dej    O
's    O
purges    O
:    O
resulting    O
in    O
the    O
rehabilitation    B-Medicine106043075
of    O
a    O
large    O
number    O
of    O
Communist    O
officials    O
(    O
including    O
,    O
among    O
others    O
,    O
Ștefan    O
Foriș    O
,    O
Lucrețiu    O
Pătrășcanu    O
,    O
Miron    O
Constantinescu    O
,    O
Vasile    O
Luca    O
,    O
and    O
Romanian    O
victims    O
of    O
the    O
Soviet    O
Great    O
Purge    O
)    O
.    O

After    O
Khrushchev    O
's    O
Secret    O
Speech    O
in    O
1956    O
,    O
Solzhenitsyn    O
was    O
freed    O
from    O
exile    O
and    O
exonerated    B-Medicine106043075
.    O

After    O
Stalin    O
's    O
death    O
in    O
1953    O
,    O
the    O
communist    O
government    O
of    O
Lithuania    O
,    O
especially    O
the    O
first    O
secretary    O
of    O
the    O
Lithuanian    O
Communist    O
Party    O
,    O
Antanas    O
Sniečkus    O
,    O
started    B-Medicine106043075
reviving    I-Medicine106043075
the    I-Medicine106043075
memory    I-Medicine106043075
of    O
Mickevičius    O
.    O

He    O
was    O
among    O
the    O
first    O
to    O
be    O
rehabilitated    B-Medicine106043075
,    O
in    O
1956    O
(    O
at    O
the    O
very    O
beginning    O
of    O
De    O
-    O
Stalinization    O
)    O
.    O

He    O
was    O
rehabilitated    B-Medicine106043075
under    O
Nikita    O
Khrushchev    O
in    O
1961    O
.    O

The    O
new    O
Soviet    O
leadership    O
of    O
Nikita    O
Khrushchev    O
admitted    O
that    O
the    O
case    O
was    O
fabricated    O
and    O
eventually    O
rehabilitated    B-Medicine106043075
its    O
victims    O
.    O

In    O
the    O
broadest    O
sense    O
,    O
nearly    O
all    O
research    O
which    O
links    O
manifestations    O
of    O
disease    O
to    O
identifiable    O
processes    O
in    O
cells    O
,    O
tissues    O
,    O
or    O
organs    O
can    O
be    O
considered    O
experimental    B-Medicine106043075
pathology    I-Medicine106043075
.    O

Among    O
his    O
writings    O
were    O
the    O
multi    O
-    O
volume    O
"    O
"    O
Médecine    O
clinique    O
"    O
,    O
a    O
work    O
that    O
he    O
co    O
-    O
authored    O
with    O
Frédéric    O
Labadie    O
-    O
Lagrave    O
,    O
and    O
"    O
Leçons    O
de    O
pathologie    O
expérimentale    O
"    O
,    O
a    O
book    O
on    O
experimental    B-Medicine106043075
pathology    I-Medicine106043075
that    O
was    O
edited    O
by    O
Maurice    O
Raynaud    O
.    O

It    O
covers    O
all    O
aspects    O
of    O
experimental    B-Medicine106043075
and    O
clinical    O
pathology    O
and    O
publishes    O
review    O
articles    O
,    O
original    O
research    O
articles    O
,    O
case    O
reports    O
,    O
and    O
editorials    O
.    O

:    O
"    O
a    O
collaborative    O
process    O
of    O
assessment    B-Medicine106043075
,    O
planning    O
,    O
facilitation    O
,    O
care    O
coordination    O
,    O
evaluation    O
,    O
and    O
advocacy    O
for    O
options    O
and    O
services    O
to    O
meet    O
an    O
individual    O
's    O
and    O
family    O
's    O
comprehensive    O
health    O
needs    O
through    O
communication    O
and    O
available    O
resources    O
to    O
promote    O
quality    O
costeffective    O
outcomes    O
.    O
"    O

Gordon    O
's    O
functional    O
health    O
patterns    O
is    O
a    O
method    O
devised    O
by    O
Marjory    O
Gordon    O
to    O
be    O
used    O
by    O
nurses    O
in    O
the    O
nursing    O
process    O
to    O
provide    O
a    O
more    O
comprehensive    O
nursing    B-Medicine106043075
assessment    I-Medicine106043075
of    O
the    O
patient    O
.    O

Marjory    O
Gordon    O
was    O
a    O
nursing    O
theorist    O
and    O
professor    O
who    O
created    O
a    O
nursing    B-Medicine106043075
assessment    I-Medicine106043075
theory    O
known    O
as    O
Gordon    O
's    O
functional    O
health    O
patterns    O
.    O

In    O
April    O
2006    O
one    O
of    O
Featherstone    O
's    O
researchers    O
received    O
a    O
hoax    O
email    O
warning    O
about    O
an    O
apparent    O
date    O
rape    O
drug    O
called    O
Progesterex    B-Medicine106043075
.    O

The    O
university    O
offers    O
interns    O
the    O
opportunity    O
to    O
specialize    O
in    O
any    O
of    O
25    O
areas    O
—    O
obstetrics    O
and    O
gynaecology    O
,    O
anaesthesiology    O
and    O
intensive    O
therapy    O
,    O
internal    O
medicine    O
,    O
dermatology    O
,    O
children    O
’s    O
anaesthesiology    O
,    O
children    O
’s    O
otolaryngology    O
,    O
paediatric    B-Medicine106043075
surgery    I-Medicine106043075
,    O
family    O
medicine    O
(    O
general    O
practice    O
)    O
,    O
general    O
pharmacy    O
,    O
infectious    O
diseases    O
,    O
clinical    O
oncology    O
,    O
emergency    O
medicine    O
,    O
neurology    O
,    O
neonatology    O
,    O
orthopaedics    B-Medicine106043075
and    O
traumatology    O
,    O
otolaryngology    O
,    O
ophthalmology    O
,    O
anatomical    O
pathology    O
,    O
paediatrics    O
,    O
psychiatry    O
,    O
pulmonology    B-Medicine106043075
and    O
phthisiology    B-Medicine106043075
,    O
radiology    O
,    O
dentistry    O
,    O
urology    O
and    O
surgery    O
.    O

Treatment    O
with    O
anthelmintics    O
,    O
such    O
as    O
levamisole    B-Medicine106043075
or    O
fenbendazole    O
,    O
is    O
usually    O
sufficient    O
to    O
cure    O
"    O
C.    O
aerophila    O
"    O
infestations    O
.    O

Ergamisol    O
(    O
levamisole    B-Medicine106043075
)    O

For    O
example    O
,    O
morantel    O
,    O
mesulfenfos    O
,    O
levamisole    B-Medicine106043075
,    O
emamectin    O
,    O
milbemectin    O
,    O
thionazin    O
.    O

Ecstasydata.org    O
has    O
broadened    O
in    O
scope    O
,    O
and    O
now    O
is    O
running    O
analysis    O
of    O
other    O
recreational    O
drugs    O
(    O
Including    O
street    O
cocaine    O
to    O
determine    O
the    O
spread    O
of    O
the    O
contaminant    O
Levamisole    B-Medicine106043075
)    O
,    O
and    O
provided    O
testing    O
of    O
uncommon    O
research    O
chemicals    O
.    O

Other    O
anthelmintics    O
that    O
can    O
be    O
used    O
include    O
thiabendazole    O
,    O
mebendazole    O
,    O
levamisole    B-Medicine106043075
and    O
pyrantel    B-Medicine106043075
pamoate    I-Medicine106043075
.    O

In    O
a    O
study    O
,    O
a    O
mixture    O
of    O
levamisole    B-Medicine106043075
and    O
oxfendazole    O
killed    O
larvae    O
in    O
sheep    O
feces    O
.    O

Numerous    O
trials    O
evaluating    O
traditional    O
antifilarial    O
drugs    O
such    O
as    O
ivermectin    O
and    O
DEC    O
,    O
as    O
well    O
as    O
other    O
benzimidazoles    O
such    O
as    O
mebendazole    O
,    O
albendazole    B-Medicine106043075
,    O
levamisole    B-Medicine106043075
,    O
and    O
thiabendazole    O
,    O
have    O
been    O
conducted    O
.    O

Also    O
,    O
antifungal    O
drug    O
therapy    O
and    O
surgical    O
excision    O
can    O
be    O
used    O
to    O
treat    O
the    O
infection    O
separately    O
or    O
together    O
.    O
"    O
O.    O
gallopava    O
"    O
infection    O
treatment    O
widely    O
use    O
antifungal    O
drugs    O
such    O
as    O
amphotericin    O
B    O
,    O
itraconazole    O
,    O
triazole    O
,    O
voriconazole    O
,    O
fluconazole    B-Medicine106043075
,    O
posaconazole    O
,    O
and    O
many    O
others    O
.    O

Fluconazole    B-Medicine106043075

It    O
has    O
been    O
investigated    O
for    O
use    O
in    O
patients    O
after    O
liver    O
transplantation    O
,    O
but    O
fluconazole    B-Medicine106043075
was    O
found    O
to    O
be    O
much    O
more    O
effective    O
for    O
preventing    O
colonization    O
,    O
invasive    O
infection    O
,    O
and    O
death    O
.    O

In    O
the    O
past    O
it    O
had    O
been    O
used    O
for    O
fungal    O
infections    O
of    O
the    O
surface    O
of    O
the    O
GI    O
tract    O
such    O
as    O
thrush    O
,    O
but    O
has    O
been    O
replaced    O
by    O
other    O
antifungals    O
such    O
as    O
nystatin    O
and    O
fluconazole    B-Medicine106043075
.    O

Treatment    O
has    O
often    O
also    O
used    O
combination    O
therapy    O
with    O
multiple    O
other    O
antimicrobials    O
in    O
addition    O
to    O
amphotericin    O
,    O
such    O
as    O
fluconazole    B-Medicine106043075
,    O
miconazole    O
,    O
rifampicin    B-Medicine106043075
and    O
azithromycin    O
.    O

Current    O
advances    O
in    O
further    O
treatments    O
include    O
evaluations    O
of    O
triazoles    O
such    O
as    O
itraconazole    O
and    O
fluconazole    B-Medicine106043075
"    O
as    O
therapeutic    O
options    O
in    O
ophthalmic    O
mycoses    O
.    O
"    O

"    O
Coniochaeta    O
hoffmannii    O
"    O
has    O
proven    O
to    O
be    O
resistant    O
to    O
multiple    O
antifungal    O
agents    O
,    O
including    O
amphotericin    O
B    O
,    O
flucytosine    B-Medicine106043075
,    O
ketoconazole    O
,    O
and    O
fluconazole    B-Medicine106043075
.    O
Because    O
of    O
this    O
,    O
precautions    O
have    O
been    O
taken    O
,    O
such    O
as    O
antifungal    O
susceptibility    O
testing    O
,    O
in    O
order    O
to    O
circumvent    O
such    O
drawbacks    O
.    O

Additionally    O
,    O
the    O
metabolism    O
of    O
zonisamide    O
is    O
inhibited    O
by    O
ketoconazole    O
,    O
ciclosporin    O
,    O
miconazole    O
,    O
fluconazole    B-Medicine106043075
and    O
carbamazepine    B-Medicine106043075
(    O
in    O
descending    O
order    O
of    O
inhibition    O
)    O
due    O
to    O
their    O
effects    O
on    O
the    O
CYP3A4    O
enzyme    O
.    O

Oral    O
fluconazole    B-Medicine106043075
is    O
then    O
administered    O
for    O
six    O
months    O
or    O
more    O
.    O

The    O
few    O
that    O
have    O
been    O
characterized    O
transport    O
Cystine    O
(    O
TC    O
#    O
2.A.43.1.1    O
)    O
,    O
basic    O
amino    O
acids    O
such    O
as    O
L    O
-    O
lysine    O
and    O
L    O
-    O
arginine    O
(    O
TC    O
#    O
2.A.43.2.1    O
)    O
and    O
drugs    O
such    O
as    O
fluconazole    B-Medicine106043075
and    O
caspofungin    O
(    O
TC    O
#    O
2.A.43.2.7    O
)    O
.    O

If    O
the    O
scalp    O
is    O
involved    O
,    O
antifungals    O
by    O
mouth    O
such    O
as    O
fluconazole    B-Medicine106043075
may    O
be    O
needed    O
.    O

Fluconazole    B-Medicine106043075

Additionally    O
,    O
while    O
using    O
venetoclax    O
it    O
is    O
not    O
recommended    O
to    O
use    O
other    O
drugs    O
which    O
contain    O
CYP3A    O
inhibitors    O
(    O
i.e    O
:    O
erythromycin    O
,    O
ciprofloxacin    O
,    O
diltiazem    O
,    O
dronedarone    O
,    O
fluconazole    B-Medicine106043075
,    O
verapamil    O
)    O
.    O

Of    O
particular    O
note    O
,    O
Fluconazole    B-Medicine106043075
-    O
resistant    O
Candida    O
species    O
have    O
been    O
highlighted    O
as    O
a    O
growing    O
problem    O
by    O
the    O
CDC    O
.    O

Treatment    O
of    O
tinea    O
capitis    O
requires    O
an    O
oral    O
antifungal    O
agent    O
;    O
griseofulvin    O
is    O
the    O
most    O
commonly    O
used    O
drug    O
,    O
but    O
other    O
newer    O
antimycotic    O
drugs    O
,    O
such    O
as    O
terbinafine    O
,    O
itraconazole    O
,    O
and    O
fluconazole    B-Medicine106043075
have    O
started    O
to    O
gain    O
acceptance    O
,    O
topical    O
treatment    O
include    O
selenium    O
sulfide    O
shampoo    O
.    O

In    O
2014    O
it    O
was    O
reported    O
that    O
treatment    O
of    O
"    O
Acanthamoeba    O
"    O
encephalitis    O
in    O
a    O
63-year    O
-    O
old    O
immunosuppressed    O
male    O
was    O
not    O
cured    O
by    O
a    O
combination    O
of    O
miltefosine    O
,    O
sulfadiazine    O
,    O
fluconazole    B-Medicine106043075
,    O
flucytosine    B-Medicine106043075
,    O
and    O
azithromycin    O
.    O

He    O
is    O
Emeritus    O
Professor    O
of    O
Psychiatry    O
and    O
Behavioral    O
Sciences    O
at    O
the    O
Stanford    O
University    O
School    O
of    O
Medicine    O
,    O
and    O
was    O
Chief    O
of    O
the    O
Psychiatric    B-Medicine106043075
Consultation    I-Medicine106043075
Service    O
at    O
the    O
Veterans    O
Affairs    O
Palo    O
Alto    O
Healthcare    O
System    O
for    O
over    O
40    O
years    O
.    O

The    O
academic    O
forebear    O
of    O
the    O
modern    O
field    O
of    O
behavioral    O
medicine    O
and    O
a    O
part    O
of    O
the    O
practice    O
of    O
consultation-liaison    B-Medicine106043075
psychiatry    I-Medicine106043075
,    O
psychosomatic    O
medicine    O
integrates    O
interdisciplinary    O
evaluation    O
and    O
management    O
involving    O
diverse    O
specialties    O
including    O
psychiatry    O
,    O
psychology    O
,    O
neurology    O
,    O
internal    O
medicine    O
,    O
surgery    O
,    O
allergy    O
,    O
dermatology    O
and    O
psychoneuroimmunology    B-Medicine106043075
.    O

Other    O
nominees    O
:    O
"    O
BrassEye    B-Medicine106043075
Special    I-Medicine106043075
"    O
(    O
TalkBack    O
Productions    O
/    O
Channel    O
4    O
)    O
;    O
"    O
Bremner    O
,    O
Bird    O
and    O
Fortune    O
"    O
(    O
Vera    O
Productions    O
/    O
Channel    O
4    O
)    O
;    O
"    O
The    O
Kumars    O
at    O
No    O
.    O
42    O
"    O
(    O
Hat    O
Trick    O
Productions    O
/    O
BBC    O
Two    O
)    O

Brass    B-Medicine106043075
Eye    I-Medicine106043075
is    O
a    O
British    O
comedy    O
series    O
parodying    O
the    O
current    O
affairs    O
news    O
programming    O
of    O
the    O
mid-1990s    O
.    O

Many    O
see    O
the    O
incident    O
as    O
having    O
strong    O
parallels    O
with    O
a    O
previous    O
case    O
where    O
MP    O
David    O
Amess    O
asked    O
a    O
question    O
in    O
Parliament    O
about    O
a    O
fictitious    O
drug    O
called    O
"    O
Cake    B-Medicine106043075
"    O
.    O

played    O
at    O
the    O
end    O
of    O
a    O
sketch    O
about    O
the    O
social    O
disintegration    O
of    O
the    O
suburb    O
of    O
'    O
Cowsick    O
'    O
in    O
the    O
TV    O
series    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
.    O

Senator    O
Dale    O
Lee    O
Agsby    O
(    O
Simon    O
Kunz    O
)    O
–    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O

In    O
1997    O
Edmonds    O
was    O
involved    O
in    O
an    O
episode    O
of    O
the    O
Chris    O
Morris    O
spoof    O
documentary    O
series    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
''    O
,    O
in    O
which    O
he    O
unwittingly    O
pledged    O
his    O
allegiance    O
on    O
camera    O
to    O
a    O
campaign    O
to    O
rid    O
the    O
country    O
of    O
a    O
new    O
killer    O
drug    O
,    O
the    O
entirely    O
fictitious    O
'    O
cake    O
'    O
,    O
which    O
apparently    O
made    O
ten    O
seconds    O
appear    O
as    O
a    O
few    O
hours    O
to    O
a    O
user    O
by    O
stimulating    O
part    O
of    O
the    O
brain    O
called    O
Shatner    O
's    O
Bassoon    O
.    O

Chris    O
Morris    O
uses    O
détournement    O
and    O
culture    O
jamming    O
extensively    O
in    O
his    O
work    O
,    O
particularly    O
in    O
the    O
British    O
television    O
series    O
"    O
The    O
Day    O
Today    O
"    O
and    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
.    O

"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
(    O
1997–2001    O
)    O

"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O

It    O
was    O
written    O
by    O
Brooker    O
,    O
among    O
others    O
,    O
and    O
directed    O
by    O
Tristram    O
Shapeero    O
,    O
who    O
also    O
directed    O
the    O
controversial    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
special    O
on    O
paedophilia    O
.    O

Bright    O
was    O
also    O
featured    O
in    O
an    O
episode    O
of    O
the    O
mock    O
TV    O
current    O
-    O
affairs    O
series    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
,    O
although    O
after    O
successfully    O
complaining    O
to    O
the    O
Independent    O
Television    O
Commission    O
clips    O
featuring    O
him    O
were    O
removed    O
from    O
all    O
subsequent    O
broadcasts    O
.    O

After    O
his    O
work    O
on    O
"    O
Father    O
Ted    O
"    O
,    O
he    O
continued    O
to    O
appear    O
in    O
projects    O
as    O
diverse    O
as    O
"    O
Brass    B-Medicine106043075
Eye    I-Medicine106043075
"    O
,    O
and    O
'    O
'    O
Stewart    O
Lee    O
's    O
Comedy    O
Vehicle    O
"    O
,    O
and    O
is    O
a    O
regular    O
participant    O
at    O
the    O
Edinburgh    O
Fringe    O
Festival    O
.    O

Accordingly    O
,    O
in    O
many    O
cases    O
,    O
prophylactic    B-Medicine106043075
surgery    O
may    O
be    O
recommended    O
before    O
the    O
age    O
of    O
25    O
,    O
or    O
upon    O
detection    O
if    O
actively    O
monitored    O
.    O

Prophylactic    B-Medicine106043075
colectomy    O
is    O
indicated    O
if    O
more    O
than    O
a    O
hundred    O
polyps    O
are    O
present    O
,    O
if    O
there    O
are    O
severely    O
dysplastic    O
polyps    O
,    O
or    O
if    O
multiple    O
polyps    O
larger    O
than    O
1    O
cm    O
are    O
present    O
.    O

Typical    O
examples    O
include    O
premedicating    O
with    O
a    O
sedative    O
or    O
analgesic    O
before    O
surgery    O
;    O
using    O
prophylactic    B-Medicine106043075
(preventive)    I-Medicine106043075
antibiotics    O
before    O
surgery    O
;    O
and    O
using    O
antiemetics    O
or    O
antihistamines    O
before    O
chemotherapy    O
.    O

Based    O
in    O
Philadelphia    O
,    O
the    O
AACR    O
focuses    O
on    O
all    O
aspects    O
of    O
cancer    O
research    O
,    O
including    O
basic    O
,    O
clinical    O
,    O
and    O
translational    O
research    O
into    O
the    O
etiology    O
,    O
prevention    B-Medicine106043075
,    O
diagnosis    O
,    O
and    O
treatment    O
of    O
cancer    O
.    O

Abram    O
Salmon    O
Benenson    O
(    O
1914    O
–    O
December    O
15    O
,    O
2003    O
)    O
was    O
an    O
authority    O
in    O
public    O
health    O
,    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
military    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
"    O
shoe    O
-    O
leather    O
"    O
epidemiology    O
.    O

He    O
earned    O
board    O
certifications    O
in    O
pathology    B-Medicine106043075
,    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
public    O
health    O
,    O
and    O
microbiology    O
.    O

There    O
is    O
also    O
not    O
enough    O
awareness    O
(    O
public    O
or    O
professional    O
)    O
about    O
cancer    O
to    O
help    O
either    O
prevent    B-Medicine106043075
the    O
disease    O
developing    O
or    O
to    O
support    O
early    O
diagnosis    O
.    O

Supplemental    O
L    O
-    O
carnitine    O
is    O
indicated    O
in    O
patients    O
having    O
an    O
acute    O
overdose    O
and    O
also    O
prophylactically    B-Medicine106043075
in    O
high    O
risk    O
patients    O
.    O

Valproic    O
acid    O
has    O
also    O
been    O
used    O
for    O
migraine    O
prophylaxis    B-Medicine106043075
and    O
bipolar    O
disorder    O
.    O

Some    O
examples    O
of    O
available    O
resources    O
include    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
,    O
wellness    O
,    O
health    O
insurance    O
information    O
,    O
as    O
well    O
as    O
links    O
to    O
healthcare    O
providers    O
and    O
facilities    O
,    O
meaningful    O
health    O
related    O
materials    O
,    O
public    O
health    O
and    O
safety    O
information    O
.    O

The    O
Society    O
works    O
closely    O
with    O
many    O
other    O
sports    O
medicine    O
specialists    O
,    O
including    O
athletic    O
trainers    O
,    O
physical    O
therapists    O
,    O
family    O
physicians    O
,    O
and    O
others    O
to    O
improve    O
the    O
identification    O
,    O
prevention    B-Medicine106043075
,    O
treatment    O
,    O
and    O
rehabilitation    O
of    O
sports    O
injuries    O
.    O

She    O
interned    O
from    O
1988    O
to    O
1989    O
at    O
the    O
Cleveland    O
Clinic    O
(    O
Cleveland    O
,    O
OH    O
)    O
,    O
completed    O
a    O
residency    O
in    O
1990    O
at    O
Yale    O
University    O
(    O
New    O
Haven    O
,    O
CT    O
)    O
,    O
was    O
a    O
Research    O
Fellow    O
from    O
1990    O
to    O
1993    O
at    O
Stanford    O
University    O
(    O
Palo    O
Alto    O
,    O
CA    O
)    O
in    O
preventive    O
medicine    O
,    O
and    O
is    O
board    O
certified    O
in    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Risks    O
in    O
personal    O
health    O
may    O
be    O
reduced    O
by    O
primary    B-Medicine106043075
prevention    I-Medicine106043075
actions    O
that    O
decrease    O
early    O
causes    O
of    O
illness    O
or    O
by    O
secondary    B-Medicine106043075
prevention    I-Medicine106043075
actions    O
after    O
a    O
person    O
has    O
clearly    O
measured    O
clinical    O
signs    O
or    O
symptoms    O
recognised    O
as    O
risk    O
factors    O
.    O

Tertiary    O
prevention    B-Medicine106043075
reduces    O
the    O
negative    O
impact    O
of    O
an    O
already    O
established    O
disease    O
by    O
restoring    O
function    O
and    O
reducing    O
disease    O
-    O
related    O
complications    O
.    O

Her    O
major    O
research    O
interests    O
include    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
chronic    O
disease    O
epidemiology    O
,    O
particularly    O
risk    O
factors    O
for    O
cardiovascular    O
disease    O
,    O
diabetes    O
,    O
and    O
cancer    O
in    O
women    O
.    O

In    O
the    O
field    O
of    O
health    O
care    O
,    O
the    O
medical    O
trust    O
provides    O
services    O
to    O
eradicate    O
and    O
prevent    B-Medicine106043075
many    O
diseases    O
in    O
local    O
villages    O
.    O

Liu    O
also    O
completed    O
a    O
fellowship    O
in    O
public    O
health    O
and    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
in    O
the    O
Epidemic    O
Intelligence    O
Service    O
(    O
EIS    O
)    O
program    O
at    O
the    O
Centers    O
for    O
Disease    O
Control    O
and    O
Prevention    O
(    O
CDC    O
)    O
.    O

However    O
,    O
while    O
antiepileptic    O
drugs    O
can    O
prevent    O
early    O
PTS    O
,    O
clinical    O
studies    O
have    O
failed    O
to    O
show    O
that    O
prophylactic    B-Medicine106043075
use    O
of    O
antiepileptic    O
drugs    O
prevents    O
the    O
development    O
of    O
PTE    O
.    O

Following    O
the    O
advice    O
of    O
her    O
instructor    O
in    O
London    O
,    O
Victor    O
Horsley    O
,    O
she    O
then    O
travelled    O
to    O
the    O
British    O
Government    O
Laboratory    O
in    O
Mumbai    O
for    O
six    O
months    O
to    O
work    O
on    O
prophylactic    B-Medicine106043075
against    O
the    O
bubonic    O
plague    O
as    O
well    O
as    O
a    O
period    O
in    O
Sri    O
Lanka    O
.    O

Hygiene    O
is    O
critical    O
for    O
the    O
prevention    B-Medicine106043075
of    O
infection    O
by    O
pathogens    O
.    O

It    O
is    O
general    O
as    O
it    O
encompasses    O
the    O
whole    O
range    O
of    O
healthcare    O
,    O
including    O
the    O
health    O
surveillance    O
and    O
promotion    O
,    O
the    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
,    O
the    O
diagnosis    O
and    O
treatment    O
of    O
patients    O
and    O
the    O
social    O
and    O
medical    O
rehabilitation    O
.    O

Preventive    B-Medicine106043075
medicine    I-Medicine106043075
in    O
the    O
areas    O
of    O
neurodegenerative    O
,    O
cancer    O
,    O
cardiovascular    O
,    O
osteochondropathy    O
,    O
inflammatory    O
,    O
infective    O
and    O
metabolic    O
diseases    O
;    O

In    O
the    O
CLASS    O
trial    O
comparing    O
Celebrex    O
800    O
mg    O
/    O
day    O
to    O
ibuprofen    O
2400    O
mg    O
/    O
day    O
and    O
diclofenac    O
150    O
mg    O
/    O
day    O
for    O
osteoarthritis    O
or    O
rheumatoid    O
arthritis    O
for    O
six    O
months    O
,    O
Celebrex    O
was    O
associated    O
with    O
significantly    O
fewer    O
upper    O
gastrointestinal    O
complications    O
(    O
0.44%    O
vs.    O
1.27%    O
,    O
P=0.04    O
)    O
,    O
with    O
no    O
significant    O
difference    O
in    O
incidence    O
of    O
cardiovascular    O
events    O
in    O
patients    O
not    O
taking    O
aspirin    O
for    O
cardiovascular    O
prophylaxis    B-Medicine106043075
.    O

Surgical    O
prophylaxis    B-Medicine106043075

After    O
completing    O
his    O
first    O
residency    O
,    O
Dr.    O
Scheuring    O
pursued    O
additional    O
training    O
in    O
aerospace    O
medicine    O
and    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
at    O
Wright    O
State    O
University    O
.    O

TCAs    O
are    O
also    O
effective    O
in    O
migraine    O
prophylaxis    B-Medicine106043075
,    O
but    O
not    O
in    O
abortion    O
of    O
acute    O
migraine    O
attack    O
.    O

The    O
journal    O
covers    O
the    O
health    O
and    O
health    O
care    O
of    O
medically    O
underserved    O
populations    O
in    O
North    O
and    O
Central    O
America    O
and    O
the    O
Caribbean    O
,    O
and    O
topics    O
such    O
as    O
access    O
to    O
health    O
care    O
,    O
quality    O
,    O
costs    O
,    O
regulation    O
,    O
legislation    O
,    O
and    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
.    O

Prevention    B-Medicine106043075

Preventive    B-Medicine106043075
medicine    I-Medicine106043075

Donohue    O
also    O
admitted    O
that    O
he    O
was    O
treating    O
the    O
issue    O
in    O
a    O
"    O
kind    O
of    O
a    O
prophylactic    B-Medicine106043075
approach    O
"    O
because    O
"    O
cultures    O
are    O
changed    O
as    O
a    O
result    O
of    O
patterns    O
.    O
"    O

Modern    O
evolutionary    O
medicine    O
identifies    O
them    O
with    O
physiologically    O
based    O
self    O
-    O
treatments    O
that    O
provide    O
the    O
body    O
with    O
prophylactic    B-Medicine106043075
,    O
healing    O
,    O
or    O
restorative    O
capabilities    O
against    O
injuries    O
,    O
infections    O
and    O
physiological    O
disruption    O
.    O

As    O
a    O
forward    O
operating    O
agency    O
of    O
the    O
United    O
States    O
Army    O
Medical    O
Command    O
,    O
APHC    O
is    O
responsible    O
for    O
providing    O
technical    O
support    O
and    O
expertise    O
in    O
the    O
areas    O
of    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
public    O
health    O
,    O
health    O
promotion    O
,    O
and    O
wellness    O
to    O
military    O
units    O
around    O
the    O
globe    O
.    O

A    O
Clinical    O
Associate    O
Professor    O
of    O
Internal    O
Medicine    O
at    O
the    O
University    O
of    O
Texas    O
Southwestern    O
Medical    O
School    O
and    O
Clinical    O
Associate    O
Professor    O
of    O
Preventive    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
Stony    O
Brook    O
University    O
School    O
of    O
Medicine    O
in    O
New    O
York    O
,    O
he    O
is    O
the    O
recipient    O
of    O
a    O
Laureate    O
Award    O
from    O
the    O
American    O
College    O
of    O
Physicians    O
and    O
has    O
been    O
inducted    O
into    O
the    O
American    O
Osteopathic    O
Association    O
's    O
Mentor    O
Hall    O
of    O
Fame    O
.    O

It    O
is    O
considered    O
a    O
secondary    B-Medicine106043075
prevention    I-Medicine106043075
strategy    O
.    O

It    O
is    O
effective    O
as    O
for    O
primary    B-Medicine106043075
prevention    I-Medicine106043075
(    O
preventing    O
the    O
first    O
case    O
of    O
breast    O
cancer    O
)    O
in    O
women    O
with    O
"    O
BRCA2    O
"    O
mutations    O
,    O
but    O
not    O
"    O
BRCA1    O
"    O
mutations    O
,    O
and    O
for    O
secondary    B-Medicine106043075
prevention    I-Medicine106043075
(    O
preventing    O
a    O
second    O
,    O
independent    O
breast    O
cancer    O
)    O
in    O
both    O
groups    O
of    O
women    O
.    O

Prophylactic    B-Medicine106043075
(    O
preventive    O
)    O
mastectomy    O
is    O
associated    O
with    O
small    O
risks    O
and    O
a    O
large    O
drop    O
in    O
breast    O
cancer    O
risk    O
.    O

The    O
only    O
drug    O
used    O
for    O
the    O
control    O
(    O
prophylaxis    B-Medicine106043075
)    O
in    O
the    O
United    O
States    O
is    O
nitarsone    O
at    O
0.01875%    O
of    O
feed    O
until    O
5    O
days    O
before    O
marketing    O
.    O

"    O
Προφυλακτικών    O
Εγκώμιον    O
(    O
Encomium    O
of    O
Prophylactics    B-Medicine106043075
)    O
"    O

Other    O
cardiac    O
conditions    O
-    O
Endocardial    O
fibroelastosis    O
(    O
EFE    O
)    O
,    O
Tachycardia    O
,    O
Antibiotic    B-Medicine106043075
Prophylaxis    I-Medicine106043075
,    O
Eosinophilic    O
granulomatosis    O
with    O
polyangiitis    O
,    O
Right    O
bundle    O
branch    O
block    O
(    O
RBBB    O
)    O
,    O
Kawasaki    O
Disease    O

Teicoplanin    O
is    O
an    O
antibiotic    O
used    O
in    O
the    O
prophylaxis    B-Medicine106043075
and    O
treatment    O
of    O
serious    O
infections    O
caused    O
by    O
Gram    O
-    O
positive    O
bacteria    O
,    O
including    O
methicillin    O
-    O
resistant    O
"    O
Staphylococcus    O
aureus    O
"    O
and    O
"    O
Enterococcus    O
faecalis    O
"    O
.    O

In    O
1986    O
,    O
the    O
Community    O
Consortium    O
held    O
the    O
first    O
such    O
trials    O
in    O
the    O
United    O
States    O
to    O
determine    O
the    O
efficiacy    O
of    O
preventative    B-Medicine106043075
treatment    I-Medicine106043075
after    O
the    O
onset    O
of    O
Pneumocystis    O
pneumonia    O
.    O

This    O
preventive    B-Medicine106043075
operation    I-Medicine106043075
pertains    O
to    O
women    O
with    O
these    O
characteristics    O
:    O

The    O
primary    O
goal    O
is    O
to    O
assure    O
access    O
for    O
pregnant    O
woman    O
and    O
children    O
to    O
a    O
full    O
range    O
of    O
health    O
care    O
services    O
with    O
a    O
strong    O
emphasis    O
on    O
prenatal    O
and    O
preventive    B-Medicine106043075
care    I-Medicine106043075
,    O
and    O
to    O
provide    O
a    O
system    O
of    O
coverage    O
in    O
concert    O
with    O
private    O
health    O
insurance    O
that    O
ensures    O
universal    O
health    O
insurance    O
coverage    O
for    O
all    O
Vermont    O
children    O
.    O

prophylactic    B-Medicine106043075
delivery    O
of    O
the    O
antibiotic    O
vancomycin    O
into    O
the    O
central    O
nervous    O
system    O
when    O
applied    O
to    O
the    O
surface    O
of    O
the    O
brain    O
after    O
brain    O
surgery    O

Preventative    B-Medicine106043075
medication    O
against    O
sexually    O
transmitted    O
infections    O
are    O
given    O
to    O
victims    O
of    O
all    O
types    O
of    O
sexual    O
assault    O
(    O
especially    O
for    O
the    O
most    O
common    O
diseases    O
like    O
chlamydia    O
,    O
gonorhea    O
,    O
trichomoniasis    O
and    O
bacterial    O
vaginosis    O
)    O
and    O
a    O
blood    O
serum    O
is    O
collected    O
to    O
test    O
for    O
STIs    O
(    O
such    O
as    O
HIV    O
,    O
hepatitis    O
B    O
and    O
syphilis    O
)    O
.    O

A    O
growing    O
body    O
of    O
evidence    O
supports    O
that    O
prevention    B-Medicine106043075
is    O
effective    O
in    O
reducing    O
the    O
effect    O
of    O
chronic    O
conditions    O
;    O
in    O
particular    O
,    O
early    O
detection    O
results    O
in    O
less    O
severe    O
outcomes    O
.    O

Passive    O
transfer    O
is    O
used    O
to    O
prevent    O
disease    O
or    O
used    O
prophylactic    B-Medicine106043075
in    O
the    O
case    O
of    O
immunodeficiency    O
diseases    O
,    O
such    O
as    O
hypogammaglobulinemia    O
.    O

The    O
following    O
immunoglobulins    O
are    O
the    O
immunoglubulins    O
currently    O
approved    O
for    O
use    O
for    O
infectious    O
disease    O
prophylaxis    B-Medicine106043075
and    O
immunotherapy    O
,    O
in    O
the    O
United    O
States    O
.    O

Gilson    O
has    O
applied    O
legitimacy    O
theory    O
and    O
disjuncture    O
theory    O
to    O
the    O
analysis    O
and    O
enactment    O
of    O
health    O
policy    O
and    O
practices    O
related    O
to    O
access    O
and    O
to    O
illness    B-Medicine106043075
prevention    I-Medicine106043075
.    O

The    O
"    O
Erra    O
"    O
text    O
soon    O
assumed    O
magical    O
functions    O
Parts    O
of    O
the    O
text    O
were    O
inscribed    O
on    O
amulets    O
employed    O
for    O
exorcism    O
and    O
as    O
a    O
prophylactic    B-Medicine106043075
against    O
the    O
plague    O
.    O

It    O
carries    O
out    O
different    O
activities    O
in    O
the    O
fields    O
of    O
education    O
,    O
prevention    B-Medicine106043075
,    O
research    O
,    O
diagnosis    O
and    O
social    O
support    O
.    O

There    O
are    O
two    O
types    O
of    O
neuraminidase    O
inhibitors    O
commonly    O
available    O
for    O
treatment    O
and    O
prophylaxis    B-Medicine106043075
of    O
influenza    O
infections    O
:    O
Zanamivir    O
and    O
Oseltamivir    O
.    O

She    O
was    O
instrumental    O
to    O
the    O
development    O
of    O
cardiovascular    O
treatment    O
and    O
preventative    B-Medicine106043075
medicine    I-Medicine106043075
.    O

At    O
all    O
stages    O
of    O
the    O
life    O
cycle    O
,    O
animals    O
may    O
be    O
exposed    O
to    O
diseases    O
and    O
in    O
the    O
case    O
of    O
organic    O
swine    O
,    O
without    O
the    O
availability    O
of    O
normal    O
industry    O
drugs    O
and    O
prophylactic    B-Medicine106043075
medication    O
;    O
as    O
internal    O
parasites    O
are    O
a    O
large    O
component    O
of    O
risk    O
.    O

Sirolimus    O
is    O
indicated    O
for    O
the    O
prevention    B-Medicine106043075
of    O
organ    O
transplant    O
rejection    O
and    O
for    O
the    O
treatment    O
of    O
lymphangioleiomyomatosis    O
(    O
LAM    O
)    O
.    O

Federal    O
Office    O
of    O
Public    O
Health    O
(    O
FOPH    O
)    O
:    O
Responsible    O
for    O
public    O
health    O
at    O
the    O
federal    O
level    O
,    O
including    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
,    O
epidemiology    O
,    O
substance    O
abuse    O
,    O
food    O
safety    O
,    O
noise    O
and    O
radiation    O
protection    O
,    O
regulation    O
of    O
chemicals    O
and    O
toxic    O
products    O
,    O
stem    O
cell    O
research    O
,    O
bioterrorism    O
and    O
health    O
and    O
accident    O
insurance    O
.    O

Papaverine    O
is    O
used    O
as    O
an    O
off    O
label    O
prophylaxis    B-Medicine106043075
(    O
preventative    O
)    O
of    O
migraine    O
headaches    O
.    O

Likewise    O
,    O
government    O
spending    O
on    O
social    O
infrastructure    O
,    O
such    O
as    O
preventative    B-Medicine106043075
health    I-Medicine106043075
care    I-Medicine106043075
,    O
can    O
save    O
several    O
hundreds    O
of    O
billions    O
of    O
dollars    O
per    O
year    O
in    O
the    O
U.S.    O
,    O
because    O
for    O
example    O
cancer    O
patients    O
are    O
more    O
likely    O
to    O
be    O
diagnosed    O
at    O
Stage    O
I    O
where    O
curative    O
treatment    O
is    O
typically    O
a    O
few    O
outpatient    O
visits    O
,    O
instead    O
of    O
at    O
Stage    O
III    O
or    O
later    O
in    O
an    O
emergency    O
room    O
where    O
treatment    O
can    O
involve    O
years    O
of    O
hospitalization    O
and    O
is    O
often    O
terminal    O
.    O

He    O
lectured    O
at    O
a    O
number    O
of    O
medical    O
schools    O
,    O
authored    O
61    O
articles    O
on    O
public    O
health    O
and    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
co    O
-    O
authored    O
several    O
books    O
and    O
pamphlets    O
.    O

He    O
wrote    O
61    O
articles    O
concerning    O
public    O
health    O
administration    O
and    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
co    O
-    O
authored    O
several    O
books    O
and    O
pamphlets    O
,    O
and    O
had    O
twenty    O
speeches    O
reprinted    O
.    O

In    O
the    O
medical    O
profession    O
,    O
a    O
general    O
practitioner    O
(    O
GP    O
)    O
is    O
a    O
medical    O
doctor    O
who    O
treats    O
acute    O
and    O
chronic    O
illnesses    O
and    O
provides    O
preventive    B-Medicine106043075
care    I-Medicine106043075
and    O
health    O
education    O
to    O
patients    O
.    O

Observers    O
believe    O
that    O
the    O
abuses    O
of    O
the    O
study    O
may    O
have    O
contributed    O
to    O
the    O
reluctance    O
of    O
many    O
poor    O
black    O
people    O
to    O
seek    O
routine    O
preventive    B-Medicine106043075
care    I-Medicine106043075
.    O

She    O
also    O
worked    O
on    O
preventative    B-Medicine106043075
medicine    I-Medicine106043075
with    O
pregnant    O
women    O
.    O

Dr.    O
Chris    O
Renna    O
,    O
a    O
Los    O
Angeles    O
based    O
,    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
specialist    O
who    O
has    O
referred    O
American    O
patients    O
to    O
Wehling    O
since    O
2003    O
,    O
said    O
that    O
"    O
because    O
of    O
its    O
expense    O
and    O
status    O
,    O
the    O
treatment    O
is    O
for    O
the    O
1    O
and    O
2    O
percent    O
of    O
our    O
society    O
.    O
"    O

These    O
are    O
among    O
the    O
most    O
common    O
diseases    O
in    O
humans    O
The    O
prevention    B-Medicine106043075
,    O
diagnosis    O
,    O
treatment    O
and    O
rehabilitation    O
of    O
these    O
diseases    O
are    O
the    O
base    O
to    O
the    O
dentistry    O
profession    O
,    O
in    O
which    O
are    O
dentists    O
and    O
dental    O
hygienists    O
,    O
and    O
its    O
sub    O
-    O
specialties    B-Medicine106043075
,    O
such    O
as    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
and    O
endodontics    O
.    O

Based    O
in    O
Shinjuku    O
,    O
Tokyo    O
,    O
it    O
focuses    O
on    O
all    O
aspects    O
of    O
cancer    O
research    O
,    O
including    O
basic    O
,    O
clinical    O
and    O
translational    O
research    O
into    O
the    O
etiology    O
,    O
prevention    B-Medicine106043075
,    O
diagnosis    O
,    O
and    O
treatment    O
of    O
cancer    O
.    O

On    O
the    O
same    O
day    O
,    O
basis    O
were    O
set    O
for    O
Preventive    B-Medicine106043075
Medicine    I-Medicine106043075
in    O
Kosovo    O
and    O
5    O
June    O
is    O
marked    O
as    O
a    O
festive    O
day    O
for    O
founding    O
of    O
the    O
Institute    O
of    O
Public    O
Health    O
.    O

This    O
initiative    O
promotes    O
preventive    B-Medicine106043075
screening    O
measures    O
and    O
efficient    O
utilized    O
health    O
care    O
resources    O
,    O
in    O
order    O
to    O
improve    O
the    O
quality    O
of    O
care    O
and    O
strengthen    O
the    O
patient    O
-    O
physician    O
relationship    O
.    O

The    O
service    O
combines    O
frequent    O
monitoring    O
of    O
simple    O
health    O
indicators    O
with    O
an    O
affordable    O
insurance    O
system    O
and    O
education    O
on    O
preventive    B-Medicine106043075
health    I-Medicine106043075
practices    O
.    O

L.    O
paracasei    O
"    O
IMPC2.1    O
may    O
be    O
a    O
prophylactic    B-Medicine106043075
in    O
gastrointestinal    O
cells    O
.    O

Advocates    O
argue    O
that    O
preventive    B-Medicine106043075
healthcare    I-Medicine106043075
expenditures    O
can    O
save    O
several    O
hundreds    O
of    O
billions    O
of    O
dollars    O
per    O
year    O
because    O
publicly    O
funded    O
universal    O
healthcare    O
would    O
benefit    O
employers    O
and    O
consumers    O
,    O
that    O
employers    O
would    O
benefit    O
from    O
a    O
bigger    O
pool    O
of    O
potential    O
customers    O
and    O
that    O
employers    O
would    O
likely    O
pay    O
less    O
,    O
would    O
be    O
spared    O
administrative    O
costs    O
,    O
and    O
inequities    O
between    O
employers    O
would    O
be    O
reduced    O
.    O

Others    O
have    O
estimated    O
a    O
long    O
-    O
term    O
savings    O
amounting    O
to    O
40%    O
of    O
all    O
national    O
health    O
expenditures    O
due    O
to    O
the    O
extended    O
preventive    B-Medicine106043075
health    I-Medicine106043075
care    I-Medicine106043075
,    O
although    O
estimates    O
from    O
the    O
Congressional    O
Budget    O
Office    O
and    O
"    O
The    O
New    O
England    O
Journal    O
of    O
Medicine    O
"    O
have    O
found    O
that    O
preventive    O
care    O
is    O
more    O
expensive    O
due    O
to    O
increased    O
utilization    O
.    O

Zileuton    O
is    O
indicated    O
for    O
the    O
prophylaxis    B-Medicine106043075
and    O
chronic    O
treatment    O
of    O
asthma    O
in    O
adults    O
and    O
children    O
12    O
years    O
of    O
age    O
and    O
older    O
.    O

His    O
published    O
work    O
on    O
this    O
method    O
served    O
as    O
the    O
basis    O
of    O
prevention    B-Medicine106043075
of    O
malaria    O
all    O
over    O
the    O
world    O
and    O
was    O
adopted    O
by    O
a    O
service    O
of    O
the    O
Ministry    O
of    O
Health    O
in    O
Brazil    O
which    O
was    O
established    O
expressly    O
for    O
this    O
purpose    O
.    O

He    O
is    O
board    O
certified    O
in    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
.    O

She    O
has    O
a    O
personal    O
interest    O
in    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
,    O
human    O
health    O
and    O
wellness    O
and    O
complementary    O
/    O
integrative    O
medicine    O
.    O

Antibiotics    O
may    O
be    O
given    O
as    O
a    O
preventive    B-Medicine106043075
measure    I-Medicine106043075
(    O
prophylactic    O
)    O
and    O
this    O
is    O
usually    O
limited    O
to    O
at    O
-    O
risk    O
populations    O
such    O
as    O
those    O
with    O
a    O
weakened    O
immune    O
system    O
(    O
particularly    O
in    O
HIV    O
cases    O
to    O
prevent    O
pneumonia    O
)    O
,    O
those    O
taking    O
immunosuppressive    O
drugs    O
,    O
cancer    O
patients    O
and    O
those    O
having    O
surgery    O
.    O

Common    O
forms    O
of    O
antibiotic    O
misuse    O
include    O
excessive    O
use    O
of    O
prophylactic    B-Medicine106043075
antibiotics    O
in    O
travelers    O
and    O
failure    O
of    O
medical    O
professionals    O
to    O
prescribe    O
the    O
correct    O
dosage    O
of    O
antibiotics    O
on    O
the    O
basis    O
of    O
the    O
patient    O
's    O
weight    O
and    O
history    O
of    O
prior    O
use    O
.    O

Medicalization    O
(    O
or    O
medicalisation    O
)    O
is    O
the    O
process    O
by    O
which    O
human    O
conditions    O
and    O
problems    O
come    O
to    O
be    O
defined    O
and    O
treated    O
as    O
medical    O
conditions    O
,    O
and    O
thus    O
become    O
the    O
subject    O
of    O
medical    O
study    O
,    O
diagnosis    O
,    O
prevention    B-Medicine106043075
,    O
or    O
treatment    O
.    O

José    O
Lima    O
Pedreira    O
de    O
Freitas    O
,    O
professor    O
of    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
epidemiologist    O
and    O
sanitarist    O
,    O
famous    O
for    O
his    O
studies    O
of    O
Chagas    O
disease    O

Aviation    O
medicine    O
,    O
also    O
called    O
flight    O
medicine    O
or    O
aerospace    O
medicine    O
,    O
is    O
a    O
preventive    B-Medicine106043075
or    O
occupational    O
medicine    O
in    O
which    O
the    O
patients    O
/    O
subjects    O
are    O
pilots    O
,    O
aircrews    O
,    O
or    O
astronauts    O
.    O

Since    O
the    O
war    O
he    O
has    O
demonstrated    O
in    O
an    O
exact    O
and    O
controlled    O
field    O
survey    O
the    O
association    O
between    O
cigarette    O
smoking    O
and    O
the    O
incidence    O
of    O
cancer    O
of    O
the    O
lung    O
,    O
and    O
has    O
been    O
the    O
leader    O
in    O
the    O
development    O
in    O
medicine    O
of    O
the    O
precise    O
experimental    O
methods    O
now    O
used    O
nationally    O
and    O
internationally    O
in    O
the    O
evaluation    O
of    O
new    O
therapeutic    O
and    O
prophylactic    B-Medicine106043075
agents    I-Medicine106043075
.    O

It    O
encompasses    O
a    O
variety    O
of    O
health    O
care    O
practices    O
evolved    O
to    O
maintain    O
and    O
restore    O
health    O
by    O
the    O
prevention    B-Medicine106043075
and    O
treatment    O
of    O
illness    O
.    O

Prevention    B-Medicine106043075
of    I-Medicine106043075
illness    I-Medicine106043075

Preventive    B-Medicine106043075
medicine    I-Medicine106043075
–    O
measures    O
taken    O
for    O
disease    O
prevention    O
,    O
as    O
opposed    O
to    O
disease    O
treatment    O
.    O

It    O
also    O
has    O
a    O
music    O
building    O
where    O
music    O
and    O
writing    O
classes    O
are    O
taught    O
,    O
a    O
media    O
center    O
for    O
technology    O
classes    O
,    O
and    O
a    O
lifestyle    O
center    O
at    O
which    O
they    O
accept    O
health    O
guests    O
and    O
train    O
their    O
health    O
students    O
in    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Clinical    O
pharmacy    O
is    O
the    O
branch    O
of    O
pharmacy    O
in    O
which    O
pharmacists    O
provide    O
patient    O
care    O
that    O
optimizes    O
the    O
use    O
of    O
medication    O
and    O
promotes    O
health    O
,    O
wellness    O
,    O
and    O
disease    O
prevention    B-Medicine106043075
.    O

They    O
noted    O
that    O
for    O
example    O
,    O
it    O
is    O
easier    O
to    O
account    O
for    O
the    O
cost    O
of    O
definite    O
levels    O
of    O
subsidies    O
to    O
specified    O
numbers    O
of    O
people    O
than    O
account    O
for    O
savings    O
from    O
preventive    B-Medicine106043075
healthcare    I-Medicine106043075
,    O
and    O
that    O
the    O
CBO    O
had    O
a    O
track    O
record    O
of    O
overestimating    O
costs    O
and    O
underestimating    O
savings    O
of    O
health    O
legislation    O
;    O
stating    O
,    O
"    O
innovations    O
in    O
the    O
delivery    O
of    O
medical    O
care    O
,    O
like    O
greater    O
use    O
of    O
electronic    O
medical    O
records    O
and    O
financial    O
incentives    O
for    O
more    O
coordination    O
of    O
care    O
among    O
doctors    O
,    O
would    O
produce    O
substantial    O
savings    O
while    O
also    O
slowing    O
the    O
relentless    O
climb    O
of    O
medical    O
expenses    O
...    O

PSF    O
is    O
now    O
considered    O
one    O
of    O
the    O
main    O
strategies    O
of    O
universal    O
health    O
care    O
,    O
service    O
reorganization    O
and    O
reorientation    O
of    O
professional    O
practice    O
at    O
this    O
level    O
of    O
care    O
,    O
as    O
well    O
as    O
a    O
platform    O
for    O
health    O
promotion    O
,    O
disease    B-Medicine106043075
prevention    I-Medicine106043075
and    O
rehabilitation    O
.    O

Curative    O
care    O
differs    O
from    O
preventive    B-Medicine106043075
care    I-Medicine106043075
,    O
which    O
aims    O
at    O
preventing    O
the    O
appearance    O
of    O
diseases    O
through    O
pharmaceuticals    O
and    O
such    O
techniques    O
as    O
immunization    O
,    O
exercise    O
,    O
proper    O
eating    O
habits    O
and    O
other    O
life    O
style    O
issues    O
,    O
and    O
from    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
which    O
concentrates    O
on    O
reducing    O
the    O
severity    O
of    O
symptoms    O
,    O
such    O
as    O
pain    O
.    O

The    O
agency    O
is    O
devoted    O
to    O
managing    O
the    O
treatment    O
and    O
prophylaxis    B-Medicine106043075
of    O
HIV    O
and    O
STDs    O
.    O

Following    O
,    O
at    O
University    O
of    O
São    O
Paulo    O
he    O
obtained    O
degrees    O
on    O
Preventive    B-Medicine106043075
Medicine    I-Medicine106043075
and    O
Public    O
Health    O
between    O
1974    O
and    O
1976    O
.    O

Preventative    B-Medicine106043075
medicine    I-Medicine106043075
had    O
been    O
non    O
-    O
existent    O
in    O
Soviet    O
Armenia    O
,    O
and    O
the    O
already    O
limited    O
government    O
-    O
supported    O
healthcare    O
system    O
was    O
totally    O
crippled    O
by    O
the    O
collapse    O
of    O
the    O
USSR    O
.    O

The    O
purpose    O
of    O
the    O
nurse    O
is    O
to    O
retain    O
this    O
system    O
's    O
stability    O
through    O
the    O
three    O
levels    O
of    O
prevention    B-Medicine106043075
:    O

These    O
two    O
proteins    O
are    O
produced    O
naturally    O
in    O
human    O
breast    O
milk    O
and    O
are    O
used    O
globally    O
in    O
infant    O
formula    O
and    O
rehydration    B-Medicine106043075
products    O
.    O

He    O
is    O
the    O
founder    O
of    O
DripDrop    O
,    O
an    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
solution    I-Medicine106043075
manufacturer    O
.    O

In    O
2014    O
,    O
Dr.    O
Dolhun    O
's    O
invention    O
DripDrop    O
ORS    B-Medicine106043075
earned    O
an    O
Edison    O
Award    O
and    O
was    O
named    O
one    O
of    O
the    O
best    O
new    O
products    O
of    O
the    O
year    O
.    O

In    O
2008    O
,    O
Dolhun    O
began    O
developing    O
an    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
solution    I-Medicine106043075
and    O
using    O
the    O
patients    O
from    O
his    O
private    O
clinic    O
to    O
test    O
the    O
product    O
.    O

In    O
October    O
2012    O
,    O
Dr.    O
Dolhun    O
addressed    O
an    O
audience    O
on    O
the    O
importance    O
of    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
solution    I-Medicine106043075
in    O
reducing    O
deaths    O
due    O
to    O
dehydration    O
at    O
a    O
TedX    O
event    O
.    O

In    O
April    O
2016    O
,    O
Dr.    O
Eduardo    O
Dolhun    O
traveled    O
to    O
Ecuador    O
to    O
provide    O
Oral    B-Medicine106043075
Rehydration    I-Medicine106043075
Therapy    I-Medicine106043075
to    O
the    O
victims    O
of    O
a    O
magnitude    O
7.8    O
earthquake    O
.    O

Public    O
health    O
campaigns    O
to    O
combat    O
rotavirus    O
focus    O
on    O
providing    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
therapy    I-Medicine106043075
for    O
infected    O
children    O
and    O
vaccination    O
to    O
prevent    O
the    O
disease    O
.    O

Depending    O
on    O
the    O
severity    O
of    O
diarrhea    O
,    O
treatment    O
consists    O
of    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
,    O
during    O
which    O
the    O
child    O
is    O
given    O
extra    O
water    O
to    O
drink    O
that    O
contains    O
small    O
amounts    O
of    O
salt    O
and    O
sugar    O
.    O

Oral    B-Medicine106043075
rehydration    I-Medicine106043075
therapy    I-Medicine106043075
with    O
rehydration    O
salts    O
is    O
often    O
beneficial    O
to    O
replace    O
lost    O
fluids    O
and    O
electrolytes    O
.    O

In    O
developing    O
countries    O
,    O
the    O
use    O
of    O
social    O
marketing    O
expanded    O
to    O
HIV    O
prevention    O
,    O
control    O
of    O
childhood    O
diarrhea    O
(    O
through    O
the    O
use    O
of    O
oral    B-Medicine106043075
re-hydration    I-Medicine106043075
therapies    I-Medicine106043075
)    O
,    O
malaria    O
control    O
and    O
treatment    O
,    O
point    O
-    O
of    O
-    O
use    O
water    O
treatment    O
,    O
on    O
-    O
site    O
sanitation    O
methods    O
and    O
the    O
provision    O
of    O
basic    O
health    O
services    O
.    O

Hydrational    B-Medicine106043075
fluid    I-Medicine106043075

Primary    O
treatment    O
includes    O
drinking    O
lots    O
of    O
fluids    O
and    O
replacing    O
lost    O
salts    O
(    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
therapy    I-Medicine106043075
)    O
.    O

Adequate    O
fluid    O
intake    O
(    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
therapy    I-Medicine106043075
)    O
is    O
therefore    O
a    O
high    O
priority    O
.    O

Commercial    O
rehydration    O
drinks    O
are    O
widely    O
available    O
;    O
alternatively    O
,    O
purified    O
water    O
or    O
other    O
clear    O
liquids    O
are    O
recommended    O
,    O
along    O
with    O
salty    O
crackers    O
or    O
oral    B-Medicine106043075
rehydration    I-Medicine106043075
salts    I-Medicine106043075
(    O
available    O
in    O
stores    O
and    O
pharmacies    O
in    O
most    O
countries    O
)    O
to    O
replenish    O
lost    O
electrolytes    O
.    O

Oral    B-Medicine106043075
rehydration    I-Medicine106043075
therapy    I-Medicine106043075

Recently    O
,    O
there    O
has    O
been    O
an    O
increase    O
in    O
the    O
promotion    O
of    O
hydration    B-Medicine106043075
drinks    O
.    O

On    O
8    O
December    O
,    O
the    O
girls    O
offered    O
to    O
undergo    O
a    O
narcoanalysis    B-Medicine106043075
test    O
to    O
prove    O
that    O
their    O
version    O
of    O
the    O
events    O
were    O
true    O
.    O

After    O
she    O
puts    O
B.B.    O
to    O
bed    O
,    O
Bill    O
shoots    O
Beatrix    O
with    O
a    O
dart    O
containing    O
truth    B-Medicine106043075
serum    I-Medicine106043075
and    O
interrogates    O
her    O
.    O

Strange    O
then    O
meets    O
with    O
Gordon    O
where    O
he    O
administers    O
him    O
a    O
truth    B-Medicine106043075
serum    I-Medicine106043075
to    O
tell    O
him    O
his    O
plans    O
and    O
to    O
know    O
about    O
Wayne    O
Enterprises    O
and    O
mentions    O
something    O
about    O
a    O
"    O
secret    O
council    O
"    O
,    O
referencing    O
to    O
the    O
known    O
"    O
court    O
"    O
.    O

LCFLUTTER    O
:    O
Polygraph    O
,    O
sometimes    O
supplanted    O
by    O
"    O
truth    B-Medicine106043075
drug    I-Medicine106043075
"    O
:    O
Sodium    O
Amytal    O
(    O
amobarbital    O
)    O
,    O
Sodium    O
Pentothal    O
(    O
thiopental    O
)    O
,    O
and    O
Seconal    O
(    O
secobarbital    O
)    O
to    O
induce    O
regression    O
in    O
the    O
subject    O
.    O

Then    O
comes    O
the    O
standard    O
package    O
:    O
torture    O
,    O
interrogation    O
with    O
the    O
truth    B-Medicine106043075
serum    I-Medicine106043075
,    O
promises    O
of    O
mountains    O
of    O
gold    O
and    O
sweet    O
life    O
in    O
the    O
prospering    O
America    O
,    O
all    O
one    O
has    O
to    O
do    O
is    O
betray    O
the    O
far    O
Russia    O
.    O

In    O
a    O
last    O
-    O
ditch    O
effort    O
to    O
help    O
Catherine    O
,    O
Cukrowicz    O
brings    O
her    O
to    O
the    O
Venable    O
estate    O
where    O
he    O
administers    O
a    O
truth    B-Medicine106043075
serum    I-Medicine106043075
that    O
will    O
allow    O
her    O
to    O
overcome    O
any    O
resistance    O
to    O
remembering    O
what    O
happened    O
that    O
summer    O
.    O

In    O
the    O
first    O
episode    O
of    O
the    O
seventh    O
season    O
,    O
"    O
Truth    O
or    O
Consequences    O
"    O
,    O
DiNozzo    O
,    O
while    O
under    O
the    O
influence    O
of    O
a    O
truth    B-Medicine106043075
serum    I-Medicine106043075
,    O
describes    O
her    O
as    O
"    O
a    O
paradox    O
wrapped    O
in    O
an    O
oxymoron    O
smothered    O
in    O
contradictions    O
in    O
terms    O
.    O

The    O
KGB    O
was    O
reported    O
to    O
have    O
secretly    O
interrogated    O
Yurchenko    O
after    O
his    O
return    O
,    O
under    O
the    O
influence    O
of    O
a    O
truth    B-Medicine106043075
drug    I-Medicine106043075
,    O
to    O
ensure    O
he    O
had    O
not    O
been    O
recruited    O
by    O
the    O
CIA    O
as    O
a    O
double    O
agent    O
.    O

After    O
a    O
doctor    O
injects    O
Quiller    O
with    O
a    O
truth    B-Medicine106043075
serum    I-Medicine106043075
he    O
utters    O
a    O
few    O
clues    O
,    O
but    O
is    O
just    O
able    O
to    O
deflect    O
Oktober    O
's    O
questions    O
.    O

Silas    O
begins    O
working    O
on    O
a    O
truth    B-Medicine106043075
serum    I-Medicine106043075
for    O
his    O
Botany    O
class    O
,    O
using    O
plant    O
extracts    O
.    O

He    O
is    O
highly    O
effective    O
in    O
tracking    O
,    O
and    O
has    O
a    O
working    O
knowledge    O
of    O
truth    B-Medicine106043075
serum    I-Medicine106043075
.    O

The    O
title    O
of    O
his    O
book    O
referred    O
to    O
the    O
Inquisition    O
,    O
who    O
was    O
said    O
to    O
put    O
people    O
"    O
to    O
the    O
question    O
.    O
"    O
Alleg    O
's    O
book    O
detailed    O
the    O
various    O
torture    O
methods    O
,    O
which    O
included    O
the    O
infamous    O
"    O
gégène    O
"    O
,    O
an    O
electricity    O
generator    O
initially    O
used    O
for    O
telephones    O
,    O
sleep    O
deprivation    O
,    O
and    O
truth    B-Medicine106043075
serum    I-Medicine106043075
,    O
etc    O
.    O

Psychodermatology    B-Medicine106043075

One    O
interpretation    O
of    O
this    O
implies    O
that    O
men    O
and    O
women    O
ought    O
to    O
be    O
informed    O
of    O
and    O
to    O
have    O
access    O
to    O
safe    O
,    O
effective    O
,    O
affordable    O
and    O
acceptable    O
methods    O
of    O
birth    O
control    O
;    O
also    O
access    O
to    O
appropriate    O
health    B-Medicine106043075
care    I-Medicine106043075
services    I-Medicine106043075
of    O
sexual    B-Medicine106043075
,    O
reproductive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
implementation    O
of    O
health    O
education    O
programs    O
to    O
stress    O
the    O
importance    O
of    O
women    O
to    O
go    O
safely    O
through    O
pregnancy    O
and    O
childbirth    O
could    O
provide    O
couples    O
with    O
the    O
best    O
chance    O
of    O
having    O
a    O
healthy    O
infant    O
.    O

He    O
published    O
numerous    O
works    O
on    O
sexual    B-Medicine106043075
medicine    I-Medicine106043075
and    O
was    O
considered    O
as    O
one    O
of    O
the    O
founders    O
of    O
the    O
comparative    O
gynecology    O
and    O
pediatrics    O
.    O

Prompt    O
treatment    O
of    O
any    O
symptoms    O
of    O
decompression    O
sickness    O
(    O
DCS    O
)    O
with    O
recompression    O
and    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
also    O
reduce    O
the    O
risk    O
of    O
subsequent    O
DON    O
.    O

Hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
is    O
a    O
corollary    O
field    O
associated    O
with    O
diving    O
,    O
since    O
recompression    O
in    O
a    O
hyperbaric    O
chamber    O
is    O
used    O
as    O
a    O
treatment    O
for    O
two    O
of    O
the    O
most    O
significant    O
diving    O
-    O
related    O
illnesses    O
,    O
decompression    O
sickness    O
and    O
arterial    O
gas    O
embolism    O
.    O

Fife    O
was    O
also    O
a    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
specialist    O
who    O
was    O
known    O
for    O
his    O
pioneering    O
research    O
on    O
pressurized    O
environments    O
ranging    O
from    O
high    O
altitude    O
to    O
underwater    O
habitats    O
.    O

Fife    O
was    O
a    O
pioneer    O
in    O
undersea    B-Medicine106043075
medicine    I-Medicine106043075
and    O
served    O
as    O
director    O
of    O
the    O
Texas    O
A&M    O
University    O
Hyperbaric    B-Medicine106043075
laboratory    O
.    O

Fife    O
's    O
interest    O
in    O
clinical    O
hyperbaric    O
medicine    O
lead    O
to    O
several    O
research    O
projects    O
to    O
look    O
for    O
new    O
indications    O
for    O
the    O
use    O
of    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
.    O

Richard    O
"    O
Dick    O
"    O
Rutkowski    O
is    O
a    O
pioneer    O
in    O
the    O
fields    O
of    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
,    O
diving    B-Medicine106043075
medicine    I-Medicine106043075
and    O
diver    O
training    O
,    O
especially    O
in    O
relation    O
to    O
the    O
use    O
of    O
breathing    O
gases    O
.    O

Outpatient    O
services    O
cover    O
internal    O
medicine    O
,    O
home    O
health    O
and    O
hospice    B-Medicine106043075
care    O
,    O
memory    O
care    O
,    O
physical    O
therapy    O
and    O
rehabilitation    O
,    O
school    O
nursing    O
,    O
wound    O
care    O
,    O
and    O
hyperbaric    B-Medicine106043075
medicine    O
.    O

He    O
was    O
also    O
the    O
founder    O
and    O
director    O
of    O
the    O
Center    O
for    O
Hyperbaric    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
the    O
Clinical    O
Center    O
"    O
Zemun    O
"    O
,    O
in    O
1974    O
.    O

Science    O
:    O
Recipients    O
in    O
the    O
Science    O
category    O
include    O
renowned    O
underwater    O
archaeologists    O
such    O
as    O
E.    O
Lee    O
Spence    O
and    O
George    O
Bass    O
,    O
inventors    O
like    O
Edwin    O
Link    O
,    O
undersea    O
explorers    O
like    O
Sylvia    O
Earle    O
and    O
Robert    O
Ballard    O
,    O
doctors    O
involved    O
in    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
such    O
as    O
Joseph    O
MacInnis    O
,    O
as    O
well    O
as    O
marine    O
biologists    O
,    O
and    O
other    O
marine    O
scientists    O
.    O

Recompression    B-Medicine106043075
with    O
oxygen    O
is    O
effective    O
for    O
relief    O
of    O
symptoms    O
resulting    O
from    O
ICD    O
.    O

Hyperbaric    B-Medicine106043075
oxygenation    I-Medicine106043075
may    O
be    O
useful    O
in    O
addition    O
to    O
traditional    O
treatments    O
.    O

Hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
has    O
been    O
suggested    O
by    O
case    O
reports    O
–    O
though    O
as    O
of    O
2011    O
not    O
proven    O
in    O
controlled    O
randomized    O
trials    O
–    O
to    O
be    O
an    O
effective    O
adjunctive    O
therapy    O
for    O
crush    O
injury    O
,    O
compartment    O
syndrome    O
,    O
and    O
other    O
acute    O
traumatic    O
ischemias    O
,    O
by    O
improving    O
wound    O
healing    O
and    O
reducing    O
the    O
need    O
for    O
repetitive    O
surgery    O
.    O

Preventative    O
treatment    O
of    O
oxygen    O
toxicity    O
during    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075

Wound    O
care    O
and    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
(HBOT)    I-Medicine106043075
.    O

Hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075

Hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075

National    O
Board    O
of    O
Diving    O
and    O
Hyperbaric    O
Medical    O
Technology    O
(    O
NBDHMT    O
)    O
,    O
formally    O
known    O
as    O
the    O
National    O
Association    O
of    O
Diving    O
Technicians    O
,    O
is    O
a    O
non    O
-    O
profit    O
organization    O
devoted    O
to    O
the    O
education    O
and    O
certification    O
of    O
qualified    O
personnel    O
in    O
the    O
fields    O
of    O
diving    B-Medicine106043075
and    O
hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
pathophysiology    O
of    O
DCS    O
is    O
not    O
yet    O
fully    O
understood    O
,    O
but    O
decompression    O
practice    O
has    O
reached    O
a    O
stage    O
where    O
the    O
risk    O
is    O
fairly    O
low    O
,    O
and    O
most    O
incidences    O
are    O
successfully    O
treated    O
by    O
therapeutic    B-Medicine106043075
recompression    I-Medicine106043075
and    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
.    O
Mixed    O
breathing    O
gases    O
are    O
used    O
to    O
reduce    O
the    O
effects    O
of    O
the    O
hyperbaric    O
environment    O
on    O
ambient    O
pressure    O
divers    O
.    O

The    O
medical    O
aspects    O
of    O
diving    O
and    O
hyperbaric    O
exposure    O
include    O
examination    O
of    O
divers    O
to    O
establish    O
medical    O
fitness    O
to    O
dive    O
,    O
diagnosis    O
and    O
treatment    O
of    O
diving    O
disorders    O
,    O
treatment    O
by    O
recompression    O
and    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
,    O
toxic    O
effects    O
of    O
gases    O
in    O
a    O
hyperbaric    O
environment    O
,    O
and    O
treatment    O
of    O
injuries    O
incurred    O
while    O
diving    O
which    O
are    O
not    O
directly    O
associated    O
with    O
depth    O
or    O
pressure    O
.    O

Hyperbaric    B-Medicine106043075
medicine    I-Medicine106043075
is    O
another    O
field    O
associated    O
with    O
diving    O
,    O
since    O
recompression    O
in    O
a    O
hyperbaric    O
chamber    O
with    O
hyperbaric    O
oxygen    O
therapy    O
is    O
the    O
definitive    O
treatment    O
for    O
two    O
of    O
the    O
most    O
important    O
diving    O
-    O
related    O
illnesses    O
,    O
DCS    O
and    O
arterial    O
gas    O
embolism    O
.    O

The    O
campus    O
consists    O
of    O
a    O
2,800    O
square    O
-    O
meter    O
(    O
30,000    O
square    O
-    O
foot    O
)    O
laboratory    O
building    O
,    O
a    O
dormitory    O
housing    O
,    O
a    O
cafeteria    O
,    O
a    O
hyperbaric    B-Medicine106043075
chamber    I-Medicine106043075
,    O
and    O
a    O
large    O
waterfront    O
staging    O
area    O
complete    O
with    O
dock    O
,    O
pier    O
,    O
helipad    O
,    O
and    O
diving    O
lockers    O
.    O

The    O
school    O
campus    O
includes    O
a    O
32-acre    O
60-foot    O
deep    O
commercial    O
dive    O
training    O
quarry    O
,    O
hyperbaric    B-Medicine106043075
chamber    O
,    O
Lincoln    O
welding    O
facilities    O
and    O
fully    O
equipped    O
classrooms    O
.    O

Duke    O
was    O
also    O
used    O
so    O
that    O
Thompson    O
could    O
talk    O
about    O
himself    O
–    O
after    O
a    O
diving    O
accident    O
Thompson    O
had    O
to    O
spend    O
some    O
time    O
in    O
a    O
decompression    B-Medicine106043075
chamber    I-Medicine106043075
,    O
and    O
wrote    O
a    O
letter    O
signed    O
'    O
Raoul    O
Duke    O
'    O
in    O
which    O
the    O
pseudonym    O
described    O
the    O
insanity    O
of    O
Thompson    O
's    O
condition    O
in    O
the    O
chamber    O
–    O
holding    O
up    O
scrawled    O
notes    O
to    O
the    O
single    O
glass    O
window    O
and    O
ordering    O
a    O
television    O
set    O
to    O
watch    O
coverage    O
of    O
the    O
Watergate    O
hearings    O
.    O

Some    O
data    O
supports    O
the    O
use    O
of    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
to    O
improve    O
outcomes    O
.    O

Hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
(    O
HBO    O
)    O
has    O
been    O
evaluated    O
as    O
an    O
add    O
on    O
treatment    O
following    O
TBI    O
.    O

These    O
ulcers    O
are    O
difficult    O
to    O
heal    O
by    O
basic    O
wound    O
care    O
and    O
require    O
advanced    O
therapy    O
,    O
such    O
as    O
hyperbaric    B-Medicine106043075
oxygen    I-Medicine106043075
therapy    I-Medicine106043075
or    O
bioengineered    O
skin    O
substitutes    O
.    O

An    O
example    O
of    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
,    O
the    O
book    O
has    O
been    O
cited    O
by    O
medical    O
journals    O
and    O
lecturers    O
as    O
an    O
argument    O
for    O
greater    O
cultural    O
competence    O
,    O
and    O
often    O
assigned    O
to    O
medical    O
,    O
pharmaceutic    O
,    O
and    O
anthropological    O
students    O
in    O
the    O
US    O
.    O

An    O
undergraduate    O
major    O
in    O
anthropology    O
at    O
the    O
University    O
of    O
Michigan    O
(    O
1974    O
)    O
,    O
she    O
received    O
her    O
PhD    O
in    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
from    O
Brown    O
University    O
and    O
then    O
served    O
as    O
Research    O
Fellow    O
at    O
the    O
Harvard    O
University    O
Medical    O
School    O
from    O
1984    O
to    O
1990    O
.    O

Professor    O
Groce    O
is    O
also    O
known    O
widely    O
for    O
her    O
teaching    O
and    O
mentoring    O
.    O
While    O
a    O
research    O
scientist    O
at    O
Harvard    O
she    O
regularly    O
taught    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
and    O
international    O
health    O
courses    O
.    O

Areas    O
of    O
Interest    O
:    O
Race    O
and    O
Ethnicity    O
,    O
Medical    B-Medicine106043075
Anthropology    I-Medicine106043075
,    O
Conflict    O
in    O
Northern    O
Ireland    O

Her    O
major    O
was    O
cell    O
developmental    O
biology    O
,    O
with    O
a    O
minor    O
in    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
.    O

Anthropometric    O
measurements    O
also    O
have    O
uses    O
in    O
epidemiology    O
and    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
,    O
for    O
example    O
in    O
helping    O
to    O
determine    O
the    O
relationship    O
between    O
various    O
body    O
measurements    O
(    O
height    O
,    O
weight    O
,    O
percentage    O
body    O
fat    O
,    O
etc    O
.    O
)    O
and    O
medical    O
outcomes    O
.    O

Cecil    O
Helman    O
(    O
born    O
4    O
January    O
1944    O
in    O
Cape    O
Town    O
,    O
South    O
Africa    O
,    O
died    O
15    O
June    O
2009    O
)    O
was    O
a    O
South    O
African    O
doctor    O
,    O
author    O
,    O
and    O
medical    B-Medicine106043075
anthropologist    I-Medicine106043075
.    O

Reichel    O
taught    O
classes    O
in    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
at    O
the    O
university    O
there    O
and    O
engaged    O
in    O
programs    O
of    O
public    O
health    O
with    O
an    O
anthropological    O
perspective    O
.    O

Nancy    O
Romero    O
-    O
Daza    O
is    O
a    O
medical    B-Medicine106043075
anthropologist    I-Medicine106043075
with    O
an    O
appointment    O
as    O
associate    O
professor    O
at    O
the    O
University    O
of    O
South    O
Florida    O
.    O

Jean    O
J.    O
Schensul    O
is    O
a    O
medical    B-Medicine106043075
anthropologist    I-Medicine106043075
and    O
senior    O
scientist    O
at    O
The    O
Institute    O
for    O
Community    O
Research    O
,    O
in    O
Hartford    O
,    O
Connecticut    O
.    O

Polunin    O
also    O
contributed    O
a    O
number    O
of    O
articles    O
and    O
book    O
chapters    O
in    O
the    O
field    O
of    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
.    O

Medical    B-Medicine106043075
anthropology    I-Medicine106043075

He    O
holds    O
master    O
's    O
degrees    O
from    O
the    O
University    O
of    O
Hawaii    O
in    O
medical    O
botany    O
and    O
medical    B-Medicine106043075
anthropology    I-Medicine106043075
,    O
and    O
a    O
Ph.D.    O
from    O
the    O
University    O
of    O
California    O
,    O
Berkeley    O
in    O
nutritional    O
ethnomedicine    O
.    O

A    O
candidate    O
needs    O
to    O
have    O
good    O
knowledge    O
of    O
medical    O
sciences    O
,    O
such    O
as    O
anatomy    O
,    O
physiology    O
and    O
pathology    B-Medicine106043075
and    O
psychiatry    O
;    O
a    O
good    O
knowledge    O
of    O
law    O
regulations    O
is    O
also    O
needed    O
.    O

Cornell    O
Medical    O
Center    O
(    O
1958–60    O
)    O
,    O
a    O
clinical    O
fellowship    O
in    O
pathology    B-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
(    O
1960–61    O
)    O
,    O
and    O
a    O
research    O
fellowship    O
in    O
hematology    O
at    O
the    O
Thorndike    O
Memorial    O
Laboratory    O
of    O
Harvard    O
Medical    O
School    O
,    O
Boston    O
City    O
Hospital    O
(    O
1961–63    O
)    O
.    O

Often    O
,    O
a    O
potential    O
cause    O
is    O
identified    O
by    O
epidemiological    O
observations    O
before    O
a    O
pathological    B-Medicine106043075
link    O
can    O
be    O
drawn    O
between    O
the    O
cause    O
and    O
the    O
disease    O
.    O

Pathology    B-Medicine106043075

But    O
this    O
verdict    O
has    O
been    O
disputed    O
by    O
a    O
number    O
of    O
experts    O
,    O
including    O
the    O
British    O
army    O
's    O
senior    O
ballistics    O
officer    O
Lieutenant    O
Colonel    O
George    O
Styles    O
and    O
Home    O
Office    O
pathologist    B-Medicine106043075
Hugh    O
Thomas    O
.    O

The    O
developers    O
define    O
"    O
Caligula    O
"    O
as    O
a    O
"    O
next    O
-    O
generation    O
juvenile    O
RPG    O
"    O
focusing    O
on    O
modern    O
pathology    B-Medicine106043075
and    O
trauma    O
.    O

Sir    O
Harry    O
Brookes    O
Allen    O
(    O
13    O
June    O
1854    O
–    O
28    O
March    O
1926    O
)    O
was    O
a    O
noted    O
Australian    O
pathologist    B-Medicine106043075
.    O

Common    O
causes    O
include    O
trauma    O
,    O
various    O
pathological    B-Medicine106043075
conditions    O
and    O
complications    O
of    O
medical    O
therapy    O
.    O

Genitourinary    O
pathologists    B-Medicine106043075
generally    O
work    O
closely    O
with    O
urologic    O
surgeons    O
.    O

A    O
few    O
endocrinologists    O
began    O
to    O
help    O
parents    O
of    O
severely    O
GH    O
-    O
deficient    O
children    O
to    O
make    O
arrangements    O
with    O
local    O
pathologist    B-Medicine106043075
to    O
collect    O
human    O
pituitary    O
glands    O
after    O
removal    O
at    O
autopsy    O
.    O

Cinchonism    O
or    O
quinism    O
is    O
a    O
pathological    B-Medicine106043075
condition    O
caused    O
by    O
an    O
overdose    O
of    O
quinine    O
or    O
quinidine    O
,    O
or    O
their    O
natural    O
source    O
,    O
cinchona    O
bark    O
.    O

October    O
12    O
–    O
Ruth    O
L.    O
Kirschstein    O
(    O
died    O
2009    O
)    O
,    O
American    O
pathologist    B-Medicine106043075
and    O
science    O
administrator    O
at    O
the    O
National    O
Institutes    O
of    O
Health    O
.    O

February    O
18    O
–    O
Baron    O
Carl    O
von    O
Rokitansky    O
,    O
Bohemian    O
pathologist    B-Medicine106043075
(    O
died    O
1878    O
)    O

Matthew    O
Baillie    O
begins    O
publication    O
in    O
London    O
of    O
"    O
A    O
Series    O
of    O
Engravings    O
,    O
Accompanied    O
with    O
Explanations    O
,    O
which    O
are    O
Intended    O
to    O
Illustrate    O
the    O
Morbid    O
Anatomy    O
of    O
Some    O
of    O
the    O
Most    O
Important    O
Parts    O
of    O
the    O
Human    O
Body    O
"    O
,    O
the    O
first    O
comprehensive    O
atlas    O
of    O
pathology    B-Medicine106043075
as    O
a    O
separate    O
subject    O
.    O

February    O
13    O
–    O
John    O
Hunter    O
,    O
Scottish    O
surgeon    O
,    O
pathologist    B-Medicine106043075
and    O
comparative    O
anatomist    O
(    O
died    O
1793    O
)    O

Johns    O
Hopkins    O
Hospital    O
opens    O
in    O
Baltimore    O
,    O
Maryland    O
,    O
with    O
senior    O
founding    O
staff    O
comprising    O
pathologist    B-Medicine106043075
William    O
Henry    O
Welch    O
,    O
surgeon    O
William    O
Stewart    O
Halsted    O
,    O
gynecologist    O
Howard    O
Atwood    O
Kelly    O
and    O
internist    O
William    O
Osler    O
,    O
who    O
originates    O
the    O
concept    O
of    O
a    O
residency    O
for    O
training    O
junior    O
doctors    O
.    O

July    O
23    O
–    O
Baron    O
Carl    O
von    O
Rokitansky    O
,    O
Bohemian    O
pathologist    B-Medicine106043075
(    O
born    O
1804    O
)    O

The    O
definitive    O
diagnosis    O
is    O
made    O
after    O
excision    O
by    O
a    O
pathologist    B-Medicine106043075
based    O
on    O
microscopic    O
appearance    O
of    O
a    O
cystic    O
lesion    O
lined    O
by    O
cornified    O
epithelium    O
containing    O
lamellated    O
keratin    O
without    O
calcifications    O
.    O

The    O
ballot    O
argument    O
in    O
favor    O
of    O
the    O
proposition    O
were    O
pathologist    B-Medicine106043075
John    O
Grauerholz    O
,    O
psychiatrist    O
Nancy    O
T.    O
Mullan    O
,    O
and    O
former    O
Centers    O
for    O
Disease    O
Control    O
advisor    O
Gus    O
S.    O
Sermos    O
.    O

USUHS    O
currently    O
offers    O
the    O
Ph.D.    O
in    O
emerging    O
infectious    O
diseases    O
,    O
medical    O
and    O
clinical    O
psychology    O
,    O
molecular    O
and    O
cellular    O
biology    O
,    O
neuroscience    O
,    O
pathology    B-Medicine106043075
,    O
Environmental    O
Health    O
Sciences    O
and    O
Medical    O
Zoology    O
.    O

The    O
Citrus    O
Center    O
attracts    O
scholars    O
and    O
research    O
projects    O
from    O
around    O
the    O
world    O
,    O
incorporating    O
undergraduate    O
and    O
graduate    O
student    O
training    O
into    O
its    O
diverse    O
research    O
programs    O
,    O
such    O
as    O
Biotechnology    O
,    O
Entomology    O
,    O
Pathology    B-Medicine106043075
and    O
Budwood    O
Certification    O
.    O

Human    O
Pathology    O
is    O
a    O
monthly    O
peer    O
-    O
reviewed    O
medical    O
journal    O
covering    O
pathology    B-Medicine106043075
in    O
humans    O
.    O

Pathology    B-Medicine106043075

After    O
holding    O
a    O
Post    O
-    O
Doctoral    O
position    O
at    O
Duke    O
University    O
,    O
he    O
went    O
on    O
to    O
hold    O
faculty    O
positions    O
in    O
biochemistry    O
,    O
physiology    O
,    O
molecular    O
pharmacology    O
,    O
toxicology    O
,    O
pediatrics    O
,    O
and    O
pathology    B-Medicine106043075
.    O

Tumor    O
cells    O
often    O
show    O
an    O
aberrant    O
nuclear    O
structure    O
,    O
which    O
is    O
used    O
by    O
pathologists    B-Medicine106043075
in    O
diagnostics    O
.    O

Pathologic    O
stage    O
adds    O
additional    O
information    O
gained    O
by    O
examination    O
of    O
the    O
tumor    O
microscopically    O
by    O
a    O
pathologist    B-Medicine106043075
after    O
it    O
has    O
been    O
surgically    O
removed    O
.    O

The    O
results    O
of    O
testing    O
,    O
such    O
as    O
blood    O
tests    O
(    O
e.g.    O
,    O
complete    O
blood    O
count    O
)    O
radiology    O
examinations    O
(    O
e.g.    O
,    O
X    O
-    O
rays    O
)    O
,    O
pathology    B-Medicine106043075
(    O
e.g.    O
,    O
biopsy    O
results    O
)    O
,    O
or    O
specialized    O
testing    O
(    O
e.g.    O
,    O
pulmonary    O
function    O
testing    O
)    O
are    O
included    O
.    O

An    O
ECD    O
might    O
compensate    O
for    O
such    O
pathology    B-Medicine106043075
by    O
adjusting    O
the    O
appropriate    O
neurons    O
to    O
a    O
neutral    O
point    O
in    O
adaptation    O
to    O
orientation    O
contingent    O
color    O
.    O

Some    O
plesiosaur    O
fossils    O
show    O
pathologies    B-Medicine106043075
,    O
the    O
result    O
of    O
illness    O
or    O
old    O
age    O
.    O

It    O
may    O
be    O
pathological    B-Medicine106043075
(    O
in    O
which    O
sense    O
it    O
is    O
also    O
called    O
embolism    O
)    O
,    O
for    O
example    O
a    O
pulmonary    O
embolism    O
,    O
or    O
therapeutic    O
,    O
as    O
a    O
hemostatic    O
treatment    O
for    O
bleeding    O
or    O
as    O
a    O
treatment    O
for    O
some    O
types    O
of    O
cancer    O
by    O
deliberately    O
blocking    O
blood    O
vessels    O
to    O
starve    O
the    O
tumor    O
cells    O
.    O

The    O
test    O
is    O
often    O
done    O
as    O
part    O
of    O
point    O
-    O
of    O
-    O
care    O
diagnostics    O
,    O
to    O
eliminate    O
the    O
time    O
and    O
expense    O
required    O
to    O
detect    O
"    O
H.    O
pylori    O
"    O
on    O
pathology    B-Medicine106043075
testing    O
.    O

The    O
Royal    O
College    O
of    O
Pathologists    O
of    O
Australasia    O
is    O
a    O
medical    O
organization    O
that    O
promotes    O
the    O
science    O
and    O
practice    O
of    O
pathology    B-Medicine106043075
.    O

General    B-Medicine106043075
Pathology    I-Medicine106043075

Osteoporosis    O
with    O
pathological    B-Medicine106043075
fracture    O

Osteoporosis    O
without    O
pathological    B-Medicine106043075
fracture    O

Rudolf    O
Robert    O
Maier    O
(    O
April    O
9    O
,    O
1824    O
–    O
November    O
7    O
,    O
1888    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
who    O
was    O
a    O
native    O
of    O
Freiburg    O
i    O
m    O
Breisgau    O
.    O

In    O
1870    O
he    O
earned    O
his    O
medical    O
doctorate    O
in    O
Berlin    O
,    O
and    O
subsequently    O
became    O
an    O
assistant    O
to    O
pathologist    B-Medicine106043075
Friedrich    O
Theodor    O
von    O
Frerichs    O
(    O
1819–1885    O
)    O
.    O

Carl    O
Ewald    O
was    O
a    O
pioneer    O
in    O
the    O
field    O
of    O
gastroenterology    O
,    O
and    O
was    O
a    O
catalyst    O
in    O
making    O
Augusta    O
Hospital    O
a    O
center    O
for    O
pathological    B-Medicine106043075
studies    O
of    O
digestion    O
.    O

Small    O
masses    O
are    O
usually    O
completely    O
excised    O
and    O
sent    O
to    O
the    O
pathology    B-Medicine106043075
lab    O
to    O
confirm    O
that    O
the    O
surrounding    O
healthy    O
tissues    O
that    O
were    O
excised    O
along    O
with    O
the    O
tumor    O
do    O
not    O
contain    O
any    O
cancer    O
cells    O
.    O

By    O
using    O
animal    O
models    O
,    O
the    O
underlying    O
molecular    O
alterations    O
and    O
the    O
causal    O
relationship    O
between    O
genetic    O
or    O
environmental    O
alterations    O
and    O
depression    O
can    O
be    O
examined    O
,    O
which    O
would    O
afford    O
a    O
better    O
insight    O
into    O
pathology    B-Medicine106043075
of    O
depression    O
.    O

In    O
his    O
classic    O
paper    O
,    O
Weeks    O
characterizes    O
"    O
H.    O
aegyptius    O
"    O
by    O
its    O
high    O
contagiousness    O
,    O
direct    O
transmission    O
from    O
patient    O
to    O
volunteer    O
,    O
pathogenesis    O
,    O
pathology    B-Medicine106043075
,    O
treatment    O
and    O
epidemiology    O
.    O

He    O
earned    O
board    O
certifications    O
in    O
pathology    B-Medicine106043075
,    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
public    O
health    O
,    O
and    O
microbiology    O
.    O

Pathology    B-Medicine106043075
and    O
biorepository    O

Kenneth    O
Merle    O
Brinkhous    O
(    O
1908–2000    O
)    O
was    O
a    O
professor    O
and    O
chairperson    O
in    O
the    O
Department    O
of    O
Pathology    B-Medicine106043075
and    O
Laboratory    O
Medicine    O
at    O
the    O
University    O
of    O
North    O
Carolina    O
at    O
Chapel    O
Hill    O
.    O

Apoptosis    O
occurs    O
in    O
many    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O
.    O

Apoptosis    O
occurs    O
in    O
many    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O
.    O

Apoptosis    O
occurs    O
in    O
many    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O
.    O

On    O
the    O
way    O
,    O
they    O
meet    O
Alex    O
,    O
a    O
trekker    O
who    O
appears    O
lost    O
in    O
the    O
Romanian    O
Carpathians    O
,    O
while    O
doing    O
a    O
pathology    B-Medicine106043075
project    O
.    O

"    O
Beiträge    O
zur    O
Pathologie    O
und    O
Histologie    O
der    O
Zahnpulpa    O
"    O
(    O
Contributions    O
to    O
the    O
pathology    B-Medicine106043075
and    O
histology    O
of    O
the    O
dental    O
pulp    O
)    O

At    O
DU    O
,    O
she    O
supervised    O
a    O
contract    O
with    O
the    O
Veteran    O
’s    O
Administration    O
,    O
doing    O
all    O
the    O
veterans’    O
speech    O
pathology    B-Medicine106043075
and    O
audiology    O
exams    O
and    O
hearing    O
aid    O
assessments    O
.    O

David    O
Carl    O
Dahlin    O
,    O
Jr.    O
,    O
(    O
1917–2003    O
)    O
was    O
a    O
North    O
American    O
physician    O
and    O
pathologist    B-Medicine106043075
who    O
trained    O
and    O
worked    O
at    O
the    O
Mayo    O
Clinic    O
in    O
Rochester    O
,    O
Minnesota    O
for    O
virtually    O
his    O
entire    O
career    O
in    O
medicine    O
.    O

Pathology    B-Medicine106043075

Biorheological    O
analyses    O
include    O
study    O
of    O
pathological    B-Medicine106043075
processes    O
through    O
clinical    O
research    O
in    O
the    O
related    O
fields    O
of    O
hemodynamics    O
and    O
hemorheology    O
,    O
and    O
may    O
have    O
clinical    O
implications    O
in    O
aiding    O
the    O
treatment    O
of    O
specific    O
diseases    O
.    O

During    O
its    O
time    O
,    O
it    O
became    O
the    O
leading    O
medico    O
–    O
legal    O
textual    O
authority    O
on    O
sexual    O
pathology    B-Medicine106043075
.    O

In    O
medicine    O
,    O
physiotherapy    O
,    O
chiropractic    O
,    O
and    O
osteopathy    O
the    O
hip    O
examination    O
,    O
or    O
hip    O
exam    O
,    O
is    O
undertaken    O
when    O
a    O
patient    O
has    O
a    O
complaint    O
of    O
hip    O
pain    O
and/or    O
signs    O
and/or    O
symptoms    O
suggestive    O
of    O
hip    O
joint    O
pathology    B-Medicine106043075
.    O

Allan    O
S.    O
Walker    O
was    O
a    O
pathology    B-Medicine106043075
specialist    O
who    O
served    O
with    O
Australian    O
Army    O
medical    O
units    O
in    O
both    O
world    O
wars    O
and    O
taught    O
at    O
the    O
University    O
of    O
Sydney    O
.    O

General    B-Medicine106043075
Pathology    I-Medicine106043075
and    O
Microbiology    O

Special    B-Medicine106043075
Pathology    I-Medicine106043075

Various    O
studies    O
have    O
compared    O
the    O
predictive    O
performance    O
of    O
PI    O
-    O
RADS    O
v1    O
for    O
detecting    O
significant    O
prostate    O
cancer    O
against    O
either    O
image    O
-    O
guided    O
biopsy    O
results    O
(    O
definitive    O
pathology    B-Medicine106043075
)    O
and/or    O
prostatectomy    O
specimens    O
(    O
histopathology    B-Medicine106043075
)    O
.    O

The    O
immune    O
reaction    O
interpreted    O
as    O
a    O
causal    O
pathology    B-Medicine106043075
by    O
the    O
autoimmunity    O
hypothesis    O
is    O
regarded    O
by    O
the    O
accelerator    O
hypothesis    O
as    O
a    O
physiological    O
response    O
to    O
beta    O
cell    O
stress    O
.    O

These    O
can    O
be    O
then    O
assessed    O
on    O
a    O
computer    O
screen    O
similar    O
to    O
conventional    O
microscopy    O
,    O
allowing    O
the    O
pathologist    B-Medicine106043075
to    O
maneuver    O
around    O
the    O
image    O
and    O
view    O
every    O
part    O
of    O
the    O
slide    O
at    O
any    O
magnification    O
.    O

Graduates    O
from    O
the    O
medical    O
radiation    O
sciences    O
possess    O
a    O
good    O
understanding    O
of    O
nuclear    O
physics    O
,    O
quantum    O
physics    O
,    O
radiation    O
physics    O
,    O
wave    O
physics    O
,    O
medical    O
terminologies    O
,    O
pathology    B-Medicine106043075
,    O
oncology    O
,    O
radiobiology    O
,    O
mathematics    O
,    O
anatomy    O
and    O
physiology    O
,    O
and    O
are    O
highly    O
skilled    O
in    O
the    O
operation    O
of    O
complex    O
electronic    O
equipments    O
,    O
computers    O
,    O
and    O
precision    O
instruments    O
which    O
often    O
cost    O
millions    O
of    O
dollars    O
.    O

Hanns    O
von    O
Meyenburg    O
(    O
actually    O
"    O
Walter    O
"    O
but    O
called    O
"    O
Hanns    O
"    O
;    O
born    O
6    O
June    O
1887    O
in    O
Dresden    O
;    O
died    O
6    O
November    O
1971    O
)    O
was    O
a    O
Swiss    O
Pathologist    B-Medicine106043075
.    O

Dr.    O
Lynch    O
's    O
primary    O
research    O
interests    O
include    O
the    O
pathology    B-Medicine106043075
of    O
cancer    O
,    O
cancer    O
epidemiology    O
,    O
radon    O
,    O
and    O
environmental    O
epidemiology    O
.    O

Afterwards    O
,    O
he    O
was    O
a    O
pathologist    B-Medicine106043075
at    O
the    O
Senckenberg    O
Institute    O
in    O
Frankfurt    O
am    O
Main    O
(    O
1890    O
-    O
92    O
)    O
,    O
a    O
surgeon    O
at    O
the    O
city    O
hospital    O
at    O
Hamburg    O
-    O
Altona    O
(    O
1892    O
-    O
1900    O
)    O
,    O
and    O
later    O
head    O
of    O
the    O
surgical    O
department    O
at    O
Augusta    O
Hospital    O
in    O
Berlin    O
.    O

Curt    O
Theodor    O
Schimmelbusch    O
(    O
November    O
16    O
,    O
1860    O
–    O
August    O
2    O
,    O
1895    O
)    O
was    O
a    O
German    O
physician    O
and    O
pathologist    B-Medicine106043075
who    O
invented    O
the    O
Schimmelbusch    O
mask    O
,    O
for    O
the    O
safe    O
delivery    O
of    O
anaesthetics    O
to    O
surgical    O
patients    O
.    O

Anton    O
Ghon    O
(    O
1866    O
in    O
Villach    O
–    O
1936    O
)    O
Austrian    O
pathologist    B-Medicine106043075
viz    O
Ghon    O
focus    O
and    O
Ghon    O
's    O
complex    O

Yamagiwa    O
.    O
JPG|Katsusaburō    O
Yamagiwa    O
pathologist    B-Medicine106043075

The    O
hospital    O
has    O
since    O
leased    O
the    O
ward    O
to    O
the    O
Royal    O
Australian    O
Navy    O
,    O
whilst    O
their    O
Balmoral    O
Navy    O
Hospital    O
is    O
refurbished    O
,    O
using    O
their    O
own    O
staff    O
,    O
but    O
making    O
use    O
of    O
St    O
Vincent    O
's    O
pathology    B-Medicine106043075
and    O
radiology    O
services    O
.    O

Hans    O
Chiari    O
(    O
4    O
September    O
1851    O
−    O
6    O
May    O
1916    O
)    O
was    O
an    O
Austrian    O
pathologist    B-Medicine106043075
who    O
was    O
a    O
native    O
of    O
Vienna    O
.    O

Pathology    B-Medicine106043075

He    O
studied    O
medicine    O
at    O
the    O
universities    O
of    O
Munich    O
and    O
Erlangen    O
,    O
where    O
he    O
also    O
served    O
as    O
an    O
assistant    O
to    O
pathologist    B-Medicine106043075
Adolph    O
Henke    O
.    O

Pathologist    B-Medicine106043075
classify    O
serous    O
cystic    O
neoplasms    O
into    O
two    O
broad    O
groups    O
.    O

Serous    O
cystadenomas    O
are    O
diagnosed    O
by    O
histomorphologic    O
examination    O
,    O
by    O
pathologist    B-Medicine106043075
.    O
Grossly    O
,    O
they    O
are    O
,    O
usually    O
,    O
unilocular    O
cysts    O
that    O
contain    O
clear    O
,    O
straw    O
-    O
coloured    O
fluid    O
.    O

In    O
1874    O
he    O
was    O
appointed    O
as    O
lecturer    O
in    O
medicine    O
at    O
the    O
Athenaeum    O
Illustre    O
in    O
medicine    O
,    O
pathology    B-Medicine106043075
and    O
pharmacodynamics    O
,    O
and    O
became    O
a    O
professor    O
when    O
the    O
Athenaeum    O
received    O
university    O
status    O
and    O
became    O
the    O
Municipal    O
University    O
of    O
Amsterdam    O
.    O

Pyknocytes    O
are    O
red    O
blood    O
cells    O
that    O
appear    O
distorted    O
,    O
irregular    O
and    O
small    O
with    O
abnormal    O
projections    O
and    O
would    O
typically    O
be    O
identified    O
by    O
a    O
pathologist    B-Medicine106043075
on    O
a    O
peripheral    O
blood    O
smear    O
.    O

He    O
later    O
studied    O
physiology    O
at    O
Heidelberg    O
University    O
under    O
Wilhelm    O
Kühne    O
,    O
and    O
pathology    B-Medicine106043075
at    O
the    O
University    O
of    O
Würzburg    O
.    O

From    O
1859    O
to    O
1861    O
he    O
was    O
an    O
associate    O
professor    O
at    O
Leipzig    O
,    O
afterwards    O
relocating    O
to    O
the    O
University    O
of    O
Halle    O
,    O
where    O
he    O
was    O
a    O
full    O
professor    O
of    O
pathology    B-Medicine106043075
and    O
therapy    O
from    O
1862    O
to    O
1899    O
.    O

Hinrich    O
Bitter    O
-    O
Suermann    O
(    O
born    O
March    O
10    O
,    O
1940    O
)    O
is    O
a    O
German    O
-    O
Canadian    O
pathologist    B-Medicine106043075
and    O
Professor    O
of    O
Surgery    O
specialized    O
in    O
organ    O
transplantation    O
.    O

MiR-155    O
plays    O
a    O
role    O
in    O
various    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O

Pathology    B-Medicine106043075

James    O
picks    O
up    O
Tristan    O
from    O
the    O
station    O
upon    O
his    O
return    O
from    O
veterinary    O
college    O
in    O
Edinburgh    O
,    O
having    O
failed    O
pathology    B-Medicine106043075
and    O
parasitology    B-Medicine106043075
.    O

The    O
clinical    O
officers    O
'    O
basic    O
training    O
and    O
practice    O
is    O
focused    O
on    O
the    O
major    O
essential    O
specialties    O
of    O
medicine    O
,    O
surgery    O
,    O
pediatrics    O
,    O
obstetrics    O
and    O
gynecology    O
,    O
pathology    B-Medicine106043075
,    O
pharmacology    O
and    O
community    O
health    O
(    O
including    O
health    O
service    O
management    O
)    O
and    O
,    O
unlike    O
nurses    O
and    O
physician    O
assistants    O
,    O
a    O
clinical    O
officer    O
is    O
a    O
gazetted    O
officer    O
who    O
is    O
legally    O
authorized    O
to    O
prepare    O
and    O
sign    O
medico    O
-    O
legal    O
documents    O
such    O
as    O
medical    O
examination    O
reports    O
,    O
sick    O
notes    O
,    O
postmortem    O
examination    O
reports    O
and    O
death    O
certificates    O
on    O
behalf    O
of    O
the    O
state    O
,    O
and    O
to    O
appear    O
in    O
courts    O
of    O
law    O
as    O
an    O
expert    O
witness    O
.    O

Students    O
study    O
the    O
biomedical    O
and    O
clinical    O
sciences    O
such    O
as    O
anatomy    O
,    O
physiology    O
and    O
pathology    B-Medicine106043075
in    O
the    O
first    O
year    O
followed    O
by    O
the    O
clinical    O
subjects    O
(    O
medicine    O
,    O
surgery    O
,    O
pediatrics    O
,    O
obstetrics    O
and    O
gynecology    O
)    O
in    O
the    O
second    O
year    O
.    O

The    O
Higher    O
Diploma    O
in    O
Clinical    O
Medicine    O
and    O
Surgery    O
requires    O
at    O
least    O
three    O
years    O
of    O
working    O
experience    O
and    O
lasts    O
twelve    O
to    O
eighteen    O
months    O
leading    O
to    O
a    O
specialised    O
qualification    O
and    O
re    O
-    O
designation    O
as    O
a    O
specialised    O
clinical    O
officer    O
in    O
one    O
of    O
the    O
medical    O
specialties    O
such    O
as    O
paediatrics    O
,    O
reproductive    O
health    O
,    O
anaesthesia    O
,    O
ENT    O
,    O
ophthalmology    O
and    O
cataract    O
surgery    O
,    O
orthopaedics    B-Medicine106043075
,    O
psychiatry    O
/    O
clinical    O
psychology    O
,    O
skin    O
and    O
chest    O
diseases    O
,    O
epidemiology    O
,    O
pathology    B-Medicine106043075
and    O
Community    O
medicine    O
.    O

David    O
Marine    O
(    O
20    O
September    O
1888    O
–    O
6    O
November    O
1976    O
)    O
was    O
an    O
American    O
pathologist    B-Medicine106043075
.    O

In    O
the    O
fall    O
of    O
1895    O
the    O
Hamilton    O
sisters    O
departed    O
for    O
Germany    O
,    O
where    O
Alice    O
intended    O
to    O
continue    O
her    O
studies    O
in    O
pathology    B-Medicine106043075
at    O
the    O
University    O
of    O
Leipzig    O
and    O
Edith    O
planned    O
to    O
study    O
the    O
classics    O
and    O
attend    O
lectures    O
.    O

It    O
is    O
usually    O
performed    O
by    O
a    O
specialized    O
medical    O
doctor    O
called    O
a    O
pathologist    B-Medicine106043075
.    O

They    O
are    O
performed    O
to    O
gain    O
more    O
insight    O
into    O
pathological    B-Medicine106043075
processes    O
and    O
determine    O
what    O
factors    O
contributed    O
to    O
a    O
patient    O
's    O
death    O
.    O

Toxicology    O
,    O
biochemical    O
tests    O
or    O
genetic    O
testing    O
/    O
molecular    O
autopsy    O
often    O
supplement    O
these    O
and    O
frequently    O
assist    O
the    O
pathologist    B-Medicine106043075
in    O
assigning    O
the    O
cause    O
or    O
causes    O
of    O
death    O
.    O

Autopsy    O
—    O
a    O
detailed    O
description    O
by    O
a    O
pathologist    B-Medicine106043075
complete    O
with    O
cartoon    O
figures    O
.    O

Josef    O
Kyrle    O
(    O
8    O
December    O
1880    O
–    O
30    O
March    O
1926    O
)    O
was    O
an    O
Austrian    O
pathologist    B-Medicine106043075
and    O
dermatologist    O
who    O
was    O
a    O
native    O
of    O
Schärding    O
.    O

Although    O
imaging    O
of    O
removed    O
organs    O
and    O
tissues    O
can    O
be    O
performed    O
for    O
medical    O
reasons    O
,    O
such    O
procedures    O
are    O
usually    O
considered    O
part    O
of    O
pathology    B-Medicine106043075
instead    O
of    O
medical    O
imaging    O
.    O

Sir    O
James    O
also    O
founded    O
the    O
chair    O
of    O
pathology    B-Medicine106043075
at    O
Queen    O
's    O
College    O
,    O
Belfast    O
,    O
now    O
Queen    O
's    O
University    O
.    O

Sir    O
Charles    O
Scott    O
Sherrington    O
(    O
27    O
November    O
1857    O
–    O
4    O
March    O
1952    O
)    O
was    O
an    O
English    O
neurophysiologist    O
,    O
histologist    O
,    O
bacteriologist    O
,    O
and    O
a    O
pathologist    B-Medicine106043075
,    O
Nobel    O
laureate    O
and    O
president    O
of    O
the    O
Royal    O
Society    O
in    O
the    O
early    O
1920s    O
.    O

Under    O
these    O
two    O
,    O
Sherrington    O
parted    O
with    O
a    O
good    O
foundation    O
in    O
physiology    O
,    O
morphology    O
,    O
histology    O
,    O
and    O
pathology    B-Medicine106043075
.    O

The    O
MBBS    O
course    O
starts    O
with    O
the    O
basic    O
pre    O
and    O
para    O
-    O
clinical    O
subjects    O
such    O
as    O
biochemistry    O
,    O
physiology    O
,    O
anatomy    O
,    O
microbiology    O
,    O
pathology    B-Medicine106043075
and    O
pharmacology    O
.    O

They    O
are    O
available    O
in    O
different    O
streams    O
of    O
medical    O
science    O
such    O
as    O
General    O
medicine    O
,    O
General    B-Medicine106043075
surgery    I-Medicine106043075
,    O
Orthopaedics    B-Medicine106043075
,    O
Radiodiagnosis    O
,    O
Radiotherapy    O
,    O
ENT    O
,    O
Obstetrics    O
and    O
gynaecology    O
,    O
Ophthalmology    O
,    O
Anaesthesia    O
,    O
Paediatrics    O
,    O
Community    O
medicine    O
,    O
Pathology    B-Medicine106043075
,    O
Microbiology    O
,    O
Forensic    O
medicine    O
,    O
Pharmacology    O
,    O
Anatomy    O
,    O
Physiology    O
etc    O
.    O

Pathology    B-Medicine106043075
,    O
Pharmacology    O
,    O
Microbiology    O
,    O
and    O
Forensic    O
Medicine    O
for    O
one    O
and    O
half    O
years    O
.    O

The    O
pathologist    B-Medicine106043075
determined    O
Charlie    O
Keever    O
was    O
alive    O
when    O
the    O
bite    O
marks    O
were    O
inflicted    O
.    O

René    O
Dubos    O
,    O
microbiologist    O
,    O
experimental    O
pathologist    B-Medicine106043075
,    O
environmentalist    O
and    O
humanist    O
(    O
died    O
1982    O
)    O

13    O
February    O
–    O
Gabriel    O
Andral    O
,    O
pathologist    B-Medicine106043075
(    O
born    O
1797    O
)    O

Aldo    O
Castellani    O
(    O
8    O
September    O
1874    O
–    O
3    O
October    O
1971    O
)    O
was    O
an    O
Italian    O
pathologist    B-Medicine106043075
and    O
bacteriologist    O
.    O

The    O
Latin    O
specific    O
epithet    O
"    O
heweri    O
"    O
refers    O
to    O
Professor    O
Thomas    O
Frederick    O
Hewer    O
(    O
born    O
12    O
April    O
1903    O
-    O
15    O
March    O
1994    O
)    O
,    O
who    O
became    O
a    O
practising    O
pathologist    B-Medicine106043075
in    O
1935    O
.    O

Apoptosis    O
occurs    O
in    O
many    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O
.    O

Apoptosis    O
occurs    O
in    O
many    O
physiological    O
and    O
pathological    B-Medicine106043075
processes    O
.    O

Sibte    O
Hasan    O
Zaidi    O
(    O
15    O
April    O
1918    O
–    O
5    O
April    O
2008    O
)    O
was    O
an    O
Indian    O
pathologist    B-Medicine106043075
and    O
toxicologist    O
.    O

Accordingly    O
,    O
they    O
have    O
an    O
important    O
role    O
in    O
protective    O
immunity    O
and    O
the    O
regulation    O
of    O
homeostasis    O
and    O
inflammation    O
,    O
so    O
their    O
dysregulation    O
can    O
lead    O
to    O
immune    O
pathology    B-Medicine106043075
such    O
as    O
allergy    O
,    O
bronchial    O
asthma    O
and    O
autoimmune    O
disease    O
.    O

He    O
also    O
described    O
the    O
artworks    O
as    O
a    O
"    O
cross    O
between    O
the    O
forensic    O
and    O
a    O
pathology    B-Medicine106043075
of    O
the    O
personal    O
in    O
which    O
only    O
fragments    O
remain    O
,    O
in    O
which    O
minimal    O
clues    O
can    O
suggest    O
events    O
that    O
may    O
have    O
occurred    O
.    O
"    O

Magnus    O
John    O
Karl    O
August    O
Forssman    O
(    O
22    O
November    O
1868    O
–    O
12    O
March    O
1947    O
)    O
was    O
a    O
Swedish    O
pathologist    B-Medicine106043075
and    O
bacteriologist    O
born    O
in    O
Kalmar    O
.    O

Molecular    O
pathological    O
epidemiology    O
(    O
MPE    O
,    O
also    O
molecular    O
pathologic    O
epidemiology    O
)    O
is    O
a    O
discipline    O
combining    O
epidemiology    O
and    O
pathology    B-Medicine106043075
.    O

Grover    O
M.    O
Hutchins    O
(    O
1933    O
-    O
2010    O
)    O
was    O
an    O
American    O
professor    O
of    O
pathology    B-Medicine106043075
at    O
Johns    O
Hopkins    O
University    O
School    O
of    O
Medicine    O
in    O
Baltimore    O
,    O
Maryland    O
,    O
for    O
more    O
than    O
30    O
years    O
,    O
including    O
22    O
years    O
as    O
director    O
of    O
autopsy    O
services    O
.    O

From    O
1968    O
until    O
his    O
retirement    O
in    O
the    O
early    O
1992    O
,    O
Rose    O
taught    O
pathology    B-Medicine106043075
at    O
the    O
University    O
of    O
Iowa    O
.    O

Robert    O
Collins    O
,    O
M.D.    O
,    O
F.C.A.P.    O
was    O
an    O
accomplished    O
American    O
physician    O
and    O
pathologist    B-Medicine106043075
,    O
who    O
worked    O
for    O
his    O
entire    O
career    O
at    O
Vanderbilt    O
University    O
.    O

Molecular    O
Aspects    O
of    O
Medicine    O
is    O
a    O
peer    O
-    O
reviewed    O
medical    O
journal    O
for    O
clinicians    O
of    O
all    O
relevant    O
specialities    O
and    O
biomedical    O
scientists    O
working    O
in    O
areas    O
from    O
biochemistry    O
and    O
molecular    O
and    O
cell    O
biology    O
to    O
physiology    O
,    O
pharmacology    O
and    O
pathology    B-Medicine106043075
.    O

Theobald    O
Smith    O
ForMemRS    O
(    O
July    O
31    O
,    O
1859    O
–    O
December    O
10    O
,    O
1934    O
)    O
was    O
a    O
pioneering    O
epidemiologist    O
and    O
pathologist    B-Medicine106043075
and    O
is    O
widely    O
considered    O
to    O
be    O
America    O
's    O
first    O
internationally    O
significant    O
medical    O
research    O
scientist    O
.    O

In    O
1895    O
Smith    O
moved    O
to    O
Cambridge    O
,    O
Massachusetts    O
to    O
accept    O
a    O
dual    O
appointment    O
:    O
serve    O
as    O
professor    O
of    O
comparative    O
pathology    B-Medicine106043075
at    O
Harvard    O
University    O
,    O
and    O
direct    O
the    O
pathology    O
lab    O
at    O
the    O
Massachusetts    O
State    O
Board    O
of    O
Health    O
.    O

Anatomical    O
&    O
Cellular    O
Pathology    B-Medicine106043075

b    O
)    O
The    O
organism    O
has    O
been    O
effectively    O
eliminated    O
by    O
the    O
immune    O
system    O
and    O
the    O
pathology    B-Medicine106043075
is    O
due    O
to    O
an    O
excessive    O
immune    O
response    O
after    O
the    O
organism    O
has    O
been    O
cleared    O
.    O

Erich    O
Franz    O
Eugen    O
Bracht    O
(    O
5    O
June    O
1882    O
–    O
1969    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
and    O
gynaecologist    O
born    O
in    O
Berlin    O
.    O

Pathology    B-Medicine106043075

Among    O
his    O
better    O
known    O
publications    O
were    O
works    O
on    O
ovarian    O
pathology    B-Medicine106043075
,    O
uterine    O
tumors    O
and    O
the    O
formation    O
of    O
carcinomas    O
following    O
ovariotomy    O
.    O

With    O
pathologist    B-Medicine106043075
Jean    O
Baptiste    O
Barth    O
(    O
1806    O
-    O
1877    O
)    O
,    O
Roger    O
published    O
works    O
on    O
auscultation    O
,    O
including    O
"    O
A    O
Manual    O
of    O
Auscultation    O
and    O
Percussion    O
"    O
and    O
"    O
A    O
Practical    O
Treatise    O
on    O
Auscultation    O
"    O
;    O
both    O
being    O
translated    O
into    O
English    O
by    O
Patrick    O
Newbigging    O
.    O

Family    O
members    O
of    O
alcoholics    O
begin    O
to    O
improve    O
as    O
they    O
learn    O
to    O
recognize    O
family    O
pathology    B-Medicine106043075
,    O
assign    O
responsibility    O
for    O
the    O
pathology    O
to    O
a    O
disease    O
,    O
forgive    O
themselves    O
,    O
accept    O
that    O
they    O
were    O
adversely    O
affected    O
by    O
the    O
pathology    O
and    O
learn    O
to    O
accept    O
their    O
family    O
members    O
'    O
shortcomings    O
.    O

Pathology    B-Medicine106043075

The    O
Koebner    O
phenomenon    O
is    O
the    O
development    O
of    O
isomorphic    O
pathologic    B-Medicine106043075
lesions    O
in    O
the    O
traumatized    O
"    O
uninvolved    O
skin    O
"    O
of    O
persons    O
who    O
have    O
cutaneous    O
diseases    O
such    O
as    O
psoriasis    O
.    O

Careful    O
pathological    B-Medicine106043075
examination    O
may    O
be    O
necessary    O
to    O
distinguish    O
a    O
thyroid    O
adenoma    O
from    O
a    O
minimally    O
invasive    O
follicular    O
thyroid    O
carcinoma    O
.    O

Providing    O
appropriate    O
support    O
to    O
affected    O
families    O
,    O
including    O
expert    O
cardiac    O
pathology    B-Medicine106043075

Synergy    O
also    O
provides    O
a    O
range    O
of    O
laboratory    O
services    O
including    O
occupational    O
pathology    B-Medicine106043075
services    O
and    O
workplace    O
drug    O
and    O
alcohol    O
testing    O
.    O

Adalbert    O
Duchek    O
(;    O
December    O
1    O
,    O
1824    O
–    O
March    O
2    O
,    O
1882    O
)    O
was    O
a    O
Czech    O
internist    O
and    O
pathologist    B-Medicine106043075
who    O
was    O
a    O
native    O
of    O
Prague    O
.    O

Further    O
discrimination    O
may    O
involve    O
labeling    O
some    O
as    O
"    O
high    O
functioning    O
"    O
and    O
some    O
as    O
"    O
low    O
-    O
functioning    O
"    O
;    O
while    O
this    O
may    O
enable    O
the    O
targeting    O
of    O
resources    O
,    O
in    O
both    O
categories    O
human    O
behaviors    O
are    O
recast    O
in    O
pathological    B-Medicine106043075
terms    O
.    O

Eugen    O
Albrecht    O
(    O
21    O
June    O
1872    O
,    O
in    O
Sonthofen    O
–    O
18    O
June    O
1908    O
,    O
in    O
Frankfurt    O
am    O
Main    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
.    O

Hans    O
Schmaus    O
(    O
22    O
May    O
1862    O
in    O
Munich    O
–    O
4    O
December    O
1905    O
in    O
Munich    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
.    O

Gustav    O
Hauser    O
(    O
13    O
July    O
1856    O
in    O
Nördlingen    O
–    O
30    O
June    O
1935    O
in    O
Erlangen    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
and    O
bacteriologist    O
.    O

Ernst    O
Ziegler    O
(    O
17    O
March    O
1849    O
,    O
Messen    O
–    O
30    O
November    O
1905    O
,    O
Freiburg    O
i    O
m    O
Breisgau    O
)    O
was    O
a    O
Swiss    O
pathologist    B-Medicine106043075
.    O

Mourning    O
is    O
considered    O
a    O
healthy    O
and    O
natural    O
process    O
of    O
grieving    O
a    O
loss    O
,    O
while    O
melancholia    O
is    O
considered    O
pathological    B-Medicine106043075
.    O

Eosinophilic    O
granulomatosis    O
with    O
polyangiitis    O
was    O
first    O
described    O
by    O
pathologists    B-Medicine106043075
Jacob    O
Churg    O
(    O
1910–2005    O
)    O
and    O
Lotte    O
Strauss    O
(    O
1913–1985    O
)    O
at    O
Mount    O
Sinai    O
Hospital    O
in    O
New    O
York    O
City    O
in    O
1951    O
,    O
using    O
the    O
term    O
"    O
allergic    O
granulomatosis    O
"    O
to    O
describe    O
it    O
.    O

The    O
first    O
year    O
of    O
the    O
posts    O
in    O
other    O
specialties    O
,    O
such    O
as    O
general    O
practice    O
,    O
emergency    O
medicine    O
,    O
paediatrics    O
,    O
psychiatry    O
,    O
obstetrics    O
or    O
pathology    B-Medicine106043075
.    O

In    O
pathology    B-Medicine106043075
,    O
diastasis    O
is    O
the    O
separation    O
of    O
parts    O
of    O
the    O
body    O
that    O
are    O
normally    O
joined    O
together    O
,    O
such    O
as    O
the    O
separation    O
of    O
certain    O
abdominal    O
muscles    O
during    O
pregnancy    O
,    O
or    O
of    O
adjacent    O
bones    O
without    O
fracture    O
.    O

This    O
is    O
best    O
accomplished    O
by    O
evaluation    O
of    O
the    O
patient    O
's    O
blood    O
,    O
bone    O
marrow    O
,    O
and    O
occasionally    O
lymph    O
node    O
cells    O
by    O
a    O
pathologist    B-Medicine106043075
with    O
specific    O
training    O
in    O
blood    O
disorders    O
.    O

He    O
made    O
important    O
contributions    O
to    O
avian    O
pathology    B-Medicine106043075
,    O
most    O
notably    O
a    O
cure    O
for    O
the    O
hemorrhagic    O
septicemia    O
family    O
of    O
diseases    O
,    O
gaining    O
much    O
respect    O
and    O
some    O
level    O
of    O
sympathy    O
among    O
ornithologists    O
and    O
farmers    O
.    O

In    O
1773    O
,    O
he    O
became    O
an    O
associate    O
professor    O
of    O
botany    O
at    O
Leipzig    O
,    O
where    O
he    O
later    O
served    O
as    O
a    O
professor    O
of    O
pathology    B-Medicine106043075
(    O
1789–96    O
)    O
and    O
therapy    O
(    O
1796–1800    O
)    O
.    O

On    O
3    O
April    O
,    O
it    O
was    O
reported    O
that    O
both    O
the    O
Israeli    O
and    O
Palestinian    O
pathologist    B-Medicine106043075
ruled    O
that    O
it    O
was    O
the    O
bullet    O
of    O
the    O
Kfir    O
Brigade    O
soldier    O
who    O
shot    O
the    O
wounded    O
al    O
-    O
Sharif    O
in    O
Hebron    O
and    O
killed    O
him    O
.    O

On    O
16    O
June    O
,    O
Dr.    O
Hadas    O
Gips    O
,    O
a    O
pathologist    B-Medicine106043075
from    O
the    O
Abu    O
Kabir    O
Forensic    O
Institute    O
,    O
testified    O
before    O
the    O
court    O
.    O

She    O
was    O
later    O
a    O
pathologist    B-Medicine106043075
and    O
expert    O
on    O
syphilis    O
.    O

Dr    O
Jane    O
Mercer    O
,    O
pathologist    B-Medicine106043075
at    O
Eastbourne    O
District    O
General    O
Hospital    O
,    O
reviewed    O
Morrell    O
's    O
case    O
from    O
a    O
modern    O
perspective    O
after    O
the    O
opening    O
of    O
the    O
police    O
archives    O
in    O
2003    O
.    O

It    O
was    O
her    O
transplant    O
in    O
1995    O
which    O
caused    O
her    O
to    O
change    O
her    O
career    O
direction    O
from    O
pathology    B-Medicine106043075
towards    O
the    O
newly    O
developing    O
field    O
of    O
tissue    O
engineering    O
.    O

His    O
specialty    O
was    O
physiology    O
and    O
pathology    B-Medicine106043075
of    O
the    O
eye    O
,    O
particularly    O
in    O
regards    O
to    O
research    O
of    O
eye    O
movement    O
,    O
space    O
perception    O
and    O
diagnosis    O
of    O
oculomotor    O
anomalies    O
.    O

Not    O
all    O
medical    O
microbiologists    O
study    O
microbial    O
pathology    B-Medicine106043075
;    O
some    O
study    O
common    O
,    O
non    O
-    O
pathogenic    O
species    O
to    O
determine    O
whether    O
their    O
properties    O
can    O
be    O
used    O
to    O
develop    O
antibiotics    O
or    O
other    O
treatment    O
methods    O
.    O

Pathology    B-Medicine106043075

His    O
fame    O
as    O
a    O
toxicologist    O
and    O
medical    O
jurist    O
,    O
together    O
with    O
his    O
work    O
on    O
the    O
pathology    B-Medicine106043075
of    O
the    O
kidneys    O
and    O
on    O
fevers    O
,    O
secured    O
him    O
a    O
large    O
private    O
practice    O
,    O
and    O
he    O
succeeded    O
to    O
a    O
fair    O
share    O
of    O
the    O
honors    O
that    O
commonly    O
attend    O
the    O
successful    O
physician    O
,    O
being    O
appointed    O
physician    O
to    O
Queen    O
Victoria    O
in    O
1848    O
and    O
receiving    O
a    O
baronetcy    O
in    O
1871    O
.    O

Theriogenology    O
is    O
the    O
branch    O
of    O
veterinary    O
medicine    O
concerned    O
with    O
reproduction    O
,    O
including    O
the    O
physiology    O
and    O
pathology    B-Medicine106043075
of    O
male    O
and    O
female    O
reproductive    O
systems    O
of    O
animals    O
and    O
the    O
clinical    O
practice    O
of    O
veterinary    O
obstetrics    O
,    O
gynecology    O
,    O
and    O
andrology    B-Medicine106043075
.    O

There    O
is    O
a    O
lack    O
of    O
agreement    O
on    O
its    O
definition    O
,    O
implications    O
or    O
whether    O
it    O
is    O
pathological    B-Medicine106043075
.    O

The    O
main    O
pathological    B-Medicine106043075
characteristics    O
of    O
PD    O
are    O
cell    O
death    O
in    O
the    O
brain    O
's    O
basal    O
ganglia    O
(    O
affecting    O
up    O
to    O
70%    O
of    O
the    O
dopamine    O
secreting    O
neurons    O
in    O
the    O
substantia    O
nigra    O
pars    O
compacta    O
by    O
the    O
end    O
of    O
life    O
)    O
and    O
the    O
presence    O
of    O
Lewy    O
bodies    O
(    O
accumulations    O
of    O
the    O
protein    O
alpha    O
-    O
synuclein    O
)    O
in    O
many    O
of    O
the    O
remaining    O
neurons    O
.    O

In    O
human    O
pathology    B-Medicine106043075
,    O
a    O
gall    O
is    O
a    O
raised    O
sore    O
on    O
the    O
skin    O
,    O
usually    O
caused    O
by    O
chafing    O
or    O
rubbing    O
.    O

Reference    O
ranges    O
for    O
blood    O
tests    O
are    O
studied    O
within    O
the    O
field    O
of    O
clinical    O
chemistry    O
(    O
also    O
known    O
as    O
"    O
clinical    O
biochemistry    O
"    O
,    O
"    O
chemical    O
pathology    O
"    O
or    O
"    O
pure    O
blood    O
chemistry    O
"    O
)    O
,    O
the    O
area    O
of    O
pathology    B-Medicine106043075
that    O
is    O
generally    O
concerned    O
with    O
analysis    O
of    O
bodily    O
fluids    O
.    O

In    O
1897    O
,    O
Christiaan    O
Eijkman    O
,    O
a    O
Dutch    O
physician    O
and    O
pathologist    B-Medicine106043075
,    O
demonstrated    O
that    O
beriberi    O
is    O
caused    O
by    O
poor    O
diet    O
,    O
and    O
discovered    O
that    O
feeding    O
unpolished    O
rice    O
(    O
instead    O
of    O
the    O
polished    O
variety    O
)    O
to    O
chickens    O
helped    O
to    O
prevent    O
beriberi    O
.    O

Although    O
pathologic    B-Medicine106043075
examination    I-Medicine106043075
is    O
the    O
current    O
standard    O
method    O
for    O
molecular    O
characterization    O
in    O
testing    O
for    O
the    O
presence    O
of    O
biomarkers    O
in    O
tumors    O
,    O
these    O
single    O
-    O
sample    O
analyses    O
fail    O
to    O
account    O
for    O
the    O
diverse    O
genomic    O
nature    O
of    O
tumors    O
.    O

Following    O
is    O
a    O
table    O
of    O
the    O
approximate    O
values    O
of    O
the    O
two    O
relaxation    O
time    O
constants    O
for    O
chemicals    O
that    O
commonly    O
show    O
up    O
in    O
human    O
brain    O
magnetic    O
resonance    O
spectroscopy    O
(    O
MRS    O
)    O
studies    O
,    O
physiologically    O
or    O
pathologically    B-Medicine106043075
.    O

In    O
medicine    O
,    O
"    O
patho-    O
"    O
has    O
a    O
more    O
specific    O
meaning    O
of    O
disease    O
(    O
thus    O
"    O
pathology    B-Medicine106043075
"    O
has    O
meant    O
the    O
study    O
of    O
disease    O
since    O
1610    O
,    O
and    O
"    O
psychopathology    O
"    O
has    O
meant    O
the    O
study    O
of    O
mental    O
disorder    O
in    O
general    O
since    O
1847    O
.    O

Even    O
though    O
SHR    O
is    O
usually    O
considered    O
to    O
be    O
a    O
purely    O
pathological    B-Medicine106043075
model    O
,    O
the    O
strain    O
exhibit    O
interesting    O
compensatory    O
abilities    O
.    O

It    O
weaves    O
fable    O
,    O
fiction    O
,    O
science    O
,    O
and    O
metaphor    O
to    O
tell    O
the    O
story    O
of    O
Hope    O
,    O
a    O
pathologist    B-Medicine106043075
who    O
embarks    O
on    O
an    O
unusual    O
journey    O
of    O
reconciliation    O
.    O

The    O
induction    O
of    O
type    O
2    O
cytokines    O
by    O
IL-33    O
"    O
in    O
vivo    O
"    O
is    O
believed    O
to    O
induce    O
the    O
severe    O
pathological    B-Medicine106043075
changes    O
observed    O
in    O
mucosal    O
organs    O
following    O
administration    O
of    O
IL-33    O
.    O

1916    O
Pathologist    B-Medicine106043075
Henrique    O
da    O
Rocha    O
Lima    O
identifies    O
the    O
causative    O
agent    O
(    O
"    O
Rickettsia    O
prowazeki    O
"    O
)    O
of    O
epidemic    O
typhus    O
.    O

In    O
dermatologic    O
pathology    B-Medicine106043075
,    O
a    O
dermal    O
cylindroma    O
,    O
also    O
dermal    O
eccrine    O
cylindroma    O
or    O
Cutaneous    O
Cylindroma    O
)    O
and    O
(    O
less    O
specifically    O
)    O
cylindroma    O
,    O
is    O
a    O
benign    O
adnexal    O
tumor    O
,    O
which    O
occurs    O
on    O
the    O
scalp    O
and    O
forehead.when    O
multiple    O
Cylindroma    O
-    O
Show    O
Hat    O
like    O
configration    O
.    O

From    O
1922    O
to    O
1925    O
,    O
Bailey    O
performed    O
extensive    O
pathological    B-Medicine106043075
and    O
histological    O
studies    O
of    O
brain    O
tumors    O
,    O
and    O
based    O
on    O
cellular    O
configuration    O
,    O
he    O
created    O
a    O
classification    O
system    O
of    O
thirteen    O
categories    O
.    O

The    O
different    O
isoforms    O
are    O
also    O
associated    O
with    O
different    O
pathologies    B-Medicine106043075
associated    O
with    O
abnormalities    O
in    O
lipid    O
metabolism    O
.    O

By    O
using    O
animal    O
models    O
,    O
the    O
underlying    O
molecular    O
alterations    O
and    O
the    O
causal    O
relationship    O
between    O
genetic    O
or    O
environmental    O
alterations    O
and    O
depression    O
can    O
be    O
examined    O
,    O
which    O
would    O
afford    O
a    O
better    O
insight    O
into    O
pathology    B-Medicine106043075
of    O
depression    O
.    O

Antidepressant    O
screening    O
tests    O
,    O
not    O
like    O
the    O
models    O
which    O
can    O
be    O
defined    O
as    O
an    O
[    O
organism    O
]    O
or    O
a    O
particular    O
state    O
of    O
an    O
organism    O
that    O
reproduces    O
aspects    O
of    O
human    O
pathology    B-Medicine106043075
,    O
provide    O
only    O
an    O
end    O
-    O
point    O
behavioral    O
or    O
physiological    O
measure    O
designed    O
to    O
assess    O
the    O
effect    O
of    O
the    O
genetic    O
,    O
pharmacological    O
,    O
or    O
environmental    O
manipulation    O
.    O

Since    O
the    O
majority    O
of    O
stress    O
stimuli    O
in    O
humans    O
that    O
lead    O
to    O
pathological    B-Medicine106043075
changes    O
are    O
of    O
social    O
nature    O
,    O
SDS    O
model    O
have    O
gained    O
increasing    O
attention    O
as    O
they    O
might    O
render    O
useful    O
to    O
study    O
certain    O
endophenotypes    O
of    O
depression    O
.    O

GCCs    O
are    O
diagnosed    O
by    O
pathology    B-Medicine106043075
.    O

Louis    O
B.    O
Wilson    O
,    O
M.D.    O
was    O
the    O
chief    O
of    O
pathology    B-Medicine106043075
at    O
Mayo    O
Clinic    O
from    O
1905    O
to    O
1937    O
.    O

Pathology    B-Medicine106043075

The    O
school    O
also    O
has    O
departments    O
in    O
the    O
following    O
clinical    O
practices    O
:    O
Anesthesiology    O
and    O
Critical    B-Medicine106043075
Care    I-Medicine106043075
,    O
Dermatology    O
,    O
Emergency    O
Medicine    O
,    O
Family    O
Practice    O
and    O
Community    O
Medicine    O
,    O
Medicine    O
,    O
Neurology    O
,    O
Neurosurgery    O
,    O
Obstetrics    O
and    O
Gynecology    O
,    O
Ophthalmology    O
(    O
See    O
Scheie    O
Eye    O
Institute    O
)    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
,    O
Pathology    B-Medicine106043075
and    O
Laboratory    O
Medicine    O
,    O
Pediatrics    O
(    O
See    O
Children    O
's    O
Hospital    O
of    O
Philadelphia    O
)    O
,    O
Physical    O
Medicine    O
and    O
Rehabilitation    O
,    O
Psychiatry    O
,    O
Radiation    O
Oncology    O
,    O
Radiology    O
,    O
and    O
Surgery    O
.    O

His    O
most    O
famous    O
book    O
was    O
"    O
The    O
Book    O
of    O
Causes    O
and    O
Symptoms    O
"    O
,    O
a    O
comprehensive    O
manual    O
of    O
therapeutics    O
and    O
pathology    B-Medicine106043075
.    O

The    O
field    O
of    O
ecopsychology    O
intends    O
to    O
illustrate    O
how    O
environmental    O
disconnection    O
functions    O
as    O
an    O
aspect    O
of    O
existing    O
pathologies    B-Medicine106043075
,    O
without    O
creating    O
a    O
new    O
category    O
.    O

Smaller    O
-    O
sized    O
seminar    O
rooms    O
are    O
utilized    O
by    O
the    O
speech    O
and    O
language    O
pathologist    B-Medicine106043075
,    O
reading    O
specialist    O
,    O
and    O
school    O
psychologist    O
.    O

She    O
also    O
had    O
a    O
recurring    O
role    O
in    O
the    O
Australian    O
drama    O
,    O
"    O
Murder    O
Call    O
"    O
as    O
Pathologist    B-Medicine106043075
,    O
Dr.    O
Imogen    O
Soames    O
between    O
1997–2000    O
.    O

Currently    O
has    O
eight    O
hospital    O
departments    O
,    O
all    O
of    O
which    O
are    O
currently    O
accredited    O
with    O
their    O
respective    O
specialty    O
societies    O
except    O
for    O
EENT    O
and    O
Pathology    B-Medicine106043075
which    O
are    O
still    O
in    O
the    O
process    O
of    O
accreditation    O
with    O
the    O
DOH    O
.    O

Edward    O
Joseph    O
Lister    O
Lowbury    O
(    O
December    O
12    O
,    O
1913    O
-    O
July    O
10    O
,    O
2007    O
)    O
was    O
a    O
pioneering    O
and    O
innovative    O
English    O
medical    O
bacteriologist    O
and    O
pathologist    B-Medicine106043075
,    O
and    O
also    O
a    O
published    O
poet    O
.    O

In    O
1988    O
he    O
began    O
a    O
training    O
to    O
become    O
a    O
pathologist    B-Medicine106043075
at    O
the    O
National    O
Cancer    O
Institute    O
of    O
the    O
National    O
Institutes    O
of    O
Health    O
.    O

Eugen    O
Woldemar    O
Bostroem    O
(    O
October    O
13    O
,    O
1850    O
–    O
May    O
24    O
,    O
1928    O
)    O
was    O
a    O
Baltic    O
German    O
pathologist    B-Medicine106043075
.    O

From    O
1883    O
to    O
1926    O
he    O
was    O
a    O
professor    O
of    O
general    O
pathology    B-Medicine106043075
and    O
pathological    O
anatomy    O
in    O
Gießen    O
.    O

From    O
1897    O
to    O
1903    O
he    O
was    O
a    O
professor    O
of    O
comparative    O
and    O
experimental    O
pathology    B-Medicine106043075
in    O
Paris    O
,    O
becoming    O
a    O
member    O
of    O
the    O
Académie    O
de    O
Médecine    O
in    O
1901    O
.    O

Abdulmumini    O
Hassan    O
Rafindadi    O
(    O
born    O
15    O
January    O
1957    O
)    O
is    O
a    O
Nigerian    O
professor    O
of    O
pathology    B-Medicine106043075
,    O
educational    O
administrator    O
,    O
and    O
pioneer    O
vice    O
chancellor    O
of    O
Federal    O
University    O
,    O
Lokoja    O
,    O
located    O
in    O
Lokoja    O
,    O
Kogi    O
State    O
,    O
Nigeria    O
.    O

He    O
joined    O
the    O
service    O
of    O
Ahmadu    O
Bello    O
University    O
in    O
1994    O
as    O
a    O
lecturer    O
and    O
in    O
2004    O
he    O
was    O
appointed    O
a    O
professor    O
of    O
pathology    B-Medicine106043075
.    O

From    O
1912    O
he    O
lectured    O
in    O
Pathology    B-Medicine106043075
lecturer    O
at    O
Glasgow    O
University    O
,    O
and    O
started    O
to    O
specialise    O
in    O
streptococci    O
.    O

This    O
affected    O
some    O
of    O
my    O
strong    O
convictions    O
acquired    O
in    O
my    O
work    O
and    O
study    O
of    O
clinical    O
pathology    B-Medicine106043075
.    O

Herman    O
Maximilien    O
de    O
Burlet    O
(    O
Rotterdam    O
,    O
6    O
November    O
1883    O
–    O
Königswinter    O
,    O
1957    O
)    O
,    O
was    O
a    O
Dutch    O
anatomist    O
,    O
embryologist    O
,    O
physiologist    O
and    O
pathologist    B-Medicine106043075
.    O

Home    O
Office    O
pathologist    B-Medicine106043075
Francis    O
Camps    O
,    O
however    O
,    O
suspected    O
Adams    O
of    O
causing    O
the    O
deaths    O
of    O
163    O
patients    O
in    O
total    O
.    O

Staging    O
may    O
also    O
be    O
categorized    O
as    O
either    O
clinical    O
or    O
as    O
pathological    B-Medicine106043075
/    O
surgical    O
staging    O
.    O

Pathologic    B-Medicine106043075
staging    O
is    O
more    O
accurate    O
than    O
clinical    O
staging    O
,    O
but    O
clinical    O
staging    O
is    O
the    O
first    O
and    O
sometimes    O
the    O
only    O
staging    O
type    O
.    O

Clinical    O
Pathology    B-Medicine106043075
lab    O

She    O
was    O
a    O
pathologist    B-Medicine106043075
noted    O
for    O
establishing    O
cancer    O
prevention    O
clinics    O
in    O
New    O
York    O
.    O

Justus    O
Wilhelm    O
Martin    O
Radius    O
(    O
14    O
November    O
1797    O
,    O
in    O
Leipzig    O
–    O
7    O
March    O
1884    O
,    O
in    O
Leipzig    O
)    O
was    O
a    O
German    O
pathologist    B-Medicine106043075
and    O
ophthalmologist    O
.    O

He    O
was    O
appointed    O
by    O
the    O
governor    O
of    O
Lagos    O
State    O
,    O
Akinwunmi    O
Ambode    O
to    O
succeed    O
professor    O
John    O
Obafunwa    O
,    O
a    O
Nigerian    O
pathologist    B-Medicine106043075
whose    O
tenure    O
ended    O
on    O
31    O
October    O
2015    O
.    O

His    O
early    O
studies    O
were    O
directed    O
chiefly    O
to    O
anatomical    O
pathology    B-Medicine106043075
.    O

Richard    O
Paltauf    O
(    O
9    O
February    O
1858    O
–    O
21    O
April    O
1924    O
)    O
was    O
an    O
Austrian    O
pathologist    B-Medicine106043075
and    O
bacteriologist    O
born    O
in    O
Judenburg    O
,    O
Styria    O
.    O

He    O
is    O
known    O
for    O
his    O
studies    O
of    O
blood    O
diseases    O
and    O
his    O
research    O
on    O
the    O
pathology    B-Medicine106043075
of    O
the    O
spleen    O
.    O

He    O
was    O
the    O
son    O
of    O
pathologist    B-Medicine106043075
Heinrich    O
von    O
Bamberger    O
(    O
1822–1888    O
)    O
.    O

In    O
1961    O
,    O
Epstein    O
,    O
a    O
pathologist    B-Medicine106043075
and    O
expert    O
electron    O
microscopist    O
,    O
attended    O
a    O
lecture    O
on    O
"    O
The    O
Commonest    O
Children    O
's    O
Cancer    O
in    O
Tropical    O
Africa—    O

The    O
Ramirez    O
family    O
's    O
pathologist    B-Medicine106043075
was    O
unable    O
to    O
determine    O
a    O
cause    O
of    O
death    O
because    O
her    O
heart    O
was    O
missing    O
,    O
her    O
other    O
organs    O
were    O
cross    O
-    O
contaminated    O
with    O
fecal    O
matter    O
,    O
and    O
her    O
body    O
was    O
too    O
badly    O
decomposed    O
.    O

OAs    O
are    O
also    O
required    O
to    O
collect    O
blood    O
products    O
from    O
the    O
blood    O
bank    O
and    O
deliver    O
urgent    O
frozen    O
section    O
samples    O
to    O
the    O
pathology    B-Medicine106043075
laboratory    O
.    O

Franz    O
Büchner    O
(    O
20    O
January    O
1895    O
–    O
9    O
March    O
1991    O
)    O
was    O
a    O
prominent    O
German    O
pathologist    B-Medicine106043075
of    O
the    O
20th    O
century    O
.    O

Atkinson    O
next    O
received    O
a    O
Ph.D.    O
from    O
the    O
Department    O
of    O
Pathology    B-Medicine106043075
at    O
the    O
University    O
of    O
Florida    O
in    O
1987    O
.    O

Simeon    O
Burt    O
Wolbach    O
,    O
pathologist    B-Medicine106043075

John    O
E.    O
Dohms    O
(    O
1948    O
-    O
2012    O
)    O
,    O
researcher    O
of    O
the    O
pathology    B-Medicine106043075
of    O
avian    O
diseases    O
.    O

Tamara    O
Taylor    O
as    O
Dr.    O
Camille    O
Saroyan    O
(    O
seasons    O
2–12    O
)    O
:    O
Succeeds    O
Dr.    O
Goodman    O
as    O
the    O
head    O
of    O
the    O
Forensic    O
Division    O
at    O
Jeffersonian    O
Institute    O
and    O
is    O
a    O
pathologist    B-Medicine106043075
.    O

Pathology    B-Medicine106043075

The    O
classified    O
IDF    O
report    O
made    O
no    O
mention    O
of    O
the    O
pathologist    B-Medicine106043075
's    O
conclusion    O
.    O

A    O
Norwegian    O
study    O
in    O
1928    O
had    O
reported    O
on    O
the    O
pathologic    B-Medicine106043075
manifestations    O
of    O
untreated    O
syphilis    O
in    O
several    O
hundred    O
white    O
males    O
.    O

The    O
degree    O
is    O
awarded    O
after    O
three    O
years    O
of    O
pre    O
-    O
clinical    O
instruction    O
and    O
examination    O
in    O
anatomy    O
,    O
physiology    O
,    O
biochemistry    O
,    O
microbiology    O
,    O
pathology    B-Medicine106043075
,    O
and    O
pharmacology    O
,    O
followed    O
by    O
two    O
years    O
of    O
clinical    O
instruction    O
and    O
examination    O
in    O
general    O
surgery    O
,    O
internal    O
medicine    O
,    O
pediatrics    O
,    O
obstetrics    O
&    O
gynecology    O
,    O
psychiatry    O
,    O
otolaryngology    O
,    O
neurosurgery    O
,    O
orthopedics    B-Medicine106043075
,    O
anesthesiology    O
,    O
urology    O
,    O
and    O
public    O
health    O
.    O

Research    O
programs    O
were    O
developed    O
for    O
biology    O
(    O
zoology    O
and    O
botany    O
)    O
,    O
bacteriology    O
,    O
limnology    O
,    O
biochemistry    O
,    O
animal    O
and    O
human    O
physiology    O
,    O
pathology    B-Medicine106043075
,    O
ecology    O
,    O
oceanography    O
,    O
meteorology    O
,    O
cosmic    O
rays    O
and    O
ionospheric    O
observations    O
,    O
environmental    O
nuclear    O
radiation    O
,    O
continental    O
and    O
sea    O
ice    O
glaciology    O
,    O
satellite    O
geodesy    O
,    O
geology    O
,    O
geophysics    O
,    O
seismology    O
,    O
ozone    O
monitoring    O
and    O
tide    O
measurement    O
.    O

#    O
Department    O
of    O
Pathology    B-Medicine106043075
and    O
Microbiology    O

The    O
team    O
takes    O
on    O
the    O
case    O
of    O
Dr.    O
Peter    O
Treiber    O
,    O
a    O
pathologist    B-Medicine106043075
at    O
Princeton    O
-    O
Plainsboro    O
Teaching    O
Hospital    O
who    O
knows    O
too    O
much    O
about    O
the    O
hospital    O
staff    O
to    O
trust    O
any    O
of    O
the    O
physicians    O
,    O
thus    O
adding    O
to    O
the    O
drama    O
.    O

Vladimir    O
Kanjuh    O
(    O
Serbian    O
Cyrillic    O
:    O
Владимир    O
Кањух    O
;    O
Ohrid    O
,    O
4    O
March    O
1929    O
)    O
,    O
is    O
a    O
professor    O
of    O
pathology    B-Medicine106043075
and    O
cardiovascular    O
pathology    O
at    O
the    O
University    O
of    O
Belgrade    O
's    O
School    O
of    O
Medicine    O
.    O

#    O
Pathology    B-Medicine106043075
Museum    O

They    O
were    O
first    O
characterized    O
in    O
1907    O
by    O
Siegfried    O
Oberndorfer    O
,    O
a    O
German    O
pathologist    B-Medicine106043075
at    O
the    O
University    O
of    O
Munich    O
,    O
who    O
coined    O
the    O
term    O
"    O
karzinoide    O
"    O
,    O
or    O
"    O
carcinoma    O
-    O
like    O
"    O
,    O
to    O
describe    O
the    O
unique    O
feature    O
of    O
behaving    O
like    O
a    O
benign    O
tumor    O
despite    O
having    O
a    O
malignant    O
appearance    O
microscopically    O
.    O

In    O
1872    O
he    O
became    O
habilitated    O
for    O
special    O
pathology    B-Medicine106043075
and    O
therapy    O
(    O
internal    O
medicine    O
)    O
,    O
and    O
from    O
1874    O
was    O
a    O
professor    O
of    O
internal    O
medicine    O
at    O
the    O
University    O
of    O
Dorpat    O
.    O

The    O
Pathology    O
Atlas    O
also    O
contains    O
5    O
million    O
pathology    B-Medicine106043075
-    O
based    O
images    O
generated    O
by    O
the    O
Human    O
Protein    O
Atlas    O
consortium    O
.    O

Pathology    B-Medicine106043075
Division    O

In    O
1837    O
Alcock    O
became    O
the    O
first    O
Professor    O
of    O
anatomy    O
,    O
physiology    O
and    O
pathology    B-Medicine106043075
at    O
Queen    O
's    O
College    O
,    O
Cork    O
working    O
there    O
for    O
more    O
than    O
ten    O
years    O
at    O
the    O
Apothecaries    O
'    O
Hall    O
.    O

It    O
consists    O
of    O
Emergency    O
Care    O
Center    O
,    O
12    O
clinics    O
,    O
National    O
Institute    O
of    O
Public    O
Health    O
,    O
Central    O
Pharmacy    O
,    O
Private    O
Pharmacies    O
,    O
and    O
Institutes    O
like    O
Anatomy    O
,    O
Pathology    B-Medicine106043075
,    O
Physiology    O
,    O
Pharmacology    O
and    O
Toxicology    O
.    O

There    O
are    O
many    O
services    O
offered    O
including    O
gastroenterology    O
,    O
cardiology    O
,    O
neonatology    O
,    O
neurology    O
,    O
pathology    B-Medicine106043075
,    O
pediatrics    O
,    O
urology    O
and    O
different    O
types    O
of    O
surgeries    O
.    O

Emilio    O
Veratti    O
(    O
24    O
March    O
1872    O
,    O
Varese    O
–    O
24    O
February    O
1967    O
)    O
was    O
an    O
Italian    O
anatomist    O
and    O
pathologist    B-Medicine106043075
.    O

He    O
is    O
veterinarian    O
,    O
with    O
specializations    O
received    O
in    O
health    O
-    O
related    O
sciences    O
including    O
pathology    B-Medicine106043075
,    O
endocrinology    O
,    O
quantitative    O
genetics    O
,    O
epidemiology    O
and    O
public    O
health    O
.    O

The    O
courses    O
offered    O
during    O
the    O
1860s    O
and    O
1870s    O
included    O
physiology    O
,    O
descriptive    O
and    O
practical    O
anatomy    O
,    O
chemistry    O
,    O
principles    O
and    O
practices    O
of    O
medicine    O
and    O
of    O
surgery    O
,    O
pathology    B-Medicine106043075
,    O
forensic    O
medicine    O
and    O
midwifery    O
.    O

He    O
qualified    O
in    O
1896    O
and    O
in    O
the    O
following    O
year    O
was    O
awarded    O
the    O
Golding    O
-    O
Bird    O
gold    O
medal    O
and    O
scholarship    O
in    O
public    O
health    O
,    O
and    O
the    O
Gull    O
research    O
scholarship    O
in    O
pathology    B-Medicine106043075
.    O

They    O
are    O
diagnosed    O
by    O
pathologists    B-Medicine106043075
by    I-Medicine106043075
taking    I-Medicine106043075
a    I-Medicine106043075
sample    I-Medicine106043075
of    I-Medicine106043075
the    I-Medicine106043075
tumour    I-Medicine106043075
via    I-Medicine106043075
Fine    I-Medicine106043075
Needle    I-Medicine106043075
Aspiration    I-Medicine106043075
or    I-Medicine106043075
Core    I-Medicine106043075
Needle    I-Medicine106043075
Aspiration    I-Medicine106043075
or    O
from    O
a    O
splenectomy    O
.    O

physiology    O
,    O
pathology    B-Medicine106043075
,    O
anatomy    O
,    O

They    O
are    O
named    O
after    O
German    O
pathologist    B-Medicine106043075
,    O
Karl    O
Gottfried    O
Paul    O
Döhle    O
(    O
1855    O
-    O
1928    O
)    O
.    O

To    O
complete    O
his    O
work    O
on    O
the    O
pathology    B-Medicine106043075
of    O
the    O
new    O
disease    O
,    O
Chagas    O
described    O
27    O
cases    O
of    O
the    O
acute    O
form    O
of    O
the    O
disease    O
and    O
performed    O
more    O
than    O
100    O
autopsies    O
on    O
patients    O
who    O
exhibited    O
the    O
chronic    O
form    O
.    O

Her    O
skill    O
in    O
pathology    B-Medicine106043075
usually    O
helps    O
by    O
revealing    O
a    O
great    O
deal    O
of    O
useful    O
evidence    O
to    O
aid    O
Murdoch    O
in    O
solving    O
cases    O
.    O

It    O
focuses    O
on    O
the    O
discovery    O
and    O
pathologies    B-Medicine106043075
of    O
the    O
"    O
Allosaurus    O
"    O
specimen    O
nicknamed    O
Big    O
Al    O
.    O

Sanford    O
H.    O
Barsky    O
is    O
an    O
American    O
professor    O
of    O
pathology    B-Medicine106043075
and    O
a    O
writer    O
of    O
more    O
than    O
150    O
peer    O
reviewed    O
articles    O
.    O

Jonathan    O
Braun    O
is    O
an    O
American    O
professor    O
of    O
pathology    B-Medicine106043075
and    O
pharmacology    O
who    O
have    O
more    O
than    O
140    O
peer    O
reviewed    O
articles    O
.    O

Christopher    O
D.    O
M.    O
Fletcher    O
(    O
born    O
March    O
13    O
,    O
1958    O
)    O
is    O
a    O
British    O
pathologist    B-Medicine106043075
who    O
has    O
written    O
more    O
than    O
500    O
peer    O
reviewed    O
articles    O
and    O
is    O
a    O
chairman    O
of    O
the    O
World    O
Health    O
Organization    O
's    O
Working    O
Group    O
on    O
the    O
Pathology    O
and    O
Genetics    O
of    O
Tumours    O
of    O
Soft    O
Tissue    O
and    O
Bone    O
.    O

At    O
the    O
age    O
of    O
17    O
Hamilton    O
became    O
a    O
medical    O
student    O
at    O
Edinburgh    O
,    O
and    O
was    O
drawn    O
to    O
pathology    B-Medicine106043075
by    O
William    O
Rutherford    O
Sanders    O
.    O

Thomas    O
Strangeways    O
Pigg    O
Strangeways    O
(    O
1866    O
-    O
1926    O
)    O
was    O
a    O
British    O
pathologist    B-Medicine106043075
,    O
known    O
for    O
founding    O
the    O
Cambridge    O
Research    O
Hospital    O
,    O
which    O
was    O
renamed    O
the    O
Strangeways    O
Research    O
Laboratory    O
following    O
Strangeways    O
'    O
death    O
in    O
1926    O
.    O

25    O
November    O
–    O
Cecil    O
George    O
Paine    O
,    O
a    O
pathologist    B-Medicine106043075
at    O
the    O
Sheffield    O
Royal    O
Infirmary    O
,    O
achieves    O
the    O
first    O
recorded    O
cure    O
(    O
of    O
an    O
eye    O
infection    O
)    O
using    O
penicillin    O
.    O

In    O
the    O
U.S.    O
,    O
the    O
Penrose    O
Research    O
Laboratory    O
of    O
the    O
Philadelphia    O
Zoo    O
focuses    O
on    O
the    O
study    O
of    O
comparative    O
pathology    B-Medicine106043075
.    O

He    O
eventually    O
decided    O
to    O
move    O
on    O
and    O
starts    O
dating    O
pathologist    B-Medicine106043075
,    O
Nina    O
Shore    O
(    O
portrayed    O
by    O
Patti    O
Murin    O
,    O
the    O
real    O
-    O
life    O
wife    O
of    O
Gehlfuss    O
'    O
co    O
-    O
star    O
Colin    O
Donnell    O
)    O
.    O

Later    O
researchers    O
suggested    O
that    O
the    O
bone    O
was    O
pathologic    B-Medicine106043075
,    O
showing    O
an    O
injury    O
to    O
the    O
living    O
animal    O
,    O
and    O
that    O
part    O
of    O
the    O
unusual    O
form    O
of    O
the    O
rear    O
of    O
the    O
bone    O
was    O
due    O
to    O
plaster    O
reconstruction    O
.    O

Pathology    B-Medicine106043075
and    O
Pediatrics    O

Fritz    O
Köberle    O
,    O
professor    O
of    O
Pathology    B-Medicine106043075
,    O
proponent    O
of    O
the    O
neurogenic    O
theory    O
of    O
the    O
chronic    O
phase    O
of    O
Chagas    O
disease    O

Its    O
members    O
make    O
up    O
a    O
multi    O
-    O
disciplinary    O
group    O
,    O
consisting    O
of    O
gynecologic    O
oncologists    O
,    O
medical    O
oncologists    O
,    O
pathologists    B-Medicine106043075
,    O
radiation    O
oncologists    O
,    O
nurses    O
,    O
statisticians    O
,    O
and    O
basic    O
scientists    O
.    O

John    O
Hughes    O
Bennett    O
PRCPE    O
FRSE    O
(    O
31    O
August    O
1812    O
–    O
25    O
September    O
1875    O
)    O
was    O
an    O
English    O
physician    O
,    O
physiologist    O
and    O
pathologist    B-Medicine106043075
.    O

Sir    O
Jonathan    O
Hutchinson    O
(    O
23    O
July    O
1828    O
–    O
23    O
June    O
1913    O
)    O
,    O
was    O
an    O
English    O
surgeon    O
,    O
ophthalmologist    O
,    O
dermatologist    O
,    O
venereologist    B-Medicine106043075
and    O
pathologist    B-Medicine106043075
.    O

Neuromuscular    O
disease    O
is    O
a    O
very    O
broad    O
term    O
that    O
encompasses    O
many    O
diseases    O
and    O
ailments    O
that    O
impair    O
the    O
functioning    O
of    O
the    O
muscles    O
,    O
either    O
directly    O
,    O
being    O
pathologies    B-Medicine106043075
of    O
the    O
voluntary    O
muscle    O
,    O
or    O
indirectly    O
,    O
being    O
pathologies    O
of    O
nerves    O
or    O
neuromuscular    O
junctions    O
.    O

benign    O
pathology    B-Medicine106043075
(    O
cysts    O
,    O
tumors    O
etc    O
.    O
)    O

Albert    O
Neuberger    O
professor    O
of    O
chemical    O
pathology    B-Medicine106043075

Cytopathology    O
–    O
a    O
branch    O
of    O
pathology    B-Medicine106043075
that    O
studies    O
and    O
diagnoses    O
diseases    O
on    O
the    O
cellular    O
level    O
.    O

Pathology    B-Medicine106043075
–    O
study    O
of    O
causes    O
and    O
pathogenesis    O
of    O
diseases    O
.    O

Pathology    B-Medicine106043075
–    O
study    O
of    O
disease    O
,    O
including    O
the    O
causes    O
,    O
course    O
,    O
progression    O
and    O
resolution    O
thereof    O
.    O

In    O
1905    O
he    O
relocated    O
to    O
London    O
,    O
where    O
he    O
worked    O
as    O
registrar    O
and    O
pathologist    B-Medicine106043075
at    O
the    O
National    O
Hospital    O
,    O
Queens    O
Square    O
.    O

Charles    O
-    O
Joseph    O
Bouchard    O
(    O
6    O
September    O
1837    O
–    O
28    O
October    O
1915    O
)    O
was    O
a    O
French    O
pathologist    B-Medicine106043075
and    O
an    O
esperantist    O
born    O
in    O
Montier    O
-    O
en    O
-    O
Der    O
,    O
a    O
commune    O
the    O
department    O
of    O
Haute    O
-    O
Marne    O
.    O

Michael    O
Wells    O
is    O
the    O
president    O
of    O
the    O
European    O
Society    O
of    O
Pathology    B-Medicine106043075
.    O

In    O
vertebrates    O
,    O
mineralized    O
tissues    O
not    O
only    O
develop    O
through    O
normal    O
physiological    O
processes    O
,    O
but    O
can    O
also    O
be    O
involved    O
in    O
pathological    B-Medicine106043075
processes    O
.    O

Systems    O
also    O
exist    O
to    O
classify    O
TBI    O
by    O
its    O
pathological    B-Medicine106043075
features    O
.    O

From    O
1940–1946    O
he    O
was    O
a    O
Captain    O
and    O
Major    O
in    O
the    O
Australian    O
Army    O
Medical    O
Corps    O
with    O
service    O
in    O
Australia    O
,    O
Palestine    O
,    O
Egypt    O
,    O
New    O
Guinea    O
,    O
and    O
Borneo    O
,    O
as    O
medical    O
officer    O
in    O
field    O
ambulance    O
and    O
casualty    O
clearing    O
station    O
,    O
pathologist    B-Medicine106043075
to    O
general    O
hospital    O
,    O
and    O
malariologist    O
.    O

Dr.    O
Martin    O
is    O
a    O
Professor    O
Emeritus    O
(    O
Active    O
)    O
in    O
the    O
Department    O
of    O
Pathology    B-Medicine106043075
,    O
Adjunct    O
Professor    O
of    O
Genome    O
Sciences    O
(    O
Retired    O
)    O
and    O
Director    O
Emeritus    O
of    O
the    O
University    O
of    O
Washington    O
’s    O
Alzheimer    O
's    O
Disease    O
Research    O
Center    O
.    O

Prussian    O
blue    O
is    O
a    O
common    O
stain    O
used    O
by    O
pathologist    B-Medicine106043075
to    O
detect    O
the    O
presence    O
of    O
iron    O
in    O
biopsy    O
specimens    O
,    O
such    O
as    O
deposits    O
of    O
storage    O
ferritin    O
in    O
bone    O
marrow    O
biopsy    O
samples    O
.    O

Morten    O
Ansgar    O
Kveim    O
(    O
27    O
December    O
189    O
–    O
24    O
March    O
1966    O
)    O
was    O
a    O
Norwegian    O
pathologist    B-Medicine106043075
most    O
remembered    O
for    O
describing    O
the    O
Kveim    O
test    O
.    O

Franz    O
Dittrich    O
(    O
16    O
October    O
1815    O
–    O
29    O
August    O
1859    O
)    O
was    O
an    O
Austrian    O
pathologist    B-Medicine106043075
born    O
in    O
Nixdorf    O
,    O
Bohemia    O
(    O
today    O
Mikulášovice    O
,    O
Czech    O
Republic    O
)    O
.    O

Pathology    B-Medicine106043075

He    O
has    O
two    O
doctorates    O
:    O
one    O
in    O
Pathology    B-Medicine106043075
,    O
from    O
the    O
Autonomous    O
University    O
of    O
Madrid    O
and    O
one    O
in    O
Medicine    O
from    O
the    O
UANL    O
.    O

In    O
a    O
voice    O
-    O
over    O
narration    O
,    O
Mulder    O
traces    O
Pfaster    O
's    O
pathology    B-Medicine106043075
to    O
his    O
childhood    O
,    O
when    O
he    O
was    O
raised    O
in    O
a    O
family    O
of    O
four    O
older    O
sisters    O
.    O

Hoochie    O
and    O
his    O
party    O
visits    O
Lenus    O
City    O
and    O
solves    O
affairs    O
with    O
the    O
city    O
's    O
arena    O
,    O
and    O
at    O
the    O
next    O
city    O
they    O
visit    O
,    O
Fief    O
Carlyle    O
,    O
they    O
face    O
difficulties    O
from    O
a    O
strange    O
pathological    B-Medicine106043075
phenomenon    O
all    O
over    O
the    O
city    O
.    O

"    O
Vorlesungen    O
über    O
spezielle    O
Pathologie    O
und    O
Therapie    O
"    O
,    O
(    O
Lectures    O
on    O
Special    O
Pathology    B-Medicine106043075
and    O
Therapy    O
)    O
;    O
2    O
volumes    O
,    O
1866/1872    O
.    O

A    O
pathology    B-Medicine106043075
laboratory    O
was    O
also    O
established    O
in    O
June    O
2001    O
,    O
to    O
facilitate    O
the    O
work    O
of    O
the    O
Breast    O
Health    O
and    O
Gynecology    O
Departments    O
.    O

175    O
Pathology    B-Medicine106043075
,    O
Human    O
and    O
Animal    O

Shortly    O
afterwards    O
,    O
pathologist    B-Medicine106043075
Tadeusz    O
Browicz    O
(    O
1847    O
-    O
1928    O
)    O
from    O
Jagellonian    O
University    O
in    O
Krakow    O
,    O
correctly    O
identified    O
them    O
as    O
macrophages    O
.    O

Frédéric    O
Justin    O
Collet    O
(    O
28    O
April    O
1870    O
–    O
1966    O
)    O
was    O
a    O
French    O
pathologist    B-Medicine106043075
and    O
otolaryngologist    O
.    O

MEN1    O
mutations    O
comprise    O
mostly    O
frameshift    O
deletions    O
or    O
insertions    O
,    O
followed    O
by    O
nonsense    O
,    O
missense    O
,    O
splice    O
-    O
site    O
mutations    O
and    O
either    O
part    O
or    O
complete    O
gene    O
deletions    O
resulting    O
in    O
disease    O
pathology    B-Medicine106043075
.    O

He    O
also    O
had    O
been    O
said    O
to    O
have    O
hands    O
13    O
inches    O
long    O
and    O
feet    O
19    O
inches    O
long    O
,    O
and    O
appears    O
in    O
photographs    O
to    O
be    O
proportionate    O
/    O
not    O
obviously    O
a    O
pathological    B-Medicine106043075
(    O
acromegalic    O
,    O
for    O
example    O
)    O
giant    O
.    O

He    O
received    O
his    O
MBBS    O
degree    O
in    O
1966    O
at    O
the    O
University    O
of    O
Queensland    O
(    O
and    O
later    O
the    O
M.D.    O
)    O
,    O
and    O
completed    O
residency    O
training    O
in    O
pathology    B-Medicine106043075
at    O
that    O
institution    O
and    O
the    O
Mayo    O
Clinic    O
in    O
Rochester    O
,    O
MN    O
in    O
the    O
U.S.    O
Weedon    O
has    O
authored    O
two    O
notable    O
books    O
in    O
the    O
field    O
of    O
pathology    O
.    O

In    O
1889    O
,    O
he    O
qualified    O
as    O
a    O
lecturer    O
of    O
comparative    O
anatomy    O
,    O
and    O
in    O
1912    O
,    O
was    O
appointed    O
an    O
associate    O
professor    O
to    O
the    O
museum    O
of    O
pathology    B-Medicine106043075
at    O
the    O
University    O
of    O
Berlin    O
.    O

Janet    O
Simpson    O
Ferguson    O
Niven    O
FCPath    O
,    O
(    O
20    O
August    O
1902    O
–    O
15    O
July    O
1974    O
)    O
was    O
a    O
British    O
histologist    O
and    O
pathologist    B-Medicine106043075
.    O

Her    O
guide    O
was    O
Dr.    O
V.    O
R.    O
Khanolkar    O
,    O
a    O
pathologist    B-Medicine106043075
of    O
repute    O
and    O
the    O
founder    O
of    O
the    O
Indian    O
Cancer    O
Research    O
Centre    O
(    O
ICRC    O
)    O
.    O

When    O
Kamal    O
was    O
working    O
for    O
Tata    O
Memorial    O
Cancer    O
Hospital    O
in    O
Bombay    O
(    O
which    O
later    O
became    O
Cancer    O
Research    O
Centre    O
)    O
in    O
the    O
department    O
of    O
pathology    B-Medicine106043075
she    O
reported    O
on    O
the    O
research    O
studies    O
on    O
the    O
"    O
Comparative    O
morphology    O
of    O
normal    O
mammary    O
glands    O
of    O
four    O
strains    O
of    O
mice    O
varying    O
in    O
their    O
susceptibility    O
to    O
breast    O
cancer    O
"    O
.    O

"    O
Anatomie    O
und    O
Pathologie    O
der    O
Schleimbeutel    O
und    O
Sehnenscheiden    O
"    O
,    O
1868    O
-    O
Anatomy    O
and    O
pathology    B-Medicine106043075
of    O
the    O
bursa    O
and    O
tendon    O
sheaths    O
.    O

Bernard    O
Spilsbury    O
,    O
British    O
pathologist    B-Medicine106043075

William    O
Hallock    O
Park    O
(    O
December    O
30    O
,    O
1863    O
–    O
April    O
6    O
,    O
1939    O
)    O
was    O
an    O
American    O
bacteriologist    O
and    O
laboratory    O
director    O
at    O
the    O
New    O
York    O
City    O
Board    O
of    O
Health    O
,    O
Division    O
of    O
Pathology    B-Medicine106043075
,    O
Bacteriology    O
,    O
and    O
Disinfection    O
from    O
1893    O
to    O
1936    O
.    O

In    O
1873    O
he    O
earned    O
his    O
habilitation    O
for    O
pathology    B-Medicine106043075
and    O
anatomy    O
of    O
the    O
nervous    O
system    O
at    O
the    O
University    O
of    O
Vienna    O
,    O
becoming    O
an    O
associate    O
professor    O
in    O
1880    O
,    O
and    O
receiving    O
the    O
title    O
of    O
"    O
full    O
professor    O
"    O
in    O
1898    O
.    O

Environmental    O
medicine    O
is    O
a    O
multidisciplinary    O
field    O
involving    O
medicine    O
,    O
environmental    O
science    O
,    O
chemistry    O
and    O
others    O
,    O
overlapping    O
with    O
environmental    O
pathology    B-Medicine106043075
.    O

Landers    O
journeys    O
to    O
the    O
mainland    O
to    O
seek    O
the    O
help    O
of    O
a    O
noted    O
London    O
pathologist    B-Medicine106043075
,    O
Dr.    O
Brian    O
Stanley    O
.    O

He    O
studied    O
skin    O
pathology    B-Medicine106043075
and    O
skin    O
disease    O
at    O
the    O
Royal    O
Hungarian    O
Elisabeth    O
University    O
of    O
Medical    O
Sciences    O
in    O
Budapest    O
,    O
and    O
completed    O
his    O
clinical    O
studies    O
in    O
Berlin    O
,    O
Germany    O
,    O
under    O
Max    O
Joseph    O
.    O

Correctional    B-Medicine106043075
medicine    I-Medicine106043075

Those    O
familiar    O
with    O
altitude    B-Medicine106043075
training    I-Medicine106043075
know    O
that    O
prolonged    O
exposure    O
to    O
the    O
reduced    O
pressures    O
of    O
high    O
altitudes    O
will    O
produce    O
more    O
red    O
blood    O
cells    O
to    O
offset    O
the    O
lower    O
oxygen    O
availability    O
.    O

Abebe    O
brought    O
to    O
the    O
forefront    O
the    O
now    O
-    O
accepted    O
relationship    O
between    O
endurance    O
and    O
high-altitude    B-Medicine106043075
training    I-Medicine106043075
.    O

Shortly    O
before    O
the    O
trials    O
,    O
he    O
went    O
the    O
Olympic    O
Training    O
Center    O
in    O
Colorado    O
Springs    O
,    O
Colorado    O
to    O
train    B-Medicine106043075
at    I-Medicine106043075
altitude    I-Medicine106043075
.    O

She    O
led    O
the    O
race    O
throughout    O
,    O
holding    O
off    O
China    O
's    O
Li    O
Yanfei    O
,    O
and    O
after    O
the    O
win    O
she    O
began    O
altitude    B-Medicine106043075
training    I-Medicine106043075
to    O
prepare    O
for    O
the    O
upcoming    O
World    O
Race    O
Walking    O
Cup    O
.    O

Altitude    B-Medicine106043075
training    I-Medicine106043075

Medical    B-Medicine106043075
genetics    I-Medicine106043075

R.    O
Ellen    O
Magenis    O
(    O
September    O
24    O
,    O
1925    O
–    O
February    O
4    O
,    O
2014    O
)    O
was    O
a    O
distinguished    O
American    O
pediatrician    O
,    O
medical    B-Medicine106043075
geneticist    I-Medicine106043075
and    O
cytogeneticist    O
.    O

In    O
Forensics    O
,    O
Kinship    O
analysis    O
is    O
used    O
about    O
forms    O
of    O
Genetic    B-Medicine106043075
profiling    I-Medicine106043075
aimed    O
at    O
discovering    O
possible    O
genealogical    O
relations    O
between    O
individuals    O
based    O
on    O
DNA    O
samples    O
.    O

Additionally    O
,    O
she    O
is    O
a    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
fellow    O
.    O

Group    O
I    O
hospitals    O
can    O
also    O
provide    O
some    O
additional    O
valences    O
like    O
ophthalmology    O
and    O
cardiology    O
,    O
but    O
never    O
provide    O
the    O
valences    O
of    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
,    O
allergology    O
,    O
pediatric    O
cardiology    O
,    O
vascular    O
surgery    O
,    O
neurosurgery    O
,    O
plastic    O
surgery    O
,    O
cardiothoracic    O
surgery    O
,    O
maxillofacial    O
surgery    O
,    O
pediatric    O
surgery    O
and    O
neuroradiology    O
;    O

The    O
providing    O
of    O
some    O
highly    O
specialized    O
valences    O
like    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
,    O
pediatric    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
is    O
reserved    O
to    O
group    O
III    O
hospitals    O
;    O

The    O
American    O
College    O
of    O
Medical    O
Genetics    O
and    O
Genomics    O
(    O
ACMG    O
)    O
is    O
an    O
organization    O
composed    O
of    O
biochemical    O
,    O
clinical    O
,    O
cytogenetic    O
,    O
medical    O
and    O
molecular    O
geneticists    O
,    O
genetic    O
counselors    O
and    O
other    O
health    O
care    O
professionals    O
committed    O
to    O
the    O
practice    O
of    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
.    O

A    O
medical    B-Medicine106043075
geneticist    I-Medicine106043075
is    O
a    O
physician    O
who    O
specializes    O
in    O
genetics    O
.    O

(    O
William    O
Henry    O
)    O
Irwin    O
McLean    O
(    O
born    O
1963    O
)    O
FRS    O
FRSE    O
FMedSci    O
is    O
Professor    O
of    O
Human    B-Medicine106043075
genetics    I-Medicine106043075
,    O
Head    O
of    O
the    O
Division    O
of    O
Molecular    O
Medicine    O
and    O
Scientific    O
Director    O
of    O
the    O
Centre    O
for    O
Dermatology    O
and    O
Genetic    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
the    O
University    O
of    O
Dundee    O
.    O

Clinical    B-Medicine106043075
Genetics    I-Medicine106043075

She    O
remained    O
at    O
UCLA    O
and    O
completed    O
post    O
-    O
doctoral    O
fellowships    O
in    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
and    O
childhood    O
psychopathology    O
.    O

He    O
has    O
developed    O
several    O
software    O
to    O
manage    O
Medical    B-Medicine106043075
Genetics    I-Medicine106043075
information    O
and    O
commercial    O
websites    O
.    O

Bruce    O
R.    O
Korf    O
is    O
a    O
medical    B-Medicine106043075
geneticist    I-Medicine106043075
,    O
the    O
director    O
of    O
the    O
Heflin    O
Center    O
for    O
Human    O
Genetics    O
and    O
chairman    O
of    O
the    O
Department    O
of    O
Genetics    O
at    O
the    O
University    O
of    O
Alabama    O
at    O
Birmingham    O
.    O

The    O
spatial    O
geometry    O
of    O
RNA    O
can    O
explain    O
diseases    O
of    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
:    O
specifically    O
,    O
when    O
folding    O
and    O
twisting    O
becomes    O
a    O
difficulty    O
for    O
ribosomal    O
processing    O
.    O

NS    O
can    O
be    O
confirmed    O
genetically    B-Medicine106043075
by    O
the    O
presence    O
of    O
any    O
of    O
the    O
known    O
mutations    O
listed    O
above    O
.    O

In    O
due    O
course    O
,    O
the    O
Defence    O
and    O
Civil    O
Institute    O
of    O
Environmental    B-Medicine106043075
Medicine    I-Medicine106043075
(    O
DCIEM    O
)    O
,    O
as    O
this    O
agency    O
was    O
oddly    O
renamed    O
,    O
became    O
the    O
birthplace    O
,    O
in    O
1968    O
,    O
of    O
the    O
Human    O
Factors    O
Association    O
of    O
Canada    O
(    O
HFAC    O
)    O
,    O
the    O
Canadian    O
organisation    O
affiliated    O
to    O
the    O
International    O
Ergonomics    O
Association    O
.    O

Environmental    B-Medicine106043075
medicine    I-Medicine106043075

-    O
Environmental    B-Medicine106043075
medicine    I-Medicine106043075

Although    O
some    O
of    O
the    O
mainstream    O
medical    O
community    O
continue    O
to    O
reject    O
these    O
claims    O
,    O
the    O
concept    O
is    O
gaining    O
in    O
recognition    O
under    O
the    O
modern    O
and    O
more    O
clearly    O
articulated    O
classification    O
of    O
environmental    B-Medicine106043075
medicine    I-Medicine106043075
.    O

In    O
2004    O
,    O
Gilead    O
launched    O
Truvada    O
,    O
a    O
fixed    O
-    O
dose    O
combination    O
of    O
tenofovir    B-Medicine106043075
and    O
emtricitabine    B-Medicine106043075
.    O

In    O
July    O
2006    O
,    O
the    O
U.S.    O
Food    O
and    O
Drug    O
Administration    O
(    O
FDA    O
)    O
approved    O
Atripla    B-Medicine106043075
,    O
a    O
once    O
a    O
day    O
single    O
tablet    O
regimen    O
for    O
HIV    O
,    O
combining    O
Sustiva    O
(    O
efavirenz    O
)    O
,    O
a    O
Bristol    O
-    O
Myers    O
Squibb    O
product    O
,    O
and    O
Truvada    O
(    O
emtricitabine    B-Medicine106043075
and    O
tenofovir    B-Medicine106043075
disoproxil    I-Medicine106043075
)    O
,    O
a    O
Gilead    O
product    O
.    O

Tenofovir    B-Medicine106043075
,    O
also    O
known    O
as    O
TDF    O
is    O
a    O
so    O
-    O
called    O
'    O
prodrug    O
'    O
with    O
the    O
active    O
compound    O
deactivated    O
by    O
a    O
molecular    O
side    O
chain    O
that    O
dissolves    O
in    O
the    O
human    O
body    O
allowing    O
a    O
low    O
dose    O
of    O
tenofovir    O
to    O
reach    O
the    O
site    O
of    O
desired    O
activity    O
.    O

Adenosine    O
analogues    O
:    O
didanosine    O
(    O
ddI    O
)    O
,    O
tenofovir    B-Medicine106043075
(    O
TDF    O
)    O
,    O
and    O
adefovir    O
(    O
ADV    O
)    O

Zidovudine    O
(    O
AZT    O
)    O
or    O
tenofovir    B-Medicine106043075
(    O
TDF    O
)    O
are    O
recommended    O
as    O
less    O
toxic    O
and    O
equally    O
effective    O
alternatives    O
.    O
"    O

The    O
drug    O
tenofovir    B-Medicine106043075
has    O
had    O
its    O
efficacy    O
and    O
toxicology    O
evaluated    O
in    O
macaques    O
and    O
found    O
long    O
-    O
term    O
/    O
high    O
-    O
dose    O
treatments    O
had    O
adverse    O
effects    O
not    O
found    O
using    O
short    O
-    O
term    O
/    O
high    O
-    O
dose    O
treatment    O
followed    O
by    O
long    O
-    O
term    O
/    O
low    O
-    O
dose    O
treatment    O
.    O

iPrEx    O
(    O
from    O
,    O
"    O
pre    O
-    O
exposure    O
prophylaxis    O
initiative    O
"    O
)    O
was    O
a    O
phase    O
III    O
clinical    O
trial    O
to    O
determine    O
whether    O
the    O
antiretroviral    O
medication    O
emtricitabine    O
/    O
tenofovir    O
(    O
as    O
tenofovir    B-Medicine106043075
disoproxil    I-Medicine106043075
fumarate    I-Medicine106043075
)    O
could    O
safely    O
and    O
effectively    O
prevent    O
HIV    O
acquisition    O
through    O
sex    O
in    O
men    O
who    O
have    O
sex    O
with    O
men    O
and    O
transgender    O
women    O
.    O

Elvitegravir    O
,    O
emtricitabine    B-Medicine106043075
and    O
tenofovir    B-Medicine106043075
directly    O
suppress    O
viral    O
reproduction    O
.    O

Taking    O
the    O
AIDS    O
drug    O
tenofovir    B-Medicine106043075
greatly    O
reduces    O
the    O
risk    O
of    O
HIV    O
infection    O
among    O
intravenous    O
drug    O
users    O
,    O
according    O
to    O
a    O
new    O
study    O
.    O

The    O
"    O
mono"-    O
and    O
"    O
bis    O
"-    O
quaternary    O
azasteroid    O
series    O
of    O
compounds    O
to    O
which    O
candocuronium    O
belongs    O
are    O
based    O
on    O
the    O
same    O
principle    O
that    O
led    O
to    O
aminosteroids    O
such    O
as    O
pancuronium    O
,    O
vecuronium    O
and    O
rocuronium    B-Medicine106043075
:    O
use    O
of    O
the    O
steroid    O
skeleton    O
to    O
provide    O
a    O
somewhat    O
rigid    O
distance    O
between    O
the    O
two    O
quaternary    O
ammonium    O
centers    O
,    O
with    O
appendages    O
incorporating    O
fragments    O
of    O
choline    O
or    O
acetylcholine    O
.    O

The    O
site    O
has    O
a    O
long    O
history    O
of    O
research    O
in    O
the    O
area    O
of    O
neuromuscular    O
blockers    O
,    O
which    O
are    O
commonly    O
used    O
during    O
surgery    O
,    O
and    O
was    O
responsible    O
for    O
the    O
identification    O
of    O
rocuronium    B-Medicine106043075
as    O
well    O
as    O
a    O
number    O
of    O
other    O
drugs    O
.    O

Rocuronium    B-Medicine106043075

Commonly    O
used    O
neuromuscular    O
blocking    O
agents    O
used    O
include    O
succinylcholine    O
and    O
rocuronium    B-Medicine106043075
.    O

Desferrioxamine    B-Medicine106043075
,    O
a    O
chelating    O
agent    O
,    O
is    O
used    O
to    O
treat    O
iron    O
overload    O
from    O
transfusions    O
.    O

It    O
is    O
one    O
of    O
only    O
two    O
species    O
of    O
"    O
Staphylococcus    O
"    O
to    O
display    O
sensitivity    O
to    O
desferrioxamine    B-Medicine106043075
,    O
the    O
other    O
being    O
"    O
S.    O
epidermidis    O
"    O
.    O

Desferrioxamine    B-Medicine106043075
,    O
a    O
chelating    O
agent    O
used    O
to    O
remove    O
excess    O
iron    O
from    O
the    O
body    O

Deferoxamine    B-Medicine106043075

Deferoxamine    B-Medicine106043075
(    O
DFOA    B-Medicine106043075
)    O
,    O
sold    O
under    O
the    O
brand    O
name    O
Desferal    B-Medicine106043075
,    O
is    O
a    O
medication    O
that    O
binds    O
iron    O
and    O
aluminium    O
.    O

Second    O
generation    O
drugs    O
include    O
glibenclamide    B-Medicine106043075
(    O
glyburide    O
)    O
,    O
glibornuride    O
,    O
gliclazide    O
,    O
glipizide    O
,    O
gliquidone    O
,    O
glisoxepide    O
and    O
glyclopyramide    O
.    O

It    O
showed    O
a    O
synergistic    O
effect    O
with    O
the    O
antidiabetic    O
drug    O
glibenclamide    B-Medicine106043075
,    O
supporting    O
the    O
possibility    O
of    O
effective    O
combination    O
therapy    O
of    O
glibenclamide    O
and    O
"    O
P.    O
pulmonarius    O
"    O
for    O
diabetes    O
.    O

Drug    O
-    O
induced    O
psoriasis    O
may    O
occur    O
with    O
beta    O
blockers    O
,    O
lithium    O
,    O
antimalarial    O
medications    O
,    O
non    O
-    O
steroidal    O
anti    O
-    O
inflammatory    O
drugs    O
,    O
terbinafine    O
,    O
calcium    O
channel    O
blockers    O
,    O
captopril    O
,    O
glyburide    B-Medicine106043075
,    O
granulocyte    O
colony    O
-    O
stimulating    O
factor    O
,    O
interleukins    O
,    O
interferons    O
,    O
lipid    O
-    O
lowering    O
drugs    O
,    O
and    O
paradoxically    O
TNF    O
inhibitors    O
such    O
as    O
infliximab    O
or    O
adalimumab    O
.    O

:*    O
Origlucon    O
(    O
"    O
glibenclamide    B-Medicine106043075
"    O
)    O

According    O
to    O
Zeev    O
Vlodaver    O
,    O
Robert    O
F.    O
Wilson    O
and    O
Daniel    O
J.    O
Garry    O
,    O
"    O
exenatide    O
and    O
liraglutide    O
are    O
synthetic    O
GLP-1    O
agonists    O
and    O
have    O
demonstrated    O
glycemic    O
efficacy    O
(    O
HbA1c    O
reductions    O
of    O
between    O
0.7    O
and    O
2%    O
)    O
associated    O
with    O
mild    O
weight    O
loss    O
.    O
"    O
Glyburide    B-Medicine106043075
,    O
metformin    O
and    O
rosiglitazone    O
have    O
been    O
assessed    O
as    O
a    O
monotherapy    O
in    O
the    O
durability    O
of    O
glycemic    O
efficacy    O
.    O

The    O
Australian    O
Stem    O
Cell    O
Centre    O
is    O
an    O
Australian    O
medical    O
research    O
and    O
development    O
centre    O
which    O
focuses    O
on    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
through    O
the    O
use    O
of    O
stem    O
cells    O
.    O

ARMI    O
is    O
one    O
of    O
the    O
world    O
's    O
largest    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
and    O
stem    O
cell    O
research    O
hubs    O
.    O

is    O
a    O
clinical    O
-    O
stage    O
biotechnology    O
company    O
in    O
the    O
field    O
of    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
headquartered    O
in    O
Alameda    O
,    O
California    O
.    O

BioTime    O
focuses    O
primarily    O
on    O
two    O
areas    O
:    O
stem    O
cell    O
technology    O
and    O
products    O
for    O
use    O
in    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
focusing    O
on    O
areas    O
such    O
as    O
oncology    O
,    O
orthopedics    B-Medicine106043075
,    O
blood    O
diseases    O
,    O
and    O
blood    O
plasma    O
volume    O
expanders    O
for    O
use    O
in    O
surgery    O
and    O
treatment    O
of    O
traumatic    O
injuries    O
.    O

Regenerative    B-Medicine106043075
medicine    I-Medicine106043075

Rao    O
was    O
also    O
the    O
VP    O
of    O
Regenerative    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
Life    O
Technologies    O
.    O

TR-ClarifEYE    B-Medicine106043075
is    O
an    O
implant    O
made    O
of    O
a    O
biomaterial    O
,    O
the    O
STAR    O
BioMaterial    O
,    O
which    O
consists    O
of    O
silicone    O
with    O
a    O
very    O
precise    O
homogenous    O
pore    O
size    O
,    O
a    O
property    O
which    O
reduces    O
fibrosis    O
and    O
improves    O
tissue    O
integration    O
.    O

Regenerative    B-Medicine106043075
medicine    I-Medicine106043075

Developmental    O
,    O
Stem    O
Cell    O
,    O
and    O
Regenerative    B-Medicine106043075
Biology    I-Medicine106043075

A    O
tissue    O
regenerating    O
bioscaffold    O
material    O
,    O
being    O
developed    O
by    O
TR    B-Medicine106043075
BioSurgical    I-Medicine106043075
,    O
has    O
unique    O
properties    O
that    O
permits    O
angiogenesis    O
and    O
produces    O
fetal    O
-    O
like    O
repair    O
mechanisms    O
,    O
known    O
to    O
be    O
involved    O
in    O
tissue    O
turnover    O
and    O
repair    O
.    O

TR    B-Medicine106043075
BioSurgical    I-Medicine106043075

Current    O
uses    O
of    O
transdifferentiation    O
include    O
disease    O
modeling    O
and    O
drug    O
discovery    O
and    O
in    O
the    O
future    O
may    O
include    O
gene    O
therapy    O
and    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
.    O

a    O
startup    O
focused    O
on    O
the    O
field    O
of    O
interventional    O
gerontology    O
,    O
and    O
Co    O
-    O
CEO    O
of    O
its    O
parent    O
company    O
,    O
BioTime    O
,    O
Inc.    O
of    O
Alameda    O
,    O
California    O
(    O
San    O
Francisco    O
Bay    O
Area    O
)    O
,    O
a    O
biotechnology    O
company    O
regarded    O
as    O
a    O
leader    O
in    O
the    O
field    O
of    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
with    O
a    O
focus    O
on    O
cell    O
therapy    O
.    O

West    O
organized    O
the    O
first    O
collaborative    O
effort    O
to    O
isolate    O
human    O
pluripotent    O
(    O
embryonic    O
)    O
stem    O
cells    O
for    O
the    O
purpose    O
of    O
manufacturing    O
products    O
in    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
in    O
collaboration    O
with    O
James    O
Thomson    O
at    O
the    O
University    O
of    O
Wisconsin    O
at    O
Madison    O
John    O
Gearhart    O
at    O
Johns    O
Hopkins    O
School    O
of    O
Medicine    O
and    O
Roger    O
Pedersen    O
at    O
the    O
University    O
of    O
California    O
,    O
San    O
Francisco    O
.    O

regenerative    B-Medicine106043075
medicine    I-Medicine106043075

The    O
in    O
vivo    O
bioreactor    O
(    O
IVB    O
)    O
is    O
a    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
paradigm    O
where    O
bone    O
is    O
grown    O
in    O
vivo    O
.    O

Therapeutic    O
cloning    O
–    O
application    O
of    O
somatic    O
-    O
cell    O
nuclear    O
transfer    O
(    O
a    O
laboratory    O
technique    O
for    O
creating    O
a    O
clonal    O
embryo    O
using    O
an    O
ovum    O
with    O
a    O
donor    O
nucleus    O
)    O
in    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
.    O

This    O
breakthrough    O
is    O
a    O
major    O
step    O
forward    O
for    O
the    O
nascent    O
field    O
of    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
.    O

In    O
a    O
breakthrough    O
for    O
regenerative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
Japanese    O
scientists    O
grow    O
functional    O
livers    O
from    O
stem    O
cells    O
and    O
successfully    O
transplant    O
them    O
into    O
mice    O
.    O

This    O
discovery    O
assisted    O
other    O
scientists    O
in    O
the    O
elucidation    O
of    O
similar    O
glycolipid    O
storage    O
diseases    O
such    O
as    O
Gaucher    O
's    O
disease    O
and    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
and    O
in    O
their    O
prenatal    O
diagnosis    O
.    O

Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075

HEXA    O
:    O
hexosaminidase    O
A    O
(    O
alpha    O
Tay-Sachs    B-Medicine106043075
disease    I-Medicine106043075
)    O

Tay-Sachs    B-Medicine106043075
disease    I-Medicine106043075

Several    O
organizations    O
,    O
such    O
as    O
Dor    O
Yeshorim    O
,    O
offer    O
screening    O
for    O
Ashkenazi    O
genetic    O
diseases    O
,    O
and    O
these    O
screening    O
programs    O
have    O
had    O
a    O
significant    O
impact    O
,    O
in    O
particular    O
by    O
reducing    O
the    O
number    O
of    O
cases    O
of    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
.    O

Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
,    O
which    O
can    O
present    O
as    O
a    O
fatal    O
illness    O
of    O
children    O
that    O
causes    O
mental    O
deterioration    O
prior    O
to    O
death    O
,    O
was    O
historically    O
more    O
prevalent    O
among    O
Ashkenazi    O
Jews    O
,    O
although    O
high    O
levels    O
of    O
the    O
disease    O
are    O
also    O
found    O
in    O
some    O
Pennsylvania    O
Dutch    O
,    O
southern    O
Louisiana    O
Cajun    O
,    O
and    O
eastern    O
Quebec    O
French    O
Canadian    O
populations    O
.    O

He    O
allowed    O
first    O
trimester    O
abortion    O
of    O
a    O
fetus    O
which    O
would    O
be    O
born    O
with    O
a    O
deformity    O
that    O
would    O
cause    O
it    O
to    O
suffer    O
,    O
and    O
termination    O
of    O
a    O
fetus    O
with    O
a    O
lethal    O
fetal    O
defect    O
such    O
as    O
Tay-Sachs    B-Medicine106043075
disease    I-Medicine106043075
up    O
to    O
the    O
end    O
of    O
the    O
second    O
trimester    O
of    O
gestation    O
.    O

Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
,    O
a    O
genetic    O
disorder    O
,    O
fatal    O
in    O
its    O
most    O
common    O
variant    O

Recessive    O
genetic    O
disorders    O
include    O
albinism    O
,    O
cystic    O
fibrosis    O
,    O
galactosemia    O
,    O
phenylketonuria    O
(    O
PKU    O
)    O
,    O
and    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
.    O

Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075

He    O
is    O
very    O
fond    O
of    O
Reza    O
,    O
who    O
bears    O
a    O
great    O
resemblance    O
to    O
his    O
mother    O
and    O
is    O
dying    O
of    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
.    O

The    O
rare    O
autosomal    O
recessive    O
neurodegenerative    O
disorder    O
is    O
clinically    O
almost    O
indistinguishable    O
from    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
,    O
another    O
genetic    O
disorder    O
that    O
disrupts    O
beta    O
-    O
hexosaminidases    O
A    O
and    O
S.    O
There    O
are    O
three    O
subsets    O
of    O
Sandhoff    O
disease    O
based    O
on    O
when    O
first    O
symptoms    O
appear    O
:    O
classic    O
infantile    O
,    O
juvenile    O
and    O
adult    O
late    O
onset    O
.    O

Sandhoff    O
disease    O
symptoms    O
are    O
clinically    O
indeterminable    O
from    O
Tay–Sachs    B-Medicine106043075
disease    I-Medicine106043075
.    O

It    O
has    O
a    O
similar    O
pathology    O
to    O
Sandhoff    O
disease    O
and    O
Tay-Sachs    B-Medicine106043075
disease    I-Medicine106043075
.    O

5-ASA    O
compounds    O
,    O
such    O
as    O
mesalazine    O
and    O
sulfasalazine    B-Medicine106043075
,    O
have    O
shown    O
to    O
be    O
of    O
very    O
little    O
efficacy    O
in    O
the    O
treatment    O
of    O
Crohn    O
's    O
disease    O
,    O
either    O
for    O
induction    O
or    O
for    O
maintenance    O
of    O
remission    O
.    O

Additional    O
treatments    O
include    O
retinoids    O
,    O
such    O
as    O
acitretin    O
,    O
or    O
sulfasalazine    B-Medicine106043075
.    O

Mesalazine    O
is    O
the    O
active    O
moiety    O
of    O
sulfasalazine    B-Medicine106043075
,    O
which    O
is    O
metabolized    O
to    O
sulfapyridine    O
and    O
mesalazine    O
.    O

It    O
has    O
also    O
been    O
used    O
as    O
a    O
second    O
line    O
agent    O
to    O
sulfasalazine    B-Medicine106043075
in    O
people    O
with    O
inflammatory    O
bowel    O
disease    O
such    O
as    O
ulcerative    O
colitis    O
and    O
Crohn    O
's    O
disease    O
.    O

PAS    O
has    O
also    O
been    O
used    O
in    O
the    O
treatment    O
of    O
inflammatory    O
bowel    O
disease    O
(    O
ulcerative    O
colitis    O
and    O
Crohn    O
's    O
disease    O
)    O
,    O
but    O
has    O
been    O
superseded    O
by    O
other    O
drugs    O
such    O
as    O
sulfasalazine    B-Medicine106043075
and    O
mesalazine    O
.    O

Lipotomy    O
is    O
a    O
lipodissolution    O
technique    O
of    O
aesthetic    B-Medicine106043075
medicine    I-Medicine106043075
which    O
aims    O
at    O
dissolving    O
undesirable    O
greasy    O
clusters    O
without    O
the    O
use    O
of    O
harsh    O
techniques    O
or    O
surgery    O
.    O

Artists    O
and    O
architects    O
have    O
been    O
using    O
this    O
ratio    O
to    O
create    O
works    O
that    O
are    O
pleasing    O
to    O
the    O
eye    O
for    O
centuries    O
.    O
Aesthetic    B-Medicine106043075
medicine    I-Medicine106043075
and    O
facial    O
rejuvenation    O
techniques    O

Aesthetic    B-Medicine106043075
medicine    I-Medicine106043075

Further    O
storylines    O
include    O
relationships    O
between    O
her    O
and    O
plastic    O
surgeon    O
,    O
Mark    O
Sloan    O
(    O
Eric    O
Dane    O
)    O
,    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
Erica    O
Hahn    O
(    O
Brooke    O
Smith    O
)    O
,    O
as    O
well    O
as    O
a    O
marriage    O
to    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
Arizona    O
Robbins    O
(    O
Jessica    O
Capshaw    O
)    O
.    O

They    O
attempt    O
to    O
return    O
to    O
their    O
former    O
life    O
,    O
taking    O
residence    O
in    O
his    O
trailer    O
,    O
and    O
Addison    O
becomes    O
the    O
head    O
of    O
a    O
unique    O
surgical    O
service    O
integrating    O
neonatal    O
surgery    B-Medicine106043075
and    O
obstetrics    O
and    O
gynecology    O
.    O

The    O
providing    O
of    O
some    O
highly    O
specialized    O
valences    O
like    O
medical    B-Medicine106043075
genetics    I-Medicine106043075
,    O
pediatric    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
and    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
is    O
reserved    O
to    O
group    O
III    O
hospitals    O
;    O

The    O
aggressiveness    O
of    O
this    O
cancer    O
requires    O
the    O
response    O
of    O
a    O
large    O
team    O
of    O
specialists    O
,    O
possibly    O
including    O
a    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
oncologist    O
,    O
hematologist    O
,    O
specialty    O
nurse    O
,    O
and    O
rehabilitation    O
specialists    O
.    O

Rowena    O
Spencer    O
(    O
July    O
3    O
,    O
1922    O
-    O
May    O
13    O
,    O
2014    O
)    O
was    O
an    O
American    O
physician    O
who    O
specialized    O
in    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
at    O
a    O
time    O
when    O
it    O
was    O
unusual    O
for    O
a    O
female    O
to    O
become    O
a    O
surgeon    O
.    O

Pediatric    B-Medicine106043075
Surgery    I-Medicine106043075

Ascher    O
Lawrence    O
Mestel    O
(    O
born    O
17    O
September    O
1926    O
)    O
is    O
a    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
who    O
lives    O
in    O
Brooklyn    O
,    O
New    O
York    O
.    O

Upon    O
returning    O
to    O
Brazil    O
,    O
Dr.    O
Santos    O
dedicated    O
himself    O
to    O
pediatric    O
care    O
,    O
research    O
and    O
teaching    O
,    O
especially    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
,    O
first    O
at    O
the    O
Teaching    O
Dept    O
of    O
the    O
Hospital    O
Infantil    O
Álvaro    O
Ribeiro    O
in    O
Campinas    O
(    O
1980–1986    O
)    O
and    O
afterwards    O
as    O
a    O
professor    O
at    O
the    O
Medical    O
School    O
of    O
the    O
Pontificial    O
Catholic    O
University    O
of    O
Campinas    O
(    O
PUCCAMP    O
)    O
,    O
a    O
position    O
he    O
held    O
until    O
1989    O
.    O

The    O
American    O
Pediatric    O
Surgical    O
Association    O
is    O
an    O
American    O
professional    O
organization    O
dedicated    O
to    O
pediatric    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Paediatric    B-Medicine106043075
surgery    I-Medicine106043075

Again    O
,    O
he    O
returned    O
to    O
Boston    O
to    O
complete    O
a    O
two    O
-    O
year    O
fellowship    O
in    O
Pediatric    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
.    O

CNN    O
medical    O
correspondent    O
and    O
neurosurgeon    O
Sanjay    O
Gupta    O
,    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
Henri    O
Ford    O
,    O
and    O
two    O
Navy    O
doctors    O
removed    O
a    O
piece    O
of    O
concrete    O
from    O
the    O
skull    O
of    O
a    O
12-year    O
-    O
old    O
earthquake    O
victim    O
in    O
an    O
operation    O
performed    O
aboard    O
"    O
Carl    O
Vinson    O
"    O
on    O
18    O
January    O
.    O

Specialists    O
consultants    O
in    O
Dentistry    O
,    O
ENT    O
,    O
Cardiology    O
,    O
Diabetology    O
,    O
Endocrinology    O
,    O
Urology    O
,    O
Psychiatry    O
,    O
Pulmonology    B-Medicine106043075
,    O
Pediatric    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Gastroentrology    O
are    O
available    O
.    O

In    O
1981    O
,    O
Al    O
Rabeeah    O
was    O
formally    O
licensed    O
to    O
practice    O
medicine    O
;    O
he    O
then    O
decided    O
to    O
continue    O
his    O
studies    O
in    O
Canada    O
,    O
attending    O
the    O
University    O
of    O
Alberta    O
Hospital    O
,    O
Edmonton    O
(    O
1985    O
)    O
and    O
IWK    O
Hospital    O
for    O
Children    O
,    O
Dalhousie    O
University    O
,    O
Halifax    O
,    O
Nova    O
Scotia    O
(    O
1987    O
)    O
where    O
he    O
completed    O
Fellowships    O
in    O
General    O
and    O
Pediatric    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
respectively    O
.    O

Teddy    O
develops    O
a    O
friendship    O
with    O
pediatric    B-Medicine106043075
surgeon    I-Medicine106043075
Arizona    O
Robbins    O
(    O
Jessica    O
Capshaw    O
)    O
,    O
who    O
sets    O
her    O
up    O
with    O
plastic    O
surgeon    O
Mark    O
Sloan    O
(    O
Eric    O
Dane    O
)    O
.    O

Assessments    O
for    O
developmental    O
coordination    O
disorder    O
typically    O
require    O
a    O
developmental    O
history    O
,    O
detailing    O
ages    O
at    O
which    O
significant    O
developmental    B-Medicine106043075
milestones    I-Medicine106043075
,    O
such    O
as    O
crawling    O
and    O
walking    O
,    O
occurred    O
.    O

post-birth    B-Medicine106043075
development    I-Medicine106043075
stages    I-Medicine106043075

The    O
notion    O
of    O
age    O
regression    O
is    O
central    O
to    O
attachment    O
therapy    O
whose    O
proponents    O
believe    O
that    O
a    O
child    O
who    O
has    O
missed    O
out    O
on    O
developmental    B-Medicine106043075
stages    I-Medicine106043075
can    O
be    O
made    O
to    O
redo    O
those    O
stages    O
at    O
a    O
later    O
age    O
by    O
a    O
variety    O
of    O
techniques    O
.    O

Her    O
work    O
emphasized    O
stages    B-Medicine106043075
in    I-Medicine106043075
child    I-Medicine106043075
development    I-Medicine106043075
.    O

Developmental    O
stage    O
theories    O
/    O
Child    B-Medicine106043075
development    I-Medicine106043075
stages    I-Medicine106043075
–    O
stages    O
of    O
child    O
development    O

"    O
The    O
tendency    O
to    O
use    O
informal    O
milestones    B-Medicine106043075
checklists    O
.    O
"    O

Helminth    O
infection    O
can    O
be    O
effectively    O
treated    O
with    O
benzimidazole    O
drugs    O
(    O
such    O
as    O
mebendazole    O
or    O
albendazole    B-Medicine106043075
)    O
,    O
and    O
efforts    O
led    O
by    O
the    O
World    O
Health    O
Organization    O
have    O
focused    O
on    O
one    O
to    O
three    O
yearly    O
de    O
-    O
worming    O
doses    O
in    O
schools    O
because    O
hookworm    O
infections    O
with    O
the    O
heaviest    O
intensities    O
are    O
most    O
common    O
in    O
school    O
-    O
age    O
children    O
.    O

Humans    O
infested    O
with    O
"    O
C.    O
aerophila    O
"    O
have    O
been    O
successfully    O
treated    O
with    O
albendazole    B-Medicine106043075
and    O
mebendazole    O
.    O

Successful    O
treatment    O
of    O
human    O
cases    O
with    O
thiabendazole    O
or    O
albendazole    B-Medicine106043075
(    O
with    O
or    O
without    O
corticosteroids    O
)    O
have    O
been    O
reported    O
.    O

VPWA    O
’s    O
annual    O
Deworm    O
outreach    O
program    O
involves    O
volunteers    O
going    O
from    O
school    O
to    O
school    O
,    O
community    O
to    O
community    O
,    O
treating    O
children    O
against    O
worm    O
infections    O
by    O
administering    O
Mebendazole    O
and    O
Albendazole    B-Medicine106043075
.    O

A    O
case    O
of    O
the    O
Mazzotti    O
reaction    O
has    O
been    O
reported    O
after    O
presumptive    O
treatment    O
of    O
schistosomiasis    O
and    O
strongyloidiasis    O
with    O
ivermectin    O
,    O
praziquantel    O
and    O
albendazole    B-Medicine106043075
.    O

Single    O
-    O
dose    O
albendazole    B-Medicine106043075
(    O
400    O
mg    O
)    O
is    O
also    O
very    O
efficacious    O
(    O
>    O
95%    O
)    O
.    O

Surgical    O
removal    O
or    O
treatment    O
with    O
albendazole    B-Medicine106043075
or    O
ivermectin    O
is    O
recommended    O
.    O

Benzimidazoles    O
:    O
triclabendazole    O
(    O
Fasinex    O
)    O
,    O
albendazole    B-Medicine106043075
(    O
Vermitan    O
,    O
Valbazen    O
)    O
,    O
mebendazol    O
(    O
Telmin    O
)    O
,    O
luxabendazole    O
(    O
Fluxacur    O
)    O

Albendazole    B-Medicine106043075
(    O
broad    O
spectrum    O
)    O

Furthermore    O
,    O
treatment    O
of    O
"    O
M.    O
perstans    O
"    O
is    O
challenging    O
because    O
the    O
most    O
antifilarial    O
drugs    O
,    O
such    O
as    O
ivermectin    O
,    O
diethylcarbamazine    O
,    O
and    O
albendazole    B-Medicine106043075
are    O
not    O
effective    O
.    O

Numerous    O
trials    O
evaluating    O
traditional    O
antifilarial    O
drugs    O
such    O
as    O
ivermectin    O
and    O
DEC    O
,    O
as    O
well    O
as    O
other    O
benzimidazoles    O
such    O
as    O
mebendazole    O
,    O
albendazole    B-Medicine106043075
,    O
levamisole    B-Medicine106043075
,    O
and    O
thiabendazole    O
,    O
have    O
been    O
conducted    O
.    O

Single    O
doses    O
of    O
albendazole    B-Medicine106043075
alone    O
have    O
been    O
consistently    O
reported    O
to    O
have    O
little    O
or    O
no    O
effect    O
on    O
"    O
M.    O
perstans    O
"    O
microfilaremias    O
in    O
6    O
and    O
12    O
m    O
after    O
treatment    O
,    O
with    O
counts    O
of    O
microfilaremias    O
remaining    O
close    O
to    O
pretreatment    O
values    O
.    O

An    O
infection    O
of    O
"    O
N.    O
americanus    O
"    O
parasites    O
can    O
be    O
treated    O
by    O
using    O
benzimidazoles    O
,    O
albendazole    B-Medicine106043075
,    O
and    O
mebendazole    O
.    O

An    O
infection    O
of    O
"    O
N.    O
americanus    O
"    O
parasites    O
can    O
be    O
treated    O
by    O
using    O
benzimidazoles    O
:    O
albendazole    B-Medicine106043075
or    O
mebendazole    O
.    O

Oxamniquine    B-Medicine106043075

While    O
chemotherepeutic    O
drugs    O
,    O
such    O
as    O
praziquantel    O
,    O
oxamniquine    B-Medicine106043075
and    O
metrifonate    O
,    O
are    O
currently    O
considered    O
safe    O
and    O
effective    O
for    O
the    O
treatment    O
of    O
schistosomiasis    O
,    O
reinfection    O
occurs    O
frequently    O
following    O
drug    O
treatment    O
,    O
thus    O
a    O
vaccine    O
is    O
sought    O
to    O
provide    O
long    O
-    O
term    O
treatment    O
.    O

Obstetric    B-Medicine106043075
medicine    I-Medicine106043075
,    O
sometimes    O
maternal    B-Medicine106043075
medicine    I-Medicine106043075
,    O
is    O
a    O
subspecialty    O
of    O
general    O
internal    O
medicine    O
and    O
obstetrics    O
that    O
specialises    O
in    O
the    O
dealing    O
with    O
physical    O
health    O
problems    O
in    O
pregnant    O
women    O
.    O

Medical    B-Medicine106043075
technologist    I-Medicine106043075

The    O
American    O
Society    O
for    O
Clinical    O
Pathology    O
(    O
ASCP    O
)    O
is    O
a    O
professional    O
association    O
based    O
in    O
Chicago    O
,    O
Illinois    O
encompassing    O
130,000    O
pathologists    O
and    O
laboratory    B-Medicine106043075
professionals    I-Medicine106043075
.    O

#    O
Affiliate    O
Member    O
:    O
Allied    O
health    O
professional    O
,    O
technician    B-Medicine106043075
,    O
office    O
manager    O
,    O
or    O
other    O
medical    O
specialist    O
(    O
outside    O
of    O
General    O
Surgery    O
)    O
.    O

James    O
Lance    O
Bass    O
was    O
born    O
in    O
Laurel    O
,    O
Mississippi    O
,    O
to    O
James    O
Irvin    O
Bass    O
,    O
Jr.    O
,    O
a    O
medical    B-Medicine106043075
technologist    I-Medicine106043075
,    O
and    O
Diane    O
(    O
née    O
Pulliam    O
)    O
,    O
a    O
middle    O
school    O
mathematics    O
,    O
English    O
,    O
and    O
career    O
discovery    O
teacher    O
.    O

Medical    B-Medicine106043075
technologist    I-Medicine106043075

Medical    B-Medicine106043075
technologist    I-Medicine106043075

Medical    B-Medicine106043075
technologist    I-Medicine106043075

Medical    B-Medicine106043075
technologist    I-Medicine106043075

An    O
interactive    O
model    O
of    O
pain    O
and    O
myocardial    O
ischemia    O
.    O
"    O
Psychosomatic    B-Medicine106043075
Medicine    I-Medicine106043075
"    O
,    O
69(7    O
)    O
,    O
632    O
-    O
9    O
.    O

Validity    O
of    O
the    O
Quality    O
of    O
Well    O
-    O
Being    O
Scale    O
for    O
persons    O
with    O
human    O
immunodeficiency    O
virus    O
infection    O
.    O
"    O
Psychosomatic    B-Medicine106043075
Medicine    I-Medicine106043075
"    O
,    O
March    O
1    O
,    O
1995    O
,    O
vol    O
.    O

Some    O
believe    O
it    O
to    O
be    O
a    O
psychosomatic    B-Medicine106043075
condition    O
,    O
while    O
others    O
believe    O
it    O
may    O
have    O
biological    O
causes    O
relating    O
to    O
hormone    O
changes    O
.    O

She    O
was    O
the    O
daughter    O
of    O
noted    O
psychiatrist    O
Peter    O
H.    O
Knapp    O
,    O
who    O
did    O
groundbreaking    O
research    O
into    O
psychosomatic    B-Medicine106043075
medicine    O
.    O

Joseph    O
Augustus    O
Winter    O
,    O
an    O
American    O
medical    O
doctor    O
and    O
"    O
psychosomatacist    B-Medicine106043075
"    O
,    O
had    O
previously    O
served    O
on    O
the    O
board    O
of    O
directors    O
and    O
as    O
the    O
medical    O
director    O
of    O
L.    O
Ron    O
Hubbard    O
's    O
Dianetic    O
Research    O
Foundation    O
.    O

Indian    O
doctor    O
Narendra    O
Wig    O
coined    O
the    O
term    O
Dhat    O
syndrome    O
in    O
1960    O
and    O
described    O
it    O
as    O
being    O
characterized    O
by    O
vague    O
psychosomatic    B-Medicine106043075
symptoms    O
of    O
fatigue    O
,    O
weakness    O
,    O
anxiety    O
,    O
loss    O
of    O
appetite    O
,    O
guilt    O
,    O
and    O
sexual    O
dysfunction    O
,    O
attributed    O
by    O
the    O
patient    O
to    O
loss    O
of    O
semen    O
in    O
nocturnal    O
emission    O
,    O
through    O
urine    O
or    O
masturbation    O
.    O

Graziella    O
Magherini    O
is    O
most    O
well    O
known    O
for    O
her    O
1989    O
book    O
"    O
La    O
sindrome    O
di    O
Stendhal    O
"    O
(    O
"    O
The    O
Stendhal    O
syndrome    O
"    O
)    O
,    O
which    O
introduced    O
this    O
term    O
to    O
indicate    O
a    O
psychosomatic    B-Medicine106043075
illness    I-Medicine106043075
affecting    O
individuals    O
when    O
exposed    O
to    O
art    O
.    O

Franz    O
Gabriel    O
Alexander    O
(    O
22    O
January    O
1891    O
–    O
8    O
March    O
1964    O
)    O
was    O
a    O
Hungarian    O
-    O
American    O
psychoanalyst    O
and    O
physician    O
,    O
who    O
is    O
considered    O
one    O
of    O
the    O
founders    O
of    O
psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075
and    O
psychoanalytic    O
criminology    O
.    O

Inglis    O
's    O
book    O
"    O
Revolution    O
in    O
Medicine    O
"    O
(    O
1958    O
)    O
is    O
a    O
criticism    O
of    O
modern    O
medicine    O
and    O
its    O
materialistic    O
viewpoints    O
and    O
a    O
defense    O
of    O
psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075
and    O
psychotherapy    O
.    O

Odor    O
cues    O
make    O
double    O
blind    O
studies    O
of    O
MCS    O
patients    O
difficult    O
,    O
as    O
scents    O
can    O
provoke    O
a    O
psychosomatic    B-Medicine106043075
response    I-Medicine106043075
or    O
recall    O
expectations    O
and    O
prior    O
beliefs    O
.    O

:    O
2    O
.    O
Pre    O
-    O
existing    O
theories    O
of    O
disease    O
:    O
Before    O
a    O
pathogen    O
is    O
well    O
-    O
recognized    O
,    O
scientists    O
may    O
attribute    O
the    O
symptoms    O
of    O
infection    O
to    O
other    O
causes    O
,    O
such    O
as    O
toxicological    O
,    O
psychological    B-Medicine106043075
,    O
or    O
genetic    O
causes    O
.    O

Some    O
researchers    O
suggested    O
that    O
ulcers    O
were    O
a    O
psychosomatic    B-Medicine106043075
illness    O
.    O

When    O
her    O
parents    O
attempted    O
to    O
limit    O
her    O
academic    O
work    O
she    O
developed    O
severe    O
psychosomatic    B-Medicine106043075
illnesses    I-Medicine106043075
.    O

Most    O
recently    O
she    O
headed    O
up    O
the    O
Anthroposophic    O
Psychosomatic    B-Medicine106043075
Rehabilitation    O
Clinic    O
at    O
Badenweiler    O
on    O
the    O
south    O
-    O
western    O
tip    O
of    O
Germany    O
.    O

Search    O
activity    O
concept    O
(    O
SAC    O
)    O
is    O
a    O
psychophysiological    O
concept    O
that    O
integrates    O
subject    O
’s    O
behavior    O
,    O
resistance    O
to    O
stress    O
and    O
deteriorating    O
factors    O
,    O
pathogenetic    O
mechanisms    O
of    O
different    O
mental    O
and    O
psychosomatic    B-Medicine106043075
disorders    O
,    O
REM    O
sleep    O
functions    O
,    O
brain    O
monoamines    O
activity    O
and    O
brain    O
laterality    O
.    O

Phobia    O
of    O
pregnancy    O
and    O
childbirth    O
,    O
as    O
with    O
any    O
phobia    O
,    O
can    O
manifest    O
through    O
a    O
number    O
of    O
symptoms    O
including    O
nightmares    O
,    O
difficulty    O
in    O
concentrating    O
on    O
work    O
or    O
on    O
family    O
activities    O
,    O
panic    O
attacks    O
and    O
psychosomatic    B-Medicine106043075
complaints    O
.    O

According    O
to    O
Betz    O
,    O
the    O
explanations    O
can    O
be    O
found    O
in    O
the    O
field    O
of    O
psychosomatics    B-Medicine106043075
(    O
which    O
studies    O
how    O
the    O
mind    O
can    O
affect    O
the    O
body    O
)    O
,    O
in    O
the    O
placebo    O
effect    O
,    O
in    O
the    O
fact    O
that    O
many    O
illnesses    O
disappear    O
spontaneously    O
(    O
e.g.    O
,    O
common    O
colds    O
)    O
or    O
fluctuate    O
(    O
e.g.    O
,    O
allergies    O
)    O
,    O
as    O
well    O
as    O
in    O
the    O
deceptive    O
methods    O
of    O
quackery    O
.    O

Psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075

It    O
was    O
a    O
placebo    O
,    O
and    O
Sardonicus    O
'    O
affliction    O
was    O
only    O
psychosomatic    B-Medicine106043075
.    O

The    O
syndrome    O
is    O
characterized    O
by    O
a    O
number    O
of    O
psychiatric    O
symptoms    O
such    O
as    O
acute    O
delusional    O
states    O
,    O
hallucinations    O
,    O
feelings    O
of    O
persecution    O
(    O
perceptions    O
of    O
being    O
a    O
victim    O
of    O
prejudice    O
,    O
aggression    O
,    O
or    O
hostility    O
from    O
others    O
)    O
,    O
derealization    O
,    O
depersonalization    O
,    O
anxiety    O
,    O
and    O
also    O
psychosomatic    B-Medicine106043075
manifestations    O
such    O
as    O
dizziness    O
,    O
tachycardia    O
,    O
sweating    O
,    O
and    O
others    O
,    O
such    O
as    O
vomiting    O
.    O

Psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075

Psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075
,    O
an    O
interdisciplinary    O
medical    O
field    O
exploring    O
the    O
relationships    O
among    O
social    O
,    O
psychological    O
,    O
and    O
behavioral    O
factors    O
on    O
bodily    O
processes    O
and    O
quality    O
of    O
life    O
in    O
humans    O
and    O
animals    O

The    O
concept    O
of    O
the    O
show    O
was    O
to    O
highlight    O
the    O
power    B-Medicine106043075
of    I-Medicine106043075
suggestion    I-Medicine106043075
with    O
regard    O
to    O
beliefs    O
and    O
people    O
's    O
abilities    O
,    O
and    O
failure    O
to    O
question    O
them    O
.    O

It    O
was    O
during    O
those    O
early    O
years    O
that    O
the    O
medical    O
establishment    O
first    O
criticized    O
the    O
chiropractic    O
profession    O
,    O
saying    O
that    O
the    O
conditions    O
that    O
those    O
early    O
chiropractors    O
were    O
treating    O
were    O
only    O
psychophysiologic    B-Medicine106043075
disorders    I-Medicine106043075
.    O

The    O
claims    O
to    O
be    O
tested    O
were    O
increased    O
IQ    O
,    O
the    O
relief    O
of    O
psychoses    O
,    O
and    O
the    O
relief    O
of    O
psychosomatic    B-Medicine106043075
illnesses    O
.    O

By    O
acting    O
a    O
certain    O
way    O
while    O
dreaming    O
,    O
one    O
can    O
cause    O
psychosomatic    B-Medicine106043075
changes    O
in    O
one    O
's    O
being    O
,    O
including    O
an    O
alternate    O
way    O
of    O
dying    O
.    O

Budzynski    O
's    O
research    O
and    O
clinical    O
findings    O
have    O
been    O
published    O
in    O
professional    O
journals    O
including    O
:    O
the    O
Journal    O
of    O
Applied    O
Behavioral    O
Analysis    O
;    O
Experimental    O
&    O
Clinical    O
Psychopharmacology    O
;    O
the    O
Journal    O
of    O
Behavior    O
Therapy    O
and    O
Experimental    O
Psychiatry    O
;    O
Biofeedback    O
and    O
Self    O
-    O
Control    O
;    O
Biofeedback    O
:    O
Behavioral    O
Medicine    O
;    O
Psychosomatic    B-Medicine106043075
Medicine    I-Medicine106043075
;    O
the    O
Journal    O
of    O
Dental    O
Research    O
;    O
Biofeedback    O
and    O
Self    O
-    O
Regulation    O
;    O
Consciousness    O
and    O
Self    O
-    O
Regulation    O
;    O
Psychology    O
Today    O
;    O
Somatics    O
;    O
Education    O
;    O
the    O
Journal    O
of    O
Neurotherapy    O
;    O
Applied    O
Neurophysiology    O
and    O
Brainwave    O
Biofeedback    O
;    O
Clinical    B-Medicine106043075
Neurophysiology    I-Medicine106043075
;    O
and    O
Neuroimage    O
.    O

Jerome    O
Littlefield    O
(    O
Jerry    O
Lewis    O
)    O
is    O
an    O
orderly    O
at    O
the    O
Whitestone    O
Sanatorium    O
and    O
Hospital    O
who    O
suffers    O
from    O
"    O
neurotic    O
identification    O
empathy    O
"—    O
a    O
psychosomatic    B-Medicine106043075
problem    O
that    O
causes    O
him    O
to    O
suffer    O
the    O
symptoms    O
of    O
others    O
and    O
interferes    O
with    O
his    O
ability    O
to    O
function    O
effectively    O
on    O
the    O
job    O
.    O

Also    O
interviewed    O
is    O
actress    O
Peng    O
Phan    O
(    O
she    O
appeared    O
in    O
Rithy    O
Panh    O
's    O
"    O
One    O
Evening    O
After    O
the    O
War    O
"    O
and    O
"    O
Rice    O
People    O
"    O
)    O
,    O
who    O
is    O
racked    O
with    O
Survivor    O
guilt    O
and    O
is    O
overcome    O
by    O
psychosomatic    B-Medicine106043075
illness    I-Medicine106043075
.    O

In    O
2005    O
's    O
"    O
The    O
Burnt    O
Theatre    O
"    O
,    O
she    O
portrayed    O
herself    O
,    O
or    O
a    O
character    O
who    O
was    O
an    O
actress    O
named    O
Peng    O
Phan    O
who    O
suffered    O
survivor    O
guilt    O
and    O
psychosomatic    B-Medicine106043075
illness    I-Medicine106043075
.    O

The    O
book    O
endorses    O
phenomena    O
related    O
to    O
psychosomatic    B-Medicine106043075
medicine    I-Medicine106043075
,    O
placebo    O
effects    O
,    O
near    O
-    O
death    O
experiences    O
,    O
mystical    O
experiences    O
,    O
and    O
creative    O
genius    O
,    O
to    O
argue    O
for    O
a    O
"    O
strongly    O
dualistic    O
theory    O
of    O
mind    O
and    O
brain    O
"    O
.    O

"    O
Medicine    O
for    O
Moderns    O
:    O
The    O
New    O
Science    O
of    O
Psychosomatic    B-Medicine106043075
Medicine    I-Medicine106043075
"    O
(    O
1947    O
)    O

Digital    B-Medicine106043075
pathology    I-Medicine106043075
is    O
an    O
image    O
-    O
based    O
information    O
environment    O
which    O
is    O
enabled    O
by    O
computer    O
technology    O
that    O
allows    O
for    O
the    O
management    O
of    O
information    O
generated    O
from    O
a    O
digital    O
slide    O
.    O

Digital    B-Medicine106043075
pathology    I-Medicine106043075
and    O
Telepathology    B-Medicine106043075

Ludwig    O
Merzbacher    O
(    O
9    O
February    O
1875    O
–    O
30    O
October    O
1942    O
)    O
was    O
a    O
German    O
-    O
Argentine    O
neuropathologist    B-Medicine106043075
and    O
psychiatrist    O
born    O
in    O
Florence    O
,    O
Italy    O
.    O

In    O
1885    O
he    O
provided    O
the    O
first    O
description    O
of    O
a    O
dysmyelinating    O
central    O
nervous    O
system    O
disorder    O
that    O
was    O
to    O
become    O
known    O
as    O
"    O
Pelizaeus    O
–    O
Merzbacher    O
disease    O
"    O
,    O
named    O
in    O
conjunction    O
with    O
neuropathologist    B-Medicine106043075
Ludwig    O
Merzbacher    O
(    O
1875–1942    O
)    O
.    O

July    O
2    O
–    O
Alfons    O
Maria    O
Jakob    O
(    O
died    O
1931    O
)    O
,    O
German    O
neuropathologist    B-Medicine106043075
.    O

The    O
2015    O
film    O
"    O
Concussion    O
"    O
aimed    O
to    O
shed    O
light    O
on    O
the    O
sport    O
's    O
safety    O
,    O
specifically    O
in    O
the    O
NFL    O
by    O
having    O
Will    O
Smith    O
portrey    O
Dr.    O
Bennet    O
Omalu    O
,    O
a    O
neuropathologist    B-Medicine106043075
who    O
was    O
the    O
first    O
to    O
discover    O
and    O
publish    O
findings    O
of    O
chronic    O
traumatic    O
encephalopathy    O
(    O
CTE    O
)    O
.    O

It    O
was    O
here    O
where    O
Bekhterev    O
's    O
interest    O
in    O
the    O
discipline    O
neuropathology    B-Medicine106043075
and    O
psychiatry    O
was    O
first    O
sparked    O
.    O

"    O
Concussion    O
"    O
(    O
2015    O
)    O
–    O
American    O
sports    O
drama    O
,    O
based    O
on    O
the    O
2009    O
"    O
GQ    O
"    O
article    O
"    O
Game    O
Brain    O
"    O
by    O
Jeanne    O
Marie    O
Laskas    O
,    O
focused    O
on    O
a    O
forensic    O
pathologist    O
and    O
neuropathologist    B-Medicine106043075
,    O
Dr.    O
Bennet    O
Omalu    O
,    O
who    O
discovers    O
CTE    O
in    O
the    O
brains    O
of    O
two    O
NFL    O
players    O

Leopold    O
Auerbach    O
(    O
27    O
April    O
1828    O
–    O
30    O
September    O
1897    O
)    O
was    O
a    O
German    O
anatomist    O
and    O
neuropathologist    B-Medicine106043075
born    O
in    O
Breslau    O
.    O

It    O
is    O
located    O
at    O
National    O
Institute    O
of    O
Mental    O
Health    O
and    O
Neurosciences    O
(    O
NIMHANS    O
)    O
and    O
is    O
run    O
by    O
its    O
department    O
of    O
neuropathology    B-Medicine106043075
.    O

In    O
1936    O
he    O
emigrated    O
to    O
the    O
United    O
States    O
,    O
where    O
from    O
1937    O
to    O
1954    O
,    O
he    O
served    O
as    O
a    O
professor    O
of    O
neurology    O
and    O
neuropathology    B-Medicine106043075
at    O
Wayne    O
State    O
University    O
School    O
of    O
Medicine    O
in    O
Detroit    O
.    O

These    O
differences    O
include    O
volume    O
of    O
gray    O
matter    O
,    O
neuropathological    B-Medicine106043075
size    O
differences    O
variations    O
,    O
and    O
cortical    O
thickness    O
,    O
which    O
then    O
associated    O
with    O
cognitive    O
differences    O
on    O
tests    O
.    O

These    O
findings    O
are    O
also    O
consistent    O
with    O
neuropathological    B-Medicine106043075
changes    O
seen    O
in    O
early    O
AD    O
patients    O
in    O
areas    O
such    O
as    O
the    O
cholinergic    O
system    O
,    O
and    O
prefrontal    O
and    O
parietal    O
regions    O
.    O

As    O
she    O
had    O
suffered    O
a    O
minor    O
head    O
injury    O
during    O
the    O
struggle    O
samples    O
of    O
brain    O
tissue    O
were    O
subsequently    O
examined    O
by    O
an    O
independent    O
neuropathologist    B-Medicine106043075
to    O
establish    O
whether    O
brain    O
injury    O
may    O
have    O
caused    O
the    O
hypoxia    O
rather    O
than    O
asphyxiation    O
as    O
a    O
direct    O
result    O
of    O
the    O
gag    O
and    O
tape    O
.    O

Percival    O
Sylvester    O
Bailey    O
(    O
May    O
9    O
,    O
1892    O
–    O
August    O
10    O
,    O
1973    O
)    O
was    O
an    O
American    O
neuropathologist    B-Medicine106043075
,    O
neurosurgeon    O
and    O
psychiatrist    O
who    O
was    O
a    O
native    O
of    O
rural    O
southern    O
Illinois    O
.    O

Paul    O
Bucy    O
(;    O
November    O
13    O
,    O
1904    O
–    O
September    O
22    O
,    O
1992    O
)    O
was    O
an    O
American    O
neurosurgeon    O
and    O
neuropathologist    B-Medicine106043075
who    O
was    O
a    O
native    O
of    O
Hubbard    O
,    O
Iowa    O
.    O

He    O
received    O
his    O
bachelor`s    O
degree    O
,    O
a    O
master`s    O
in    O
neuropathology    B-Medicine106043075
and    O
his    O
doctorate    O
from    O
the    O
University    O
of    O
Iowa    O
.    O

Neuropathology    B-Medicine106043075

Louise    O
Eisenhardt    O
(    O
1891–1967    O
)    O
,    O
early    O
neuropathologist    B-Medicine106043075
who    O
was    O
the    O
first    O
woman    O
to    O
serve    O
as    O
president    O
of    O
the    O
American    O
Association    O
of    O
Neurological    O
Surgeons    O
.    O

Ann    O
McKee    O
(    O
born    O
1953    O
)    O
is    O
a    O
neuropathologist    B-Medicine106043075
and    O
expert    O
in    O
neurodegenerative    O
disease    O
at    O
Boston    O
University    O
School    O
of    O
Medicine    O
.    O

He    O
identified    O
type    O
2    O
diabetes    O
(    O
T2D    O
)    O
as    O
one    O
of    O
the    O
major    O
risk    O
factors    O
that    O
might    O
affect    O
AD    O
neuropathology    B-Medicine106043075
and    O
synaptic    O
plasticity    O
in    O
part    O
through    O
epigenetic    O
mechanisms    O
.    O

His    O
lectures    O
on    O
neuropathogenesis    B-Medicine106043075
,    O
gout    O
,    O
leprosy    O
,    O
diseases    O
of    O
the    O
tongue    O
,    O
etc    O
.    O

Glutamatergic    O
neurotransmission    O
is    O
involved    O
in    O
most    O
aspects    O
of    O
normal    O
brain    O
function    O
and    O
can    O
be    O
perturbed    O
in    O
many    O
neuropathologic    B-Medicine106043075
conditions    O
.    O

Their    O
goal    O
was    O
to    O
investigate    O
comparative    O
neuroanatomy    O
and    O
neuropathology    B-Medicine106043075
.    O

Rehabilitation    B-Medicine106043075
engineering    I-Medicine106043075
–    O
Design    O
of    O
devices    O
and    O
systems    O
used    O
to    O
aid    O
the    O
disabled    O

The    O
study    O
of    O
gait    O
allows    O
diagnoses    O
and    O
intervention    O
strategies    O
to    O
be    O
made    O
,    O
as    O
well    O
as    O
permitting    O
future    O
developments    O
in    O
rehabilitation    B-Medicine106043075
engineering    I-Medicine106043075
.    O

Medical    O
,    O
rehabilitation    B-Medicine106043075
and    O
assistive    O
engineering    O

Addiction    B-Medicine106043075
Medicine    I-Medicine106043075

Addiction    B-Medicine106043075
medicine    I-Medicine106043075
is    O
a    O
medical    O
specialty    O
that    O
deals    O
with    O
the    O
treatment    O
of    O
addiction    O
.    O

Addiction    B-Medicine106043075
medicine    I-Medicine106043075

Gitlow    O
is    O
a    O
regular    O
columnist    O
for    O
"    O
Counselor    O
"    O
,    O
frequent    O
contributor    O
to    O
textbooks    O
about    O
addiction    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
in    O
2001    O
published    O
the    O
book    O
"    O
Practical    O
Guides    O
in    O
Psychiatry    O
:    O
Substance    O
Use    O
Disorders    O
"    O

A    O
board    O
-    O
certified    O
internist    O
and    O
addiction    B-Medicine106043075
medicine    I-Medicine106043075
specialist    B-Medicine106043075
,    O
he    O
rose    O
to    O
fame    O
as    O
the    O
host    O
of    O
the    O
nationally    O
syndicated    O
radio    O
talk    O
show    O
,    O
"    O
Loveline    O
"    O
.    O

Specific    O
therapy    O
for    O
treating    O
high    O
blood    O
pressure    O
(    O
e.g.    O
,    O
amlodipine    B-Medicine106043075
)    O
,    O
should    O
be    O
added    O
if    O
necessary    O
.    O

For    O
example    O
,    O
calcium    O
channel    O
blockers    O
(    O
i.e.    O
diltiazem    O
,    O
amlodipine    B-Medicine106043075
)    O
are    O
P    O
-    O
gp    O
substrates    O
and    O
can    O
lead    O
to    O
increased    O
concentrations    O
of    O
these    O
drugs    O
when    O
taken    O
with    O
simeprevir    O
.    O

Dr.    O
Reddy    O
’s    O
Para    O
4    O
application    O
strategy    O
for    O
generic    O
business    O
received    O
a    O
severe    O
setback    O
when    O
Reddy    O
’s    O
lost    O
the    O
patent    O
challenge    O
in    O
the    O
case    O
of    O
Pfizer    O
’s    O
drug    O
Norvasc    B-Medicine106043075
(    O
amlodipine    B-Medicine106043075
maleate    I-Medicine106043075
)    O
,    O
a    O
drug    O
indicated    O
for    O
the    O
treatment    O
of    O
hypertension    O
and    O
angina    O
.    O

Some    O
of    O
these    O
calcium    O
antagonists    O
include    O
verapamil    O
,    O
diltiazem    O
,    O
amlodipine    B-Medicine106043075
,    O
benidipine    O
,    O
cilnidipine    O
,    O
nicardipine    O
,    O
and    O
barnidipine    O
.    O

Amlodipine    B-Medicine106043075

:*    O
Amlodipin    O
Orion    O
(    O
"    O
amlodipine    B-Medicine106043075
"    O
)    O

amlodipine    B-Medicine106043075
(    O
calcium    O
channel    O
blocker    O
)    O

Don    O
Cheadle    O
as    O
himself    O
(    O
Episode    O
:    O
"    O
Unwindulax    B-Medicine106043075
"    O
)    O

Teleophthalmology    B-Medicine106043075

Vasodilators    O
such    O
as    O
sodium    B-Medicine106043075
nitroprusside    I-Medicine106043075
can    O
be    O
considered    O
for    O
patients    O
with    O
ongoing    O
hypertension    O
,    O
but    O
they    O
should    O
never    O
be    O
used    O
alone    O
,    O
as    O
they    O
generally    O
cause    O
reflex    O
tachycardia    O
.    O

Mössbauer    O
spectrum    O
of    O
sodium    B-Medicine106043075
nitroprusside    I-Medicine106043075
,    O
exhibiting    O
quadruple    O
splitting    O
.    O

Hypertension    O
presents    O
a    O
risk    O
for    O
intracranial    O
hemorrhage    O
(    O
i.e.    O
,    O
bleeding    O
in    O
the    O
brain    O
)    O
and    O
,    O
if    O
severe    O
,    O
is    O
typically    O
treated    O
with    O
intravenous    O
phentolamine    O
or    O
nitroprusside    B-Medicine106043075
.    O

Sodium    B-Medicine106043075
nitroprusside    I-Medicine106043075
.    O

Sodium    B-Medicine106043075
nitroprusside    I-Medicine106043075
,    O
a    O
peripheral    O
vasodilator    O

Functions    O
as    O
a    O
vasodilator    O
during    O
cryopreservation    O
when    O
used    O
in    O
conjunction    O
with    O
verapamil    O
,    O
phentolamine    O
,    O
nifedipine    O
,    O
tolazoline    O
or    O
nitroprusside    B-Medicine106043075
.    O

Sodium    B-Medicine106043075
nitroprusside    I-Medicine106043075
and    O
nitroglycerin    O
function    O
by    O
causing    O
vasodilation    O
through    O
nitric    O
oxide    O
,    O
which    O
manipulates    O
cGMP    O
levels    O
through    O
guanylate    O
cyclase    O
.    O

Telepathology    B-Medicine106043075

Digital    B-Medicine106043075
pathology    I-Medicine106043075
and    O
Telepathology    B-Medicine106043075

These    O
methods    O
range    O
from    O
professional    O
training    O
to    O
animal    O
husbandry    O
to    O
conservation    B-Medicine106043075
medicine    I-Medicine106043075
.    O

-    O
Conservation    B-Medicine106043075
medicine    I-Medicine106043075

Organon    O
deals    O
in    O
the    O
following    O
core    O
therapeutic    O
fields    O
:    O
reproductive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
contraception    O
,    O
psychiatry    O
,    O
HRT    O
and    O
anesthesia    O
.    O

His    O
initial    O
specialization    O
was    O
obstetrics    O
and    O
gynaecology    O
,    O
which    O
further    O
broadened    O
to    O
cryosurgery    O
and    O
endoscopy    O
,    O
immunology    O
,    O
reproductive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
genetic    B-Medicine106043075
medicine    I-Medicine106043075
,    O
stem    O
cells    O
,    O
and    O
bioethics    O
.    O

Martin    O
Hume    O
Johnson    O
(    O
born    O
1944    O
)    O
FRS    O
FMedSci    O
FRSB    O
FRCOG    O
is    O
emeritus    O
professor    O
of    O
Reproductive    B-Medicine106043075
Sciences    I-Medicine106043075
in    O
the    O
Department    O
of    O
Physiology    O
,    O
Development    O
and    O
Neuroscience    O
(    O
PDN    O
)    O
at    O
the    O
University    O
of    O
Cambridge    O
.    O

The    O
Genito-urinary    B-Medicine106043075
medicine    I-Medicine106043075
,    O
Dermatology    O
Unit    O
,    O
diabetes    O
screening    O
and    O
resource    O
centre    O
,    O
Chronic    O
pain    O
and    O
Elderly    O
care    O
outpatients    O
services    O
,    O
non    O
-    O
specialist    O
endoscopy    O
,    O
direct    O
access    O
therapies    O
and    O
interface    O
outpatient    O
clinics    O
all    O
remained    O
at    O
the    O
RSH    O
site    O
,    O
along    O
with    O
the    O
restaurant    O
and    O
canteen    O
(    O
which    O
will    O
be    O
refurbished    O
)    O
,    O
shop    O
and    O
coffee    O
bar    O
.    O

In    O
the    O
revival    O
,    O
it    O
was    O
revealed    O
that    O
she    O
went    O
into    O
reproductive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
running    O
a    O
successful    O
surrogacy    O
/    O
fertility    O
clinic    O
in    O
New    O
York    O
known    O
as    O
Dynasty    O
Makers    O
,    O
which    O
Lorelai    O
and    O
Luke    O
visit    O
while    O
considering    O
having    O
a    O
child    O
of    O
their    O
own    O
.    O

Reproductive    B-Medicine106043075
medicine    I-Medicine106043075
and    O
stem    O
cell    O
research    O

Reproductive    B-Medicine106043075
medicine    I-Medicine106043075

Specifically    O
,    O
these    O
were    O
genitourinary    B-Medicine106043075
medicine    I-Medicine106043075
(    O
e.g.    O
,    O
Hardwick    O
and    O
Woodcock    O
)    O
and    O
urology    O
(    O
e.g.    O
,    O
Burns    O
,    O
Cox    O
,    O
Ball    O
)    O
.    O

Louis    O
Jacques    O
Bégin    O
(    O
2    O
November    O
1793    O
,    O
Liège    O
–    O
13    O
April    O
1859    O
)    O
was    O
a    O
French    O
military    B-Medicine106043075
physician    I-Medicine106043075
.    O

Staff    O
corps    O
officers    O
are    O
specialists    O
in    O
career    O
fields    O
that    O
are    O
professions    O
unto    O
themselves    O
,    O
such    O
as    O
physicians    B-Medicine106043075
,    O
lawyers    O
,    O
civil    O
engineers    O
,    O
chaplains    O
,    O
and    O
supply    O
specialists    O
.    O

John    O
Pringle    O
publishes    O
"    O
Observations    O
on    O
the    O
Diseases    O
of    O
the    O
Army    O
in    O
Camp    O
and    O
Garrison    O
"    O
in    O
London    O
,    O
a    O
pioneering    O
text    O
in    O
modern    O
military    B-Medicine106043075
medicine    I-Medicine106043075
.    O

Abram    O
Salmon    O
Benenson    O
(    O
1914    O
–    O
December    O
15    O
,    O
2003    O
)    O
was    O
an    O
authority    O
in    O
public    O
health    O
,    O
preventive    B-Medicine106043075
medicine    I-Medicine106043075
,    O
military    B-Medicine106043075
medicine    I-Medicine106043075
,    O
and    O
"    O
shoe    O
-    O
leather    O
"    O
epidemiology    O
.    O

Adam    O
Hjalmar    O
Egede    O
-    O
Nissen    O
was    O
born    O
on    O
an    O
Øvre    O
Rinnan    O
farm    O
at    O
Frol    O
(    O
today    O
part    O
of    O
Levanger    O
)    O
in    O
Nord    O
-    O
Trøndelag    O
,    O
where    O
his    O
father    O
Paul    O
Christian    O
Egede    O
-    O
Nissen    O
(    O
1835–1891    O
)    O
was    O
then    O
serving    O
in    O
the    O
medical    B-Medicine106043075
corps    I-Medicine106043075
of    O
the    O
Norwegian    O
Army    O
.    O

The    O
medical    O
volumes    O
were    O
written    O
primarily    O
for    O
the    O
benefit    O
of    O
practitioners    O
of    O
military    B-Medicine106043075
medicine    I-Medicine106043075
,    O
but    O
have    O
a    O
wider    O
appeal    O
as    O
they    O
contain    O
military    O
detail    O
not    O
found    O
in    O
other    O
volumes    O
.    O

The    O
daughter    O
of    O
a    O
doctor    O
and    O
trained    O
in    O
first    O
aid    O
,    O
Ms.    O
Bang    O
would    O
stay    O
in    O
the    O
fortress    O
for    O
the    O
duration    O
of    O
the    O
siege    O
,    O
helping    O
two    O
military    B-Medicine106043075
doctors    I-Medicine106043075
in    O
caring    O
for    O
the    O
sick    O
and    O
wounded    O
.    O

After    O
his    O
return    O
to    O
Germany    O
,    O
he    O
spent    O
six    O
years    O
as    O
a    O
military    B-Medicine106043075
physician    I-Medicine106043075
in    O
Würzburg    O
,    O
where    O
in    O
1898    O
he    O
gained    O
his    O
habilitation    O
in    O
hygiene    O
at    O
the    O
university    O
.    O

The    O
BEF    O
was    O
(    O
theoretically    O
)    O
organized    O
as    O
a    O
standard    O
US    O
infantry    O
division    O
of    O
that    O
time    O
,    O
complete    O
in    O
all    O
aspects    O
,    O
down    O
to    O
its    O
logistical    O
tail    O
(    O
including    O
postal    O
and    O
banking    O
services    O
)    O
,    O
although    O
some    O
of    O
these    O
,    O
like    O
its    O
health    B-Medicine106043075
services    I-Medicine106043075
,    O
were    O
found    O
to    O
be    O
deficient    O
and    O
had    O
to    O
be    O
complemented    O
,    O
and    O
in    O
many    O
cases    O
controlled    O
or    O
managed    O
by    O
Americans    O
.    O

Rail    O
tracks    O
were    O
constructed    O
from    O
the    O
main    O
railway    O
line    O
to    O
enable    O
ambulance    O
trains    O
to    O
bring    O
Allied    O
wounded    O
into    O
these    O
medical    B-Medicine106043075
unit    I-Medicine106043075
from    O
Poperinge    O
and    O
to    O
take    O
them    O
from    O
there    O
on    O
to    O
the    O
large    O
military    O
hospitals    O
on    O
the    O
French    O
coast    O
.    O

In    O
June    O
2009    O
,    O
a    O
research    O
project    O
on    O
military    B-Medicine106043075
medicine    I-Medicine106043075
during    O
the    O
First    O
World    O
War    O
was    O
started    O
at    O
Lijssenthoek    O
Military    O
Cemetery    O
,    O
with    O
a    O
focus    O
on    O
medical    O
assistance    O
behind    O
the    O
front    O
line    O
.    O

Military    B-Medicine106043075
medicine    I-Medicine106043075

Conscripts    O
are    O
given    O
survival    O
training    O
during    O
every    O
season    O
of    O
the    O
year    O
,    O
they    O
can    O
specialize    O
further    O
into    O
reconnaissance    O
,    O
sniping    O
,    O
dog    O
handling    O
,    O
battlefield    B-Medicine106043075
medical    I-Medicine106043075
service    I-Medicine106043075
or    O
signals    O
.    O

Surgeon    B-Medicine106043075
continued    O
,    O
however    O
,    O
to    O
be    O
used    O
as    O
the    O
title    O
for    O
military    O
medical    O
officers    O
until    O
the    O
end    O
of    O
the    O
19th    O
century    O
,    O
and    O
the    O
title    O
of    O
Surgeon    O
General    O
continues    O
to    O
exist    O
for    O
both    O
senior    O
military    O
medical    O
officers    O
and    O
senior    O
government    O
public    O
health    O
officers    O
.    O

In    O
many    O
English    O
-    O
speaking    O
countries    O
the    O
"military"    B-Medicine106043075
title    I-Medicine106043075
of    I-Medicine106043075
surgeon    I-Medicine106043075
is    O
applied    O
to    O
any    O
medical    O
practitioner    O
,    O
due    O
to    O
the    O
historical    O
evolution    O
of    O
the    O
term    O
.    O

Sir    O
Samuel    O
Halliday    O
Macartney    O
(    O
1833–1906    O
)    O
was    O
a    O
military    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
later    O
a    O
diplomat    O
serving    O
the    O
Chinese    O
government    O
during    O
the    O
late    O
Qing    O
dynasty    O
.    O

Such    O
officers    O
are    O
typically    O
military    B-Medicine106043075
physician    I-Medicine106043075
.    O

Bernhard    O
Rawitz    O
(    O
23    O
August    O
1857    O
,    O
Ostrowo    O
-    O
28    O
December    O
1932    O
)    O
was    O
a    O
German    O
military    B-Medicine106043075
physician    I-Medicine106043075
,    O
anatomist    O
and    O
zoologist    O
.    O

In    O
1984    O
,    O
following    O
the    O
birth    O
of    O
her    O
daughter    O
,    O
Drexel    O
retired    O
from    O
the    O
music    O
industry    O
and    O
a    O
year    O
later    O
she    O
started    O
working    O
in    O
Transfusion    B-Medicine106043075
medicine    I-Medicine106043075

Clinical    O
Chemistry    O
and    O
Nuclear    O
Medicine    O
,    O
Immunology    O
and    O
Transfusion    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Microbiology    O
,    O
Pathological    O
anatomy    O
,    O
Radiology    O

Transfusion    B-Medicine106043075
medicine    I-Medicine106043075

He    O
has    O
authored    O
numerous    O
articles    O
and    O
many    O
books    O
in    O
the    O
fields    O
of    O
anesthesiology    O
,    O
critical    B-Medicine106043075
care    I-Medicine106043075
,    O
transfusion    B-Medicine106043075
medicine    I-Medicine106043075
and    O
other    O
disciplines    O
.    O

Among    O
other    O
specialty    O
services    O
are    O
cardiology    O
,    O
physiotherapy    O
and    O
sports    O
medicine    O
,    O
and    O
transfusion    B-Medicine106043075
medicine    I-Medicine106043075
.    O

For    O
example    O
the    O
other    O
memory    O
,    O
a    O
concept    O
Herbert    O
based    O
on    O
the    O
idea    O
of    O
a    O
genetic    O
memory    O
and    O
Jung    O
's    O
collective    O
unconscious    O
,    O
is    O
in    O
"    O
The    O
GM    O
Effect    O
"    O
discovered    O
by    O
Dr.    O
Valeric    O
Sabantoce    O
and    O
accessed    O
by    O
both    O
males    O
and    O
females    O
by    O
a    O
simple    O
use    O
of    O
a    O
drug    O
compound    O
,    O
while    O
in    O
the    O
"    O
Dune    O
"    O
universe    O
the    O
spice    B-Medicine106043075
melange    I-Medicine106043075
,    O
as    O
a    O
drug    O
,    O
would    O
come    O
to    O
dominate    O
the    O
future    O
of    O
mankind    O
for    O
both    O
its    O
ability    O
to    O
prolong    O
life    O
and    O
to    O
grant    O
superhuman    O
abilities    O
.    O

Set    O
tens    O
of    O
thousands    O
of    O
years    O
in    O
the    O
future    O
,    O
the    O
saga    O
chronicles    O
a    O
civilization    O
which    O
has    O
banned    O
computers    O
but    O
has    O
also    O
developed    O
advanced    O
technology    O
and    O
mental    O
and    O
physical    O
abilities    O
through    O
physical    O
training    O
,    O
eugenics    O
and    O
the    O
use    O
of    O
the    O
drug    O
melange    B-Medicine106043075
.    O

The    O
Emperor    O
's    O
power    O
derives    O
from    O
Imperial    O
control    O
of    O
the    O
seemingly    O
invincible    O
military    O
forces    O
of    O
the    O
Sardaukar    O
,    O
and    O
of    O
the    O
planet    O
Arrakis    O
and    O
its    O
priceless    O
melange    B-Medicine106043075
,    O
a    O
source    O
of    O
endless    O
wealth    O
.    O

As    O
"    O
Dune    O
"    O
begins    O
,    O
the    O
81st    O
Padishah    O
Emperor    O
is    O
Shaddam    O
IV    O
,    O
but    O
by    O
the    O
end    O
of    O
the    O
novel    O
he    O
is    O
deposed    O
by    O
Duke    O
Paul    O
Atreides    O
in    O
10,193    O
A.G.    O
(    O
After    O
Guild    O
)    O
after    O
Paul    O
seizes    O
control    O
of    O
the    O
desert    O
planet    O
Arrakis    O
,    O
the    O
only    O
source    O
of    O
the    O
vitally    O
all    O
-    O
important    O
spice    O
melange    B-Medicine106043075
.    O

The    O
Spacing    O
Guild    O
is    O
an    O
organization    O
in    O
the    O
"    O
Dune    O
"    O
universe    O
whose    O
monopoly    O
on    O
interstellar    O
travel    O
and    O
banking    O
makes    O
it    O
a    O
balance    O
of    O
power    O
against    O
the    O
Padishah    O
Emperor    O
and    O
the    O
assembled    O
noble    O
Houses    O
of    O
the    O
Landsraad    O
.    O
Mutated    O
Guild    O
Navigators    O
use    O
the    O
spice    O
drug    O
melange    B-Medicine106043075
to    O
successfully    O
navigate    O
"    O
folded    O
space    O
"    O
and    O
safely    O
guide    O
enormous    O
heighliner    O
starships    O
from    O
planet    O
to    O
planet    O
instantaneously    O
.    O

Meanwhile    O
,    O
a    O
riot    O
incited    O
by    O
Torondo    O
results    O
in    O
the    O
death    O
of    O
Roderick    O
's    O
daughter    O
;    O
Salvador    O
seizes    O
the    O
lucrative    O
melange    B-Medicine106043075
mining    O
operations    O
on    O
Arrakis    O
from    O
Venport    O
,    O
who    O
soon    O
uses    O
the    O
constant    O
danger    O
of    O
giant    O
sandworms    O
to    O
orchestrate    O
the    O
Emperor    O
's    O
assassination    O
.    O

Suk    O
doctor    O
Wellington    O
Yueh    O
,    O
the    O
Bene    O
Gesserit    O
Lady    O
Jessica    O
and    O
Harkonnen    O
enemies    O
Duncan    O
Idaho    O
and    O
Gurney    O
Halleck    O
ally    O
themselves    O
with    O
Leto    O
,    O
and    O
Shaddam    O
nearly    O
destroys    O
the    O
all    O
-    O
important    O
planet    O
Arrakis    O
thinking    O
he    O
has    O
found    O
a    O
replacement    O
for    O
its    O
priceless    O
and    O
essential    O
export    O
,    O
melange    B-Medicine106043075
.    O

"    O
Dune    O
"    O
is    O
set    O
on    O
the    O
dangerous    O
,    O
sandworm    O
-    O
ridden    O
desert    O
planet    O
Arrakis    O
,    O
sole    O
source    O
of    O
the    O
spice    B-Medicine106043075
melange    I-Medicine106043075
,    O
the    O
most    O
valuable    O
substance    O
in    O
the    O
universe    O
.    O

The    O
Baron    O
Vladimir    O
Harkonnen    O
has    O
just    O
taken    O
over    O
the    O
governorship    O
of    O
Arrakis    O
(    O
also    O
called    O
Dune    O
)    O
from    O
his    O
younger    O
brother    O
Abulurd    O
,    O
who    O
has    O
allowed    O
spice    B-Medicine106043075
production    O
to    O
decrease    O
heavily    O
.    O

A    O
Tleilaxu    O
delegation    O
arrives    O
and    O
they    O
begin    O
discussing    O
the    O
possibility    O
of    O
producing    O
melange    O
in    O
laboratories    O
;    O
Elrood    O
becomes    O
very    O
interested    O
in    O
this    O
"    O
Project    B-Medicine106043075
Amal    I-Medicine106043075
"    O
.    O

Bellonda    O
suspects    O
that    O
the    O
Honored    O
Matres    O
had    O
originally    O
been    O
Reverend    O
Mothers    O
sent    O
out    O
in    O
the    O
Scattering    O
,    O
and    O
calculates    O
that    O
melange    B-Medicine106043075
withdrawal    O
and    O
hypnosis    O
had    O
caused    O
them    O
to    O
deny    O
their    O
origins    O
.    O

Corysta    O
manages    O
to    O
improve    O
the    O
efficiency    O
and    O
output    O
of    O
the    O
operation    O
,    O
which    O
is    O
the    O
Sisterhood    O
's    O
only    O
source    O
of    O
revenue    O
besides    O
melange    B-Medicine106043075
and    O
is    O
essential    O
to    O
their    O
plan    O
to    O
amass    O
arms    O
for    O
a    O
final    O
battle    O
with    O
the    O
Unknown    O
Enemy    O
.    O

Doria    O
and    O
Bellonda    O
are    O
on    O
opposite    O
sides    O
from    O
the    O
beginning    O
;    O
hoping    O
to    O
force    O
them    O
to    O
at    O
least    O
respect    O
each    O
other    O
's    O
differences    O
,    O
Murbella    O
makes    O
them    O
partners    O
managing    O
the    O
spice    B-Medicine106043075
operations    O
on    O
Chapterhouse    O
.    O

She    O
further    O
attributes    O
to    O
him    O
a    O
motive    O
based    O
on    O
the    O
concept    O
of    O
hydraulic    O
despotism    O
,    O
in    O
which    O
a    O
government    O
structure    O
maintains    O
power    O
and    O
control    O
through    O
exclusive    O
control    O
over    O
a    O
basic    O
resource    O
needed    O
to    O
live    O
(    O
in    O
this    O
case    O
,    O
melange    B-Medicine106043075
)    O
,    O
proposing    O
that    O
he    O
is    O
building    O
the    O
Empire    O
toward    O
an    O
even    O
greater    O
dependence    O
on    O
the    O
spice    O
.    O

An    O
alliance    O
with    O
the    O
Tleilaxu    O
,    O
the    O
only    O
remaining    O
source    O
of    O
melange    B-Medicine106043075
,    O
would    O
be    O
essential    O
after    O
such    O
a    O
scenario    O
.    O

The    O
building    O
is    O
contained    O
within    O
the    O
Primary    O
Care    O
Trust    O
but    O
the    O
clinical    O
services    O
are    O
in    O
the    O
main    O
,    O
the    O
responsibility    O
of    O
the    O
Argyll    O
and    O
Clyde    O
acute    B-Medicine106043075
hospitals    I-Medicine106043075
NHS    O
trust    O
.    O

Both    O
hospitals    O
will    O
continue    O
to    O
operate    O
emergency    O
departments    O
,    O
acute    B-Medicine106043075
medicine    I-Medicine106043075
services    O
and    O
maternity    O
units    O
following    O
the    O
High    O
Court    O
decision    O
which    O
ruled    O
that    O
the    O
plan    O
to    O
close    O
services    O
at    O
Lewisham    O
Hospital    O
was    O
unlawful    O
,    O
a    O
judgement    O
which    O
was    O
subsequently    O
upheld    O
in    O
the    O
Court    O
of    O
Appeal    O
.    O

Acute    B-Medicine106043075
medicine    I-Medicine106043075

In    O
1954    O
,    O
between    O
his    O
internship    O
and    O
residency    O
in    O
internal    O
medicine    O
,    O
Harman    O
became    O
a    O
research    O
associate    O
at    O
the    O
Donner    O
Laboratory    O
of    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
at    O
UC    O
Berkeley    O
,    O
where    O
he    O
was    O
able    O
to    O
pursue    O
the    O
puzzle    O
of    O
the    O
cause    O
of    O
aging    O
.    O

Cardiophysics    O
is    O
an    O
interdisciplinary    O
science    O
that    O
stands    O
at    O
the    O
junction    O
of    O
cardiology    O
and    O
medical    B-Medicine106043075
physics    I-Medicine106043075
,    O
with    O
researchers    O
using    O
the    O
methods    O
of    O
,    O
and    O
theories    O
from    O
,    O
physics    O
to    O
study    O
cardiovascular    O
system    O
at    O
different    O
levels    O
of    O
its    O
organisation    O
,    O
from    O
the    O
molecular    O
scale    O
to    O
whole    O
organisms    O
.    O

Medical    B-Medicine106043075
physics    I-Medicine106043075

In    O
medical    B-Medicine106043075
physics    I-Medicine106043075
,    O
the    O
optical    O
window    O
is    O
the    O
portion    O
of    O
the    O
visible    O
and    O
infrared    O
spectrum    O
where    O
living    O
tissue    O
absorbs    O
relatively    O
little    O
light    O
.    O

Medical    B-Medicine106043075
physics    I-Medicine106043075

He    O
has    O
made    O
significant    O
contributions    O
to    O
the    O
development    O
and    O
global    O
dissemination    O
of    O
medical    B-Medicine106043075
physics    I-Medicine106043075
education    O
and    O
training    O
and    O
has    O
pioneered    O
e    O
-    O
learning    O
in    O
the    O
profession    O
.    O

As    O
a    O
field    O
of    O
scientific    O
investigation    O
,    O
medical    O
imaging    O
constitutes    O
a    O
sub    O
-    O
discipline    O
of    O
biomedical    O
engineering    O
,    O
medical    B-Medicine106043075
physics    I-Medicine106043075
or    O
medicine    O
depending    O
on    O
the    O
context    O
:    O
Research    O
and    O
development    O
in    O
the    O
area    O
of    O
instrumentation    O
,    O
image    O
acquisition    O
(    O
e.g.    O
,    O
radiography    O
)    O
,    O
modeling    O
and    O
quantification    O
are    O
usually    O
the    O
preserve    O
of    O
biomedical    O
engineering    O
,    O
medical    B-Medicine106043075
physics    I-Medicine106043075
,    O
and    O
computer    O
science    O
;    O
Research    O
into    O
the    O
application    O
and    O
interpretation    O
of    O
medical    O
images    O
is    O
usually    O
the    O
preserve    O
of    O
radiology    O
and    O
the    O
medical    O
sub    O
-    O
discipline    O
relevant    O
to    O
medical    O
condition    O
or    O
area    O
of    O
medical    O
science    O
(    O
neuroscience    O
,    O
cardiology    O
,    O
psychiatry    O
,    O
psychology    O
,    O
etc    O
.    O
)    O
under    O
investigation    O
.    O

physics    O
(    O
Medical    B-Medicine106043075
physics    I-Medicine106043075
)    O
to    O
understand    O
radioisotopes    O
and    O
radiation    O
,    O

Herbert    O
Mermagen    O
worked    O
in    O
the    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
section    O
as    O
a    O
radiological    B-Medicine106043075
physicist    I-Medicine106043075
,    O
known    O
today    O
as    O
a    O
health    B-Medicine106043075
physicist    I-Medicine106043075
.    O

Medical    B-Medicine106043075
physics    I-Medicine106043075
,    O
Physics    O
in    O
medicine    O
and    O
biology    O

Harold    O
Elford    O
Johns    O
,    O
OC    O
(    O
4    O
July    O
1915    O
–    O
23    O
August    O
1998    O
)    O
was    O
a    O
Canadian    O
medical    B-Medicine106043075
physicist    I-Medicine106043075
,    O
noted    O
for    O
his    O
extensive    O
contributions    O
to    O
the    O
use    O
of    O
ionizing    O
radiation    O
to    O
treat    O
cancer    O
.    O

May    O
also    O
include    O
radiation    O
protection    O
,    O
particle    O
detectors    O
,    O
and    O
medical    B-Medicine106043075
physics    I-Medicine106043075
.    O

#    O
Computational    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
(    O
WG    O
)    O

There    O
is    O
also    O
a    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
department    O
,    O
responsible    O
for    O
maintaining    O
the    O
wide    O
variety    O
of    O
medical    O
equipment    O
,    O
in    O
use    O
,    O
throughout    O
NHS    O
Shetland    O
.    O

The    O
purposes    O
of    O
the    O
American    O
Association    O
of    O
Physicists    O
in    O
Medicine    O
are    O
to    O
promote    O
the    O
application    O
of    O
physics    O
to    O
medicine    O
and    O
biology    O
and    O
to    O
encourage    O
interest    O
and    O
training    O
in    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
and    O
related    O
fields    O
.    O

577    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
/    O
Radiological    O
Science    O

Pert    O
received    O
the    O
first    O
time    O
award    O
of    O
the    O
Theophrastus    O
Paracelsus    O
Foundation    O
in    O
Holistic    O
Medicine    O
for    O
her    O
pioneering    O
work    O
in    O
the    O
area    O
of    O
psychoneuroimmunology    B-Medicine106043075
(    O
St    O
Gallen    O
,    O
Switzerland    O
)    O
on    O
April    O
12    O
,    O
2008    O
.    O

Psychoneuroimmunology    B-Medicine106043075
(    O
PNI    B-Medicine106043075
)    O
,    O
also    O
referred    O
to    O
as    O
psychoendoneuroimmunology    B-Medicine106043075
(    O
PENI    B-Medicine106043075
)    O
or    O
psychoneuroendocrinoimmunology    B-Medicine106043075
(    O
PNEI    B-Medicine106043075
)    O
,    O
is    O
the    O
study    O
of    O
the    O
interaction    O
between    O
psychological    O
processes    O
and    O
the    O
nervous    O
and    O
immune    O
systems    O
of    O
the    O
human    O
body    O
.    O

Psychoneuroimmunology    B-Medicine106043075

These    O
studies    O
warrant    O
investigation    O
for    O
antidepressants    O
for    O
use    O
in    O
both    O
psychiatric    O
and    O
non    O
-    O
psychiatric    O
illness    O
and    O
that    O
a    O
psycho-neuroimmunological    B-Medicine106043075
approach    O
may    O
be    O
required    O
for    O
optimal    O
pharmacotherapy    O
.    O

Raz    O
Yirmiya    O
(    O
Hebrew    O
:    O
רז    O
ירמיה    O
)    O
(    O
born    O
1956    O
)    O
is    O
an    O
Israeli    O
behavioral    O
neuroscientist    O
and    O
director    O
of    O
the    O
Laboratory    O
for    O
Psychoneuroimmunology    B-Medicine106043075
at    O
the    O
Hebrew    O
University    O
of    O
Jerusalem    O
in    O
Israel    O
.    O

After    O
a    O
2-year    O
post    O
-    O
doctoral    O
fellowship    O
at    O
the    O
Cousins    O
Center    O
for    O
Psychoneuroimmunology    B-Medicine106043075
at    O
UCLA    O
he    O
returned    O
in    O
1990    O
to    O
an    O
academic    O
position    O
in    O
the    O
Department    O
of    O
Psychology    O
at    O
the    O
Hebrew    O
University    O
of    O
Jerusalem    O
,    O
in    O
which    O
he    O
was    O
appointed    O
to    O
a    O
full    O
Professor    O
in    O
2003    O
.    O

General    B-Medicine106043075
and    O
Vascular    B-Medicine106043075
Surgery    I-Medicine106043075

In    O
1987    O
he    O
qualified    O
in    O
heart    B-Medicine106043075
and    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
at    O
Moscow    O
Bakulev    O
Cardiovascular    O
Institute    O
and    O
in    O
the    O
same    O
year    O
he    O
took    O
part    O
in    O
the    O
first    O
heart    O
transplantation    O
in    O
the    O
history    O
of    O
Lithuanian    O
medicine    O
.    O

He    O
is    O
a    O
former    O
professor    O
of    O
Vascular    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
the    O
University    O
of    O
London    O
and    O
former    O
world    O
president    O
of    O
the    O
International    O
College    O
of    O
Surgeons    O
.    O

Specialties    O
for    O
which    O
The    O
Medical    O
Center    O
of    O
Aurora    O
is    O
best    O
known    O
locally    O
and    O
nationally    O
include    O
heart    O
and    O
vascular    B-Medicine106043075
care    O
,    O
surgical    O
services    O
,    O
women    O
's    O
services    O
,    O
cancer    O
services    O
,    O
and    O
neurosciences    O
,    O
including    O
spine    O
,    O
brain    O
and    O
stroke    O
care    O
.    O

Vascular    B-Medicine106043075
Surgery    I-Medicine106043075
Fellowship    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

Guthrie    O
collaborated    O
in    O
his    O
work    O
on    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
with    O
French    O
physician    O
Alexis    O
Carrel    O
,    O
who    O
won    O
the    O
1912    O
Nobel    O
Prize    O
in    O
Physiology    O
or    O
Medicine    O
.    O

Vascular    B-Medicine106043075
surgeon    I-Medicine106043075
focus    O
on    O
other    O
parts    O
of    O
the    O
circulatory    O
system    O
.    O

Vascular    B-Medicine106043075
surgery    I-Medicine106043075

German    O
's    O
father    O
is    O
a    O
vascular    B-Medicine106043075
surgeon    I-Medicine106043075
.    O

He    O
joined    O
the    O
staff    O
of    O
Evanston    O
Hospital    O
in    O
1952    O
,    O
where    O
he    O
eventually    O
rose    O
to    O
become    O
the    O
head    O
of    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Group    O
II    O
hospitals    O
provide    O
the    O
group    O
I    O
valences    O
in    O
their    O
own    O
area    O
of    O
direct    O
influence    O
and    O
also    O
provide    O
the    O
medical    O
and    O
chirurgical    O
valences    O
of    O
ophthalmology    O
,    O
pneumology    B-Medicine106043075
,    O
cardiology    O
,    O
rheumatology    O
,    O
gastroenterology    O
,    O
nephrology    O
,    O
clinical    O
hematology    O
,    O
infectiology    O
,    O
medical    O
oncology    O
,    O
neonatology    O
,    O
allergology    O
,    O
gynecology    O
-    O
obstetrics    O
,    O
dermatology    O
-    O
venereology    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
urology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
pathological    O
anatomy    O
,    O
nuclear    O
medicine    O
and    O
neuroradiology    B-Medicine106043075
in    O
an    O
indirect    O
area    O
of    O
influence    O
.    O

In    O
some    O
cases    O
,    O
treatment    O
can    O
involve    O
prostaglandin    O
tablets    O
in    O
the    O
urethra    O
,    O
injections    O
into    O
the    O
penis    O
,    O
a    O
penile    O
prosthesis    O
,    O
a    O
penis    O
pump    O
or    O
vascular    B-Medicine106043075
reconstructive    I-Medicine106043075
surgery    I-Medicine106043075
.    O

The    O
University    O
of    O
Mainz    O
specialist    O
and    O
teaching    O
hospital    O
,    O
which    O
grew    O
out    O
of    O
the    O
former    O
Municipal    O
Hospitals    O
,    O
is    O
part    O
of    O
the    O
"    O
Saarland    O
Heilstätten    O
"    O
(    O
a    O
group    O
of    O
hospitals    O
)    O
–    O
even    O
though    O
it    O
is    O
not    O
in    O
the    O
Saarland    O
–    O
and    O
has    O
some    O
500    O
beds    O
and    O
1,000    O
employees    O
,    O
as    O
well    O
as    O
departments    O
for    O
general    B-Medicine106043075
,    O
abdominal    B-Medicine106043075
and    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
gynaecology    O
with    O
obstetrics    O
,    O
internal    O
medicine    O
with    O
gastroenterology    O
,    O
nephrology    O
,    O
diabetology    O
and    O
dialysis    O
,    O
diagnostic    O
and    O
interventional    O
radiology    O
,    O
cardiology    O
,    O
bone    O
marrow    O
transplantation    O
and    O
haematology    O
/    O
oncology    O
,    O
neurology    O
with    O
a    O
stroke    O
unit    O
and    O
neurosurgery    O
,    O
psychiatry    O
with    O
child    O
and    O
adolescent    O
psychiatry    O
and    O
psychotherapy    O
,    O
paediatrics    O
with    O
neonatology    O
,    O
radiation    O
therapy    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
urology    O
as    O
well    O
as    O
wards    O
for    O
ophthalmology    O
and    O
otorhinolaryngology    O
.    O

Nikolai    O
Korotkov    O
,    O
invented    O
auscultatory    O
blood    O
pressure    O
measurement    O
,    O
pioneered    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075

Vascular    B-Medicine106043075
Surgery    I-Medicine106043075

John    O
R.    O
"    O
Jack    O
"    O
Pfeifer    O
(    O
1934–2009    O
)    O
was    O
a    O
prominent    O
vascular    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
local    O
leader    O
in    O
The    O
Church    O
of    O
Jesus    O
Christ    O
of    O
Latter    O
-    O
day    O
Saints    O
(    O
LDS    O
Church    O
)    O
in    O
Michigan    O
.    O

He    O
was    O
the    O
author    O
of    O
'    O
'    O
Glenn    O
's    O
Thoracic    O
and    O
Cardiovascular    O
Surgery    O
''    O
,    O
a    O
standard    O
textbook    O
for    O
the    O
practice    O
of    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
that    O
was    O
in    O
its    O
sixth    O
edition    O
by    O
the    O
time    O
of    O
his    O
death    O
.    O

In    O
1973    O
,    O
he    O
visited    O
New    O
York    O
City    O
to    O
train    O
in    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
in    O
1975    O
he    O
trained    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
in    O
Detroit    O
.    O

Debakey    O
forceps    O
are    O
a    O
type    O
of    O
atraumatic    O
tissue    O
forceps    O
used    O
in    O
vascular    B-Medicine106043075
procedures    I-Medicine106043075
to    O
avoid    O
tissue    O
damage    O
during    O
manipulation    O
.    O

The    O
College    O
of    O
Medicine    O
offers    O
degree    O
programs    O
in    O
anatomy    O
,    O
bioengineering    O
,    O
biomedical    O
sciences    O
,    O
bioinformatics    O
and    O
genomics    O
,    O
genetics    O
,    O
immunology    O
and    O
infectious    O
diseases    O
,    O
integrative    O
biosciences    O
,    O
molecular    B-Medicine106043075
medicine    I-Medicine106043075
,    O
molecular    O
toxicology    O
,    O
neuroscience    O
,    O
pharmacology    O
,    O
and    O
physiology    O
.    O

The    O
use    O
of    O
molecular    O
biology    O
or    O
molecular    O
cell    O
biology    O
approaches    O
in    O
medicine    O
is    O
now    O
called    O
molecular    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
Side    O
-    O
Out    O
Protocol    O
focuses    O
on    O
the    O
treatment    O
of    O
Metastatic    O
breast    O
cancer    O
using    O
Applied    O
Proteomics    O
and    O
Molecular    B-Medicine106043075
Medicine    I-Medicine106043075
.    O

Department    O
of    O
Molecular    B-Medicine106043075
and    O
Developmental    O
Medicine    O

The    O
Journal    O
of    O
Molecular    O
and    O
Cellular    O
Cardiology    O
is    O
a    O
monthly    O
peer    O
-    O
reviewed    O
medical    O
journal    O
covering    O
molecular    B-Medicine106043075
and    O
cellular    O
aspects    O
of    O
cardiology    O
.    O

The    O
“    O
Modern    O
Medical    O
Technologies    O
at    O
Semmelweis    O
University    O
”    O
project    O
ensuring    O
institution    O
's    O
place    O
among    O
the    O
leading    O
research    O
universities    O
in    O
four    O
main    O
areas    O
:    O
Personalised    O
medicine    O
;    O
Imaging    O
processes    O
and    O
bioimaging    O
:    O
from    O
molecule    O
to    O
the    O
human    O
being    O
;    O
Bio    O
-    O
engineering    O
and    O
nanomedicine    B-Medicine106043075
;    O
Molecular    B-Medicine106043075
medicine    I-Medicine106043075
.    O

The    O
Instituto    O
de    O
Medicina    O
Molecular    O
of    O
the    O
University    O
of    O
Lisbon    O
,    O
a    O
research    O
institute    O
in    O
molecular    B-Medicine106043075
medicine    I-Medicine106043075
,    O
is    O
one    O
of    O
the    O
most    O
noted    O
biosciences    O
research    O
institutions    O
in    O
Portugal    O
.    O

Medical    O
biology    O
based    O
on    O
molecular    O
biology    O
combines    O
all    O
issues    O
of    O
developing    O
molecular    B-Medicine106043075
medicine    I-Medicine106043075
into    O
large    O
-    O
scale    O
structural    O
and    O
functional    O
relationships    O
of    O
the    O
human    O
genome    O
,    O
transcriptome    O
,    O
proteome    O
,    O
physiome    O
and    O
metabolome    O
with    O
the    O
particular    O
point    O
of    O
view    O
of    O
devising    O
new    O
technologies    O
for    O
prediction    O
,    O
diagnosis    O
and    O
therapy    O

Molecular    B-Medicine106043075
medicine    I-Medicine106043075

Abacavir    B-Medicine106043075
(    O
ABC    B-Medicine106043075
)    O
is    O
a    O
medication    O
used    O
to    O
prevent    O
and    O
treat    O
HIV    O
/    O
AIDS    O
.    O

This    O
class    O
of    O
medicinal    O
agents    O
included    O
the    O
drug    O
abacavir    B-Medicine106043075
.    O

Abacavir    O
was    O
commercialized    O
by    O
GlaxoSmithKline    O
as    O
Ziagen    B-Medicine106043075
for    O
the    O
treatment    O
of    O
AIDS    O
.    O

His    O
synthesis    O
of    O
abacavir    B-Medicine106043075
made    O
use    O
of    O
a    O
bicyclic    O
γ-lactam    O
,    O
2-azabicyclo[2.2.1]hept-5-en-3-one    O
,    O
as    O
a    O
chemical    O
precursor    O
.    O

Abacavir    B-Medicine106043075
,    O
an    O
antiretroviral    O
drug    O
used    O
to    O
treat    O
HIV    O
/    O
AIDS    O

Nancy    O
Leigh    O
was    O
born    O
with    O
a    O
congenital    O
heart    O
defect    O
that    O
was    O
repaired    O
with    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    O
before    O
she    O
left    O
South    O
Korea    O
.    O

Warren    O
C.    O
Jyrch    O
(    O
died    O
1971    O
)    O
is    O
known    O
for    O
being    O
the    O
first    O
ever    O
hemophiliac    O
to    O
ever    O
attempt    O
and    O
survive    O
an    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
.    O

She    O
also    O
appeared    O
in    O
the    O
hospital    O
drama    O
"    O
Open    B-Medicine106043075
Heart    I-Medicine106043075
"    O
as    O
a    O
nurse    O
fighting    O
a    O
physician    O
of    O
malpractice    O
,    O
and    O
in    O
"    O
Shania    O
:    O
A    O
Life    O
in    O
Eight    O
Albums    O
"    O
,    O
as    O
the    O
mother    O
of    O
famous    O
Canadian    O
singer    O
Shania    O
Twain    O
.    O

Paolo    O
Brenner    O
(    O
born    O
21    O
May    O
1966    O
,    O
Höchstädt    O
an    O
der    O
Donau    O
)    O
is    O
a    O
German    O
physician    O
and    O
a    O
professor    O
of    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
Dept    O
.    O
of    O
Cardiac    O
Surgery    O
,    O
Klinikum    O
Großhadern    O
of    O
the    O
Ludwig    O
Maximilian    O
University    O
of    O
Munich    O
(    O
LMU    O
)    O
.    O

The    O
placement    O
technique    O
for    O
postoperative    O
drainage    O
(    O
e.g.    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
)    O
differs    O
from    O
the    O
technique    O
used    O
for    O
emergency    O
situations    O
.    O

Holmes    O
underwent    O
treatment    O
for    O
cancer    O
in    O
1999    O
and    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
in    O
2012    O
.    O

In    O
June    O
he    O
underwent    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
and    O
was    O
placed    O
into    O
an    O
induced    O
coma    O
to    O
heal    O
.    O

When    O
he    O
had    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
in    O
1976    O
it    O
was    O
suggested    O
this    O
meant    O
he    O
would    O
retire    O
.    O

Adults    O
with    O
congenital    O
heart    O
defects    O
are    O
a    O
group    O
of    O
patients    O
which    O
is    O
fast    O
growing    O
in    O
numbers    O
,    O
due    O
to    O
advances    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
and    O
intensive    O
care    O
in    O
the    O
1970s    O
and    O
1980s    O
.    O

3    O
September    O
–    O
Brian    O
Barratt    O
-    O
Boyes    O
performs    O
New    O
Zealand    O
's    O
first    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
at    O
Auckland    O
's    O
Green    O
Lane    O
Hospital    O
.    O

On    O
January    O
20    O
Vējonis    O
underwent    O
an    O
emergency    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
to    O
eliminate    O
the    O
source    O
of    O
infection    O
in    O
which    O
the    O
heart    O
valve    O
damaged    O
by    O
Sepsis    O
was    O
replaced    O
with    O
an    O
artificial    O
heart    O
valve    O
.    O

cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
including    O
heart    O
transplantation    O
,    O
coronary    O
artery    O
bypass    O
grafting    O
,    O
heart    O
valve    O
surgery    O
,    O
and    O
pulmonary    O
thromboendarterectomy    O
;    O

It    O
has    O
been    O
central    O
to    O
advancements    O
in    O
heart    B-Medicine106043075
and    O
hand    B-Medicine106043075
surgery    I-Medicine106043075
,    O
as    O
well    O
as    O
cancer    O
treatment    O
.    O

He    O
is    O
a    O
virgin    O
as    O
revealed    O
during    O
a    O
conversation    O
with    O
Pete    O
White    O
and    O
Dr.    O
Venture    O
(    O
until    O
Monstroso    O
purchased    O
prostitutes    O
for    O
him    O
,    O
in    O
exchange    O
for    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
in    O
"    O
The    O
Silent    O
Partners    O
"    O
)    O
.    O

An    O
oxygenator    O
is    O
typically    O
utilized    O
by    O
a    O
perfusionist    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
in    O
conjunction    O
with    O
the    O
heart    O
-    O
lung    O
machine    O
.    O

Cardiac    B-Medicine106043075
Surgery    I-Medicine106043075

After    O
a    O
brief    O
stint    O
as    O
a    O
faculty    O
member    O
at    O
the    O
Post    O
Graduate    O
Institute    O
of    O
Medical    O
Education    O
and    O
Research    O
,    O
Chandigarh    O
he    O
underwent    O
further    O
training    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
Johns    O
Hopkins    O
,    O
George    O
Washington    O
,    O
and    O
Georgetown    O
University    O
Hospitals    O
,    O
USA    O
.    O

The    O
"    O
Bostick    O
Heart    O
Center    O
"    O
was    O
established    O
in    O
2005    O
to    O
provide    O
emergency    O
,    O
elective    O
,    O
and    O
rehabilitative    O
heart    O
care    O
and    O
is    O
the    O
only    O
facility    O
in    O
eastern    O
Polk    O
County    O
capable    O
of    O
performing    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075
.    O

It    O
is    O
Tanzania    O
's    O
only    O
hospital    O
to    O
be    O
specialized    O
in    O
cardiology    O
,    O
and    O
the    O
only    O
hospital    O
in    O
East    O
Africa    O
doing    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
.    O

In    O
addition    O
to    O
that    O
,    O
in    O
2001    O
,    O
Nablus    O
Speciality    O
Hospital    O
was    O
built    O
,    O
in    O
which    O
it    O
is    O
specialized    O
in    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
,    O
angiograms    O
and    O
angioplasties    O
.    O

Twelve    O
years    O
later    O
,    O
after    O
passing    O
through    O
Canada    O
,    O
England    O
and    O
France    O
,    O
he    O
would    O
end    O
up    O
with    O
a    O
postgraduate    O
degree    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
.    O

In    O
SI    O
Zaporizhzhia    O
Medical    O
Academy    O
of    O
Post    O
-    O
Graduate    O
Education    O
Ministry    O
of    O
Health    O
of    O
Ukraine    O
the    O
Institute    O
of    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
and    O
transplantology    O
,    O
and    O
also    O
scientific    O
research    O
institute    O
of    O
eye    O
diseases    O
work    O
.    O

The    O
hospital    O
provides    O
tertiary    O
and    O
quaternary    O
services    O
in    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
inner    O
city    O
health    O
and    O
therapeutic    O
endoscopy    O
.    O

A    O
variety    O
of    O
cannulae    O
are    O
used    O
to    O
establish    O
cardiopulmonary    O
bypass    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
.    O

From    O
needle    O
sticks    O
to    O
tonsillectomies    O
to    O
heart    B-Medicine106043075
operations    I-Medicine106043075
were    O
done    O
with    O
no    O
anaesthesia    O
or    O
analgesia    O
,    O
other    O
than    O
muscle    O
relaxation    O
for    O
the    O
surgery    O
.    O

Mitral    O
valve    O
replacement    O
is    O
a    O
cardiac    B-Medicine106043075
surgical    I-Medicine106043075
procedure    O
in    O
which    O
a    O
patient    O
’s    O
diseased    O
mitral    O
valve    O
is    O
replaced    O
by    O
either    O
a    O
mechanical    O
or    O
bioprosthetic    O
valve    O
.    O

Since    O
a    O
mitral    O
valve    O
replacement    O
is    O
an    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgical    O
procedure    O
,    O
it    O
requires    O
placing    O
the    O
patient    O
on    O
cardiopulmonary    O
bypass    O
.    O

Cardiac    B-Medicine106043075
surgery    I-Medicine106043075

Cardiology    O
and    O
Heart    B-Medicine106043075
Surgery    I-Medicine106043075

Further    O
advancements    O
in    O
medicine    O
—    O
such    O
as    O
widespread    O
availability    O
of    O
transplant    O
surgery    O
,    O
Cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
MRIs    O
strengthened    O
his    O
views    O
of    O
the    O
need    O
to    O
contain    O
spiraling    O
costs    O
through    O
some    O
form    O
of    O
rationing    O
.    O

The    O
services    O
provided    O
at    O
the    O
hospital    O
include    O
an    O
emergency    O
department    O
,    O
cancer    O
services    O
at    O
the    O
Sussex    O
Cancer    O
Centre    O
,    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maternity    O
services    O
,    O
and    O
both    O
adult    O
and    O
neonatal    O
intensive    O
care    O
units    O
.    O

Other    O
accomplishments    O
include    O
the    O
development    O
of    O
HeLa    O
,    O
by    O
George    O
Otto    O
Gey    O
,    O
head    O
of    O
tissue    O
culture    O
research    O
in    O
1951    O
;    O
the    O
first    O
and    O
arguably    O
most    O
important    O
line    O
of    O
human    O
cells    O
grown    O
in    O
culture    O
;    O
identification    O
of    O
the    O
three    O
types    O
of    O
polio    O
virus    O
;    O
and    O
the    O
first    O
"    O
blue    O
baby    O
"    O
operation    O
,    O
which    O
was    O
done    O
by    O
surgeon    O
Alfred    O
Blalock    O
in    O
collaboration    O
with    O
Helen    O
Taussig    O
,    O
a    O
female    O
Hopkins    O
graduate    O
specializing    O
in    O
pediatric    O
cardiology    O
and    O
surgical    O
technician    O
Vivien    O
Thomas    O
which    O
opened    O
the    O
way    O
to    O
modern    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Therapeutic    O
hypothermia    O
,    O
e.g.    O
during    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
on    O
a    O
"    O
cold    O
"    O
heart    O
(    O
generated    O
by    O
cold    O
perfusion    O
without    O
any    O
ice    O
formation    O
)    O
allows    O
for    O
much    O
longer    O
operations    O
and    O
improves    O
recovery    O
rates    O
for    O
patients    O
.    O

She    O
died    O
on    O
October    O
3    O
,    O
1990    O
,    O
in    O
Langhorne    O
,    O
Pennsylvania    O
,    O
following    O
heart    B-Medicine106043075
valve    I-Medicine106043075
surgery    I-Medicine106043075
and    O
is    O
interred    O
at    O
Greenwood    O
Cemetery    O
,    O
Wheeling    O
,    O
West    O
Virginia    O
.    O

Called    O
ProvenCare    O
by    O
Geisinger    O
,    O
the    O
program    O
features    O
three    O
key    O
elements    O
:    O
a    O
strict    O
reliance    O
on    O
evidence    O
-    O
based    O
standards    O
in    O
medicine    O
,    O
a    O
fixed    O
-    O
price    O
financial    O
mechanism    O
to    O
pay    O
for    O
certain    O
procedures    O
(    O
such    O
as    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
)    O
,    O
and    O
patient    O
engagement    O
/    O
activation    O
.    O

Subsequently    O
,    O
he    O
trained    O
in    O
general    B-Medicine106043075
and    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
Free    O
University    O
of    O
Berlin    O
,    O
where    O
,    O
upon    O
completion    O
of    O
the    O
training    O
in    O
1980    O
,    O
he    O
obtained    O
the    O
medical    O
license    O
.    O

It    O
can    O
be    O
used    O
for    O
suction    O
during    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
.    O

Russell    O
Brock    O
,    O
Baron    O
Brock    O
–    O
pioneer    O
of    O
modern    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075

At    O
Rikshospitalet    O
he    O
is    O
credited    O
with    O
performing    O
the    O
first    O
surgery    B-Medicine106043075
on    I-Medicine106043075
a    I-Medicine106043075
human    I-Medicine106043075
heart    I-Medicine106043075
on    O
4    O
September    O
1895    O
.    O

In    O
Season    O
3    O
,    O
Early    O
undergoes    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
,    O
much    O
to    O
the    O
worry    O
of    O
all    O
of    O
the    O
other    O
characters    O
.    O

He    O
was    O
an    O
innovator    O
in    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
and    O
introduced    O
the    O
concept    O
of    O
the    O
intensive    O
care    O
unit    O
.    O

With    O
low    O
cardiac    O
output    O
after    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075

In    O
1955    O
,    O
he    O
went    O
back    O
to    O
Boston    O
to    O
start    O
his    O
residency    O
in    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
,    O
Harvard    O
Medical    O
School    O
and    O
completed    O
his    O
residency    O
and    O
a    O
fellowship    O
in    O
Cardiac    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
by    O
1960    O
.    O

Responding    O
to    O
this    O
change    O
in    O
status    O
,    O
in    O
1975    O
it    O
developed    O
a    O
speciality    O
for    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
.    O

The    O
mini    O
-    O
maze    O
procedures    O
are    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
procedures    O
intended    O
to    O
cure    O
atrial    O
fibrillation    O
(    O
AF    O
)    O
,    O
a    O
common    O
disturbance    O
of    O
heart    O
rhythm    O
.    O

James    O
Cox    O
,    O
MD    O
,    O
and    O
associates    O
developed    O
the    O
"    O
maze    O
"    O
or    O
"    O
Cox    O
maze    O
"    O
procedure    O
,    O
an    O
"    O
open    O
-    O
heart    O
"    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
procedure    O
intended    O
to    O
eliminate    O
atrial    O
fibrillation    O
,    O
and    O
performed    O
the    O
first    O
one    O
in    O
1987    O
.    O
“    O

Surgical    O
ablation    O
of    O
atrial    O
fibrillation    O
with    O
off    O
-    O
pump    O
,    O
epicardial    O
,    O
high    O
-    O
intensity    O
focused    O
ultrasound    O
:    O
Although    O
the    O
HIFU    O
minimaze    O
is    O
performed    O
epicardially    O
,    O
on    O
the    O
normally    O
beating    O
heart    O
,    O
it    O
is    O
also    O
usually    O
performed    O
in    O
conjunction    O
with    O
other    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
so    O
would    O
not    O
be    O
minimally    O
invasive    O
in    O
those    O
cases    O
.    O

Previous    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
provides    O
technical    O
challenges    O
due    O
to    O
scarring    O
on    O
the    O
outside    O
of    O
the    O
heart    O
,    O
but    O
does    O
not    O
always    O
preclude    O
minimaze    O
surgery    O
.    O

Anesthesiologist    O
assistants    O
provide    O
anesthesia    O
in    O
surgical    O
environments    O
such    O
as    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
transplant    O
surgery    O
,    O
and    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
centers    O
.    O

The    O
American    O
Medical    O
Association    O
(    O
AMA    O
)    O
states    O
that    O
"    O
AAs    O
are    O
most    O
commonly    O
employed    O
in    O
larger    O
facilities    O
that    O
perform    O
procedures    O
such    O
as    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurosurgery    O
,    O
transplant    O
surgery    O
,    O
and    O
trauma    O
care    O
.    O
"    O

He    O
worked    O
as    O
Chief    O
,    O
Thoracic    O
and    O
Cardiovascular    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Lock    O
Haven    O
Hospital    O
,    O
Lock    O
Haven    O
;    O
as    O
Chief    O
,    O
Section    O
of    O
Thoracic    O
and    O
Cardiovascular    O
Surgery    O
,    O
Mercy    O
St.    O
Charles    O
Hospital    O
in    O
Oregon    O
,    O
and    O
now    O
works    O
as    O
the    O
Professor    O
Emeritus    O
of    O
the    O
Medical    O
University    O
of    O
Ohio    O
,    O
Toledo    O
(    O
now    O
the    O
University    O
of    O
Toledo    O
)    O
.    O

Jen    O
-    O
Ai    O
Hospital    O
–    O
Dali    O
provides    O
medical    O
services    O
in    O
more    O
than    O
40    O
different    O
departments    O
including    O
Bariatric    O
Surgery    O
,    O
Cardiac    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Neurosurgery    O
,    O
Oncology    O
,    O
Plastic    O
Surgery    O
,    O
etc    O
.    O

Prior    O
to    O
the    O
time    O
of    O
conflict    O
,    O
Aguillard    O
in    O
2011    O
had    O
a    O
heart    O
attack    O
,    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
successful    O
rehabilitation    O
.    O

In    O
1973    O
,    O
he    O
visited    O
New    O
York    O
City    O
to    O
train    O
in    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
in    O
1975    O
he    O
trained    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
in    O
Detroit    O
.    O

To    O
facilitate    O
on    O
-    O
pump    O
cardiac    O
surgery    O
procedures    O
through    O
smaller    O
incisions    O
,    O
Edwards    O
also    O
offers    O
a    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
product    O
line    O
comprising    O
soft    O
tissue    O
retractors    O
,    O
venous    O
and    O
arterial    O
cannulae    O
,    O
aortic    O
occlusion    O
,    O
venting    O
,    O
and    O
coronary    O
sinus    O
catheters    O
,    O
as    O
well    O
as    O
reusable    O
instruments    O
for    O
performing    O
minimally    O
invasive    O
valvular    O
procedures    O
.    O

Alfred    O
Blalock    O
(    O
first    O
modern    O
day    O
successful    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
in    O
1944    O
)    O

C.    O
Walton    O
Lillehei    O
(    O
labeled    O
"    O
Father    O
of    O
modern    O
day    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
"    O
)    O

Michael    O
DeBakey    O
(    O
educator    O
and    O
innovator    O
in    O
the    O
field    O
of    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
)    O

Its    O
specialities    O
include    O
anaesthesia    O
and    O
critical    O
care    O
,    O
adult    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
ear    O
nose    O
and    O
throat    O
surgery    O
,    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurology    O
,    O
renal    O
sciences    O
and    O
nephrology    O
.    O

One    O
patient    O
receiving    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
while    O
awake    O
was    O
ultimately    O
found    O
to    O
have    O
received    O
a    O
combination    O
of    O
three    O
powerful    O
sedatives    O
as    O
well    O
as    O
large    O
injections    O
of    O
a    O
local    O
anesthetic    O
into    O
the    O
wound    O
.    O

A    O
few    O
other    O
notable    O
examples    O
include    O
the    O
first    O
successful    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
,    O
performed    O
by    O
Dr.    O
Daniel    O
Hale    O
Williams    O
,    O
and    O
the    O
air    O
conditioner    O
,    O
patented    O
by    O
Frederick    O
McKinley    O
Jones    O
.    O

During    O
the    O
first    O
Finale    O
(    O
which    O
was    O
organized    O
for    O
the    O
benefit    O
of    O
paediatric    O
cardiac-surgery    B-Medicine106043075
)    O
in    O
the    O
same    O
year    O
,    O
the    O
Foundation    O
collected    O
a    O
total    O
of    O
USD    O
1,535,440.68    O
.    O

Every    O
year    O
,    O
millions    O
of    O
Poles    O
donate    O
to    O
the    O
Foundation    O
and    O
throughout    O
24    O
Grand    O
Finales    O
,    O
the    O
Foundation    O
collected    O
over    O
$    O
130    O
million    O
for    O
cardiac-surgery    B-Medicine106043075
,    O
neonatology    O
,    O
paediatric    O
oncology    O
,    O
kidney    O
diseases    O
,    O
congenital    O
disorders    O
,    O
newborns    O
and    O
children    O
under    O
5    O
years    O
of    O
age    O
who    O
have    O
been    O
victims    O
of    O
accidents    O
.    O

Vasiliy    O
Kolesov    O
(    O
1931    O
)    O
(    O
Pioneer    O
of    O
Cardiac    B-Medicine106043075
Surgery    I-Medicine106043075
)    O

He    O
is    O
a    O
professor    O
of    O
thoracic    B-Medicine106043075
and    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
University    O
of    O
Nairobi    O
.    O

He    O
had    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075
at    O
two    O
months    O
and    O
again    O
at    O
14    O
months    O
.    O

In    O
1993    O
,    O
Con    O
Errico    O
was    O
living    O
at    O
Deerfield    O
Beach    O
,    O
Florida    O
when    O
he    O
suffered    O
a    O
stroke    O
after    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075
and    O
died    O
a    O
short    O
time    O
later    O
on    O
March    O
21    O
.    O

Examination    O
revealed    O
that    O
she    O
had    O
had    O
a    O
large    O
amount    O
of    O
dental    O
work    O
as    O
well    O
as    O
a    O
previous    O
open    B-Medicine106043075
heart    I-Medicine106043075
surgery    I-Medicine106043075
.    O

An    O
aortic    O
cross    O
-    O
clamp    O
is    O
a    O
surgical    O
instrument    O
used    O
in    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
to    O
clamp    O
the    O
aorta    O
and    O
separate    O
the    O
systemic    O
circulation    O
from    O
the    O
outflow    O
of    O
the    O
heart    O
.    O

Valve    O
-    O
sparing    O
aortic    O
root    O
replacement    O
(    O
also    O
known    O
as    O
the    O
David    O
procedure    O
)    O
is    O
a    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
procedure    O
which    O
is    O
used    O
to    O
treat    O
Aortic    O
aneurysms    O
and    O
to    O
prevent    O
Aortic    O
dissection    O
.    O

Benjamin    O
Milstein    O
,    O
British    O
cardiothoracic    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
pioneer    O
(    O
born    O
1918    O
)    O
.    O

Bishop    O
Blackburn    O
died    O
17    O
March    O
2002    O
following    O
complications    O
from    O
his    O
7    O
March    O
open-heart    B-Medicine106043075
surgery    I-Medicine106043075
at    O
Memorial    O
Hospital    O
in    O
Jacksonville    O
,    O
Florida    O
.    O

There    O
were    O
1,670    O
open-heart    B-Medicine106043075
surgeries    I-Medicine106043075
and    O
ten    O
heart    O
transplants    O
performed    O
during    O
the    O
fiscal    O
year    O
2011    O
.    O

Cheatham    O
died    O
in    O
San    O
Diego    O
,    O
California    O
,    O
in    O
January    O
2007    O
following    O
heart    B-Medicine106043075
surgery    I-Medicine106043075
,    O
at    O
the    O
age    O
of    O
82    O
.    O

Plasma    B-Medicine106043075
medicine    I-Medicine106043075

Pyrantel    B-Medicine106043075

Mebendazole    O
,    O
Pyrantel    B-Medicine106043075
Pamoate    I-Medicine106043075

Pyrantel    B-Medicine106043075
pamoate    I-Medicine106043075
is    O
also    O
used    O
,    O
and    O
a    O
closely    O
related    O
variant    O
,    O
pyrantel    O
tartrate    O
,    O
can    O
be    O
fed    O
as    O
a    O
daily    O
dose    O
that    O
is    O
effective    O
at    O
killing    O
larvae    O
.    O

Other    O
anthelmintics    O
that    O
can    O
be    O
used    O
include    O
thiabendazole    O
,    O
mebendazole    O
,    O
levamisole    B-Medicine106043075
and    O
pyrantel    B-Medicine106043075
pamoate    I-Medicine106043075
.    O

Pyrantel    B-Medicine106043075
pamoate    I-Medicine106043075
(    O
for    O
most    O
nematode    O
infections    O
)    O

Suramin    B-Medicine106043075
sodium    I-Medicine106043075

suramin    B-Medicine106043075

Suramin    B-Medicine106043075
is    O
a    O
medication    O
used    O
to    O
treat    O
African    O
sleeping    O
sickness    O
and    O
river    O
blindness    O
.    O

There    O
are    O
no    O
vaccines    O
to    O
prevent    O
these    O
infections    O
so    O
drugs    O
such    O
as    O
pentamidine    O
and    O
suramin    B-Medicine106043075
,    O
benznidazole    O
and    O
nifurtimox    O
and    O
used    O
to    O
treat    O
infections    O
.    O

Flucytosine    B-Medicine106043075
:    O
Toxicity    O
of    O
flucytosine    O
is    O
increased    O
and    O
allows    O
a    O
lower    O
dose    O
of    O
amphotericin    O
B.    O
Amphotericin    O
B    O
may    O
also    O
facilitate    O
entry    O
of    O
flucystosine    O
into    O
the    O
fungal    O
cell    O
by    O
interfering    O
with    O
the    O
permeability    O
of    O
the    O
fungal    O
cell    O
membrane    O
.    O

"    O
Coniochaeta    O
hoffmannii    O
"    O
has    O
proven    O
to    O
be    O
resistant    O
to    O
multiple    O
antifungal    O
agents    O
,    O
including    O
amphotericin    O
B    O
,    O
flucytosine    B-Medicine106043075
,    O
ketoconazole    O
,    O
and    O
fluconazole    B-Medicine106043075
.    O
Because    O
of    O
this    O
,    O
precautions    O
have    O
been    O
taken    O
,    O
such    O
as    O
antifungal    O
susceptibility    O
testing    O
,    O
in    O
order    O
to    O
circumvent    O
such    O
drawbacks    O
.    O

The    O
addition    O
of    O
oral    O
or    O
intravenous    O
flucytosine    B-Medicine106043075
improves    O
response    O
rates    O
.    O

"    O
Rhodotorula    O
"    O
is    O
most    O
commonly    O
found    O
in    O
patients    O
who    O
are    O
immunosuppressed    O
and/or    O
are    O
using    O
foreign    O
-    O
body    O
technology    O
such    O
as    O
central    O
venous    O
catheters    O
.    O
"    O
Rhodotorula    O
"    O
is    O
commonly    O
treated    O
by    O
removing    O
the    O
catheter    O
and    O
the    O
use    O
of    O
anti    O
-    O
fungals    O
.    O
"    O
Rhodotorula    O
"    O
is    O
susceptible    O
to    O
amphotericin    O
B    O
and    O
Flucytosine    B-Medicine106043075
.    O

In    O
2014    O
it    O
was    O
reported    O
that    O
treatment    O
of    O
"    O
Acanthamoeba    O
"    O
encephalitis    O
in    O
a    O
63-year    O
-    O
old    O
immunosuppressed    O
male    O
was    O
not    O
cured    O
by    O
a    O
combination    O
of    O
miltefosine    O
,    O
sulfadiazine    O
,    O
fluconazole    B-Medicine106043075
,    O
flucytosine    B-Medicine106043075
,    O
and    O
azithromycin    O
.    O

It    O
is    O
a    O
strong    O
beta    O
-    O
lactamase    O
inducer    O
,    O
as    O
are    O
certain    O
other    O
antibiotics    O
(    O
such    O
as    O
imipenem    B-Medicine106043075
)    O
.    O

An    O
early    O
randomized    O
controlled    O
trial    O
of    O
imipenem    B-Medicine106043075
0.5    O
gram    O
intravenously    O
every    O
eight    O
hours    O
for    O
two    O
weeks    O
showed    O
a    O
reduction    O
in    O
from    O
pancreatic    O
sepsis    O
from    O
30%    O
to    O
12%    O
.    O

Another    O
randomized    O
controlled    O
trial    O
with    O
patients    O
who    O
had    O
at    O
least    O
50%    O
pancreatic    O
necrosis    O
found    O
a    O
benefit    O
from    O
imipenem    B-Medicine106043075
compared    O
to    O
pefloxacin    O
with    O
a    O
reduction    O
in    O
infected    O
necrosis    O
from    O
34%    O
to    O
20%    O

It    O
is    O
made    O
from    O
a    O
combination    O
of    O
imipenem    B-Medicine106043075
and    O
cilastatin    B-Medicine106043075
.    O

It    O
is    O
a    O
broad    O
-    O
spectrum    O
beta    O
-    O
lactam    O
containing    O
equal    O
quantities    O
of    O
imipenem    B-Medicine106043075
and    O
cilastatin    B-Medicine106043075
.    O

Once    O
it    O
was    O
established    O
what    O
infected    O
the    O
researcher    O
,    O
another    O
course    O
of    O
antibiotics    O
was    O
given    O
(    O
imipenem    B-Medicine106043075
and    O
doxycycline    O
)    O
with    O
6    O
months    O
of    O
treatment    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

He    O
featured    O
as    O
a    O
medical    O
doctor    O
of    O
a    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
clinic    O
in    O
a    O
sitcom    O
TV    O
show    O
"    O
High    O
Kick    O
:    O
Revenge    O
of    O
the    O
Short    O
Legged    O
"    O
of    O
MBC    O
from    O
2011    O
.    O

Ned    O
Abraham    O
is    O
an    O
Associate    O
Professor    O
of    O
surgery    O
at    O
the    O
Faculty    O
of    O
Medicine    O
,    O
University    O
of    O
New    O
South    O
Wales    O
a    O
general    B-Medicine106043075
&    O
colorectal    B-Medicine106043075
surgeon    O
,    O
a    O
clinical    O
academic    O
and    O
a    O
retired    O
Australian    O
Army    O
Reserve    O
Officer    O
.    O

Luckily    O
for    O
them    O
,    O
Jimmy    O
went    O
on    O
to    O
become    O
a    O
successful    O
proctologist    B-Medicine106043075
.    O
"    O

The    O
American    O
Board    O
of    O
Colon    O
and    O
Rectal    O
Surgery    O
(    O
ABCRS    O
)    O
is    O
a    O
member    O
of    O
the    O
American    O
Board    O
of    O
Medical    O
Specialties    O
that    O
issues    O
certificates    O
for    O
practitioners    O
of    O
Colorectal    B-Medicine106043075
surgery    I-Medicine106043075
.    O

They    O
are    O
also    O
used    O
to    O
overcome    O
stenosis    O
in    O
non    O
-    O
gynecological    O
situations    O
,    O
such    O
as    O
in    O
urology    O
and    O
proctology    B-Medicine106043075
.    O

Caesar    O
Portes    O
,    O
M.D.    O
,    O
class    O
of    O
1928    O
,    O
was    O
a    O
notable    O
proctologist    B-Medicine106043075
and    O
surgeon    O
.    O

One    O
piece    O
contains    O
a    O
credit    O
card    O
application    O
,    O
which    O
Bart    O
fills    O
out    O
under    O
the    O
name    O
of    O
his    O
dog    O
Santa    O
's    O
Little    O
Helper    O
,    O
whom    O
he    O
claims    O
to    O
have    O
the    O
occupation    O
"    O
butt    B-Medicine106043075
doctor    I-Medicine106043075
"    O
.    O

Some    O
proctologist    B-Medicine106043075
in    O
Japan    O
have    O
named    O
this    O
or    O
.    O

Individuals    O
with    O
ORS    O
may    O
present    O
to    O
dermatologists    O
,    O
gastroentrologists    O
,    O
otolaryngologists    O
,    O
dentists    O
,    O
proctologists    B-Medicine106043075
,    O
and    O
gynecologists    O
.    O

The    O
standard    O
Medicare    O
rebate    O
is    O
100%    O
of    O
a    O
general    O
practitioner    O
and    O
85%    O
of    O
a    O
specialist    B-Medicine106043075
schedule    O
fee    O
.    O

As    O
her    O
last    O
year    O
of    O
residency    O
is    O
coming    O
to    O
a    O
close    O
,    O
the    O
residents    O
travel    O
around    O
the    O
country    O
,    O
searching    O
for    O
the    O
best    O
jobs    O
in    O
their    O
specialties    B-Medicine106043075
.    O

After    O
his    O
medical    O
studies    O
at    O
Heidelberg    O
came    O
his    O
licensing    O
as    O
a    O
physician    O
,    O
whereupon    O
he    O
pursued    O
further    O
training    O
as    O
a    O
specialist    B-Medicine106043075
in    O
radiology    O
and    O
radiotherapy    O
in    O
Berlin    O
.    O

Regional    O
hospitals    O
(    O
โรงพยาบาลศูนย์    O
)    O
are    O
in    O
provincial    O
centres    O
,    O
have    O
a    O
capacity    O
of    O
at    O
least    O
500    O
beds    O
and    O
have    O
a    O
comprehensive    O
set    O
of    O
specialist    B-Medicine106043075
on    O
staff    O
.    O

Medical    B-Medicine106043075
specialty    I-Medicine106043075

The    O
American    O
Board    O
of    O
Nuclear    O
Medicine    O
(    O
ABNM    O
)    O
certifies    O
physicians    O
as    O
specialists    B-Medicine106043075
in    O
the    O
practice    O
of    O
nuclear    O
medicine    O
.    O

Medical    B-Medicine106043075
specialty    I-Medicine106043075

Physician    B-Medicine106043075
specialty    I-Medicine106043075
codes    I-Medicine106043075

Founded    O
in    O
February    O
1969    O
as    O
the    O
American    O
Board    O
of    O
Family    O
Practice    O
(    O
ABFP    O
)    O
,    O
the    O
group    O
was    O
the    O
20th    O
medical    B-Medicine106043075
specialty    I-Medicine106043075
to    O
be    O
recognized    O
by    O
the    O
American    O
Board    O
of    O
Medical    O
Specialties    O
and    O
was    O
formed    O
out    O
of    O
a    O
need    O
to    O
encourage    O
medical    O
school    O
graduates    O
to    O
enter    O
general    O
practice    O
.    O

The    O
hospital    O
's    O
specialist    B-Medicine106043075
outpatient    O
clinics    O
and    O
day    O
surgery    O
operating    O
theatres    O
opened    O
on    O
29    O
March    O
2010    O
.    O

A    O
board    O
-    O
certified    O
internist    O
and    O
addiction    B-Medicine106043075
medicine    I-Medicine106043075
specialist    B-Medicine106043075
,    O
he    O
rose    O
to    O
fame    O
as    O
the    O
host    O
of    O
the    O
nationally    O
syndicated    O
radio    O
talk    O
show    O
,    O
"    O
Loveline    O
"    O
.    O

Medical    B-Medicine106043075
specialist    I-Medicine106043075

Dr.    O
Twombly    O
,    O
a    O
haematology    O
and    O
oncology    O
specialist    B-Medicine106043075
in    O
Seattle    O
,    O
Washington    O
keeps    O
a    O
journal    O
detailing    O
events    O
from    O
January    O
5    O
until    O
March    O
28    O
,    O
2012    O
.    O

People    O
's    O
Hospital    O
,    O
Pragathi    O
Nagar    O
is    O
a    O
specialty    B-Medicine106043075
hospital    O
run    O
under    O
the    O
management    O
of    O
People    O
's    O
Progress    O
Trust    O
and    O
situated    O
at    O
Pragathi    O
Nagar    O
Panjayath    O
.    O

Medical    O
speciality    B-Medicine106043075
professional    O
organizations    O
do    O
not    O
recommend    O
the    O
use    O
of    O
ESAs    O
in    O
people    O
with    O
chronic    O
kidney    O
disease    O
(    O
CKD    O
)    O
who    O
have    O
hemoglobin    O
levels    O
greater    O
than    O
10    O
g    O
/    O
dL    O
and    O
do    O
not    O
have    O
anemia    O
symptoms    O
.    O

After    O
her    O
habilitation    O
she    O
founded    O
an    O
independent    O
research    O
group    O
in    O
1999    O
,    O
completed    O
her    O
medical    B-Medicine106043075
specialisation    I-Medicine106043075
in    O
immunology    O
in    O
2000    O
,    O
and    O
in    O
2007    O
became    O
professor    O
of    O
pathophysiology    B-Medicine106043075
.    O

Medical    B-Medicine106043075
specialty    I-Medicine106043075
professional    O
organizations    O
discourage    O
the    O
use    O
of    O
routine    O
cardiac    O
imaging    O
during    O
pre    O
-    O
operative    O
assessment    O
for    O
patients    O
about    O
to    O
undergo    O
low    O
or    O
mid    O
-    O
risk    O
non    O
-    O
cardiac    O
surgery    O
because    O
the    O
procedure    O
carries    O
risks    O
and    O
is    O
unlikely    O
to    O
result    O
in    O
the    O
change    O
of    O
a    O
patient    O
's    O
management    O
.    O

The    O
first    O
medical    O
journals    O
were    O
general    O
medical    O
journals    O
,    O
and    O
were    O
established    O
in    O
the    O
late    O
18th    O
century    O
;    O
specialty    B-Medicine106043075
-    O
specific    O
medical    O
journals    O
were    O
first    O
introduced    O
in    O
the    O
early    O
20th    O
century    O
.    O

It    O
is    O
used    O
by    O
pharmacists    O
and    O
doctors    O
(    O
both    O
general    O
practitioners    O
(    O
GPs    O
)    O
and    O
specialist    B-Medicine106043075
practitioners    I-Medicine106043075
)    O
,    O
and    O
by    O
other    O
prescribing    O
healthcare    O
professionals    O
(    O
such    O
as    O
nurses    O
,    O
pharmacy    O
technicians    O
,    O
paramedics    O
,    O
and    O
dentists    O
)    O
;    O
as    O
a    O
reference    O
for    O
correct    O
dosage    O
,    O
indication    O
,    O
interactions    O
and    O
side    O
effects    O
of    O
drugs    O
.    O

At    O
a    O
local    O
level    O
,    O
such    O
as    O
a    O
single    O
hospital    O
;    O
the    O
data    O
within    O
a    O
case    O
mix    O
may    O
relate    O
to    O
the    O
activity    O
of    O
an    O
individual    O
consultant    O
,    O
a    O
specific    O
speciality    B-Medicine106043075
or    O
a    O
particular    O
unit    O
(    O
such    O
as    O
a    O
ward    O
)    O
.    O

Specialty    B-Medicine106043075
professional    O
organizations    O
which    O
specialize    O
in    O
digestive    O
problems    O
advise    O
that    O
many    O
patients    O
with    O
Barrett    O
's    O
esophagus    O
are    O
too    O
frequently    O
receiving    O
endoscopies    O
.    O

Infectious    B-Medicine106043075
disease    I-Medicine106043075
,    O
also    O
known    O
as    O
infectious    B-Medicine106043075
diseases    I-Medicine106043075
,    O
infectious    B-Medicine106043075
medicine    I-Medicine106043075
,    O
infectious    B-Medicine106043075
disease    I-Medicine106043075
medicine    I-Medicine106043075
or    O
infectiology    B-Medicine106043075
,    O
is    O
a    O
medical    B-Medicine106043075
specialty    I-Medicine106043075
dealing    O
with    O
the    O
diagnosis    O
,    O
control    O
and    O
treatment    O
of    O
infections    O
.    O

On    O
completion    O
of    O
these    O
training    O
programmes    O
,    O
trainees    O
will    O
be    O
awarded    O
a    O
Certificate    O
of    O
Completion    O
of    O
Training    O
(    O
CCT    O
)    O
and    O
will    O
be    O
entitled    O
to    O
enter    O
the    O
Specialist    B-Medicine106043075
Register    O
or    O
the    O
General    O
Practitioner    O
(    O
GP    O
)    O
Register    O
as    O
appropriate    O
.    O

Following    O
completion    O
of    O
medical    O
school    O
,    O
physicians    O
partake    O
in    O
a    O
residency    O
program    O
,    O
working    O
in    O
the    O
specialty    B-Medicine106043075
field    O
in    O
which    O
they    O
will    O
practice    O
in    O
the    O
future    O
.    O

These    O
are    O
among    O
the    O
most    O
common    O
diseases    O
in    O
humans    O
The    O
prevention    B-Medicine106043075
,    O
diagnosis    O
,    O
treatment    O
and    O
rehabilitation    O
of    O
these    O
diseases    O
are    O
the    O
base    O
to    O
the    O
dentistry    O
profession    O
,    O
in    O
which    O
are    O
dentists    O
and    O
dental    O
hygienists    O
,    O
and    O
its    O
sub    O
-    O
specialties    B-Medicine106043075
,    O
such    O
as    O
oral    B-Medicine106043075
medicine    I-Medicine106043075
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
and    O
endodontics    O
.    O

He    O
and    O
Marsie    O
had    O
five    O
children    O
between    O
1898    O
and    O
1904    O
:    O
Tom    O
,    O
who    O
captained    O
the    O
Cambridge    O
University    O
cricket    O
team    O
and    O
the    O
New    O
Zealand    O
Test    O
team    O
and    O
inherited    O
Okawa    O
;    O
Jim    O
(    O
who    O
won    O
a    O
tennis    O
Blue    O
at    O
Cambridge    O
University    O
before    O
returning    O
to    O
run    O
part    O
of    O
Okawa    O
)    O
;    O
Ralph    O
(    O
Rugby    O
union    O
Blue    O
at    O
Cambridge    O
,    O
another    O
Lowry    O
farmer    O
,    O
and    O
the    O
author    O
of    O
the    O
book    O
"    O
Taihape    O
:    O
Be    O
Happy    O
,    O
Die    O
Happy    O
"    O
)    O
;    O
Gertrude    O
(    O
known    O
as    O
"    O
Beet    O
"    O
)    O
(    O
who    O
married    O
Tom    O
's    O
Cambridge    O
University    O
friend    O
Percy    O
Chapman    O
,    O
who    O
captained    O
the    O
English    O
Test    O
cricket    O
team    O
)    O
;    O
and    O
Marion    O
(    O
who    O
married    O
Reg    O
Bettington    O
,    O
Oxford    O
University    O
cricket    O
captain    O
and    O
later    O
medical    B-Medicine106043075
specialist    I-Medicine106043075
)    O
.    O

Health    O
care    O
specialists    B-Medicine106043075
claim    O
that    O
opposition    O
of    O
dividing    O
private    O
from    O
public    O
sector    O
is    O
intended    O
to    O
be    O
done    O
by    O
law    O
with    O
a    O
purpose    O
of    O
undergoing    O
the    O
ambiguity    O
embedded    O
in    O
UCCK    O
.    O

However    O
,    O
not    O
all    O
countries    O
ensure    O
equal    O
employment    O
opportunities    O
,    O
and    O
gender    O
equality    O
has    O
yet    O
to    O
be    O
achieved    O
within    O
medical    O
specialties    B-Medicine106043075
and    O
around    O
the    O
world    O
,    O
despite    O
studies    O
suggest    O
that    O
female    O
doctors    O
may    O
be    O
providing    O
higher    O
-    O
quality    O
care    O
than    O
male    O
doctors    O
.    O

The    O
Programa    O
Saúde    O
da    O
Família    O
(    O
PSF    O
)    O
,    O
Family    O
Health    O
Program    O
,    O
in    O
Portuguese    O
language    O
is    O
one    O
of    O
the    O
national    O
public    O
health    O
programs    O
in    O
Brazil    O
,    O
which    O
implements    O
a    O
national    O
policy    O
for    O
primary    O
care    O
settings    O
with    O
the    O
aim    O
of    O
substituting    O
part    O
of    O
the    O
traditional    O
model    O
of    O
primary    O
care    O
based    O
on    O
medical    B-Medicine106043075
specialist    I-Medicine106043075
.    O

This    O
is    O
in    O
the    O
face    O
of    O
much    O
older    O
and    O
established    O
specialties    B-Medicine106043075
such    O
as    O
surgery    O
and    O
internal    O
medicine    O
.    O

Medical    B-Medicine106043075
specialty    I-Medicine106043075
professional    O
organizations    O
recommend    O
no    O
follow    O
-    O
up    O
imaging    O
for    O
cysts    O
which    O
are    O
clinical    O
inconsequential    O
.    O

This    O
early    O
experience    O
with    O
biochemical    O
lab    O
work    O
inspired    O
Désiré    O
Collen    O
to    O
become    O
a    O
researcher    O
rather    O
than    O
a    O
practicing    O
general    O
physician    O
or    O
medical    B-Medicine106043075
specialist    I-Medicine106043075
.    O

A    O
native    O
of    O
Pompey    O
,    O
New    O
York    O
,    O
John    O
Harris    O
settled    O
in    O
the    O
Ohio    O
community    O
of    O
Madison    O
in    O
1819    O
;    O
after    O
practicing    O
medicine    O
with    O
a    O
specialty    B-Medicine106043075
in    O
dental    O
work    O
,    O
he    O
moved    O
to    O
Bainbridge    O
and    O
soon    O
embarked    O
on    O
training    O
young    O
doctors    O
.    O

Clinical    O
ecology    O
is    O
not    O
a    O
recognized    O
medical    B-Medicine106043075
specialty    I-Medicine106043075
.    O

In    O
smaller    O
hospitals    O
one    O
may    O
work    O
as    O
a    O
hospitalist    B-Medicine106043075
and    O
one    O
who    O
has    O
specialized    O
in    O
a    O
clinical    O
field    O
provides    O
advanced    O
medical    O
and    O
surgical    O
care    O
and    O
treatment    O
such    O
as    O
administering    O
anesthesia    O
,    O
performing    O
general    O
or    O
specialised    O
surgery    O
,    O
supervising    O
other    O
health    O
workers    O
and    O
other    O
administrative    O
duties    O
.    O

The    O
FCHC    O
facility    O
is    O
equipped    O
as    O
a    O
general    O
medical    B-Medicine106043075
and    O
surgery    O
hospital    O
,    O
with    O
the    O
following    O
special    O
units    O
:    O

Hospitalist    B-Medicine106043075

He    O
is    O
generally    O
regarded    O
as    O
the    O
academic    O
leader    O
of    O
the    O
hospitalist    B-Medicine106043075
movement    O
.    O

In    O
an    O
article    O
following    O
the    O
hospitalization    O
of    O
the    O
rapper    O
Lil    O
Wayne    O
alleged    O
to    O
be    O
related    O
to    O
purple    O
drank    O
,    O
the    O
"    O
Los    O
Angeles    O
Times    O
"    O
spoke    O
to    O
physician    O
and    O
hospitalist    B-Medicine106043075
Dr.    O
George    O
Fallieras    O
,    O
on    O
the    O
hazards    O
of    O
the    O
concoction    O
.    O

The    O
conventional    O
treatment    O
method    O
is    O
an    O
intravenous    O
injection    O
with    O
antimony    O
compounds    O
,    O
such    O
as    O
pentostam    B-Medicine106043075
.    O

In    O
1992    O
a    O
new    O
research    O
was    O
reported    O
in    O
which    O
the    O
compound    O
was    O
highly    O
effective    O
in    O
mouse    O
against    O
different    O
life    O
cycle    O
stages    O
of    O
different    O
"    O
Leishmania    O
"    O
species    O
,    O
and    O
in    O
fact    O
,    O
more    O
potent    O
than    O
the    O
conventional    O
sodium    B-Medicine106043075
stibogluconate    I-Medicine106043075
therapy    O
by    O
a    O
factor    O
of    O
more    O
than    O
600    O
.    O

Loránd    O
Kesztyűs    O
(    O
Sarkad    O
,    O
Hungary    O
,    O
11    O
April    O
1915    O
−    O
Debrecen    O
,    O
Hungary    O
,    O
17    O
August    O
1979    O
)    O
was    O
a    O
Hungarian    O
physician    O
,    O
immunologist    O
,    O
pathophysiologist    B-Medicine106043075
,    O
a    O
full    O
member    O
of    O
the    O
Hungarian    O
Academy    O
of    O
Sciences    O
.    O

The    O
pathophysiology    B-Medicine106043075
of    O
excited    O
delirium    O
has    O
been    O
unclear    O
,    O
but    O
likely    O
involves    O
multiple    O
factors    O
.    O

The    O
focus    O
of    O
this    O
journal    O
are    O
different    O
aspects    O
of    O
studying    O
hypertension    O
,    O
which    O
includes    O
pathophysiology    B-Medicine106043075
,    O
blood    O
pressure    O
regulation    O
,    O
clinical    O
treatment    O
,    O
and    O
prevention    O
.    O

Even    O
so    O
,    O
the    O
amygdala    O
might    O
still    O
be    O
a    O
place    O
of    O
partially    O
shared    O
pathophysiology    B-Medicine106043075
between    O
these    O
disorders    O
.    O

Both    O
Th1    O
and    O
Th2    O
cells    O
are    O
involved    O
in    O
the    O
pathophysiology    B-Medicine106043075
of    O
TH    O
and    O
RT    O
conditions    O
.    O

More    O
generally    O
termed    O
"    O
exercise    O
-    O
induced    O
asthma    O
"    O
,    O
the    O
preferred    O
and    O
more    O
accurate    O
term    O
"    O
exercise    O
-    O
induced    O
bronchoconstriction    O
"    O
better    O
reflects    O
underlying    O
pathophysiology    B-Medicine106043075
.    O

The    O
term    O
arose    O
in    O
the    O
field    O
of    O
pathophysiology    B-Medicine106043075
in    O
discussions    O
around    O
immune    O
disorders    O
in    O
1993    O
,    O
was    O
extended    O
to    O
discussions    O
of    O
infectious    O
disease    O
and    O
sepsis    O
,    O
and    O
has    O
been    O
used    O
to    O
describe    O
severe    O
manifestations    O
of    O
cytokine    O
release    O
syndrome    O
,    O
an    O
adverse    O
effect    O
of    O
some    O
drugs    O
.    O

Animal    O
models    O
of    O
depression    O
are    O
research    O
tools    O
used    O
to    O
investigate    O
depression    O
and    O
action    O
of    O
antidepressants    O
as    O
a    O
simulation    O
to    O
investigate    O
the    O
symptomatology    O
and    O
pathophysiology    B-Medicine106043075
of    O
depressive    O
illness    O
or    O
used    O
to    O
screen    O
novel    O
antidepressants    O
.    O

An    O
appropriate    O
animal    O
model    O
of    O
human    O
depression    O
should    O
fulfill    O
the    O
following    O
criteria    O
as    O
much    O
as    O
possible    O
:    O
strong    O
phenomenological    O
similarities    O
and    O
similar    O
pathophysiology    B-Medicine106043075
(    O
face    O
validity    O
)    O
,    O
comparable    O
etiology    O
(    O
construct    O
validity    O
)    O
,    O
and    O
common    O
treatment    O
(    O
predictive    O
validity    O
)    O
.    O

These    O
excellent    O
face    O
and    O
predictive    O
validities    O
make    O
LH    O
an    O
interesting    O
model    O
to    O
explore    O
the    O
pathophysiology    B-Medicine106043075
of    O
depression    O
.    O

Many    O
examples    O
of    O
CNS    O
pathophysiology    B-Medicine106043075
,    O
such    O
as    O
oxidative    O
stress    O
,    O
neuroinflammation    O
,    O
and    O
mitochondrial    O
dysfunction    O
,    O
could    O
be    O
by    O
-    O
products    O
of    O
environmental    O
stressors    O
such    O
as    O
pollution    O
.    O

Thus    O
the    O
pathophysiology    B-Medicine106043075
of    O
Becker    O
's    O
nevus    O
remains    O
unclear    O
.    O

After    O
her    O
habilitation    O
she    O
founded    O
an    O
independent    O
research    O
group    O
in    O
1999    O
,    O
completed    O
her    O
medical    B-Medicine106043075
specialisation    I-Medicine106043075
in    O
immunology    O
in    O
2000    O
,    O
and    O
in    O
2007    O
became    O
professor    O
of    O
pathophysiology    B-Medicine106043075
.    O

This    O
is    O
in    O
accordance    O
with    O
the    O
fact    O
that    O
the    O
5-HT2A    O
receptor    O
is    O
the    O
predominant    O
serotonin    O
receptor    O
thought    O
to    O
be    O
involved    O
in    O
the    O
pathophysiology    B-Medicine106043075
of    O
serotonin    O
syndrome    O
(    O
with    O
the    O
5-HT1A    O
receptor    O
seeming    O
to    O
be    O
protective    O
)    O
.    O

In    O
the    O
other    O
case    O
,    O
which    O
has    O
been    O
studied    O
extensively    O
since    O
the    O
early    O
1970s    O
,    O
patients    O
often    O
have    O
permanent    O
damage    O
,    O
although    O
some    O
recovery    O
is    O
possible    O
,    O
depending    O
on    O
the    O
nature    O
of    O
the    O
pathophysiology    B-Medicine106043075
.    O

Severe    O
cases    O
have    O
been    O
called    O
"    O
cytokine    O
storms    O
"    O
,    O
a    O
term    O
borrowed    O
from    O
discussions    O
of    O
the    O
pathophysiology    B-Medicine106043075
of    O
immune    O
disorders    O
and    O
infectious    O
disease    O
.    O

After    O
completing    O
his    O
education    O
at    O
the    O
University    O
of    O
Zürich    O
,    O
Bühlmann    O
specialized    O
in    O
pathophysiology    B-Medicine106043075
of    O
the    O
respiratory    O
and    O
circulatory    O
systems    O
.    O

Jan    O
Jakuš    O
(    O
born    O
18    O
February    O
1954    O
)    O
is    O
a    O
Slovak    O
medical    O
researcher    O
,    O
author    O
and    O
professor    O
of    O
Pathophysiology    B-Medicine106043075
.    O

Biomedicine    O
involves    O
the    O
study    O
of    O
(    O
patho    B-Medicine106043075
)    O
physiological    O
processes    O
with    O
methods    O
from    O
biology    O
and    O
physiology    O
.    O

As    O
the    O
Program    O
Director    O
of    O
the    O
NIH    O
/    O
NCCIH    O
funded    O
P50    O
Center    O
on    O
Molecular    O
Integrative    O
Neuroresilience    O
,    O
Pasinetti    O
's    O
focus    O
is    O
on    O
understanding    O
the    O
molecular    O
mechanisms    O
and    O
pathophysiology    B-Medicine106043075
that    O
may    O
be    O
at    O
the    O
basis    O
of    O
stress    O
-    O
induced    O
mood    O
disorders    O
,    O
including    O
anxiety    O
,    O
depression    O
,    O
and    O
other    O
neuropsychiatric    O
disorders    O
,    O
and    O
their    O
influence    O
on    O
cognitive    O
dysfunction    O
.    O

It    O
is    O
a    O
potent    O
estrogen    O
similarly    O
to    O
estrone    O
,    O
and    O
it    O
has    O
been    O
suggested    O
that    O
the    O
ratio    O
of    O
16α-hydroxyestrone    O
to    O
2-hydroxyestrone    O
,    O
the    O
latter    O
being    O
much    O
less    O
estrogenic    O
in    O
comparison    O
and    O
even    O
antiestrogenic    O
in    O
the    O
presence    O
of    O
more    O
potent    O
estrogens    O
like    O
estradiol    O
,    O
may    O
be    O
involved    O
in    O
the    O
pathophysiology    B-Medicine106043075
of    O
breast    O
cancer    O
.    O

Specifically    O
it    O
refers    O
to    O
the    O
use    O
of    O
pharmacologically    O
active    O
agents    O
or    O
physical    O
interventions    O
to    O
treat    O
or    O
suppress    O
symptoms    O
or    O
pathophysiologic    B-Medicine106043075
processes    O
of    O
diseases    O
or    O
conditions    O
.    O

While    O
this    O
had    O
much    O
improved    O
medical    O
practice    O
by    O
defining    O
with    O
increasing    O
certainty    O
the    O
pathophysiological    B-Medicine106043075
basis    O
of    O
disease    O
,    O
a    O
single    O
-    O
minded    O
focus    O
on    O
the    O
pathophysiological    O
had    O
diverted    O
much    O
of    O
mainstream    O
American    O
medicine    O
from    O
clinical    O
conditions    O
that    O
were    O
not    O
well    O
understood    O
in    O
mechanistic    O
terms    O
,    O
and    O
were    O
not    O
effectively    O
treated    O
by    O
conventional    O
therapies    O
.    O

Pathophysiology    B-Medicine106043075

To    O
date    O
,    O
most    O
pathophysiologic    B-Medicine106043075
research    O
and    O
thus    O
surgical    O
treatments    O
have    O
been    O
focused    O
on    O
the    O
disc    O
as    O
a    O
pain    O
generator    O
.    O

However    O
,    O
it    O
is    O
only    O
relatively    O
recently    O
that    O
their    O
pathophysiology    B-Medicine106043075
has    O
begun    O
to    O
be    O
understood    O
,    O
and    O
in    O
consequence    O
,    O
their    O
separation    O
from    O
reflex    O
anoxic    O
seizures    O
has    O
been    O
recognized    O
.    O

On    O
the    O
other    O
hand    O
,    O
disturbances    O
in    O
the    O
structure    O
and    O
functioning    O
of    O
microglia    O
cells    O
and    O
pathophysiological    B-Medicine106043075
levels    O
of    O
the    O
inflammatory    O
cytokine    O
interleukin-1    O
in    O
the    O
brain    O
underlie    O
the    O
impairments    O
in    O
cognition    O
and    O
neurogenesis    O
associated    O
with    O
stress    O
.    O

This    O
was    O
soon    O
rectified    O
after    O
hospital    O
management    O
held    O
discussions    O
with    O
leaders    O
of    O
HIV    O
/    O
AIDS    O
groups    O
in    O
Sydney    O
,    O
explaining    O
the    O
reasons    O
for    O
the    O
ward    O
closure    O
,    O
and    O
highlighting    O
an    O
increase    O
in    O
outpatient    O
and    O
ambulatory    B-Medicine106043075
care    I-Medicine106043075
services    O
that    O
will    O
be    O
provided    O
in    O
future    O
for    O
these    O
patients    O
.    O

Ambulatory    B-Medicine106043075
care    I-Medicine106043075

The    O
PLC    O
has    O
a    O
24    O
hours    O
emergency    O
department    O
,    O
an    O
intensive    O
care    O
unit    O
(    O
ICU    O
)    O
,    O
Level    O
IV    O
trauma    O
centre    O
and    O
offers    O
ambulatory    B-Medicine106043075
care    I-Medicine106043075
.    O

It    O
offers    O
a    O
Maternal    O
Newborn    O
Program    O
,    O
mental    O
health    O
and    O
psychiatric    O
services    O
,    O
as    O
well    O
as    O
senior    O
's    O
health    O
and    O
ambulatory    B-Medicine106043075
care    I-Medicine106043075
.    O

Outpatient    O
ambulatory-care    B-Medicine106043075
procedures    O

Ambulatory    B-Medicine106043075
health    I-Medicine106043075
care    I-Medicine106043075
settings    O
:    O
primarily    O
provides    O
outpatient    O
services    O
at    O
facilities    O
such    O
as    O
doctors    O
'    O
offices    O
,    O
outpatient    O
clinics    O
and    O
clinical    O
laboratories    O
.    O

Presbyterian    O
Hospital    O
,    O
the    O
largest    O
philanthropic    O
donation    O
in    O
its    O
history    O
,    O
beginning    O
a    O
$    O
2    O
billion    O
campaign    O
to    O
conclude    O
in    O
2019    O
for    O
a    O
new    O
ambulatory    B-Medicine106043075
care    I-Medicine106043075
center    O
and    O
renovation    O
the    O
infrastructure    O
of    O
the    O
hospital    O
's    O
five    O
sites    O
.    O

In    O
2002    O
,    O
Baptist    O
Hospital    O
-    O
DeSoto    O
added    O
an    O
Outpatient    B-Medicine106043075
Diagnostic    I-Medicine106043075
Center    I-Medicine106043075
and    O
a    O
Women    O
's    O
Center    O
.    O

It    O
is    O
an    O
outpatient    O
ambulatory    B-Medicine106043075
care    I-Medicine106043075
facility    O
.    O

The    O
system    O
's    O
main    O
hospital    O
is    O
located    O
on    O
the    O
city    O
's    O
Southside    O
,    O
with    O
additional    O
outpatient    B-Medicine106043075
facilities    O
and    O
primary    O
care    O
centers    O
throughout    O
central    O
Alabama    O
.    O

In    O
that    O
same    O
year    O
,    O
it    O
also    O
obtained    O
a    O
three    O
-    O
year    O
re    O
-    O
accreditation    O
Joint    O
Commission    O
on    O
the    O
Accreditation    O
of    O
Healthcare    O
Organizations    O
for    O
home    O
health    O
,    O
hospice    O
and    O
all    O
ambulatory    B-Medicine106043075
sites    O
.    O

PAB    O
is    O
a    O
palliative    B-Medicine106043075
operation    O
as    O
it    O
does    O
not    O
correct    O
the    O
problems    O
,    O
but    O
attempts    O
to    O
improve    O
abnormal    O
heart    O
function    O
,    O
relieve    O
symptoms    O
and    O
reduce    O
high    O
pressure    O
in    O
the    O
lungs    O
.    O

Palliative    B-Medicine106043075
care    I-Medicine106043075

Similar    O
changes    O
occurred    O
in    O
the    O
medical    O
area    O
,    O
especially    O
in    O
the    O
1980s    O
with    O
the    O
beginnings    O
of    O
hospice    B-Medicine106043075
and    O
home    O
care    O
/    O
home    O
health    O
care    O
industries    O
.    O

Land    O
-    O
based    O
medical    O
operations    O
provide    O
patient    O
screenings    O
for    O
surgeries    O
,    O
health    O
and    O
dental    O
care    O
,    O
mental    O
health    O
programs    O
,    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075
for    O
terminally    O
ill    O
patients    O
.    O

There    O
are    O
also    O
palliative    B-Medicine106043075
measures    O
like    O
castings    O
,    O
splints    O
or    O
customised    O
seatings    O
.    O

End    O
-    O
of    O
-    O
life    O
care    O
requires    O
a    O
range    O
of    O
decisions    O
,    O
including    O
questions    O
of    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
patients    O
'    O
right    O
to    O
self    O
-    O
determination    O
(    O
of    O
treatment    O
,    O
life    O
)    O
,    O
medical    O
experimentation    O
,    O
the    O
ethics    O
and    O
efficacy    O
of    O
extraordinary    O
or    O
hazardous    O
medical    O
interventions    O
,    O
and    O
the    O
ethics    O
and    O
efficacy    O
even    O
of    O
continued    O
routine    O
medical    O
interventions    O
.    O

Palliative    B-Medicine106043075
care    I-Medicine106043075

Children's    B-Medicine106043075
palliative    I-Medicine106043075
care    I-Medicine106043075

There    O
is    O
no    O
cure    O
for    O
Alzheimer    O
's    O
disease    O
;    O
available    O
treatments    O
offer    O
relatively    O
small    O
symptomatic    O
benefit    O
but    O
remain    O
palliative    B-Medicine106043075
in    O
nature    O
.    O

Donepezil    O
,    O
marketed    O
under    O
the    O
trade    O
name    O
Aricept    O
,    O
is    O
a    O
medication    O
used    O
in    O
the    O
palliative    B-Medicine106043075
treatment    I-Medicine106043075
of    O
Alzheimer    O
's    O
disease    O
.    O

This    O
measure    O
is    O
used    O
to    O
determine    O
whether    O
they    O
can    O
receive    O
chemotherapy    O
,    O
whether    O
dose    O
adjustment    O
is    O
necessary    O
,    O
and    O
as    O
a    O
measure    O
for    O
the    O
required    O
intensity    O
of    O
palliative    B-Medicine106043075
care    I-Medicine106043075
.    O

Depending    O
on    O
the    O
size    O
and    O
deterioration    O
,    O
age    O
of    O
the    O
patient    O
,    O
and    O
anaesthetic    O
risk    O
posed    O
,    O
subdural    O
hematomas    O
occasionally    O
require    O
craniotomy    O
for    O
evacuation    O
;    O
most    O
frequently    O
,    O
simple    O
burr    O
holes    O
for    O
drainage    O
;    O
often    O
conservative    O
treatment    O
;    O
and    O
rarely    O
,    O
palliative    B-Medicine106043075
treatment    I-Medicine106043075
in    O
patients    O
of    O
extreme    O
age    O
or    O
with    O
no    O
chance    O
of    O
recovery    O
.    O

Treatment    O
is    O
palliative    B-Medicine106043075
,    O
not    O
curative    O
(    O
as    O
of    O
2009    O
)    O
.    O

UMDNJ    O
also    O
operated    O
a    O
palliative    B-Medicine106043075
care    I-Medicine106043075
facility    O
for    O
people    O
living    O
with    O
AIDS    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

Crossroads    O
Inlet    O
Centre    O
Hospice    B-Medicine106043075

Unfortunately    O
,    O
in    O
many    O
cases    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
will    O
not    O
be    O
available    O
to    O
them    O
at    O
the    O
end    O
of    O
their    O
lives    O
.    O

The    O
INCTR    O
Challenge    O
Fund    O
is    O
prioritizing    O
INCTR    O
projects    O
in    O
children    O
’s    O
cancer    O
(    O
especially    O
African    O
Burkitt    O
lymphoma    O
)    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075
.    O

Due    O
to    O
the    O
scarcity    O
of    O
resources    O
and    O
the    O
limited    O
number    O
of    O
trained    O
health    O
care    O
professionals    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
is    O
unavailable    O
to    O
most    O
terminally    O
ill    O
cancer    O
patients    O
in    O
low    O
or    O
middle    O
income    O
countries    O
.    O

In    O
some    O
countries    O
the    O
situation    O
may    O
be    O
complicated    O
by    O
a    O
lack    O
of    O
professional    O
regard    O
(    O
or    O
understanding    O
)    O
of    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
as    O
a    O
bona    O
fide    O
part    O
of    O
cancer    O
control    O
,    O
and    O
by    O
local    O
medical    O
and    O
legal    O
barriers    O
to    O
the    O
use    O
of    O
opioids    O
for    O
pain    O
relief    O
.    O

Its    O
work    O
focuses    O
on    O
all    O
aspects    O
of    O
cancer    O
control    O
,    O
including    O
prevention    O
,    O
survivorship    O
,    O
palliative    B-Medicine106043075
and    O
end    O
-    O
of    O
-    O
life    O
care    O
.    O

Outpatient    O
services    O
cover    O
internal    O
medicine    O
,    O
home    O
health    O
and    O
hospice    B-Medicine106043075
care    O
,    O
memory    O
care    O
,    O
physical    O
therapy    O
and    O
rehabilitation    O
,    O
school    O
nursing    O
,    O
wound    O
care    O
,    O
and    O
hyperbaric    B-Medicine106043075
medicine    O
.    O

In    O
addition    O
to    O
the    O
acute    O
care    O
hospital    O
,    O
the    O
district    O
includes    O
an    O
attached    O
47-bed    O
unit    O
for    O
skilled    O
long    O
term    O
care    O
,    O
a    O
home    O
health    O
and    O
hospice    B-Medicine106043075
service    O
,    O
and    O
outpatient    O
services    O
.    O

It    O
has    O
a    O
family    O
birthing    O
center    O
and    O
provides    O
home    O
-    O
care    O
and    O
hospice    B-Medicine106043075
services    O
.    O

Headed    O
by    O
faculty    O
member    O
James    O
D'Amanda    O
,    O
the    O
hospice    O
program    O
allows    O
students    O
the    O
opportunity    O
to    O
offer    O
palliative    B-Medicine106043075
care    I-Medicine106043075
both    O
locally    O
and    O
as    O
far    O
away    O
as    O
Belize    O
and    O
India    O
.    O

Palliative    B-Medicine106043075
care    I-Medicine106043075
focuses    O
on    O
reducing    O
symptoms    O
and    O
improving    O
the    O
comfort    O
of    O
patients    O
rather    O
than    O
treating    O
the    O
disease    O
.    O

Health    O
Canada    O
–    O
Canada    O
's    O
federal    O
health    O
agency    O
–    O
has    O
acknowledged    O
the    O
need    O
for    O
a    O
greater    O
investment    O
in    O
palliative    B-Medicine106043075
and    O
hospice    O
care    O
as    O
the    O
country    O
faces    O
a    O
rapidly    O
growing    O
population    O
of    O
elderly    O
and    O
terminally    O
ill    O
citizens    O
.    O

Edmonton    B-Medicine106043075
Symptom    I-Medicine106043075
Assessment    I-Medicine106043075
System    I-Medicine106043075

In    O
2006    O
,    O
the    O
government    O
drafted    O
a    O
bill    O
on    O
palliative    B-Medicine106043075
care    I-Medicine106043075
and    O
support    O
for    O
people    O
at    O
the    O
end    O
of    O
their    O
life    O
.    O

The    O
friend    O
also    O
stated    O
that    O
Pausch    O
had    O
then    O
enrolled    O
in    O
a    O
hospice    O
program    O
designed    O
to    O
provide    O
palliative    B-Medicine106043075
care    I-Medicine106043075
to    O
those    O
at    O
the    O
end    O
of    O
life    O
.    O

While    O
psychiatrists    O
continue    O
to    O
prescribe    O
diazepam    O
for    O
the    O
short    O
-    O
term    O
relief    O
of    O
anxiety    O
,    O
neurology    O
has    O
taken    O
the    O
lead    O
in    O
prescribing    O
diazepam    O
for    O
the    O
palliative    B-Medicine106043075
treatment    O
of    O
certain    O
types    O
of    O
epilepsy    O
and    O
spastic    O
activity    O
,    O
for    O
example    O
,    O
forms    O
of    O
paresis    O
.    O

The    O
UK    O
's    O
palliative    B-Medicine106043075
care    I-Medicine106043075
has    O
also    O
been    O
ranked    O
as    O
the    O
best    O
in    O
the    O
world    O
by    O
the    O
Economist    O
Intelligence    O
Unit    O
.    O

Treatment    O
is    O
primarily    O
supportive    B-Medicine106043075
in    O
nature    O
.    O

Established    O
in    O
1986    O
,    O
the    O
Society    O
for    O
the    O
Promotion    O
of    O
Hospice    O
Care    O
(    O
Chinese    O
:    O
善寧會    O
)    O
is    O
a    O
non    O
-    O
profit    O
organisation    O
in    O
Hong    O
Kong    O
promoting    O
hospice    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
providing    O
bereavement    O
counselling    O
,    O
and    O
conducting    O
research    O
into    O
and    O
raising    O
public    O
awareness    O
of    O
end    O
-    O
of    O
-    O
life    O
issues    O
and    O
care    O
.    O

publishing    O
reports    O
on    O
several    O
key    O
areas    O
of    O
cancer    O
research    O
,    O
including    O
prostate    O
cancer    O
,    O
lung    O
cancer    O
,    O
radiotherapy    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
and    O
prevention    O
,    O
many    O
of    O
which    O
have    O
led    O
onto    O
the    O
establishment    O
of    O
specific    O
initiatives    O
to    O
fund    O
aspects    O
of    O
research    O
in    O
these    O
fields    O
where    O
a    O
strategic    O
gap    O
was    O
identified    O
.    O

On    O
May    O
13    O
,    O
2016    O
,    O
Cooke    O
's    O
wife    O
announced    O
on    O
his    O
official    O
blog    O
that    O
he    O
was    O
battling    O
an    O
"    O
aggressive    O
"    O
form    O
of    O
cancer    O
,    O
stating    O
,    O
"    O
It    O
is    O
with    O
tremendous    O
sadness    O
that    O
we    O
announce    O
Darwyn    O
is    O
now    O
receiving    O
palliative    B-Medicine106043075
care    I-Medicine106043075
following    O
a    O
bout    O
with    O
aggressive    O
cancer    O
.    O

In    O
the    O
final    O
stages    O
of    O
the    O
disease    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
is    O
provided    O
to    O
improve    O
quality    O
of    O
life    O
.    O

Palliative    B-Medicine106043075
care    I-Medicine106043075
is    O
specialized    O
medical    O
care    O
for    O
people    O
with    O
serious    O
illnesses    O
,    O
including    O
Parkinson    O
's    O
.    O

Acute-care    B-Medicine106043075
beds    O
for    O
patient    O
admissions    O
for    O
general    O
medicine    O
,    O
observation    O
,    O
assessment    O
,    O
convalescence    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075

Numerous    O
institutions    O
in    O
Norway    O
are    O
named    O
for    O
Sunniva    O
,    O
including    O
the    O
Catholic    O
church    O
in    O
Molde    O
,    O
various    O
schools    O
—    O
including    O
St    O
Sunniva    O
School    O
in    O
Oslo    O
—    O
several    O
Norwegian    O
ships    O
,    O
the    O
St.    O
Sunniva    O
dormitory    O
in    O
Bergen    O
,    O
and    O
the    O
Sunniva    O
Centre    O
for    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
(    O
"    O
Sunniva    O
senter    O
for    O
lindrende    O
behandling    O
"    O
)    O
in    O
Bergen    O
.    O

Other    O
work    O
includes    O
research    O
on    O
motivational    O
interviewing    O
and    O
palliative    B-Medicine106043075
care    I-Medicine106043075
of    O
cancer    O
patients    O
and    O
its    O
effect    O
on    O
long    O
term    O
well    O
-    O
being    O
in    O
surviving    O
spouses    O
.    O

Palliative    B-Medicine106043075
medications    O
may    O
sometimes    O
be    O
prescribed    O
,    O
but    O
are    O
often    O
not    O
necessary    O
because    O
there    O
is    O
usually    O
minimal    O
discomfort    O
post    O
-    O
procedure    O
.    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

Father    O
Eugeniusz    O
Dutkiewicz    O
SAC    O
Hospice    O
(    O
formerly    O
:    O
Pallottinum    O
Hospice    O
)    O
in    O
Gdańsk    O
is    O
a    O
charitable    O
organisation    O
founded    O
by    O
the    O
Pallottine    O
priest    O
E.    O
Dutkiewicz    O
in    O
1983    O
,    O
which    O
provides    O
palliative    B-Medicine106043075
care    I-Medicine106043075
for    O
the    O
terminally    O
ill    O
.    O

The    O
Liverpool    O
Care    O
Pathway    O
for    O
the    O
Dying    O
Patient    O
(    O
LCP    O
)    O
was    O
a    O
UK    O
care    O
pathway    O
(    O
excluding    O
Wales    O
)    O
covering    O
palliative    B-Medicine106043075
care    I-Medicine106043075
options    O
for    O
patients    O
in    O
the    O
final    O
days    O
or    O
hours    O
of    O
life    O
.    O

The    O
assessment    O
then    O
makes    O
suggestions    O
for    O
what    O
palliative    B-Medicine106043075
care    I-Medicine106043075
options    O
to    O
consider    O
and    O
whether    O
non    O
-    O
essential    O
treatments    O
and    O
medications    O
should    O
be    O
discontinued    O
.    O

Palliative    B-Medicine106043075
medicine    I-Medicine106043075

Aside    O
from    O
the    O
role    O
that    O
SciTech    O
plays    O
in    O
death    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
constitutes    O
a    O
specialized    O
area    O
of    O
healthcare    O
philosophy    O
that    O
specifically    O
relates    O
to    O
patients    O
who    O
are    O
terminally    O
ill    O
.    O

Palliative    B-Medicine106043075
medicine    I-Medicine106043075

The    O
director    O
,    O
Michael    O
Stillwater    O
,    O
is    O
a    O
songwriter    O
and    O
music    O
educator    O
,    O
developer    O
of    O
the    O
SongSourcing    O
method    O
for    O
spontaneous    O
songmaking    O
,    O
recording    O
artist    O
of    O
a    O
dozen    O
CDs    O
of    O
contemplative    O
songs    O
and    O
inspirational    O
music    O
,    O
co    O
-    O
author    O
of    O
"    O
Graceful    O
Passages    O
:    O
A    O
Companion    O
for    O
Living    O
and    O
Dying    O
,    O
"    O
published    O
by    O
New    O
World    O
Library    O
,    O
2002    O
,    O
applying    O
music    O
and    O
spoken    O
word    O
as    O
a    O
palliative    B-Medicine106043075
care    I-Medicine106043075
approach    O
,    O
and    O
co    O
-    O
authored    O
"    O
Music    O
at    O
the    O
End    O
of    O
Life    O
''    O
.    O

Residential    O
care    O
:    O
this    O
focuses    O
on    O
a    O
number    O
of    O
key    O
care    O
needs    O
including    O
dementia    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
rehabilitation    O
and    O
psycho    O
-    O
geriatric    O
care    O
.    O

By    O
contrast    O
,    O
there    O
is    O
no    O
treatment    O
for    O
rabbits    O
suffering    O
from    O
myxomatosis    O
,    O
other    O
than    O
palliative    B-Medicine106043075
care    I-Medicine106043075
to    O
ease    O
the    O
suffering    O
of    O
individual    O
animals    O
,    O
and    O
the    O
treatment    O
of    O
secondary    O
and    O
opportunistic    O
infections    O
,    O
in    O
the    O
hopes    O
the    O
treated    O
animal    O
will    O
survive    O
.    O

Many    O
GPs    O
have    O
a    O
specialist    O
interest    O
,    O
e.g.    O
in    O
palliative    B-Medicine106043075
care    I-Medicine106043075
.    O

Bluebell    O
Wood    O
Children    O
’s    O
Hospice    O
is    O
the    O
name    O
of    O
the    O
hospice    O
run    O
by    O
registered    O
charity    O
'    O
'    O
Bluebell    O
Wood    O
Children    O
's    O
Hospice    O
''    O
offering    O
palliative    B-Medicine106043075
care    I-Medicine106043075
and    O
support    O
to    O
families    O
who    O
have    O
a    O
child    O
or    O
young    O
person    O
with    O
a    O
shortened    O
life    O
expectancy    O
and    O
complex    O
medical    O
needs    O
.    O

It    O
also    O
has    O
geriatric    O
and    O
rehabilitation    O
services    O
,    O
elective    O
orthopaedic    B-Medicine106043075
services    O
and    O
cardiothoracic    O
services    O
,    O
an    O
in    O
-    O
patient    O
psychiatric    O
unit    O
and    O
a    O
16    O
bed    O
palliative    B-Medicine106043075
care    I-Medicine106043075
unit    O
.    O

Pasinetti    O
is    O
a    O
Professor    O
of    O
Neurology    O
,    O
Psychiatry    O
,    O
Neuroscience    O
,    O
and    O
Geriatrics    O
and    O
Palliative    B-Medicine106043075
Medicine    I-Medicine106043075
at    O
ISMMS    O
.    O

Complementary    O
therapies    O
are    O
often    O
used    O
in    O
palliative    B-Medicine106043075
care    I-Medicine106043075
or    O
by    O
practitioners    O
attempting    O
to    O
manage    O
chronic    O
pain    O
in    O
patients    O
.    O

Palliation    B-Medicine106043075

Whether    O
developing    O
or    O
disputing    O
his    O
analysis    O
,    O
subsequent    O
Jewish    O
bioethicists    O
have    O
utilized    O
his    O
work    O
on    O
abortion    O
,    O
euthanasia    O
,    O
the    O
history    O
of    O
Jewish    O
medical    O
ethics    O
,    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
treatment    O
of    O
the    O
sick    O
,    O
and    O
professional    O
duties    O
.    O

Curative    O
care    O
differs    O
from    O
preventive    B-Medicine106043075
care    I-Medicine106043075
,    O
which    O
aims    O
at    O
preventing    O
the    O
appearance    O
of    O
diseases    O
through    O
pharmaceuticals    O
and    O
such    O
techniques    O
as    O
immunization    O
,    O
exercise    O
,    O
proper    O
eating    O
habits    O
and    O
other    O
life    O
style    O
issues    O
,    O
and    O
from    O
palliative    B-Medicine106043075
care    I-Medicine106043075
,    O
which    O
concentrates    O
on    O
reducing    O
the    O
severity    O
of    O
symptoms    O
,    O
such    O
as    O
pain    O
.    O

Wells    O
is    O
married    O
to    O
Lynne    O
,    O
a    O
nurse    O
specialist    O
in    O
palliative    B-Medicine106043075
care    I-Medicine106043075
and    O
has    O
a    O
son    O
,    O
a    O
daughter    O
and    O
two    O
stepsons    O
.    O

It    O
is    O
mainly    O
used    O
in    O
palliative    B-Medicine106043075
care    I-Medicine106043075
to    O
counteract    O
the    O
constipating    O
effects    O
of    O
opioids    O
.    O

Among    O
other    O
innovations    O
,    O
he    O
created    O
the    O
first    O
intensive    O
care    O
unit    O
dedicated    O
to    O
neurosurgery    O
,    O
pioneered    O
the    O
use    O
of    O
medical    O
imaging    O
and    O
catheterization    O
in    O
the    O
diagnosis    O
and    O
treatment    O
of    O
brain    O
tumors    O
,    O
and    O
helped    O
define    O
the    O
fields    O
of    O
pediatric    O
neurosurgery    O
and    O
neuroradiology    B-Medicine106043075
.    O

The    O
story    O
revolves    O
around    O
the    O
protagonist    O
Dr.    O
Martin    O
Philips    O
from    O
then    O
on    O
,    O
who    O
is    O
a    O
doctor    O
in    O
neuroradiology    B-Medicine106043075
at    O
the    O
NYC    O
medical    O
center    O
.    O

In    O
2010    O
the    O
clinic    O
staff    O
comprised    O
consultant    O
neurologists    O
Professor    O
John    O
Collinge    O
and    O
Drs    O
Simon    O
Mead    O
and    O
Peter    O
Rudge    O
and    O
consultant    O
neuro-radiologist    B-Medicine106043075
Harpreet    O
Hyare    O
.    O

The    O
Institute    O
was    O
the    O
first    O
center    O
in    O
Texas    O
and    O
one    O
of    O
only    O
a    O
few    O
institutions    O
in    O
the    O
country    O
to    O
fully    O
integrate    O
neurology    O
,    O
neurosurgery    O
,    O
neuroradiology    B-Medicine106043075
and    O
neurorehabilitation    O
.    O

Gyldensted´s    O
parents    O
are    O
Carsten    O
Gyldensted    O
,    O
professor    O
emeritus    O
,    O
Neuroradiology    B-Medicine106043075
,    O
Center    O
of    O
Functionally    O
Integrative    O
Neuroscience    O
-    O
CFIN    O
at    O
Aarhus    O
University    O
and    O
Merete    O
Gyldensted    O
retired    O
Senior    O
Physician    O
at    O
Slagelse    O
Sygehus    O
.    O

The    O
subspecialty    B-Medicine106043075
of    O
Geriatric    O
neurology    O
is    O
defined    O
by    O
its    O
expertise    O
in    O
the    O
diagnosis    O
,    O
treatment    O
,    O
and    O
care    O
of    O
neurological    O
conditions    O
that    O
affect    O
elderly    O
and    O
by    O
its    O
unique    O
body    O
of    O
knowledge    O
regarding    O
the    O
aging    O
nervous    O
system    O
,    O
its    O
vulnerability    O
to    O
specific    O
neurological    O
disorders    O
,    O
and    O
its    O
influence    O
on    O
the    O
prevalence    O
and    O
expression    O
of    O
neurological    O
disease    O
.    O

As    O
a    O
voluntary    O
professional    O
association    O
,    O
the    O
CPS    O
represents    O
more    O
than    O
3,000    O
paediatricians    O
,    O
paediatric    O
subspecialists    B-Medicine106043075
,    O
paediatric    O
residents    O
,    O
and    O
other    O
people    O
who    O
work    O
with    O
and    O
care    O
for    O
children    O
.    O

The    O
Certified    O
Hyperbaric    O
Registered    O
Nurse    O
(    O
CHRN    O
)    O
program    O
is    O
a    O
subspecialty    B-Medicine106043075
for    O
registered    O
nurses    O
.    O
Hyperbaric    O
nursing    O
challenges    O
nurses    O
"    O
to    O
provide    O
safe    O
,    O
cost    O
-    O
effective    O
,    O
quality    O
patient    O
care    O
,    O
according    O
to    O
established    O
standards    O
.    O
"    O

The    O
American    O
Academy    O
of    O
Sleep    O
Medicine    O
(    O
AASM    O
)    O
is    O
a    O
United    O
States    O
professional    O
society    O
for    O
the    O
medical    B-Medicine106043075
subspecialty    I-Medicine106043075
of    O
sleep    B-Medicine106043075
medicine    I-Medicine106043075
which    O
includes    O
disorders    O
of    O
circadian    O
rhythms    O
.    O

The    O
monitoring    O
and    O
calculation    O
of    O
doses    O
to    O
safeguard    O
human    O
health    O
is    O
called    O
dosimetry    O
and    O
is    O
undertaken    O
within    O
the    O
science    O
of    O
health    B-Medicine106043075
physics    I-Medicine106043075
.    O

The    O
Radium    O
Girls    O
'    O
saga    O
holds    O
an    O
important    O
place    O
in    O
the    O
history    O
of    O
both    O
the    O
field    O
of    O
health    B-Medicine106043075
physics    I-Medicine106043075
and    O
the    O
labor    O
rights    O
movement    O
.    O

Facilities    O
and    O
physical    O
locations    O
that    O
are    O
deemed    O
to    O
be    O
contaminated    O
may    O
be    O
cordoned    O
off    O
by    O
a    O
health    B-Medicine106043075
physicist    I-Medicine106043075
and    O
labeled    O
"    O
Contaminated    O
area    O
.    O
"    O

radiation    O
biology    O
and    O
health    B-Medicine106043075
physics    I-Medicine106043075
to    O
understand    O
therapy    O
and    O
radiation    O
protection    O
,    O

Health    B-Medicine106043075
Physics    I-Medicine106043075

Herbert    O
Mermagen    O
worked    O
in    O
the    O
Medical    B-Medicine106043075
Physics    I-Medicine106043075
section    O
as    O
a    O
radiological    B-Medicine106043075
physicist    I-Medicine106043075
,    O
known    O
today    O
as    O
a    O
health    B-Medicine106043075
physicist    I-Medicine106043075
.    O

During    O
1944–1951    O
Patterson    O
oversaw    O
the    O
operational    B-Medicine106043075
health    I-Medicine106043075
physics    I-Medicine106043075
group    O
at    O
the    O
Hanford    O
Works    O
.    O

This    O
has    O
significance    O
in    O
health    B-Medicine106043075
physics    I-Medicine106043075
and    O
radiation    O
protection    O
.    O

Dade    O
William    O
Moeller    O
,    O
American    O
health    B-Medicine106043075
physicist    I-Medicine106043075
,    O
radiation    O
and    O
environmental    O
protection    O
scientist    O

Ernest    O
Omar    O
Wollan    O
(    O
November    O
6    O
,    O
1902    O
–    O
March    O
11    O
,    O
1984    O
)    O
was    O
an    O
American    O
physicist    O
who    O
made    O
major    O
contributions    O
in    O
the    O
fields    O
of    O
neutron    O
scattering    O
and    O
health    B-Medicine106043075
physics    I-Medicine106043075
.    O

The    O
Dispute    O
Over    O
Safe    O
Uses    O
of    O
X    O
-    O
Rays    O
in    O
Medical    O
Practice    O
,    O
in    O
"    O
Health    B-Medicine106043075
Physics    I-Medicine106043075
"    O
Vol    O
.    O
29    O
,    O
No.1    O
,    O
pp    O
.    O
181–206    O
.    O

Henryk    O
Skarzynski    O
(    O
born    O
.    O
1954    O
in    O
Rosochate    O
Kościelne    O
)    O
is    O
a    O
Polish    O
doctor    O
otolaryngologist    O
,    O
audiologist    O
and    O
phoniatrist    B-Medicine106043075
,    O
creator    O
and    O
director    O
of    O
Warsaw    O
Institute    O
of    O
Physiology    O
and    O
Pathology    O
of    O
Hearing    O
and    O
World    O
Hearing    O
Center    O
in    O
Kajetany    O
.    O

Nanobiopharmaceutics    B-Medicine106043075

One    O
of    O
the    O
most    O
important    O
applications    O
of    O
MNT    O
would    O
be    O
medical    O
nanorobotics    O
or    O
nanomedicine    B-Medicine106043075
,    O
an    O
area    O
pioneered    O
by    O
Robert    O
Freitas    O
in    O
numerous    O
books    O
and    O
papers    O
.    O

MNT    O
should    O
make    O
possible    O
nanomedical    B-Medicine106043075
capabilities    O
able    O
to    O
cure    O
any    O
medical    O
condition    O
not    O
already    O
cured    O
by    O
advances    O
in    O
other    O
areas    O
.    O

In    O
recent    O
years    O
DeSimone    O
’s    O
academic    O
research    O
group    O
has    O
been    O
heavily    O
focused    O
on    O
learning    O
how    O
to    O
bring    O
the    O
precision    O
,    O
uniformity    O
and    O
mass    O
production    O
techniques    O
associated    O
with    O
the    O
fabrication    O
of    O
nanoscale    O
features    O
found    O
in    O
the    O
microelectronics    O
industry    O
to    O
the    O
nanomedicine    B-Medicine106043075
field    O
for    O
the    O
fabrication    O
and    O
delivery    O
of    O
vaccines    O
and    O
therapeutics    O
for    O
the    O
treatment    O
and    O
prevention    O
of    O
diseases    O
.    O

Nanomedicine    B-Medicine106043075

Along    O
with    O
Ralph    O
Merkle    O
,    O
Taylor    O
hosted    O
the    O
"    O
Nanotech    O
and    O
Nanomedicine    B-Medicine106043075
"    O
segment    O
.    O

The    O
“    O
Modern    O
Medical    O
Technologies    O
at    O
Semmelweis    O
University    O
”    O
project    O
ensuring    O
institution    O
's    O
place    O
among    O
the    O
leading    O
research    O
universities    O
in    O
four    O
main    O
areas    O
:    O
Personalised    O
medicine    O
;    O
Imaging    O
processes    O
and    O
bioimaging    O
:    O
from    O
molecule    O
to    O
the    O
human    O
being    O
;    O
Bio    O
-    O
engineering    O
and    O
nanomedicine    B-Medicine106043075
;    O
Molecular    B-Medicine106043075
medicine    I-Medicine106043075
.    O

UCSEM    O
Landquart    O
,    O
Research    O
Center    O
for    O
nano-medicine    B-Medicine106043075
,    O
Landquart    O

Her    O
work    O
focuses    O
on    O
nanomedicine    B-Medicine106043075
,    O
nanotechnology    O
,    O
chemistry    O
and    O
polymer    O
science    O
.    O

She    O
joined    O
the    O
University    O
of    O
California    O
,    O
San    O
Diego    O
in    O
2008    O
,    O
and    O
has    O
been    O
there    O
ever    O
since    O
,    O
as    O
the    O
director    O
of    O
excellence    O
in    O
Nanomedicine    B-Medicine106043075
.    O

He    O
then    O
returned    O
to    O
his    O
home    O
state    O
of    O
Missouri    O
as    O
head    O
of    O
the    O
International    O
Institute    O
of    O
Nano    B-Medicine106043075
and    O
Molecular    O
Medicine    O
at    O
University    O
of    O
Missouri    O
.    O

NanoMission    O
is    O
a    O
serious    O
game    O
series    O
made    O
by    O
PlayGen    O
for    O
Wellcome    O
Trust    O
and    O
FEI    O
to    O
teach    O
the    O
player    O
about    O
the    O
world    O
of    O
nanomedicine    B-Medicine106043075
.    O

In    O
this    O
module    O
the    O
player    O
takes    O
on    O
the    O
role    O
of    O
a    O
scientist    O
attempting    O
to    O
create    O
better    O
nanomedicine    B-Medicine106043075
and    O
nanomachines    O
.    O

This    O
could    O
aid    O
the    O
delivery    O
of    O
medicinal    O
nanoparticles    O
in    O
future    O
nanomedicine    B-Medicine106043075
.    O

Applications    O
are    O
numerous    O
,    O
however    O
,    O
there    O
appears    O
to    O
be    O
strong    O
emphasis    O
on    O
medical    O
and    O
biological    O
use    O
-    O
cases    O
in    O
nanomedicine    B-Medicine106043075
.    O

In    O
April    O
2002    O
,    O
pharmaceutical    B-Medicine106043075
medicine    I-Medicine106043075
was    O
officially    O
recognised    O
as    O
a    O
medical    O
specialty    O
in    O
the    O
UK    O
and    O
the    O
GMC    O
guidelines    O
on    O
Pharmaceutical    O
Medicine    O
stipulate    O
the    O
professional    O
expectations    O
of    O
pharmaceutical    O
physicians    O
.    O

Many    O
other    O
different    O
structures    O
have    O
been    O
used    O
for    O
their    O
muscle    O
relaxant    O
effect    O
such    O
as    O
alcuronium    B-Medicine106043075
(    O
alloferin    O
)    O
,    O
anatruxonium    O
,    O
diadonium    O
,    O
fazadinium    O
(    O
AH8165    O
)    O
and    O
tropeinium    O
.    O

Alcuronium    B-Medicine106043075

He    O
is    O
a    O
practicing    O
triple    O
board    B-Medicine106043075
certified    I-Medicine106043075
physician    O
specialist    O
in    O
internal    O
medicine    O
,    O
pediatrics    O
,    O
and    O
nephrology    O
.    O

A    O
reprimand    O
may    O
be    O
a    O
formal    O
legal    O
action    O
issued    O
by    O
a    O
government    O
agency    O
or    O
professional    O
governing    O
board    O
(    O
e.g.    O
medical    B-Medicine106043075
board    I-Medicine106043075
,    O
bar    O
council    O
)    O
.    O

Blair    O
S.    O
Lewis    O
,    O
M.D.    O
,    O
F.A.C.P.    O
,    O
F.A.C.G.    O
,    O
(    O
born    O
November    O
23    O
,    O
1956    O
in    O
Hartford    O
,    O
Connecticut    O
)    O
is    O
an    O
American    O
board-certified    B-Medicine106043075
gastroenterologist    O
and    O
Clinical    O
Professor    O
of    O
Medicine    O
at    O
the    O
Mount    O
Sinai    O
School    O
of    O
Medicine    O
.    O

Miguel    O
A.    O
Sanchez    O
,    O
MD    O
,    O
is    O
a    O
board-certified    B-Medicine106043075
pathologist    B-Medicine106043075
who    O
specializes    O
in    O
anatomic    O
pathology    O
,    O
clinical    O
pathology    O
and    O
cytopathology    O
.    O

They    O
are    O
then    O
eligible    O
to    O
sit    O
for    O
a    O
board    B-Medicine106043075
certification    I-Medicine106043075
examination    O
,    O
which    O
is    O
now    O
required    O
by    O
most    O
hospitals    O
and    O
health    O
plans    O
.    O

In    O
order    O
to    O
become    O
board    B-Medicine106043075
certified    I-Medicine106043075
,    O
family    O
physicians    O
must    O
complete    O
a    O
residency    O
in    O
family    O
medicine    O
,    O
possess    O
a    O
full    O
and    O
unrestricted    O
medical    O
license    O
,    O
and    O
take    O
a    O
written    O
cognitive    O
examination    O
.    O

In    O
that    O
definition    O
,    O
"    O
other    O
countries    O
"    O
refers    O
to    O
nations    O
that    O
do    O
not    O
have    O
a    O
mature    O
emergency    O
care    O
system    O
(    O
exemplified    O
by    O
board-certified    B-Medicine106043075
emergency    O
physicians    O
and    O
academic    O
emergency    O
medicine    O
,    O
among    O
other    O
things    O
)    O
.    O

In    O
1983    O
,    O
she    O
became    O
board    B-Medicine106043075
certified    I-Medicine106043075
in    O
ophthalmology    O
.    O

As    O
the    O
purpose    O
of    O
the    O
Disaster    O
Medicine    O
Core    O
Competencies    O
was    O
to    O
define    O
the    O
core    O
body    O
of    O
knowledge    O
required    O
to    O
demonstrate    O
proficiency    O
in    O
Disaster    O
Medicine    O
towards    O
physician    B-Medicine106043075
board    I-Medicine106043075
certification    I-Medicine106043075
in    O
the    O
specialty    O
,    O
the    O
Disaster    O
Medicine    O
Core    O
Competency    O
document    O
reflects    O
that    O
bias    O
.    O

Board    B-Medicine106043075
certification    I-Medicine106043075
is    O
the    O
process    O
by    O
which    O
a    O
physician    O
or    O
other    O
professional    O
in    O
the    O
United    O
States    O
demonstrates    O
a    O
mastery    O
of    O
basic    O
knowledge    O
and    O
skills    O
through    O
written    O
,    O
practical    O
,    O
or    O
simulator    O
-    O
based    O
testing    O
.    O

He    O
received    O
board    B-Medicine106043075
certification    I-Medicine106043075
by    O
the    O
American    O
Board    O
of    O
Radiology    O
in    O
1950    O
.    O

Addison    O
is    O
a    O
world    O
-    O
class    O
neonatal    O
surgeon    O
with    O
board    B-Medicine106043075
certification    I-Medicine106043075
in    O
both    O
Obstetrics    O
and    O
Gynaecology    O
and    O
Maternal    O
and    O
Fetal    O
Medicine    O
.    O

Mr    O
Reinstein    O
is    O
recognized    O
by    O
three    O
sub    O
-    O
specialty    O
bodies    O
:    O
he    O
is    O
a    O
Fellow    O
of    O
the    O
Royal    O
College    O
of    O
Surgeons    O
of    O
Canada    O
(    O
RCPSC    O
)    O
(    O
FRCSC    O
)    O
,    O
Fellow    O
of    O
the    O
Royal    O
College    O
of    O
Ophthalmologists    O
of    O
the    O
United    O
Kingdom    O
(    O
FRCOphth    O
)    O
,    O
and    O
is    O
board    B-Medicine106043075
certified    I-Medicine106043075
by    O
the    O
American    O
Board    O
of    O
Ophthalmology    O
(    O
DABO    O
)    O
.    O

In    O
1984    O
,    O
he    O
was    O
board    B-Medicine106043075
certified    I-Medicine106043075
in    O
psychiatry    O
by    O
the    O
American    O
Board    O
of    O
Psychiatry    O
and    O
Neurology    O
.    O

A    O
physician    O
who    O
specializes    O
in    O
"    O
family    O
medicine    O
"    O
must    O
now    O
complete    O
a    O
residency    O
in    O
family    O
medicine    O
,    O
and    O
must    O
be    O
eligible    O
for    O
board    B-Medicine106043075
certification    I-Medicine106043075
,    O
which    O
is    O
required    O
by    O
many    O
hospitals    O
and    O
health    O
plans    O
for    O
hospital    O
privileges    O
and    O
remuneration    O
,    O
respectively    O
.    O

Avellone    O
is    O
board    B-Medicine106043075
certified    I-Medicine106043075
in    O
general    O
surgery    O
and    O
is    O
a    O
fellow    O
of    O
the    O
American    O
College    O
of    O
Surgeons    O
.    O

Selman    O
Uranues    O
received    O
his    O
degree    O
in    O
1981    O
from    O
the    O
Medical    O
University    O
of    O
Graz    O
and    O
board    B-Medicine106043075
certification    I-Medicine106043075
in    O
surgery    O
in    O
1988    O
.    O

Additionally    O
,    O
he    O
was    O
a    O
recognized    O
expert    O
in    O
forensic    B-Medicine106043075
psychiatry    I-Medicine106043075
.    O

Stefan    O
P.    O
Kruszewski    O
-    O
clinical    O
and    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
,    O
fraud    O
investigator    O

Lecter    O
was    O
introduced    O
in    O
the    O
1981    O
thriller    O
novel    O
"    O
Red    O
Dragon    O
"    O
as    O
a    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
and    O
cannibalistic    O
serial    O
killer    O
.    O

Van    O
Susteren    O
's    O
sister    O
,    O
Lise    O
,    O
is    O
a    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
in    O
Bethesda    O
,    O
Maryland    O
.    O

Psychiatric    B-Medicine106043075
Forensic    I-Medicine106043075
Assess    O

Elissa    O
Panush    O
Benedek    O
(    O
born    O
September    O
28    O
,    O
1936    O
)    O
is    O
an    O
American    O
psychiatrist    O
specializing    O
in    O
child    O
and    O
adolescent    O
psychiatry    O
and    O
forensic    B-Medicine106043075
psychiatry    I-Medicine106043075
.    O

During    O
this    O
more    O
recent    O
wave    O
of    O
Chinese    B-Medicine106043075
forensic    I-Medicine106043075
psychiatry    I-Medicine106043075
,    O
political    O
dissidents    O
and    O
practicers    O
of    O
non    O
-    O
mainstream    O
religions    O
were    O
sent    O
to    O
Ankang    O
(    O
meaning    O
peace    O
and    O
health    O
)    O
hospitals    O
.    O

Important    O
evidence    O
at    O
the    O
appeal    O
was    O
to    O
be    O
the    O
statement    O
of    O
a    O
detainee    O
in    O
the    O
Pieter    O
Baan    O
Center    O
,    O
a    O
criminal    B-Medicine106043075
psychological    I-Medicine106043075
observation    I-Medicine106043075
unit    I-Medicine106043075
,    O
at    O
the    O
same    O
time    O
as    O
Lucia    O
de    O
Berk    O
,    O
that    O
she    O
had    O
said    O
during    O
outdoor    O
exercise    O
:    O
"    O
I    O
released    O
these    O
13    O
people    O
from    O
their    O
suffering    O
"    O
.    O

As    O
a    O
part    O
of    O
the    O
trial    O
Amble    O
was    O
assessed    O
by    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
Gabriel    O
Langfeldt    O
,    O
who    O
among    O
other    O
things    O
diagnosed    O
Amble    O
with    O
"    O
enduringly    O
weakened    O
mental    O
faculties    O
"    O
.    O

The    O
Portman    O
specialises    O
in    O
areas    O
of    O
Forensic    B-Medicine106043075
psychiatry    I-Medicine106043075
,    O
including    O
the    O
treatment    O
of    O
addictive    O
,    O
sociopathic    O
and    O
criminal    O
behaviours    O
and    O
tendencies    O
.    O

B.    O
D.    O
Wong    O
was    O
asked    O
to    O
film    O
four    O
episodes    O
as    O
Dr.    O
George    O
Huang    O
,    O
a    O
Federal    O
Bureau    O
of    O
Investigation    O
(    O
FBI    O
)    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
and    O
criminal    O
profiler    O
on    O
loan    O
to    O
the    O
Special    O
Victims    O
Unit    O
.    O

A    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
,    O
David    O
Somekh    O
,    O
concluded    O
that    O
Childs    O
had    O
a    O
personality    O
disorder    O
that    O
led    O
him    O
to    O
compulsively    O
lie    O
,    O
and    O
the    O
original    O
trial    O
jury    O
were    O
blocked    O
from    O
being    O
told    O
this    O
.    O

James    O
Grigson    O
(    O
January    O
30    O
,    O
1932    O
–    O
June    O
3    O
,    O
2004    O
)    O
,    O
nicknamed    O
"    O
Doctor    O
Death    O
"    O
by    O
some    O
press    O
accounts    O
,    O
was    O
a    O
Texas    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
who    O
testified    O
in    O
167    O
capital    O
trials    O
,    O
nearly    O
all    O
of    O
which    O
resulted    O
in    O
death    O
sentences    O
.    O

Following    O
his    O
arrest    O
,    O
Breivik    O
underwent    O
examination    O
by    O
court    O
-    O
appointed    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
,    O
who    O
diagnosed    O
him    O
with    O
paranoid    O
schizophrenia    O
and    O
concluded    O
he    O
had    O
been    O
psychotic    O
at    O
the    O
time    O
of    O
the    O
attacks    O
and    O
was    O
criminally    O
insane    O
.    O

Two    O
teams    O
of    O
court    O
-    O
appointed    O
forensic    B-Medicine106043075
psychiatrists    I-Medicine106043075
examined    O
Breivik    O
before    O
his    O
trial    O
.    O

Breivik    O
underwent    O
his    O
first    O
examination    O
by    O
court    O
-    O
appointed    O
forensic    B-Medicine106043075
psychiatrists    I-Medicine106043075
in    O
2011    O
.    O

"    O
Ideen    O
zur    O
Begründung    O
eines    O
obersten    O
Princips    O
für    O
die    O
psychische    O
Legalmedicin    O
"    O
,    O
1829    O
-    O
Ideas    O
for    O
the    O
creation    O
of    O
a    O
supreme    O
principle    O
for    O
forensic    B-Medicine106043075
psychiatry    I-Medicine106043075
.    O

ABC    O
interviewed    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
Dr.    O
James    O
Knoll    O
for    O
psychological    O
perspective    O
on    O
the    O
case    O
and    O
he    O
answered    O
viewers    O
'    O
questions    O
via    O
video    O
on    O
April    O
23    O
,    O
2009    O
,    O
and    O
via    O
site    O
comments    O
on    O
April    O
27    O
,    O
2009    O
.    O

Countries    O
where    O
deinstitutionalisation    O
has    O
happened    O
may    O
be    O
experiencing    O
a    O
process    O
of    O
"    O
re    O
-    O
institutionalisation    O
"    O
or    O
relocation    O
to    O
different    O
institutions    O
,    O
as    O
evidenced    O
by    O
increases    O
in    O
the    O
number    O
of    O
supported    O
housing    O
facilities    O
,    O
forensic    B-Medicine106043075
psychiatric    I-Medicine106043075
beds    O
and    O
rising    O
numbers    O
in    O
the    O
prison    O
population    O
.    O

Dr.    O
Huang    O
is    O
an    O
FBI    O
forensic    B-Medicine106043075
psychiatrist    I-Medicine106043075
and    O
criminal    O
profiler    O
,    O
specializing    O
in    O
studying    O
sexual    O
predators    O
and    O
their    O
victims    O
.    O

The    O
hospital    O
has    O
a    O
forensic    B-Medicine106043075
unit    O
where    O
people    O
who    O
have    O
committed    O
crimes    O
and    O
been    O
judged    O
insane    O
receive    O
care    O
.    O

Amikacin    O
in    O
the    O
eye    O
can    O
be    O
accompanied    O
by    O
cephazolin    B-Medicine106043075
.    O

Kefzol    B-Medicine106043075

Cefazolin    B-Medicine106043075

It    O
works    O
similarly    O
to    O
other    O
agents    O
within    O
this    O
class    O
,    O
including    O
intravenous    O
cefazolin    B-Medicine106043075
,    O
but    O
can    O
be    O
taken    O
by    O
mouth    O
.    O

Lynette    O
is    O
a    O
paediatric    O
neurologist    O
and    O
epileptologist    B-Medicine106043075
.    O

An    O
epileptologist    B-Medicine106043075
is    O
a    O
neurologist    O
who    O
specializes    O
in    O
the    O
treatment    O
of    O
epilepsy    O
.    O

the    O
number    O
of    O
affected    O
mitochondria    O
varies    O
from    O
cell    O
(    O
in    O
this    O
case    O
,    O
the    O
fertilized    O
oocyte    O
)    O
to    O
cell    O
depending    O
both    O
on    O
the    O
number    O
it    O
inherited    O
from    O
its    O
mother    O
cell    O
and    O
environmental    O
factors    O
which    O
may    O
favor    O
mutant    O
or    O
wildtype    B-Medicine106043075
mitochondrial    O
DNA    O
,    O

Surprisingly    O
however    O
,    O
substituting    O
either    O
of    O
the    O
two    O
residues    O
with    O
serine    O
did    O
not    O
appreciable    O
change    O
the    O
rate    O
of    O
the    O
reaction    O
significantly    O
;    O
the    O
kcat    O
value    O
remained    O
within    O
.3%    O
to    O
3%    O
compared    O
to    O
the    O
wild-type    B-Medicine106043075
enzyme    O
.    O

Three    O
of    O
these    O
were    O
of    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
:    O
the    O
apoenzyme    O
in    O
,    O
the    O
enzyme    O
plus    O
its    O
magnesium    O
ion    O
cofactor    O
in    O
,    O
and    O
the    O
enzyme    O
at    O
high    O
ionic    O
strength    O
in    O
.    O

The    O
study    O
of    O
"    O
mutants    O
"    O
–    O
organisms    O
which    O
lack    O
one    O
or    O
more    O
functional    O
components    O
with    O
respect    O
to    O
the    O
so    O
-    O
called    O
"    O
wild    B-Medicine106043075
type    I-Medicine106043075
"    O
or    O
normal    O
phenotype    O
.    O

Hypomorph    O
,    O
after    O
Mullarian    O
classification    O
is    O
altered    O
gene    O
product    O
that    O
acts    O
with    O
decreased    O
gene    O
expression    O
compared    O
to    O
wild    B-Medicine106043075
type    I-Medicine106043075
allele    O
.    O

A    O
wild    B-Medicine106043075
type    I-Medicine106043075
or    O
homozygous    O
non    O
-    O
mutated    O
organism    O
is    O
one    O
in    O
which    O
neither    O
allele    O
is    O
mutated    O
.    O

If    O
delivered    O
to    O
cells    O
,    O
Rev    O
M10    O
will    O
compete    O
with    O
the    O
wild-type    B-Medicine106043075
Rev    O
protein    O
for    O
the    O
RRE    O
binding    O
site    O
,    O
and    O
therefore    O
decrease    O
Rev    O
’s    O
normal    O
cellular    O
functions    O
.    O

These    O
data    O
types    O
include    O
mutant    O
phenotypes    O
,    O
molecular    O
characterization    O
of    O
mutant    O
alleles    O
and    O
other    O
deviations    O
,    O
cytological    O
maps    O
,    O
wild-type    B-Medicine106043075
expression    O
patterns    O
,    O
anatomical    O
images    O
,    O
transgenic    O
constructs    O
and    O
insertions    O
,    O
sequence    O
-    O
level    O
gene    O
models    O
and    O
molecular    O
classification    O
of    O
gene    O
product    O
functions    O
.    O

It    O
was    O
found    O
that    O
while    O
one    O
and    O
two    O
base    O
insertions    O
/    O
deletions    O
of    O
the    O
same    O
sign    O
resulted    O
in    O
a    O
mutant    O
phenotype    O
,    O
deleting    O
or    O
inserting    O
three    O
bases    O
could    O
give    O
a    O
wild    B-Medicine106043075
type    I-Medicine106043075
phenotype    O
.    O

In    O
Japan    O
this    O
plant    O
's    O
leaves    O
are    O
used    O
as    O
a    O
vegetable    O
-    O
these    O
are    O
from    O
the    O
cultivar    O
,    O
not    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
which    O
has    O
a    O
far    O
more    O
pungent    O
taste    O
.    O

Visible    O
-    O
light    O
-    O
induced    O
photoinhibition    O
is    O
~25%    O
faster    O
in    O
an    O
"    O
Arabidopsis    O
thaliana    O
"    O
mutant    O
lacking    O
non    O
-    O
photochemical    O
quenching    O
than    O
in    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
.    O

Among    O
amodiaquine    O
users    O
,    O
several    O
rare    O
but    O
serious    O
side    O
effects    O
have    O
been    O
reported    O
and    O
linked    O
to    O
variants    O
in    O
the    O
CYP2C8    O
alleles    O
.    O
CYP2C8    O
1    O
is    O
characterized    O
as    O
the    O
wild-type    B-Medicine106043075
allele    O
,    O
which    O
shows    O
an    O
acceptable    O
safety    O
profile    O
,    O
while    O
CYP2C8    O
2    O
,    O
3    O
and    O
4    O
all    O
show    O
a    O
range    O
of    O
"    O
poor    O
metabolizer    O
"    O
phenotypes    O
.    O

When    O
heterozygous    O
with    O
the    O
wild    O
-    O
type    O
allele    O
with    O
the    O
genotype    O
"    O
dil+"/"dilgw    O
"    O
the    O
phenotype    O
is    O
identical    O
to    O
the    O
wild-type    B-Medicine106043075
Light    O
Green    O
and    O
the    O
bird    O
is    O
known    O
as    O
a    O
Greywing    O
/    O
dilute    O
.    O

In    O
this    O
model    O
,    O
EP33-deficient    O
mice    O
,    O
upon    O
ovalbumin    O
challenge    O
,    O
exhibited    O
worsened    O
allergic    O
inflammation    O
as    O
measured    O
by    O
increased    O
airway    O
eosinophils    O
,    O
neutrophils    O
,    O
lymphocytes    O
,    O
and    O
pro    O
-    O
allergic    O
cytokines    O
(    O
i.e.    O
interleukin    O
4    O
,    O
interleukin    O
5    O
,    O
and    O
interleukin    O
13    O
)    O
as    O
compared    O
to    O
wild    B-Medicine106043075
type    I-Medicine106043075
mice    O
.    O
EP3    O
receptor    O
-    O
deficient    O
mice    O
and/or    O
wild    O
type    O
mice    O
treated    O
with    O
an    O
EP3    O
receptor    O
agonist    O
are    O
similarly    O
protected    O
from    O
allergic    O
responses    O
in    O
models    O
of    O
allergic    O
conjunctivitis    O
and    O
contact    O
hypersensitivity    O
.    O

PGF2α    O
simulates    O
an    O
increase    O
in    O
systolic    O
blood    O
pressure    O
in    O
wild    B-Medicine106043075
type    I-Medicine106043075
but    O
not    O
FP(−/−    O
)    O
mice    O
.    O

It    O
has    O
not    O
been    O
shown    O
yet    O
that    O
DXV    O
naturally    O
infects    O
"    O
Drosophila    O
"    O
flies    O
therefore    O
;    O
there    O
are    O
no    O
wild-type    B-Medicine106043075
strains    O
of    O
DXV    O
.    O

Therefore    O
the    O
goal    O
is    O
to    O
breed    O
cattle    O
that    O
are    O
considerably    O
larger    O
,    O
more    O
long    O
-    O
legged    O
and    O
long    O
-    O
snouted    O
and    O
have    O
horns    O
curving    O
forwards    O
additionally    O
to    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
colour    O
scheme    O
that    O
was    O
already    O
present    O
in    O
the    O
population    O
.    O

In    O
plants    O
,    O
"    O
inbred    O
backcross    O
lines    O
"    O
(    O
IBLs    O
)    O
refers    O
to    O
lines    O
(    O
i.e.    O
populations    O
)    O
of    O
plants    O
derived    O
from    O
the    O
repeated    O
backcrossing    O
of    O
a    O
line    O
with    O
artificially    O
recombinant    O
DNA    O
with    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
,    O
operating    O
some    O
kind    O
of    O
selection    O
that    O
can    O
be    O
phenotypical    O
or    O
through    O
a    O
molecular    O
marker    O
(    O
for    O
the    O
production    O
of    O
introgression    O
lines    O
)    O
.    O

For    O
example    O
,    O
Drosophila    O
containing    O
only    O
one    O
copy    O
of    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
Nocth    O
gene    O
have    O
visible    O
wing    O
abnormalities    O
but    O
otherwise    O
seem    O
to    O
function    O
normally    O
.    O

Keeping    O
birds    O
who    O
through    O
natural    O
adaptation    O
or    O
selective    O
breeding    O
have    O
lost    O
the    O
ability    O
to    O
fly    O
removes    O
the    O
need    O
for    O
pinioning    O
;    O
for    O
example    O
,    O
keeping    O
Indian    O
runner    O
ducks    O
as    O
opposed    O
to    O
wild-type    B-Medicine106043075
mallard    O
ducks    O
.    O

The    O
term    O
"    O
wild    B-Medicine106043075
type    I-Medicine106043075
"    O
allele    O
is    O
sometimes    O
used    O
to    O
describe    O
an    O
allele    O
that    O
is    O
thought    O
to    O
contribute    O
to    O
the    O
typical    O
phenotypic    O
character    O
as    O
seen    O
in    O
"    O
wild    O
"    O
populations    O
of    O
organisms    O
,    O
such    O
as    O
fruit    O
flies    O
(    O
"    O
Drosophila    O
melanogaster    O
"    O
)    O
.    O

Western    O
blot    O
-    O
wildtype    B-Medicine106043075
-    O
wobble    O
position    O
-    O
Wolfram    O
syndrome    O
-    O

The    O
Sex    O
-    O
linked    O
Clearbody    O
mutation    O
is    O
sex    O
-    O
linked    O
and    O
recessive    O
to    O
wild-type    B-Medicine106043075
.    O

Microorganisms    O
used    O
in    O
fermentation    O
are    O
rarely    O
identical    O
to    O
the    O
wild    B-Medicine106043075
type    I-Medicine106043075
.    O

It    O
is    O
a    O
combination    O
consisting    O
of    O
amoxicillin    O
,    O
a    O
β-lactam    O
antibiotic    O
,    O
and    O
potassium    B-Medicine106043075
clavulanate    I-Medicine106043075
,    O
a    O
β-lactamase    O
inhibitor    O
.    O

Augmentin    O
250    O
,    O
for    O
example    O
,    O
contains    O
250    O
mg    O
of    O
amoxicillin    O
and    O
125    O
mg    O
of    O
clavulanic    B-Medicine106043075
acid    I-Medicine106043075
.    O

This    O
enzyme    O
participates    O
in    O
clavulanic    B-Medicine106043075
acid    I-Medicine106043075
biosynthesis    I-Medicine106043075
.    O

This    O
enzyme    O
participates    O
in    O
clavulanic    B-Medicine106043075
acid    I-Medicine106043075
biosynthesis    I-Medicine106043075
.    O

Beta    O
-    O
lactamase    O
inhibitors    O
,    O
such    O
as    O
clavulanic    B-Medicine106043075
acid    I-Medicine106043075
and    O
sulbactam    O

It    O
is    O
almost    O
invariably    O
sold    O
and    O
used    O
in    O
combination    O
with    O
clavulanate    B-Medicine106043075
as    O
Timentin    O
.    O

Ticarcillin    O
is    O
also    O
often    O
paired    O
with    O
a    O
β-lactamase    O
inhibitor    O
such    O
as    O
clavulanic    B-Medicine106043075
acid    I-Medicine106043075
(    O
co    O
-    O
ticarclav    O
)    O
.    O

"    O
Island    O
"    O
explores    O
many    O
of    O
the    O
themes    O
and    O
ideas    O
that    O
interested    O
Huxley    O
in    O
the    O
post    O
-    O
World    O
War    O
II    O
decades    O
and    O
were    O
the    O
subject    O
of    O
many    O
of    O
his    O
nonfiction    O
books    O
of    O
essays    O
,    O
including    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
Revisited    I-Medicine106043075
"    O
,    O
"    O
Tomorrow    O
and    O
Tomorrow    O
and    O
Tomorrow    O
"    O
,    O
"    O
The    O
Doors    O
of    O
Perception    O
"    O
,    O
and    O
"    O
The    O
Perennial    O
Philosophy    O
"    O
.    O

"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
by    O
Aldous    O
Huxley    O
.    O

"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O

The    O
name    O
"    O
Bubble    O
Puppy    O
"    O
was    O
taken    O
from    O
"    O
Centrifugal    O
Bumble    O
-    O
Puppy    O
"    O
,    O
a    O
fictitious    O
children    O
's    O
game    O
in    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

Lenina    O
Crowne    O
,    O
the    O
female    O
protagonist    O
in    O
Aldous    O
Huxley    O
's    O
1932    O
dystopian    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O

The    O
song    O
contains    O
the    O
lyrics    O
"    O
Hug    O
me    O
till    O
you    O
drug    O
me    O
honey    O
;    O
Kiss    O
me    O
till    O
I    O
'm    O
in    O
a    O
coma    O
"    O
,    O
taken    O
from    O
the    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

Early    O
shows    O
produced    O
by    O
VideoCabaret    O
included    O
Taylor    O
's    O
"    O
The    O
Patty    O
Rehearst    O
Story    O
"    O
,    O
"    O
The    O
Bible    O
As    O
Told    O
to    O
Karen    O
Ann    O
Quinlan    O
"    O
,    O
"    O
Nympho    O
Warrior    O
"    O
and    O
'    O
'    O
Where    O
's    O
Fluffy    O
''    O
,    O
Hollingsworth    O
's    O
"    O
"    O
and    O
"    O
Electric    O
Eye    O
"    O
,    O
and    O
adaptations    O
of    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
George    O
Orwell    O
's    O
"    O
1984    O
"    O
.    O

World    O
premieres    O
have    O
included    O
Arthur    O
Miller    O
's    O
"    O
The    O
Hook    O
"    O
,    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
a    O
new    O
play    O
about    O
Marvin    O
Gaye    O
,    O
"    O
Soul    O
"    O
by    O
Roy    O
Williams    O
.    O

The    O
"    O
Made    O
In    O
Northampton    O
"    O
2015    O
season    O
included    O
world    O
premieres    O
of    O
Arthur    O
Miller    O
’s    O
"    O
The    O
Hook    O
"    O
in    O
a    O
co    O
-    O
production    O
with    O
Liverpool    O
Everyman    O
&    O
Playhouse    O
and    O
Aldous    O
Huxley    O
’s    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
in    O
a    O
co    O
-    O
production    O
with    O
Touring    O
Consortium    O
Theatre    O
Company    O
.    O

The    O
"    O
New    O
York    O
Times    O
"    O
dismissed    O
"    O
Equilibrium    O
"    O
for    O
having    O
heavily    O
borrowed    O
from    O
"    O
Fahrenheit    O
451    O
"    O
,    O
"    O
Nineteen    O
Eighty    O
-    O
Four    O
"    O
,    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
,    O
and    O
other    O
science    O
fiction    O
classics    O
.    O

George    O
Orwell    O
claimed    O
that    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
(    O
1932    O
)    O
must    O
be    O
partly    O
derived    O
from    O
"    O
We    O
"    O
.    O

Kurt    O
Vonnegut    O
said    O
that    O
in    O
writing    O
"    O
Player    O
Piano    O
"    O
(    O
1952    O
)    O
,    O
he    O
"    O
cheerfully    O
ripped    O
off    O
the    O
plot    O
of    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
,    O
whose    O
plot    O
had    O
been    O
cheerfully    O
ripped    O
off    O
from    O
Yevgeny    O
Zamyatin    O
's    O
"    O
We    O
"    O
"    O
.    O

A    O
year    O
later    O
,    O
"    O
We    O
"    O
and    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
were    O
published    O
together    O
in    O
a    O
combined    O
edition    O
.    O

Aldous    O
Huxley    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
(    O
1932    O
)    O

Most    O
critics    O
compared    O
it    O
unfavourably    O
with    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
,    O
which    O
had    O
been    O
published    O
the    O
year    O
before    O
.    O

The    O
Aldous    O
Huxley    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
was    O
published    O
.    O

"    O
Brave    B-Medicine106043075
new    I-Medicine106043075
world    I-Medicine106043075
"    O
–    O

Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O

In    O
fact    O
,    O
except    O
for    O
his    O
targets    O
,    O
when    O
have    O
the    O
many    O
little    O
Eichmanns    O
who    O
are    O
preparing    O
the    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
ever    O
been    O
called    O
to    O
account    O
?    O
...    O

Bernard    B-Medicine106043075
Marx    I-Medicine106043075
from    O
"    O
Brave    O
New    O
World    O
"    O

Helios    O
desires    O
to    O
remake    O
the    O
world    O
in    O
the    O
image    O
of    O
Huxley    O
's    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
,    O
incapable    O
of    O
acknowledging    O
that    O
his    O
creations    O
are    O
destroying    O
themselves    O
or    O
being    O
driven    O
mad    O
because    O
they    O
can    O
not    O
cope    O
with    O
the    O
inability    O
to    O
grow    O
beyond    O
their    O
pre    O
-    O
programmed    O
limits    O
and    O
be    O
more    O
than    O
what    O
he    O
wants    O
them    O
to    O
be    O
.    O

H.    O
G.    O
Wells    O
'    O
"    O
The    O
Time    O
Machine    O
"    O
postulates    O
a    O
devolved    O
society    O
of    O
humans    O
,    O
as    O
does    O
the    O
short    O
story    O
"    O
The    O
Marching    O
Morons    O
"    O
by    O
Cyril    O
M.    O
Kornbluth    O
,    O
akin    O
to    O
the    O
"    O
Epsilon    O
-    O
minus    O
Semi    O
-    O
Morons    O
"    O
of    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

Essays    O
on    O
Aldous    O
Huxley    O
and    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
for    O
The    O
Encyclopedia    O
of    O
Literature    O
and    O
Politics    O
,    O
M.    O
Keith    O
Booker    O
,    O
ed    O
.    O
,    O
London    O
:    O
Greenwood    O
Press    O
,    O
2005    O
.    O

It    O
references    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
"    O
Nineteen    O
Eighty    O
-    O
Four    O
"    O
to    O
begin    O
a    O
discussion    O
of    O
the    O
relationship    O
between    O
Internet    O
media    O
and    O
governments    O
.    O

In    O
Aldous    O
Huxley    O
's    O
1932    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
,    O
it    O
is    O
used    O
for    O
the    O
conditioning    O
of    O
children    O
into    O
the    O
novel    O
's    O
fictional    O
future    O
culture    O
.    O

The    O
second    O
portion    O
of    O
the    O
book    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
by    O
Aldous    O
Huxley    O
takes    O
place    O
on    O
the    O
"    O
savage    O
reservation    O
"    O
,    O
which    O
is    O
located    O
on    O
land    O
encompassing    O
the    O
parks    O
area    O
.    O

The    O
band    O
name    O
was    O
largely    O
inspired    O
by    O
author    O
Neil    O
Postman    O
's    O
summation    O
of    O
"    O
A    B-Medicine106043075
Brave    I-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
,    O
where    O
instead    O
of    O
being    O
subjugated    O
and    O
destroyed    O
by    O
things    O
we    O
hate    O
,    O
humanity    O
is    O
oppressed    O
by    O
the    O
things    O
they    O
love    O
.    O

All    O
lyrics    O
are    O
written    O
by    O
Soling    O
,    O
who    O
claims    O
to    O
be    O
influenced    O
by    O
writers    O
such    O
as    O
Guy    O
Debord    O
,    O
founder    O
of    O
the    O
Situationist    O
International    O
,    O
and    O
Aldous    O
Huxley    O
,    O
author    O
of    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
"    O
Yellow    O
Chrome    O
"    O
.    O

Lyrics    O
are    O
written    O
by    O
Soling    O
,    O
who    O
claims    O
to    O
be    O
influenced    O
by    O
writers    O
such    O
as    O
Guy    O
Debord    O
,    O
founder    O
of    O
the    O
Situationist    O
International    O
,    O
and    O
Aldous    O
Huxley    O
,    O
author    O
of    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
"    O
Yellow    O
Chrome    O
"    O
.    O

Aldous    O
Huxley    O
(    O
1894–1963    O
)    O
:    O
English    O
writer    O
best    O
known    O
for    O
novels    O
,    O
such    O
as    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
,    O
and    O
essays    O
on    O
a    O
wide    O
range    O
of    O
topics    O
.    O

Her    O
lines    O
spoken    O
at    O
the    O
end    O
of    O
Act    O
V    O
,    O
Scene    O
I    O
are    O
the    O
inspiration    O
for    O
the    O
title    O
of    O
the    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

The    O
most    O
common    O
material    O
for    O
bindings    O
is    O
buckram    O
or    O
a    O
similar    O
bookcloth    O
,    O
but    O
there    O
are    O
many    O
exceptions    O
:    O
aluminium    O
foil    O
was    O
used    O
in    O
binding    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
in    O
1971    O
,    O
and    O
vegetable    O
parchment    O
in    O
binding    O
Voltaire    O
's    O
"    O
The    O
Calas    O
Affair    O
"    O
in    O
1994    O
;    O
more    O
commonly    O
,    O
marbled    O
papers    O
(    O
often    O
produced    O
by    O
Ann    O
Muir    O
Marbling    O
Ltd.    O
)    O
have    O
been    O
used    O
for    O
several    O
volumes    O
in    O
recent    O
years    O
,    O
either    O
as    O
endpapers    O
or    O
as    O
board    O
-    O
papers    O
of    O
quarter    O
bindings    O
;    O
moiré    O
silk    O
(    O
usually    O
artificial    O
)    O
has    O
been    O
used    O
sporadically    O
over    O
the    O
years    O
as    O
a    O
binding    O
material    O
,    O
and    O
leather    O
(    O
vellum    O
and    O
goatskin    O
)    O
and    O
bonded    O
leather    O
are    O
sometimes    O
used    O
,    O
chiefly    O
for    O
the    O
more    O
expensive    O
editions    O
.    O

Government    O
which    O
bears    O
resemblance    O
to    O
Plato    O
's    O
"    O
Republic    O
"    O
is    O
found    O
in    O
Aldous    O
Huxley    O
's    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
and    O
Lois    O
Lowry    O
's    O
"    O
The    O
Giver    O
"    O
.    O

The    O
name    O
"    O
Epsilon    O
Minus    O
"    O
is    O
a    O
reference    O
to    O
Aldous    O
Huxley    O
's    O
novel    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
by    O
Aldous    O
Huxley    O
(    O
England    O
)    O

"    O
The    O
Ice    O
People    O
"    O
has    O
been    O
compared    O
to    O
George    O
Orwell    O
’s    O
"    O
Nineteen    O
Eighty    O
-    O
Four    O
"    O
and    O
Aldous    O
Huxley    O
’s    O
"    O
Brave    B-Medicine106043075
New    I-Medicine106043075
World    I-Medicine106043075
"    O
.    O

In    O
1998    O
,    O
she    O
starred    O
with    O
Peter    O
Gallagher    O
in    O
the    O
TV    O
movie    O
"    O
Brave    O
New    O
World    O
"    O
loosely    O
based    O
on    O
Aldous    O
Huxley    O
's    O
1932    B-Medicine106043075
novel    I-Medicine106043075
of    I-Medicine106043075
the    I-Medicine106043075
same    I-Medicine106043075
name    I-Medicine106043075
.    O

A    O
vascular    O
snare    O
is    O
a    O
endovascular    B-Medicine106043075
device    O
that    O
is    O
used    O
to    O
remove    O
foreign    O
bodies    O
from    O
inside    O
arteries    O
and    O
veins    O
.    O

Endovascular    B-Medicine106043075
therapies    O
have    O
advanced    O
to    O
an    O
improved    O
approach    O
called    O
lumivascular    O
.    O

Interventional    B-Medicine106043075
Radiology    I-Medicine106043075

It    O
is    O
a    O
non    O
-    O
profit    O
,    O
educational    O
and    O
scientific    O
association    O
aiming    O
to    O
improve    O
patient    O
care    O
through    O
the    O
support    O
of    O
teaching    O
,    O
science    O
,    O
research    O
and    O
clinical    O
practice    O
in    O
the    O
field    O
of    O
cardiovascular    O
and    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
.    O

Percutaneous    O
nephrostomy    O
is    O
an    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
/    O
surgical    O
procedure    O
in    O
which    O
the    O
renal    O
pelvis    O
is    O
punctured    O
whilst    O
using    O
imaging    O
as    O
guidance    O
.    O

Interventional    B-Medicine106043075
radiology    I-Medicine106043075

Endovascular    B-Medicine106043075
surgery    I-Medicine106043075

Interventional    B-Medicine106043075
radiology    I-Medicine106043075

The    O
lack    O
of    O
harmful    O
effects    O
on    O
the    O
patient    O
and    O
the    O
operator    O
make    O
MRI    O
well    O
-    O
suited    O
for    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
,    O
where    O
the    O
images    O
produced    O
by    O
an    O
MRI    O
scanner    O
guide    O
minimally    O
invasive    O
procedures    O
.    O

IGI    O
are    O
commonly    O
performed    O
manually    O
by    O
physicians    O
operating    O
instruments    O
,    O
such    O
as    O
needles    O
,    O
based    O
on    O
medical    O
images    O
and    O
are    O
used    O
in    O
most    O
medical    O
fields    O
,    O
particularly    O
in    O
the    O
specialty    O
area    O
of    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
.    O

RFA    O
procedures    O
are    O
performed    O
under    O
image    O
guidance    O
(    O
such    O
as    O
X    O
-    O
ray    O
screening    O
,    O
CT    O
scan    O
or    O
ultrasound    O
)    O
by    O
an    O
interventional    O
pain    O
specialist    O
(    O
such    O
as    O
an    O
anesthesiologist    O
)    O
,    O
interventional    B-Medicine106043075
radiologist    I-Medicine106043075
,    O
otolaryngologists    O
,    O
a    O
gastrointestinal    O
or    O
surgical    O
endoscopist    O
,    O
or    O
a    O
cardiac    O
electrophysiologist    O
,    O
a    O
subspecialty    O
of    O
cardiologists    O
.    O

Interventional    B-Medicine106043075
radiology    I-Medicine106043075

Interventional    B-Medicine106043075
Radiology    I-Medicine106043075

Microwave    O
ablation    O
,    O
a    O
type    O
of    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
,    O
is    O
an    O
ISM    O
application    O
which    O
treats    O
solid    O
tumors    O
through    O
the    O
use    O
of    O
RF    O
heating    O
.    O

An    O
inferior    O
vena    O
cava    O
filter    O
(    O
IVC    O
filter    O
)    O
is    O
a    O
type    O
of    O
vascular    O
filter    O
,    O
a    O
medical    O
device    O
that    O
is    O
implanted    O
by    O
interventional    B-Medicine106043075
radiologist    I-Medicine106043075
or    O
vascular    O
surgeons    O
into    O
the    O
inferior    O
vena    O
cava    O
to    O
presumably    O
prevent    O
life    O
-    O
threatening    O
pulmonary    O
emboli    O
(    O
PEs    O
)    O
.    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

Biliary    O
drainage    O
is    O
performed    O
with    O
a    O
tube    O
or    O
catheter    O
(    O
called    O
a    O
"    O
biliary    O
drain    O
"    O
,    O
"    O
biliary    O
stent    O
"    O
or    O
"    O
biliary    O
catheter    O
"    O
)    O
by    O
a    O
surgeon    O
or    O
,    O
commonly    O
,    O
an    O
interventional    B-Medicine106043075
radiologist    I-Medicine106043075
.    O

This    O
can    O
additionally    O
be    O
performed    O
as    O
part    O
of    O
a    O
percutaneous    O
transhepatic    O
cholangiography    O
,    O
then    O
a    O
form    O
of    O
interventional    B-Medicine106043075
radiology    I-Medicine106043075
.    O

In    O
rare    O
occasions    O
,    O
rupture    O
of    O
an    O
Abdominal    O
Aortic    O
Aneurysm    O
may    O
be    O
repaired    O
via    O
an    O
endovascular    B-Medicine106043075
technique    O
,    O
though    O
this    O
is    O
generally    O
not    O
performed    O
in    O
the    O
setting    O
of    O
acute    O
rupture    O
.    O

Broadwell    O
is    O
married    O
to    O
Dr.    O
Scott    O
Broadwell    O
,    O
an    O
interventional    B-Medicine106043075
radiologist    I-Medicine106043075
who    O
graduated    O
from    O
George    O
Washington    O
University    O
School    O
of    O
Medicine    O
in    O
1996    O
.    O

A    O
Gift    O
From    O
Earth    O
is    O
a    O
science    O
fiction    O
novel    O
by    O
American    O
writer    O
Larry    O
Niven    O
,    O
first    O
published    O
in    O
1968    O
and    O
set    O
in    O
his    O
Known    B-Medicine106043075
Space    I-Medicine106043075
universe    O
.    O

Plateau    B-Medicine106043075
,    O
a    O
colony    O
in    O
the    O
Tau    O
Ceti    O
system    O
,    O
was    O
settled    O
by    O
humans    O
some    O
300    O
years    O
before    O
the    O
plot    O
begins    O
.    O

As    O
the    O
story    O
began    O
with    O
a    O
robot    O
ramship    O
in    O
flight    O
,    O
it    O
ends    O
with    O
another    O
ramship    O
headed    O
from    O
Earth    O
to    O
the    O
human    O
colony    O
known    O
as    O
'    O
We    B-Medicine106043075
Made    I-Medicine106043075
It    I-Medicine106043075
'    O
(    O
in    O
the    O
Procyon    O
system    O
)    O
with    O
the    O
same    O
discovery    O
.    O

Jinx    B-Medicine106043075
("Known    I-Medicine106043075
Space")    I-Medicine106043075
,    O
a    O
fictional    O
world    O
in    O
the    O
"    O
Known    O
Space    O
"    O
universe    O

Nessus    O
is    O
a    O
fictional    O
character    O
in    O
Larry    O
Niven    O
's    O
Known    B-Medicine106043075
Space    I-Medicine106043075
universe    O
,    O
a    O
member    O
of    O
the    O
technologically    O
advanced    O
alien    O
race    O
known    O
to    O
Humans    O
as    O
Pierson    O
's    O
Puppeteer    O
,    O
and    O
amongst    O
themselves    O
as    O
Citizens    O
.    O

Trolls    O
and    O
Bridges    O
-    O
a    O
game    O
in    O
the    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
used    O
to    O
recruit    O
military    O
officers    O
into    O
an    O
underground    O
command    O
structure    O

From    O
Larry    O
Niven    O
's    O
Known    B-Medicine106043075
Space    I-Medicine106043075
series    O
of    O
science    O
fiction    O
books    O
,    O
the    O
Kzinti    O
Patriarch    O
is    O
the    O
leader    O
of    O
the    O
Kzin    O
race    O
.    O

Larry    O
Niven    O
wrote    O
a    O
number    O
of    O
science    O
fiction    O
books    O
set    O
in    O
a    O
mythical    O
universe    O
called    O
Known    B-Medicine106043075
Space    I-Medicine106043075
.    O

Man    O
-    O
Kzin    O
Wars    O
X    O
:    O
The    O
Wunder    O
War    O
(    O
,    O
Baen    O
Books    O
,    O
2003    O
)    O
is    O
a    O
collection    O
of    O
four    O
stories    O
totalling    O
about    O
140,000    O
words    O
by    O
Australian    O
author    O
Hal    O
Colebatch    O
set    O
in    O
Larry    O
Niven    O
's    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
,    O
as    O
part    O
of    O
the    O
"    O
Man    O
-    O
Kzin    O
Wars    O
"    O
series    O
.    O

Beginning    O
with    O
the    O
devastating    O
invasion    O
of    O
the    O
peaceful    O
planet    O
Wunderland    B-Medicine106043075
by    O
the    O
ferocious    O
,    O
tiger    O
-    O
like    O
Kzin    O
,    O
they    O
deal    O
with    O
the    O
human    O
attempts    O
at    O
resistance    O
,    O
the    O
aftermath    O
of    O
eventual    O
human    O
victory    O
and    O
the    O
slow    O
growth    O
of    O
human    O
-    O
Kzin    O
co    O
-    O
operation    O
.    O

Flatlander    O
is    O
a    O
1995    O
collection    O
of    O
stories    O
by    O
Larry    O
Niven    O
,    O
all    O
set    O
in    O
Known    B-Medicine106043075
Space    I-Medicine106043075
.    O

It    O
is    O
the    O
definitive    O
collection    O
of    O
all    O
stories    O
by    O
Niven    O
about    O
ARM    B-Medicine106043075
agent    O
Gil    O
Hamilton    O
.    O

Flatlander    O
(    O
short    O
story    O
)    O
-    O
an    O
unrelated    O
Known    B-Medicine106043075
Space    I-Medicine106043075
short    O
story    O
,    O
also    O
by    O
Larry    O
Niven    O

Droud    O
,    O
a    O
pleasure    O
-    O
inducing    O
device    O
in    O
Known    B-Medicine106043075
Space    I-Medicine106043075
stories    O

For    O
example    O
,    O
Larry    O
Niven    O
opened    O
his    O
Known    B-Medicine106043075
Space    I-Medicine106043075
setting    O
to    O
other    O
writers    O
initially    O
because    O
he    O
considered    O
his    O
lack    O
of    O
military    O
experience    O
prevented    O
him    O
from    O
adequately    O
describing    O
the    O
wars    O
between    O
mankind    O
and    O
the    O
Kzinti    O
.    O

He    O
has    O
also    O
contributed    O
one    O
title    O
,    O
"    O
An    O
Honorable    O
Defense    O
"    O
(    O
1988    O
)    O
,    O
to    O
the    O
"    O
Crisis    O
of    O
Empire    O
"    O
series    O
(    O
with    O
David    O
Drake    O
)    O
,    O
and    O
the    O
novelette    O
"    O
Hey    O
Diddle    O
Diddle    O
"    O
to    O
the    O
fifth    O
installment    O
of    O
the    O
"    O
Man    O
-    O
Kzin    O
Wars    O
"    O
series    O
(    O
based    O
in    O
the    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
Universe    O
of    O
Larry    O
Niven    O
)    O
.    O

The    O
Jotoki    O
(    O
singular    O
Jotok    O
)    O
are    O
a    O
fictional    O
alien    O
race    O
from    O
Larry    O
Niven    O
's    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
books    O
.    O

In    O
Larry    O
Niven    O
's    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
(    O
1964–present    O
)    O
,    O
humanity    O
is    O
descended    O
from    O
aliens    O
called    O
the    O
Pak    O
.    O

In    O
Larry    O
Niven    O
's    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
,    O
skintights    O
are    O
the    O
preferred    O
type    O
of    O
spacesuit    O
used    O
by    O
belters    O
in    O
the    O
22nd    O
and    O
23rd    O
century    O
.    O
They    O
often    O
decorated    O
them    O
with    O
elaborate    O
(    O
and    O
expensive    O
)    O
torso    O
paintings    O
as    O
a    O
form    O
of    O
heraldry    O
.    O

Gilbert    O
Gilgamesh    O
Hamilton    O
is    O
a    O
fictional    O
character    O
in    O
the    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
created    O
by    O
Larry    O
Niven    O
.    O

There    O
he    O
begins    O
work    O
on    O
an    O
arduous    O
ten    O
-    O
year    O
apprenticeship    O
towards    O
the    O
acquisition    O
of    O
his    O
singleship    B-Medicine106043075
licence    O
.    O

To    O
make    O
amends    O
,    O
Gil    O
joins    O
the    O
ARM    B-Medicine106043075
,    O
the    O
elite    O
global    O
police    O
force    O
.    O

The    O
collection    O
reprints    O
the    O
stories    O
originally    O
appearing    O
in    O
the    O
1969    O
collection    O
"    O
The    O
Shape    O
of    O
Space    O
"    O
that    O
were    O
not    O
part    O
of    O
the    O
Known    B-Medicine106043075
Space    I-Medicine106043075
series    O
(    O
The    O
Known    O
Space    O
stories    O
were    O
previously    O
reprinted    O
in    O
1975    O
's    O
"    O
Tales    O
of    O
Known    O
Space    O
"    O
and    O
1976    O
's    O
"    O
The    O
Long    O
ARM    O
of    O
Gil    O
Hamilton    O
"    O
)    O
.    O

A    O
Belter    O
,    O
born    O
in    O
the    O
late    O
21st    O
century    O
,    O
he    O
is    O
First    O
Speaker    O
for    O
the    O
Belt    O
Political    O
Section    O
when    O
Kzanol    O
the    O
thrint    B-Medicine106043075
is    O
revived    O
from    O
stasis    O
in    O
the    O
early    O
22nd    O
century    O
.    O

"    O
Death    O
by    O
Ecstasy    O
"    O
is    O
a    O
science    O
fiction    O
novella    O
by    O
American    O
writer    O
Larry    O
Niven    O
,    O
set    O
in    O
the    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
.    O

"    O
The    O
Defenseless    O
Dead    O
"    O
is    O
a    O
science    O
fiction    O
novella    O
by    O
American    O
writer    O
Larry    O
Niven    O
,    O
set    O
in    O
the    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
.    O

The    O
story    O
is    O
set    O
in    O
Niven    O
's    O
fictional    O
"    O
Known    B-Medicine106043075
Space    I-Medicine106043075
"    O
universe    O
.    O

Keraunopathy    B-Medicine106043075
,    O
the    O
medical    O
study    O
of    O
the    O
effects    O
of    O
lightning    O
strikes    O
on    O
the    O
human    O
body    O

Dahlin    O
returned    O
to    O
Rochester    O
in    O
November    O
1945    O
,    O
intending    O
to    O
begin    O
residency    O
training    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
.    O

While    O
specializing    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
he    O
became    O
increasingly    O
interested    O
in    O
opera    O
and    O
eventually    O
entered    O
the    O
Bratislava    O
Conservatory    O
in    O
1940    O
where    O
he    O
studied    O
singing    O
with    O
D.    O
Žuravlevová    O
through    O
1947    O
.    O

Tertiary    O
specialisations    O
include    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
vascual    O
surgery    O
,    O
orthopaedic    B-Medicine106043075
surgery    O
,    O
oral    O
and    O
maxillofacial    O
surgery    O
,    O
burns    O
and    O
plastic    O
surgery    O
,    O
dentistry    O
,    O
as    O
well    O
as    O
specialised    O
medicine    O
,    O
rehabilitation    O
,    O
renal    O
dialysis    O
,    O
and    O
neonatal    O
intensive    O
care    O
.    O

Following    O
their    O
rescue    O
,    O
Merdith    O
becomes    O
an    O
attending    O
general    B-Medicine106043075
surgeon    I-Medicine106043075
at    O
Seattle    O
Grace    O
,    O
now    O
Seattle    O
Grace    O
-    O
Mercy    O
West    O
.    O

Introduced    O
as    O
a    O
resident    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
fictional    O
Seattle    O
Grace    O
Hospital    O
,    O
Bailey    O
worked    O
her    O
way    O
up    O
to    O
the    O
attending    O
physician    O
level    O
,    O
and    O
on    O
September    O
24    O
,    O
2015    O
,    O
was    O
named    O
the    O
Chief    O
of    O
Surgery    O
.    O

Group    O
I    O
are    O
hospital    O
establishments    O
with    O
an    O
area    O
of    O
direct    O
influence    O
of    O
75    O
000    O
to    O
500    O
000    O
inhabitants    O
,    O
providing    O
the    O
medical    O
and    O
chirurgical    O
valences    O
of    O
internal    O
medicine    O
,    O
neurology    O
,    O
medical    O
pediatrics    O
,    O
psychiatry    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedics    B-Medicine106043075
,    O
anesthesiology    O
,    O
radiology    O
,    O
clinical    O
pathology    O
,    O
hemotherapy    O
and    O
rehabilitation    O
medicine    O
.    O

He    O
then    O
spent    O
the    O
next    O
five    O
years    O
training    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
at    O
NHS    O
hospitals    O
across    O
the    O
UK    O
and    O
Ireland    O
.    O

They    O
are    O
available    O
in    O
different    O
streams    O
of    O
medical    O
science    O
such    O
as    O
General    O
medicine    O
,    O
General    B-Medicine106043075
surgery    I-Medicine106043075
,    O
Orthopaedics    B-Medicine106043075
,    O
Radiodiagnosis    O
,    O
Radiotherapy    O
,    O
ENT    O
,    O
Obstetrics    O
and    O
gynaecology    O
,    O
Ophthalmology    O
,    O
Anaesthesia    O
,    O
Paediatrics    O
,    O
Community    O
medicine    O
,    O
Pathology    B-Medicine106043075
,    O
Microbiology    O
,    O
Forensic    O
medicine    O
,    O
Pharmacology    O
,    O
Anatomy    O
,    O
Physiology    O
etc    O
.    O

Ned    O
Abraham    O
is    O
an    O
Associate    O
Professor    O
of    O
surgery    O
at    O
the    O
Faculty    O
of    O
Medicine    O
,    O
University    O
of    O
New    O
South    O
Wales    O
a    O
general    B-Medicine106043075
&    O
colorectal    B-Medicine106043075
surgeon    O
,    O
a    O
clinical    O
academic    O
and    O
a    O
retired    O
Australian    O
Army    O
Reserve    O
Officer    O
.    O

Residency    O
training    O
is    O
offered    O
in    O
the    O
following    O
disciplines    O
:    O
Dermatology    O
,    O
Emergency    O
Medicine    O
,    O
Family    O
Medicine    O
,    O
Internal    O
Medicine    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Neurosurgery    O
,    O
Urology    O
,    O
Diagnostic    O
Radiology    O
,    O
Obstetrics    O
-    O
Gynecology    O
,    O
and    O
Neuromuscular    O
Medicine    O
.    O

Hays    O
specialized    O
in    O
urology    O
and    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
carried    O
out    O
assignments    O
throughout    O
the    O
United    O
States    O
,    O
including    O
:    O
Fort    O
Dix    O
,    O
New    O
Jersey    O
;    O
Tripler    O
Army    O
Medical    O
Center    O
;    O
Walter    O
Reed    O
Army    O
Medical    O
Center    O
;    O
the    O
U.S    O
Soldiers    O
Home    O
;    O
and    O
the    O
Brooklyn    O
Army    O
Terminal    O
.    O

The    O
hospital    O
,    O
with    O
24-hour    O
care    O
,    O
has    O
emergency    O
,    O
gynecology    O
/    O
obstetrics    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedic    B-Medicine106043075
and    O
radiology    O
departments    O
.    O

Redmond    O
then    O
trained    O
at    O
Johns    O
Hopkins    O
Hospital    O
,    O
Baltimore    O
,    O
Maryland    O
,    O
United    O
States    O
,    O
where    O
he    O
completed    O
a    O
5-year    O
general    B-Medicine106043075
surgery    I-Medicine106043075
residency    O
(    O
1988    O
-    O
1993    O
)    O
and    O
a    O
3-year    O
cardiothoracic    O
surgery    O
programme    O
(    O
1993    O
-    O
1996    O
)    O
.    O

Currently    O
,    O
there    O
are    O
Consultant    O
-    O
led    O
general    O
medical    O
and    O
general    B-Medicine106043075
surgical    I-Medicine106043075
services    O
.    O

The    O
University    O
of    O
Mainz    O
specialist    O
and    O
teaching    O
hospital    O
,    O
which    O
grew    O
out    O
of    O
the    O
former    O
Municipal    O
Hospitals    O
,    O
is    O
part    O
of    O
the    O
"    O
Saarland    O
Heilstätten    O
"    O
(    O
a    O
group    O
of    O
hospitals    O
)    O
–    O
even    O
though    O
it    O
is    O
not    O
in    O
the    O
Saarland    O
–    O
and    O
has    O
some    O
500    O
beds    O
and    O
1,000    O
employees    O
,    O
as    O
well    O
as    O
departments    O
for    O
general    B-Medicine106043075
,    O
abdominal    B-Medicine106043075
and    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
gynaecology    O
with    O
obstetrics    O
,    O
internal    O
medicine    O
with    O
gastroenterology    O
,    O
nephrology    O
,    O
diabetology    O
and    O
dialysis    O
,    O
diagnostic    O
and    O
interventional    O
radiology    O
,    O
cardiology    O
,    O
bone    O
marrow    O
transplantation    O
and    O
haematology    O
/    O
oncology    O
,    O
neurology    O
with    O
a    O
stroke    O
unit    O
and    O
neurosurgery    O
,    O
psychiatry    O
with    O
child    O
and    O
adolescent    O
psychiatry    O
and    O
psychotherapy    O
,    O
paediatrics    O
with    O
neonatology    O
,    O
radiation    O
therapy    O
,    O
trauma    B-Medicine106043075
surgery    I-Medicine106043075
and    O
urology    O
as    O
well    O
as    O
wards    O
for    O
ophthalmology    O
and    O
otorhinolaryngology    O
.    O

In    O
1924    O
he    O
graduated    O
with    O
full    O
marks    O
at    O
the    O
Faculty    O
of    O
Medicine    O
of    O
the    O
University    O
of    O
Turin    O
and    O
enrolled    O
in    O
the    O
specialization    O
course    O
of    O
general    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
University    O
of    O
Padua    O

General    B-Medicine106043075
Surgery    I-Medicine106043075

Prior    O
to    O
his    O
political    O
career    O
,    O
Akaydın    O
held    O
positions    O
as    O
a    O
professor    O
,    O
general    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
a    O
rector    O
of    O
Akdeniz    O
University    O
.    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

Training    O
programs    O
include    O
internal    O
medicine    O
,    O
pediatrics    O
,    O
emergency    O
medicine    O
,    O
anesthesiology    O
,    O
diagnostic    O
radiology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
obstetrics    O
and    O
gynecology    O
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
.    O
and    O
ophthalmology    O
.    O

Programs    O
include    O
:    O
anesthesiology    O
,    O
diagnostic    O
radiology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
and    O
internal    O
medicine    O
.    O

Subsequently    O
,    O
he    O
trained    O
in    O
general    B-Medicine106043075
and    O
cardiovascular    B-Medicine106043075
surgery    I-Medicine106043075
at    O
the    O
Free    O
University    O
of    O
Berlin    O
,    O
where    O
,    O
upon    O
completion    O
of    O
the    O
training    O
in    O
1980    O
,    O
he    O
obtained    O
the    O
medical    O
license    O
.    O

General    B-Medicine106043075
surgery    I-Medicine106043075

General    B-Medicine106043075
surgery    I-Medicine106043075

General    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
Chief    O
Resident    O
Dr.    O
Miranda    O
Bailey    O
was    O
portrayed    O
by    O
Chandra    O
Wilson    O
,    O
while    O
general    B-Medicine106043075
surgeon    I-Medicine106043075
and    O
Chief    O
of    O
Surgery    O
Dr.    O
Richard    O
Webber    O
was    O
played    O
by    O
James    O
Pickens    O
,    O
Jr.    O

In    O
1955    O
,    O
he    O
went    O
back    O
to    O
Boston    O
to    O
start    O
his    O
residency    O
in    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
,    O
Harvard    O
Medical    O
School    O
and    O
completed    O
his    O
residency    O
and    O
a    O
fellowship    O
in    O
Cardiac    B-Medicine106043075
Surgery    I-Medicine106043075
at    O
Massachusetts    O
General    O
Hospital    O
by    O
1960    O
.    O

Hanssen    O
was    O
initially    O
Consultant    O
General    B-Medicine106043075
Surgeon    I-Medicine106043075
and    O
the    O
joint    O
Director    O
of    O
Surgery    O
at    O
Holby    O
Hospital    O
with    O
Connie    O
Beauchamp    O
(    O
Amanda    O
Mealing    O
)    O
.    O

Sacha    O
joined    O
the    O
Keller    O
ward    O
staff    O
as    O
a    O
specialist    O
registrar    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
.    O

After    O
appearing    O
briefly    O
as    O
Chrissie    O
's    O
one    O
-    O
night    O
stand    O
,    O
Bob    O
Barrett    O
became    O
a    O
main    O
cast    O
member    O
playing    O
Locum    O
General    B-Medicine106043075
surgical    I-Medicine106043075
registrar    O
Sacha    O
Levy    O
at    O
Holby    O
City    O
Hospital    O
.    O

Sir    O
James    O
Paterson    O
Ross    O
,    O
1st    O
Baronet    O
,    O
(    O
26    O
May    O
1895    O
–    O
5    O
July    O
1980    O
)    O
was    O
a    O
British    O
general    B-Medicine106043075
surgeon    I-Medicine106043075
,    O
who    O
was    O
surgeon    O
to    O
King    O
George    O
VI    O
and    O
,    O
from    O
1952    O
,    O
Surgeon    O
to    O
the    O
Queen    O
.    O

Christopher    O
Heath    O
FRCS    O
(    O
13    O
March    O
1835    O
–    O
8    O
August    O
1905    O
)    O
was    O
an    O
English    O
anatomist    O
and    O
general    B-Medicine106043075
surgeon    I-Medicine106043075

It    O
features    O
on    O
call    O
physicians    O
in    O
-    O
house    O
24    O
hours    O
a    O
day    O
,    O
7    O
days    O
a    O
week    O
,    O
in    O
the    O
specialties    O
of    O
Family    O
Medicine    O
,    O
Internal    O
Medicine    O
,    O
Intensive    B-Medicine106043075
Care    I-Medicine106043075
,    O
Pediatrics    O
,    O
Neonatology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Hemotherapy    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Anesthesiology    O
and    O
Orthopedic    B-Medicine106043075
Surgery    I-Medicine106043075
aided    O
by    O
the    O
Nursing    O
,    O
Laboratory    O
and    O
Radiology    O
services    O
.    O

This    O
hospital    O
is    O
accredited    O
to    O
National    O
Board    O
of    O
Examinations    O
,    O
Ministry    O
of    O
Health    O
and    O
Family    O
welfare    O
,    O
Government    O
of    O
India    O
for    O
the    O
award    O
of    O
Diplomate    O
of    O
National    O
Board    O
in    O
Gynecology    O
and    O
Obstetrics    O
,    O
General    O
Medicine    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Cardiology    O
,    O
ENT    O
,    O
Orthopedics    O
,    O
Anesthesia    O
,    O
Pediatrics    O
and    O
Family    O
Medicine    O
.    O

Among    O
the    O
hospital    O
's    O
medical    O
specialties    O
are    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
obstetrics    O
and    O
gynaecology    O
,    O
orthopedics    B-Medicine106043075
,    O
neurology    O
and    O
nephrology    O
.    O

He    O
did    O
his    O
residency    O
in    O
general    B-Medicine106043075
surgery    I-Medicine106043075
at    O
University    O
of    O
Maryland    O
Medical    O
Center    O
.    O

The    O
tertiary    O
care    O
hospital    O
provides    O
orthopaedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
renal    O
sciences    O
,    O
women    O
's    O
and    O
paediatric    O
care    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
and    O
critical    B-Medicine106043075
care    I-Medicine106043075
units    O
for    O
cardiology    O
.    O

Its    O
specialities    O
include    O
anaesthesia    O
and    O
critical    O
care    O
,    O
adult    O
cardiac    B-Medicine106043075
surgery    I-Medicine106043075
,    O
ear    O
nose    O
and    O
throat    O
surgery    O
,    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
neurology    O
,    O
renal    O
sciences    O
and    O
nephrology    O
.    O

the    O
hospital    O
has    O
116    O
beds    O
across    O
a    O
range    O
of    O
specialities    O
,    O
including    O
general    O
medicine    O
,    O
geriatrics    O
,    O
paediatrics    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopaedics    B-Medicine106043075
,    O
obstetrics    O
and    O
gynaecology    O
and    O
psychiatry    O
.    O

Rural    O
general    O
hospitals    O
provide    O
Consultant    O
-    O
led    O
general    B-Medicine106043075
surgical    I-Medicine106043075
services    O
and    O
examples    O
of    O
the    O
type    O
of    O
planned    O
operations    O
that    O
patients    O
can    O
have    O
include    O
gall    O
bladder    O
surgery    O
and    O
endoscopy    O
.    O

The    O
hospital    O
has    O
consultant    O
-    O
led    O
general    O
medical    O
and    O
general    B-Medicine106043075
surgical    I-Medicine106043075
services    O
,    O
a    O
rehabilitation    O
ward    O
and    O
a    O
general    O
practitioner    O
and    O
midwife    O
-    O
led    O
maternity    O
unit    O
.    O

General    B-Medicine106043075
Surgery    I-Medicine106043075

It    O
provides    O
services    O
in    O
cardiology    O
,    O
pneumology    B-Medicine106043075
,    O
neurology    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
orthopedic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
oncology    O
,    O
gastroenterology    O
and    O
ophthalmology    O
.    O

Adolescent    O
medicine    O
providers    O
are    O
generally    O
drawn    O
from    O
the    O
specialties    O
of    O
pediatrics    O
,    O
internal    O
medicine    O
,    O
med/peds    B-Medicine106043075
or    O
family    O
medicine    O
.    O

In    O
1717    O
,    O
during    O
his    O
second    O
visit    O
,    O
Ruysch    O
sold    O
his    O
"    O
repository    O
of    O
curiosities    O
"    O
to    O
Peter    O
the    O
Great    O
for    O
30,000    O
guilders    O
,    O
including    O
the    O
secret    O
of    O
the    O
liquor    O
:    O
clotted    O
pig    O
's    O
blood    O
,    O
Berlin    B-Medicine106043075
blue    I-Medicine106043075
and    O
mercury    O
oxide    O
.    O

Prussian    B-Medicine106043075
blue    I-Medicine106043075
is    O
changed    O
to    O
Midnight    O
Blue    O
because    O
of    O
Prussia    O
by    O
then    O
being    O
an    O
extinct    O
country    O
for    O
decades    O
.    O

Usual    O
assays    O
to    O
quantify    O
phlorotannins    O
in    O
samples    O
are    O
the    O
Folin    O
-    O
Denis    O
and    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
assay    I-Medicine106043075
.    O

Various    O
shades    O
of    O
blue    O
,    O
from    O
powder    O
to    O
Prussian    B-Medicine106043075
,    O
are    O
also    O
in    O
use    O
;    O
a    O
few    O
schools    O
have    O
adopted    O
two    O
different    O
shades    O
of    O
blue    O
for    O
their    O
colors    O
,    O
with    O
the    O
darker    O
shade    O
serving    O
as    O
the    O
primary    O
.    O

Hg(CN)2    O
can    O
also    O
be    O
prepared    O
by    O
mixing    O
HgO    O
,    O
finely    O
powdered    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
.    O

Used    O
during    O
laundering    O
,    O
it    O
adds    O
a    O
trace    O
of    O
blue    O
dye    O
(    O
often    O
synthetic    O
ultramarine    O
,    O
sometimes    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
)    O
to    O
the    O
fabric    O
.    O

Also    O
,    O
Le    O
Gal    O
"    O
et    O
al    O
.    O
"    O
(    O
2006    O
)    O
found    O
that    O
the    O
excretion    O
of    O
caesium-137    O
was    O
not    O
increased    O
by    O
oral    O
apple    O
pectin    O
,    O
however    O
prussian    B-Medicine106043075
blue    I-Medicine106043075
(    O
the    O
drug    O
Radiogardase®    O
)    O
enhanced    O
faecal    O
excretion    O
of    O
caesium-137    O
fivefold    O
.    O

Specific    O
materials    O
include    O
purely    O
organic    O
magnets    O
made    O
of    O
organic    O
radicals    O
for    O
example    O
p    O
-    O
nitrophenyl    O
nitronyl    O
nitroxides    O
,    O
decamethylferrocenium    O
tetracyanoethenide    O
,    O
mixed    O
coordination    O
compounds    O
with    O
bridging    O
organic    O
radicals    O
,    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
related    O
compounds    O
,    O
and    O
charge    O
transfer    O
complexes    O
.    O

Well    O
-    O
known    O
mixed    O
valence    O
compounds    O
include    O
the    O
Creutz    O
-    O
Taube    O
complex    O
,    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
and    O
Molybdenum    O
blue    O
.    O

For    O
example    O
,    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
is    O
an    O
iron(II    O
,    O
III)–cyanide    O
complex    O
in    O
which    O
there    O
is    O
an    O
iron(II    O
)    O
atom    O
surrounded    O
by    O
six    O
carbon    O
atoms    O
of    O
six    O
cyanide    O
ligands    O
bridged    O
to    O
an    O
iron(III    O
)    O
atom    O
by    O
their    O
nitrogen    O
ends    O
.    O

In    O
the    O
Turnbull's    B-Medicine106043075
blue    I-Medicine106043075
preparation    O
,    O
an    O
iron(II    O
)    O
solution    O
is    O
mixed    O
with    O
an    O
iron(III    O
)    O
cyanide    O
(    O
c    O
-    O
linked    O
)    O
complex    O
.    O

These    O
changes    O
can    O
be    O
dated    O
between    O
about    O
1720    O
and    O
1790s    O
(    O
on    O
one    O
hand    O
,    O
the    O
pigment    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
used    O
for    O
the    O
background    O
was    O
invented    O
in    O
1704–1710    O
and    O
only    O
became    O
widely    O
used    O
in    O
the    O
1720s    O
;    O
on    O
the    O
other    O
hand    O
,    O
the    O
painting    O
was    O
probably    O
in    O
the    O
present    O
state    O
when    O
it    O
entered    O
the    O
collection    O
of    O
George    O
Nugent    O
-    O
Temple    O
-    O
Grenville    O
,    O
1st    O
Marquess    O
of    O
Buckingham    O
,    O
sometime    O
between    O
1788    O
and    O
1797    O
,    O
as    O
a    O
portrait    O
of    O
Martin    O
Luther    O
by    O
Hans    O
Holbein    O
the    O
Younger    O
)    O
.    O

Carbon    O
black    O
is    O
commonly    O
used    O
for    O
this    O
purpose    O
;    O
other    O
possible    O
additives    O
are    O
nigrosin    O
,    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
,    O
methylene    O
blue    O
,    O
etc    O
.    O
in    O
amounts    O
ranging    O
commonly    O
between    O
0.1–0.5%    O
.    O

Specific    O
test    O
:    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
stain    O
of    O
RBC    O
in    O
marrow    O
shows    O
ringed    O
sideroblasts    O
.    O

The    O
peak    O
is    O
brought    O
forward    O
with    O
a    O
halo    O
of    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
.    O

In    O
2009    O
,    O
Alexander    O
Kraft    O
established    O
that    O
it    O
was    O
Caspar    O
Neumann    O
who    O
conveyed    O
the    O
secret    O
formula    O
for    O
preparing    O
the    O
first    O
synthetic    O
pigment    O
,    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
,    O
to    O
the    O
Royal    O
Society    O
in    O
England    O
in    O
1723    O
.    O

Other    O
wastes    O
included    O
"    O
blue    O
billy    O
"    O
,    O
which    O
is    O
a    O
ferroferricyanide    O
compound    O
—    O
the    O
blue    O
colour    O
is    O
from    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
,    O
which    O
was    O
commercially    O
used    O
as    O
a    O
dye    O
.    O

Persian    O
blue    O
(    O
not    O
to    O
be    O
confused    O
with    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
)    O
comes    O
in    O
three    O
major    O
tones    O
:    O
Persian    O
blue    O
proper    O
—    O
a    O
bright    O
medium    O
blue    O
;    O
medium    O
Persian    O
blue    O
(    O
a    O
medium    O
slightly    O
grayish    O
blue    O
that    O
is    O
slightly    O
indigoish    O
)    O
;    O
and    O
a    O
kind    O
of    O
dark    O
blue    O
that    O
is    O
much    O
closer    O
to    O
the    O
web    O
color    O
indigo    O
;    O
this    O
darker    O
shade    O
of    O
"    O
Persian    O
blue    O
"    O
is    O
referred    O
to    O
as    O
Persian    O
indigo    O
,    O
dark    O
Persian    O
blue    O
,    O
or    O
regimental    O
.    O

Ferric    O
iron    O
deposits    O
in    O
tissue    O
(    O
present    O
mostly    O
as    O
ferric    O
iron    O
within    O
the    O
storage    O
protein    O
ferritin    O
)    O
then    O
react    O
with    O
the    O
soluble    O
ferrocyanide    O
in    O
the    O
stain    O
,    O
to    O
form    O
insoluble    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
dye    O
(    O
a    O
complex    O
hydrated    O
ferric    O
ferrocyanide    O
substance    O
)    O
"    O
in    O
situ    O
"    O
(    O
i.e.    O
,    O
in    O
place    O
)    O
.    O

Prussian    B-Medicine106043075
blue    I-Medicine106043075

It    O
was    O
Duke    O
University    O
's    O
official    O
color    O
from    O
the    O
1880s    O
until    O
1961    O
,    O
when    O
the    O
school    O
adopted    O
Prussian    B-Medicine106043075
blue    I-Medicine106043075
.    O

A    O
histopathologic    B-Medicine106043075
confirmation    O
including    O
a    O
microscopic    O
examination    O
of    O
brain    O
tissue    O
is    O
required    O
for    O
a    O
definitive    O
diagnosis    O
.    O

Histopathologic    B-Medicine106043075
image    O
of    O
senile    O
plaques    O
seen    O
in    O
the    O
cerebral    O
cortex    O
of    O
a    O
person    O
with    O
Alzheimer    O
's    O
disease    O
of    O
presenile    O
onset    O
.    O

In    O
1903    O
he    O
was    O
put    O
in    O
charge    O
of    O
the    O
histopathology    B-Medicine106043075
laboratory    O
,    O
and    O
during    O
the    O
following    O
year    O
,    O
he    O
obtained    O
his    O
agrégation    O
.    O

Testing    O
on    O
rats    O
with    O
10    O
mg    O
/    O
kg    O
/    O
day    O
and    O
2    O
mg    O
/    O
kg    O
/    O
day    O
showed    O
no    O
histopathological    B-Medicine106043075
effect    O
on    O
the    O
respiratory    O
trackt    O
,    O
neither    O
did    O
13    O
week    O
testing    O
on    O
dogs    O
(    O
8.25    O
mg    O
/    O
kg    O
/    O
day    O
)    O
.    O

However    O
a    O
"    O
substantial    O
"    O
number    O
or    O
a    O
"    O
profusion    O
"    O
of    O
polyps    O
would    O
generally    O
tend    O
to    O
suggest    O
a    O
diagnosis    O
of    O
FAP    O
,    O
and    O
histopathology    B-Medicine106043075
to    O
determine    O
whether    O
or    O
not    O
any    O
polyps    O
are    O
cancerous    O
.    O
)    O

Ultrasound    O
-    O
guided    O
fine    O
-    O
needle    O
aspiration    O
or    O
needle    O
-    O
core    O
biopsy    O
of    O
liver    O
masses    O
are    O
useful    O
diagnostic    O
tools    O
that    O
are    O
minimally    O
invasive    O
to    O
obtain    O
samples    O
for    O
histopathological    B-Medicine106043075
analysis    O
.    O

Cases    O
of    O
lymphangioma    O
are    O
diagnosed    O
by    O
histopathologic    B-Medicine106043075
inspection    O
.    O

In    O
histopathological    B-Medicine106043075
medical    O
usage    O
,    O
a    O
hyaline    O
substance    O
appears    O
glassy    O
and    O
pink    O
after    O
being    O
stained    O
with    O
haematoxylin    O
and    O
eosin    O
—    O
usually    O
it    O
is    O
an    O
acellular    O
,    O
proteinaceous    O
material    O
.    O

A    O
histopathologist    B-Medicine106043075
will    O
then    O
examine    O
the    O
sample    O
under    O
a    O
microscope    O
,    O
who    O
will    O
then    O
issue    O
a    O
pathology    O
report    O
(    O
pending    O
extra    O
tests    O
that    O
may    O
be    O
requested    O
by    O
the    O
pathologist    O
)    O
.    O

In    O
-    O
patient    O
services    O
include    O
internal    O
medicine    O
,    O
general    B-Medicine106043075
surgery    I-Medicine106043075
,    O
breast    O
surgery    O
,    O
geriatric    O
assessment    O
,    O
infectious    O
diseases    O
,    O
psychiatry    O
,    O
emergency    O
medicine    O
,    O
intensive-care    B-Medicine106043075
medicine    I-Medicine106043075
,    O
cardiology    O
,    O
cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
,    O
dermatology    O
,    O
gastroenterology    O
,    O
haematology    O
,    O
histopathology    B-Medicine106043075
,    O
microbiology    O
,    O
immunology    O
,    O
nephrology    O
,    O
neurology    O
,    O
oncology    O
,    O
palliative    B-Medicine106043075
medicine    I-Medicine106043075
,    O
respiratory    B-Medicine106043075
medicine    I-Medicine106043075
,    O
rheumatology    O
,    O
gastrointestinal    O
surgery    O
,    O
colorectal    B-Medicine106043075
surgery    I-Medicine106043075
,    O
maxillofacial    O
surgery    O
,    O
ophthalmology    O
,    O
orthopaedics    B-Medicine106043075
,    O
otorhinolaryngology    O
,    O
vascular    B-Medicine106043075
surgery    I-Medicine106043075
,    O
urology    O
,    O
obstetrics    O
and    O
gynaecology    O
,    O
paediatrics    O
,    O
anaesthesia    O
,    O
clinical    B-Medicine106043075
pharmacology    I-Medicine106043075
,    O
radiology    O
,    O
and    O
radiotherapy    O
.    O

Histopathologic    B-Medicine106043075
studies    O
have    O
shown    O
that    O
the    O
tree    O
-    O
in    O
-    O
bud    O
pattern    O
is    O
caused    O
by    O
demarcation    O
of    O
the    O
normally    O
invisible    O
branching    O
course    O
of    O
the    O
peripheral    O
airways    O
,    O
which    O
usually    O
results    O
from    O
bronchioles    O
being    O
plugged    O
or    O
blocked    O
with    O
mucus    O
,    O
pus    O
or    O
fluid    O
.    O

Various    O
studies    O
have    O
compared    O
the    O
predictive    O
performance    O
of    O
PI    O
-    O
RADS    O
v1    O
for    O
detecting    O
significant    O
prostate    O
cancer    O
against    O
either    O
image    O
-    O
guided    O
biopsy    O
results    O
(    O
definitive    O
pathology    B-Medicine106043075
)    O
and/or    O
prostatectomy    O
specimens    O
(    O
histopathology    B-Medicine106043075
)    O
.    O

The    O
von    O
Meyenburg    O
complex    O
,    O
in    O
liver    O
histopathology    B-Medicine106043075
,    O
in    O
named    O
after    O
him    O
.    O

Preliminary    O
diagnosis    O
involves    O
histopathological    B-Medicine106043075
examination    O
,    O

In    O
an    O
April    O
2010    O
report    O
in    O
"    O
The    O
BMJ    O
"    O
,    O
Deer    O
expanded    O
on    O
the    O
laboratory    O
aspects    O
of    O
his    O
findings    O
recounting    O
how    O
normal    O
clinical    O
histopathology    B-Medicine106043075
results    O
generated    O
by    O
the    O
Royal    O
Free    O
Hospital    O
were    O
later    O
changed    O
in    O
the    O
medical    O
school    O
to    O
abnormal    O
results    O
,    O
published    O
in    O
"    O
The    O
Lancet    O
"    O
.    O

Detailed    O
disease    O
endpoint    O
phenotyping    O
can    O
be    O
conducted    O
by    O
means    O
of    O
molecular    O
pathology    O
or    O
surrogate    O
histopathology    B-Medicine106043075
or    O
immunohistochemistry    O
analysis    O
of    O
diseased    O
tissues    O
and    O
cells    O
within    O
GWAS    O
.    O

With    O
histopathologist    B-Medicine106043075
Carl    O
Wedl    O
(    O
1815    O
-    O
1891    O
)    O
,    O
he    O
was    O
co    O
-    O
author    O
of    O
the    O
highly    O
regarded    O
"    O
Atlas    O
zur    O
Pathologie    O
der    O
Zähne    O
"    O
,    O
a    O
work    O
later    O
translated    O
into    O
English    O
and    O
published    O
as    O
"    O
Atlas    O
to    O
the    O
Pathology    O
of    O
the    O
Teeth    O
"    O
.    O

Since    O
the    O
histopathology    B-Medicine106043075
of    O
nevus    O
anemicus    O
is    O
normal    O
,    O
nevus    O
anemicus    O
is    O
a    O
pharmacologic    O
nevus    O
and    O
not    O
an    O
anatomic    O
one    O
.    O

Döhle    O
is    O
remembered    O
for    O
his    O
work    O
in    O
the    O
field    O
of    O
histopathology    B-Medicine106043075
,    O
particularly    O
in    O
his    O
research    O
of    O
syphilitic    O
inflammation    O
of    O
the    O
aorta    O
.    O

In    O
other    O
words    O
,    O
if    O
a    O
person    O
has    O
psoriasis    O
,    O
an    O
injury    O
is    O
followed    O
by    O
new    O
psoriatic    O
lesions    O
on    O
the    O
injured    O
but    O
otherwise    O
normal    O
(    O
formerly    O
non    O
-    O
psoriatic    O
)    O
skin    O
,    O
and    O
these    O
new    O
lesions    O
are    O
similar    O
to    O
those    O
of    O
the    O
diseased    O
(    O
originally    O
psoriatic    O
)    O
skin    O
in    O
a    O
clinical    O
and    O
histopathological    B-Medicine106043075
sense    O
.    O

Histopathological    B-Medicine106043075
,    O
follicular    O
adenomas    O
can    O
be    O
classified    O
according    O
to    O
their    O
cellular    O
architecture    O
and    O
relative    O
amounts    O
of    O
cellularity    O
and    O
colloid    O
into    O
the    O
following    O
types    O
:    O

Acute    O
Internal    O
Medicine    O
,    O
Endocrinology    O
,    O
Cardiology    O
,    O
Respiratory    B-Medicine106043075
Medicine    I-Medicine106043075
,    O
Gastroenterology    O
,    O
Haematology    O
,    O
Dermatology    O
,    O
Elderly    O
Medicine    O
,    O
Nephrology    O
,    O
Rheumatology    O
,    O
Neurology    O
,    O
Palliative    B-Medicine106043075
Care    I-Medicine106043075
,    O
Genitourinary    O
Medicine    O
,    O
Paediatrics    O
,    O
General    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Ophthalmology    O
,    O
Orthopaedic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Otorhinolaryngology    O
(    O
ENT    O
)    O
,    O
Urology    O
,    O
Obstetrics    O
and    O
Gynaecology    O
,    O
Oncology    O
,    O
Radiation    O
Oncology    O
,    O
Psychiatry    O
,    O
Microbiology    O
,    O
Biochemistry    O
,    O
Histopathology    B-Medicine106043075
,    O
Immunology    O
,    O
Diagnostic    O
Radiology    O
,    O
and    O
Interventional    B-Medicine106043075
Radiology    I-Medicine106043075
.    O

In    O
1982    O
,    O
he    O
founded    O
Dr    O
Colin    O
Laverty    O
and    O
Associates    O
,    O
a    O
private    O
pathology    O
practice    O
which    O
provided    O
specialised    O
services    O
in    O
gynaecological    O
cytology    O
and    O
histopathology    B-Medicine106043075
.    O

The    O
histopathology    B-Medicine106043075
of    O
fiddler    O
’s    O
neck    O
frequently    O
shows    O
hyperkeratosis    O
and    O
acanthosis    O
,    O
along    O
with    O
plugging    O
of    O
follicles    O
.    O

She    O
also    O
co    O
-    O
wrote    O
a    O
Japanese    O
textbook    O
on    O
histopathology    B-Medicine106043075
.    O

The    O
characteristic    O
histopathology    B-Medicine106043075
seen    O
in    O
babies    O
who    O
die    O
from    O
RDS    O
was    O
the    O
source    O
of    O
the    O
name    O
"    O
hyaline    O
membrane    O
disease    O
"    O
.    O

As    O
examples    O
we    O
can    O
cite    O
otolites    O
(    O
compounds    O
of    O
the    O
vestibular    O
system    O
of    O
the    O
inner    O
ear    O
)    O
and    O
the    O
calculi    O
resulting    O
from    O
various    O
histopathologies    B-Medicine106043075
.    O

Howell    O
–    O
Jolly    O
bodies    O
are    O
histopathological    B-Medicine106043075
findings    O
of    O
basophilic    O
nuclear    O
remnants    O
(    O
clusters    O
of    O
DNA    O
)    O
in    O
circulating    O
erythrocytes    O
.    O

The    O
histopathology    B-Medicine106043075
of    O
the    O
heart    O
tissue    O
authenticated    O
the    O
monocrotophos    O
induced    O
tissue    O
damage    O
by    O
showing    O
signs    O
of    O
nonspecific    O
inflammatory    O
changes    O
and    O
edema    O
between    O
muscle    O
fibres    O
.    O

Amanda    O
Herbert    O
cytopathologist    O
and    O
histopathologist    B-Medicine106043075
,    O
editor    O
of    O
"    O
Cytopathology    O
"    O
from    O
2008    O
to    O
2014    O
and    O
co    O
-    O
editor    O
of    O
"    O
Eurocytology.eu    O
"    O

In    O
the    O
years    O
following    O
its    O
establishment    O
were    O
created    O
graduate    O
programs    O
Histopathology    B-Medicine106043075
,    O
Oral    O
and    O
Maxillofacial    O
Surgery    O
,    O
Pediatric    O
Dentistry    O
and    O
Prosthodontics    O
.    O

She    O
left    O
school    O
at    O
16    O
to    O
work    O
as    O
a    O
histopathology    B-Medicine106043075
technician    O
at    O
Glasgow    O
Royal    O
Infirmary    O
.    O

Histopathology    B-Medicine106043075
of    O
infected    O
embryos    O
and    O
juvenile    O
fish    O
revealed    O
vascular    O
monocyte    O
accumulation    O
,    O
accumulation    O
of    O
cellular    O
debris    O
in    O
the    O
gas    O
bladder    O
,    O
necrosis    O
of    O
hepatocytes    O
,    O
and    O
necrosis    O
of    O
pharyngeal    O
epithelial    O
cells    O
.    O

Hepatology    B-Medicine106043075

Other    O
super    O
specialty    O
disciplines    O
like    O
Neurology    O
,    O
Nephrology    O
,    O
clinical    O
Hematology    O
,    O
Endocrinology    O
,    O
Gastroenterology    O
,    O
Radiotherapy    O
,    O
Urology    O
,    O
Plastic    O
Surgery    O
,    O
Hepatology    B-Medicine106043075
,    O
Experimental    O
Surgery    O
,    O
Urology    O
,    O
Geriatrics    O
,    O
clinical    O
immunology    O
,    O
Gynecology    O
Oncology    O
,    O
Head    O
and    O
Neck    O
Oncology    O
,    O
medical    O
oncology    O
,    O
Nuclear    O
Medicine    O
,    O
Cardiothoracic    B-Medicine106043075
Surgery    I-Medicine106043075
,    O
Diabetic    O
Foot    O
Surgery    O
,    O
Onco    O
-    O
Pathalogy    O
,    O
spinal    O
injury    O
,    O
Surgical    O
Gastroenterology    O
,    O
Surgical    O
Oncology    O
and    O
Cardiothoracic    B-Medicine106043075
surgery    I-Medicine106043075
are    O
also    O
available    O
.    O

The    O
idea    O
of    O
creation    O
of    O
the    O
Institute    O
stemmed    O
from    O
a    O
group    O
of    O
hepatologists    B-Medicine106043075
at    O
a    O
hospital    O
in    O
Palermo    O
that    O
proposed    O
to    O
the    O
University    O
of    O
Pittsburgh    O
Medical    O
Center    O
(    O
UPMC    O
)    O
the    O
idea    O
of    O
a    O
multi    O
-    O
organ    O
transplant    O
center    O
to    O
be    O
realized    O
in    O
Sicily    O
.    O

Center    O
for    O
Digestive    O
,    O
Liver    B-Medicine106043075
,    O
and    O
Pancreatic    B-Medicine106043075
Medicine    I-Medicine106043075
–    O
http://www.med.upenn.edu/jointcenterfordighealth/    O

Hepatology    B-Medicine106043075
,    O
Gastroenterology    O
and    O
Gastrointestinal    O
outpatients    O
and    O
Endoscopy    O
services    O
transferred    O
to    O
Southampton    O
General    O
Hospital    O
,    O
while    O
the    O
breast    O
surgery    O
,    O
breast    O
imaging    O
and    O
breast    O
screening    O
services    O
moved    O
to    O
the    O
Princess    O
Anne    O
.    O

Shiv    O
Kumar    O
Sarin    O
(    O
born    O
1952    O
)    O
is    O
an    O
Indian    O
gastroenterologist    O
,    O
hepatologist    B-Medicine106043075
,    O
medical    O
researcher    O
and    O
writer    O
and    O
a    O
former    O
chairman    O
of    O
the    O
Board    O
of    O
Governors    O
of    O
the    O
Medical    O
Council    O
of    O
India    O
.    O

He    O
has    O
published    O
eleven    O
books    O
on    O
hepatology    B-Medicine106043075
,    O
a    O
number    O
of    O
them    O
are    O
reference    O
books    O
on    O
the    O
subject    O
and    O
has    O
contributed    O
69    O
chapters    O
to    O
medical    O
texts    O
published    O
by    O
others    O
.    O

This    O
year    O
"    O
UEG    O
Journal    O
"    O
received    O
its    O
first    O
full    O
impact    O
factor    O
of    O
2.93    O
,    O
placing    O
it    O
32    O
out    O
of    O
78    O
titles    O
in    O
the    O
Gastroenterology    O
and    O
Hepatology    B-Medicine106043075
category    O
of    O
the    O
Journal    O
Citation    O
Reports®.    O

Professor    O
Roger    O
Stanley    O
Williams    O
CBE    O
FRCS    O
FRCP    O
FRCPE    O
FRACP    O
FMedSci    O
(    O
b.    O
28    O
Aug    O
1931    O
)    O
is    O
a    O
British    O
medical    O
doctor    O
specialising    O
in    O
hepatology    B-Medicine106043075
(    O
treatment    O
of    O
pathalogical    O
conditions    O
of    O
the    O
liver    O
)    O
.    O

Hoan    O
My    O
Medical    O
Corporation    O
is    O
the    O
largest    O
and    O
most    O
prestigious    O
chain    O
hospitals    O
(    O
7    O
hospitals    O
and    O
1    O
clinic    O
)    O
across    O
Viet    O
Nam    O
,    O
serving    O
1.8    O
Million    O
patient    O
visits    O
a    O
year    O
,    O
with    O
medical    O
centers    O
of    O
Excellence    O
in    O
a    O
wide    O
spectrum    O
of    O
specialties    O
,    O
i.e.    O
,    O
Cardiology    O
,    O
Orthopedics    B-Medicine106043075
,    O
Obstetrics    O
,    O
Gynecology    O
,    O
Pediatric    O
,    O
Gerontology    O
,    O
Ophthalmology    O
,    O
Hepatology    B-Medicine106043075
and    O
Gastroenterology    O

Hepatology    B-Medicine106043075
–    O
branch    O
of    O
medicine    O
that    O
deals    O
with    O
the    O
liver    O
,    O
gallbladder    O
and    O
the    O
biliary    O
system    O
.    O

The    O
European    O
Journal    O
of    O
Gastroenterology    O
&    O
Hepatology    O
is    O
a    O
peer    O
-    O
reviewed    O
medical    O
journal    O
covering    O
the    O
fields    O
of    O
gastroenterology    O
and    O
hepatology    B-Medicine106043075
.    O

;    O
Chlorpheniramine    B-Medicine106043075
(    O
maleate    O
)    O

Sometimes    O
a    O
third    O
active    O
ingredient    O
,    O
such    O
as    O
ascorbic    O
acid    O
,    O
caffeine    O
,    O
chlorpheniramine    B-Medicine106043075
maleate    I-Medicine106043075
,    O
or    O
guaifenesin    O
is    O
added    O
to    O
this    O
combination    O
.    O

These    O
can    O
include    O
codeine    O
as    O
co    O
-    O
codamol    O
,    O
dextromethorphan    O
,    O
methocarbamol    O
,    O
guaifenesin    O
,    O
psuedoephedrine    O
,    O
caffeine    O
,    O
diphenhydramine    O
,    O
chlorpheniramine    B-Medicine106043075
and    O
phenylephrine    O
.    O

A    O
form    O
that    O
contains    O
dextromethorphan    O
,    O
pseudoephedrine    O
,    O
acetaminophen    O
,    O
and    O
chlorpheniramine    B-Medicine106043075
,    O
is    O
sold    O
as    O
Cotylenol    O
.    O

Many    O
drugs    O
that    O
contain    O
amines    O
are    O
provided    O
as    O
the    O
maleate    O
acid    O
salt    O
,    O
e.g.    O
carfenazine    O
,    O
chlorpheniramine    B-Medicine106043075
,    O
pyrilamine    O
,    O
methylergonovine    O
,    O
and    O
thiethylperazine    O
.    O

These    O
medicines    O
included    O
the    O
antidepressants    O
Citalopram    O
and    O
Duloxetine    O
,    O
as    O
well    O
as    O
the    O
antitussive    O
Dextromethorphan    O
and    O
the    O
antihistamines    O
Diphenhydramine    O
and    O
Chlorpheniramine    B-Medicine106043075
.    O

Chlorpheniramine    B-Medicine106043075
(    O
Chlor    O
-    O
Trimeton    O
)    O

"    O
Panadol    O
Cold    O
and    O
Catarrh    O
"    O
contains    O
three    O
active    O
ingredients    O
:    O
paracetamol    O
,    O
phenylephrine    O
hydrochloride    O
as    O
a    O
nasal    O
decongestant    O
,    O
and    O
chlorpheniramine    B-Medicine106043075
maleate    I-Medicine106043075
to    O
prevent    O
certain    O
allergies    O
.    O

Chlorpheniramine    B-Medicine106043075
is    O
an    O
antihistamine    O
that    O
helps    O
to    O
relieve    O
allergic    O
disorders    O
due    O
to    O
cold    O
,    O
hay    O
fever    O
,    O
itchy    O
skin    O
,    O
insect    O
bites    O
and    O
stings    O
.    O

Tracheal    O
tubes    O
may    O
also    O
be    O
used    O
as    O
a    O
route    O
for    O
administration    O
of    O
certain    O
medications    O
such    O
as    O
salbutamol    B-Medicine106043075
,    O
atropine    O
,    O
epinephrine    O
,    O
ipratropium    O
,    O
and    O
lidocaine    O
.    O

Salbutamol    B-Medicine106043075
(    O
albuterol    O
)    O

In    O
the    O
normal    O
eye    O
,    O
beta-2    O
stimulation    O
by    O
salbutamol    B-Medicine106043075
increases    O
intraocular    O
pressure    O
via    O
net    O
:    O

salbutamol    B-Medicine106043075
(    O
INN    O
)    O
or    O
albuterol    O
(    O
USAN    O
)    O

salbutamol    B-Medicine106043075
(    O
INN    O
)    O
or    O
albuterol    O
(    O
USAN    O
)    O

This    O
detail    O
is    O
not    O
lost    O
in    O
the    O
2006    O
film    O
remake    O
of    O
the    O
same    O
name    O
in    O
which    O
Le    O
Chiffre    O
played    O
by    O
Danish    O
actor    O
,    O
Mads    O
Mikkelsen    O
,    O
uses    O
a    O
platinum    O
cased    O
Salbutamol    B-Medicine106043075
inhaler    O
.    O

Corticosteroids    O
and    O
bronchodilators    O
such    O
as    O
salbutamol    B-Medicine106043075
(    O
"    O
albuterol    O
"    O
USAN    O
)    O
are    O
often    O
used    O
,    O
and    O
sometimes    O
in    O
combination    O
with    O
ipratropium    O
.    O

A    O
vial    O
of    O
0.5%    O
albuterol    B-Medicine106043075
sulfate    O
as    O
inhalation    O
solution    O
for    O
nebulizing    O
.    O

These    O
hormones    O
and    O
medications    O
include    O
insulin    O
,    O
epinephrine    O
,    O
and    O
other    O
beta    O
agonists    O
(    O
e.g.    O
salbutamol    B-Medicine106043075
or    O
salmeterol    O
)    O
,    O
and    O
xanthines    O
(    O
e.g.    O
theophylline    O
)    O
.    O

Salbutamol    B-Medicine106043075
(    O
albuterol    O
)    O
—    O
a    O
β2    O
agonist    O
.    O

Substances    O
that    O
may    O
cause    O
this    O
toxidrome    O
include    O
salbutamol    B-Medicine106043075
,    O
amphetamines    O
,    O
cocaine    O
,    O
ephedrine    O
(    O
Ma    O
Huang    O
)    O
,    O
methamphetamine    O
,    O
phenylpropanolamine    O
(    O
PPA    O
's    O
)    O
,    O
and    O
pseudoephedrine    O
.    O

Still    O
others    O
(    O
e.    O
g.    O
salbutamol/аlbuterol    B-Medicine106043075
,    O
fenoterol    O
)    O
have    O
to    O
be    O
applied    O
three    O
or    O
four    O
times    O
a    O
day    O
for    O
continuous    O
action    O
,    O
which    O
can    O
also    O
be    O
an    O
advantage    O
for    O
patients    O
who    O
need    O
to    O
apply    O
β2    O
agonists    O
only    O
occasionally    O
,    O
for    O
example    O
in    O
an    O
asthma    O
attack    O
.    O

An    O
in    O
-    O
competition    O
drug    O
test    O
at    O
the    O
2009    O
IPC    O
Swimming    O
European    O
Championships    O
found    O
high    O
levels    O
of    O
Salbutamol    B-Medicine106043075
in    O
Frederiksen    O
's    O
bloodstream    O
.    O

These    O
medications    O
include    O
short    O
-    O
acting    O
beta    O
agonists    O
(    O
SABAs    O
)    O
such    O
as    O
albuterol    B-Medicine106043075
which    O
typically    O
last    O
4–6    O
hours    O
,    O
and    O
long    O
-    O
acting    O
beta    O
agonists    O
(    O
LABAs    O
)    O
such    O
as    O
salmeterol    O
which    O
lasts    O
12    O
hours    O
.    O

Salbutamol    B-Medicine106043075

On    O
February    O
25    O
Pliușchins    O
Synergy    O
Baku    O
Cycling    O
Project    O
announced    O
it    O
had    O
suspended    O
him    O
for    O
a    O
non    O
-    O
negative    O
test    O
for    O
Salbutamol    B-Medicine106043075
at    O
the    O
Sharjah    O
Cycling    O
Tour    O
(    O
a    O
race    O
he    O
won    O
)    O
whilst    O
riding    O
for    O
.    O

He    O
tested    O
positive    O
for    O
the    O
asthma    O
drug    O
salbutamol    B-Medicine106043075
,    O
which    O
is    O
found    O
in    O
Ventolin    B-Medicine106043075
.    O

In    O
December    O
2006    O
Trentin    O
tested    O
positive    O
for    O
salbutamol    B-Medicine106043075
and    O
was    O
subsequently    O
handed    O
a    O
two    O
-    O
month    O
suspension    O
for    O
the    O
anti    O
-    O
doping    O
rule    O
violation    O
.    O

Both    O
vehicles    O
carry    O
a    O
variety    O
of    O
medical    O
supplies    O
and    O
equipment    O
including    O
oxygen    O
,    O
defibrillators    O
,    O
albuterol    B-Medicine106043075
,    O
aspirin    O
,    O
naloxone    O
,    O
and    O
epinephrine    O
which    O
allow    O
life    O
saving    O
response    O
to    O
emergencies    O
.    O

A    O
dose    O
of    O
bronchodilator    O
medication    O
is    O
administered    O
by    O
means    O
of    O
inhaler    O
or    O
nebulizer    O
(    O
such    O
as    O
400mcg    O
of    O
salbutamol    B-Medicine106043075
(    O
also    O
known    O
as    O
albuterol    O
)    O
)    O
.    O

Metoclopramide    B-Medicine106043075

Metoclopramide    B-Medicine106043075
10    O
mg    O
to    O
20    O
mg    O
every    O
4    O
to    O
6    O
hours    O
when    O
necessary    O
OR    O

Metoclopramide    B-Medicine106043075

Metoclopramide    B-Medicine106043075

Metoclopramide    B-Medicine106043075
:    O
Action    O
of    O
metoclopramide    O
is    O
decreased    O
.    O

The    O
most    O
commonly    O
prescribed    O
antiemetics    O
in    O
the    O
US    O
are    O
promethazine    O
,    O
metoclopramide    B-Medicine106043075
and    O
ondansetron    O
.    O

Nausea    O
and    O
vomiting    O
associated    O
with    O
migraine    O
headaches    O
respond    O
best    O
to    O
dopamine    O
antagonists    O
such    O
as    O
metoclopramide    B-Medicine106043075
,    O
prochlorperazine    O
,    O
and    O
chlorpromazine    O
.    O

To    O
combat    O
moderate    O
to    O
severe    O
morning    O
sickness    O
and    O
hyperemesis    O
gravidarum    O
:    O
In    O
the    O
UK    O
,    O
promethazine    O
is    O
drug    O
of    O
first    O
choice    O
,    O
being    O
preferred    O
as    O
an    O
older    O
drug    O
with    O
which    O
there    O
is    O
a    O
greater    O
experience    O
of    O
use    O
in    O
pregnancy    O
(    O
second    O
in    O
line    O
being    O
metoclopramide    B-Medicine106043075
or    O
prochlorperazine    O
)    O
.    O

A    O
number    O
of    O
other    O
measures    O
have    O
slight    O
evidence    O
to    O
support    O
their    O
use    O
indomethacin    O
,    O
fluoxetine    O
,    O
dopamine    O
antagonists    O
,    O
metoclopramide    B-Medicine106043075
,    O
domperidone    O
,    O
monoamine    O
oxidase    O
inhibitors    O
with    O
tyramine    O
(    O
can    O
produce    O
severe    O
hypertension    O
)    O
,    O
oxilofrine    O
,    O
potassium    O
chloride    O
,    O
and    O
yohimbine    O
.    O

The    O
D2    O
receptor    O
is    O
involved    O
in    O
the    O
regulation    O
of    O
prolactin    O
secretion    O
,    O
and    O
agonists    O
of    O
the    O
receptor    O
such    O
as    O
bromocriptine    O
and    O
cabergoline    O
decrease    O
prolactin    O
levels    O
while    O
antagonists    O
of    O
the    O
receptor    O
such    O
as    O
domperidone    O
,    O
metoclopramide    B-Medicine106043075
,    O
haloperidol    O
,    O
risperidone    O
,    O
and    O
sulpiride    O
increase    O
prolactin    O
levels    O
.    O

Trismus    O
can    O
be    O
seen    O
as    O
an    O
extra    O
-    O
pyramidal    O
side    O
-    O
effect    O
of    O
metoclopromide    B-Medicine106043075
,    O
phenothiazines    O
and    O
other    O
medications    O
.    O

Underground    O
Stage    O
:    O
Axe    O
Murder    O
Boyz    O
,    O
Cash    O
Amigo    O
,    O
Osirus    O
,    O
Beast    O
Mode    O
,    O
Hazmat    O
E.T.G.    O
,    O
Kegan    O
Ault    O
,    O
Ill    O
Wit    O
It    O
,    O
Wildcard    O
,    O
Insane    O
Eric    O
,    O
7    O
Second    O
Suicide    O
,    O
Freddy    O
Grimes    O
,    O
Haystak    O
,    O
Alphamatic    O
,    O
Dirty    O
Advile    O
,    O
Insane    O
Poetry    O
,    O
Prescription    O
,    O
Will    O
D.O.B.    O
,    O
Draztik    O
,    O
Super    O
Smash    O
Bros    O
,    O
Bukshot    O
,    O
Jelly    O
Roll    O
,    O
Krizz    O
Kaliko    O
,    O
Wazteland    O
Warriorz    O
,    O
T.O.S.    O
,    O
Krak    O
Rok    O
,    O
S.P.E.    O
,    O
Murdaface    O
,    O
Sixx    O
Digit    O
,    O
Razorz    O
Edge    O
,    O
Mastamind    O
,    O
ClaAs    O
,    O
Buckwheat    O
Gators    O
,    O
The    O
Underground    O
Avengers    O
,    O
Seth    O
Brock    O
,    O
Fury    O
,    O
Tre    O
LB    O
,    O
Demented    O
,    O
Pixy    O
,    O
Sketch    O
,    O
Southside    O
Hatchet    O
Swingin'Mob    O
,    O
Origix    O
&    O
DC    O
,    O
Project    O
Born    O
,    O
Psycho    O
Realm    O
,    O
Karnage    O
,    O
Randum    B-Medicine106043075
,    O
Hostile    O
6    O
,    O
Cykoskifrantik    O
,    O
Izzy    O
Dunafore    O
,    O
Pimp    O
On    O
Wheels    O
,    O
17    O
Ent    O
.    O
,    O
Sedated    O
,    O
The    O
Deadly    O
Medly    O
.    O

Metoclopramide    B-Medicine106043075
(    O
a    O
prokinetic    O
)    O
is    O
not    O
recommended    O
either    O
alone    O
or    O
in    O
combination    O
with    O
other    O
treatments    O
due    O
to    O
concerns    O
around    O
adverse    O
effects    O
.    O

The    O
treatments    O
for    O
significant    O
retching    O
include    O
correction    O
of    O
fluid    O
and    O
electrolyte    O
balance    O
,    O
nutritional    O
support    O
and    O
medications    O
like    O
phenothiazines    O
(    O
such    O
as    O
Compazine    O
and    O
Phenergan    O
)    O
,    O
5-HT3    O
antagonist    O
(    O
such    O
as    O
Zofran    O
)    O
,    O
dopamine    O
receptor    O
antagonists    O
(    O
such    O
as    O
Reglan    B-Medicine106043075
)    O
,    O
antihistamines    O
(    O
Antivert    O
,    O
and    O
Dramamine    O
,    O
Benadryl    O
)    O
and    O
anticholinergics    O
(    O
Scopolamine    O
)    O
.    O

It    O
was    O
known    O
for    O
six    O
major    O
products    O
,    O
including    O
[    O
[    O
Lovaza|Omacor    O
/    O
Lovaza](Omega-3    O
)    O
]    O
,    O
Axid(H2    O
blocker    O
)    O
,    O
Dynacirc    O
CR    O
(    O
calcium    O
channel    O
blocker    O
)    O
,    O
Antara    O
(    O
fenofibrate    O
)    O
,    O
InnoPran    B-Medicine106043075
XL    I-Medicine106043075
(    O
beta    O
blocker    O
)    O
,    O
Lescol    O
XL    O
(    O
Fluvastatin    O
)    O
)    O
and    O
Rythmol    O
SR    O
(    O
Class    O
IC    O
anti    O
-    O
arrhythmic    O
)    O
.    O

James    O
W.    O
Black    O
synthesises    O
propranolol    B-Medicine106043075
,    O
the    O
first    O
beta    O
blocker    O
(    O
used    O
for    O
regulation    O
of    O
angina    O
pectoris    O
)    O
,    O
which    O
becomes    O
the    O
world    O
's    O
best    O
-    O
selling    O
drug    O
.    O

Propranolol    B-Medicine106043075

Propranolol    B-Medicine106043075

Propranolol    B-Medicine106043075

Medications    O
that    O
have    O
been    O
reported    O
to    O
provide    O
some    O
relief    O
are    O
isoniazid    O
,    O
carbamazepine    B-Medicine106043075
,    O
propranolol    B-Medicine106043075

The    O
effects    O
of    O
beta    O
-    O
agonists    O
such    O
as    O
dobutamine    O
can    O
be    O
reversed    O
by    O
administering    O
beta    O
-    O
blockers    O
such    O
as    O
propranolol    B-Medicine106043075
.    O

Propranolol    B-Medicine106043075

Agents    O
which    O
have    O
been    O
used    O
clinically    O
to    O
stimulate    O
and    O
assess    O
GH    O
secretion    O
are    O
arginine    O
,    O
levodopa    O
,    O
clonidine    O
,    O
epinephrine    O
and    O
propranolol    B-Medicine106043075
,    O
glucagon    O
and    O
insulin    O
.    O

Taking    O
ketamine    O
along    O
with    O
propranolol    B-Medicine106043075
and    O
doxazosin    O
may    O
cause    O
hypotension    O
,    O
and    O
combining    O
ketamine    O
with    O
lisdexamfetamine    O
and    O
amphetamine    O
/    O
dextroamphetamine    O
will    O
lead    O
to    O
cardiovascular    O
problems    O
.    O

The    O
sport    O
also    O
faced    O
its    O
first    O
major    O
doping    O
case    O
,    O
when    O
Kim    O
Jong    O
-    O
su    O
of    O
North    O
Korea    O
was    O
stripped    O
of    O
his    O
medals    O
in    O
50    O
metre    O
pistol    O
and    O
10    O
metre    O
air    O
pistol    O
after    O
testing    O
positive    O
for    O
propranolol    B-Medicine106043075
,    O
a    O
beta    O
blocker    O
that    O
some    O
performers    O
use    O
to    O
reduce    O
stage    O
fright    O
and    O
some    O
surgeons    O
use    O
to    O
reduce    O
hand    O
tremors    O
during    O
operations    O
.    O

Kim    O
Jong    O
-    O
su    O
of    O
North    O
Korea    O
originally    O
won    O
the    O
silver    O
medal    O
in    O
the    O
50    O
metre    O
pistol    O
and    O
bronze    O
in    O
the    O
10    O
metre    O
air    O
pistol    O
,    O
but    O
was    O
disqualified    O
after    O
he    O
tested    O
positive    O
for    O
propranolol    B-Medicine106043075
.    O

In    O
this    O
manner    O
they    O
indeed    O
generated    O
a    O
positive    O
feedback    O
:    O
the    O
beta    O
blocker    O
propranolol    B-Medicine106043075
reduced    O
the    O
release    O
.    O

Cimetidine    O
,    O
omeprazole    O
,    O
oxcarbazepine    O
,    O
ticlopidine    O
,    O
topiramate    O
,    O
ketoconazole    O
,    O
itraconazole    O
,    O
disulfiram    O
,    O
fluvoxamine    O
,    O
isoniazid    O
,    O
erythromycin    O
,    O
probenecid    O
,    O
propranolol    B-Medicine106043075
,    O
imipramine    O
,    O
ciprofloxacin    O
,    O
fluoxetine    O
,    O
and    O
valproic    O
acid    O
prolong    O
the    O
action    O
of    O
diazepam    O
by    O
inhibiting    O
its    O
elimination    O
.    O

Propranolol    B-Medicine106043075
was    O
not    O
found    O
to    O
increase    O
the    O
discontinuation    O
success    O
rate    O
.    O

In    O
the    O
1940s    O
and    O
50s    O
,    O
the    O
company    O
established    O
its    O
pharmaceutical    O
business    O
and    O
developed    O
a    O
number    O
of    O
key    O
products    O
,    O
including    O
Paludrine    O
(    O
1940s    O
,    O
an    O
anti    O
-    O
malarial    O
drug    O
)    O
,    O
halothane    O
(    O
1951    O
,    O
an    O
anaesthetic    O
agent    O
)    O
,    O
Inderal    B-Medicine106043075
(    O
1965    O
,    O
a    O
beta    O
-    O
blocker    O
)    O
,    O
tamoxifen    O
(    O
1978    O
,    O
a    O
frequently    O
used    O
drug    O
for    O
breast    O
cancer    O
)    O
,    O

:*    O
Propral    O
(    O
"    O
propranolol    B-Medicine106043075
"    O
)    O

Many    O
of    O
these    O
uses    O
have    O
been    O
exemplified    O
in    O
the    O
syntheses    O
of    O
various    O
pharmaceuticals    O
including    O
the    O
β-blocker    O
("S")-propranolol    B-Medicine106043075
,    O
the    O
HIV    O
protease    O
inhibitor    O
Amprenavir    O
(    O
Vertex    O
478    O
)    O
,    O
and    O
construction    O
of    O
the    O
carbohydrate    O
subunit    O
of    O
the    O
anthracycline    O
class    O
of    O
antibiotics    O
,    O
L    O
-    O
Acosamine    O
.    O

The    O
effects    O
of    O
excess    O
thyroid    O
hormone    O
typically    O
respond    O
to    O
the    O
administration    O
of    O
a    O
non    O
-    O
selective    O
beta    O
blocker    O
,    O
such    O
as    O
propranolol    B-Medicine106043075
(    O
as    O
most    O
of    O
the    O
symptoms    O
are    O
driven    O
by    O
increased    O
levels    O
of    O
adrenaline    O
and    O
its    O
effect    O
on    O
the    O
β-adrenergic    O
receptors    O
)    O
.    O

Zileuton    O
is    O
a    O
weak    O
inhibitor    O
of    O
CYP1A2    O
and    O
thus    O
has    O
three    O
clinically    O
important    O
drug    O
interactions    O
,    O
which    O
include    O
increasing    O
theophylline    O
,    O
and    O
propranolol    B-Medicine106043075
levels    O
.    O

The    O
drug    O
has    O
been    O
shown    O
to    O
increase    O
the    O
serum    O
concentration    O
or    O
effects    O
of    O
theophylline    O
,    O
propranolol    B-Medicine106043075
,    O
and    O
warfarin    O
,    O
although    O
significant    O
increase    O
in    O
prothrombin    O
time    O
is    O
not    O
obvious    O
.    O

Two    O
of    O
the    O
most    O
valuable    O
drug    O
treatments    O
for    O
essential    O
tremor    O
are    O
propranolol    B-Medicine106043075
,    O
a    O
beta    O
blocker    O
,    O
and    O
primidone    O
,    O
an    O
anticonvulsant    O
.    O

Class    O
II    O
—    O
Beta    O
blockers    O
(    O
carvedilol    O
,    O
propranolol    B-Medicine106043075
,    O
esmolol    O
,    O
timolol    O
,    O
metoprolol    O
,    O
atenolol    O
,    O
bisoprolol    O
)    O

Treatment(s    O
)    O
with    O
mixed    O
success    O
:    O
omalizumab    O
(    O
anti    O
-    O
IgE    O
therapy    O
)    O
,    O
danazol    O
(    O
synthetic    O
androgen    O
)    O
,    O
propranolol    B-Medicine106043075
(    O
beta    O
blocker    O
)    O
,    O
zileuton    O
(    O
antileukotriene    O
)    O
.    O

North    O
Korean    O
shooter    O
Kim    O
Jong    O
Su    O
was    O
tested    O
positive    O
for    O
the    O
banned    O
substance    O
propranolol    B-Medicine106043075
,    O
and    O
thereby    O
stripped    O
off    O
his    O
two    O
medals    O
from    O
the    O
pistol    O
events    O
.    O

ACI    O
procedures    O
aim    O
to    O
provide    O
complete    O
hyaline    O
repair    O
tissues    O
for    O
articular    B-Medicine106043075
cartilage    I-Medicine106043075
repair    I-Medicine106043075
.    O

This    O
cell    O
based    O
articular    B-Medicine106043075
cartilage    I-Medicine106043075
repair    I-Medicine106043075
procedure    O
takes    O
place    O
in    O
three    O
stages    O
.    O

In    O
those    O
who    O
are    O
seriously    O
allergic    O
to    O
penicillin    O
,    O
erythromycin    O
or    O
clindamycin    B-Medicine106043075
may    O
be    O
used    O
.    O

Depending    O
on    O
the    O
severity    O
,    O
treatment    O
involves    O
either    O
oral    O
or    O
intravenous    O
antibiotics    O
,    O
using    O
penicillins    O
,    O
clindamycin    B-Medicine106043075
,    O
or    O
erythromycin    O
.    O

Treatment    O
with    O
ampicillin    O
/    O
sulbactam    O
,    O
amoxicillin    O
/    O
clavulanic    O
acid    O
,    O
or    O
clindamycin    B-Medicine106043075
is    O
appropriate    O
if    O
deep    O
oropharyngeal    O
abscesses    O
are    O
present    O
,    O
in    O
conjunction    O
with    O
aspiration    O
or    O
drainage    O
.    O

It    O
is    O
resistant    O
to    O
lysozyme    O
(    O
minimum    O
inhibitory    O
concentration    O
(    O
MIC    O
)    O
>    O
1,000    O
kg    O
/    O
ml    O
)    O
and    O
susceptible    O
to    O
novobiocin    O
(    O
MIC    O
,    O
0.06    O
to    O
0.1    O
pg    O
/    O
ml    O
)    O
,    O
penicillin    O
(    O
MIC    O
,    O
0.01    O
to    O
0.06    O
pg    O
/    O
ml    O
)    O
,    O
oxacillin    O
(    O
MIC,0.2    O
pg    O
/    O
ml    O
)    O
,    O
ampicillin    O
(    O
MIC    O
,    O
0.06    O
to    O
1.0    O
pg    O
/    O
ml    O
)    O
,    O
cephaloridine(MIC    O
,    O
0.1    O
to    O
0.2    O
pg    O
/    O
ml    O
)    O
,    O
erythromycin    O
(    O
MIC    O
,    O
0.06    O
pg    O
/    O
ml    O
)    O
,    O
lincomycin    O
(    O
MIC    O
,    O
0.2    O
to    O
0.5    O
pg    O
/    O
ml    O
)    O
,    O
clindamycin    B-Medicine106043075
(    O
MIC    O
,    O
0.1    O
pg    O
/    O
ml    O
)    O
,    O
chloramphenicol    O
(    O
MIC    O
,    O
2.0    O
pg    O
/    O
ml    O
)    O
,    O
tetracycline    O
(    O
MIC    O
,    O
0.1    O
to    O
0.2    O
pg    O
/    O
ml    O
)    O
,    O
gentamicin    O
(    O
MIC    O
,    O
0.2    O
pg    O
/    O
ml    O
)    O
and    O
vancomycin    O
(    O
MIC    O
,    O
1.0    O
pg    O
/    O
ml    O
)    O
.    O

Resistance    O
to    O
clindamycin    B-Medicine106043075
is    O
common    O
and    O
has    O
been    O
seen    O
in    O
over    O
10%    O
of    O
isolates    O
in    O
the    O
US    O
.    O

Lincosamides    O
are    O
a    O
class    O
of    O
antibiotics    O
which    O
include    O
lincomycin    O
,    O
clindamycin    B-Medicine106043075
,    O
and    O
pirlimycin    O
.    O

The    O
use    O
of    O
lincomycin    O
as    O
an    O
antibiotic    O
has    O
been    O
largely    O
superseded    O
by    O
clindamycin    B-Medicine106043075
which    O
exhibits    O
improved    O
antibacterial    O
activity    O
.    O

Clindamycin    B-Medicine106043075
.    O
(    O
Note    O
extra    O
chlorine    O
compared    O
to    O
lincomycin    O
,    O
but    O
disregard    O
inversion    O
of    O
image    O
.    O
)    O
.    O

Indeed    O
,    O
fosmidomycin    O
has    O
been    O
tested    O
in    O
combination    O
treatment    O
with    O
clindamycin    B-Medicine106043075
for    O
treatment    O
of    O
malaria    O
with    O
favorable    O
results    O
.    O

Cephalosporins    O
,    O
and    O
particularly    O
quinolones    O
and    O
clindamycin    B-Medicine106043075
,    O
are    O
more    O
likely    O
to    O
produce    O
colonisation    O
with    O
"    O
Clostridium    O
difficile    O
"    O
.    O

Six    O
strains    O
of    O
"    O
Clostridium    O
"    O
,    O
found    O
in    O
the    O
bowels    O
of    O
William    O
Braine    O
and    O
John    O
Hartnell    O
(    O
members    O
of    O
the    O
Franklin    O
Expedition    O
)    O
showed    O
resistance    O
to    O
cefoxitin    O
and    O
clindamycin    B-Medicine106043075
.    O

"    O
C.    O
difficile    O
"    O
colitis    O
is    O
most    O
strongly    O
associated    O
with    O
fluoroquinolones    O
,    O
cephalosporins    O
,    O
carbapenems    O
,    O
and    O
clindamycin    B-Medicine106043075
.    O

Pseudomembranous    O
colitis    O
can    O
follow    O
,    O
creating    O
generalized    O
inflammation    O
of    O
the    O
colon    O
and    O
the    O
development    O
of    O
"    O
pseudomembrane    O
"    O
,    O
a    O
viscous    O
collection    O
of    O
inflammatory    O
cells    O
,    O
fibrin    O
,    O
and    O
necrotic    O
cells.[4    O
]    O
Clindamycin    B-Medicine106043075
-    O
resistant    O
"    O
C.    O
difficile    O
"    O
was    O
reported    O
as    O
the    O
causative    O
agent    O
of    O
large    O
outbreaks    O
of    O
diarrheal    O
disease    O
in    O
hospitals    O
in    O
New    O
York    O
,    O
Arizona    O
,    O
Florida    O
and    O
Massachusetts    O
between    O
1989    O
and    O
1992    O
.    O

If    O
infection    O
is    O
present    O
,    O
appropriate    O
cultures    O
should    O
be    O
obtained    O
,    O
followed    O
by    O
empirical    O
antibiotic    O
therapy    O
initially    O
,    O
for    O
example    O
amoxicillin    O
/    O
clavulanate    O
or    O
clindamycin    B-Medicine106043075
which    O
cover    O
oral    O
flora    O
.    O


